data_2jph_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jph _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.394 -3.232 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.496 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 17.8 mmt180 -124.11 115.9 27.41 Favored Pre-proline 0 C--N 1.263 -3.158 0 C-N-CA 119.893 -0.723 . . . . 1.0 111.632 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.38 109.18 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.785 1.657 . . . . 1.0 108.334 168.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 tp -113.04 158.49 20.25 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.212 -0.903 . . . . 1.0 111.001 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 m -103.56 127.61 50.94 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.497 HD21 ' SD ' ' A' ' 44' ' ' MET . 14.8 tp -126.94 139.83 52.77 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.41 HD21 HG21 ' A' ' 106' ' ' THR . 6.4 t30 -96.72 114.0 25.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.39 114.73 13.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.799 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 12.8 tp -142.14 167.34 22.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.7 pt? -135.94 144.96 45.73 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -110.94 30.76 6.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.909 0.385 . . . . 1.0 111.034 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.94 -47.79 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.816 0 CA-C-N 115.897 -0.592 . . . . 1.0 112.383 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.4 -81.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.2 -1.476 . . . . 1.0 113.819 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.63 -27.67 83.64 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 123.599 2.866 . . . . 1.0 112.821 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.91 37.63 2.02 Favored Glycine 0 N--CA 1.408 -3.173 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.68 48.97 0.09 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.465 0.913 . . . . 1.0 113.465 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.42 -3.78 3.65 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.795 -0.922 . . . . 1.0 110.795 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.02 29.75 2.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.06 0.457 . . . . 1.0 111.597 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.96 -76.03 0.27 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -140.76 -63.83 0.47 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.585 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.19 88.84 0.59 Allowed Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.273 -0.965 . . . . 1.0 111.089 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.6 126.54 28.93 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.86 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.937 1.758 . . . . 1.0 111.86 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.413 HG12 HE21 ' A' ' 47' ' ' GLN . 13.9 t -112.34 155.35 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -107.67 144.28 34.97 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 m -142.21 -175.22 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 113.598 -1.637 . . . . 1.0 109.504 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.3 158.88 25.19 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 110.27 -0.27 . . . . 1.0 110.27 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.496 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.1 t70 -66.43 -31.33 72.02 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.6 t -103.27 33.36 3.34 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.872 -1.513 . . . . 1.0 109.491 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 95' ' ' THR . 12.8 p-10 -71.58 -165.76 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.216 -0.902 . . . . 1.0 109.013 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 50.1 p -139.07 157.92 45.11 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 169.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.5 mm -59.22 -41.41 83.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.91 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.559 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 13.5 m -61.8 -43.47 98.79 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.861 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.87 -41.21 75.11 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.207 0.527 . . . . 1.0 111.196 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.88 -39.16 93.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.491 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.51 -40.53 75.16 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.429 176.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mt-10 -68.59 -47.9 65.57 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 123.754 0.659 . . . . 1.0 110.778 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -63.58 -44.03 95.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.232 0.333 . . . . 1.0 111.621 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.2 mmm -65.03 -40.85 95.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.47 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.0 pp -74.45 -33.18 62.85 Favored 'General case' 0 C--O 1.188 -2.147 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.098 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -51.6 -31.15 23.82 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 124.951 1.301 . . . . 1.0 112.932 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.413 HE21 HG12 ' A' ' 29' ' ' VAL . 11.5 mm-40 -69.48 -36.61 76.71 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.722 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 122.044 0.926 . . . . 1.0 110.058 -178.289 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.776 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.17 138.17 39.47 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.53 117.14 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.446 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -91.34 111.82 23.47 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 105.836 -1.913 . . . . 1.0 105.836 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.633 ' CE2' HG13 ' A' ' 101' ' ' VAL . 3.9 t-105 -88.72 126.04 35.14 Favored 'General case' 0 N--CA 1.39 -3.446 0 CA-C-N 115.197 -0.911 . . . . 1.0 108.927 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.86 88.98 2.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 107.057 -1.46 . . . . 1.0 107.057 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.428 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 62.7 p -71.33 -27.24 63.24 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.483 -1.235 . . . . 1.0 110.082 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 -57.31 4.84 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.484 -1.235 . . . . 1.0 110.7 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.9 m -64.29 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 120.924 0.393 . . . . 1.0 111.895 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.48 -1.4 30.68 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.557 0.694 . . . . 1.0 110.354 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.71 -119.7 6.31 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 27.8 p-80 -140.42 138.26 34.61 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.604 0.24 . . . . 1.0 110.742 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.0 tp -134.73 144.48 47.76 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.62 118.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.854 -1.165 . . . . 1.0 107.854 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.409 HD21 ' CE3' ' A' ' 67' ' ' TRP . 10.2 mp -107.71 157.6 17.97 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.4 0.619 . . . . 1.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.3 m -157.32 160.32 38.4 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.17 -48.06 77.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.422 -1.874 0 CA-C-O 121.676 0.75 . . . . 1.0 109.14 170.445 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--O 1.245 0.861 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -85.06 142.24 29.69 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.942 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.1 p -107.32 168.39 9.26 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 124.604 1.162 . . . . 1.0 108.53 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD12 HG21 ' A' ' 101' ' ' VAL . 4.0 pp -72.97 -24.33 60.77 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.064 173.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.48 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.36 -26.54 68.51 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.335 176.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -66.05 -41.7 90.48 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.6 t80 -80.05 -16.26 55.45 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.653 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 58.78 52.12 6.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.778 0.831 . . . . 1.0 110.983 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' A' ' 67' ' ' TRP . 0.7 OUTLIER -78.36 146.83 71.14 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 113.346 0.869 . . . . 1.0 113.346 -178.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.16 158.41 26.63 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 123.481 2.788 . . . . 1.0 112.155 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.55 122.65 18.05 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.437 0.637 . . . . 1.0 109.542 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.68 21.85 10.88 Favored Glycine 0 C--N 1.288 -2.131 0 C-N-CA 120.309 -0.948 . . . . 1.0 110.852 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 11' ' ' LEU . . . -74.62 162.52 28.68 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.41 HG21 HD21 ' A' ' 12' ' ' ASN . 87.4 m -114.52 133.52 55.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 120.783 0.325 . . . . 1.0 110.389 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.74 136.27 53.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.19 144.55 51.01 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.13 147.72 46.49 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.825 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.24 136.17 27.65 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.242 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.5 82.42 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.258 1.972 . . . . 1.0 111.97 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 4.3 p . . . . . 0 CA--C 1.498 -1.026 0 C-N-CA 125.148 1.379 . . . . 1.0 111.477 -179.664 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.398 -3.058 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.453 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 23.0 mmt180 -119.3 116.4 33.76 Favored Pre-proline 0 C--N 1.268 -2.961 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.208 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.32 104.82 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 107.35 -1.827 . . . . 1.0 107.35 167.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.428 ' HG ' ' H ' ' A' ' 10' ' ' THR . 3.2 tp -110.82 159.72 17.4 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.648 -0.705 . . . . 1.0 111.036 -171.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.428 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 24.3 m -108.51 125.95 52.37 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.468 HD21 ' SD ' ' A' ' 44' ' ' MET . 20.0 tp -127.45 141.89 51.55 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -96.45 114.73 26.43 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 122.405 -0.184 . . . . 1.0 110.857 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.14 119.96 20.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.171 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 13.4 tp -148.46 163.27 37.67 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.55 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -129.58 144.12 51.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.017 -0.427 . . . . 1.0 110.079 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.85 37.17 3.19 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.913 0.387 . . . . 1.0 111.023 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.85 -44.31 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.314 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.813 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.07 -88.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.4 -1.381 . . . . 1.0 113.888 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.31 -37.82 88.57 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.906 2.404 . . . . 1.0 113.139 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.48 33.74 5.38 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -70.58 48.51 0.11 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.468 0.914 . . . . 1.0 113.468 -176.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.85 -12.38 1.47 Allowed Glycine 0 C--N 1.299 -1.49 0 C-N-CA 120.68 -0.771 . . . . 1.0 112.402 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.88 25.47 5.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.089 0.471 . . . . 1.0 111.432 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.8 -77.38 0.19 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -129.56 -58.77 1.1 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.467 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 75.61 0.61 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 1.0 111.591 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.35 125.18 38.59 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 110.277 -0.268 . . . . 1.0 110.277 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.43 102.07 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.859 1.706 . . . . 1.0 111.045 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG12 HE21 ' A' ' 47' ' ' GLN . 15.0 t -111.02 155.06 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.52 143.71 38.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 113.746 1.017 . . . . 1.0 113.746 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.6 -175.19 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 113.74 -1.573 . . . . 1.0 109.165 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.45 157.61 27.9 Favored 'General case' 0 C--O 1.191 -1.988 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.453 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 31.7 t70 -66.06 -31.54 72.47 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.87 0.731 . . . . 1.0 109.124 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.2 t -104.99 37.2 2.22 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 114.034 -1.439 . . . . 1.0 109.552 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 95' ' ' THR . 14.2 p-10 -71.83 -161.44 0.07 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.633 -1.167 . . . . 1.0 109.121 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.0 p -143.87 155.16 44.0 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 103.71 -2.7 . . . . 1.0 103.71 167.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mm -57.69 -39.54 70.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 118.614 0.643 . . . . 1.0 110.357 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 m -61.26 -43.95 98.04 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.512 175.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -68.17 -41.47 81.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.519 0.328 . . . . 1.0 110.74 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.95 -38.66 91.71 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.101 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -40.9 73.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 38' ' ' SER . 45.9 mt-10 -68.71 -51.78 37.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.67 0.606 . . . . 1.0 111.379 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.06 -42.43 99.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.807 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.5 mmm -65.21 -41.06 94.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.25 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.88 -30.47 58.85 Favored 'General case' 0 C--O 1.201 -1.493 0 C-N-CA 120.71 -0.396 . . . . 1.0 112.028 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -53.99 -31.4 50.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.536 1.134 . . . . 1.0 112.438 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.405 HE21 HG12 ' A' ' 29' ' ' VAL . 13.6 mm-40 -68.83 -40.06 79.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 1.0 110.551 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.875 0.845 . . . . 1.0 110.855 -174.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.752 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -103.48 139.42 38.86 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 120.026 -0.669 . . . . 1.0 111.054 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.61 115.07 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 N-CA-C 106.596 -1.631 . . . . 1.0 106.596 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.392 -3.345 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.622 ' CE2' HG13 ' A' ' 101' ' ' VAL . 4.6 t-105 -85.93 124.15 32.07 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.505 -1.225 . . . . 1.0 109.327 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -111.5 89.19 2.98 Favored 'General case' 0 N--CA 1.396 -3.127 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.401 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 57.9 p -68.12 -31.59 71.29 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.087 -1.415 . . . . 1.0 109.924 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.55 -50.61 4.36 Favored Glycine 0 C--N 1.303 -1.294 0 CA-C-N 114.359 -1.291 . . . . 1.0 111.343 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.21 -39.95 85.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 122.872 0.469 . . . . 1.0 111.897 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.25 -29.51 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.164 0.507 . . . . 1.0 110.073 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.15 -120.95 3.21 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 10.7 p-80 -136.32 136.75 39.98 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.611 0.243 . . . . 1.0 110.701 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.6 tp -134.94 145.27 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -83.43 117.48 29.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.47 HD21 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -110.53 151.2 27.87 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-O 121.306 0.574 . . . . 1.0 110.816 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 m -159.14 161.4 36.28 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 105.203 -2.147 . . . . 1.0 105.203 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -64.7 -37.98 89.45 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.418 -2.07 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.055 172.886 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.243 0.754 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -85.09 138.59 32.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.058 -0.657 . . . . 1.0 111.099 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -113.84 169.04 9.28 Favored 'General case' 0 C--O 1.26 1.637 0 C-N-CA 125.061 1.344 . . . . 1.0 108.489 178.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.33 -24.34 61.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 118.751 -1.18 . . . . 1.0 109.145 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.466 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -63.98 -26.11 68.43 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.705 176.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -65.25 -40.02 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.6 t80 -85.44 -15.79 41.83 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.409 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 57.44 51.19 10.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.112 0.965 . . . . 1.0 110.422 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.622 HG13 ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -74.62 148.28 85.27 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.31 157.08 29.48 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.247 2.631 . . . . 1.0 112.743 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.36 120.15 12.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.06 16.87 11.63 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 110.861 -0.895 . . . . 1.0 110.861 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.97 162.67 28.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.044 0.45 . . . . 1.0 110.579 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m -115.98 133.29 56.18 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.38 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.24 137.94 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 C-N-CA 120.593 -0.443 . . . . 1.0 109.982 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -128.46 139.88 52.11 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.55 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.39 147.52 40.44 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.934 -178.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.45 151.46 66.84 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.187 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.16 72.66 5.81 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.522 2.148 . . . . 1.0 111.152 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 125.027 1.331 . . . . 1.0 110.399 -175.627 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 . . . . . 0 N--CA 1.403 -2.808 0 N-CA-C 105.914 -1.884 . . . . 1.0 105.914 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -109.25 106.92 59.36 Favored Pre-proline 0 C--N 1.273 -2.74 0 C-N-CA 118.877 -1.129 . . . . 1.0 109.74 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -64.59 111.6 1.72 Allowed 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.87 1.713 . . . . 1.0 108.22 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 10' ' ' THR . 5.8 tp -115.48 159.43 21.19 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-O 121.248 0.547 . . . . 1.0 111.368 -172.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.408 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 31.2 m -111.5 132.59 54.39 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -125.05 154.58 41.1 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 123.486 0.714 . . . . 1.0 111.065 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -98.93 106.69 18.98 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.384 -0.825 . . . . 1.0 108.868 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.48 112.92 8.0 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.878 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 29.4 tp -144.6 149.98 36.68 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -122.9 143.84 49.62 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 122.27 -0.269 . . . . 1.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -113.57 29.92 7.63 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.164 0.506 . . . . 1.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.7 t -64.19 -47.03 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 CA-C-N 115.608 -0.724 . . . . 1.0 112.222 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.47 -78.69 0.1 OUTLIER Glycine 0 C--O 1.213 -1.17 0 C-N-CA 119.079 -1.534 . . . . 1.0 113.8 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.0 -28.75 87.76 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 123.012 2.475 . . . . 1.0 113.106 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.56 33.14 3.35 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.19 79.09 0.35 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.29 37.76 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.9 30.75 0.71 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.406 0.622 . . . . 1.0 110.925 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 -75.37 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.295 -0.562 . . . . 1.0 112.068 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.88 -67.43 0.44 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.964 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 77.23 0.91 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.131 -1.588 . . . . 1.0 109.131 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.49 130.42 23.09 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.428 -0.386 . . . . 1.0 110.541 -173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -72.5 104.51 1.72 Allowed 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.128 1.885 . . . . 1.0 111.431 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.584 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 25.5 t -114.04 155.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.247 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -104.6 146.14 29.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.728 0.299 . . . . 1.0 111.542 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.74 -174.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 124.79 1.236 . . . . 1.0 109.496 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 mt -122.37 167.71 12.96 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 123.049 0.54 . . . . 1.0 110.065 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.77 -31.28 72.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.73 -0.841 . . . . 1.0 108.73 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 t -112.94 19.82 16.95 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 114.344 1.238 . . . . 1.0 114.344 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.336 24.6 p-10 -85.22 140.2 31.07 Favored 'General case' 0 N--CA 1.415 -2.211 0 C-N-CA 115.853 -2.339 . . . . 1.0 109.411 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -75.17 166.42 23.68 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.637 -1.165 . . . . 1.0 110.852 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -59.31 -41.1 83.12 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.599 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -59.83 -48.1 83.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -73.11 -44.91 59.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.365 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.13 -36.53 82.08 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.593 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 34.1 ttpt -61.74 -34.9 76.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.679 ' HG3' ' O ' ' A' ' 38' ' ' SER . 61.3 mt-10 -65.85 -46.95 76.58 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.043 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -61.8 -41.77 98.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 123.301 0.376 . . . . 1.0 111.408 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.584 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.6 mmt -61.42 -48.56 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.129 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -77.48 -24.52 50.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 16.4 t70 -58.04 -34.08 69.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.771 0.828 . . . . 1.0 111.828 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -66.36 -31.92 72.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.521 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.496 -1.133 0 CA-C-O 121.011 0.434 . . . . 1.0 111.182 -171.769 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 120.964 0.411 . . . . 1.0 112.001 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 12.6 p-10 -107.26 166.3 10.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.642 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.56 126.43 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.56 0.695 . . . . 1.0 110.276 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -94.66 113.51 25.31 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 105.636 -1.987 . . . . 1.0 105.636 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.629 ' CE2' HG12 ' A' ' 101' ' ' VAL . 5.0 t-105 -89.85 137.18 32.56 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.742 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.31 88.99 3.04 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 107.327 -1.36 . . . . 1.0 107.327 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.402 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 68.4 p -72.5 -31.84 65.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.251 1.024 . . . . 1.0 108.731 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.93 -55.1 4.62 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 113.708 -1.587 . . . . 1.0 110.525 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -64.27 -42.3 95.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.476 -0.362 . . . . 1.0 111.54 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.41 -21.44 15.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.217 0.532 . . . . 1.0 109.677 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.21 -130.78 9.95 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.142 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.541 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 63.2 m-70 -111.42 122.49 47.98 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 123.322 0.649 . . . . 1.0 109.505 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.52 136.89 43.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.1 mm -84.21 123.1 38.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.866 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.595 HD21 ' CE3' ' A' ' 67' ' ' TRP . 9.9 mp -108.58 150.48 27.43 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.483 0.658 . . . . 1.0 111.427 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 m -152.09 150.94 30.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.34 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.2 p30 -74.21 -41.15 61.84 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.839 -0.619 . . . . 1.0 109.9 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.316 -0.877 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.799 178.384 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 70.3 mt . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -90.45 159.87 16.33 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.711 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.2 p -119.21 -178.95 3.7 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.056 0.942 . . . . 1.0 108.503 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -78.71 -19.71 51.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.464 -1.294 . . . . 1.0 109.532 175.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -66.71 -25.79 66.7 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 120.979 0.418 . . . . 1.0 110.518 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -62.16 -35.33 78.47 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.5 t80 -97.25 -16.43 20.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.334 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.52 59.59 4.05 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.703 0.801 . . . . 1.0 110.282 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.629 HG12 ' CE2' ' A' ' 67' ' ' TRP . 1.8 m -73.98 146.8 85.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 119.909 -0.716 . . . . 1.0 112.139 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.56 162.46 35.65 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.793 2.328 . . . . 1.0 112.074 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.06 128.82 37.49 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.642 -0.708 . . . . 1.0 109.37 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.33 25.27 40.34 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.55 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.94 160.19 31.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.984 0.421 . . . . 1.0 110.205 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.5 m -110.78 134.16 52.73 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.121 0.486 . . . . 1.0 110.232 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.54 HG22 ' SD ' ' A' ' 44' ' ' MET . 16.1 m -113.25 155.76 14.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 176.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -135.01 130.05 35.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 172.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.59 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 mp -102.33 130.71 49.13 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.04 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.57 149.48 71.06 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.5 82.21 2.54 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 121.939 1.76 . . . . 1.0 112.4 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.43 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 8.7 p . . . . . 0 CA--C 1.505 -0.769 0 C-N-CA 125.148 1.379 . . . . 1.0 111.18 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.471 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 33.1 p90 . . . . . 0 N--CA 1.383 -3.824 0 N-CA-C 107.664 -1.236 . . . . 1.0 107.664 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.5 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 18.7 mmt180 -130.33 113.84 17.05 Favored Pre-proline 0 C--N 1.255 -3.535 0 N-CA-C 105.944 -1.872 . . . . 1.0 105.944 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -49.4 115.92 2.01 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.781 1.654 . . . . 1.0 108.875 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 tp -124.13 155.87 37.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.209 0.528 . . . . 1.0 112.151 -170.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.6 m -105.79 128.8 53.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.427 HD21 ' SD ' ' A' ' 44' ' ' MET . 17.7 tp -127.43 142.58 51.38 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 5.5 t30 -96.03 116.06 28.38 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.33 -0.248 . . . . 1.0 110.33 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.69 121.75 22.96 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.034 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 27.6 tp -151.5 168.12 25.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.569 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 2.1 pt? -136.11 145.06 45.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.123 0.569 . . . . 1.0 109.655 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.18 30.62 7.16 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.027 0.442 . . . . 1.0 110.52 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.91 -46.78 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.273 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.75 -81.92 0.08 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 118.511 -1.804 . . . . 1.0 114.66 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.15 -32.28 94.34 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.4 2.733 . . . . 1.0 112.679 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -130.48 42.36 1.42 Allowed Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.33 39.8 0.05 OUTLIER 'General case' 0 C--O 1.244 0.768 0 N-CA-C 114.057 1.132 . . . . 1.0 114.057 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.16 -20.53 0.65 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.06 57.4 1.7 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.189 0.995 . . . . 1.0 110.333 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 20' ' ' GLY . . . -106.07 -83.08 0.53 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.363 -1.29 . . . . 1.0 111.324 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.516 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 7.0 pt20 -111.62 -59.51 1.97 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.609 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.516 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 60.05 71.65 0.74 Allowed Glycine 0 CA--C 1.519 0.33 0 O-C-N 123.694 0.621 . . . . 1.0 112.05 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -108.57 127.59 27.16 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 122.656 -0.32 . . . . 1.0 110.218 -174.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.37 110.73 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.687 1.591 . . . . 1.0 111.584 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.439 HG12 HE21 ' A' ' 47' ' ' GLN . 21.9 t -116.13 155.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.901 -1.045 . . . . 1.0 108.267 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -106.22 145.3 31.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 114.085 1.143 . . . . 1.0 114.085 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.41 -175.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 113.515 -1.675 . . . . 1.0 108.766 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -117.3 158.23 24.73 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 24.4 t70 -66.95 -29.71 69.64 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.801 0.688 . . . . 1.0 109.475 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.72 34.07 2.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.426 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -74.61 -166.39 0.44 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.756 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.6 p -137.29 153.9 50.21 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 168.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.87 -40.0 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.857 0.361 . . . . 1.0 110.103 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.3 p -62.47 -43.88 97.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.122 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.6 -41.43 68.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.84 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.708 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.09 -37.7 88.39 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.606 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -55.66 -41.52 73.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 176.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' SER . 34.3 mt-10 -71.17 -45.63 63.08 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.284 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -63.37 -43.65 97.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.941 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.5 mmm -64.89 -41.48 95.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.701 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.62 -28.37 58.81 Favored 'General case' 0 C--O 1.198 -1.616 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.846 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.54 -32.53 65.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.874 0.87 . . . . 1.0 112.245 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.439 HE21 HG12 ' A' ' 29' ' ' VAL . 16.7 mm-40 -69.81 -39.79 76.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.231 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.512 -0.516 0 CA-C-O 122.05 0.928 . . . . 1.0 110.496 -174.611 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 107.155 -1.424 . . . . 1.0 107.155 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.569 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 8.2 p-10 -107.3 150.16 27.0 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 -169.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.86 121.93 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.563 -1.198 . . . . 1.0 108.939 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.18 112.16 23.94 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.628 ' CE2' HG13 ' A' ' 101' ' ' VAL . 4.2 t-105 -87.26 124.19 33.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.49 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.63 88.19 2.69 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 106.853 -1.536 . . . . 1.0 106.853 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.7 p -72.16 -31.61 66.11 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.143 -1.389 . . . . 1.0 109.895 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.03 3.76 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 114.166 -1.379 . . . . 1.0 110.421 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -64.04 -38.04 81.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 122.911 0.485 . . . . 1.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.32 3.18 18.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.741 0.781 . . . . 1.0 110.143 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.51 -121.54 6.52 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.951 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.6 p-80 -134.78 134.87 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.85 0.357 . . . . 1.0 111.185 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.9 tp -134.02 146.12 50.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mm -83.13 118.69 31.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.467 HD21 ' CE3' ' A' ' 67' ' ' TRP . 11.0 mp -111.68 159.99 17.69 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.959 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -160.38 162.08 33.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -62.52 -42.1 99.29 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.416 -2.126 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.454 172.255 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.19 144.93 28.64 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.159 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -111.46 165.61 11.84 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 125.078 1.351 . . . . 1.0 108.049 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -72.1 -22.86 61.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.63 -1.228 . . . . 1.0 109.322 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.64 -25.93 68.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.053 175.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -63.23 -35.82 81.59 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -90.14 -15.86 30.72 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.331 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 57.66 54.28 6.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.773 0.829 . . . . 1.0 110.826 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.628 HG13 ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -81.44 146.87 58.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.111 0.782 . . . . 1.0 113.111 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.41 157.99 29.2 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.187 2.591 . . . . 1.0 112.093 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.87 123.39 20.03 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.509 0.671 . . . . 1.0 109.956 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.82 19.7 11.65 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.68 162.64 28.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 84.9 m -115.35 131.06 57.05 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.659 0.266 . . . . 1.0 110.965 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -115.2 136.49 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 N-CA-C 109.948 -0.39 . . . . 1.0 109.948 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.6 141.22 49.61 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.606 ' HG ' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -123.89 150.65 44.41 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.878 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.45 156.39 78.89 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.21 75.13 5.14 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.054 1.836 . . . . 1.0 111.781 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.569 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 20.1 p . . . . . 0 C--O 1.242 0.702 0 C-N-CA 125.019 1.327 . . . . 1.0 110.854 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 m-85 . . . . . 0 N--CA 1.418 -2.061 0 N-CA-C 103.769 -2.678 . . . . 1.0 103.769 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -98.86 111.12 59.83 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 119.526 1.057 . . . . 1.0 111.243 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 38.8 Cg_exo -61.16 140.23 88.07 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.561 2.174 . . . . 1.0 111.03 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 10' ' ' THR . 5.7 tp -138.92 161.69 36.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.425 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 59.8 m -107.98 126.83 53.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.226 -1.028 . . . . 1.0 108.226 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.6 tp -127.29 138.0 52.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 7.1 t30 -90.48 120.43 31.57 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.283 -0.261 . . . . 1.0 111.447 -174.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.08 119.6 25.65 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 36.3 tp -146.67 151.9 37.99 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.544 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -114.23 139.51 49.33 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 176.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -114.41 50.1 0.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.037 0.446 . . . . 1.0 110.769 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.92 -46.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.546 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.21 -94.55 0.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.299 -0.953 . . . . 1.0 112.705 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.1 -28.23 73.9 Favored 'Trans proline' 0 N--CA 1.484 0.964 0 C-N-CA 123.251 2.634 . . . . 1.0 112.47 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -116.41 32.21 5.66 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 110.879 -0.888 . . . . 1.0 110.879 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -74.14 29.03 0.08 Allowed 'General case' 0 C--O 1.246 0.921 0 C-N-CA 123.446 0.698 . . . . 1.0 112.545 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 20' ' ' GLY . . . -176.99 -40.13 0.06 OUTLIER Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 120.572 -0.823 . . . . 1.0 112.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.37 4.3 46.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.6 -73.85 0.12 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 113.73 1.011 . . . . 1.0 113.73 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -129.91 -61.8 0.98 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.443 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.49 62.92 5.71 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.7 t -95.24 126.02 47.9 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 115.58 -0.31 . . . . 1.0 110.334 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -73.74 90.86 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.216 1.944 . . . . 1.0 110.291 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 t -93.91 154.73 3.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -108.7 152.13 25.23 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.18 177.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.944 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 31.4 mt -108.62 158.16 17.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.623 0.725 . . . . 1.0 110.999 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 -32.75 73.86 Favored 'General case' 0 C--O 1.282 2.805 0 C-N-CA 124.9 1.28 . . . . 1.0 111.422 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.561 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.9 t -98.78 13.18 33.25 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.006 -0.997 . . . . 1.0 111.715 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.504 ' OD2' ' HB2' ' A' ' 32' ' ' LEU . 1.7 m-20 -73.24 133.82 44.1 Favored 'General case' 0 CA--C 1.47 -2.097 0 C-N-CA 119.655 -0.818 . . . . 1.0 109.21 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.579 ' OG1' ' HB2' ' A' ' 39' ' ' GLN . 70.8 p -81.28 171.14 15.2 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 107.554 -1.276 . . . . 1.0 107.554 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.2 -43.47 93.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 118.134 0.424 . . . . 1.0 110.197 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -67.36 -40.22 85.77 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-O 121.774 0.797 . . . . 1.0 110.707 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.716 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 4.4 tt0 -66.9 -32.52 73.84 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.485 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.279 -0.418 . . . . 1.0 111.045 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.527 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.5 mmmp? -56.52 -33.95 66.55 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.225 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.716 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 17.9 pt-20 -54.43 -50.44 67.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 124.288 0.992 . . . . 1.0 110.273 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.523 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 30.6 mmmt -77.27 -36.59 54.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -47.83 84.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.186 0.517 . . . . 1.0 110.462 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 41' ' ' LYS 0.266 0.8 OUTLIER -78.75 -23.37 45.4 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 112.419 0.526 . . . . 1.0 112.419 176.602 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.5 t70 -50.65 -29.69 11.68 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 125.025 1.33 . . . . 1.0 112.684 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -75.31 -17.97 60.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.359 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.994 0.902 . . . . 1.0 109.853 179.178 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.6 pp . . . . . 0 N--CA 1.418 -2.043 0 N-CA-C 106.569 -1.641 . . . . 1.0 106.569 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -103.83 156.96 17.41 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 120.406 -0.518 . . . . 1.0 110.145 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.76 117.92 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.54 0.686 . . . . 1.0 109.557 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -92.7 118.03 30.62 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-O 121.459 0.647 . . . . 1.0 109.937 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.601 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 16.9 t90 -82.7 119.65 24.58 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.603 -1.18 . . . . 1.0 108.491 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.01 89.22 3.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 120.952 0.406 . . . . 1.0 109.911 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.4 p -91.43 -23.1 20.13 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.893 0.854 . . . . 1.0 109.029 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.67 -52.27 4.43 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.009 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.02 -38.12 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.045 0.45 . . . . 1.0 111.492 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.79 -3.09 36.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.726 0.774 . . . . 1.0 109.589 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.39 -144.11 17.03 Favored Glycine 0 N--CA 1.416 -2.683 0 CA-C-N 114.883 -1.053 . . . . 1.0 110.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.601 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.4 p80 -133.48 115.27 14.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.028 0.531 . . . . 1.0 109.705 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.42 144.47 49.48 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.676 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.4 mm -83.46 117.69 29.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.79 146.44 28.98 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.3 -0.864 . . . . 1.0 109.817 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.7 t -161.88 166.15 26.68 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.257 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.65 -27.41 65.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 178.104 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 106.887 -1.523 . . . . 1.0 106.887 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 36' ' ' THR . 65.8 m-80 -87.27 137.77 32.05 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.786 -0.765 . . . . 1.0 111.994 -173.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 1.5 p -105.42 168.98 8.73 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 124.054 0.941 . . . . 1.0 109.312 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.01 -33.18 71.69 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.351 -0.94 . . . . 1.0 108.81 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.561 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 pt20 -65.65 -26.09 67.65 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.576 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -65.57 -35.62 81.36 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.992 0.425 . . . . 1.0 110.422 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.94 -8.09 21.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.199 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 52.47 68.45 0.82 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.454 1.101 . . . . 1.0 112.312 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.503 HG12 ' CE2' ' A' ' 67' ' ' TRP . 2.7 m -78.33 136.7 60.46 Favored Pre-proline 0 N--CA 1.433 -1.285 0 C-N-CA 119.941 -0.704 . . . . 1.0 109.124 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.3 160.54 48.56 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.256 1.97 . . . . 1.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -64.68 124.38 21.76 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.58 25.49 38.79 Favored Glycine 0 C--N 1.303 -1.281 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.798 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.23 36.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.818 0.342 . . . . 1.0 111.039 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 51.1 m -107.97 123.89 49.32 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.055 0.455 . . . . 1.0 110.962 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.15 138.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.446 -0.946 . . . . 1.0 108.446 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -125.72 138.45 53.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.999 0.428 . . . . 1.0 112.019 -176.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.544 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.2 mp -96.39 126.88 41.9 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 30.1 m -116.21 140.13 26.05 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 116.761 -0.199 . . . . 1.0 110.692 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.81 85.06 1.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.633 2.222 . . . . 1.0 112.027 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.216 -0.678 0 C-N-CA 125.874 1.67 . . . . 1.0 113.141 177.115 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.512 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 21.9 m-85 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 103.655 -2.72 . . . . 1.0 103.655 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -100.38 109.56 57.32 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 118.729 -1.188 . . . . 1.0 111.578 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 33.7 Cg_exo -62.53 139.17 74.65 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 122.357 2.038 . . . . 1.0 110.607 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -135.12 158.81 43.41 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 116.278 -0.419 . . . . 1.0 109.916 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -100.24 128.5 46.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 105' ' ' ALA . 22.2 tp -127.82 138.74 52.82 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 5.2 t30 -91.51 116.89 29.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 122.165 -0.334 . . . . 1.0 110.573 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.84 118.59 21.76 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.606 0.566 . . . . 1.0 109.564 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 33.8 tp -151.41 158.22 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.7 144.34 48.83 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.9 38.79 3.22 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.654 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.22 -44.39 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 115.707 -0.679 . . . . 1.0 111.671 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.33 -78.56 0.2 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.902 -1.142 . . . . 1.0 112.611 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.5 -25.94 76.03 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.236 2.624 . . . . 1.0 111.95 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -133.49 41.67 1.45 Allowed Glycine 0 N--CA 1.416 -2.665 0 N-CA-C 110.068 -1.213 . . . . 1.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 24.22 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.115 0.783 . . . . 1.0 113.115 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 20' ' ' GLY . . . 169.83 -38.54 0.2 Allowed Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.808 -177.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.02 21.68 2.25 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.179 0.514 . . . . 1.0 111.769 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.99 -78.25 0.35 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.74 0.644 . . . . 1.0 112.74 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -125.32 -64.67 1.06 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.863 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.08 63.38 4.79 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 t -93.64 126.08 51.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.94 100.33 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.552 1.501 . . . . 1.0 109.738 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 t -108.32 156.85 8.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -119.3 152.77 36.16 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -158.26 169.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -89.95 157.72 17.72 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.35 -32.44 71.27 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-N 114.624 -1.171 . . . . 1.0 110.056 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 23.2 t -101.7 12.54 36.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.775 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 N--CA 1.409 -2.506 0 C-N-CA 118.601 -1.239 . . . . 1.0 108.032 171.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.2 p -80.51 174.33 11.71 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.15 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.3 -42.25 86.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 p -63.79 -45.38 89.96 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 121.986 0.898 . . . . 1.0 111.047 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.47 -16.06 58.96 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.253 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.43 -31.49 22.83 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.042 168.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.9 mmmp? -56.41 -39.86 73.73 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 3.1 pt-20 -58.41 -44.92 89.21 Favored 'General case' 0 N--CA 1.416 -2.159 0 O-C-N 124.333 1.021 . . . . 1.0 111.966 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 28.3 mmmt -72.86 -39.57 66.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.868 1.062 . . . . 1.0 113.868 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.5 mmt -61.27 -46.92 88.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.322 0.582 . . . . 1.0 110.639 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.4 pp -77.45 -24.07 50.35 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.128 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.6 t70 -50.65 -35.57 31.32 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.132 1.373 . . . . 1.0 112.334 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -71.73 -32.93 68.26 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.194 0.521 . . . . 1.0 111.62 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.309 -1.178 0 CA-C-O 122.01 0.909 . . . . 1.0 109.674 -176.549 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.442 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.3 pp . . . . . 0 N--CA 1.412 -2.343 0 N-CA-C 104.599 -2.371 . . . . 1.0 104.599 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -122.85 152.82 40.36 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.541 -0.864 . . . . 1.0 109.332 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 p -119.27 120.94 65.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.728 -0.789 . . . . 1.0 109.522 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.13 116.3 28.7 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.556 0.693 . . . . 1.0 109.667 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.645 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 15.8 t90 -82.29 119.27 23.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.668 -1.151 . . . . 1.0 108.042 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -123.11 89.06 3.04 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.5 p -88.77 -20.13 25.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.033 0.92 . . . . 1.0 108.932 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.87 -54.5 4.05 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 114.629 -1.168 . . . . 1.0 111.85 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 m -64.49 -42.11 94.28 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 111.587 0.217 . . . . 1.0 111.587 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.5 -9.41 47.43 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.722 0.773 . . . . 1.0 109.028 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.11 13.75 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 114.507 -1.224 . . . . 1.0 111.321 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.645 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.0 p80 -138.4 118.29 13.29 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 123.722 0.809 . . . . 1.0 110.06 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.25 145.17 48.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.405 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.6 mm -88.46 111.49 22.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.098 0.475 . . . . 1.0 109.789 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.6 151.69 20.89 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.289 -0.869 . . . . 1.0 110.347 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.1 t -162.68 165.46 25.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 6.4 p-10 -71.67 -31.0 66.32 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 N--CA 1.422 -1.828 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 177.27 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 98.2 mt . . . . . 0 C--O 1.245 0.834 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -89.93 139.09 30.94 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 119.894 -0.722 . . . . 1.0 111.013 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.551 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.5 p -111.39 171.13 7.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 124.007 0.923 . . . . 1.0 108.599 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 pp -68.52 -30.59 69.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.551 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.35 -26.32 68.42 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.987 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -65.76 -39.96 91.56 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 120.981 0.42 . . . . 1.0 110.376 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.38 -7.21 24.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.521 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 51.75 61.55 3.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.923 1.289 . . . . 1.0 113.143 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.462 HG12 ' CE2' ' A' ' 67' ' ' TRP . 3.0 m -70.98 136.87 84.91 Favored Pre-proline 0 N--CA 1.438 -1.032 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.13 160.21 50.8 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.545 2.163 . . . . 1.0 111.326 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -66.45 117.96 9.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.712 0.768 . . . . 1.0 109.891 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.41 22.94 20.59 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.712 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.4 ' O ' HD11 ' A' ' 11' ' ' LEU . . . -68.31 152.47 45.39 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.466 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 27.7 m -108.56 123.46 48.95 Favored 'General case' 0 C--N 1.279 -2.47 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.253 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.66 155.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -138.45 137.02 36.8 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.307 -0.557 . . . . 1.0 112.003 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.555 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.6 mp -94.97 132.67 39.57 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.224 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 31.9 m -129.26 137.64 31.41 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.056 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.23 86.3 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.227 1.951 . . . . 1.0 111.065 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 21.0 p . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 1.0 112.467 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.52 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.4 m-85 . . . . . 0 N--CA 1.393 -3.283 0 N-CA-C 102.928 -2.99 . . . . 1.0 102.928 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 23.2 mmt180 -104.66 111.05 65.17 Favored Pre-proline 0 C--N 1.273 -2.757 0 C-N-CA 117.233 -1.787 . . . . 1.0 114.673 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 19.6 Cg_exo -65.69 121.78 9.25 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.383 2.056 . . . . 1.0 109.173 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 9.5 tp -114.9 159.79 20.28 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.374 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m -99.36 124.26 44.33 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.459 HD13 ' CZ2' ' A' ' 67' ' ' TRP . 2.8 mm? -125.69 144.08 50.76 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.24 0.616 . . . . 1.0 110.179 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -92.67 113.8 26.18 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.25 107.94 6.73 Favored 'General case' 0 C--O 1.253 1.273 0 C-N-CA 123.313 0.645 . . . . 1.0 110.166 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 25.7 tp -142.11 158.95 43.16 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -128.5 143.63 51.01 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.71 36.33 3.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.902 0.382 . . . . 1.0 111.184 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.59 -45.15 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 112.556 0.576 . . . . 1.0 112.556 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.42 -81.97 0.14 Allowed Glycine 0 C--N 1.31 -0.885 0 C-N-CA 119.656 -1.259 . . . . 1.0 112.469 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.59 -24.39 77.88 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.995 2.464 . . . . 1.0 112.584 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.57 27.16 5.81 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.4 68.0 2.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.767 0.794 . . . . 1.0 112.445 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 127.05 -15.68 6.48 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.27 27.65 6.19 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.98 -0.61 . . . . 1.0 112.273 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.82 -93.21 0.07 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.154 0.502 . . . . 1.0 110.583 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -114.56 -62.7 1.56 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.791 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.13 75.0 0.66 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.215 -1.154 . . . . 1.0 110.215 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.1 127.79 26.46 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 110.244 -0.28 . . . . 1.0 110.244 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.02 108.07 2.51 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.708 1.605 . . . . 1.0 110.675 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.498 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 60.6 t -114.98 139.16 42.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 96.6 mttt -100.54 139.0 36.84 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.856 -0.738 . . . . 1.0 110.339 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG11 HD23 ' A' ' 11' ' ' LEU . 11.2 p -144.16 159.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.87 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.4 156.16 24.31 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.855 0.836 . . . . 1.0 112.697 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.7 -31.65 72.6 Favored 'General case' 0 C--O 1.27 2.16 0 CA-C-N 113.674 -1.603 . . . . 1.0 108.81 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 18.5 t -85.18 -8.64 58.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 113.533 -1.667 . . . . 1.0 111.947 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.88 133.29 45.34 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.72 0.771 . . . . 1.0 109.714 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.0 p -81.93 177.62 8.75 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.446 -1.252 . . . . 1.0 109.875 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 37.8 mm -60.82 -46.64 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 119.259 -0.401 . . . . 1.0 110.298 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 40.1 m -60.98 -47.72 85.13 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.833 0.708 . . . . 1.0 111.341 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -64.87 -42.84 94.51 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.204 0.526 . . . . 1.0 110.608 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.697 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.41 -35.64 81.08 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.414 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -60.95 -40.06 91.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 38' ' ' SER . 40.6 mt-10 -65.3 -49.54 69.12 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.054 -0.976 . . . . 1.0 110.605 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.99 -40.92 95.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.465 0.542 . . . . 1.0 112.465 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.697 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.6 mmm -65.3 -43.53 90.8 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.71 -27.08 58.08 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -55.6 -28.16 53.52 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.801 1.24 . . . . 1.0 113.072 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HG3' HG22 ' A' ' 29' ' ' VAL . 71.4 mm-40 -69.11 -31.32 69.94 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.282 0.563 . . . . 1.0 110.489 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.432 -1.339 0 CA-C-N 115.914 -0.585 . . . . 1.0 112.347 -174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . 0.291 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.663 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -119.94 152.29 37.63 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.9 0.381 . . . . 1.0 111.204 -173.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -123.61 132.13 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.055 0 C-N-CA 120.026 -0.67 . . . . 1.0 109.365 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 40.9 mt-10 -89.6 112.49 23.72 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.608 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.2 t-105 -91.45 118.27 30.41 Favored 'General case' 1 N--CA 1.374 -4.273 0 C-N-CA 119.299 -0.96 . . . . 1.0 108.525 178.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -104.46 88.72 3.02 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 106.241 -1.763 . . . . 1.0 106.241 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -90.12 -16.38 29.71 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.561 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.05 -51.16 3.48 Favored Glycine 0 C--N 1.291 -1.962 0 CA-C-N 114.764 -1.107 . . . . 1.0 111.836 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.29 -38.88 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.023 0.529 . . . . 1.0 110.976 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.78 7.24 30.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.932 0.872 . . . . 1.0 108.82 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.33 -132.43 12.66 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 114.168 -1.378 . . . . 1.0 110.925 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 4.5 p80 -117.06 101.3 8.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.81 0.814 . . . . 1.0 109.296 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.68 143.9 34.12 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.049 -174.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.419 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 20.0 mm -88.43 109.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 75' ' ' LEU . 9.0 mp -99.9 144.22 29.21 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.47 -0.786 . . . . 1.0 112.62 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.3 m -153.99 146.55 24.11 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.293 -2.114 . . . . 1.0 105.293 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 0.5 OUTLIER -74.45 -40.67 61.78 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.557 -0.857 . . . . 1.0 110.702 175.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 112.259 0.466 . . . . 1.0 112.259 179.426 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 N--CA 1.433 -1.313 0 N-CA-C 106.948 -1.501 . . . . 1.0 106.948 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.425 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 38.5 m-80 -89.66 139.8 30.2 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.332 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.73 171.3 8.3 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 124.043 0.937 . . . . 1.0 109.406 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.96 -27.43 62.78 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 6.1 pt20 -63.74 -25.76 68.34 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 115.789 -0.642 . . . . 1.0 112.584 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -64.19 -45.8 86.74 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -93.04 -3.76 53.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.37 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 13.5 mmtm 43.44 67.92 0.58 Allowed 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 124.96 1.304 . . . . 1.0 113.046 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.608 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.8 m -74.81 148.24 84.78 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 114.703 -1.135 . . . . 1.0 111.566 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.8 164.24 33.99 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.338 2.692 . . . . 1.0 112.924 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.09 116.4 6.45 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.74 24.94 12.37 Favored Glycine 0 C--N 1.303 -1.269 0 C-N-CA 119.283 -1.437 . . . . 1.0 112.11 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.15 164.2 26.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.9 m -113.26 130.67 56.18 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.663 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.46 135.37 50.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -130.82 130.57 43.82 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.511 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 3.9 pp -113.45 144.74 42.31 Favored 'General case' 0 C--N 1.262 -3.199 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.258 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 m -133.64 130.73 20.94 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.156 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.49 84.09 0.79 Allowed 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.555 2.17 . . . . 1.0 111.485 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.663 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 4.8 p . . . . . 0 CA--C 1.505 -0.764 0 C-N-CA 125.544 1.538 . . . . 1.0 112.374 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.427 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 50.3 m-85 . . . . . 0 N--CA 1.384 -3.769 0 N-CA-C 100.733 -3.803 . . . . 1.0 100.733 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -107.43 111.24 63.1 Favored Pre-proline 0 C--N 1.268 -2.948 0 C-N-CA 116.902 -1.919 . . . . 1.0 112.53 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 16.1 Cg_exo -68.45 111.09 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.2 1.933 . . . . 1.0 107.742 173.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 10' ' ' THR . 3.7 tp -106.73 154.9 20.29 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.626 -0.716 . . . . 1.0 111.162 -172.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.421 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 17.9 m -88.09 119.14 28.18 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 106.679 -1.6 . . . . 1.0 106.679 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.561 HD21 ' CZ2' ' A' ' 67' ' ' TRP . 1.0 OUTLIER -127.92 140.26 52.11 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -102.18 120.16 39.99 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.732 -0.605 . . . . 1.0 111.052 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HB3' ' HE3' ' A' ' 44' ' ' MET . . . -80.53 108.38 14.12 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.306 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.4 tp -141.67 159.83 41.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -130.02 143.79 50.98 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.69 39.85 2.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.839 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.26 -45.44 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.91 -79.46 0.19 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.823 -1.18 . . . . 1.0 112.142 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.31 -31.51 89.11 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.788 2.325 . . . . 1.0 112.378 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.98 27.95 7.55 Favored Glycine 0 N--CA 1.432 -1.598 0 C-N-CA 121.0 -0.619 . . . . 1.0 111.67 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.49 76.03 5.0 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.47 0.652 . . . . 1.0 111.665 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.57 -15.16 7.61 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 110.446 -1.061 . . . . 1.0 110.446 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.65 29.93 6.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.722 -0.739 . . . . 1.0 111.606 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.2 -90.39 0.19 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.301 -0.56 . . . . 1.0 110.95 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -111.76 -56.07 2.43 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.654 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.01 65.74 3.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.395 -0.682 . . . . 1.0 111.395 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.8 t -110.41 124.23 33.78 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.44 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.26 104.3 1.88 Allowed 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.245 1.963 . . . . 1.0 110.822 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.526 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 42.9 t -109.29 155.63 10.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.19 137.4 40.51 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.881 0.848 . . . . 1.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.76 157.81 23.63 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 114.299 -1.319 . . . . 1.0 108.082 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.74 155.86 18.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.402 0.62 . . . . 1.0 112.245 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.6 -30.79 71.82 Favored 'General case' 0 C--O 1.267 1.991 0 CA-C-N 114.559 -1.2 . . . . 1.0 109.189 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 5.8 t -88.82 -0.16 57.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.877 -1.511 . . . . 1.0 111.565 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.33 135.41 40.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.694 . . . . 1.0 109.402 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -81.78 174.67 11.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.569 -1.196 . . . . 1.0 109.579 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.603 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 36.5 mm -60.54 -44.39 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.329 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -62.21 -47.29 85.12 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.135 0.897 . . . . 1.0 110.045 178.005 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -65.47 -41.28 93.53 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.785 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.69 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.329 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.22 -38.01 89.51 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 177.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 38' ' ' SER . 37.3 mt-10 -65.83 -45.22 83.09 Favored 'General case' 0 C--O 1.205 -1.245 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.83 -176.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.01 -41.71 98.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.69 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 72.4 mmm -65.63 -42.5 91.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.035 0.445 . . . . 1.0 110.625 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.27 -29.9 57.62 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.848 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.2 -28.61 58.9 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.924 1.69 . . . . 1.0 113.031 -172.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.39 -34.72 78.59 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.099 0.476 . . . . 1.0 110.877 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.6 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.778 -173.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 7.1 p-10 -112.32 151.71 29.39 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 120.652 0.263 . . . . 1.0 110.8 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 77' ' ' LEU . 12.5 p -121.28 130.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 C-N-CA 119.581 -0.847 . . . . 1.0 111.219 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 35.9 mt-10 -90.41 113.12 24.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.564 -2.013 . . . . 1.0 105.564 172.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.635 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -89.61 120.69 31.12 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -113.45 89.1 3.0 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.578 -1.268 . . . . 1.0 107.578 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.4 p -81.86 -19.76 40.33 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.863 -1.062 . . . . 1.0 109.676 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.46 -50.26 4.31 Favored Glycine 0 C--N 1.308 -1.023 0 CA-C-N 114.572 -1.195 . . . . 1.0 112.002 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.45 -37.84 81.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 1.0 111.432 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.59 -7.2 22.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.759 0.79 . . . . 1.0 109.395 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 -121.5 6.82 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.99 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.3 p80 -135.24 120.35 18.8 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.264 0.554 . . . . 1.0 111.055 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.12 149.41 44.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 21.7 mm -88.81 114.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 65' ' ' VAL . 10.6 mp -110.37 143.5 40.53 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.293 0.568 . . . . 1.0 111.63 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.4 m -161.09 155.84 23.64 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.988 -0.685 . . . . 1.0 111.418 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 N--CA 1.439 -1.015 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -176.06 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.9 mt . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -99.16 140.94 32.58 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.563 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 2.0 p -112.35 173.88 6.15 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.328 0.651 . . . . 1.0 109.736 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 101' ' ' VAL . 3.3 pp -75.67 -26.0 57.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.105 -1.038 . . . . 1.0 109.175 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.5 pt20 -66.2 -25.63 67.02 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -61.34 -41.57 97.26 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.439 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 84.5 m-85 -97.18 -8.41 30.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.935 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 100' ' ' LYS 0.275 8.6 mmtm 46.15 75.92 0.11 Allowed 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 125.278 1.431 . . . . 1.0 113.773 -176.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.635 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.1 m -84.7 150.19 55.76 Favored Pre-proline 0 C--N 1.285 -2.23 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.206 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.09 165.1 19.5 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 123.515 2.81 . . . . 1.0 112.567 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 119.66 11.01 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.399 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.72 19.01 12.63 Favored Glycine 0 C--N 1.29 -2.008 0 C-N-CA 120.7 -0.762 . . . . 1.0 111.405 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.98 155.67 37.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.198 0.523 . . . . 1.0 110.207 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.8 m -118.49 131.36 56.25 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.045 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.476 ' CG1' HD13 ' A' ' 11' ' ' LEU . 33.7 m -112.98 139.29 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.48 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.19 120.89 32.59 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.541 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.3 pp -106.35 141.97 36.8 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.771 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 18.4 m -133.29 137.09 28.44 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.547 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.89 84.09 1.51 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.166 1.911 . . . . 1.0 111.614 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.427 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 27.4 p . . . . . 0 CA--C 1.506 -0.725 0 C-N-CA 125.066 1.346 . . . . 1.0 110.338 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CG ' ' HB2' ' A' ' 34' ' ' CYS . 65.8 m-85 . . . . . 0 N--CA 1.395 -3.219 0 N-CA-C 104.921 -2.252 . . . . 1.0 104.921 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.473 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 17.7 mmt180 -116.06 111.3 42.88 Favored Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 117.492 -1.683 . . . . 1.0 113.778 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 23.2 Cg_exo -64.47 104.65 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.967 1.778 . . . . 1.0 108.866 171.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -107.59 161.41 14.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.983 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -105.4 130.24 53.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.37 148.12 47.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 123.514 0.726 . . . . 1.0 110.704 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.06 111.21 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.364 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.16 115.13 15.58 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.68 0.613 . . . . 1.0 109.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 32.2 tp -147.73 155.43 41.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.475 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.64 144.44 48.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.73 30.29 7.45 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.625 0.726 . . . . 1.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.69 -47.1 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 115.023 -0.989 . . . . 1.0 112.691 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.93 -86.36 0.07 OUTLIER Glycine 0 C--O 1.22 -0.768 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.906 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.7 -30.53 85.33 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.151 2.567 . . . . 1.0 113.019 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.06 29.92 6.3 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.445 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.35 83.24 1.42 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.581 0.705 . . . . 1.0 112.063 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 3.99 56.16 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -135.73 26.45 3.36 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.382 -0.909 . . . . 1.0 110.605 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.03 -95.44 0.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.72 -60.26 1.47 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 112.753 0.649 . . . . 1.0 112.753 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.26 0.6 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.525 -1.321 . . . . 1.0 109.969 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.0 130.13 23.49 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 122.821 -0.223 . . . . 1.0 110.711 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.25 109.39 1.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.132 1.888 . . . . 1.0 111.28 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 44' ' ' MET . 58.1 t -120.08 138.58 50.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 123.538 0.735 . . . . 1.0 109.144 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -102.95 155.89 18.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.129 0.49 . . . . 1.0 112.195 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 5.2 p -158.06 -175.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.463 ' H ' HG22 ' A' ' 31' ' ' VAL . 13.2 tp -109.19 158.52 17.73 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 119.267 0.94 . . . . 1.0 108.632 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 27.1 t70 -62.26 -29.99 70.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 123.429 0.692 . . . . 1.0 109.495 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.404 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 12.2 t -99.25 31.02 3.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.903 -1.499 . . . . 1.0 110.392 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.623 ' O ' HG22 ' A' ' 95' ' ' THR . 11.7 p-10 -68.49 -165.56 0.06 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.549 0.69 . . . . 1.0 109.149 171.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 p -141.6 161.59 37.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.857 -2.645 . . . . 1.0 103.857 167.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.672 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 44.5 mm -58.57 -46.09 90.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.741 -0.783 . . . . 1.0 110.557 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 36.7 t -63.52 -46.74 84.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 124.016 0.822 . . . . 1.0 110.37 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -64.82 -41.46 95.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.041 0.448 . . . . 1.0 111.426 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.623 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -64.32 -39.59 94.22 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.57 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.3 -35.33 79.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.625 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.0 mt-10 -64.44 -45.96 85.21 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.771 0.669 . . . . 1.0 110.062 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.808 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.623 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 13.3 mtp -63.59 -42.42 98.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.6 pp -74.72 -26.88 60.11 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.243 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.45 -32.91 73.85 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.414 0.626 . . . . 1.0 111.596 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HG3' HG13 ' A' ' 29' ' ' VAL . 14.5 mm-40 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.676 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 CA--C 1.503 -0.846 0 CA-C-O 121.833 0.825 . . . . 1.0 112.256 -169.056 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.688 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 112.167 0.432 . . . . 1.0 112.167 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 7.6 p-10 -117.18 157.38 26.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.28 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -122.61 127.17 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.254 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -91.91 112.93 25.06 Favored 'General case' 0 N--CA 1.399 -2.997 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.56 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -93.18 122.18 35.3 Favored 'General case' 1 N--CA 1.377 -4.089 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.991 -177.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 88.0 mtm180 -112.56 89.81 3.17 Favored 'General case' 0 N--CA 1.389 -3.508 0 CA-C-O 122.601 1.191 . . . . 1.0 108.243 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.0 p -84.66 -16.89 40.31 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.64 -1.618 . . . . 1.0 109.232 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.29 -54.66 4.31 Favored Glycine 0 C--N 1.293 -1.846 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.239 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.3 -42.25 94.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.039 0.447 . . . . 1.0 111.126 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.04 -10.21 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.468 0.652 . . . . 1.0 109.318 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.77 -143.01 16.23 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.83 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.464 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 3.5 p80 -116.55 112.21 21.01 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.574 0.702 . . . . 1.0 109.623 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.05 144.96 48.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.825 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -85.2 115.65 27.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.721 -1.215 . . . . 1.0 107.721 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.464 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.8 mp -103.66 140.56 37.41 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.886 0.851 . . . . 1.0 111.338 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 m -152.39 148.15 27.13 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.96 -41.19 71.39 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.899 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--N 1.311 -1.085 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 176.078 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--O 1.239 0.503 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -81.34 136.57 35.75 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.51 -0.876 . . . . 1.0 110.765 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.2 p -106.75 171.71 7.22 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 124.791 1.236 . . . . 1.0 109.334 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.57 -28.53 63.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.93 -25.64 67.97 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.921 176.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -61.62 -41.72 97.87 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.03 -4.36 30.11 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.518 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 65.2 mmtt 43.49 68.16 0.55 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.738 1.215 . . . . 1.0 112.227 -177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.56 HG11 ' NE1' ' A' ' 67' ' ' TRP . 2.9 m -75.57 149.01 83.44 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 114.915 -1.038 . . . . 1.0 111.636 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.74 162.98 38.36 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 122.828 2.352 . . . . 1.0 112.697 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.76 116.86 6.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.502 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.83 35.09 8.53 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 119.981 -1.105 . . . . 1.0 111.509 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.03 162.89 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -108.9 123.83 49.69 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.524 -0.47 . . . . 1.0 111.156 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.492 HG22 ' SD ' ' A' ' 44' ' ' MET . 5.9 m -104.79 144.83 14.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -139.85 132.86 29.47 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.475 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 1.6 pt? -118.13 143.49 46.44 Favored 'General case' 0 C--N 1.269 -2.934 0 C-N-CA 120.326 -0.55 . . . . 1.0 110.379 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.688 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 14.6 m -124.26 164.87 27.36 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.81 56.32 4.61 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.497 2.132 . . . . 1.0 111.472 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.559 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 5.2 t . . . . . 0 CA--C 1.516 -0.34 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.488 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 N--CA 1.415 -2.189 0 N-CA-C 105.149 -2.167 . . . . 1.0 105.149 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 33.9 mmt180 -109.6 110.96 59.54 Favored Pre-proline 0 C--N 1.278 -2.542 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.765 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.16 100.1 0.21 Allowed 'Trans proline' 0 C--O 1.245 0.843 0 N-CA-C 107.859 -1.631 . . . . 1.0 107.859 167.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.45 130.2 55.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 -171.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 m -89.36 129.45 35.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.409 HD13 ' CZ2' ' A' ' 67' ' ' TRP . 1.7 mm? -120.95 147.51 45.36 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 123.343 0.657 . . . . 1.0 110.366 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -90.92 108.5 19.89 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.38 109.19 7.67 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.026 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 30.8 tp -137.52 166.59 23.53 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.567 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -131.38 143.93 50.84 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.96 38.75 3.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.449 HG23 ' HD3' ' A' ' 111' ' ' PRO . 47.8 t -66.63 -44.48 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.52 -88.2 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 119.123 -1.513 . . . . 1.0 113.713 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.88 -29.35 82.37 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 123.253 2.635 . . . . 1.0 113.546 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.45 24.99 10.05 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 84.6 0.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.354 0.597 . . . . 1.0 111.826 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.33 -5.72 21.41 Favored Glycine 0 CA--C 1.487 -1.687 0 CA-C-N 115.163 -0.926 . . . . 1.0 111.271 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.63 19.13 3.9 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.264 -0.468 . . . . 1.0 112.082 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.99 -92.37 0.09 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.424 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 10.7 pt20 -110.04 -59.18 1.96 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.461 0.541 . . . . 1.0 112.461 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.424 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.7 69.7 1.25 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.89 127.01 30.25 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.99 -0.105 . . . . 1.0 110.743 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.48 107.43 2.29 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 121.862 1.708 . . . . 1.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 44' ' ' MET . 83.7 t -119.95 140.09 45.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.17 -0.923 . . . . 1.0 109.586 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -104.73 146.31 29.13 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.081 -0.648 . . . . 1.0 111.808 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.94 171.21 11.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 124.241 1.017 . . . . 1.0 109.08 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -88.37 159.15 18.17 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.118 0.485 . . . . 1.0 111.267 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 37.5 t70 -61.93 -30.75 71.11 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 115.049 -0.978 . . . . 1.0 108.505 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.5 t -96.12 6.08 49.63 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 114.25 -1.341 . . . . 1.0 113.365 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.19 134.91 48.56 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.433 ' CG2' HD12 ' A' ' 93' ' ' LEU . 49.3 p -79.75 166.88 21.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.12 -44.59 91.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.89 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.65 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.6 p -61.84 -47.32 85.57 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 48.9 mt-30 -72.01 -38.23 69.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.975 0.732 . . . . 1.0 112.975 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.4 -39.96 85.59 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -33.66 75.33 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.65 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.2 mt-10 -65.36 -48.64 72.25 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.086 0.866 . . . . 1.0 110.208 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 41.4 mmtm -60.83 -44.35 97.05 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.621 ' SD ' HG23 ' A' ' 107' ' ' VAL . 9.3 mtp -64.94 -41.97 95.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.751 -1.113 . . . . 1.0 112.288 -178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -76.02 -32.91 59.61 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.765 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.44 -29.78 70.16 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.508 0.723 . . . . 1.0 112.049 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 11.3 mm-40 -67.54 -39.18 85.02 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.607 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.441 -0.884 0 CA-C-N 115.639 -0.709 . . . . 1.0 112.468 -169.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 120.571 0.224 . . . . 1.0 110.682 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 9.7 m-20 -108.89 151.63 26.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.925 -1.139 . . . . 1.0 107.925 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.16 128.52 75.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 119.807 -0.757 . . . . 1.0 109.482 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.74 112.47 23.77 Favored 'General case' 0 CA--C 1.457 -2.615 0 N-CA-C 105.612 -1.995 . . . . 1.0 105.612 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.604 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -91.25 117.27 29.5 Favored 'General case' 1 N--CA 1.367 -4.625 0 C-N-CA 119.273 -0.971 . . . . 1.0 108.501 177.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -102.8 88.25 3.15 Favored 'General case' 0 N--CA 1.394 -3.245 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.1 p -83.65 -14.4 51.96 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.824 -1.535 . . . . 1.0 110.34 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.53 -57.73 3.77 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.765 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.2 -43.73 98.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.28 0.632 . . . . 1.0 111.766 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.37 -8.54 21.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.299 0.571 . . . . 1.0 110.347 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.41 -149.38 19.43 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.9 p80 -105.91 108.87 20.6 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.498 0.666 . . . . 1.0 111.299 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.03 146.42 36.74 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.368 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.87 99.27 8.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -89.34 156.37 18.76 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.564 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.3 t -160.84 164.41 31.37 Favored 'General case' 0 CA--C 1.465 -2.303 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -63.58 -37.21 86.45 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.714 0.634 . . . . 1.0 110.079 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.445 -0.707 0 O-C-N 123.107 0.254 . . . . 1.0 110.846 -178.392 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.433 HD12 ' CG2' ' A' ' 36' ' ' THR . 3.0 tm? . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 106.449 -1.685 . . . . 1.0 106.449 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.6 m-80 -96.74 139.59 32.57 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.929 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -129.39 176.45 7.95 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 125.855 1.662 . . . . 1.0 106.821 175.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 pp -73.32 -25.31 60.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.237 -1.385 . . . . 1.0 108.944 174.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.514 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 5.1 pt20 -66.36 -24.73 66.55 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.31 -40.71 91.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -103.45 2.58 33.93 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.514 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 30.9 mmmt 40.76 64.09 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.401 1.08 . . . . 1.0 112.097 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.604 HG11 ' NE1' ' A' ' 67' ' ' TRP . 2.1 m -68.74 150.95 97.49 Favored Pre-proline 0 C--N 1.294 -1.833 0 CA-C-N 115.539 -0.755 . . . . 1.0 111.786 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.12 155.83 37.92 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.154 1.903 . . . . 1.0 111.462 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.95 124.5 22.7 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.654 0.74 . . . . 1.0 110.208 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.99 22.23 23.58 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.092 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -71.08 164.42 25.62 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.911 0.386 . . . . 1.0 109.993 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.3 m -111.56 130.55 55.7 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.282 -0.567 . . . . 1.0 110.767 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.621 HG23 ' SD ' ' A' ' 44' ' ' MET . 27.5 m -114.13 139.49 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.49 138.94 49.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.567 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.1 pp -108.89 139.55 43.57 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.548 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 36.0 m -130.42 130.92 23.08 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.569 -0.741 . . . . 1.0 109.511 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD3' HG23 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -68.67 78.72 0.68 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.791 2.327 . . . . 1.0 112.458 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.471 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 43.6 t . . . . . 0 C--O 1.246 0.887 0 C-N-CA 124.781 1.232 . . . . 1.0 111.132 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 89.3 m-85 . . . . . 0 N--CA 1.397 -3.108 0 N-CA-C 105.905 -1.887 . . . . 1.0 105.905 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.4 mmt-85 -104.31 114.57 64.12 Favored Pre-proline 0 C--N 1.271 -2.809 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.409 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.02 111.69 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.39 2.06 . . . . 1.0 108.938 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.36 127.97 54.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -171.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -88.49 122.31 31.83 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 105' ' ' ALA . 16.5 tp -126.97 138.99 53.36 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -97.64 119.54 36.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.847 -0.533 . . . . 1.0 110.835 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.01 121.11 23.79 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.504 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -149.19 169.53 20.51 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.448 0.299 . . . . 1.0 110.437 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -127.26 144.58 51.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.419 0.288 . . . . 1.0 110.692 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.12 39.79 3.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.126 0.489 . . . . 1.0 110.555 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.47 -46.33 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 C-N-CA 123.302 0.641 . . . . 1.0 110.728 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.99 -94.39 0.12 Allowed Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.387 -0.911 . . . . 1.0 112.204 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.46 -32.85 88.91 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.42 2.746 . . . . 1.0 113.543 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.45 25.58 15.12 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.887 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.88 79.8 0.12 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.387 0.613 . . . . 1.0 111.78 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -5.33 3.08 Favored Glycine 0 N--CA 1.423 -2.19 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.32 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.63 18.53 21.32 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.178 0.807 . . . . 1.0 113.178 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.58 -76.91 0.19 Allowed 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.897 -0.721 . . . . 1.0 112.141 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -138.41 -53.1 0.61 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.261 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 59.94 8.55 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 t -114.71 126.99 27.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.261 -0.469 . . . . 1.0 110.552 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.45 103.36 1.73 Allowed 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.97 1.78 . . . . 1.0 110.562 175.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.51 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 57.7 t -102.16 153.81 5.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -109.57 139.61 44.37 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.314 -0.955 . . . . 1.0 111.433 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.57 174.63 12.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.095 -1.411 . . . . 1.0 108.239 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -104.59 159.73 15.52 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.542 0.687 . . . . 1.0 110.637 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 38.5 t70 -59.67 -29.87 68.37 Favored 'General case' 0 C--O 1.272 2.249 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.952 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 45.8 t -82.6 -12.01 58.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.753 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.03 132.67 47.02 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 44.3 p -78.32 172.55 13.44 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 94' ' ' ASN . 43.7 mm -60.37 -45.61 96.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.926 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.3 t -66.39 -41.92 88.64 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 8.4 tt0 -66.31 -34.38 77.86 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.993 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -81.67 -38.48 25.83 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 122.307 -0.245 . . . . 1.0 111.518 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' ' HZ1' ' A' ' 41' ' ' LYS . 2.6 mmmp? -60.51 -35.51 76.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.916 0.388 . . . . 1.0 110.34 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -66.48 -41.23 89.27 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.391 -0.822 . . . . 1.0 109.905 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 46.7 mmtm -63.6 -41.49 98.33 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.834 0.709 . . . . 1.0 111.861 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.584 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 86.1 mmm -60.96 -45.94 92.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.146 0.498 . . . . 1.0 110.627 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.5 -25.33 50.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.681 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 24.9 t70 -56.94 -28.83 62.56 Favored 'General case' 0 C--O 1.203 -1.371 0 C-N-CA 125.374 1.47 . . . . 1.0 112.145 -174.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.454 HE21 HG13 ' A' ' 29' ' ' VAL . 14.1 mm-40 -65.78 -33.92 76.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.067 0.46 . . . . 1.0 111.082 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.308 -1.219 0 CA-C-O 121.881 0.848 . . . . 1.0 109.127 -178.478 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.482 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.4 pp . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.52 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 7.7 m-20 -105.83 151.53 24.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 77' ' ' LEU . 12.4 p -114.6 124.53 71.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.428 172.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.63 112.28 24.14 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.594 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -93.28 125.82 38.08 Favored 'General case' 1 N--CA 1.374 -4.225 0 CA-C-N 114.554 -1.203 . . . . 1.0 109.165 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.29 89.39 3.05 Favored 'General case' 0 N--CA 1.395 -3.203 0 N-CA-C 106.672 -1.603 . . . . 1.0 106.672 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.8 p -79.0 -22.56 45.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.339 -1.301 . . . . 1.0 109.393 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.16 -45.72 3.5 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.837 -1.074 . . . . 1.0 112.163 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.55 -39.45 85.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.023 0.439 . . . . 1.0 111.062 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.22 -9.41 16.89 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.447 0.641 . . . . 1.0 109.937 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.07 -126.17 8.82 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.212 -0.904 . . . . 1.0 111.51 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -120.28 118.32 30.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.238 0.542 . . . . 1.0 110.204 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.66 151.91 45.92 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 9.8 mm -98.34 120.3 47.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.469 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.455 HD23 ' CE3' ' A' ' 67' ' ' TRP . 10.7 mp -111.99 163.32 14.38 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -167.58 163.03 14.57 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.234 -2.506 . . . . 1.0 104.234 175.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 21.3 p-10 -93.68 -3.25 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 117.9 -1.52 . . . . 1.0 111.033 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 170.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 79.3 mt . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . 93.8 m-20 -89.6 141.02 28.98 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -107.27 173.29 6.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 124.448 1.099 . . . . 1.0 109.704 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.66 -25.41 61.26 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.303 -0.959 . . . . 1.0 108.783 173.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.483 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -66.68 -25.34 66.51 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.22 0.533 . . . . 1.0 110.904 173.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -64.4 -37.73 88.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -104.55 -1.78 26.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.934 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 49.71 66.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.837 1.255 . . . . 1.0 112.997 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.594 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.1 m -85.27 150.71 55.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.636 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.19 155.89 22.61 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.844 2.362 . . . . 1.0 111.926 175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.0 122.17 17.16 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.52 10.34 13.24 Favored Glycine 0 C--N 1.285 -2.264 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.427 ' O ' HD13 ' A' ' 11' ' ' LEU . . . -69.89 162.3 28.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.288 0.566 . . . . 1.0 111.069 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.9 m -120.92 132.71 55.11 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.73 135.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.506 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.38 137.54 54.24 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.572 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.5 tt -97.92 126.86 43.52 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.974 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 64' ' ' ASP . 33.9 m -127.88 127.1 23.96 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.35 82.02 0.91 Allowed 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 122.355 2.037 . . . . 1.0 111.823 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.482 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.7 p . . . . . 0 N--CA 1.493 1.688 0 C-N-CA 126.038 1.735 . . . . 1.0 111.026 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 34' ' ' CYS . 74.8 m-85 . . . . . 0 N--CA 1.401 -2.918 0 N-CA-C 105.261 -2.126 . . . . 1.0 105.261 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -113.39 114.63 47.78 Favored Pre-proline 0 C--N 1.273 -2.721 0 C-N-CA 118.111 -1.436 . . . . 1.0 113.287 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 124.98 16.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.247 1.964 . . . . 1.0 109.098 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tp -122.18 161.81 22.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.801 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m -109.48 128.44 55.17 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.1 mt -126.66 149.99 49.22 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.751 0.82 . . . . 1.0 111.011 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -94.62 116.05 28.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.74 120.59 24.83 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 31.0 tp -151.64 152.32 32.67 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.558 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.1 pt? -122.13 143.03 49.79 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.728 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -117.25 32.41 6.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.363 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.18 -45.32 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 C-N-CA 123.572 0.749 . . . . 1.0 111.814 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.64 -87.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.363 -1.398 . . . . 1.0 113.475 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.33 -30.76 88.22 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.954 2.436 . . . . 1.0 113.171 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.3 26.08 11.64 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.694 -0.765 . . . . 1.0 111.547 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.7 82.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.05 0.12 48.04 Favored Glycine 0 CA--C 1.48 -2.14 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.41 22.04 3.7 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.664 -0.768 . . . . 1.0 111.242 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.66 -69.33 0.62 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.189 -0.459 . . . . 1.0 112.129 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.41 -51.77 0.17 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.7 -177.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.0 68.19 1.73 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.508 -1.037 . . . . 1.0 110.508 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.37 127.34 29.87 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.94 108.45 2.72 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 C-N-CA 121.623 1.549 . . . . 1.0 111.624 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 ' NE2' ' A' ' 47' ' ' GLN . 44.1 t -106.23 154.83 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.985 -1.007 . . . . 1.0 108.729 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.84 143.96 34.18 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.324 0.583 . . . . 1.0 110.769 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.48 166.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 tp -100.4 156.83 17.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.05 -30.29 70.88 Favored 'General case' 0 C--O 1.268 2.033 0 CA-C-O 121.473 0.654 . . . . 1.0 109.596 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.611 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -90.82 1.56 56.83 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.355 -176.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.17 136.24 46.4 Favored 'General case' 0 CA--C 1.48 -1.734 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.014 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.36 168.81 17.15 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 78' ' ' SER . 42.1 mm -61.59 -42.23 93.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 120.799 -0.361 . . . . 1.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -61.68 -43.72 98.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 121.109 -0.237 . . . . 1.0 110.547 177.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.435 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 27.0 mt-30 -67.33 -39.33 85.81 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 123.461 0.476 . . . . 1.0 111.238 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.66 -39.1 91.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.09 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.2 mptm? -56.93 -40.28 76.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 176.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 38' ' ' SER . 41.3 mt-10 -65.43 -53.81 37.65 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.42 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.27 -40.86 96.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.319 0.859 . . . . 1.0 113.319 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.67 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.5 mmm -64.04 -46.42 84.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.441 . . . . 1.0 110.406 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.7 pp -76.7 -25.19 53.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.13 -29.66 58.18 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.461 1.104 . . . . 1.0 112.67 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.457 ' NE2' HG12 ' A' ' 29' ' ' VAL . 27.7 mt-30 -69.25 -31.36 69.86 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.884 -0.327 . . . . 1.0 111.315 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 121.93 0.871 . . . . 1.0 108.713 -178.633 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 2.2 pp . . . . . 0 N--CA 1.409 -2.483 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.405 ' HA ' ' HZ1' ' A' ' 41' ' ' LYS . 53.6 m-20 -112.91 169.5 8.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 1.0 108.329 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 77' ' ' LEU . 13.3 p -121.62 129.21 75.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 C-N-CA 119.791 -0.764 . . . . 1.0 108.962 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 108' ' ' ALA . 10.3 pt-20 -91.49 111.89 23.58 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.159 -1.793 . . . . 1.0 106.159 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 2.5 t-105 -89.99 126.06 35.61 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.164 -1.38 . . . . 1.0 110.054 -174.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.47 88.97 2.85 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.7 p -91.9 -14.15 30.09 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.826 -1.534 . . . . 1.0 110.907 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.52 -52.53 4.38 Favored Glycine 0 C--N 1.303 -1.279 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.793 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.88 -38.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 122.669 0.388 . . . . 1.0 111.394 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.69 1.97 21.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.57 0.7 . . . . 1.0 109.665 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.23 -129.47 10.6 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.648 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 19.4 p-80 -110.73 112.73 24.8 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.317 0.579 . . . . 1.0 110.069 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.43 140.19 53.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -79.14 115.06 20.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.484 HD23 ' CE3' ' A' ' 67' ' ' TRP . 10.5 mp -109.79 148.36 31.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.763 0.792 . . . . 1.0 112.351 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.518 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -164.12 157.05 17.7 Favored 'General case' 0 CA--C 1.467 -2.216 0 C-N-CA 125.805 1.642 . . . . 1.0 107.082 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.411 ' N ' ' HB ' ' A' ' 37' ' ' ILE . 21.6 p-10 -73.69 -38.33 64.91 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 123.293 0.371 . . . . 1.0 111.399 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 C--N 1.316 -0.882 0 C-N-CA 120.592 -0.443 . . . . 1.0 112.014 -178.878 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.433 -1.306 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' HG12 ' A' ' 37' ' ' ILE . 41.5 m-80 -82.44 140.16 33.57 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.851 -0.74 . . . . 1.0 109.52 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -114.64 174.74 5.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.09 -29.59 63.05 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.235 -0.986 . . . . 1.0 108.368 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.611 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.0 pt20 -65.76 -24.48 66.96 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.024 -0.535 . . . . 1.0 112.17 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -59.9 -44.23 94.38 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 108.971 -0.751 . . . . 1.0 108.971 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -96.65 -10.28 27.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.569 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 64.7 mmtt 53.0 73.16 0.37 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.259 1.024 . . . . 1.0 113.121 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.6 HG12 ' CE2' ' A' ' 67' ' ' TRP . 1.2 m -83.08 147.99 55.42 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.958 . . . . 1.0 110.838 177.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.54 159.57 35.65 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.56 2.173 . . . . 1.0 112.911 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.77 121.54 15.26 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 121.764 0.792 . . . . 1.0 109.415 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.96 9.72 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.232 -0.985 . . . . 1.0 111.177 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.61 163.04 27.75 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.941 0.401 . . . . 1.0 110.315 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -115.61 131.33 56.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.835 0.35 . . . . 1.0 110.426 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.07 138.07 46.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -126.38 128.03 46.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.187 0.518 . . . . 1.0 110.593 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.558 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.3 mp -92.71 127.15 38.1 Favored 'General case' 0 C--N 1.269 -2.928 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.033 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.94 154.01 80.21 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.13 74.09 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.224 1.949 . . . . 1.0 110.633 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.458 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.266 0 C-N-CA 125.486 1.514 . . . . 1.0 111.836 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 . . . . . 0 N--CA 1.403 -2.775 0 N-CA-C 105.461 -2.051 . . . . 1.0 105.461 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.467 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 31.5 mmt180 -104.98 104.28 45.9 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 119.444 -0.903 . . . . 1.0 109.313 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.81 105.18 0.76 Allowed 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.436 ' HB3' HG22 ' A' ' 31' ' ' VAL . 4.3 tp -110.37 162.08 15.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-O 121.626 0.727 . . . . 1.0 112.334 -168.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.414 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 14.7 m -112.79 129.92 56.26 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.383 -1.281 . . . . 1.0 108.387 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.7 mt -126.26 149.86 48.81 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.287 0.565 . . . . 1.0 111.258 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -98.03 107.45 19.93 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.286 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.94 111.21 6.16 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 123.903 0.752 . . . . 1.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.485 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 30.4 tp -145.23 146.77 31.84 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.407 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.549 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.86 143.91 49.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -113.15 29.64 7.82 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.193 0.521 . . . . 1.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.441 HG23 ' HD3' ' A' ' 111' ' ' PRO . 53.2 t -64.9 -47.15 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 123.857 0.863 . . . . 1.0 112.56 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.85 -75.6 0.11 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.611 -1.281 . . . . 1.0 113.773 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.9 -26.44 80.97 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 123.68 2.92 . . . . 1.0 113.057 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.43 39.31 1.59 Allowed Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.751 -1.339 . . . . 1.0 109.751 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -63.75 80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.193 1.183 . . . . 1.0 114.193 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.35 39.96 Favored Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 110.403 -1.079 . . . . 1.0 110.403 172.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -157.05 38.07 0.3 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.612 0.72 . . . . 1.0 110.427 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.63 -77.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.811 -0.631 . . . . 1.0 112.546 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 1.6 pt20 -127.13 -59.14 1.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.418 -172.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.42 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 69.56 68.37 1.66 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -99.34 131.25 25.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.666 -0.267 . . . . 1.0 110.561 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.14 103.36 1.49 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.917 1.745 . . . . 1.0 111.597 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.554 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 37.5 t -110.38 155.36 11.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.23 -0.895 . . . . 1.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.22 144.76 31.17 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.16 0.505 . . . . 1.0 112.177 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 9' ' ' LEU . 2.6 m -147.64 -176.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.69 -1.141 . . . . 1.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 29.5 mt -121.45 174.35 6.81 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.641 0.734 . . . . 1.0 110.097 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.467 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 28.8 t70 -66.18 -32.3 73.65 Favored 'General case' 0 C--O 1.265 1.881 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.607 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 3.9 t -103.46 2.78 34.16 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.417 1.636 . . . . 1.0 115.417 -169.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 32' ' ' LEU 0.393 0.2 OUTLIER -79.08 141.92 36.93 Favored 'General case' 0 CA--C 1.467 -2.245 0 C-N-CA 115.969 -2.293 . . . . 1.0 111.607 172.475 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.2 p -77.24 170.15 17.06 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.527 -1.67 . . . . 1.0 110.217 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.5 mm -59.64 -42.9 89.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.605 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.8 p -61.59 -46.99 87.49 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 123.431 0.457 . . . . 1.0 111.401 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.77 -42.54 63.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.114 0.483 . . . . 1.0 111.558 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.63 -37.4 82.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.716 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.528 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 32.9 ttpt -59.29 -38.31 79.9 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.444 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 38' ' ' SER . 63.5 mt-10 -66.9 -40.0 87.59 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.402 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.92 -40.93 97.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 121.335 -0.146 . . . . 1.0 111.05 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.554 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.1 mmt -61.82 -49.35 76.65 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.739 0.65 . . . . 1.0 110.601 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -76.64 -23.08 53.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 30.7 t70 -55.27 -30.82 60.87 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.247 1.019 . . . . 1.0 111.567 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -67.96 -30.93 70.34 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.845 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.497 -1.088 0 CA-C-O 121.091 0.472 . . . . 1.0 111.46 -171.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.9 pp . . . . . 0 C--O 1.248 1.002 0 CA-C-O 120.92 0.39 . . . . 1.0 111.181 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 11.2 p-10 -113.5 162.71 15.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.305 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.14 127.06 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.302 0.572 . . . . 1.0 110.472 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.45 113.21 25.31 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 105.132 -2.173 . . . . 1.0 105.132 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.566 ' CE2' HG12 ' A' ' 101' ' ' VAL . 4.9 t-105 -91.55 133.54 35.44 Favored 'General case' 0 N--CA 1.403 -2.806 0 CA-C-N 115.39 -0.823 . . . . 1.0 111.912 -173.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -117.08 88.69 2.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 106.446 -1.687 . . . . 1.0 106.446 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 71.3 p -73.48 -31.99 64.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.785 -1.098 . . . . 1.0 110.763 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.14 -50.99 4.35 Favored Glycine 0 C--N 1.303 -1.282 0 CA-C-N 114.566 -1.197 . . . . 1.0 111.365 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.8 -41.28 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.524 0.329 . . . . 1.0 111.703 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.4 -40.04 5.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.275 -1.009 . . . . 1.0 108.275 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.16 -130.16 6.76 Favored Glycine 0 N--CA 1.426 -2.021 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.042 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 88.9 m-70 -100.94 118.86 37.8 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.544 0.737 . . . . 1.0 110.652 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.35 134.43 39.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 mm -79.72 118.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.566 HD21 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -109.98 152.27 26.09 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.234 0.54 . . . . 1.0 111.4 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -154.92 148.99 25.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 p-10 -66.25 -44.14 84.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.422 -1.858 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.935 178.48 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.0 mt . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 120.709 0.29 . . . . 1.0 110.938 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -103.42 146.21 28.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.211 -0.45 . . . . 1.0 109.847 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.541 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -109.23 171.84 7.2 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 pp -77.02 -17.55 58.74 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.585 -1.246 . . . . 1.0 109.43 175.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.541 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -66.67 -26.42 67.03 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.896 173.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -64.07 -40.99 97.47 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 2.0 t80 -88.74 -16.14 32.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.604 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.35 57.91 5.42 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.103 0.961 . . . . 1.0 111.01 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.566 HG12 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -74.31 144.22 81.04 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.208 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.06 158.49 41.95 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.878 2.385 . . . . 1.0 111.861 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.49 119.2 11.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.812 0.815 . . . . 1.0 109.827 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.99 20.33 10.72 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.417 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.88 162.12 29.93 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.867 0.365 . . . . 1.0 110.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 76.1 m -115.24 132.3 56.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.093 0.473 . . . . 1.0 110.667 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 13.5 m -113.22 156.89 14.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -139.26 124.87 19.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.232 0.539 . . . . 1.0 109.598 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.7 mp -101.32 131.38 47.4 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.234 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 17.5 m -130.2 147.96 67.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.441 ' HD3' HG23 ' A' ' 17' ' ' VAL . 77.7 Cg_endo -83.07 82.96 2.03 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 121.769 1.646 . . . . 1.0 111.741 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.424 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 12.6 p . . . . . 0 CA--C 1.499 -0.999 0 C-N-CA 125.227 1.411 . . . . 1.0 111.247 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 47.0 m-85 . . . . . 0 N--CA 1.391 -3.42 0 N-CA-C 103.355 -2.831 . . . . 1.0 103.355 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -101.21 110.66 61.99 Favored Pre-proline 0 C--N 1.264 -3.126 0 C-N-CA 118.805 -1.158 . . . . 1.0 111.746 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -60.44 119.83 7.23 Favored 'Trans proline' 0 CA--C 1.508 -0.825 0 C-N-CA 122.397 2.064 . . . . 1.0 108.617 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.94 128.41 56.27 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 -171.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.2 m -87.37 120.3 28.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.496 HD23 ' SD ' ' A' ' 44' ' ' MET . 16.3 tp -124.65 142.84 51.08 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.465 HD21 HG22 ' A' ' 106' ' ' THR . 8.1 t30 -98.76 117.07 32.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.106 -0.371 . . . . 1.0 110.814 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.92 116.93 17.11 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.148 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 25.7 tp -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.618 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -128.65 141.21 51.42 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.955 -0.465 . . . . 1.0 110.741 176.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' HG11 ' A' ' 110' ' ' VAL . . . -115.63 54.0 0.82 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.234 0.54 . . . . 1.0 110.933 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.71 -43.21 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.604 0.716 . . . . 1.0 109.865 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.94 -84.59 0.14 Allowed Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.94 -32.82 76.42 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.792 2.328 . . . . 1.0 112.142 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.65 18.58 50.11 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 121.32 -0.467 . . . . 1.0 112.152 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -77.79 64.42 3.04 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.449 0.642 . . . . 1.0 111.924 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.54 -29.34 1.89 Allowed Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -94.31 17.99 11.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.122 0.487 . . . . 1.0 111.187 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.07 -83.31 0.08 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -143.7 -62.8 0.39 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.569 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.86 72.57 0.95 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.38 126.72 27.62 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.34 -0.43 . . . . 1.0 110.264 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.36 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 121.737 1.625 . . . . 1.0 111.496 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.505 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 40.6 t -110.61 142.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.117 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.48 140.7 29.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.283 0.563 . . . . 1.0 111.765 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.33 172.86 9.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.06 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.485 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 9.8 mt -107.95 158.4 17.39 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.421 0.629 . . . . 1.0 111.483 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.22 -30.83 68.52 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.03 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.9 t -88.6 -3.61 58.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.501 -1.227 . . . . 1.0 112.277 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -73.23 132.34 43.06 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 p -74.55 172.08 12.66 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -59.94 -44.99 95.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 117.993 0.36 . . . . 1.0 111.198 -177.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.428 ' HB2' ' OD1' ' A' ' 79' ' ' ASP . 4.0 t -71.87 -35.97 69.94 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.955 -1.098 . . . . 1.0 110.519 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.761 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 9.1 tt0 -68.25 -38.02 81.39 Favored 'General case' 0 C--O 1.206 -1.226 0 C-N-CA 123.136 0.574 . . . . 1.0 111.007 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -73.69 -39.75 64.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.539 -0.726 . . . . 1.0 110.596 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.22 -35.91 72.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.316 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.761 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 3.7 pt-20 -68.41 -40.44 81.27 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.919 -176.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 44.9 mmtm -63.99 -41.45 97.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 124.186 0.929 . . . . 1.0 110.245 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.1 mmm -61.59 -48.59 80.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.694 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.4 pp -77.28 -24.72 50.98 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 112.579 0.585 . . . . 1.0 112.579 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -52.89 -28.92 25.4 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.092 1.357 . . . . 1.0 112.076 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -66.76 -36.83 83.34 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.45 0.643 . . . . 1.0 110.348 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.315 -0.895 0 CA-C-O 121.696 0.76 . . . . 1.0 109.545 -177.448 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 C--O 1.192 -1.962 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.08 152.45 33.58 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.487 -1.301 . . . . 1.0 107.487 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 77' ' ' LEU . 8.4 p -115.75 125.94 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 118.825 -1.15 . . . . 1.0 110.137 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -93.87 113.11 25.06 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.357 -1.349 . . . . 1.0 107.357 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.594 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.5 t-105 -93.61 124.49 37.63 Favored 'General case' 0 N--CA 1.388 -3.549 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.97 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -109.96 89.57 3.06 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 p -84.59 -13.47 51.6 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.054 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.06 -55.87 3.94 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.42 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.03 -40.93 90.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.003 0.521 . . . . 1.0 111.293 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.35 -10.76 26.99 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.694 0.759 . . . . 1.0 109.03 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.35 -128.23 9.5 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.083 -0.962 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 3.8 p80 -130.65 108.19 9.72 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.298 0.571 . . . . 1.0 109.836 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.68 151.71 36.7 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.0 mm -94.07 120.68 43.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 10.4 mp -111.22 165.18 12.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.525 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -167.06 157.72 11.67 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 105.141 -2.17 . . . . 1.0 105.141 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 9.3 p-10 -78.51 -19.72 52.35 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.42 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 173.964 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 94.3 mt . . . . . 0 C--O 1.251 1.154 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.448 ' O ' HG12 ' A' ' 37' ' ' ILE . 82.7 m-20 -98.58 140.58 32.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.207 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -111.39 173.1 6.5 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.991 1.316 . . . . 1.0 108.921 177.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.427 HD12 HG21 ' A' ' 101' ' ' VAL . 3.9 pp -72.21 -22.8 61.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 119.136 -1.025 . . . . 1.0 109.49 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.536 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.77 -26.47 67.73 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.327 175.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -66.7 -40.68 88.6 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.496 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 88.1 m-85 -97.47 -1.33 44.41 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.652 -0.703 . . . . 1.0 111.61 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? 48.53 63.61 2.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.034 1.334 . . . . 1.0 113.589 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.594 HG11 ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -84.52 146.29 46.81 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 119.075 -1.05 . . . . 1.0 112.601 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.14 158.08 23.41 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.026 2.484 . . . . 1.0 111.827 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.07 122.46 17.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.4 14.59 12.7 Favored Glycine 0 C--N 1.287 -2.151 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.971 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 11' ' ' LEU . . . -71.3 162.68 29.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.269 0.557 . . . . 1.0 110.697 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.465 HG22 HD21 ' A' ' 12' ' ' ASN . 97.4 m -123.04 134.5 54.29 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.309 -0.405 . . . . 1.0 109.92 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.38 138.81 44.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.461 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -126.13 135.17 51.37 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.528 0.68 . . . . 1.0 110.539 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.618 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 tt -100.04 125.8 46.15 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.315 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 16' ' ' ALA . 32.2 m -119.54 130.45 24.84 Favored Pre-proline 0 C--N 1.316 -0.883 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.094 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.15 86.35 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.344 2.029 . . . . 1.0 111.699 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.492 1.638 0 C-N-CA 125.833 1.653 . . . . 1.0 113.714 177.614 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 N--CA 1.406 -2.628 0 N-CA-C 103.481 -2.785 . . . . 1.0 103.481 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.445 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 33.6 mmt180 -108.52 111.61 61.23 Favored Pre-proline 0 C--N 1.267 -3.004 0 C-N-CA 119.362 -0.935 . . . . 1.0 112.301 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.38 109.51 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.144 1.896 . . . . 1.0 109.57 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 10' ' ' THR . 4.6 tp -112.85 156.02 23.64 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.026 -174.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.426 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 47.3 m -96.51 128.59 43.58 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.504 HD22 ' SD ' ' A' ' 44' ' ' MET . 29.0 tp -127.37 143.73 51.17 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 7.3 t30 -97.68 113.47 25.23 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.03 -0.419 . . . . 1.0 110.966 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.16 115.98 16.41 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.811 -0.632 . . . . 1.0 110.167 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 tp -147.81 154.81 40.95 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.66 143.67 50.61 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.731 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -116.36 33.29 5.63 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.329 0.585 . . . . 1.0 110.368 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.78 -46.23 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 C-N-CA 123.645 0.778 . . . . 1.0 111.918 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.29 -77.47 0.14 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 119.295 -1.431 . . . . 1.0 113.684 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.45 -35.06 97.08 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.761 2.307 . . . . 1.0 112.141 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.39 36.63 3.22 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -68.39 74.46 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.79 1.033 . . . . 1.0 113.79 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.6 -5.58 40.73 Favored Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 110.14 -1.184 . . . . 1.0 110.14 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -119.9 16.61 12.6 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.244 -0.978 . . . . 1.0 111.371 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.81 -75.31 0.17 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -148.53 -58.06 0.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.965 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 75.54 1.18 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.3 t -92.9 126.51 51.2 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.419 . . . . 1.0 110.723 -173.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.18 99.06 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.941 1.76 . . . . 1.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 t -109.6 156.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -123.01 151.32 41.98 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.811 -1.156 . . . . 1.0 112.021 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 32' ' ' LEU . 5.1 p -151.34 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.812 -1.181 . . . . 1.0 107.812 -175.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.458 ' H ' HG23 ' A' ' 31' ' ' VAL . 19.7 mt -100.56 160.55 14.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-N 118.755 0.707 . . . . 1.0 111.195 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 19.6 t70 -64.62 -31.08 72.14 Favored 'General case' 0 C--O 1.251 1.159 0 O-C-N 124.025 0.828 . . . . 1.0 108.857 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 8.2 t -108.61 39.52 1.98 Allowed 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.013 -1.449 . . . . 1.0 110.168 -177.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 95' ' ' THR . 11.9 p-10 -66.89 -164.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.33 170.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 p -142.01 153.46 44.28 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 168.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -56.55 -40.68 70.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 118.122 0.419 . . . . 1.0 111.316 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.554 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -62.59 -43.02 99.85 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.62 176.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 45.7 mt-30 -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.974 0.416 . . . . 1.0 111.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.705 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.02 -38.19 90.17 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.27 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -55.56 -41.89 73.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.7 mt-10 -68.13 -48.52 65.18 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.259 -0.882 . . . . 1.0 110.625 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 34.9 mmtp -65.33 -42.54 92.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.128 0.788 . . . . 1.0 113.128 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.705 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 83.2 mmm -63.94 -42.84 97.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.863 0.363 . . . . 1.0 110.577 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.77 -25.63 56.63 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.0 111.682 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.2 t70 -53.02 -31.45 41.29 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.858 1.263 . . . . 1.0 112.224 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -71.32 -38.27 71.71 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.147 0.498 . . . . 1.0 111.401 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 CA--C 1.497 -1.076 0 CA-C-O 122.072 0.939 . . . . 1.0 108.912 -175.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.1 pp . . . . . 0 N--CA 1.427 -1.619 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 1.7 m-20 -107.8 141.09 39.89 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.89 114.31 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 C-N-CA 118.352 -1.339 . . . . 1.0 108.054 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -91.0 112.67 24.66 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 107.614 -1.254 . . . . 1.0 107.614 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.645 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -83.42 127.52 33.76 Favored 'General case' 0 N--CA 1.385 -3.683 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.723 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.59 89.01 3.03 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.456 -0.793 . . . . 1.0 109.562 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.0 m -97.05 -17.56 19.92 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.683 0.754 . . . . 1.0 109.335 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.95 -46.0 3.5 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.505 -1.225 . . . . 1.0 112.411 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.6 -44.93 97.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-O 120.89 0.376 . . . . 1.0 110.989 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . . . -102.46 0.59 34.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.057 0.932 . . . . 1.0 108.703 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.68 -127.75 8.09 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.282 -1.327 . . . . 1.0 113.236 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 9.3 m170 -115.73 118.46 33.11 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.382 1.073 . . . . 1.0 109.294 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.98 139.04 48.51 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.68 118.29 31.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.29 -0.564 . . . . 1.0 109.638 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.43 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -108.49 159.59 16.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.474 0.654 . . . . 1.0 111.44 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 m -165.81 162.75 18.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 12.6 p-10 -66.08 -38.76 89.08 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--N 1.305 -1.347 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 175.846 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.2 mt . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -90.71 141.14 29.1 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.974 -0.691 . . . . 1.0 109.826 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 35' ' ' ASP . 1.8 p -121.97 171.49 8.9 Favored 'General case' 0 C--O 1.266 1.922 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 101' ' ' VAL . 3.2 pp -66.8 -29.94 70.01 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.96 . . . . 1.0 108.979 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.542 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -67.83 -26.09 65.88 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.533 177.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -64.13 -41.36 97.24 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD1' HG13 ' A' ' 101' ' ' VAL . 3.1 t80 -83.45 -18.62 38.0 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.733 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 10.6 mmmm 52.15 60.7 3.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.947 0.899 . . . . 1.0 110.788 -171.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.6 m -74.23 149.78 87.16 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.65 -0.705 . . . . 1.0 112.575 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.3 164.03 31.59 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.142 2.561 . . . . 1.0 111.742 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.65 129.01 38.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.366 0.603 . . . . 1.0 109.712 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.27 40.64 Favored Glycine 0 C--N 1.295 -1.727 0 C-N-CA 120.623 -0.799 . . . . 1.0 111.999 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.464 ' O ' HD11 ' A' ' 11' ' ' LEU . . . -64.42 154.87 34.36 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 120.716 0.293 . . . . 1.0 111.018 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 98.9 m -107.45 132.52 53.11 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.988 0.423 . . . . 1.0 111.345 -176.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.5 m -113.0 142.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.33 136.57 53.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.578 0.704 . . . . 1.0 110.581 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.596 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.0 tt -102.68 124.47 48.29 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 115.191 -0.913 . . . . 1.0 109.184 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.552 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 26.3 m -129.03 144.25 51.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.01 51.54 3.69 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 122.934 2.422 . . . . 1.0 114.002 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.486 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.495 -1.161 0 C-N-CA 124.495 1.118 . . . . 1.0 111.095 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.661 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 m-85 . . . . . 0 N--CA 1.407 -2.577 0 N-CA-C 101.202 -3.629 . . . . 1.0 101.202 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 34.9 mmt180 -98.01 108.24 45.41 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 121.063 1.756 . . . . 1.0 111.22 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.661 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 15.4 Cg_exo -69.58 120.07 6.94 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.106 1.871 . . . . 1.0 108.469 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tp -117.87 158.34 25.02 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.223 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -98.34 125.56 43.51 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 105' ' ' ALA . 18.5 tp -127.21 142.03 51.59 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.724 -1.213 . . . . 1.0 107.724 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 10.8 t30 -94.94 122.0 37.13 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.916 -0.49 . . . . 1.0 111.25 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.48 113.31 20.14 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.494 -0.776 . . . . 1.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 33.2 tp -146.61 151.71 37.73 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.912 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.612 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -120.82 140.45 51.72 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.93 42.79 2.1 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.035 0.445 . . . . 1.0 110.901 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.479 HG21 ' HD3' ' A' ' 111' ' ' PRO . 82.7 t -65.2 -46.34 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-N 115.461 -0.791 . . . . 1.0 111.825 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.85 -80.35 0.15 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.239 -0.981 . . . . 1.0 112.986 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.62 -30.95 79.61 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.947 2.432 . . . . 1.0 112.829 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -126.38 41.49 1.63 Allowed Glycine 0 N--CA 1.408 -3.23 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.67 31.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.14 0.576 . . . . 1.0 112.195 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' GLY . . . 168.35 -41.28 0.23 Allowed Glycine 0 C--N 1.3 -1.45 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.74 10.11 19.4 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.195 0.521 . . . . 1.0 112.093 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 20' ' ' GLY . . . -76.16 -68.54 0.57 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.472 0.653 . . . . 1.0 112.603 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -131.24 -69.51 0.63 Allowed 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.793 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.35 64.33 4.49 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.329 -0.708 . . . . 1.0 111.329 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.2 t -107.95 125.82 31.2 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.46 104.93 1.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.63 1.553 . . . . 1.0 110.575 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.61 156.01 8.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.95 148.06 34.57 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.392 -0.923 . . . . 1.0 110.561 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 40' ' ' ALA . 13.9 p -158.55 163.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.393 -0.821 . . . . 1.0 108.974 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 ' HB2' ' CG ' ' A' ' 35' ' ' ASP . 18.3 mt -86.05 158.2 19.89 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.739 0.78 . . . . 1.0 112.423 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 30.2 t70 -64.24 -32.03 73.46 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-N 113.904 -1.498 . . . . 1.0 109.289 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.428 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 53.0 t -95.29 6.56 48.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.548 -1.66 . . . . 1.0 111.239 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.408 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 95.2 m-20 -85.54 144.79 27.71 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 119.399 -0.92 . . . . 1.0 108.656 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 p -83.56 169.96 14.87 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.444 -0.798 . . . . 1.0 109.328 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 94' ' ' ASN . 44.2 mm -61.52 -43.44 96.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 117.752 0.251 . . . . 1.0 110.457 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -63.88 -40.76 97.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.22 0.533 . . . . 1.0 110.655 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.619 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 8.1 tt0 -75.78 -25.0 56.03 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.797 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.484 ' CB ' HG22 ' A' ' 31' ' ' VAL . . . -82.3 -37.6 25.55 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 121.701 -0.624 . . . . 1.0 111.098 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 2.5 mmmp? -57.64 -36.2 71.51 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.646 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 11.3 pt-20 -62.54 -45.8 91.31 Favored 'General case' 0 N--CA 1.414 -2.239 0 O-C-N 124.154 0.909 . . . . 1.0 110.925 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -70.72 -38.59 73.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.4 mmt -59.58 -49.01 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.363 0.602 . . . . 1.0 109.532 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 2.4 pp -78.11 -23.9 47.69 Favored 'General case' 0 C--O 1.197 -1.709 0 CA-C-N 115.604 -0.726 . . . . 1.0 112.659 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 20.1 t70 -50.18 -34.69 23.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.11 1.364 . . . . 1.0 112.366 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -67.36 -29.96 69.64 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.744 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 C--N 1.315 -0.907 0 CA-C-O 121.717 0.77 . . . . 1.0 110.581 -177.022 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.472 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.2 pp . . . . . 0 N--CA 1.415 -2.222 0 N-CA-C 106.589 -1.634 . . . . 1.0 106.589 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HB3' HG23 ' A' ' 76' ' ' ILE . 21.5 m-20 -102.93 154.12 19.54 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.13 112.77 41.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -91.34 122.32 33.85 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.771 0.796 . . . . 1.0 110.342 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.655 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 17.8 t90 -82.73 116.87 22.27 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.787 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.417 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 49.5 mtm105 -122.95 90.43 3.29 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 p -88.01 -20.47 25.77 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.74 -54.41 4.12 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.191 -1.368 . . . . 1.0 111.657 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.48 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 123.773 0.829 . . . . 1.0 111.498 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.94 -15.12 20.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.821 0.344 . . . . 1.0 110.673 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.67 -158.63 15.58 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 111.465 -0.654 . . . . 1.0 111.465 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.655 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.4 p80 -136.43 120.58 17.79 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.156 0.582 . . . . 1.0 110.861 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -127.39 148.78 50.27 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.421 -174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 64' ' ' ASP . 27.9 mm -84.9 116.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 120.87 0.367 . . . . 1.0 110.194 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.433 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 11.1 mp -106.51 148.64 27.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.937 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.0 t -164.04 161.97 22.86 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -71.38 -30.21 65.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 N--CA 1.409 -2.504 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 178.357 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.432 -1.336 0 N-CA-C 106.448 -1.686 . . . . 1.0 106.448 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.422 ' O ' HG12 ' A' ' 37' ' ' ILE . 78.5 m-20 -84.92 141.49 30.35 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.969 -173.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.546 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -105.67 172.49 6.77 Favored 'General case' 0 N--CA 1.425 -1.69 0 C-N-CA 123.731 0.813 . . . . 1.0 108.917 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.428 HD13 HG23 ' A' ' 101' ' ' VAL . 3.2 pp -71.25 -27.31 63.37 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.503 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.546 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -65.83 -25.25 67.13 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.439 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -65.32 -35.39 80.86 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.433 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 87.4 m-85 -103.32 -11.8 17.67 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.918 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 54.0 69.3 0.73 Allowed 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.615 1.166 . . . . 1.0 112.649 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.428 HG23 HD13 ' A' ' 96' ' ' LEU . 2.5 m -78.97 137.8 57.31 Favored Pre-proline 0 N--CA 1.434 -1.239 0 C-N-CA 120.041 -0.664 . . . . 1.0 109.471 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.25 160.39 49.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.315 2.01 . . . . 1.0 111.171 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.84 125.73 25.76 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.884 -0.727 . . . . 1.0 110.293 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 21.74 39.52 Favored Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.881 -1.054 . . . . 1.0 111.164 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.406 ' O ' HD11 ' A' ' 11' ' ' LEU . . . -72.92 155.54 39.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.783 0.325 . . . . 1.0 110.403 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 99.0 m -107.01 125.83 51.54 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.108 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.66 137.06 56.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -122.82 135.13 54.43 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.662 0.744 . . . . 1.0 112.826 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.612 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 11.0 mp -90.14 124.09 34.53 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.322 -0.853 . . . . 1.0 109.549 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 23.6 m -125.54 134.7 26.07 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.433 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 17' ' ' VAL . 40.2 Cg_endo -68.69 86.15 0.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.525 2.15 . . . . 1.0 111.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.472 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 23.3 p . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 125.541 1.537 . . . . 1.0 111.715 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 . . . . . 0 N--CA 1.404 -2.773 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -110.26 105.03 56.82 Favored Pre-proline 0 C--N 1.272 -2.774 0 C-N-CA 118.773 -1.171 . . . . 1.0 110.547 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.87 118.44 5.33 Favored 'Trans proline' 0 C--O 1.25 1.093 0 N-CA-C 108.504 -1.383 . . . . 1.0 108.504 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.439 ' CD1' ' HA ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER -119.13 131.68 55.91 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 -172.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -87.12 128.74 35.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.436 HD13 ' CZ2' ' A' ' 67' ' ' TRP . 1.1 mm? -122.82 147.35 46.64 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.064 0.946 . . . . 1.0 109.996 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -89.95 110.94 21.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.49 109.45 7.98 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 123.489 0.493 . . . . 1.0 109.78 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 29.9 tp -138.56 160.77 38.74 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.318 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.529 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -125.73 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.21 33.92 4.99 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.921 0.391 . . . . 1.0 110.597 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.407 HG22 ' CD ' ' A' ' 111' ' ' PRO . 47.1 t -63.79 -47.66 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 115.849 -0.614 . . . . 1.0 112.392 -174.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.73 -85.14 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.63 -33.78 93.03 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 122.998 2.466 . . . . 1.0 113.072 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.05 29.63 6.99 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -76.24 75.98 3.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.397 0.617 . . . . 1.0 111.985 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.498 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 121.2 -7.91 10.55 Favored Glycine 0 CA--C 1.488 -1.629 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.391 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -128.76 28.3 5.38 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.234 0.54 . . . . 1.0 111.27 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 -88.78 0.18 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.449 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.451 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 8.9 pt20 -117.62 -58.49 2.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.243 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.451 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 65.97 71.81 0.84 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 -175.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.3 t -103.97 126.98 30.28 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.626 -0.287 . . . . 1.0 110.432 -173.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.21 106.51 2.18 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.963 1.775 . . . . 1.0 111.581 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 44' ' ' MET . 79.4 t -116.1 155.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.95 -1.13 . . . . 1.0 107.95 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -125.69 144.3 50.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.72 170.31 15.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.571 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -84.52 159.64 20.66 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.043 0.449 . . . . 1.0 111.454 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.65 -30.89 71.71 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-N 115.286 -0.87 . . . . 1.0 108.834 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.553 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 10.0 t -95.27 6.11 49.92 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.048 -1.433 . . . . 1.0 112.562 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.24 132.51 45.06 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.453 ' CG2' HD11 ' A' ' 93' ' ' LEU . 69.8 p -79.26 167.26 21.19 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -60.11 -43.32 92.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.541 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.646 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -61.04 -47.13 87.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 123.32 0.387 . . . . 1.0 110.745 177.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 47.5 mt-30 -71.24 -40.23 71.16 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.6 -39.78 84.77 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.108 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -61.96 -34.66 76.54 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.718 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.9 mt-10 -64.46 -46.23 84.01 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 124.412 1.07 . . . . 1.0 110.073 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 39.2 mmtm -62.94 -46.61 86.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.662 0.744 . . . . 1.0 109.051 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.604 ' SD ' HG23 ' A' ' 107' ' ' VAL . 7.2 mtp -65.3 -40.34 93.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.444 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.55 -33.18 64.58 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.514 -0.474 . . . . 1.0 111.123 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.1 -33.95 75.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.606 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 19.0 mm-40 -67.08 -30.88 71.04 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.52 -0.764 . . . . 1.0 111.584 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.432 -1.33 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.501 -173.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.2 pp . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 120.876 0.369 . . . . 1.0 111.437 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.444 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 4.9 m-20 -107.81 150.64 26.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.53 128.89 75.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 120.108 -0.637 . . . . 1.0 109.5 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 33.7 mt-10 -90.93 112.97 25.06 Favored 'General case' 0 CA--C 1.462 -2.407 0 N-CA-C 106.119 -1.808 . . . . 1.0 106.119 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.616 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -91.34 119.16 31.13 Favored 'General case' 1 N--CA 1.37 -4.448 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -108.98 89.48 3.01 Favored 'General case' 0 N--CA 1.394 -3.225 0 N-CA-C 106.738 -1.579 . . . . 1.0 106.738 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.2 p -83.95 -12.49 55.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 113.797 -1.547 . . . . 1.0 110.906 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.4 -60.97 3.58 Favored Glycine 0 C--N 1.302 -1.325 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.695 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.279 0.631 . . . . 1.0 112.049 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.12 -6.52 31.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.58 0.705 . . . . 1.0 109.751 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.35 -153.72 26.68 Favored Glycine 0 N--CA 1.414 -2.831 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.24 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.565 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -101.01 117.0 34.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.489 0.662 . . . . 1.0 111.678 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.92 146.75 45.5 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.772 -1.103 . . . . 1.0 108.069 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.499 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 22.0 mm -89.76 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.8 159.47 15.79 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.669 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 3.3 t -167.95 165.74 13.59 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 105.789 -1.93 . . . . 1.0 105.789 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.41 ' O ' HD22 ' A' ' 93' ' ' LEU . 11.3 p-10 -63.0 -39.54 95.06 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 N--CA 1.44 -0.956 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.253 -179.432 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.453 HD11 ' CG2' ' A' ' 36' ' ' THR . 3.3 tm? . . . . . 0 CA--C 1.56 1.331 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.0 m-80 -101.97 137.9 39.64 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 119.533 -0.867 . . . . 1.0 112.03 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -126.77 175.3 8.11 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.579 -1.637 . . . . 1.0 106.579 174.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.42 -28.02 62.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.104 -1.438 . . . . 1.0 108.334 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 4.4 pt20 -66.86 -24.31 66.12 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.513 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -57.61 -40.95 80.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.217 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -107.62 8.92 29.38 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.011 0.745 . . . . 1.0 113.011 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 31.2 mmmt 38.02 65.13 0.61 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.207 1.403 . . . . 1.0 112.745 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -67.71 149.69 98.16 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 115.058 -0.973 . . . . 1.0 112.003 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.58 155.5 40.31 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.422 2.081 . . . . 1.0 111.228 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.439 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 8.3 p-10 -66.05 127.62 32.85 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 177.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.82 20.72 27.9 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.087 -1.054 . . . . 1.0 110.934 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.65 163.95 26.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 1.0 110.129 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.6 m -112.01 131.15 55.58 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.854 -0.529 . . . . 1.0 111.452 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.604 HG23 ' SD ' ' A' ' 44' ' ' MET . 17.3 m -117.07 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -129.0 137.83 51.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.529 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.2 pp -109.85 143.83 39.19 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.891 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 35.0 m -131.8 125.54 20.4 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.407 ' CD ' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -70.49 80.7 1.07 Allowed 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.458 2.105 . . . . 1.0 112.067 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.447 -0.608 0 CA-C-N 114.877 -1.056 . . . . 1.0 110.597 178.223 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.421 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.5 m-85 . . . . . 0 N--CA 1.399 -2.989 0 N-CA-C 105.427 -2.064 . . . . 1.0 105.427 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -109.12 111.03 60.54 Favored Pre-proline 0 C--N 1.283 -2.308 0 C-N-CA 117.625 -1.63 . . . . 1.0 113.196 -170.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 21.8 Cg_exo -63.39 112.6 1.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.16 1.907 . . . . 1.0 108.44 171.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -113.06 160.94 17.64 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.994 -172.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -98.9 125.99 44.46 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.091 -1.077 . . . . 1.0 108.091 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.545 HD13 ' SD ' ' A' ' 44' ' ' MET . 1.3 tm? -127.32 141.1 51.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.26 111.38 23.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.884 -0.51 . . . . 1.0 110.319 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.68 106.37 5.4 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 115.407 -0.815 . . . . 1.0 111.132 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 29.2 tp -143.24 144.44 32.15 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.563 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.528 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.02 144.29 48.61 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.851 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -114.25 34.54 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.447 0.642 . . . . 1.0 109.531 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 38.4 t -65.14 -45.44 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 C-N-CA 123.839 0.856 . . . . 1.0 112.924 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.38 -80.9 0.1 OUTLIER Glycine 0 C--N 1.313 -0.713 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.902 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -58.98 -32.46 97.56 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.957 2.438 . . . . 1.0 112.429 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -127.45 41.36 1.61 Allowed Glycine 0 N--CA 1.419 -2.468 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -66.07 76.53 0.09 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.46 3.08 57.57 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.58 24.51 5.09 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.593 -0.804 . . . . 1.0 110.143 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 20' ' ' GLY . . . -96.07 -77.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -172.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.434 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 8.0 pt20 -125.89 -65.48 0.99 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.229 -0.896 . . . . 1.0 111.919 -169.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.434 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.83 64.71 3.48 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 25' ' ' GLN . 43.2 t -108.3 129.9 23.46 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 110.24 -0.282 . . . . 1.0 110.24 -174.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.49 108.25 2.18 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.126 1.884 . . . . 1.0 111.309 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.461 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 59.6 t -117.71 138.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -84.16 155.94 22.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.885 0.698 . . . . 1.0 112.885 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 32' ' ' LEU . 14.2 p -151.3 -178.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.415 -1.266 . . . . 1.0 108.192 -176.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.456 ' H ' HG22 ' A' ' 31' ' ' VAL . 12.8 tp -119.1 155.39 31.62 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.0 -30.6 71.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.354 0.597 . . . . 1.0 109.649 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 2.7 t -104.81 33.48 3.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.401 -1.272 . . . . 1.0 110.352 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -70.22 -163.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.636 172.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.4 p -140.51 161.91 36.59 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 103.668 -2.716 . . . . 1.0 103.668 167.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 43.8 mm -57.78 -47.74 85.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.371 -0.531 . . . . 1.0 111.741 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 t -65.81 -43.87 87.35 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 123.677 0.611 . . . . 1.0 109.902 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.17 -40.44 97.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.28 0.562 . . . . 1.0 111.356 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -63.92 -40.76 97.22 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.524 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -62.08 -33.17 73.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 123.674 0.609 . . . . 1.0 110.633 -178.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.36 -46.21 84.41 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 123.589 0.556 . . . . 1.0 110.526 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -66.39 -37.68 85.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.193 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.545 ' SD ' HD13 ' A' ' 11' ' ' LEU . 3.8 mtp -62.61 -43.96 97.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.307 0.575 . . . . 1.0 110.633 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -75.9 -25.66 56.26 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.126 -0.488 . . . . 1.0 112.25 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.47 -29.02 68.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.493 0.663 . . . . 1.0 110.991 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -83.87 -32.68 25.08 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.973 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 CA--C 1.497 -1.084 0 CA-C-O 121.607 0.718 . . . . 1.0 112.572 -167.538 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.6 pp . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 113.57 0.952 . . . . 1.0 113.57 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 9.9 p-10 -114.71 153.2 30.7 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.468 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 p -120.73 126.94 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.186 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.75 112.55 24.52 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.597 ' NE1' HG12 ' A' ' 101' ' ' VAL . 2.3 t-105 -91.51 122.65 34.28 Favored 'General case' 0 N--CA 1.383 -3.801 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.951 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.458 HH22 HD21 ' A' ' 14' ' ' LEU . 67.5 mtm180 -110.3 90.13 3.23 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-O 123.025 1.393 . . . . 1.0 107.314 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.6 p -79.72 -17.68 53.0 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.061 -1.881 . . . . 1.0 110.553 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.7 -56.95 4.52 Favored Glycine 0 C--N 1.298 -1.565 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.676 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.83 -43.01 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.505 0.557 . . . . 1.0 112.505 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.54 -10.33 21.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.332 0.587 . . . . 1.0 109.541 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.11 -149.96 19.48 Favored Glycine 0 N--CA 1.418 -2.565 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.656 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 7.2 p80 -105.56 114.0 27.91 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.314 0.578 . . . . 1.0 110.853 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.95 146.74 49.22 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.324 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.5 mm -85.97 115.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.496 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -105.87 143.26 34.25 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.903 0.859 . . . . 1.0 111.768 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.6 m -158.3 146.03 18.26 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 104.238 -2.505 . . . . 1.0 104.238 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.82 -36.2 67.47 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.043 -1.063 . . . . 1.0 111.004 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.432 -1.339 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.228 176.706 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 C--O 1.24 0.597 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -94.24 135.96 35.05 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 119.228 -0.989 . . . . 1.0 110.723 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.4 p -109.46 172.75 6.67 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 125.115 1.366 . . . . 1.0 108.237 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 pp -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.839 -1.145 . . . . 1.0 108.015 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.558 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.62 -25.05 67.79 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.327 -0.851 . . . . 1.0 112.029 177.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -59.55 -41.61 90.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -102.08 -3.44 27.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.578 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 68.1 mmtt 46.26 68.52 0.59 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.223 1.009 . . . . 1.0 112.827 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' NE1' ' A' ' 67' ' ' TRP . 1.5 m -78.3 148.9 75.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.462 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.66 160.58 34.57 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.071 2.514 . . . . 1.0 111.898 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.19 117.93 9.19 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.01 22.17 9.01 Favored Glycine 0 C--N 1.288 -2.135 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.437 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.406 ' O ' HD21 ' A' ' 11' ' ' LEU . . . -69.09 156.8 38.06 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.0 m -120.52 130.35 54.21 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.182 0.515 . . . . 1.0 110.687 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 33.8 m -113.74 165.83 8.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.692 -0.803 . . . . 1.0 111.077 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -148.3 120.81 8.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.311 -0.859 . . . . 1.0 108.961 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.528 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -106.17 137.7 43.64 Favored 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.072 -176.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 29.3 m -126.91 149.77 69.9 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.43 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 73.5 Cg_endo -77.19 63.66 7.76 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 122.858 2.372 . . . . 1.0 113.32 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.401 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 42.1 t . . . . . 0 C--O 1.243 0.759 0 CA-C-O 122.075 0.941 . . . . 1.0 108.928 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.561 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 m-85 . . . . . 0 N--CA 1.405 -2.715 0 N-CA-C 104.544 -2.391 . . . . 1.0 104.544 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -99.78 108.77 53.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 C-N-CA 119.746 -0.782 . . . . 1.0 111.93 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 31.6 Cg_exo -60.66 133.5 48.76 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.691 2.261 . . . . 1.0 110.893 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 tp -126.95 156.27 41.79 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.604 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.1 m -99.91 127.28 46.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.43 HD11 ' CZ2' ' A' ' 67' ' ' TRP . 2.3 mm? -126.56 146.88 49.97 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.061 0.545 . . . . 1.0 110.697 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -96.2 117.1 30.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.927 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.67 113.19 18.69 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 27.2 tp -142.67 155.39 44.91 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 -177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -123.59 140.95 52.48 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.424 -0.511 . . . . 1.0 110.078 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -119.29 36.19 4.56 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.239 0.542 . . . . 1.0 110.444 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.4 t -66.08 -46.44 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.028 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.87 -80.56 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 118.761 -1.685 . . . . 1.0 114.553 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.42 -31.29 94.56 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.097 2.531 . . . . 1.0 112.781 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.89 38.37 2.19 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.149 -1.18 . . . . 1.0 110.149 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -65.23 80.3 0.05 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.682 0.753 . . . . 1.0 112.808 -176.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.14 -1.74 65.18 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -113.93 20.6 15.62 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.472 -1.364 . . . . 1.0 110.177 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.24 -82.14 0.18 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.368 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.79 -56.13 0.26 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.65 91.81 1.11 Allowed Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.49 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.29 126.1 30.41 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -74.8 104.53 1.91 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.719 1.613 . . . . 1.0 111.057 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.436 HG13 HE21 ' A' ' 47' ' ' GLN . 22.0 t -110.71 155.78 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -121.64 148.52 44.45 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.436 -0.906 . . . . 1.0 112.76 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG23 HD21 ' A' ' 11' ' ' LEU . 7.6 m -147.91 -174.29 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 125.071 1.349 . . . . 1.0 108.312 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.2 158.63 16.95 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-O 120.544 0.211 . . . . 1.0 110.662 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -32.07 73.14 Favored 'General case' 0 C--O 1.26 1.629 0 O-C-N 124.224 0.953 . . . . 1.0 109.344 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 t -108.97 37.39 2.57 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.856 -1.52 . . . . 1.0 109.791 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.405 ' O ' HG21 ' A' ' 95' ' ' THR . 11.1 p-10 -68.53 -166.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.267 173.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 p -139.95 146.18 38.85 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 26.5 mm -57.17 -29.37 31.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 118.482 0.583 . . . . 1.0 110.863 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -60.99 -50.18 74.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -73.41 -40.36 64.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.34 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.705 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.95 -39.28 90.3 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.469 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.612 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.1 ttmp? -57.48 -41.85 81.48 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -67.28 -51.84 47.97 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.267 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.705 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 87.4 mmm -62.6 -45.96 90.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.337 0.398 . . . . 1.0 110.998 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.9 pp -77.23 -28.5 53.72 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.51 -29.08 64.02 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.459 1.104 . . . . 1.0 112.775 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.436 HE21 HG13 ' A' ' 29' ' ' VAL . 15.1 mm-40 -64.88 -37.27 87.06 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.581 0.705 . . . . 1.0 110.207 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.317 -0.842 0 CA-C-O 121.98 0.895 . . . . 1.0 109.828 -177.627 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.513 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.503 ' OD2' ' HA ' ' A' ' 112' ' ' CYS . 9.5 m-20 -129.15 165.22 21.72 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.309 -1.367 . . . . 1.0 107.309 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.1 128.92 73.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.616 -0.833 . . . . 1.0 109.859 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -90.23 112.66 24.27 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 106.206 -1.776 . . . . 1.0 106.206 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.43 ' CZ2' HD11 ' A' ' 11' ' ' LEU . 3.4 t-105 -95.08 122.1 37.4 Favored 'General case' 1 N--CA 1.372 -4.325 0 C-N-CA 119.395 -0.922 . . . . 1.0 109.01 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -108.16 89.28 2.95 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.7 t -83.24 -17.7 41.75 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.511 -1.677 . . . . 1.0 109.261 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.13 -58.56 3.17 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 112.728 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.65 -37.16 79.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 122.737 0.415 . . . . 1.0 111.328 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.01 -5.23 30.8 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.777 0.798 . . . . 1.0 109.351 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.12 -140.31 15.01 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.832 -1.077 . . . . 1.0 110.642 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -117.57 120.55 38.4 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.034 0.445 . . . . 1.0 109.915 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.56 146.48 49.66 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -85.01 116.43 28.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 10.6 mp -108.48 155.86 20.13 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.421 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -171.58 172.5 5.0 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 115.004 -0.998 . . . . 1.0 108.485 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -81.5 -2.48 49.92 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.859 -1.064 . . . . 1.0 109.438 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 105.937 -1.875 . . . . 1.0 105.937 168.05 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.42 -1.959 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -74.56 142.39 44.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 -173.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.5 p -105.06 169.41 8.45 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 124.913 1.285 . . . . 1.0 108.709 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.32 -32.73 70.6 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.416 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -62.13 -29.79 70.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.429 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -65.23 -35.21 80.34 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 92.6 m-85 -98.06 8.66 44.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.89 -0.595 . . . . 1.0 112.189 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 52.99 54.63 10.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.045 . . . . 1.0 111.334 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.8 t -74.86 124.37 89.53 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.779 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.0 159.1 27.23 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.525 2.816 . . . . 1.0 112.191 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.39 117.99 10.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.071 -0.513 . . . . 1.0 109.87 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.88 18.3 14.3 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.291 -0.957 . . . . 1.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.01 27.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.027 0.441 . . . . 1.0 110.554 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -115.8 132.06 56.75 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 122.066 -0.397 . . . . 1.0 111.076 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 m -114.03 138.68 43.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.98 135.26 49.68 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.42 0.628 . . . . 1.0 110.773 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.568 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 94.6 mt -95.43 129.26 42.65 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 19.0 m -132.84 142.38 44.52 Favored Pre-proline 0 C--N 1.31 -1.15 0 O-C-N 123.172 0.295 . . . . 1.0 110.284 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.37 79.6 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.14 1.893 . . . . 1.0 110.664 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.513 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 3.1 t . . . . . 0 C--N 1.323 -0.547 0 C-N-CA 125.931 1.692 . . . . 1.0 111.411 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 26.8 m-85 . . . . . 0 N--CA 1.406 -2.657 0 N-CA-C 105.025 -2.213 . . . . 1.0 105.025 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.458 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 20.1 mmt180 -104.01 108.17 59.17 Favored Pre-proline 0 C--N 1.277 -2.572 0 C-N-CA 119.384 -0.926 . . . . 1.0 111.841 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -59.43 131.45 40.73 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.255 1.97 . . . . 1.0 110.763 175.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -136.41 159.93 40.27 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.085 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.1 m -95.22 131.26 41.46 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 105' ' ' ALA . 27.1 tp -127.66 142.09 51.43 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -99.88 113.35 25.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.784 -0.572 . . . . 1.0 110.604 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.51 112.69 14.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.626 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.437 HD23 ' HA2' ' A' ' 22' ' ' GLY . 31.3 tp -142.01 152.67 43.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.573 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.02 140.2 53.21 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.881 -0.512 . . . . 1.0 110.897 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.42 41.74 3.03 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.622 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.88 -45.2 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 CA-C-N 116.546 -0.297 . . . . 1.0 110.546 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.32 -75.29 0.18 Allowed Glycine 0 C--O 1.22 -0.729 0 C-N-CA 119.777 -1.202 . . . . 1.0 113.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.51 -27.38 76.76 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.53 2.82 . . . . 1.0 113.307 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.69 34.41 2.88 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.68 76.3 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 114.19 -10.81 22.35 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 173.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -109.88 8.66 24.46 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.948 -0.626 . . . . 1.0 111.613 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.87 -86.54 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.321 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -132.38 -61.69 0.86 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.23 71.31 1.08 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.854 -1.165 . . . . 1.0 110.535 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.34 125.33 38.11 Favored Pre-proline 0 C--N 1.306 -1.323 0 O-C-N 122.898 -0.177 . . . . 1.0 110.818 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.46 101.79 1.54 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.021 1.814 . . . . 1.0 111.757 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.515 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 45.7 t -104.99 155.42 6.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.465 -1.309 . . . . 1.0 107.465 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -102.31 150.04 23.73 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.813 -1.155 . . . . 1.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 32' ' ' LEU . 4.4 p -148.26 -178.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.05 -0.977 . . . . 1.0 108.709 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.434 ' H ' HG23 ' A' ' 31' ' ' VAL . 14.4 mt -110.92 162.29 14.98 Favored 'General case' 0 C--O 1.179 -2.617 0 CA-C-N 118.39 0.541 . . . . 1.0 110.852 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 18.0 t70 -65.11 -31.3 72.44 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-O 121.407 0.623 . . . . 1.0 110.88 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.437 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -102.85 28.6 6.03 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.334 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.684 ' O ' ' HA ' ' A' ' 95' ' ' THR . 17.1 p-10 -67.75 135.54 52.85 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -91.08 157.05 17.46 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 45.0 mm -55.86 -40.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.889 0.376 . . . . 1.0 110.446 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 p -62.8 -43.96 97.43 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.294 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -73.15 -37.69 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 1.0 111.677 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.68 -38.39 89.13 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.37 -41.49 72.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -68.32 -47.75 66.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.261 -0.882 . . . . 1.0 110.846 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.83 -44.6 92.73 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.994 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.0 mmm -64.99 -42.76 94.23 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.567 0.542 . . . . 1.0 110.621 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -74.24 -29.33 61.64 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.818 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.08 -30.89 62.66 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.228 1.011 . . . . 1.0 112.539 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.444 HE21 HG12 ' A' ' 29' ' ' VAL . 14.3 mm-40 -70.38 -37.13 74.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.162 0.506 . . . . 1.0 111.283 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.504 -0.822 0 CA-C-O 122.124 0.964 . . . . 1.0 109.654 -176.384 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.3 pp . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 109.908 -0.404 . . . . 1.0 109.908 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' CG ' ' HA ' ' A' ' 112' ' ' CYS . 0.1 OUTLIER -115.02 157.7 23.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 -177.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.09 121.87 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -91.55 112.72 24.75 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 105.792 -1.929 . . . . 1.0 105.792 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.617 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -86.49 128.72 34.99 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.906 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.98 89.84 3.18 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.4 m -90.1 -17.07 28.36 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.428 -0.909 . . . . 1.0 109.409 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.25 -46.88 3.48 Favored Glycine 0 C--N 1.309 -0.969 0 CA-C-N 114.998 -1.001 . . . . 1.0 112.306 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.35 -27.06 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.146 0.578 . . . . 1.0 111.439 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.405 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . . . -124.08 4.37 8.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.584 0.707 . . . . 1.0 109.775 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.13 -130.43 10.23 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.882 -1.054 . . . . 1.0 113.55 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.34 123.97 46.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 125.144 1.377 . . . . 1.0 108.665 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -132.05 148.43 52.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 mm -94.55 116.11 35.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.282 -0.567 . . . . 1.0 109.616 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.429 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.1 mp -111.03 158.02 19.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.061 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -158.0 159.7 36.69 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.851 -1.907 . . . . 1.0 105.851 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 17.7 p-10 -66.71 -53.74 30.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.237 -0.585 . . . . 1.0 110.384 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--N 1.294 -1.807 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.141 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 89.0 mt . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -73.6 143.21 46.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.646 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -120.58 165.96 14.3 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 124.641 1.176 . . . . 1.0 108.799 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.39 -28.53 69.33 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.476 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.41 -25.93 68.23 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.483 177.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -64.72 -39.4 93.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.472 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -88.5 -19.22 26.72 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 115.506 -0.77 . . . . 1.0 109.79 176.273 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm 53.03 60.83 3.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.77 0.828 . . . . 1.0 110.957 -171.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.617 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.3 m -76.62 150.46 82.0 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 113.185 0.809 . . . . 1.0 113.185 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 162.12 28.41 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 123.501 2.801 . . . . 1.0 111.307 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.19 130.97 45.06 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.611 0.719 . . . . 1.0 109.748 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.42 17.74 44.75 Favored Glycine 0 C--N 1.284 -2.313 0 CA-C-N 114.979 -1.01 . . . . 1.0 111.58 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.439 ' O ' HD11 ' A' ' 11' ' ' LEU . . . -62.64 151.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 43.7 m -108.0 127.65 53.96 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.213 0.53 . . . . 1.0 110.995 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.5 m -109.74 141.36 25.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.79 52.66 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.703 0.763 . . . . 1.0 110.596 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.573 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.3 tt -95.18 122.91 38.35 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.319 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 13.7 m -128.05 145.39 55.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.15 55.95 5.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.875 2.384 . . . . 1.0 113.511 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.466 ' HA ' ' CG ' ' A' ' 64' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.51 -0.585 0 C-N-CA 124.586 1.154 . . . . 1.0 111.233 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp . . . . . 0 C--O 1.236 0.387 0 CA-C-O 121.093 0.473 . . . . 1.0 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.7 100.19 10.84 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -127.09 88.56 2.83 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.809 -1.182 . . . . 1.0 107.809 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.7 p -122.26 7.65 5.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-O 122.001 0.905 . . . . 1.0 110.118 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -89.82 61.53 5.4 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.48 1.133 . . . . 1.0 110.446 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.86 161.59 39.64 Favored 'General case' 0 N--CA 1.394 -3.232 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 17.8 mmt180 -124.11 115.9 27.41 Favored Pre-proline 0 C--N 1.263 -3.158 0 C-N-CA 119.893 -0.723 . . . . 1.0 111.632 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.38 109.18 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.785 1.657 . . . . 1.0 108.334 168.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 tp -113.04 158.49 20.25 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.212 -0.903 . . . . 1.0 111.001 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 m -103.56 127.61 50.94 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD21 ' SD ' ' A' ' 44' ' ' MET . 14.8 tp -126.94 139.83 52.77 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.41 HD21 HG21 ' A' ' 106' ' ' THR . 6.4 t30 -96.72 114.0 25.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.39 114.73 13.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.799 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 12.8 tp -142.14 167.34 22.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.7 pt? -135.94 144.96 45.73 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -110.94 30.76 6.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.909 0.385 . . . . 1.0 111.034 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 71.5 t -65.94 -47.79 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.816 0 CA-C-N 115.897 -0.592 . . . . 1.0 112.383 -175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.4 -81.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.2 -1.476 . . . . 1.0 113.819 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.63 -27.67 83.64 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 123.599 2.866 . . . . 1.0 112.821 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.91 37.63 2.02 Favored Glycine 0 N--CA 1.408 -3.173 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.68 48.97 0.09 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.465 0.913 . . . . 1.0 113.465 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.42 -3.78 3.65 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.795 -0.922 . . . . 1.0 110.795 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.02 29.75 2.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.06 0.457 . . . . 1.0 111.597 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.96 -76.03 0.27 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -140.76 -63.83 0.47 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.585 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.19 88.84 0.59 Allowed Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.273 -0.965 . . . . 1.0 111.089 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.6 126.54 28.93 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.86 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.937 1.758 . . . . 1.0 111.86 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.413 HG12 HE21 ' A' ' 47' ' ' GLN . 13.9 t -112.34 155.35 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -107.67 144.28 34.97 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 m -142.21 -175.22 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 113.598 -1.637 . . . . 1.0 109.504 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.3 158.88 25.19 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 110.27 -0.27 . . . . 1.0 110.27 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.496 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.1 t70 -66.43 -31.33 72.02 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.6 t -103.27 33.36 3.34 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.872 -1.513 . . . . 1.0 109.491 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.463 ' O ' HG22 ' A' ' 95' ' ' THR . 12.8 p-10 -71.58 -165.76 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.216 -0.902 . . . . 1.0 109.013 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 50.1 p -139.07 157.92 45.11 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 169.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 39.5 mm -59.22 -41.41 83.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.91 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.559 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 13.5 m -61.8 -43.47 98.79 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.861 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.87 -41.21 75.11 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.207 0.527 . . . . 1.0 111.196 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.88 -39.16 93.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.491 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.51 -40.53 75.16 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.429 176.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.559 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mt-10 -68.59 -47.9 65.57 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 123.754 0.659 . . . . 1.0 110.778 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -63.58 -44.03 95.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.232 0.333 . . . . 1.0 111.621 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.2 mmm -65.03 -40.85 95.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.47 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.517 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 4.0 pp -74.45 -33.18 62.85 Favored 'General case' 0 C--O 1.188 -2.147 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.098 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -51.6 -31.15 23.82 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 124.951 1.301 . . . . 1.0 112.932 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.413 HE21 HG12 ' A' ' 29' ' ' VAL . 11.5 mm-40 -69.48 -36.61 76.71 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.722 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -97.32 -39.33 9.28 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 122.044 0.926 . . . . 1.0 110.058 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.517 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 25.3 m-85 -96.48 32.51 2.0 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 125.469 1.508 . . . . 1.0 109.676 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -53.55 119.43 4.87 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.63 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.4 -6.06 49.37 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.092 -0.575 . . . . 1.0 112.527 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.9 t -77.89 122.9 86.22 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-O 120.718 0.294 . . . . 1.0 111.365 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -66.84 165.43 25.92 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.707 2.938 . . . . 1.0 112.285 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.13 -42.8 99.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.535 0.569 . . . . 1.0 112.535 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.4 t -66.26 -23.09 66.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.939 0.4 . . . . 1.0 111.803 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -89.02 -25.27 22.08 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 111.779 0.289 . . . . 1.0 111.779 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -66.21 116.71 36.07 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.31 140.33 58.04 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.621 2.214 . . . . 1.0 113.094 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.47 142.25 57.81 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.11 9.29 0.67 Allowed 'Trans proline' 0 N--CA 1.483 0.867 0 C-N-CA 123.174 2.583 . . . . 1.0 113.699 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -94.56 -31.29 13.96 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.412 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.61 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 12.8 t -90.96 -23.2 20.51 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 121.33 0.586 . . . . 1.0 110.606 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -126.14 147.93 49.51 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 172.162 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.17 138.17 39.47 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.53 117.14 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.446 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -91.34 111.82 23.47 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 105.836 -1.913 . . . . 1.0 105.836 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.633 ' CE2' HG13 ' A' ' 101' ' ' VAL . 3.9 t-105 -88.72 126.04 35.14 Favored 'General case' 0 N--CA 1.39 -3.446 0 CA-C-N 115.197 -0.911 . . . . 1.0 108.927 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.86 88.98 2.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 107.057 -1.46 . . . . 1.0 107.057 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.428 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 62.7 p -71.33 -27.24 63.24 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.483 -1.235 . . . . 1.0 110.082 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 -57.31 4.84 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.484 -1.235 . . . . 1.0 110.7 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.9 m -64.29 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 120.924 0.393 . . . . 1.0 111.895 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.48 -1.4 30.68 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.557 0.694 . . . . 1.0 110.354 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.71 -119.7 6.31 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.549 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 27.8 p-80 -140.42 138.26 34.61 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.604 0.24 . . . . 1.0 110.742 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.0 tp -134.73 144.48 47.76 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.62 118.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.854 -1.165 . . . . 1.0 107.854 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD21 ' CE3' ' A' ' 67' ' ' TRP . 10.2 mp -107.71 157.6 17.97 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.4 0.619 . . . . 1.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.3 m -157.32 160.32 38.4 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.17 -48.06 77.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -126.59 111.02 13.85 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.676 0.75 . . . . 1.0 109.14 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 25.8 t70 -116.3 -82.92 0.63 Allowed 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 122.66 1.219 . . . . 1.0 108.105 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.401 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 8.6 p -76.4 -19.73 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.558 0 CA-C-N 112.962 -1.926 . . . . 1.0 108.655 177.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.9 p -98.25 6.93 46.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.12 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 t -76.02 -4.6 42.14 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.371 -0.832 . . . . 1.0 110.522 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -76.1 118.33 18.74 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.49 0.662 . . . . 1.0 110.392 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.39 91.69 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -143.03 -19.59 0.65 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.426 -1.261 . . . . 1.0 110.602 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.98 -112.67 0.26 Allowed Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 110.273 -1.131 . . . . 1.0 110.273 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 pp -87.97 -3.88 58.87 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -63.25 -30.69 71.78 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -64.79 105.83 1.08 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -156.99 143.61 18.33 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.615 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.9 mt -77.59 138.81 39.36 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -85.06 142.24 29.69 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.942 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.48 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.1 p -107.32 168.39 9.26 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 124.604 1.162 . . . . 1.0 108.53 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD12 HG21 ' A' ' 101' ' ' VAL . 4.0 pp -72.97 -24.33 60.77 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.064 173.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.48 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.36 -26.54 68.51 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.335 176.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -66.05 -41.7 90.48 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.6 t80 -80.05 -16.26 55.45 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.653 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 58.78 52.12 6.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.778 0.831 . . . . 1.0 110.983 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.633 HG13 ' CE2' ' A' ' 67' ' ' TRP . 0.7 OUTLIER -78.36 146.83 71.14 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 113.346 0.869 . . . . 1.0 113.346 -178.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.16 158.41 26.63 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 123.481 2.788 . . . . 1.0 112.155 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.55 122.65 18.05 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.437 0.637 . . . . 1.0 109.542 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.68 21.85 10.88 Favored Glycine 0 C--N 1.288 -2.131 0 C-N-CA 120.309 -0.948 . . . . 1.0 110.852 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.411 ' O ' HD13 ' A' ' 11' ' ' LEU . . . -74.62 162.52 28.68 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.41 HG21 HD21 ' A' ' 12' ' ' ASN . 87.4 m -114.52 133.52 55.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 120.783 0.325 . . . . 1.0 110.389 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.5 m -115.74 136.27 53.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.19 144.55 51.01 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.13 147.72 46.49 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.825 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.24 136.17 27.65 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.242 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.5 82.42 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.258 1.972 . . . . 1.0 111.97 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 62' ' ' THR . 4.3 p 45.68 66.95 0.81 Allowed 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 125.148 1.379 . . . . 1.0 111.477 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -113.71 -50.77 2.82 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 114.676 -1.147 . . . . 1.0 110.839 -173.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.0 t -144.89 71.79 1.31 Allowed 'General case' 0 N--CA 1.412 -2.332 0 CA-C-O 122.014 0.911 . . . . 1.0 113.264 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 65.87 4.27 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.218 -0.993 . . . . 1.0 109.699 172.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -80.02 102.75 9.46 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.04 -170.74 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 114.573 -1.194 . . . . 1.0 108.918 -173.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 pp -59.73 137.11 58.14 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.519 0.676 . . . . 1.0 110.001 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -118.8 161.99 19.22 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.487 -0.779 . . . . 1.0 109.885 -174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.96 114.24 21.1 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 122.156 0.979 . . . . 1.0 109.961 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -163.14 127.26 2.92 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 . . . . . 0 N--CA 1.422 -1.843 0 C-N-CA 120.196 -0.602 . . . . 1.0 109.873 177.783 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 120.769 0.319 . . . . 1.0 110.613 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -123.35 76.0 1.36 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.073 -1.084 . . . . 1.0 108.073 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -85.35 81.87 8.58 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.635 -1.166 . . . . 1.0 109.748 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 p -138.73 80.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-O 122.234 1.016 . . . . 1.0 111.36 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.06 74.11 1.28 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 122.813 1.292 . . . . 1.0 109.618 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -145.23 165.04 29.52 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 114.317 -1.31 . . . . 1.0 108.842 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.453 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 23.0 mmt180 -119.3 116.4 33.76 Favored Pre-proline 0 C--N 1.268 -2.961 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.208 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.32 104.82 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 107.35 -1.827 . . . . 1.0 107.35 167.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.428 ' HG ' ' H ' ' A' ' 10' ' ' THR . 3.2 tp -110.82 159.72 17.4 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.648 -0.705 . . . . 1.0 111.036 -171.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.428 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 24.3 m -108.51 125.95 52.37 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.468 HD21 ' SD ' ' A' ' 44' ' ' MET . 20.0 tp -127.45 141.89 51.55 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -96.45 114.73 26.43 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 122.405 -0.184 . . . . 1.0 110.857 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.14 119.96 20.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.171 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.618 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 13.4 tp -148.46 163.27 37.67 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.55 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -129.58 144.12 51.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.017 -0.427 . . . . 1.0 110.079 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -112.85 37.17 3.19 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.913 0.387 . . . . 1.0 111.023 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.85 -44.31 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.314 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.813 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.07 -88.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.4 -1.381 . . . . 1.0 113.888 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.31 -37.82 88.57 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.906 2.404 . . . . 1.0 113.139 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.48 33.74 5.38 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -70.58 48.51 0.11 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.468 0.914 . . . . 1.0 113.468 -176.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.85 -12.38 1.47 Allowed Glycine 0 C--N 1.299 -1.49 0 C-N-CA 120.68 -0.771 . . . . 1.0 112.402 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.88 25.47 5.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.089 0.471 . . . . 1.0 111.432 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.8 -77.38 0.19 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -129.56 -58.77 1.1 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.467 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 75.61 0.61 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 1.0 111.591 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.35 125.18 38.59 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 110.277 -0.268 . . . . 1.0 110.277 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.43 102.07 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.859 1.706 . . . . 1.0 111.045 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG12 HE21 ' A' ' 47' ' ' GLN . 15.0 t -111.02 155.06 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.52 143.71 38.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 113.746 1.017 . . . . 1.0 113.746 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.6 -175.19 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 113.74 -1.573 . . . . 1.0 109.165 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.45 157.61 27.9 Favored 'General case' 0 C--O 1.191 -1.988 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.453 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 31.7 t70 -66.06 -31.54 72.47 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.87 0.731 . . . . 1.0 109.124 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.2 t -104.99 37.2 2.22 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 114.034 -1.439 . . . . 1.0 109.552 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 95' ' ' THR . 14.2 p-10 -71.83 -161.44 0.07 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.633 -1.167 . . . . 1.0 109.121 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.0 p -143.87 155.16 44.0 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 103.71 -2.7 . . . . 1.0 103.71 167.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mm -57.69 -39.54 70.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 118.614 0.643 . . . . 1.0 110.357 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 m -61.26 -43.95 98.04 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.512 175.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -68.17 -41.47 81.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.519 0.328 . . . . 1.0 110.74 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.95 -38.66 91.71 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.101 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -40.9 73.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 38' ' ' SER . 45.9 mt-10 -68.71 -51.78 37.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.67 0.606 . . . . 1.0 111.379 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.06 -42.43 99.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.807 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.5 mmm -65.21 -41.06 94.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.25 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.88 -30.47 58.85 Favored 'General case' 0 C--O 1.201 -1.493 0 C-N-CA 120.71 -0.396 . . . . 1.0 112.028 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.404 ' O ' ' HE3' ' A' ' 50' ' ' LYS . 25.7 t70 -53.99 -31.4 50.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.536 1.134 . . . . 1.0 112.438 -173.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.405 HE21 HG12 ' A' ' 29' ' ' VAL . 13.6 mm-40 -68.83 -40.06 79.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 1.0 110.551 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -95.82 -41.86 8.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.875 0.845 . . . . 1.0 110.855 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -95.74 28.65 2.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 125.39 1.476 . . . . 1.0 110.046 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.404 ' HE3' ' O ' ' A' ' 46' ' ' ASP . 4.5 tppp? -51.31 123.7 10.21 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.453 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.84 1.21 34.26 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.687 -0.768 . . . . 1.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 t -89.45 121.0 69.67 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.69 167.75 18.46 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 123.416 2.744 . . . . 1.0 111.683 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.97 -42.7 98.85 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.496 0.554 . . . . 1.0 112.496 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 t -70.81 -20.62 62.56 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.159 0.504 . . . . 1.0 111.473 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -88.92 -6.78 57.04 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.738 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -82.18 117.01 66.84 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 108.493 -0.928 . . . . 1.0 108.493 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.7 143.68 75.28 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.777 2.318 . . . . 1.0 113.342 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 61' ' ' ARG . 10.0 m-20 -77.61 135.39 64.57 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.133 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.06 12.35 0.46 Allowed 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.322 2.681 . . . . 1.0 112.962 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 59' ' ' ASP . 2.6 ptm180 -93.53 -13.38 27.86 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.031 177.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.1 t -117.42 -2.97 11.44 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.792 0.33 . . . . 1.0 111.88 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.51 151.8 42.02 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 174.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 115' ' ' LYS . 16.7 m-20 -103.48 139.42 38.86 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 120.026 -0.669 . . . . 1.0 111.054 -171.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.61 115.07 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 N-CA-C 106.596 -1.631 . . . . 1.0 106.596 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.392 -3.345 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.622 ' CE2' HG13 ' A' ' 101' ' ' VAL . 4.6 t-105 -85.93 124.15 32.07 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.505 -1.225 . . . . 1.0 109.327 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -111.5 89.19 2.98 Favored 'General case' 0 N--CA 1.396 -3.127 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.401 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 57.9 p -68.12 -31.59 71.29 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.087 -1.415 . . . . 1.0 109.924 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.55 -50.61 4.36 Favored Glycine 0 C--N 1.303 -1.294 0 CA-C-N 114.359 -1.291 . . . . 1.0 111.343 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.21 -39.95 85.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 122.872 0.469 . . . . 1.0 111.897 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.25 -29.51 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.164 0.507 . . . . 1.0 110.073 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.15 -120.95 3.21 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 10.7 p-80 -136.32 136.75 39.98 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.611 0.243 . . . . 1.0 110.701 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.6 tp -134.94 145.27 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -83.43 117.48 29.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.47 HD21 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -110.53 151.2 27.87 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-O 121.306 0.574 . . . . 1.0 110.816 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 m -159.14 161.4 36.28 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 105.203 -2.147 . . . . 1.0 105.203 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -64.7 -37.98 89.45 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.494 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 14.2 pt-20 -125.35 112.41 16.3 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.055 172.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -134.9 -87.26 0.38 Allowed 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.2 p -72.84 -23.14 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.4 0 CA-C-N 113.479 -1.691 . . . . 1.0 108.408 176.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.3 p -99.47 4.19 45.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.696 -1.593 . . . . 1.0 111.109 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.494 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 35.4 t -67.2 -17.92 65.03 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.796 -0.638 . . . . 1.0 112.65 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.51 137.29 34.65 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.674 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -118.11 94.15 2.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -151.81 -14.11 0.19 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.309 -0.86 . . . . 1.0 112.435 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.94 -109.24 0.24 Allowed Glycine 0 N--CA 1.424 -2.115 0 C-N-CA 120.304 -0.951 . . . . 1.0 111.287 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.25 -9.65 59.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.263 0.554 . . . . 1.0 112.193 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -64.2 -46.61 83.16 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 115.102 -0.954 . . . . 1.0 112.974 -176.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -68.22 106.1 2.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.355 0.598 . . . . 1.0 111.927 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -164.26 144.53 8.01 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 92.6 mt -75.32 142.12 43.27 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -85.09 138.59 32.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.058 -0.657 . . . . 1.0 111.099 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -113.84 169.04 9.28 Favored 'General case' 0 C--O 1.26 1.637 0 C-N-CA 125.061 1.344 . . . . 1.0 108.489 178.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.33 -24.34 61.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 118.751 -1.18 . . . . 1.0 109.145 173.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.466 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -63.98 -26.11 68.43 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.705 176.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -65.25 -40.02 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.6 t80 -85.44 -15.79 41.83 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.409 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 57.44 51.19 10.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.112 0.965 . . . . 1.0 110.422 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.622 HG13 ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -74.62 148.28 85.27 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.31 157.08 29.48 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.247 2.631 . . . . 1.0 112.743 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.36 120.15 12.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.06 16.87 11.63 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 110.861 -0.895 . . . . 1.0 110.861 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.97 162.67 28.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.044 0.45 . . . . 1.0 110.579 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m -115.98 133.29 56.18 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.38 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.24 137.94 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 C-N-CA 120.593 -0.443 . . . . 1.0 109.982 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -128.46 139.88 52.11 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 177.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.55 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.39 147.52 40.44 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.934 -178.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.503 HG21 ' H ' ' A' ' 114' ' ' THR . 16.5 m -139.45 151.46 66.84 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.187 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.16 72.66 5.81 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.522 2.148 . . . . 1.0 111.152 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 p 45.49 76.85 0.09 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.027 1.331 . . . . 1.0 110.399 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.08 -40.12 0.32 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 113.353 0.871 . . . . 1.0 113.353 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.503 ' H ' HG21 ' A' ' 110' ' ' VAL . 6.3 t -98.23 10.79 39.77 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.688 0.756 . . . . 1.0 112.045 -170.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HD2' ' OD1' ' A' ' 64' ' ' ASP . 20.5 ptmt -81.84 114.96 20.81 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.916 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -95.94 104.79 16.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.957 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.27 147.61 6.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.935 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.44 148.65 44.87 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.123 0.487 . . . . 1.0 111.568 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -100.22 169.41 9.16 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.0 124.47 32.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.87 106.83 11.22 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.56 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 C--N 1.284 -2.25 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 176.109 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 59.1 tptt . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.79 134.26 3.68 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 106.635 -1.617 . . . . 1.0 106.635 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -81.86 77.51 8.68 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.849 0.833 . . . . 1.0 112.179 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.8 t -119.45 81.1 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-N 114.429 -1.26 . . . . 1.0 107.999 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -126.84 82.79 2.11 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 122.517 1.151 . . . . 1.0 108.522 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -126.14 -178.12 4.2 Favored 'General case' 0 N--CA 1.403 -2.808 0 N-CA-C 105.914 -1.884 . . . . 1.0 105.914 -176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -109.25 106.92 59.36 Favored Pre-proline 0 C--N 1.273 -2.74 0 C-N-CA 118.877 -1.129 . . . . 1.0 109.74 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -64.59 111.6 1.72 Allowed 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.87 1.713 . . . . 1.0 108.22 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 10' ' ' THR . 5.8 tp -115.48 159.43 21.19 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-O 121.248 0.547 . . . . 1.0 111.368 -172.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.408 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 31.2 m -111.5 132.59 54.39 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 176.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -125.05 154.58 41.1 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 123.486 0.714 . . . . 1.0 111.065 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -98.93 106.69 18.98 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.384 -0.825 . . . . 1.0 108.868 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.48 112.92 8.0 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.878 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.422 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 29.4 tp -144.6 149.98 36.68 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -122.9 143.84 49.62 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 122.27 -0.269 . . . . 1.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -113.57 29.92 7.63 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.164 0.506 . . . . 1.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.7 t -64.19 -47.03 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 CA-C-N 115.608 -0.724 . . . . 1.0 112.222 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.47 -78.69 0.1 OUTLIER Glycine 0 C--O 1.213 -1.17 0 C-N-CA 119.079 -1.534 . . . . 1.0 113.8 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.0 -28.75 87.76 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 123.012 2.475 . . . . 1.0 113.106 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.56 33.14 3.35 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.19 79.09 0.35 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.86 9.29 37.76 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.9 30.75 0.71 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.406 0.622 . . . . 1.0 110.925 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 -75.37 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.295 -0.562 . . . . 1.0 112.068 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.88 -67.43 0.44 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.964 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 77.23 0.91 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.131 -1.588 . . . . 1.0 109.131 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.49 130.42 23.09 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.428 -0.386 . . . . 1.0 110.541 -173.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -72.5 104.51 1.72 Allowed 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.128 1.885 . . . . 1.0 111.431 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.584 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 25.5 t -114.04 155.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.247 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -104.6 146.14 29.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.728 0.299 . . . . 1.0 111.542 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.74 -174.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 124.79 1.236 . . . . 1.0 109.496 -178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 mt -122.37 167.71 12.96 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 123.049 0.54 . . . . 1.0 110.065 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -65.77 -31.28 72.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.73 -0.841 . . . . 1.0 108.73 175.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 t -112.94 19.82 16.95 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 114.344 1.238 . . . . 1.0 114.344 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.336 24.6 p-10 -85.22 140.2 31.07 Favored 'General case' 0 N--CA 1.415 -2.211 0 C-N-CA 115.853 -2.339 . . . . 1.0 109.411 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -75.17 166.42 23.68 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.637 -1.165 . . . . 1.0 110.852 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -59.31 -41.1 83.12 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.599 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -59.83 -48.1 83.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -73.11 -44.91 59.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.365 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.13 -36.53 82.08 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.593 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 34.1 ttpt -61.74 -34.9 76.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.679 ' HG3' ' O ' ' A' ' 38' ' ' SER . 61.3 mt-10 -65.85 -46.95 76.58 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.043 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -61.8 -41.77 98.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 123.301 0.376 . . . . 1.0 111.408 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.584 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.6 mmt -61.42 -48.56 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.129 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -77.48 -24.52 50.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.762 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 16.4 t70 -58.04 -34.08 69.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.771 0.828 . . . . 1.0 111.828 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -66.36 -31.92 72.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.521 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.09 -43.39 8.14 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.011 0.434 . . . . 1.0 111.182 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.762 ' CE2' ' HA ' ' A' ' 46' ' ' ASP . 1.1 p90 -75.39 -11.67 60.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.824 -0.625 . . . . 1.0 112.069 -175.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -57.74 114.76 2.43 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.6 5.93 66.38 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.91 -0.586 . . . . 1.0 112.438 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -100.98 147.83 34.24 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 17.8 Cg_endo -60.33 154.57 51.94 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.015 2.477 . . . . 1.0 112.27 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.41 -43.23 96.93 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.344 0.658 . . . . 1.0 112.057 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -69.45 -17.27 63.62 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -89.39 -15.4 33.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.307 0.575 . . . . 1.0 110.433 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.416 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 94.1 mtt180 -76.9 135.16 67.65 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.881 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.07 151.24 61.4 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 122.468 2.112 . . . . 1.0 110.999 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -91.23 102.95 6.33 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 116.224 -0.443 . . . . 1.0 109.908 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.21 -24.12 72.55 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.239 1.959 . . . . 1.0 112.86 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -68.79 -22.21 64.29 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.516 0.562 . . . . 1.0 112.516 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -119.02 17.27 13.31 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.942 0.401 . . . . 1.0 110.868 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.95 143.16 51.36 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 119.838 -0.745 . . . . 1.0 112.001 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 12.6 p-10 -107.26 166.3 10.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.642 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.56 126.43 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.56 0.695 . . . . 1.0 110.276 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -94.66 113.51 25.31 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 105.636 -1.987 . . . . 1.0 105.636 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.629 ' CE2' HG12 ' A' ' 101' ' ' VAL . 5.0 t-105 -89.85 137.18 32.56 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.742 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.31 88.99 3.04 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 107.327 -1.36 . . . . 1.0 107.327 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.402 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 68.4 p -72.5 -31.84 65.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.251 1.024 . . . . 1.0 108.731 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.93 -55.1 4.62 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 113.708 -1.587 . . . . 1.0 110.525 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -64.27 -42.3 95.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.476 -0.362 . . . . 1.0 111.54 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.41 -21.44 15.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.217 0.532 . . . . 1.0 109.677 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.21 -130.78 9.95 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.142 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.541 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 63.2 m-70 -111.42 122.49 47.98 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 123.322 0.649 . . . . 1.0 109.505 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.52 136.89 43.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 114' ' ' THR . 16.1 mm -84.21 123.1 38.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.866 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.595 HD21 ' CE3' ' A' ' 67' ' ' TRP . 9.9 mp -108.58 150.48 27.43 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.483 0.658 . . . . 1.0 111.427 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.524 ' OG ' HG11 ' A' ' 82' ' ' VAL . 10.9 m -152.09 150.94 30.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.34 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.2 p30 -74.21 -41.15 61.84 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.839 -0.619 . . . . 1.0 109.9 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -153.05 63.63 0.77 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.799 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.461 ' HB2' ' CB ' ' A' ' 78' ' ' SER . 11.2 m-20 -143.92 -103.84 0.12 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.243 -0.583 . . . . 1.0 112.433 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG11 ' OG ' ' A' ' 78' ' ' SER . 8.9 p -68.39 -41.39 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.617 0.969 . . . . 1.0 113.617 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.566 HG22 ' ND2' ' A' ' 94' ' ' ASN . 9.1 t -97.19 16.51 19.61 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.894 0.854 . . . . 1.0 110.535 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 m -128.15 112.99 15.15 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.896 -1.15 . . . . 1.0 107.896 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -76.2 114.0 14.38 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.56 0.695 . . . . 1.0 110.287 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -103.87 77.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 123.208 1.48 . . . . 1.0 110.1 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -141.22 21.3 2.25 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.525 -1.671 . . . . 1.0 109.99 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.18 -140.51 7.41 Favored Glycine 1 N--CA 1.385 -4.722 0 N-CA-C 108.586 -1.806 . . . . 1.0 108.586 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.532 ' H ' HD21 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -79.84 4.71 15.71 Favored 'General case' 0 C--N 1.262 -3.21 0 C-N-CA 124.272 1.029 . . . . 1.0 111.229 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -77.05 -14.36 59.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.905 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -67.85 105.33 1.94 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 153.41 42.75 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.315 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 70.3 mt -79.66 129.99 34.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.566 ' ND2' HG22 ' A' ' 83' ' ' THR . 68.5 m-80 -90.45 159.87 16.33 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.711 -177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.2 p -119.21 -178.95 3.7 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.056 0.942 . . . . 1.0 108.503 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -78.71 -19.71 51.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.464 -1.294 . . . . 1.0 109.532 175.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -66.71 -25.79 66.7 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 120.979 0.418 . . . . 1.0 110.518 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -62.16 -35.33 78.47 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.5 t80 -97.25 -16.43 20.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.334 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.52 59.59 4.05 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.703 0.801 . . . . 1.0 110.282 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.629 HG12 ' CE2' ' A' ' 67' ' ' TRP . 1.8 m -73.98 146.8 85.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 119.909 -0.716 . . . . 1.0 112.139 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.56 162.46 35.65 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.793 2.328 . . . . 1.0 112.074 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.06 128.82 37.49 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.642 -0.708 . . . . 1.0 109.37 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.33 25.27 40.34 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.55 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.94 160.19 31.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.984 0.421 . . . . 1.0 110.205 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.5 m -110.78 134.16 52.73 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.121 0.486 . . . . 1.0 110.232 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.54 HG22 ' SD ' ' A' ' 44' ' ' MET . 16.1 m -113.25 155.76 14.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 176.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -135.01 130.05 35.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 172.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.59 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 mp -102.33 130.71 49.13 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.04 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.9 m -134.57 149.48 71.06 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.5 82.21 2.54 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 121.939 1.76 . . . . 1.0 112.4 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.43 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 8.7 p 49.6 57.87 6.05 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 125.148 1.379 . . . . 1.0 111.18 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.82 -48.92 3.31 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.92 -1.036 . . . . 1.0 112.641 -172.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 76' ' ' ILE . 11.6 t -122.12 23.63 9.81 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 113.913 1.079 . . . . 1.0 113.913 -170.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.501 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 18.5 pttp -79.55 18.74 0.7 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.611 0.72 . . . . 1.0 112.67 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -85.5 155.43 21.22 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.627 -1.619 . . . . 1.0 106.627 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 m -68.85 139.92 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.43 -162.31 1.0 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.34 -1.726 . . . . 1.0 106.34 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -66.42 112.89 4.28 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 108.315 -0.995 . . . . 1.0 108.315 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -82.78 85.23 7.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.426 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -116.69 95.71 5.16 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 . . . . . 0 C--N 1.302 -1.484 0 N-CA-C 108.254 -1.017 . . . . 1.0 108.254 -177.268 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp . . . . . 0 CA--C 1.509 -0.604 0 N-CA-C 110.224 -0.287 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -130.17 88.48 2.66 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -84.66 81.98 8.62 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.441 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 2.4 p -114.39 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.157 -0.929 . . . . 1.0 112.413 -175.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.84 42.16 2.47 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.067 -1.457 . . . . 1.0 107.067 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.471 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 33.1 p90 -139.3 156.07 47.29 Favored 'General case' 0 N--CA 1.383 -3.824 0 CA-C-N 113.272 -1.786 . . . . 1.0 107.664 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.5 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 18.7 mmt180 -130.33 113.84 17.05 Favored Pre-proline 0 C--N 1.255 -3.535 0 N-CA-C 105.944 -1.872 . . . . 1.0 105.944 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -49.4 115.92 2.01 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.781 1.654 . . . . 1.0 108.875 172.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 tp -124.13 155.87 37.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.209 0.528 . . . . 1.0 112.151 -170.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.6 m -105.79 128.8 53.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.427 HD21 ' SD ' ' A' ' 44' ' ' MET . 17.7 tp -127.43 142.58 51.38 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 5.5 t30 -96.03 116.06 28.38 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.33 -0.248 . . . . 1.0 110.33 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.69 121.75 22.96 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.034 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 27.6 tp -151.5 168.12 25.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.569 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 2.1 pt? -136.11 145.06 45.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.123 0.569 . . . . 1.0 109.655 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.18 30.62 7.16 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.027 0.442 . . . . 1.0 110.52 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.91 -46.78 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.273 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.75 -81.92 0.08 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 118.511 -1.804 . . . . 1.0 114.66 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.15 -32.28 94.34 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.4 2.733 . . . . 1.0 112.679 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -130.48 42.36 1.42 Allowed Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.33 39.8 0.05 OUTLIER 'General case' 0 C--O 1.244 0.768 0 N-CA-C 114.057 1.132 . . . . 1.0 114.057 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 154.16 -20.53 0.65 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.06 57.4 1.7 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.189 0.995 . . . . 1.0 110.333 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 20' ' ' GLY . . . -106.07 -83.08 0.53 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.363 -1.29 . . . . 1.0 111.324 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.516 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 7.0 pt20 -111.62 -59.51 1.97 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.609 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.516 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 60.05 71.65 0.74 Allowed Glycine 0 CA--C 1.519 0.33 0 O-C-N 123.694 0.621 . . . . 1.0 112.05 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -108.57 127.59 27.16 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 122.656 -0.32 . . . . 1.0 110.218 -174.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.37 110.73 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.687 1.591 . . . . 1.0 111.584 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.439 HG12 HE21 ' A' ' 47' ' ' GLN . 21.9 t -116.13 155.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.901 -1.045 . . . . 1.0 108.267 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -106.22 145.3 31.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 114.085 1.143 . . . . 1.0 114.085 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.41 -175.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 113.515 -1.675 . . . . 1.0 108.766 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -117.3 158.23 24.73 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 24.4 t70 -66.95 -29.71 69.64 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.801 0.688 . . . . 1.0 109.475 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.72 34.07 2.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.426 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.486 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -74.61 -166.39 0.44 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.756 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.6 p -137.29 153.9 50.21 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 168.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.0 mm -57.87 -40.0 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.857 0.361 . . . . 1.0 110.103 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.3 p -62.47 -43.88 97.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.122 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.6 -41.43 68.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.84 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.708 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.09 -37.7 88.39 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.606 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -55.66 -41.52 73.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 176.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' SER . 34.3 mt-10 -71.17 -45.63 63.08 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.284 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -63.37 -43.65 97.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.941 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.708 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.5 mmm -64.89 -41.48 95.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.701 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 pp -75.62 -28.37 58.81 Favored 'General case' 0 C--O 1.198 -1.616 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.846 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.54 -32.53 65.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.874 0.87 . . . . 1.0 112.245 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.439 HE21 HG12 ' A' ' 29' ' ' VAL . 16.7 mm-40 -69.81 -39.79 76.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.231 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.5 -46.28 7.06 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.05 0.928 . . . . 1.0 110.496 -174.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -93.51 29.79 1.9 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 113.893 -1.503 . . . . 1.0 110.087 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -49.87 116.51 1.84 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.872 -1.058 . . . . 1.0 109.847 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.6 -9.29 19.51 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.579 -0.819 . . . . 1.0 111.758 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.33 115.78 61.93 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.74 169.28 16.4 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.274 2.649 . . . . 1.0 112.357 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.24 -40.97 92.14 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.759 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -68.1 -20.66 64.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.968 -0.56 . . . . 1.0 112.247 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -100.55 -3.87 29.77 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.256 0.836 . . . . 1.0 113.256 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -82.38 126.96 72.76 Favored Pre-proline 0 C--N 1.31 -1.127 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.419 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.28 144.21 45.59 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.417 2.078 . . . . 1.0 111.919 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' O ' HG22 ' A' ' 62' ' ' THR . 19.5 m-20 -89.68 140.53 28.08 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.64 12.97 0.37 Allowed 'Trans proline' 0 N--CA 1.48 0.683 0 C-N-CA 123.654 2.903 . . . . 1.0 114.159 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -89.61 -23.18 22.0 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 173.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 14.1 t -104.33 -13.4 16.14 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.687 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 146.71 43.09 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.155 -1.424 . . . . 1.0 107.155 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.569 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 8.2 p-10 -107.3 150.16 27.0 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 -169.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.86 121.93 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.563 -1.198 . . . . 1.0 108.939 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.18 112.16 23.94 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.628 ' CE2' HG13 ' A' ' 101' ' ' VAL . 4.2 t-105 -87.26 124.19 33.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.49 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.63 88.19 2.69 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 106.853 -1.536 . . . . 1.0 106.853 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.7 p -72.16 -31.61 66.11 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.143 -1.389 . . . . 1.0 109.895 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.03 3.76 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 114.166 -1.379 . . . . 1.0 110.421 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -64.04 -38.04 81.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 122.911 0.485 . . . . 1.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.32 3.18 18.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.741 0.781 . . . . 1.0 110.143 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.51 -121.54 6.52 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.951 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.582 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.6 p-80 -134.78 134.87 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.85 0.357 . . . . 1.0 111.185 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.9 tp -134.02 146.12 50.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mm -83.13 118.69 31.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.467 HD21 ' CE3' ' A' ' 67' ' ' TRP . 11.0 mp -111.68 159.99 17.69 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.959 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -160.38 162.08 33.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -62.52 -42.1 99.29 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -132.71 119.46 20.39 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.454 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -140.19 -79.38 0.29 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-O 122.283 1.04 . . . . 1.0 108.316 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.07 -22.42 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.064 0 CA-C-N 113.283 -1.781 . . . . 1.0 109.075 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.2 p -99.87 1.61 43.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.349 -1.296 . . . . 1.0 110.178 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.4 t -71.78 -17.38 62.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.34 0.59 . . . . 1.0 110.255 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.89 112.1 11.94 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.29 -0.868 . . . . 1.0 109.88 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -98.65 89.19 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -129.11 -18.68 3.67 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 114.8 -1.091 . . . . 1.0 110.702 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.17 -116.04 0.37 Allowed Glycine 0 N--CA 1.407 -3.274 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pp -81.2 -5.86 58.21 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 113.591 0.959 . . . . 1.0 113.591 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -67.47 -28.41 67.84 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -64.88 94.03 0.12 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.802 0.334 . . . . 1.0 110.55 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -167.71 155.05 8.47 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 93.2 mt -77.12 148.93 35.74 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.19 144.93 28.64 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.159 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.493 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.0 OUTLIER -111.46 165.61 11.84 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 125.078 1.351 . . . . 1.0 108.049 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 pp -72.1 -22.86 61.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.63 -1.228 . . . . 1.0 109.322 173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.64 -25.93 68.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.053 175.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -63.23 -35.82 81.59 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -90.14 -15.86 30.72 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.331 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 57.66 54.28 6.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.773 0.829 . . . . 1.0 110.826 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.628 HG13 ' CE2' ' A' ' 67' ' ' TRP . 0.8 OUTLIER -81.44 146.87 58.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.111 0.782 . . . . 1.0 113.111 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.41 157.99 29.2 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.187 2.591 . . . . 1.0 112.093 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.87 123.39 20.03 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.509 0.671 . . . . 1.0 109.956 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.82 19.7 11.65 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.68 162.64 28.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 84.9 m -115.35 131.06 57.05 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.659 0.266 . . . . 1.0 110.965 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -115.2 136.49 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 N-CA-C 109.948 -0.39 . . . . 1.0 109.948 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.6 141.22 49.61 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.606 ' HG ' ' NZ ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -123.89 150.65 44.41 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.878 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.45 156.39 78.89 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.21 75.13 5.14 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.054 1.836 . . . . 1.0 111.781 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.603 ' HB3' ' O ' ' A' ' 62' ' ' THR . 20.1 p 50.31 69.38 0.63 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 125.019 1.327 . . . . 1.0 110.854 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.25 -49.27 1.09 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -173.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 13.5 t -108.73 19.69 19.39 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.644 -0.822 . . . . 1.0 111.529 -172.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.429 ' HB3' ' CB ' ' A' ' 64' ' ' ASP . 21.4 ptmt -77.25 86.12 3.69 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 122.111 0.958 . . . . 1.0 113.414 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -141.7 113.33 7.75 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.702 -1.135 . . . . 1.0 109.378 175.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.48 -176.15 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.281 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.17 138.27 26.25 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.738 0.649 . . . . 1.0 111.537 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -86.89 154.31 20.95 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.116 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.77 122.21 39.47 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.716 -1.216 . . . . 1.0 107.716 174.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -142.85 111.95 6.56 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.971 -174.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 . . . . . 0 N--CA 1.423 -1.805 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 177.685 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.537 ' HG3' ' OD2' ' A' ' 35' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.48 -1.749 0 CA-C-O 121.449 0.642 . . . . 1.0 110.353 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -130.64 142.61 50.45 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 104.104 -2.554 . . . . 1.0 104.104 170.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.42 74.78 8.41 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 122.527 1.156 . . . . 1.0 112.348 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 m -136.31 -177.26 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.01 -1.45 . . . . 1.0 108.257 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -98.97 96.81 8.08 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.926 0.87 . . . . 1.0 112.531 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 m-85 -128.83 -176.64 3.91 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 103.769 -2.678 . . . . 1.0 103.769 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -98.86 111.12 59.83 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 119.526 1.057 . . . . 1.0 111.243 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 38.8 Cg_exo -61.16 140.23 88.07 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.561 2.174 . . . . 1.0 111.03 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 10' ' ' THR . 5.7 tp -138.92 161.69 36.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.425 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 59.8 m -107.98 126.83 53.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.226 -1.028 . . . . 1.0 108.226 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 30.6 tp -127.29 138.0 52.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 7.1 t30 -90.48 120.43 31.57 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.283 -0.261 . . . . 1.0 111.447 -174.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.08 119.6 25.65 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.644 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 36.3 tp -146.67 151.9 37.99 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.544 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -114.23 139.51 49.33 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 176.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -114.41 50.1 0.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.037 0.446 . . . . 1.0 110.769 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.7 t -65.92 -46.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.546 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.21 -94.55 0.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.299 -0.953 . . . . 1.0 112.705 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.1 -28.23 73.9 Favored 'Trans proline' 0 N--CA 1.484 0.964 0 C-N-CA 123.251 2.634 . . . . 1.0 112.47 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.467 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -116.41 32.21 5.66 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 110.879 -0.888 . . . . 1.0 110.879 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -74.14 29.03 0.08 Allowed 'General case' 0 C--O 1.246 0.921 0 C-N-CA 123.446 0.698 . . . . 1.0 112.545 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 20' ' ' GLY . . . -176.99 -40.13 0.06 OUTLIER Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 120.572 -0.823 . . . . 1.0 112.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.37 4.3 46.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.6 -73.85 0.12 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 113.73 1.011 . . . . 1.0 113.73 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -129.91 -61.8 0.98 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.443 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.49 62.92 5.71 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.7 t -95.24 126.02 47.9 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 115.58 -0.31 . . . . 1.0 110.334 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -73.74 90.86 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.216 1.944 . . . . 1.0 110.291 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.7 t -93.91 154.73 3.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -108.7 152.13 25.23 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.2 p -159.18 177.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.944 -172.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 31.4 mt -108.62 158.16 17.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.623 0.725 . . . . 1.0 110.999 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 -32.75 73.86 Favored 'General case' 0 C--O 1.282 2.805 0 C-N-CA 124.9 1.28 . . . . 1.0 111.422 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.561 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.9 t -98.78 13.18 33.25 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.006 -0.997 . . . . 1.0 111.715 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.537 ' OD2' ' HG3' ' A' ' 1' ' ' LYS . 1.7 m-20 -73.24 133.82 44.1 Favored 'General case' 0 CA--C 1.47 -2.097 0 C-N-CA 119.655 -0.818 . . . . 1.0 109.21 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.579 ' OG1' ' HB2' ' A' ' 39' ' ' GLN . 70.8 p -81.28 171.14 15.2 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 107.554 -1.276 . . . . 1.0 107.554 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.2 -43.47 93.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 118.134 0.424 . . . . 1.0 110.197 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -67.36 -40.22 85.77 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-O 121.774 0.797 . . . . 1.0 110.707 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.716 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 4.4 tt0 -66.9 -32.52 73.84 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.485 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.279 -0.418 . . . . 1.0 111.045 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.527 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.5 mmmp? -56.52 -33.95 66.55 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.225 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.716 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 17.9 pt-20 -54.43 -50.44 67.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 124.288 0.992 . . . . 1.0 110.273 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 30.6 mmmt -77.27 -36.59 54.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -47.83 84.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.186 0.517 . . . . 1.0 110.462 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.598 ' HB2' ' CD1' ' A' ' 49' ' ' TYR 0.266 0.8 OUTLIER -78.75 -23.37 45.4 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 112.419 0.526 . . . . 1.0 112.419 176.602 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.617 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.5 t70 -50.65 -29.69 11.68 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 125.025 1.33 . . . . 1.0 112.684 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -75.31 -17.97 60.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.359 -178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.36 -30.99 6.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.994 0.902 . . . . 1.0 109.853 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.598 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 32.1 m-85 -98.37 20.02 13.37 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.909 -1.041 . . . . 1.0 111.401 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.13 118.97 9.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.99 -14.1 21.7 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 110.472 -1.051 . . . . 1.0 110.472 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.3 t -97.98 133.1 23.56 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HG2' ' CG ' ' A' ' 56' ' ' GLN . 25.7 Cg_endo -61.98 156.62 48.31 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.86 2.374 . . . . 1.0 112.01 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.71 -41.41 97.56 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.436 0.694 . . . . 1.0 112.001 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 t -66.59 -24.51 66.34 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.059 0.457 . . . . 1.0 111.629 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.423 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 16.2 mm100 -86.51 -14.59 42.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.005 0.431 . . . . 1.0 111.905 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -73.98 123.27 89.12 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.165 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.52 147.75 94.67 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.422 2.748 . . . . 1.0 114.04 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -83.38 160.29 59.85 Favored Pre-proline 0 C--N 1.315 -0.893 0 C-N-CA 124.388 1.075 . . . . 1.0 110.891 -176.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.55 8.02 4.86 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.655 2.237 . . . . 1.0 112.099 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -95.0 -21.56 18.52 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.931 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 3.8 t -92.91 -15.54 26.23 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.297 0.57 . . . . 1.0 110.348 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.6 pp -145.64 149.79 35.14 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.569 -1.641 . . . . 1.0 106.569 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -103.83 156.96 17.41 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 120.406 -0.518 . . . . 1.0 110.145 -172.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.76 117.92 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.54 0.686 . . . . 1.0 109.557 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -92.7 118.03 30.62 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-O 121.459 0.647 . . . . 1.0 109.937 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.601 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 16.9 t90 -82.7 119.65 24.58 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.603 -1.18 . . . . 1.0 108.491 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.01 89.22 3.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 120.952 0.406 . . . . 1.0 109.911 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.4 p -91.43 -23.1 20.13 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.893 0.854 . . . . 1.0 109.029 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.67 -52.27 4.43 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.009 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.02 -38.12 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.045 0.45 . . . . 1.0 111.492 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.79 -3.09 36.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.726 0.774 . . . . 1.0 109.589 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.39 -144.11 17.03 Favored Glycine 0 N--CA 1.416 -2.683 0 CA-C-N 114.883 -1.053 . . . . 1.0 110.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.601 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.4 p80 -133.48 115.27 14.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.028 0.531 . . . . 1.0 109.705 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.42 144.47 49.48 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.676 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.4 mm -83.46 117.69 29.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 177.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.79 146.44 28.98 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.3 -0.864 . . . . 1.0 109.817 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.7 t -161.88 166.15 26.68 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.257 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.65 -27.41 65.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.37 81.44 1.78 Allowed 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 82' ' ' VAL . 3.0 p30 -102.17 -89.63 0.37 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.637 0.732 . . . . 1.0 112.574 -175.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 5.0 p -102.69 -14.1 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 C-N-CA 125.041 1.336 . . . . 1.0 108.746 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 16.7 p -87.48 -7.66 57.37 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.153 -0.93 . . . . 1.0 108.653 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.6 p -53.15 -44.9 68.17 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 125.205 1.402 . . . . 1.0 113.976 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -74.71 118.98 18.29 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.828 -0.804 . . . . 1.0 108.828 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.27 114.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-O 121.651 0.739 . . . . 1.0 112.546 -170.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -102.84 -26.12 13.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.779 -1.101 . . . . 1.0 109.314 172.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -114.99 -100.31 2.31 Favored Glycine 1 N--CA 1.396 -4.021 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.501 ' HB2' HH21 ' A' ' 92' ' ' ARG . 1.1 pp -127.42 24.66 6.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.372 0.606 . . . . 1.0 110.515 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -62.59 -38.46 90.22 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 115.009 1.485 . . . . 1.0 115.009 -176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.474 ' HA ' ' O ' ' A' ' 83' ' ' THR . 43.9 ttp180 -72.08 93.47 1.41 Allowed 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.191 -1.004 . . . . 1.0 112.204 -176.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.501 HH21 ' HB2' ' A' ' 89' ' ' LEU . 28.8 mmt180 -113.86 137.76 51.22 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.324 -1.361 . . . . 1.0 107.324 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.9 mt -66.65 135.62 54.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.887 -1.523 . . . . 1.0 106.887 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 36' ' ' THR . 65.8 m-80 -87.27 137.77 32.05 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.786 -0.765 . . . . 1.0 111.994 -173.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 1.5 p -105.42 168.98 8.73 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 124.054 0.941 . . . . 1.0 109.312 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.01 -33.18 71.69 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.351 -0.94 . . . . 1.0 108.81 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.561 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 pt20 -65.65 -26.09 67.65 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.576 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -65.57 -35.62 81.36 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.992 0.425 . . . . 1.0 110.422 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.94 -8.09 21.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.199 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 52.47 68.45 0.82 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.454 1.101 . . . . 1.0 112.312 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.503 HG12 ' CE2' ' A' ' 67' ' ' TRP . 2.7 m -78.33 136.7 60.46 Favored Pre-proline 0 N--CA 1.433 -1.285 0 C-N-CA 119.941 -0.704 . . . . 1.0 109.124 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.3 160.54 48.56 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.256 1.97 . . . . 1.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -64.68 124.38 21.76 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.58 25.49 38.79 Favored Glycine 0 C--N 1.303 -1.281 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.798 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.23 36.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.818 0.342 . . . . 1.0 111.039 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 51.1 m -107.97 123.89 49.32 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.055 0.455 . . . . 1.0 110.962 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.4 m -121.15 138.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.446 -0.946 . . . . 1.0 108.446 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -125.72 138.45 53.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.999 0.428 . . . . 1.0 112.019 -176.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.544 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.2 mp -96.39 126.88 41.9 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 30.1 m -116.21 140.13 26.05 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 116.761 -0.199 . . . . 1.0 110.692 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.81 85.06 1.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.633 2.222 . . . . 1.0 112.027 -178.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.623 ' SG ' ' HA ' ' A' ' 116' ' ' HIS . 20.3 p 50.15 93.97 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.874 1.67 . . . . 1.0 113.141 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.618 ' O ' HG23 ' A' ' 114' ' ' THR . 1.7 mm? 64.4 9.87 5.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.595 1.158 . . . . 1.0 110.768 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER 70.68 11.41 7.22 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 126.22 1.808 . . . . 1.0 111.829 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -149.35 107.68 3.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . 0.623 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 51.8 t-80 -62.87 95.61 0.08 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.945 0.72 . . . . 1.0 112.945 -173.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.0 163.51 37.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.53 109.11 20.51 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.475 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 74.6 ttt180 -138.49 145.77 41.2 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 53.3 mm-40 -77.79 172.42 13.46 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -79.8 78.33 6.39 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.817 0.818 . . . . 1.0 109.519 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 106.689 -1.597 . . . . 1.0 106.689 179.434 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.535 ' NZ ' ' HB2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.493 -1.234 0 N-CA-C 110.233 -0.284 . . . . 1.0 110.233 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HZ3' ' NE2' ' A' ' 39' ' ' GLN . 36.9 mtmm -144.64 71.41 1.3 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.347 -2.094 . . . . 1.0 105.347 171.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -73.03 81.99 1.24 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 122.877 1.323 . . . . 1.0 114.31 -170.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.3 m -123.95 -163.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 112.958 -1.928 . . . . 1.0 106.404 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -88.21 93.01 9.37 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.833 0.825 . . . . 1.0 112.433 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.512 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 21.9 m-85 -137.87 -176.89 4.58 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 103.655 -2.72 . . . . 1.0 103.655 175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -100.38 109.56 57.32 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 118.729 -1.188 . . . . 1.0 111.578 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 33.7 Cg_exo -62.53 139.17 74.65 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 122.357 2.038 . . . . 1.0 110.607 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.1 tp -135.12 158.81 43.41 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 116.278 -0.419 . . . . 1.0 109.916 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -100.24 128.5 46.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 105' ' ' ALA . 22.2 tp -127.82 138.74 52.82 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 5.2 t30 -91.51 116.89 29.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 122.165 -0.334 . . . . 1.0 110.573 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.84 118.59 21.76 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.606 0.566 . . . . 1.0 109.564 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 33.8 tp -151.41 158.22 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.7 144.34 48.83 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.9 38.79 3.22 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.654 -174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -66.22 -44.39 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 115.707 -0.679 . . . . 1.0 111.671 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.33 -78.56 0.2 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.902 -1.142 . . . . 1.0 112.611 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.5 -25.94 76.03 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.236 2.624 . . . . 1.0 111.95 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -133.49 41.67 1.45 Allowed Glycine 0 N--CA 1.416 -2.665 0 N-CA-C 110.068 -1.213 . . . . 1.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.75 24.22 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.115 0.783 . . . . 1.0 113.115 -177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 20' ' ' GLY . . . 169.83 -38.54 0.2 Allowed Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.808 -177.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.02 21.68 2.25 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.179 0.514 . . . . 1.0 111.769 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.99 -78.25 0.35 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.74 0.644 . . . . 1.0 112.74 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -125.32 -64.67 1.06 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.863 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.08 63.38 4.79 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 t -93.64 126.08 51.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.94 100.33 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.552 1.501 . . . . 1.0 109.738 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.3 t -108.32 156.85 8.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -119.3 152.77 36.16 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -158.26 169.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 -177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.1 mt -89.95 157.72 17.72 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.35 -32.44 71.27 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-N 114.624 -1.171 . . . . 1.0 110.056 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 23.2 t -101.7 12.54 36.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.775 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 N--CA 1.409 -2.506 0 C-N-CA 118.601 -1.239 . . . . 1.0 108.032 171.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.2 p -80.51 174.33 11.71 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.15 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.3 -42.25 86.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 p -63.79 -45.38 89.96 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 121.986 0.898 . . . . 1.0 111.047 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.527 ' NE2' ' HZ3' ' A' ' 2' ' ' LYS . 10.0 mt-30 -77.47 -16.06 58.96 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.253 -176.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.43 -31.49 22.83 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.042 168.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.9 mmmp? -56.41 -39.86 73.73 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.561 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 3.1 pt-20 -58.41 -44.92 89.21 Favored 'General case' 0 N--CA 1.416 -2.159 0 O-C-N 124.333 1.021 . . . . 1.0 111.966 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 28.3 mmmt -72.86 -39.57 66.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.868 1.062 . . . . 1.0 113.868 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.5 mmt -61.27 -46.92 88.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.322 0.582 . . . . 1.0 110.639 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.4 pp -77.45 -24.07 50.35 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.128 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.6 t70 -50.65 -35.57 31.32 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.132 1.373 . . . . 1.0 112.334 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -71.73 -32.93 68.26 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.194 0.521 . . . . 1.0 111.62 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.51 -45.55 7.37 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.01 0.909 . . . . 1.0 109.674 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.514 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 88.3 m-85 -95.34 27.63 3.24 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.065 -1.425 . . . . 1.0 110.639 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.419 ' HE3' ' O ' ' A' ' 46' ' ' ASP . 1.1 tppp? -58.76 121.7 11.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.226 0.536 . . . . 1.0 109.897 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.78 -20.24 9.4 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 110.131 -1.188 . . . . 1.0 110.131 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.3 t -82.63 125.71 75.21 Favored Pre-proline 0 N--CA 1.443 -0.796 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.21 160.34 42.61 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.566 2.177 . . . . 1.0 111.813 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.4 tp -60.68 -38.52 85.24 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.249 0.62 . . . . 1.0 111.438 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 t -66.85 -18.28 65.3 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.857 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -97.58 -11.18 23.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 120.688 -0.405 . . . . 1.0 112.027 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -77.15 110.09 11.13 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 110.304 -0.258 . . . . 1.0 110.304 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.98 154.25 52.84 Favored 'Trans proline' 0 C--O 1.256 1.394 0 C-N-CA 123.459 2.772 . . . . 1.0 115.475 -172.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.8 154.57 93.3 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.485 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -91.42 23.12 0.63 Allowed 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 123.388 2.725 . . . . 1.0 112.624 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -94.78 -28.51 15.23 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.0 t -91.06 1.41 57.11 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.134 0.969 . . . . 1.0 109.991 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.442 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.3 pp -145.39 161.88 38.61 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 104.599 -2.371 . . . . 1.0 104.599 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -122.85 152.82 40.36 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.541 -0.864 . . . . 1.0 109.332 -177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 p -119.27 120.94 65.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.728 -0.789 . . . . 1.0 109.522 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.13 116.3 28.7 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.556 0.693 . . . . 1.0 109.667 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.645 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 15.8 t90 -82.29 119.27 23.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.668 -1.151 . . . . 1.0 108.042 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -123.11 89.06 3.04 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.5 p -88.77 -20.13 25.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.033 0.92 . . . . 1.0 108.932 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.87 -54.5 4.05 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 114.629 -1.168 . . . . 1.0 111.85 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 m -64.49 -42.11 94.28 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 111.587 0.217 . . . . 1.0 111.587 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.5 -9.41 47.43 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.722 0.773 . . . . 1.0 109.028 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.11 13.75 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 114.507 -1.224 . . . . 1.0 111.321 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.645 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.0 p80 -138.4 118.29 13.29 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 123.722 0.809 . . . . 1.0 110.06 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.25 145.17 48.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.405 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.6 mm -88.46 111.49 22.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.098 0.475 . . . . 1.0 109.789 178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.6 151.69 20.89 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.289 -0.869 . . . . 1.0 110.347 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.1 t -162.68 165.46 25.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 6.4 p-10 -71.67 -31.0 66.32 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 37.7 tt0 -138.16 84.49 2.04 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -102.4 -90.43 0.36 Allowed 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.742 0.782 . . . . 1.0 112.64 -174.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.9 p -102.58 -19.02 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.503 0 CA-C-N 113.803 -1.544 . . . . 1.0 108.022 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 21.4 p -79.99 -8.99 59.65 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.916 -1.038 . . . . 1.0 109.643 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 53.0 p -56.13 -42.35 76.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.528 1.131 . . . . 1.0 113.167 -177.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.71 124.25 23.48 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.55 123.37 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-O 121.668 0.747 . . . . 1.0 112.53 -171.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -101.27 -27.01 13.43 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.081 -0.963 . . . . 1.0 109.659 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.23 -87.97 0.57 Allowed Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 120.155 -1.021 . . . . 1.0 112.469 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -127.03 14.69 7.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.943 0.401 . . . . 1.0 111.634 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -61.54 -36.92 81.93 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.879 1.066 . . . . 1.0 113.879 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.563 ' HA ' ' O ' ' A' ' 83' ' ' THR . 42.2 ttp180 -77.03 114.17 15.54 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 119.708 -0.797 . . . . 1.0 113.022 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -137.7 146.98 44.42 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 98.2 mt -70.39 142.39 52.09 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -89.93 139.09 30.94 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 119.894 -0.722 . . . . 1.0 111.013 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.551 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.5 p -111.39 171.13 7.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 124.007 0.923 . . . . 1.0 108.599 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 pp -68.52 -30.59 69.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 173.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.551 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.35 -26.32 68.42 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.987 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -65.76 -39.96 91.56 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 120.981 0.42 . . . . 1.0 110.376 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.38 -7.21 24.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.521 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 51.75 61.55 3.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.923 1.289 . . . . 1.0 113.143 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.462 HG12 ' CE2' ' A' ' 67' ' ' TRP . 3.0 m -70.98 136.87 84.91 Favored Pre-proline 0 N--CA 1.438 -1.032 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.13 160.21 50.8 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.545 2.163 . . . . 1.0 111.326 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -66.45 117.96 9.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.712 0.768 . . . . 1.0 109.891 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.41 22.94 20.59 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.712 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.4 ' O ' HD11 ' A' ' 11' ' ' LEU . . . -68.31 152.47 45.39 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.466 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 27.7 m -108.56 123.46 48.95 Favored 'General case' 0 C--N 1.279 -2.47 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.253 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 33.9 m -121.66 155.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -138.45 137.02 36.8 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.307 -0.557 . . . . 1.0 112.003 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.555 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.6 mp -94.97 132.67 39.57 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.224 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 31.9 m -129.26 137.64 31.41 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.056 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -70.23 86.3 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.227 1.951 . . . . 1.0 111.065 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.442 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 21.0 p 50.4 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 1.0 112.467 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.576 ' O ' HG23 ' A' ' 114' ' ' THR . 2.2 mm? 58.04 23.69 10.31 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.775 1.23 . . . . 1.0 110.218 -176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER 67.38 13.68 9.42 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.8 1.64 . . . . 1.0 112.545 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -124.18 104.81 9.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -72.19 93.15 1.42 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.635 0.731 . . . . 1.0 111.526 -174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.25 163.88 34.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.92 -1.036 . . . . 1.0 108.349 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.14 106.0 13.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.429 -1.693 . . . . 1.0 106.429 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -136.76 134.75 37.43 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.985 -175.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -74.48 175.19 7.99 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 176.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -76.98 72.18 3.52 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 122.001 0.905 . . . . 1.0 109.636 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 106.759 -1.571 . . . . 1.0 106.759 -178.891 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 111.783 0.29 . . . . 1.0 111.783 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 135.91 54.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 108.698 -0.852 . . . . 1.0 108.698 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -81.7 -1.55 47.29 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.489 0.662 . . . . 1.0 111.794 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.38 97.27 4.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 115.188 -0.915 . . . . 1.0 109.43 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -108.08 79.38 1.26 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.966 0.889 . . . . 1.0 112.777 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.52 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.4 m-85 -123.4 178.5 5.13 Favored 'General case' 0 N--CA 1.393 -3.283 0 N-CA-C 102.928 -2.99 . . . . 1.0 102.928 172.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.416 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 23.2 mmt180 -104.66 111.05 65.17 Favored Pre-proline 0 C--N 1.273 -2.757 0 C-N-CA 117.233 -1.787 . . . . 1.0 114.673 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 19.6 Cg_exo -65.69 121.78 9.25 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.383 2.056 . . . . 1.0 109.173 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 9.5 tp -114.9 159.79 20.28 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.374 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m -99.36 124.26 44.33 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.459 HD13 ' CZ2' ' A' ' 67' ' ' TRP . 2.8 mm? -125.69 144.08 50.76 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.24 0.616 . . . . 1.0 110.179 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -92.67 113.8 26.18 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.25 107.94 6.73 Favored 'General case' 0 C--O 1.253 1.273 0 C-N-CA 123.313 0.645 . . . . 1.0 110.166 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 25.7 tp -142.11 158.95 43.16 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -128.5 143.63 51.01 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.71 36.33 3.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.902 0.382 . . . . 1.0 111.184 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.59 -45.15 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 112.556 0.576 . . . . 1.0 112.556 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.42 -81.97 0.14 Allowed Glycine 0 C--N 1.31 -0.885 0 C-N-CA 119.656 -1.259 . . . . 1.0 112.469 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.59 -24.39 77.88 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.995 2.464 . . . . 1.0 112.584 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.57 27.16 5.81 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.4 68.0 2.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.767 0.794 . . . . 1.0 112.445 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 127.05 -15.68 6.48 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.27 27.65 6.19 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.98 -0.61 . . . . 1.0 112.273 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.82 -93.21 0.07 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.154 0.502 . . . . 1.0 110.583 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -114.56 -62.7 1.56 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.791 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.13 75.0 0.66 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.215 -1.154 . . . . 1.0 110.215 -175.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.1 127.79 26.46 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 110.244 -0.28 . . . . 1.0 110.244 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.02 108.07 2.51 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.708 1.605 . . . . 1.0 110.675 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.498 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 60.6 t -114.98 139.16 42.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 96.6 mttt -100.54 139.0 36.84 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.856 -0.738 . . . . 1.0 110.339 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG11 HD23 ' A' ' 11' ' ' LEU . 11.2 p -144.16 159.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.87 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.4 156.16 24.31 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.855 0.836 . . . . 1.0 112.697 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.7 -31.65 72.6 Favored 'General case' 0 C--O 1.27 2.16 0 CA-C-N 113.674 -1.603 . . . . 1.0 108.81 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.54 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 18.5 t -85.18 -8.64 58.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 113.533 -1.667 . . . . 1.0 111.947 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.88 133.29 45.34 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.72 0.771 . . . . 1.0 109.714 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.0 p -81.93 177.62 8.75 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.446 -1.252 . . . . 1.0 109.875 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 37.8 mm -60.82 -46.64 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 119.259 -0.401 . . . . 1.0 110.298 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 40.1 m -60.98 -47.72 85.13 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.833 0.708 . . . . 1.0 111.341 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -64.87 -42.84 94.51 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.204 0.526 . . . . 1.0 110.608 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.697 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.41 -35.64 81.08 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.414 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -60.95 -40.06 91.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 38' ' ' SER . 40.6 mt-10 -65.3 -49.54 69.12 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.054 -0.976 . . . . 1.0 110.605 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.99 -40.92 95.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.465 0.542 . . . . 1.0 112.465 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.697 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.6 mmm -65.3 -43.53 90.8 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.71 -27.08 58.08 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -55.6 -28.16 53.52 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.801 1.24 . . . . 1.0 113.072 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HG3' HG22 ' A' ' 29' ' ' VAL . 71.4 mm-40 -69.11 -31.32 69.94 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.282 0.563 . . . . 1.0 110.489 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.7 -26.32 7.03 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.914 -0.585 . . . . 1.0 112.347 -174.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -102.94 31.68 4.08 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -55.62 121.13 8.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.09 -0.959 . . . . 1.0 110.584 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.87 -5.82 51.03 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.053 -0.594 . . . . 1.0 112.22 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.46 123.45 68.19 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.456 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 95.9 Cg_endo -73.26 163.7 37.26 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 123.551 2.834 . . . . 1.0 112.748 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -60.23 -40.09 88.96 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.343 0.657 . . . . 1.0 111.14 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.5 t -64.15 -17.48 63.52 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.06 -30.27 12.78 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.222 -0.591 . . . . 1.0 110.155 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 88.4 mtt180 -66.5 147.41 98.97 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.5 145.16 91.83 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 121.799 1.666 . . . . 1.0 109.802 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 61' ' ' ARG . 31.4 t70 -70.36 117.21 52.68 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.08 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.516 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . 28.0 Cg_endo -62.97 -20.24 71.06 Favored 'Trans proline' 0 C--O 1.223 -0.241 0 C-N-CA 123.013 2.476 . . . . 1.0 114.117 -173.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.498 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 28.9 mtp-105 -72.55 -35.61 68.04 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 59' ' ' ASP . 1.8 t -87.2 -25.08 24.21 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.217 0.821 . . . . 1.0 113.217 -174.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.516 ' CD1' ' HA ' ' A' ' 60' ' ' PRO 0.291 0.0 OUTLIER -98.77 161.66 13.53 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 119.619 -0.832 . . . . 1.0 110.011 176.09 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.663 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -119.94 152.29 37.63 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.9 0.381 . . . . 1.0 111.204 -173.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -123.61 132.13 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.055 0 C-N-CA 120.026 -0.67 . . . . 1.0 109.365 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 40.9 mt-10 -89.6 112.49 23.72 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.608 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.2 t-105 -91.45 118.27 30.41 Favored 'General case' 1 N--CA 1.374 -4.273 0 C-N-CA 119.299 -0.96 . . . . 1.0 108.525 178.21 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -104.46 88.72 3.02 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 106.241 -1.763 . . . . 1.0 106.241 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -90.12 -16.38 29.71 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.561 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.05 -51.16 3.48 Favored Glycine 0 C--N 1.291 -1.962 0 CA-C-N 114.764 -1.107 . . . . 1.0 111.836 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.29 -38.88 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.023 0.529 . . . . 1.0 110.976 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.78 7.24 30.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.932 0.872 . . . . 1.0 108.82 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.33 -132.43 12.66 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 114.168 -1.378 . . . . 1.0 110.925 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.487 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 4.5 p80 -117.06 101.3 8.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.81 0.814 . . . . 1.0 109.296 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.416 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.68 143.9 34.12 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.049 -174.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.419 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 20.0 mm -88.43 109.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' CD1' ' HB3' ' A' ' 75' ' ' LEU . 9.0 mp -99.9 144.22 29.21 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.47 -0.786 . . . . 1.0 112.62 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 53.3 m -153.99 146.55 24.11 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.293 -2.114 . . . . 1.0 105.293 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.425 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 0.5 OUTLIER -74.45 -40.67 61.78 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.557 -0.857 . . . . 1.0 110.702 175.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -130.79 89.5 2.76 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.259 0.466 . . . . 1.0 112.259 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 10.8 m-20 -154.89 -151.85 0.37 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.445 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 9.1 p -54.57 -28.49 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 123.903 0.881 . . . . 1.0 111.29 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 t -83.52 3.11 33.77 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.219 0.608 . . . . 1.0 110.964 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 t -117.07 98.18 6.33 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.529 -0.915 . . . . 1.0 108.529 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.64 130.64 55.98 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.61 -1.255 . . . . 1.0 107.61 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.592 HG21 ' H ' ' A' ' 91' ' ' ARG . 15.0 p -143.49 118.89 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.954 0 CA-C-O 121.967 0.889 . . . . 1.0 112.078 -175.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -80.63 -33.85 35.46 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.73 -1.123 . . . . 1.0 110.545 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.5 -90.13 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.264 -0.735 . . . . 1.0 111.264 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pp -105.9 3.82 28.94 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.051 0.453 . . . . 1.0 111.292 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -62.02 -42.83 99.59 Favored 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 123.841 0.856 . . . . 1.0 111.97 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.592 ' H ' HG21 ' A' ' 86' ' ' VAL . 2.9 tpm_? -135.93 153.45 51.43 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.012 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 tpm_? -131.22 -67.86 0.69 Allowed 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 174.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 67.2 mt -132.41 161.81 32.69 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 106.948 -1.501 . . . . 1.0 106.948 177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.425 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 38.5 m-80 -89.66 139.8 30.2 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.332 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.73 171.3 8.3 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 124.043 0.937 . . . . 1.0 109.406 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.96 -27.43 62.78 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.54 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 6.1 pt20 -63.74 -25.76 68.34 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 115.789 -0.642 . . . . 1.0 112.584 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -64.19 -45.8 86.74 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -93.04 -3.76 53.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.37 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 13.5 mmtm 43.44 67.92 0.58 Allowed 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 124.96 1.304 . . . . 1.0 113.046 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.608 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.8 m -74.81 148.24 84.78 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 114.703 -1.135 . . . . 1.0 111.566 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.8 164.24 33.99 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.338 2.692 . . . . 1.0 112.924 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.09 116.4 6.45 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.74 24.94 12.37 Favored Glycine 0 C--N 1.303 -1.269 0 C-N-CA 119.283 -1.437 . . . . 1.0 112.11 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.15 164.2 26.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.9 m -113.26 130.67 56.18 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.663 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.46 135.37 50.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -130.82 130.57 43.82 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.511 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 3.9 pp -113.45 144.74 42.31 Favored 'General case' 0 C--N 1.262 -3.199 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.258 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 m -133.64 130.73 20.94 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.156 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.49 84.09 0.79 Allowed 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.555 2.17 . . . . 1.0 111.485 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.663 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 4.8 p 52.47 76.91 0.17 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 125.544 1.538 . . . . 1.0 112.374 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.1 -53.22 1.84 Allowed 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.447 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 t -108.68 8.37 26.91 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.051 0.929 . . . . 1.0 111.664 -173.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 3.5 tmmm? -123.66 90.12 3.22 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -148.87 -169.44 3.37 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.902 -1.888 . . . . 1.0 105.902 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.01 140.53 17.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.6 mt -76.46 135.84 39.39 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.042 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -64.55 -32.91 74.76 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.825 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -83.4 85.81 7.17 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.812 0.815 . . . . 1.0 109.84 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -145.5 88.26 1.84 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.948 -1.501 . . . . 1.0 106.948 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 118.542 -0.742 . . . . 1.0 109.281 -175.392 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 121.403 0.62 . . . . 1.0 110.003 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.73 164.45 25.94 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.948 -1.131 . . . . 1.0 107.948 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.14 67.15 9.61 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 123.069 1.414 . . . . 1.0 108.915 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.22 20.39 5.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 114.19 -1.368 . . . . 1.0 109.203 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -89.59 54.37 2.87 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 123.009 1.385 . . . . 1.0 110.331 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.427 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 50.3 m-85 -133.05 -178.93 5.19 Favored 'General case' 0 N--CA 1.384 -3.769 0 N-CA-C 100.733 -3.803 . . . . 1.0 100.733 175.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -107.43 111.24 63.1 Favored Pre-proline 0 C--N 1.268 -2.948 0 C-N-CA 116.902 -1.919 . . . . 1.0 112.53 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 16.1 Cg_exo -68.45 111.09 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.2 1.933 . . . . 1.0 107.742 173.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 10' ' ' THR . 3.7 tp -106.73 154.9 20.29 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.626 -0.716 . . . . 1.0 111.162 -172.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.421 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 17.9 m -88.09 119.14 28.18 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 106.679 -1.6 . . . . 1.0 106.679 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.561 HD21 ' CZ2' ' A' ' 67' ' ' TRP . 1.0 OUTLIER -127.92 140.26 52.11 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -102.18 120.16 39.99 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.732 -0.605 . . . . 1.0 111.052 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.412 ' HB3' ' HE3' ' A' ' 44' ' ' MET . . . -80.53 108.38 14.12 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.306 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 25.4 tp -141.67 159.83 41.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.541 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -130.02 143.79 50.98 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.69 39.85 2.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.839 -175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.26 -45.44 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.91 -79.46 0.19 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.823 -1.18 . . . . 1.0 112.142 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.31 -31.51 89.11 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.788 2.325 . . . . 1.0 112.378 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.98 27.95 7.55 Favored Glycine 0 N--CA 1.432 -1.598 0 C-N-CA 121.0 -0.619 . . . . 1.0 111.67 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.49 76.03 5.0 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.47 0.652 . . . . 1.0 111.665 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 124.57 -15.16 7.61 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 110.446 -1.061 . . . . 1.0 110.446 176.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.65 29.93 6.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.722 -0.739 . . . . 1.0 111.606 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.2 -90.39 0.19 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.301 -0.56 . . . . 1.0 110.95 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -111.76 -56.07 2.43 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.654 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.01 65.74 3.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.395 -0.682 . . . . 1.0 111.395 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.8 t -110.41 124.23 33.78 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.44 -174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.26 104.3 1.88 Allowed 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.245 1.963 . . . . 1.0 110.822 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.526 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 42.9 t -109.29 155.63 10.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.19 137.4 40.51 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.881 0.848 . . . . 1.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.76 157.81 23.63 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 114.299 -1.319 . . . . 1.0 108.082 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.74 155.86 18.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.402 0.62 . . . . 1.0 112.245 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -64.6 -30.79 71.82 Favored 'General case' 0 C--O 1.267 1.991 0 CA-C-N 114.559 -1.2 . . . . 1.0 109.189 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.575 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 5.8 t -88.82 -0.16 57.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.877 -1.511 . . . . 1.0 111.565 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.33 135.41 40.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.694 . . . . 1.0 109.402 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 81.0 p -81.78 174.67 11.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.569 -1.196 . . . . 1.0 109.579 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.603 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 36.5 mm -60.54 -44.39 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.329 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -62.21 -47.29 85.12 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.135 0.897 . . . . 1.0 110.045 178.005 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -65.47 -41.28 93.53 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.785 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.69 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.329 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.22 -38.01 89.51 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 177.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 38' ' ' SER . 37.3 mt-10 -65.83 -45.22 83.09 Favored 'General case' 0 C--O 1.205 -1.245 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.83 -176.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.01 -41.71 98.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.69 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 72.4 mmm -65.63 -42.5 91.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.035 0.445 . . . . 1.0 110.625 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 4.5 pp -76.27 -29.9 57.62 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.848 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.2 -28.61 58.9 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.924 1.69 . . . . 1.0 113.031 -172.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.39 -34.72 78.59 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.099 0.476 . . . . 1.0 110.877 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.33 -32.39 5.3 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.778 -173.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 89.9 m-85 -92.0 25.38 2.85 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 123.241 0.617 . . . . 1.0 109.507 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -58.76 118.24 5.49 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.04 -5.86 21.95 Favored Glycine 0 C--N 1.3 -1.459 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.0 t -93.12 116.17 66.09 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 108.925 -0.768 . . . . 1.0 108.925 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 76.9 Cg_endo -69.74 164.18 35.48 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.071 2.514 . . . . 1.0 111.634 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 3.1 tm? -60.62 -40.84 93.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 122.825 0.45 . . . . 1.0 110.227 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 t -63.83 -18.22 63.91 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.723 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -98.78 -25.18 14.74 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.958 -0.464 . . . . 1.0 109.988 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 85.8 mtt180 -65.72 142.99 98.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.25 144.56 95.61 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 122.269 1.98 . . . . 1.0 111.913 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.599 ' O ' HG22 ' A' ' 62' ' ' THR . 7.7 t70 -75.07 126.96 87.51 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.166 -1.05 . . . . 1.0 108.166 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.428 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . 55.9 Cg_endo -68.7 -6.75 18.65 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 122.755 2.303 . . . . 1.0 114.492 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -94.34 -17.91 22.11 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.037 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 59' ' ' ASP . 5.5 t -91.47 -8.06 48.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.411 0.624 . . . . 1.0 110.939 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -135.26 144.09 46.66 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 173.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 7.1 p-10 -112.32 151.71 29.39 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 120.652 0.263 . . . . 1.0 110.8 -177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 77' ' ' LEU . 12.5 p -121.28 130.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 C-N-CA 119.581 -0.847 . . . . 1.0 111.219 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.507 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 35.9 mt-10 -90.41 113.12 24.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.564 -2.013 . . . . 1.0 105.564 172.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.635 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -89.61 120.69 31.12 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -113.45 89.1 3.0 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.578 -1.268 . . . . 1.0 107.578 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.4 p -81.86 -19.76 40.33 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.863 -1.062 . . . . 1.0 109.676 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.46 -50.26 4.31 Favored Glycine 0 C--N 1.308 -1.023 0 CA-C-N 114.572 -1.195 . . . . 1.0 112.002 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.45 -37.84 81.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 1.0 111.432 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.59 -7.2 22.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.759 0.79 . . . . 1.0 109.395 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 -121.5 6.82 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.99 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.551 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.3 p80 -135.24 120.35 18.8 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.264 0.554 . . . . 1.0 111.055 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.12 149.41 44.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 21.7 mm -88.81 114.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 65' ' ' VAL . 10.6 mp -110.37 143.5 40.53 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.293 0.568 . . . . 1.0 111.63 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.4 m -161.09 155.84 23.64 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.988 -0.685 . . . . 1.0 111.418 178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.59 ' HA ' ' CB ' ' A' ' 84' ' ' SER . 47.5 mt-10 -129.46 65.61 1.47 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.456 ' CG ' ' HZ2' ' A' ' 115' ' ' LYS . 4.2 m-20 -141.09 -109.39 0.14 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.55 0.944 . . . . 1.0 113.55 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.94 -29.94 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 114.297 1.221 . . . . 1.0 114.297 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 t -123.06 20.62 9.89 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.321 0.581 . . . . 1.0 109.923 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.59 ' CB ' ' HA ' ' A' ' 80' ' ' GLU . 38.8 t -115.31 94.29 4.66 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 119.402 -0.919 . . . . 1.0 113.422 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -143.18 134.01 25.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 104.673 -2.343 . . . . 1.0 104.673 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.471 ' CG2' ' H ' ' A' ' 91' ' ' ARG . 5.3 p -139.91 126.64 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 CA-C-O 122.099 0.952 . . . . 1.0 111.877 -171.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -64.8 -37.3 87.15 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.331 -1.758 . . . . 1.0 111.091 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.71 -77.34 0.05 OUTLIER Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -111.69 4.96 18.92 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -61.89 -50.53 71.83 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.48 0.548 . . . . 1.0 112.48 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.471 ' H ' ' CG2' ' A' ' 86' ' ' VAL . 0.4 OUTLIER -139.85 121.07 14.83 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 116.992 -0.094 . . . . 1.0 111.048 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -93.9 -61.89 1.45 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 79.9 mt -137.4 169.4 17.84 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -99.16 140.94 32.58 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.563 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 2.0 p -112.35 173.88 6.15 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.328 0.651 . . . . 1.0 109.736 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 101' ' ' VAL . 3.3 pp -75.67 -26.0 57.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.105 -1.038 . . . . 1.0 109.175 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.575 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.5 pt20 -66.2 -25.63 67.02 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -61.34 -41.57 97.26 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.439 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 84.5 m-85 -97.18 -8.41 30.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.935 177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 100' ' ' LYS 0.275 8.6 mmtm 46.15 75.92 0.11 Allowed 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 125.278 1.431 . . . . 1.0 113.773 -176.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.635 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.1 m -84.7 150.19 55.76 Favored Pre-proline 0 C--N 1.285 -2.23 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.206 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.09 165.1 19.5 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 123.515 2.81 . . . . 1.0 112.567 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 119.66 11.01 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.399 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.72 19.01 12.63 Favored Glycine 0 C--N 1.29 -2.008 0 C-N-CA 120.7 -0.762 . . . . 1.0 111.405 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.98 155.67 37.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.198 0.523 . . . . 1.0 110.207 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.8 m -118.49 131.36 56.25 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.045 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.476 ' CG1' HD13 ' A' ' 11' ' ' LEU . 33.7 m -112.98 139.29 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.48 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.19 120.89 32.59 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 175.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.541 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.3 pp -106.35 141.97 36.8 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.771 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 113' ' ' LEU . 18.4 m -133.29 137.09 28.44 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.547 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.89 84.09 1.51 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.166 1.911 . . . . 1.0 111.614 179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.427 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 27.4 p 52.34 61.6 3.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 125.066 1.346 . . . . 1.0 110.338 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -110.89 -48.25 3.15 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.648 -173.191 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.7 t -112.78 7.76 18.61 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.662 -1.215 . . . . 1.0 111.974 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.456 ' HZ2' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -126.71 115.65 19.74 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.827 -1.079 . . . . 1.0 108.193 173.659 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -144.46 -163.88 1.79 Allowed 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.237 -1.764 . . . . 1.0 106.237 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.5 143.88 14.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.869 -1.53 . . . . 1.0 106.869 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.0 114.83 1.9 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 -172.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -72.05 -23.35 61.36 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.985 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -86.38 68.25 10.16 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 121.982 0.896 . . . . 1.0 109.635 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -145.05 92.54 2.28 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.419 -1.264 . . . . 1.0 107.728 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 . . . . . 0 C--N 1.295 -1.786 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -178.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 CA--C 1.498 -1.03 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp 56.44 30.38 16.95 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.001 0.813 . . . . 1.0 110.984 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -76.0 -17.29 59.75 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 122.222 1.01 . . . . 1.0 109.771 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' HB ' ' CD2' ' A' ' 6' ' ' TYR . 11.0 m -130.47 130.79 65.3 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 CA-C-N 113.372 -1.74 . . . . 1.0 107.285 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -100.58 82.87 2.51 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 122.503 1.144 . . . . 1.0 112.618 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.419 ' CD2' ' HB ' ' A' ' 4' ' ' VAL . 65.8 m-85 -126.58 -177.84 4.15 Favored 'General case' 0 N--CA 1.395 -3.219 0 N-CA-C 104.921 -2.252 . . . . 1.0 104.921 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.473 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 17.7 mmt180 -116.06 111.3 42.88 Favored Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 117.492 -1.683 . . . . 1.0 113.778 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 23.2 Cg_exo -64.47 104.65 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.967 1.778 . . . . 1.0 108.866 171.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -107.59 161.41 14.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.983 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -105.4 130.24 53.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.37 148.12 47.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 123.514 0.726 . . . . 1.0 110.704 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.06 111.21 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.364 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.16 115.13 15.58 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.68 0.613 . . . . 1.0 109.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.613 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 32.2 tp -147.73 155.43 41.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.475 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.64 144.44 48.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -115.73 30.29 7.45 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.625 0.726 . . . . 1.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.69 -47.1 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 115.023 -0.989 . . . . 1.0 112.691 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.93 -86.36 0.07 OUTLIER Glycine 0 C--O 1.22 -0.768 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.906 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.7 -30.53 85.33 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.151 2.567 . . . . 1.0 113.019 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.06 29.92 6.3 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.445 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.35 83.24 1.42 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.581 0.705 . . . . 1.0 112.063 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.53 3.99 56.16 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -135.73 26.45 3.36 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.382 -0.909 . . . . 1.0 110.605 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.03 -95.44 0.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.72 -60.26 1.47 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 112.753 0.649 . . . . 1.0 112.753 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.26 0.6 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.525 -1.321 . . . . 1.0 109.969 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.0 130.13 23.49 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 122.821 -0.223 . . . . 1.0 110.711 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.25 109.39 1.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.132 1.888 . . . . 1.0 111.28 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 44' ' ' MET . 58.1 t -120.08 138.58 50.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 123.538 0.735 . . . . 1.0 109.144 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -102.95 155.89 18.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.129 0.49 . . . . 1.0 112.195 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 8' ' ' PRO . 5.2 p -158.06 -175.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.463 ' H ' HG22 ' A' ' 31' ' ' VAL . 13.2 tp -109.19 158.52 17.73 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 119.267 0.94 . . . . 1.0 108.632 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.473 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 27.1 t70 -62.26 -29.99 70.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 123.429 0.692 . . . . 1.0 109.495 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.404 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 12.2 t -99.25 31.02 3.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.903 -1.499 . . . . 1.0 110.392 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.623 ' O ' HG22 ' A' ' 95' ' ' THR . 11.7 p-10 -68.49 -165.56 0.06 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.549 0.69 . . . . 1.0 109.149 171.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 p -141.6 161.59 37.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.857 -2.645 . . . . 1.0 103.857 167.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.672 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 44.5 mm -58.57 -46.09 90.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.741 -0.783 . . . . 1.0 110.557 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.527 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 36.7 t -63.52 -46.74 84.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 124.016 0.822 . . . . 1.0 110.37 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -64.82 -41.46 95.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.041 0.448 . . . . 1.0 111.426 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.623 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -64.32 -39.59 94.22 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.57 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.672 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.3 -35.33 79.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.625 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.527 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.0 mt-10 -64.44 -45.96 85.21 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.771 0.669 . . . . 1.0 110.062 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.808 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.623 ' HG3' ' O ' ' A' ' 40' ' ' ALA . 13.3 mtp -63.59 -42.42 98.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.6 pp -74.72 -26.88 60.11 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.243 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 50' ' ' LYS . 23.8 t70 -62.45 -32.91 73.85 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.414 0.626 . . . . 1.0 111.596 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.401 ' HG3' HG13 ' A' ' 29' ' ' VAL . 14.5 mm-40 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.676 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.63 -54.41 2.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.833 0.825 . . . . 1.0 112.256 -169.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -91.33 -4.8 55.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.695 -1.139 . . . . 1.0 111.789 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 46' ' ' ASP . 6.0 tmmm? -77.46 121.21 23.52 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.922 -1.51 . . . . 1.0 106.922 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.61 -7.8 56.05 Favored Glycine 0 C--N 1.306 -1.097 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.419 ' CG2' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -81.59 160.65 63.9 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 107.132 -1.432 . . . . 1.0 107.132 177.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HG2' ' CG ' ' A' ' 56' ' ' GLN . 15.8 Cg_endo -56.85 150.96 51.41 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 121.741 1.627 . . . . 1.0 111.37 176.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.5 mt -59.88 -40.37 88.48 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.351 0.66 . . . . 1.0 112.113 -171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -69.69 -14.26 62.71 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.098 0.475 . . . . 1.0 111.56 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.431 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 18.7 mm100 -95.63 -8.81 33.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.756 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.14 111.65 35.07 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.92 155.39 34.2 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.019 2.479 . . . . 1.0 112.676 -176.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -94.44 114.77 64.21 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.758 -0.656 . . . . 1.0 109.973 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.32 -3.68 14.22 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.947 2.432 . . . . 1.0 113.433 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -91.03 -21.82 21.07 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.502 -0.479 . . . . 1.0 111.025 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -105.69 -24.58 12.5 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.357 0.502 . . . . 1.0 112.357 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.688 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp -94.62 162.16 13.9 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.167 0.432 . . . . 1.0 112.167 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.559 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 7.6 p-10 -117.18 157.38 26.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.28 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -122.61 127.17 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.254 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -91.91 112.93 25.06 Favored 'General case' 0 N--CA 1.399 -2.997 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.56 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -93.18 122.18 35.3 Favored 'General case' 1 N--CA 1.377 -4.089 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.991 -177.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 88.0 mtm180 -112.56 89.81 3.17 Favored 'General case' 0 N--CA 1.389 -3.508 0 CA-C-O 122.601 1.191 . . . . 1.0 108.243 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.0 p -84.66 -16.89 40.31 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.64 -1.618 . . . . 1.0 109.232 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.29 -54.66 4.31 Favored Glycine 0 C--N 1.293 -1.846 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.239 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.9 m -62.3 -42.25 94.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.039 0.447 . . . . 1.0 111.126 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.04 -10.21 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.468 0.652 . . . . 1.0 109.318 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.77 -143.01 16.23 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.83 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.464 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 3.5 p80 -116.55 112.21 21.01 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.574 0.702 . . . . 1.0 109.623 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.05 144.96 48.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.825 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -85.2 115.65 27.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.721 -1.215 . . . . 1.0 107.721 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.464 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.8 mp -103.66 140.56 37.41 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.886 0.851 . . . . 1.0 111.338 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.417 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.4 m -152.39 148.15 27.13 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -70.96 -41.19 71.39 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.899 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.93 96.07 6.29 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 31.8 t70 -161.79 -89.29 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.945 0.878 . . . . 1.0 112.82 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.445 HG13 HD22 ' A' ' 94' ' ' ASN . 1.6 p -87.41 -2.5 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 CA-C-N 114.433 -1.258 . . . . 1.0 112.358 -171.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 92' ' ' ARG . 15.2 t -137.28 19.1 2.95 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 119.878 -0.729 . . . . 1.0 110.174 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.1 p -89.15 10.82 20.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.589 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -56.79 117.29 3.78 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.793 -0.639 . . . . 1.0 111.168 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 m -88.89 64.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 122.522 1.153 . . . . 1.0 110.969 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -101.89 0.66 35.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.418 -1.265 . . . . 1.0 110.184 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.89 -100.69 0.24 Allowed Glycine 0 N--CA 1.4 -3.765 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.3 mt -102.88 5.31 38.46 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.7 0.762 . . . . 1.0 111.148 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -91.9 0.53 57.48 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.03 -0.987 . . . . 1.0 111.624 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -67.35 93.99 0.36 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 106.278 -1.749 . . . . 1.0 106.278 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.523 ' O ' HG23 ' A' ' 83' ' ' THR . 51.5 ttp180 -133.88 157.37 46.13 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.439 -169.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 75.8 mt -95.66 148.66 22.31 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.445 HD22 HG13 ' A' ' 82' ' ' VAL . 53.5 m-80 -81.34 136.57 35.75 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.51 -0.876 . . . . 1.0 110.765 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.623 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.2 p -106.75 171.71 7.22 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 124.791 1.236 . . . . 1.0 109.334 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.57 -28.53 63.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.578 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.93 -25.64 67.97 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.921 176.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -61.62 -41.72 97.87 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.03 -4.36 30.11 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.518 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 65.2 mmtt 43.49 68.16 0.55 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.738 1.215 . . . . 1.0 112.227 -177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.56 HG11 ' NE1' ' A' ' 67' ' ' TRP . 2.9 m -75.57 149.01 83.44 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 114.915 -1.038 . . . . 1.0 111.636 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.74 162.98 38.36 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 122.828 2.352 . . . . 1.0 112.697 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.76 116.86 6.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.502 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.83 35.09 8.53 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 119.981 -1.105 . . . . 1.0 111.509 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.03 162.89 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -108.9 123.83 49.69 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.524 -0.47 . . . . 1.0 111.156 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG22 ' SD ' ' A' ' 44' ' ' MET . 5.9 m -104.79 144.83 14.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.613 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -139.85 132.86 29.47 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.475 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 1.6 pt? -118.13 143.49 46.44 Favored 'General case' 0 C--N 1.269 -2.934 0 C-N-CA 120.326 -0.55 . . . . 1.0 110.379 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.688 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 14.6 m -124.26 164.87 27.36 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.81 56.32 4.61 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.497 2.132 . . . . 1.0 111.472 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.559 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 5.2 t 63.43 82.75 0.17 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.488 -175.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -128.83 -45.79 1.28 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.499 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.9 t -127.45 36.55 4.37 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.142 0.496 . . . . 1.0 110.429 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.559 ' HD3' ' SG ' ' A' ' 112' ' ' CYS . 53.5 pttt -50.57 14.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.873 2.545 . . . . 1.0 117.873 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 68.72 14.59 9.0 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 124.063 0.945 . . . . 1.0 112.237 176.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.3 m -152.25 148.4 14.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 106.674 -1.602 . . . . 1.0 106.674 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 pp -142.73 164.35 30.34 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.034 -0.666 . . . . 1.0 112.336 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -133.8 134.82 43.33 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -71.45 133.68 46.05 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.328 0.393 . . . . 1.0 110.534 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -95.3 96.02 8.87 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.447 -1.316 . . . . 1.0 107.447 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 C--N 1.284 -2.257 0 N-CA-C 106.723 -1.584 . . . . 1.0 106.723 -178.705 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 CA--C 1.499 -0.992 0 N-CA-C 106.234 -1.765 . . . . 1.0 106.234 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -78.24 68.45 4.27 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.989 1.376 . . . . 1.0 110.028 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -88.58 11.12 18.17 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 113.645 -1.616 . . . . 1.0 109.163 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.0 t 65.97 66.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.245 -1.343 . . . . 1.0 111.356 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -104.84 32.2 4.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.444 -1.253 . . . . 1.0 109.101 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -116.23 173.35 6.64 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 105.149 -2.167 . . . . 1.0 105.149 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 33.9 mmt180 -109.6 110.96 59.54 Favored Pre-proline 0 C--N 1.278 -2.542 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.765 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.16 100.1 0.21 Allowed 'Trans proline' 0 C--O 1.245 0.843 0 N-CA-C 107.859 -1.631 . . . . 1.0 107.859 167.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.45 130.2 55.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 -171.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 m -89.36 129.45 35.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.409 HD13 ' CZ2' ' A' ' 67' ' ' TRP . 1.7 mm? -120.95 147.51 45.36 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 123.343 0.657 . . . . 1.0 110.366 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -90.92 108.5 19.89 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.38 109.19 7.67 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.026 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 30.8 tp -137.52 166.59 23.53 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.567 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -131.38 143.93 50.84 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.96 38.75 3.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.449 HG23 ' HD3' ' A' ' 111' ' ' PRO . 47.8 t -66.63 -44.48 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.52 -88.2 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 119.123 -1.513 . . . . 1.0 113.713 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.88 -29.35 82.37 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 123.253 2.635 . . . . 1.0 113.546 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.45 24.99 10.05 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 84.6 0.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.354 0.597 . . . . 1.0 111.826 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.33 -5.72 21.41 Favored Glycine 0 CA--C 1.487 -1.687 0 CA-C-N 115.163 -0.926 . . . . 1.0 111.271 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.63 19.13 3.9 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.264 -0.468 . . . . 1.0 112.082 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.99 -92.37 0.09 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.424 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 10.7 pt20 -110.04 -59.18 1.96 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.461 0.541 . . . . 1.0 112.461 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.424 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.7 69.7 1.25 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.89 127.01 30.25 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.99 -0.105 . . . . 1.0 110.743 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.48 107.43 2.29 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 121.862 1.708 . . . . 1.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.435 HG13 ' HA ' ' A' ' 44' ' ' MET . 83.7 t -119.95 140.09 45.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.17 -0.923 . . . . 1.0 109.586 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -104.73 146.31 29.13 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.081 -0.648 . . . . 1.0 111.808 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.3 m -141.94 171.21 11.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 124.241 1.017 . . . . 1.0 109.08 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -88.37 159.15 18.17 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.118 0.485 . . . . 1.0 111.267 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.406 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 37.5 t70 -61.93 -30.75 71.11 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 115.049 -0.978 . . . . 1.0 108.505 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.466 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.5 t -96.12 6.08 49.63 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 114.25 -1.341 . . . . 1.0 113.365 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.19 134.91 48.56 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.433 ' CG2' HD12 ' A' ' 93' ' ' LEU . 49.3 p -79.75 166.88 21.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.12 -44.59 91.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.89 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.65 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.6 p -61.84 -47.32 85.57 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 48.9 mt-30 -72.01 -38.23 69.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.975 0.732 . . . . 1.0 112.975 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.578 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.4 -39.96 85.59 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.51 -33.66 75.33 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.65 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.2 mt-10 -65.36 -48.64 72.25 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.086 0.866 . . . . 1.0 110.208 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 41.4 mmtm -60.83 -44.35 97.05 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.621 ' SD ' HG23 ' A' ' 107' ' ' VAL . 9.3 mtp -64.94 -41.97 95.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.751 -1.113 . . . . 1.0 112.288 -178.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -76.02 -32.91 59.61 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.765 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' O ' ' HE3' ' A' ' 50' ' ' LYS . 38.1 t70 -61.44 -29.78 70.16 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.508 0.723 . . . . 1.0 112.049 -174.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 11.3 mm-40 -67.54 -39.18 85.02 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.607 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.68 -19.15 13.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.639 -0.709 . . . . 1.0 112.468 -169.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -98.15 14.77 26.47 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 46' ' ' ASP . 4.6 tppp? -64.84 126.59 28.44 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.435 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.76 -19.1 39.38 Favored Glycine 0 C--N 1.314 -0.675 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.5 t -93.45 133.8 27.72 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 107.827 -1.175 . . . . 1.0 107.827 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.463 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 47.4 Cg_endo -63.75 153.0 77.98 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.779 2.32 . . . . 1.0 111.626 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.92 -37.46 82.39 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.085 0.554 . . . . 1.0 111.311 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.1 t -64.0 -23.83 67.48 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.837 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -96.14 -26.39 15.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.54 -0.464 . . . . 1.0 110.524 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 80.7 mtt180 -63.9 139.05 97.57 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.89 136.72 67.74 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 121.309 1.339 . . . . 1.0 110.959 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -87.34 125.19 66.58 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.566 -176.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -66.22 -17.0 53.8 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.127 2.551 . . . . 1.0 113.851 -175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -91.27 -11.05 39.24 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 120.976 0.417 . . . . 1.0 111.162 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 14.5 t -113.66 9.75 17.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.07 0.462 . . . . 1.0 110.281 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp -132.34 161.72 32.85 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.682 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.471 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 9.7 m-20 -108.89 151.63 26.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.925 -1.139 . . . . 1.0 107.925 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.16 128.52 75.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 119.807 -0.757 . . . . 1.0 109.482 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -89.74 112.47 23.77 Favored 'General case' 0 CA--C 1.457 -2.615 0 N-CA-C 105.612 -1.995 . . . . 1.0 105.612 174.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.604 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -91.25 117.27 29.5 Favored 'General case' 1 N--CA 1.367 -4.625 0 C-N-CA 119.273 -0.971 . . . . 1.0 108.501 177.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -102.8 88.25 3.15 Favored 'General case' 0 N--CA 1.394 -3.245 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.1 p -83.65 -14.4 51.96 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.824 -1.535 . . . . 1.0 110.34 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.53 -57.73 3.77 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.765 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.2 -43.73 98.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.28 0.632 . . . . 1.0 111.766 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.37 -8.54 21.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.299 0.571 . . . . 1.0 110.347 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.41 -149.38 19.43 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.57 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.9 p80 -105.91 108.87 20.6 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.498 0.666 . . . . 1.0 111.299 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.03 146.42 36.74 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.368 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.87 99.27 8.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -89.34 156.37 18.76 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.564 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.3 t -160.84 164.41 31.37 Favored 'General case' 0 CA--C 1.465 -2.303 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -63.58 -37.21 86.45 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.714 0.634 . . . . 1.0 110.079 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -163.67 88.91 0.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 123.107 0.254 . . . . 1.0 110.846 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -152.63 -142.94 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.058 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.48 -33.16 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 p -85.3 4.52 34.61 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.759 0.79 . . . . 1.0 112.706 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.5 m -85.84 9.92 15.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.353 -0.84 . . . . 1.0 110.95 177.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 62.83 30.5 16.64 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 123.048 1.404 . . . . 1.0 110.038 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.76 85.19 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.262 -3.239 0 CA-C-N 113.333 -1.758 . . . . 1.0 112.796 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.83 -25.83 6.68 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 113.853 -1.521 . . . . 1.0 108.576 170.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.29 -111.42 0.29 Allowed Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.31 -10.58 59.51 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 112.932 0.715 . . . . 1.0 112.932 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -79.51 -0.47 33.42 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.473 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -65.88 125.43 25.37 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.334 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -136.97 -172.51 3.2 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.614 0.721 . . . . 1.0 112.848 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.433 HD12 ' CG2' ' A' ' 36' ' ' THR . 3.0 tm? -102.72 138.22 39.9 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.247 1.819 . . . . 1.0 106.449 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.6 m-80 -96.74 139.59 32.57 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.929 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.425 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -129.39 176.45 7.95 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 125.855 1.662 . . . . 1.0 106.821 175.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 pp -73.32 -25.31 60.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.237 -1.385 . . . . 1.0 108.944 174.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.514 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 5.1 pt20 -66.36 -24.73 66.55 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.31 -40.71 91.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -103.45 2.58 33.93 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.514 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 30.9 mmmt 40.76 64.09 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.401 1.08 . . . . 1.0 112.097 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.604 HG11 ' NE1' ' A' ' 67' ' ' TRP . 2.1 m -68.74 150.95 97.49 Favored Pre-proline 0 C--N 1.294 -1.833 0 CA-C-N 115.539 -0.755 . . . . 1.0 111.786 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.12 155.83 37.92 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.154 1.903 . . . . 1.0 111.462 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.95 124.5 22.7 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.654 0.74 . . . . 1.0 110.208 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.99 22.23 23.58 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.092 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -71.08 164.42 25.62 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.911 0.386 . . . . 1.0 109.993 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.3 m -111.56 130.55 55.7 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.282 -0.567 . . . . 1.0 110.767 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.621 HG23 ' SD ' ' A' ' 44' ' ' MET . 27.5 m -114.13 139.49 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.49 138.94 49.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.567 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.1 pp -108.89 139.55 43.57 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.548 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 36.0 m -130.42 130.92 23.08 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.569 -0.741 . . . . 1.0 109.511 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.449 ' HD3' HG23 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -68.67 78.72 0.68 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.791 2.327 . . . . 1.0 112.458 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 62' ' ' THR . 43.6 t 57.08 83.76 0.1 Allowed 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.781 1.232 . . . . 1.0 111.132 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.538 ' O ' HG21 ' A' ' 114' ' ' THR . 3.1 mm? 62.76 22.09 13.17 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 125.301 1.44 . . . . 1.0 110.319 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.538 HG21 ' O ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER 68.06 13.13 9.05 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 113.365 -1.743 . . . . 1.0 112.682 177.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 115' ' ' LYS . 11.4 mmpt? -88.3 91.77 8.91 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.538 -0.912 . . . . 1.0 108.538 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -88.93 102.19 14.82 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.308 -0.86 . . . . 1.0 109.67 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.7 m -125.16 166.98 19.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 114.451 -1.249 . . . . 1.0 108.667 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.7 78.66 6.26 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.003 -0.739 . . . . 1.0 109.003 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -70.8 -42.59 70.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.447 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -81.79 97.94 8.23 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.56 -0.745 . . . . 1.0 111.308 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -163.03 160.06 24.08 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.691 -1.596 . . . . 1.0 106.691 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? . . . . . 0 C--N 1.27 -2.853 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 177.437 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 mppt? -146.72 178.12 8.56 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.117 -1.438 . . . . 1.0 107.117 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -84.1 88.93 7.2 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.039 -1.838 . . . . 1.0 106.039 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.79 87.69 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.168 -0.923 . . . . 1.0 113.063 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.21 31.01 4.93 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 124.089 1.899 . . . . 1.0 106.069 167.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.57 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 89.3 m-85 -134.89 -177.66 4.73 Favored 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 111.732 -2.485 . . . . 1.0 105.905 -172.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 59.4 mmt-85 -104.31 114.57 64.12 Favored Pre-proline 0 C--N 1.271 -2.809 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.409 -176.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.02 111.69 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.39 2.06 . . . . 1.0 108.938 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.36 127.97 54.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -171.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -88.49 122.31 31.83 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 105' ' ' ALA . 16.5 tp -126.97 138.99 53.36 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -97.64 119.54 36.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.847 -0.533 . . . . 1.0 110.835 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.01 121.11 23.79 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.504 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -149.19 169.53 20.51 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.448 0.299 . . . . 1.0 110.437 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -127.26 144.58 51.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.419 0.288 . . . . 1.0 110.692 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -124.12 39.79 3.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.126 0.489 . . . . 1.0 110.555 179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.47 -46.33 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 C-N-CA 123.302 0.641 . . . . 1.0 110.728 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.99 -94.39 0.12 Allowed Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.387 -0.911 . . . . 1.0 112.204 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.46 -32.85 88.91 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.42 2.746 . . . . 1.0 113.543 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -110.45 25.58 15.12 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.887 -177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.88 79.8 0.12 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.387 0.613 . . . . 1.0 111.78 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -5.33 3.08 Favored Glycine 0 N--CA 1.423 -2.19 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.32 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.63 18.53 21.32 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.178 0.807 . . . . 1.0 113.178 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.58 -76.91 0.19 Allowed 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.897 -0.721 . . . . 1.0 112.141 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -138.41 -53.1 0.61 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.261 -176.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 59.94 8.55 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.4 t -114.71 126.99 27.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.261 -0.469 . . . . 1.0 110.552 -175.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.45 103.36 1.73 Allowed 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.97 1.78 . . . . 1.0 110.562 175.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.51 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 57.7 t -102.16 153.81 5.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -109.57 139.61 44.37 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.314 -0.955 . . . . 1.0 111.433 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.57 174.63 12.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.095 -1.411 . . . . 1.0 108.239 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -104.59 159.73 15.52 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.542 0.687 . . . . 1.0 110.637 175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 38.5 t70 -59.67 -29.87 68.37 Favored 'General case' 0 C--O 1.272 2.249 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.952 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 45.8 t -82.6 -12.01 58.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.753 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.03 132.67 47.02 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.406 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 44.3 p -78.32 172.55 13.44 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 94' ' ' ASN . 43.7 mm -60.37 -45.61 96.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.926 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.3 t -66.39 -41.92 88.64 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 8.4 tt0 -66.31 -34.38 77.86 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.993 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -81.67 -38.48 25.83 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 122.307 -0.245 . . . . 1.0 111.518 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.467 ' HB3' ' HZ1' ' A' ' 41' ' ' LYS . 2.6 mmmp? -60.51 -35.51 76.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.916 0.388 . . . . 1.0 110.34 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -66.48 -41.23 89.27 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.391 -0.822 . . . . 1.0 109.905 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 46.7 mmtm -63.6 -41.49 98.33 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.834 0.709 . . . . 1.0 111.861 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.584 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 86.1 mmm -60.96 -45.94 92.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.146 0.498 . . . . 1.0 110.627 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.5 -25.33 50.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.681 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 24.9 t70 -56.94 -28.83 62.56 Favored 'General case' 0 C--O 1.203 -1.371 0 C-N-CA 125.374 1.47 . . . . 1.0 112.145 -174.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.454 HE21 HG13 ' A' ' 29' ' ' VAL . 14.1 mm-40 -65.78 -33.92 76.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.067 0.46 . . . . 1.0 111.082 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.33 -42.05 8.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.881 0.848 . . . . 1.0 109.127 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -101.72 35.73 2.25 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.116 -1.402 . . . . 1.0 111.062 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -57.0 118.97 5.51 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.98 -1.009 . . . . 1.0 109.768 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.77 -11.42 38.37 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 120.766 -0.73 . . . . 1.0 112.355 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.91 129.13 71.67 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.454 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 58.0 Cg_endo -67.23 156.7 65.14 Favored 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.75 2.3 . . . . 1.0 112.431 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.52 -38.59 87.92 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.963 0.505 . . . . 1.0 111.56 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 t -62.7 -24.02 67.45 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 121.074 0.464 . . . . 1.0 111.299 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.517 HE21 ' HA ' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -88.22 -24.51 23.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.922 0.391 . . . . 1.0 110.308 178.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 58.2 mtt180 -74.1 121.21 84.66 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.17 141.32 96.49 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.491 2.128 . . . . 1.0 112.347 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -90.1 150.54 43.57 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 115.558 -0.746 . . . . 1.0 112.466 -174.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.15 7.92 2.7 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.683 2.255 . . . . 1.0 110.894 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.84 -16.96 24.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.11 173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 t -117.39 -2.72 11.5 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.427 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.482 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.4 pp -149.48 155.45 40.39 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.52 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 7.7 m-20 -105.83 151.53 24.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 77' ' ' LEU . 12.4 p -114.6 124.53 71.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.428 172.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.63 112.28 24.14 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.594 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -93.28 125.82 38.08 Favored 'General case' 1 N--CA 1.374 -4.225 0 CA-C-N 114.554 -1.203 . . . . 1.0 109.165 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.29 89.39 3.05 Favored 'General case' 0 N--CA 1.395 -3.203 0 N-CA-C 106.672 -1.603 . . . . 1.0 106.672 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.8 p -79.0 -22.56 45.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.339 -1.301 . . . . 1.0 109.393 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.16 -45.72 3.5 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.837 -1.074 . . . . 1.0 112.163 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.55 -39.45 85.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.023 0.439 . . . . 1.0 111.062 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.22 -9.41 16.89 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.447 0.641 . . . . 1.0 109.937 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.07 -126.17 8.82 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.212 -0.904 . . . . 1.0 111.51 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -120.28 118.32 30.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.238 0.542 . . . . 1.0 110.204 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.66 151.91 45.92 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 9.8 mm -98.34 120.3 47.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.469 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.455 HD23 ' CE3' ' A' ' 67' ' ' TRP . 10.7 mp -111.99 163.32 14.38 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -167.58 163.03 14.57 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.234 -2.506 . . . . 1.0 104.234 175.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 21.3 p-10 -93.68 -3.25 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 117.9 -1.52 . . . . 1.0 111.033 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -138.56 75.08 1.5 Allowed 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -80.75 -172.18 3.52 Favored 'General case' 0 CA--C 1.478 -1.805 0 CA-C-N 115.03 -0.986 . . . . 1.0 109.834 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.95 -27.66 39.13 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 114.881 -1.054 . . . . 1.0 109.92 172.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.0 t -81.27 -2.5 49.17 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.637 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 76.8 p -80.24 86.57 5.62 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.235 1.016 . . . . 1.0 109.711 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -81.69 118.3 22.72 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.545 0.688 . . . . 1.0 111.75 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 t -97.56 84.06 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 -177.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.05 4.44 0.4 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.547 -1.206 . . . . 1.0 111.671 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 90' ' ' PHE . . . 136.67 85.21 0.17 Allowed Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 119.246 -1.454 . . . . 1.0 113.169 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.4 mt 73.44 -17.37 0.43 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.516 1.526 . . . . 1.0 114.178 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.43 ' H ' ' C ' ' A' ' 88' ' ' GLY . 74.5 m-85 -64.84 -31.55 72.83 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.264 0.554 . . . . 1.0 109.759 177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -71.45 113.27 8.31 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.04 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -150.53 158.95 44.73 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.86 -1.163 . . . . 1.0 107.86 172.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.634 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 79.3 mt -79.88 139.48 37.12 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.462 ' O ' HG12 ' A' ' 37' ' ' ILE . 93.8 m-20 -89.6 141.02 28.98 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -107.27 173.29 6.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 124.448 1.099 . . . . 1.0 109.704 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.66 -25.41 61.26 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.303 -0.959 . . . . 1.0 108.783 173.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.483 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -66.68 -25.34 66.51 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.22 0.533 . . . . 1.0 110.904 173.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -64.4 -37.73 88.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -104.55 -1.78 26.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.934 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 49.71 66.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.837 1.255 . . . . 1.0 112.997 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.594 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.1 m -85.27 150.71 55.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.636 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.19 155.89 22.61 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.844 2.362 . . . . 1.0 111.926 175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.0 122.17 17.16 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.52 10.34 13.24 Favored Glycine 0 C--N 1.285 -2.264 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.427 ' O ' HD13 ' A' ' 11' ' ' LEU . . . -69.89 162.3 28.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.288 0.566 . . . . 1.0 111.069 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.9 m -120.92 132.71 55.11 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.6 m -115.73 135.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.506 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.38 137.54 54.24 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.572 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.5 tt -97.92 126.86 43.52 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.974 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.52 ' CG2' ' HB2' ' A' ' 64' ' ' ASP . 33.9 m -127.88 127.1 23.96 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.35 82.02 0.91 Allowed 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 122.355 2.037 . . . . 1.0 111.823 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.482 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.7 p 50.93 29.85 4.79 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 126.038 1.735 . . . . 1.0 111.026 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.1 -41.63 77.21 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 113.859 -1.519 . . . . 1.0 112.984 -172.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.0 t -111.23 -0.22 16.54 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 114.403 1.26 . . . . 1.0 114.403 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 48.02 74.1 0.18 Allowed 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 124.184 0.994 . . . . 1.0 113.483 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -103.22 4.53 36.82 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.78 1.276 . . . . 1.0 109.881 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.3 132.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.426 0 CA-C-N 112.9 -1.955 . . . . 1.0 109.144 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.8 mt -134.86 106.19 6.76 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -137.36 -7.44 1.75 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.144 -0.935 . . . . 1.0 109.642 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.561 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -82.17 -169.92 2.64 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.065 -1.425 . . . . 1.0 111.349 -176.138 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.3 t30 72.62 25.62 2.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.59 1.186 . . . . 1.0 109.299 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.0 pm0 . . . . . 0 C--O 1.252 1.209 0 CA-C-N 114.959 -1.019 . . . . 1.0 110.135 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.9 tttm . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.463 0.649 . . . . 1.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -120.84 150.4 41.09 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.466 -0.788 . . . . 1.0 109.604 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.03 2.21 56.49 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.904 0.859 . . . . 1.0 110.406 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.414 ' HB ' ' CD2' ' A' ' 6' ' ' TYR . 34.5 m -125.35 132.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 CA-C-N 114.735 -1.12 . . . . 1.0 108.514 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -108.76 78.68 1.17 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.414 1.102 . . . . 1.0 111.222 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 34' ' ' CYS . 74.8 m-85 -128.01 -178.57 4.57 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 105.261 -2.126 . . . . 1.0 105.261 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -113.39 114.63 47.78 Favored Pre-proline 0 C--N 1.273 -2.721 0 C-N-CA 118.111 -1.436 . . . . 1.0 113.287 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 124.98 16.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.247 1.964 . . . . 1.0 109.098 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tp -122.18 161.81 22.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.801 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m -109.48 128.44 55.17 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.1 mt -126.66 149.99 49.22 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.751 0.82 . . . . 1.0 111.011 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -94.62 116.05 28.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.74 120.59 24.83 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 31.0 tp -151.64 152.32 32.67 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.558 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.1 pt? -122.13 143.03 49.79 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.728 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -117.25 32.41 6.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.363 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.18 -45.32 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 C-N-CA 123.572 0.749 . . . . 1.0 111.814 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.64 -87.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.363 -1.398 . . . . 1.0 113.475 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.33 -30.76 88.22 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.954 2.436 . . . . 1.0 113.171 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.3 26.08 11.64 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.694 -0.765 . . . . 1.0 111.547 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.7 82.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.05 0.12 48.04 Favored Glycine 0 CA--C 1.48 -2.14 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 174.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.41 22.04 3.7 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.664 -0.768 . . . . 1.0 111.242 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.66 -69.33 0.62 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.189 -0.459 . . . . 1.0 112.129 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.41 -51.77 0.17 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.7 -177.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.0 68.19 1.73 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.508 -1.037 . . . . 1.0 110.508 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.4 t -103.37 127.34 29.87 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -175.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.94 108.45 2.72 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 C-N-CA 121.623 1.549 . . . . 1.0 111.624 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG12 ' NE2' ' A' ' 47' ' ' GLN . 44.1 t -106.23 154.83 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.985 -1.007 . . . . 1.0 108.729 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.84 143.96 34.18 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.324 0.583 . . . . 1.0 110.769 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.48 166.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 tp -100.4 156.83 17.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.05 -30.29 70.88 Favored 'General case' 0 C--O 1.268 2.033 0 CA-C-O 121.473 0.654 . . . . 1.0 109.596 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.611 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -90.82 1.56 56.83 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.355 -176.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.17 136.24 46.4 Favored 'General case' 0 CA--C 1.48 -1.734 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.014 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.36 168.81 17.15 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.518 ' CG2' ' HA ' ' A' ' 78' ' ' SER . 42.1 mm -61.59 -42.23 93.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 120.799 -0.361 . . . . 1.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -61.68 -43.72 98.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 121.109 -0.237 . . . . 1.0 110.547 177.323 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.435 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 27.0 mt-30 -67.33 -39.33 85.81 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 123.461 0.476 . . . . 1.0 111.238 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.66 -39.1 91.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.09 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.2 mptm? -56.93 -40.28 76.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 176.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 38' ' ' SER . 41.3 mt-10 -65.43 -53.81 37.65 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.42 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.27 -40.86 96.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.319 0.859 . . . . 1.0 113.319 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.67 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.5 mmm -64.04 -46.42 84.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.441 . . . . 1.0 110.406 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.7 pp -76.7 -25.19 53.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.13 -29.66 58.18 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.461 1.104 . . . . 1.0 112.67 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.457 ' NE2' HG12 ' A' ' 29' ' ' VAL . 27.7 mt-30 -69.25 -31.36 69.86 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.884 -0.327 . . . . 1.0 111.315 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -92.55 -40.11 10.98 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.93 0.871 . . . . 1.0 108.713 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -94.15 28.02 2.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.491 -1.232 . . . . 1.0 110.665 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -59.41 126.77 28.99 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.438 -0.801 . . . . 1.0 110.39 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.24 -11.55 57.01 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.771 -0.931 . . . . 1.0 110.771 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -97.48 116.86 65.91 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.478 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 59.2 Cg_endo -68.38 161.09 46.28 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.536 2.157 . . . . 1.0 111.06 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.3 -39.33 90.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.519 0.2 . . . . 1.0 111.436 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 t -62.85 -26.49 68.79 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.665 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -85.94 -19.35 30.58 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.549 0.69 . . . . 1.0 109.907 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 78.2 mtt180 -84.16 154.53 63.59 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.55 161.66 45.02 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.064 1.842 . . . . 1.0 110.706 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -64.0 128.88 93.52 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 109.541 -0.54 . . . . 1.0 109.541 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.27 -5.11 16.6 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.378 2.052 . . . . 1.0 114.683 -175.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.4 -6.81 43.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.093 0.406 . . . . 1.0 111.24 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.2 p -72.96 -23.67 60.69 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.145 -1.057 . . . . 1.0 108.145 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 2.2 pp -117.95 148.7 41.94 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 113.813 -1.54 . . . . 1.0 109.43 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.405 ' HA ' ' HZ1' ' A' ' 41' ' ' LYS . 53.6 m-20 -112.91 169.5 8.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 1.0 108.329 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 77' ' ' LEU . 13.3 p -121.62 129.21 75.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 C-N-CA 119.791 -0.764 . . . . 1.0 108.962 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 108' ' ' ALA . 10.3 pt-20 -91.49 111.89 23.58 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.159 -1.793 . . . . 1.0 106.159 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 2.5 t-105 -89.99 126.06 35.61 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.164 -1.38 . . . . 1.0 110.054 -174.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.47 88.97 2.85 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.7 p -91.9 -14.15 30.09 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.826 -1.534 . . . . 1.0 110.907 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.52 -52.53 4.38 Favored Glycine 0 C--N 1.303 -1.279 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.793 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.88 -38.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 122.669 0.388 . . . . 1.0 111.394 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.69 1.97 21.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.57 0.7 . . . . 1.0 109.665 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.23 -129.47 10.6 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.648 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 19.4 p-80 -110.73 112.73 24.8 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.317 0.579 . . . . 1.0 110.069 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.43 140.19 53.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -79.14 115.06 20.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.484 HD23 ' CE3' ' A' ' 67' ' ' TRP . 10.5 mp -109.79 148.36 31.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.763 0.792 . . . . 1.0 112.351 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.518 ' HA ' ' CG2' ' A' ' 37' ' ' ILE . 1.0 OUTLIER -164.12 157.05 17.7 Favored 'General case' 0 CA--C 1.467 -2.216 0 C-N-CA 125.805 1.642 . . . . 1.0 107.082 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.411 ' N ' ' HB ' ' A' ' 37' ' ' ILE . 21.6 p-10 -73.69 -38.33 64.91 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 123.293 0.371 . . . . 1.0 111.399 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -153.78 88.05 1.25 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.592 -0.443 . . . . 1.0 112.014 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -173.29 -92.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.556 0.693 . . . . 1.0 110.996 171.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.95 -28.23 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 114.406 -1.27 . . . . 1.0 110.548 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.6 p -89.54 -20.2 24.08 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.821 -1.082 . . . . 1.0 110.757 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 t -89.15 88.46 7.55 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 121.696 0.76 . . . . 1.0 111.33 -172.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.555 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 47.2 mt-10 -104.45 117.63 34.64 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 173.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.8 m -79.09 68.53 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 114.041 1.126 . . . . 1.0 114.041 -171.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -105.74 -13.13 15.64 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.222 -1.353 . . . . 1.0 109.58 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.78 -90.18 0.11 Allowed Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 120.637 -0.792 . . . . 1.0 112.285 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -71.46 -6.8 43.12 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 114.288 1.218 . . . . 1.0 114.288 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.555 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 49.1 m-85 -87.12 -2.52 58.69 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.202 -0.599 . . . . 1.0 112.309 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -84.85 91.63 8.06 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.13 -1.434 . . . . 1.0 107.13 170.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 173.58 157.44 0.13 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.98 138.08 39.41 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.495 ' O ' HG12 ' A' ' 37' ' ' ILE . 41.5 m-80 -82.44 140.16 33.57 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.851 -0.74 . . . . 1.0 109.52 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.46 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -114.64 174.74 5.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.09 -29.59 63.05 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.235 -0.986 . . . . 1.0 108.368 173.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.611 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.0 pt20 -65.76 -24.48 66.96 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.024 -0.535 . . . . 1.0 112.17 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -59.9 -44.23 94.38 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 108.971 -0.751 . . . . 1.0 108.971 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -96.65 -10.28 27.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.569 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.452 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 64.7 mmtt 53.0 73.16 0.37 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.259 1.024 . . . . 1.0 113.121 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.6 HG12 ' CE2' ' A' ' 67' ' ' TRP . 1.2 m -83.08 147.99 55.42 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.958 . . . . 1.0 110.838 177.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.54 159.57 35.65 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.56 2.173 . . . . 1.0 112.911 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.77 121.54 15.26 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 121.764 0.792 . . . . 1.0 109.415 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.96 9.72 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.232 -0.985 . . . . 1.0 111.177 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.61 163.04 27.75 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.941 0.401 . . . . 1.0 110.315 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -115.61 131.33 56.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.835 0.35 . . . . 1.0 110.426 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.07 138.07 46.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -126.38 128.03 46.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.187 0.518 . . . . 1.0 110.593 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.558 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.3 mp -92.71 127.15 38.1 Favored 'General case' 0 C--N 1.269 -2.928 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.033 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -128.94 154.01 80.21 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 -178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.13 74.09 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.224 1.949 . . . . 1.0 110.633 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.567 ' C ' ' H ' ' A' ' 114' ' ' THR . 0.2 OUTLIER 58.85 17.86 5.62 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.486 1.514 . . . . 1.0 111.836 -179.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 74.79 -39.67 0.42 Allowed 'General case' 0 C--N 1.349 0.576 0 C-N-CA 125.589 1.555 . . . . 1.0 108.627 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.567 ' H ' ' C ' ' A' ' 112' ' ' CYS . 12.7 t -117.08 117.63 30.14 Favored 'General case' 1 N--CA 1.376 -4.172 0 CA-C-N 114.179 -1.373 . . . . 1.0 107.334 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.496 ' HD2' ' N ' ' A' ' 115' ' ' LYS . 11.4 mptt -63.4 -40.24 96.69 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.259 -1.791 . . . . 1.0 114.652 -166.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -99.41 100.04 11.03 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.404 -0.918 . . . . 1.0 110.704 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.16 166.1 27.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.714 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 pp -110.19 144.77 38.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -132.7 107.35 8.33 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.135 0.493 . . . . 1.0 109.839 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -90.24 162.49 15.2 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.895 -1.521 . . . . 1.0 106.895 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -79.9 64.72 4.84 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.607 0.717 . . . . 1.0 112.031 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 . . . . . 0 N--CA 1.439 -0.977 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 177.948 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 CA--C 1.5 -0.956 0 N-CA-C 111.903 0.335 . . . . 1.0 111.903 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 132.28 54.08 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.046 0.45 . . . . 1.0 110.59 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -99.12 25.84 6.42 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.19 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 t -80.59 68.91 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 115.092 -0.958 . . . . 1.0 110.57 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -129.45 84.54 2.23 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.631 -1.168 . . . . 1.0 108.051 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -130.57 -178.53 4.82 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 105.461 -2.051 . . . . 1.0 105.461 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 31.5 mmt180 -104.98 104.28 45.9 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 119.444 -0.903 . . . . 1.0 109.313 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.81 105.18 0.76 Allowed 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.436 ' HB3' HG22 ' A' ' 31' ' ' VAL . 4.3 tp -110.37 162.08 15.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-O 121.626 0.727 . . . . 1.0 112.334 -168.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.414 ' H ' ' HG ' ' A' ' 9' ' ' LEU . 14.7 m -112.79 129.92 56.26 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.383 -1.281 . . . . 1.0 108.387 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 25.7 mt -126.26 149.86 48.81 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.287 0.565 . . . . 1.0 111.258 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -98.03 107.45 19.93 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.286 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.94 111.21 6.16 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 123.903 0.752 . . . . 1.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.485 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 30.4 tp -145.23 146.77 31.84 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.407 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.549 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.86 143.91 49.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -113.15 29.64 7.82 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.193 0.521 . . . . 1.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.441 HG23 ' HD3' ' A' ' 111' ' ' PRO . 53.2 t -64.9 -47.15 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 123.857 0.863 . . . . 1.0 112.56 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.85 -75.6 0.11 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.611 -1.281 . . . . 1.0 113.773 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.9 -26.44 80.97 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 123.68 2.92 . . . . 1.0 113.057 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.43 39.31 1.59 Allowed Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.751 -1.339 . . . . 1.0 109.751 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -63.75 80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.193 1.183 . . . . 1.0 114.193 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.35 39.96 Favored Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 110.403 -1.079 . . . . 1.0 110.403 172.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -157.05 38.07 0.3 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.612 0.72 . . . . 1.0 110.427 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -95.63 -77.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.811 -0.631 . . . . 1.0 112.546 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 1.6 pt20 -127.13 -59.14 1.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.418 -172.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.42 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 69.56 68.37 1.66 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -99.34 131.25 25.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.666 -0.267 . . . . 1.0 110.561 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.14 103.36 1.49 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.917 1.745 . . . . 1.0 111.597 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.554 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 37.5 t -110.38 155.36 11.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.23 -0.895 . . . . 1.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.22 144.76 31.17 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.16 0.505 . . . . 1.0 112.177 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.436 HG22 ' HB3' ' A' ' 9' ' ' LEU . 2.6 m -147.64 -176.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.69 -1.141 . . . . 1.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.401 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 29.5 mt -121.45 174.35 6.81 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.641 0.734 . . . . 1.0 110.097 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.467 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 28.8 t70 -66.18 -32.3 73.65 Favored 'General case' 0 C--O 1.265 1.881 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.607 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.465 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 3.9 t -103.46 2.78 34.16 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.417 1.636 . . . . 1.0 115.417 -169.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 32' ' ' LEU 0.393 0.2 OUTLIER -79.08 141.92 36.93 Favored 'General case' 0 CA--C 1.467 -2.245 0 C-N-CA 115.969 -2.293 . . . . 1.0 111.607 172.475 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.2 p -77.24 170.15 17.06 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.527 -1.67 . . . . 1.0 110.217 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.5 mm -59.64 -42.9 89.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.605 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.8 p -61.59 -46.99 87.49 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 123.431 0.457 . . . . 1.0 111.401 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.77 -42.54 63.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.114 0.483 . . . . 1.0 111.558 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.63 -37.4 82.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.716 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.528 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 32.9 ttpt -59.29 -38.31 79.9 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.444 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.605 ' HG3' ' O ' ' A' ' 38' ' ' SER . 63.5 mt-10 -66.9 -40.0 87.59 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.402 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -63.92 -40.93 97.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 121.335 -0.146 . . . . 1.0 111.05 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.554 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.1 mmt -61.82 -49.35 76.65 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.739 0.65 . . . . 1.0 110.601 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -76.64 -23.08 53.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.75 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 30.7 t70 -55.27 -30.82 60.87 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.247 1.019 . . . . 1.0 111.567 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -67.96 -30.93 70.34 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.845 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.88 -41.66 7.92 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.091 0.472 . . . . 1.0 111.46 -171.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.75 ' CE2' ' HA ' ' A' ' 46' ' ' ASP . 1.2 p90 -78.85 -11.12 59.98 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.903 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 13.9 tppt? -59.51 114.79 2.88 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.74 9.93 70.76 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.274 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.33 147.94 33.7 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -56.91 149.08 63.41 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.912 2.408 . . . . 1.0 112.067 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.7 -41.2 97.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.401 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 t -66.56 -21.49 66.15 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 112.307 0.484 . . . . 1.0 112.307 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -85.57 -23.9 27.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.018 0.437 . . . . 1.0 110.643 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -62.81 118.84 45.83 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.593 -177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.559 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 80.1 Cg_endo -72.36 159.93 48.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.082 2.522 . . . . 1.0 111.942 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -93.06 102.01 6.41 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.733 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 58' ' ' PRO . 34.4 Cg_exo -61.54 -33.41 87.45 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.989 2.46 . . . . 1.0 112.017 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -61.06 -30.17 70.17 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.273 -0.876 . . . . 1.0 113.116 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 14.7 t -101.56 2.15 38.69 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.449 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.9 pp -111.66 155.22 23.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.92 0.39 . . . . 1.0 111.181 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 11.2 p-10 -113.5 162.71 15.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.305 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.14 127.06 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.302 0.572 . . . . 1.0 110.472 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.45 113.21 25.31 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 105.132 -2.173 . . . . 1.0 105.132 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.566 ' CE2' HG12 ' A' ' 101' ' ' VAL . 4.9 t-105 -91.55 133.54 35.44 Favored 'General case' 0 N--CA 1.403 -2.806 0 CA-C-N 115.39 -0.823 . . . . 1.0 111.912 -173.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -117.08 88.69 2.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 106.446 -1.687 . . . . 1.0 106.446 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 71.3 p -73.48 -31.99 64.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.785 -1.098 . . . . 1.0 110.763 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.14 -50.99 4.35 Favored Glycine 0 C--N 1.303 -1.282 0 CA-C-N 114.566 -1.197 . . . . 1.0 111.365 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.8 -41.28 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.524 0.329 . . . . 1.0 111.703 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.4 -40.04 5.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.275 -1.009 . . . . 1.0 108.275 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.16 -130.16 6.76 Favored Glycine 0 N--CA 1.426 -2.021 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.042 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 88.9 m-70 -100.94 118.86 37.8 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.544 0.737 . . . . 1.0 110.652 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.35 134.43 39.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 mm -79.72 118.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.566 HD21 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -109.98 152.27 26.09 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.234 0.54 . . . . 1.0 111.4 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -154.92 148.99 25.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 p-10 -66.25 -44.14 84.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.472 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 43.2 tt0 -157.5 88.6 1.0 Allowed 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.935 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 3.4 t70 -159.5 -81.21 0.05 Allowed 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 119.628 -0.829 . . . . 1.0 112.208 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.424 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 7.3 p -93.96 -34.0 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.323 0 CA-C-N 114.36 -1.291 . . . . 1.0 112.617 -171.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.484 HG22 ' ND2' ' A' ' 94' ' ' ASN . 2.8 t -106.12 20.35 19.09 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.315 1.055 . . . . 1.0 109.277 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 80' ' ' GLU . 5.8 m -132.91 121.67 23.2 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 105.589 -2.004 . . . . 1.0 105.589 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -75.94 91.58 3.05 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.449 1.119 . . . . 1.0 111.078 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 p -102.64 85.58 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.1 0 CA-C-N 114.247 -1.342 . . . . 1.0 109.705 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.79 20.49 0.9 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 113.101 -1.863 . . . . 1.0 108.139 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.81 -160.86 32.81 Favored Glycine 1 N--CA 1.372 -5.622 0 N-CA-C 107.553 -2.219 . . . . 1.0 107.553 -175.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' H ' HD21 ' A' ' 89' ' ' LEU . 1.8 pt? -74.22 9.49 1.62 Allowed 'General case' 0 C--N 1.26 -3.292 0 C-N-CA 124.176 0.99 . . . . 1.0 112.314 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.433 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 61.8 m-85 -87.04 -0.62 56.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -66.06 116.45 7.19 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.252 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -144.86 160.63 40.98 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.934 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.542 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.0 mt -81.76 148.04 29.12 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.938 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.484 ' ND2' HG22 ' A' ' 83' ' ' THR . 58.2 m-80 -103.42 146.21 28.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.211 -0.45 . . . . 1.0 109.847 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.541 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -109.23 171.84 7.2 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.6 pp -77.02 -17.55 58.74 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.585 -1.246 . . . . 1.0 109.43 175.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.541 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -66.67 -26.42 67.03 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.896 173.616 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -64.07 -40.99 97.47 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 2.0 t80 -88.74 -16.14 32.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.604 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.35 57.91 5.42 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.103 0.961 . . . . 1.0 111.01 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.566 HG12 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -74.31 144.22 81.04 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.208 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.06 158.49 41.95 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.878 2.385 . . . . 1.0 111.861 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -66.49 119.2 11.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.812 0.815 . . . . 1.0 109.827 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.99 20.33 10.72 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.417 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.88 162.12 29.93 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.867 0.365 . . . . 1.0 110.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 76.1 m -115.24 132.3 56.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.093 0.473 . . . . 1.0 110.667 -175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 13.5 m -113.22 156.89 14.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -139.26 124.87 19.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.232 0.539 . . . . 1.0 109.598 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.7 mp -101.32 131.38 47.4 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.234 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.551 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 17.5 m -130.2 147.96 67.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.441 ' HD3' HG23 ' A' ' 17' ' ' VAL . 77.7 Cg_endo -83.07 82.96 2.03 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 121.769 1.646 . . . . 1.0 111.741 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 62' ' ' THR . 12.6 p 52.18 64.59 1.79 Allowed 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 125.227 1.411 . . . . 1.0 111.247 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.84 -49.75 2.86 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 114.676 -1.147 . . . . 1.0 112.833 -174.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.1 t -131.19 37.96 3.69 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.067 -1.053 . . . . 1.0 113.294 -171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -78.96 73.12 5.51 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.898 1.332 . . . . 1.0 112.658 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -158.5 133.48 8.42 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 103.677 -2.712 . . . . 1.0 103.677 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.1 m -69.21 135.89 27.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 C-N-CA 119.284 -0.967 . . . . 1.0 112.302 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.2 mt -117.95 122.13 42.45 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.877 -1.527 . . . . 1.0 106.877 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 55.26 77.44 0.22 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.937 0.875 . . . . 1.0 110.296 -175.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -84.41 95.17 8.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.008 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -144.38 121.07 11.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.893 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 C--N 1.289 -2.033 0 N-CA-C 108.34 -0.985 . . . . 1.0 108.34 177.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -77.23 164.78 25.28 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -81.16 86.35 6.2 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.591 -1.633 . . . . 1.0 106.591 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 t -87.58 74.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-O 121.741 0.782 . . . . 1.0 112.472 -173.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.91 30.03 4.05 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 124.27 1.986 . . . . 1.0 107.121 166.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 47.0 m-85 -110.28 -178.58 3.55 Favored 'General case' 0 N--CA 1.391 -3.42 0 N-CA-C 103.355 -2.831 . . . . 1.0 103.355 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.2 mmt180 -101.21 110.66 61.99 Favored Pre-proline 0 C--N 1.264 -3.126 0 C-N-CA 118.805 -1.158 . . . . 1.0 111.746 -173.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.567 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -60.44 119.83 7.23 Favored 'Trans proline' 0 CA--C 1.508 -0.825 0 C-N-CA 122.397 2.064 . . . . 1.0 108.617 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.94 128.41 56.27 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 -171.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.2 m -87.37 120.3 28.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.496 HD23 ' SD ' ' A' ' 44' ' ' MET . 16.3 tp -124.65 142.84 51.08 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.465 HD21 HG22 ' A' ' 106' ' ' THR . 8.1 t30 -98.76 117.07 32.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.106 -0.371 . . . . 1.0 110.814 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.92 116.93 17.11 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.148 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 25.7 tp -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.618 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -128.65 141.21 51.42 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.955 -0.465 . . . . 1.0 110.741 176.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.487 ' O ' HG11 ' A' ' 110' ' ' VAL . . . -115.63 54.0 0.82 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.234 0.54 . . . . 1.0 110.933 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.5 t -67.71 -43.21 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.604 0.716 . . . . 1.0 109.865 179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.94 -84.59 0.14 Allowed Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.94 -32.82 76.42 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.792 2.328 . . . . 1.0 112.142 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.65 18.58 50.11 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 121.32 -0.467 . . . . 1.0 112.152 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -77.79 64.42 3.04 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.449 0.642 . . . . 1.0 111.924 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.54 -29.34 1.89 Allowed Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -94.31 17.99 11.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.122 0.487 . . . . 1.0 111.187 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.07 -83.31 0.08 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -143.7 -62.8 0.39 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.569 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.86 72.57 0.95 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.38 126.72 27.62 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.34 -0.43 . . . . 1.0 110.264 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.36 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 121.737 1.625 . . . . 1.0 111.496 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.505 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 40.6 t -110.61 142.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.117 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.48 140.7 29.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.283 0.563 . . . . 1.0 111.765 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.33 172.86 9.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.06 179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.485 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 9.8 mt -107.95 158.4 17.39 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.421 0.629 . . . . 1.0 111.483 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -59.22 -30.83 68.52 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.03 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.9 t -88.6 -3.61 58.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.501 -1.227 . . . . 1.0 112.277 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.485 ' OD1' ' HB2' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -73.23 132.34 43.06 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 p -74.55 172.08 12.66 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -59.94 -44.99 95.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 117.993 0.36 . . . . 1.0 111.198 -177.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.428 ' HB2' ' OD1' ' A' ' 79' ' ' ASP . 4.0 t -71.87 -35.97 69.94 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.955 -1.098 . . . . 1.0 110.519 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.761 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 9.1 tt0 -68.25 -38.02 81.39 Favored 'General case' 0 C--O 1.206 -1.226 0 C-N-CA 123.136 0.574 . . . . 1.0 111.007 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -73.69 -39.75 64.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.539 -0.726 . . . . 1.0 110.596 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.632 ' HE2' ' O ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -58.22 -35.91 72.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.316 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.761 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 3.7 pt-20 -68.41 -40.44 81.27 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.919 -176.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 44.9 mmtm -63.99 -41.45 97.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 124.186 0.929 . . . . 1.0 110.245 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.538 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.1 mmm -61.59 -48.59 80.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.694 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.4 pp -77.28 -24.72 50.98 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 112.579 0.585 . . . . 1.0 112.579 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -52.89 -28.92 25.4 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.092 1.357 . . . . 1.0 112.076 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -66.76 -36.83 83.34 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.45 0.643 . . . . 1.0 110.348 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -95.16 -41.69 8.96 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.696 0.76 . . . . 1.0 109.545 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -95.46 30.91 2.11 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.413 -1.267 . . . . 1.0 110.877 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -56.6 122.94 13.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.565 -0.743 . . . . 1.0 109.71 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.67 -17.85 27.61 Favored Glycine 0 C--N 1.313 -0.728 0 N-CA-C 111.324 -0.711 . . . . 1.0 111.324 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.4 t -85.53 128.59 58.48 Favored Pre-proline 0 C--N 1.315 -0.932 0 C-N-CA 122.937 0.495 . . . . 1.0 110.301 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.514 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 75.2 Cg_endo -70.35 161.56 45.55 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.26 2.64 . . . . 1.0 112.008 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.528 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 51.6 tp -61.21 -40.06 92.57 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -176.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -64.36 -26.07 68.31 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.557 0.218 . . . . 1.0 111.308 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 56' ' ' GLN . 0.0 OUTLIER -85.61 -19.17 31.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.939 0.4 . . . . 1.0 110.145 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.528 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 83.9 mtt180 -73.92 114.2 30.43 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 107.435 -1.32 . . . . 1.0 107.435 175.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.632 ' O ' ' HE2' ' A' ' 41' ' ' LYS . 39.4 Cg_exo -53.35 133.48 53.15 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 122.489 2.126 . . . . 1.0 112.638 -172.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 61' ' ' ARG . 24.3 m-20 -83.42 146.45 50.59 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.118 -0.946 . . . . 1.0 110.959 -176.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HG2' ' NH1' ' A' ' 61' ' ' ARG . 32.5 Cg_endo -70.45 20.85 0.2 Allowed 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 122.955 2.437 . . . . 1.0 112.491 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 59' ' ' ASP . 4.2 mpt_? -86.09 -34.58 20.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 169.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.59 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 4.8 t -95.04 -20.38 19.38 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.572 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 pp -134.82 161.55 34.88 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -177.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.08 152.45 33.58 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.487 -1.301 . . . . 1.0 107.487 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG13 ' O ' ' A' ' 77' ' ' LEU . 8.4 p -115.75 125.94 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 118.825 -1.15 . . . . 1.0 110.137 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -93.87 113.11 25.06 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.357 -1.349 . . . . 1.0 107.357 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.594 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.5 t-105 -93.61 124.49 37.63 Favored 'General case' 0 N--CA 1.388 -3.549 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.97 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -109.96 89.57 3.06 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 p -84.59 -13.47 51.6 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.054 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.06 -55.87 3.94 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.42 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.03 -40.93 90.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.003 0.521 . . . . 1.0 111.293 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.35 -10.76 26.99 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.694 0.759 . . . . 1.0 109.03 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.35 -128.23 9.5 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.083 -0.962 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 3.8 p80 -130.65 108.19 9.72 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.298 0.571 . . . . 1.0 109.836 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.68 151.71 36.7 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.0 mm -94.07 120.68 43.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.496 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 10.4 mp -111.22 165.18 12.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.525 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -167.06 157.72 11.67 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 105.141 -2.17 . . . . 1.0 105.141 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 9.3 p-10 -78.51 -19.72 52.35 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.42 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.587 ' OE2' ' HD3' ' A' ' 91' ' ' ARG . 47.1 mt-10 -132.35 78.53 1.81 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -80.88 -171.95 3.44 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 122.5 1.143 . . . . 1.0 110.328 -178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.18 -24.57 35.5 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.728 0 CA-C-N 114.434 -1.257 . . . . 1.0 109.468 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 3.7 t -80.4 -7.24 59.03 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 115.657 -0.701 . . . . 1.0 111.05 178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 p -94.63 81.06 3.84 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.026 -1.102 . . . . 1.0 108.026 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.98 124.57 24.1 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.463 -0.79 . . . . 1.0 112.842 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 t -105.32 87.35 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 106.779 -1.563 . . . . 1.0 106.779 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.91 5.74 0.2 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.188 -0.915 . . . . 1.0 112.103 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.06 79.84 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 119.771 -1.205 . . . . 1.0 113.186 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.4 mt 70.47 -6.35 1.2 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.866 1.266 . . . . 1.0 113.444 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -79.94 -5.57 55.89 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.001 -0.545 . . . . 1.0 112.043 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.587 ' HD3' ' OE2' ' A' ' 80' ' ' GLU . 2.4 tmm_? -75.53 130.53 39.01 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -155.88 177.46 11.38 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.605 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 94.3 mt -110.15 149.27 30.31 Favored 'General case' 0 C--O 1.251 1.154 0 O-C-N 123.925 0.766 . . . . 1.0 109.477 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.448 ' O ' HG12 ' A' ' 37' ' ' ILE . 82.7 m-20 -98.58 140.58 32.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.207 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.536 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -111.39 173.1 6.5 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.991 1.316 . . . . 1.0 108.921 177.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.427 HD12 HG21 ' A' ' 101' ' ' VAL . 3.9 pp -72.21 -22.8 61.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 119.136 -1.025 . . . . 1.0 109.49 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.536 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.77 -26.47 67.73 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.327 175.153 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -66.7 -40.68 88.6 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.496 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 88.1 m-85 -97.47 -1.33 44.41 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.652 -0.703 . . . . 1.0 111.61 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? 48.53 63.61 2.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.034 1.334 . . . . 1.0 113.589 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.594 HG11 ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -84.52 146.29 46.81 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 119.075 -1.05 . . . . 1.0 112.601 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.14 158.08 23.41 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.026 2.484 . . . . 1.0 111.827 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.07 122.46 17.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.4 14.59 12.7 Favored Glycine 0 C--N 1.287 -2.151 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.971 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 11' ' ' LEU . . . -71.3 162.68 29.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.269 0.557 . . . . 1.0 110.697 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.465 HG22 HD21 ' A' ' 12' ' ' ASN . 97.4 m -123.04 134.5 54.29 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.309 -0.405 . . . . 1.0 109.92 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.2 m -115.38 138.81 44.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.461 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -126.13 135.17 51.37 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.528 0.68 . . . . 1.0 110.539 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.618 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 tt -100.04 125.8 46.15 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.315 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 16' ' ' ALA . 32.2 m -119.54 130.45 24.84 Favored Pre-proline 0 C--N 1.316 -0.883 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.094 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.15 86.35 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.344 2.029 . . . . 1.0 111.699 -178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.615 ' HA ' ' NH2' ' A' ' 119' ' ' ARG . 18.7 p 56.09 17.21 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.833 1.653 . . . . 1.0 113.714 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -40.97 82.9 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -172.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 14.9 t -114.62 2.41 14.51 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 115.561 1.689 . . . . 1.0 115.561 -168.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 2.3 mptp? 42.48 73.45 0.14 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 114.664 1.357 . . . . 1.0 114.664 175.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -98.21 -0.93 43.21 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 123.11 1.433 . . . . 1.0 110.229 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.13 148.29 32.95 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.854 0 CA-C-N 112.13 -2.305 . . . . 1.0 105.597 174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 95.2 mt -109.98 115.82 30.49 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.75 -0.78 . . . . 1.0 111.451 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.615 ' NH2' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -120.48 -32.55 4.05 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.553 -1.203 . . . . 1.0 108.366 177.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 120' ' ' GLU . 1.5 pm0 -78.06 143.35 37.51 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.743 -1.117 . . . . 1.0 108.021 176.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 73.56 82.69 0.12 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.51 1.131 . . . . 1.0 108.186 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 . . . . . 0 C--N 1.297 -1.695 0 CA-C-N 115.435 -0.802 . . . . 1.0 111.11 -175.021 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -115.09 37.67 3.43 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.53 86.21 6.98 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.439 -1.255 . . . . 1.0 108.904 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.61 104.16 16.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.022 -0.99 . . . . 1.0 108.847 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.54 44.95 1.2 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.204 1.002 . . . . 1.0 111.006 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -131.01 156.28 45.4 Favored 'General case' 0 N--CA 1.406 -2.628 0 N-CA-C 103.481 -2.785 . . . . 1.0 103.481 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.445 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 33.6 mmt180 -108.52 111.61 61.23 Favored Pre-proline 0 C--N 1.267 -3.004 0 C-N-CA 119.362 -0.935 . . . . 1.0 112.301 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.38 109.51 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.144 1.896 . . . . 1.0 109.57 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 10' ' ' THR . 4.6 tp -112.85 156.02 23.64 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.026 -174.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.426 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 47.3 m -96.51 128.59 43.58 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.504 HD22 ' SD ' ' A' ' 44' ' ' MET . 29.0 tp -127.37 143.73 51.17 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 7.3 t30 -97.68 113.47 25.23 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.03 -0.419 . . . . 1.0 110.966 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.16 115.98 16.41 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.811 -0.632 . . . . 1.0 110.167 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 29.7 tp -147.81 154.81 40.95 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.596 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.66 143.67 50.61 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.731 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -116.36 33.29 5.63 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.329 0.585 . . . . 1.0 110.368 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.78 -46.23 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 C-N-CA 123.645 0.778 . . . . 1.0 111.918 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.29 -77.47 0.14 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 119.295 -1.431 . . . . 1.0 113.684 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.45 -35.06 97.08 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.761 2.307 . . . . 1.0 112.141 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.39 36.63 3.22 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -68.39 74.46 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.79 1.033 . . . . 1.0 113.79 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.6 -5.58 40.73 Favored Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 110.14 -1.184 . . . . 1.0 110.14 175.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -119.9 16.61 12.6 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.244 -0.978 . . . . 1.0 111.371 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.81 -75.31 0.17 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -148.53 -58.06 0.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.965 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 75.54 1.18 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.3 t -92.9 126.51 51.2 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.419 . . . . 1.0 110.723 -173.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.18 99.06 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.941 1.76 . . . . 1.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.4 t -109.6 156.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -123.01 151.32 41.98 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.811 -1.156 . . . . 1.0 112.021 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 32' ' ' LEU . 5.1 p -151.34 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.812 -1.181 . . . . 1.0 107.812 -175.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.458 ' H ' HG23 ' A' ' 31' ' ' VAL . 19.7 mt -100.56 160.55 14.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-N 118.755 0.707 . . . . 1.0 111.195 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 19.6 t70 -64.62 -31.08 72.14 Favored 'General case' 0 C--O 1.251 1.159 0 O-C-N 124.025 0.828 . . . . 1.0 108.857 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.435 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 8.2 t -108.61 39.52 1.98 Allowed 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.013 -1.449 . . . . 1.0 110.168 -177.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 95' ' ' THR . 11.9 p-10 -66.89 -164.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.33 170.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 p -142.01 153.46 44.28 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 168.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -56.55 -40.68 70.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 118.122 0.419 . . . . 1.0 111.316 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.554 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -62.59 -43.02 99.85 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.62 176.454 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 45.7 mt-30 -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.974 0.416 . . . . 1.0 111.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.705 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.02 -38.19 90.17 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.27 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -55.56 -41.89 73.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.7 mt-10 -68.13 -48.52 65.18 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.259 -0.882 . . . . 1.0 110.625 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 34.9 mmtp -65.33 -42.54 92.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.128 0.788 . . . . 1.0 113.128 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.705 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 83.2 mmm -63.94 -42.84 97.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.863 0.363 . . . . 1.0 110.577 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.77 -25.63 56.63 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.0 111.682 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.2 t70 -53.02 -31.45 41.29 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.858 1.263 . . . . 1.0 112.224 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -71.32 -38.27 71.71 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.147 0.498 . . . . 1.0 111.401 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.97 -43.32 12.45 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 122.072 0.939 . . . . 1.0 108.912 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -95.77 32.13 1.92 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.769 -1.56 . . . . 1.0 109.636 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -50.6 117.66 2.59 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.994 -1.003 . . . . 1.0 111.331 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.47 -9.41 22.13 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.777 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.03 124.57 70.34 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 50.3 Cg_endo -66.99 160.96 44.76 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 122.877 2.384 . . . . 1.0 111.277 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.43 -41.78 97.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.859 -174.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 t -63.13 -23.87 67.64 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 112.446 0.535 . . . . 1.0 112.446 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -93.2 -10.24 36.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.077 0.465 . . . . 1.0 111.732 -175.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 88.8 mtt180 -76.6 128.45 81.99 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 111.972 0.36 . . . . 1.0 111.972 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.61 142.86 66.14 Favored 'Trans proline' 0 C--O 1.26 1.608 0 C-N-CA 123.231 2.621 . . . . 1.0 113.678 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.26 156.98 88.81 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 115.185 -0.916 . . . . 1.0 111.694 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.56 12.87 2.51 Favored 'Trans proline' 0 C--O 1.203 -1.243 0 C-N-CA 123.068 2.512 . . . . 1.0 111.489 174.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.462 ' NH1' ' HB3' ' A' ' 80' ' ' GLU . 9.7 mmm180 -74.23 -39.46 63.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.329 0.585 . . . . 1.0 111.832 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.5 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 82.0 p -81.85 -12.69 58.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.084 -0.962 . . . . 1.0 112.218 -171.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.1 pp -136.25 164.21 28.61 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.385 -1.279 . . . . 1.0 109.245 -176.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 1.7 m-20 -107.8 141.09 39.89 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.89 114.31 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 C-N-CA 118.352 -1.339 . . . . 1.0 108.054 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -91.0 112.67 24.66 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 107.614 -1.254 . . . . 1.0 107.614 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.645 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -83.42 127.52 33.76 Favored 'General case' 0 N--CA 1.385 -3.683 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.723 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.59 89.01 3.03 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.456 -0.793 . . . . 1.0 109.562 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 53.0 m -97.05 -17.56 19.92 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.683 0.754 . . . . 1.0 109.335 176.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.95 -46.0 3.5 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.505 -1.225 . . . . 1.0 112.411 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.6 -44.93 97.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-O 120.89 0.376 . . . . 1.0 110.989 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . . . -102.46 0.59 34.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.057 0.932 . . . . 1.0 108.703 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.68 -127.75 8.09 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.282 -1.327 . . . . 1.0 113.236 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 9.3 m170 -115.73 118.46 33.11 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.382 1.073 . . . . 1.0 109.294 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.98 139.04 48.51 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.68 118.29 31.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.29 -0.564 . . . . 1.0 109.638 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.43 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -108.49 159.59 16.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.474 0.654 . . . . 1.0 111.44 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 39.2 m -165.81 162.75 18.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 12.6 p-10 -66.08 -38.76 89.08 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 45.9 tt0 -135.04 126.65 28.89 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.434 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 37.8 t70 -157.31 -99.23 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.653 0.74 . . . . 1.0 111.861 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -102.17 -25.47 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 CA-C-N 114.83 -1.077 . . . . 1.0 112.621 -171.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 t -94.19 -6.12 45.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.319 0.581 . . . . 1.0 110.534 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 p -98.25 73.41 2.17 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.445 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.15 135.86 33.14 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . 15.9 m -104.37 89.38 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-O 122.23 1.014 . . . . 1.0 110.813 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -139.54 5.62 2.24 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.474 -1.239 . . . . 1.0 111.046 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.78 -60.32 0.21 Allowed Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.143 -1.027 . . . . 1.0 111.55 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.51 -38.37 89.49 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.117 0.96 . . . . 1.0 108.57 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 86' ' ' VAL 0.295 52.8 p90 60.74 -52.05 0.1 Allowed 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 130.427 3.491 . . . . 1.0 115.416 176.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -100.88 119.39 38.62 Favored 'General case' 1 C--N 1.236 -4.363 0 CA-C-N 115.666 -0.697 . . . . 1.0 109.622 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.6 mmt-85 -143.99 89.35 2.03 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.455 0.645 . . . . 1.0 111.118 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.2 mt -76.07 147.92 38.31 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.724 -1.125 . . . . 1.0 109.099 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -90.71 141.14 29.1 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.974 -0.691 . . . . 1.0 109.826 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.559 HG23 ' O ' ' A' ' 35' ' ' ASP . 1.8 p -121.97 171.49 8.9 Favored 'General case' 0 C--O 1.266 1.922 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 101' ' ' VAL . 3.2 pp -66.8 -29.94 70.01 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.96 . . . . 1.0 108.979 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.542 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -67.83 -26.09 65.88 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.533 177.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -64.13 -41.36 97.24 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.54 ' CD1' HG13 ' A' ' 101' ' ' VAL . 3.1 t80 -83.45 -18.62 38.0 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.733 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 10.6 mmmm 52.15 60.7 3.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.947 0.899 . . . . 1.0 110.788 -171.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.645 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.6 m -74.23 149.78 87.16 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.65 -0.705 . . . . 1.0 112.575 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.3 164.03 31.59 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.142 2.561 . . . . 1.0 111.742 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -65.65 129.01 38.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.366 0.603 . . . . 1.0 109.712 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.27 40.64 Favored Glycine 0 C--N 1.295 -1.727 0 C-N-CA 120.623 -0.799 . . . . 1.0 111.999 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.464 ' O ' HD11 ' A' ' 11' ' ' LEU . . . -64.42 154.87 34.36 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 120.716 0.293 . . . . 1.0 111.018 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 98.9 m -107.45 132.52 53.11 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.988 0.423 . . . . 1.0 111.345 -176.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.5 m -113.0 142.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.33 136.57 53.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.578 0.704 . . . . 1.0 110.581 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.596 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.0 tt -102.68 124.47 48.29 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 115.191 -0.913 . . . . 1.0 109.184 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.552 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 26.3 m -129.03 144.25 51.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.01 51.54 3.69 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 122.934 2.422 . . . . 1.0 114.002 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 62' ' ' THR . 0.1 OUTLIER 64.03 84.32 0.15 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 124.495 1.118 . . . . 1.0 111.095 -178.442 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.21 -55.05 2.54 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 114.304 -1.317 . . . . 1.0 110.71 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.5 t -135.55 37.41 2.9 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 113.861 1.06 . . . . 1.0 113.861 -170.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.415 ' HB2' ' CG ' ' A' ' 64' ' ' ASP . 37.5 ttpt -74.34 131.23 40.95 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.249 -0.981 . . . . 1.0 109.965 175.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -53.14 128.61 28.35 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.539 -1.21 . . . . 1.0 111.968 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.0 m -109.55 155.04 10.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.34 80.69 8.11 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.462 0.649 . . . . 1.0 110.039 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -90.85 -20.58 22.12 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.111 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -129.39 108.04 9.97 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 121.326 0.584 . . . . 1.0 111.233 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -130.49 88.79 2.68 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.786 -1.19 . . . . 1.0 107.786 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 -177.349 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? . . . . . 0 CA--C 1.484 -1.558 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.589 ' O ' HD11 ' A' ' 32' ' ' LEU . 35.1 mtmm -133.65 108.38 8.52 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.318 -1.364 . . . . 1.0 107.318 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -82.01 74.03 9.01 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.564 1.173 . . . . 1.0 110.716 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.92 -171.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 113.489 -1.687 . . . . 1.0 107.463 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -101.08 91.3 4.49 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.242 1.02 . . . . 1.0 112.347 -174.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.661 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 m-85 -137.55 -175.89 4.22 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 101.202 -3.629 . . . . 1.0 101.202 175.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.421 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 34.9 mmt180 -98.01 108.24 45.41 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 121.063 1.756 . . . . 1.0 111.22 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.661 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 15.4 Cg_exo -69.58 120.07 6.94 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.106 1.871 . . . . 1.0 108.469 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tp -117.87 158.34 25.02 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.223 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -98.34 125.56 43.51 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 105' ' ' ALA . 18.5 tp -127.21 142.03 51.59 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.724 -1.213 . . . . 1.0 107.724 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 10.8 t30 -94.94 122.0 37.13 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.916 -0.49 . . . . 1.0 111.25 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.48 113.31 20.14 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.494 -0.776 . . . . 1.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 33.2 tp -146.61 151.71 37.73 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.912 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.612 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -120.82 140.45 51.72 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.93 42.79 2.1 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.035 0.445 . . . . 1.0 110.901 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.479 HG21 ' HD3' ' A' ' 111' ' ' PRO . 82.7 t -65.2 -46.34 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-N 115.461 -0.791 . . . . 1.0 111.825 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.85 -80.35 0.15 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.239 -0.981 . . . . 1.0 112.986 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.62 -30.95 79.61 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.947 2.432 . . . . 1.0 112.829 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 24' ' ' ALA . . . -126.38 41.49 1.63 Allowed Glycine 0 N--CA 1.408 -3.23 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.67 31.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.14 0.576 . . . . 1.0 112.195 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 20' ' ' GLY . . . 168.35 -41.28 0.23 Allowed Glycine 0 C--N 1.3 -1.45 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.74 10.11 19.4 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.195 0.521 . . . . 1.0 112.093 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 20' ' ' GLY . . . -76.16 -68.54 0.57 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.472 0.653 . . . . 1.0 112.603 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -131.24 -69.51 0.63 Allowed 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.793 -172.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.35 64.33 4.49 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.329 -0.708 . . . . 1.0 111.329 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 19.2 t -107.95 125.82 31.2 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -175.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.46 104.93 1.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.63 1.553 . . . . 1.0 110.575 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.1 t -107.61 156.01 8.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.95 148.06 34.57 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.392 -0.923 . . . . 1.0 110.561 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG22 ' CB ' ' A' ' 40' ' ' ALA . 13.9 p -158.55 163.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.393 -0.821 . . . . 1.0 108.974 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 2' ' ' LYS . 18.3 mt -86.05 158.2 19.89 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.739 0.78 . . . . 1.0 112.423 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.421 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 30.2 t70 -64.24 -32.03 73.46 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-N 113.904 -1.498 . . . . 1.0 109.289 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.428 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 53.0 t -95.29 6.56 48.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.548 -1.66 . . . . 1.0 111.239 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.408 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 95.2 m-20 -85.54 144.79 27.71 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 119.399 -0.92 . . . . 1.0 108.656 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 p -83.56 169.96 14.87 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.444 -0.798 . . . . 1.0 109.328 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 94' ' ' ASN . 44.2 mm -61.52 -43.44 96.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 117.752 0.251 . . . . 1.0 110.457 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -63.88 -40.76 97.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.22 0.533 . . . . 1.0 110.655 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.619 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 8.1 tt0 -75.78 -25.0 56.03 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.797 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.484 ' CB ' HG22 ' A' ' 31' ' ' VAL . . . -82.3 -37.6 25.55 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 121.701 -0.624 . . . . 1.0 111.098 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.697 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 2.5 mmmp? -57.64 -36.2 71.51 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.646 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.619 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 11.3 pt-20 -62.54 -45.8 91.31 Favored 'General case' 0 N--CA 1.414 -2.239 0 O-C-N 124.154 0.909 . . . . 1.0 110.925 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -70.72 -38.59 73.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 176.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.4 mmt -59.58 -49.01 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.363 0.602 . . . . 1.0 109.532 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.697 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 2.4 pp -78.11 -23.9 47.69 Favored 'General case' 0 C--O 1.197 -1.709 0 CA-C-N 115.604 -0.726 . . . . 1.0 112.659 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.614 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 20.1 t70 -50.18 -34.69 23.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.11 1.364 . . . . 1.0 112.366 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.7 mm-40 -67.36 -29.96 69.64 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.744 -178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.83 -38.74 7.28 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.717 0.77 . . . . 1.0 110.581 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 25.3 m-85 -88.44 16.17 6.83 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.232 1.013 . . . . 1.0 111.652 -177.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -64.91 116.28 6.21 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.61 -14.25 15.01 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 110.006 -1.238 . . . . 1.0 110.006 -175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.5 t -105.23 130.72 22.62 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.723 -0.843 . . . . 1.0 108.723 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.443 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 60.2 Cg_endo -67.35 161.71 41.95 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.055 2.503 . . . . 1.0 112.444 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.5 tp -61.68 -36.42 80.81 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.369 0.667 . . . . 1.0 111.865 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 t -63.06 -29.55 70.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.889 0.476 . . . . 1.0 111.256 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.5 -23.08 24.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.809 0.338 . . . . 1.0 111.443 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 70.5 mtt180 -67.0 121.67 79.12 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.091 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -59.88 140.57 93.67 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.163 2.575 . . . . 1.0 113.429 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 44.6 m-20 -89.16 155.0 49.56 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.706 -0.679 . . . . 1.0 111.274 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.477 ' HG2' ' OD1' ' A' ' 79' ' ' ASP . 62.8 Cg_endo -81.19 2.23 8.72 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.329 2.019 . . . . 1.0 112.778 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -93.78 -7.07 44.52 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.889 -0.507 . . . . 1.0 111.557 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 t -118.63 -13.11 9.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.945 0.878 . . . . 1.0 109.978 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.472 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.2 pp -140.92 147.93 39.62 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 106.589 -1.634 . . . . 1.0 106.589 174.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HB3' HG23 ' A' ' 76' ' ' ILE . 21.5 m-20 -102.93 154.12 19.54 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.13 112.77 41.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -91.34 122.32 33.85 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.771 0.796 . . . . 1.0 110.342 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.655 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 17.8 t90 -82.73 116.87 22.27 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.787 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.417 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 49.5 mtm105 -122.95 90.43 3.29 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 p -88.01 -20.47 25.77 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.74 -54.41 4.12 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.191 -1.368 . . . . 1.0 111.657 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.48 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 123.773 0.829 . . . . 1.0 111.498 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.94 -15.12 20.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.821 0.344 . . . . 1.0 110.673 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.67 -158.63 15.58 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 111.465 -0.654 . . . . 1.0 111.465 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.655 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.4 p80 -136.43 120.58 17.79 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.156 0.582 . . . . 1.0 110.861 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -127.39 148.78 50.27 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.421 -174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.401 HG23 ' HB3' ' A' ' 64' ' ' ASP . 27.9 mm -84.9 116.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 120.87 0.367 . . . . 1.0 110.194 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.433 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 11.1 mp -106.51 148.64 27.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.937 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.0 t -164.04 161.97 22.86 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.477 ' OD1' ' HG2' ' A' ' 60' ' ' PRO . 4.1 p-10 -71.38 -30.21 65.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.491 ' HG2' ' CB ' ' A' ' 84' ' ' SER . 33.9 tt0 -139.33 83.2 1.93 Allowed 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -102.09 -89.08 0.37 Allowed 'General case' 0 CA--C 1.478 -1.801 0 CA-C-O 121.594 0.712 . . . . 1.0 112.291 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.04 -16.55 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.215 0 CA-C-N 114.458 -1.246 . . . . 1.0 107.998 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 14.0 p -85.45 -3.0 58.72 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.52 -1.218 . . . . 1.0 108.546 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.491 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 78.1 p -59.47 -34.55 72.69 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.314 -1.312 . . . . 1.0 112.483 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.01 125.6 29.43 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.167 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 91' ' ' ARG . 3.1 p -151.32 124.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.592 0 CA-C-O 121.576 0.703 . . . . 1.0 111.257 -174.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -102.62 -30.11 11.14 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.118 -0.946 . . . . 1.0 108.903 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.64 -97.51 1.37 Allowed Glycine 0 N--CA 1.404 -3.474 0 C-N-CA 120.015 -1.088 . . . . 1.0 111.274 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -120.91 6.49 10.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -62.89 -29.87 71.1 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 115.65 1.722 . . . . 1.0 115.65 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' THR . 49.0 ttp180 -65.86 118.01 9.08 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.625 -0.83 . . . . 1.0 110.68 177.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -132.63 147.05 52.33 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.05 132.47 38.94 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.448 -1.686 . . . . 1.0 106.448 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.422 ' O ' HG12 ' A' ' 37' ' ' ILE . 78.5 m-20 -84.92 141.49 30.35 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.969 -173.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.546 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -105.67 172.49 6.77 Favored 'General case' 0 N--CA 1.425 -1.69 0 C-N-CA 123.731 0.813 . . . . 1.0 108.917 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.428 HD13 HG23 ' A' ' 101' ' ' VAL . 3.2 pp -71.25 -27.31 63.37 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.503 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.546 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -65.83 -25.25 67.13 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.439 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -65.32 -35.39 80.86 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.433 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 87.4 m-85 -103.32 -11.8 17.67 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.918 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 54.0 69.3 0.73 Allowed 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.615 1.166 . . . . 1.0 112.649 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.428 HG23 HD13 ' A' ' 96' ' ' LEU . 2.5 m -78.97 137.8 57.31 Favored Pre-proline 0 N--CA 1.434 -1.239 0 C-N-CA 120.041 -0.664 . . . . 1.0 109.471 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.25 160.39 49.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.315 2.01 . . . . 1.0 111.171 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.84 125.73 25.76 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.884 -0.727 . . . . 1.0 110.293 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 21.74 39.52 Favored Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.881 -1.054 . . . . 1.0 111.164 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.406 ' O ' HD11 ' A' ' 11' ' ' LEU . . . -72.92 155.54 39.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.783 0.325 . . . . 1.0 110.403 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 99.0 m -107.01 125.83 51.54 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.108 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.2 m -121.66 137.06 56.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.576 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -122.82 135.13 54.43 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.662 0.744 . . . . 1.0 112.826 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.612 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 11.0 mp -90.14 124.09 34.53 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.322 -0.853 . . . . 1.0 109.549 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 23.6 m -125.54 134.7 26.07 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.433 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 17' ' ' VAL . 40.2 Cg_endo -68.69 86.15 0.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.525 2.15 . . . . 1.0 111.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.472 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 23.3 p 49.35 77.3 0.11 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.541 1.537 . . . . 1.0 111.715 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 114' ' ' THR . 3.0 mm? 69.8 12.62 8.01 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 125.019 1.328 . . . . 1.0 110.0 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER 75.03 12.84 3.38 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.874 1.669 . . . . 1.0 112.42 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -120.63 99.85 6.78 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 114.289 -1.323 . . . . 1.0 107.551 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -72.24 100.88 2.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.131 -175.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.3 164.58 31.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.938 -1.504 . . . . 1.0 106.938 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.75 92.84 8.71 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.737 -0.785 . . . . 1.0 109.62 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 73.3 ttt180 -123.75 140.46 52.97 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.877 -1.056 . . . . 1.0 109.504 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 70.0 mm-40 -75.31 162.18 28.64 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -73.84 88.35 1.8 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.63 0.728 . . . . 1.0 110.393 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 N--CA 1.435 -1.178 0 C-N-CA 126.126 1.77 . . . . 1.0 106.86 177.756 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -152.2 101.06 2.67 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.918 0.866 . . . . 1.0 108.71 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -103.52 17.66 23.6 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.65 -1.159 . . . . 1.0 109.933 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.1 t 66.43 66.53 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 122.713 1.244 . . . . 1.0 109.578 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.56 27.58 9.23 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.784 -1.553 . . . . 1.0 107.582 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -125.65 163.62 22.37 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 -175.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -110.26 105.03 56.82 Favored Pre-proline 0 C--N 1.272 -2.774 0 C-N-CA 118.773 -1.171 . . . . 1.0 110.547 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.87 118.44 5.33 Favored 'Trans proline' 0 C--O 1.25 1.093 0 N-CA-C 108.504 -1.383 . . . . 1.0 108.504 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.439 ' CD1' ' HA ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER -119.13 131.68 55.91 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 -172.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -87.12 128.74 35.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.436 HD13 ' CZ2' ' A' ' 67' ' ' TRP . 1.1 mm? -122.82 147.35 46.64 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.064 0.946 . . . . 1.0 109.996 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -89.95 110.94 21.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.49 109.45 7.98 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 123.489 0.493 . . . . 1.0 109.78 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 29.9 tp -138.56 160.77 38.74 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.318 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.529 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -125.73 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.21 33.92 4.99 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.921 0.391 . . . . 1.0 110.597 -177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.407 HG22 ' CD ' ' A' ' 111' ' ' PRO . 47.1 t -63.79 -47.66 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 115.849 -0.614 . . . . 1.0 112.392 -174.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.73 -85.14 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.63 -33.78 93.03 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 122.998 2.466 . . . . 1.0 113.072 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.05 29.63 6.99 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -76.24 75.98 3.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.397 0.617 . . . . 1.0 111.985 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.498 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 121.2 -7.91 10.55 Favored Glycine 0 CA--C 1.488 -1.629 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.391 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -128.76 28.3 5.38 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.234 0.54 . . . . 1.0 111.27 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 -88.78 0.18 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.449 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.451 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 8.9 pt20 -117.62 -58.49 2.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.243 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.451 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 65.97 71.81 0.84 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 -175.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.3 t -103.97 126.98 30.28 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.626 -0.287 . . . . 1.0 110.432 -173.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.21 106.51 2.18 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.963 1.775 . . . . 1.0 111.581 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.482 HG11 ' HA ' ' A' ' 44' ' ' MET . 79.4 t -116.1 155.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.95 -1.13 . . . . 1.0 107.95 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -125.69 144.3 50.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.0 m -139.72 170.31 15.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.571 179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.7 mt -84.52 159.64 20.66 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.043 0.449 . . . . 1.0 111.454 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.65 -30.89 71.71 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-N 115.286 -0.87 . . . . 1.0 108.834 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.553 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 10.0 t -95.27 6.11 49.92 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.048 -1.433 . . . . 1.0 112.562 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.24 132.51 45.06 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 174.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.453 ' CG2' HD11 ' A' ' 93' ' ' LEU . 69.8 p -79.26 167.26 21.19 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -60.11 -43.32 92.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.541 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.646 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -61.04 -47.13 87.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 123.32 0.387 . . . . 1.0 110.745 177.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.41 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 47.5 mt-30 -71.24 -40.23 71.16 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.6 -39.78 84.77 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.108 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.404 ' HA ' ' HE2' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -61.96 -34.66 76.54 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.718 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.646 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.9 mt-10 -64.46 -46.23 84.01 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 124.412 1.07 . . . . 1.0 110.073 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 39.2 mmtm -62.94 -46.61 86.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.662 0.744 . . . . 1.0 109.051 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.604 ' SD ' HG23 ' A' ' 107' ' ' VAL . 7.2 mtp -65.3 -40.34 93.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.444 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.55 -33.18 64.58 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.514 -0.474 . . . . 1.0 111.123 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.1 -33.95 75.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.606 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 19.0 mm-40 -67.08 -30.88 71.04 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.52 -0.764 . . . . 1.0 111.584 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.62 -28.04 9.51 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.501 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.77 13.68 21.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.181 0.515 . . . . 1.0 110.307 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -61.89 126.02 25.87 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.301 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.53 -20.02 28.08 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.75 131.85 23.0 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.485 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 51.2 Cg_endo -65.12 154.39 73.7 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.481 2.12 . . . . 1.0 111.591 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.7 tp -59.21 -39.51 82.89 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.763 0.425 . . . . 1.0 111.769 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -63.42 -23.95 67.62 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -94.16 -24.47 17.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.35 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 89.4 mtt180 -65.77 145.68 99.02 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.61 142.88 96.02 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 121.919 1.746 . . . . 1.0 110.423 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.447 ' OD2' ' HB2' ' A' ' 61' ' ' ARG . 19.8 t70 -77.35 117.28 64.33 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.599 -0.273 . . . . 1.0 110.666 -177.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.16 -13.62 38.47 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.183 2.589 . . . . 1.0 113.15 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.447 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 98.4 mtt180 -93.73 -10.93 32.66 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.287 -176.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.8 -21.15 11.33 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.037 0.446 . . . . 1.0 111.498 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.2 pp -88.54 162.93 16.13 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.437 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.444 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 4.9 m-20 -107.81 150.64 26.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.53 128.89 75.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 120.108 -0.637 . . . . 1.0 109.5 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 33.7 mt-10 -90.93 112.97 25.06 Favored 'General case' 0 CA--C 1.462 -2.407 0 N-CA-C 106.119 -1.808 . . . . 1.0 106.119 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.616 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -91.34 119.16 31.13 Favored 'General case' 1 N--CA 1.37 -4.448 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -108.98 89.48 3.01 Favored 'General case' 0 N--CA 1.394 -3.225 0 N-CA-C 106.738 -1.579 . . . . 1.0 106.738 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.2 p -83.95 -12.49 55.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 113.797 -1.547 . . . . 1.0 110.906 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.4 -60.97 3.58 Favored Glycine 0 C--N 1.302 -1.325 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.695 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.279 0.631 . . . . 1.0 112.049 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.12 -6.52 31.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.58 0.705 . . . . 1.0 109.751 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.35 -153.72 26.68 Favored Glycine 0 N--CA 1.414 -2.831 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.24 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.565 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -101.01 117.0 34.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.489 0.662 . . . . 1.0 111.678 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.92 146.75 45.5 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.772 -1.103 . . . . 1.0 108.069 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.499 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 22.0 mm -89.76 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.8 159.47 15.79 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.669 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 3.3 t -167.95 165.74 13.59 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 105.789 -1.93 . . . . 1.0 105.789 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.41 ' O ' HD22 ' A' ' 93' ' ' LEU . 11.3 p-10 -63.0 -39.54 95.06 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.429 ' CD ' ' HE ' ' A' ' 91' ' ' ARG . 3.0 tm-20 -163.47 95.2 0.82 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.253 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -150.56 -98.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.729 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.46 -44.94 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 114.034 1.124 . . . . 1.0 114.034 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -84.44 7.95 18.01 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.046 0.927 . . . . 1.0 112.084 -175.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.415 ' HG ' ' HA ' ' A' ' 80' ' ' GLU . 49.5 m -74.45 15.8 0.32 Allowed 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.718 -1.128 . . . . 1.0 113.189 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.447 ' OE1' ' HD3' ' A' ' 92' ' ' ARG . 60.4 mt-10 56.15 23.35 6.88 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.647 1.213 . . . . 1.0 111.438 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.0 70.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 113.426 -1.715 . . . . 1.0 112.0 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -99.15 -11.29 21.51 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.154 -1.384 . . . . 1.0 108.799 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.52 -114.74 0.51 Allowed Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 108.262 -1.935 . . . . 1.0 108.262 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 91' ' ' ARG . 1.0 OUTLIER -85.46 -2.65 58.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.471 0.653 . . . . 1.0 111.876 179.343 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -80.44 12.43 3.02 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.889 0.852 . . . . 1.0 110.657 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.467 ' H ' ' C ' ' A' ' 89' ' ' LEU . 75.4 ttt180 -65.34 116.42 6.65 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.117 -1.402 . . . . 1.0 109.202 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.447 ' HD3' ' OE1' ' A' ' 85' ' ' GLU . 83.9 mtp180 -131.61 157.73 42.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.343 0.592 . . . . 1.0 112.402 -173.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.453 HD11 ' CG2' ' A' ' 36' ' ' THR . 3.3 tm? -72.51 144.73 47.9 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 125.201 1.4 . . . . 1.0 108.296 175.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.0 m-80 -101.97 137.9 39.64 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 119.533 -0.867 . . . . 1.0 112.03 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.402 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -126.77 175.3 8.11 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.579 -1.637 . . . . 1.0 106.579 174.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 pp -72.42 -28.02 62.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.104 -1.438 . . . . 1.0 108.334 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 4.4 pt20 -66.86 -24.31 66.12 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.513 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -57.61 -40.95 80.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.217 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -107.62 8.92 29.38 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.011 0.745 . . . . 1.0 113.011 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 31.2 mmmt 38.02 65.13 0.61 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.207 1.403 . . . . 1.0 112.745 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.616 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -67.71 149.69 98.16 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 115.058 -0.973 . . . . 1.0 112.003 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.58 155.5 40.31 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.422 2.081 . . . . 1.0 111.228 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.439 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 8.3 p-10 -66.05 127.62 32.85 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 177.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.82 20.72 27.9 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.087 -1.054 . . . . 1.0 110.934 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.65 163.95 26.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 1.0 110.129 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.6 m -112.01 131.15 55.58 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.854 -0.529 . . . . 1.0 111.452 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.604 HG23 ' SD ' ' A' ' 44' ' ' MET . 17.3 m -117.07 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -129.0 137.83 51.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.529 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.2 pp -109.85 143.83 39.19 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.891 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 35.0 m -131.8 125.54 20.4 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.407 ' CD ' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -70.49 80.7 1.07 Allowed 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.458 2.105 . . . . 1.0 112.067 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.3 t 63.25 83.04 0.17 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.877 -1.056 . . . . 1.0 110.597 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.558 ' O ' HG21 ' A' ' 114' ' ' THR . 2.7 mm? 62.75 14.3 7.17 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 125.144 1.378 . . . . 1.0 110.723 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.558 HG21 ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER 67.76 14.49 9.48 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.077 1.351 . . . . 1.0 110.88 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 115' ' ' LYS . 11.4 mmpt? -82.85 99.54 9.79 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.596 -1.184 . . . . 1.0 110.649 -175.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -84.07 96.45 8.9 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.1 172.16 16.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.661 -1.154 . . . . 1.0 108.868 -174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.97 74.21 5.49 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.825 -0.805 . . . . 1.0 108.825 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -83.07 -51.17 7.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.306 0.574 . . . . 1.0 109.967 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.1 97.22 10.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.756 -0.657 . . . . 1.0 109.243 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -159.29 159.03 33.54 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 106.307 -1.738 . . . . 1.0 106.307 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? . . . . . 0 C--N 1.273 -2.755 0 CA-C-O 118.383 -0.817 . . . . 1.0 109.846 177.558 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 CA--C 1.509 -0.604 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp 56.02 37.21 28.6 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.863 0.84 . . . . 1.0 110.69 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -81.89 -6.21 58.91 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 122.428 1.109 . . . . 1.0 109.587 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 m -135.13 153.47 34.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 CA-C-N 113.469 -1.696 . . . . 1.0 106.585 176.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -114.23 105.07 12.74 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 122.075 0.941 . . . . 1.0 111.99 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.421 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.5 m-85 -123.17 -178.5 3.99 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 105.427 -2.064 . . . . 1.0 105.427 175.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -109.12 111.03 60.54 Favored Pre-proline 0 C--N 1.283 -2.308 0 C-N-CA 117.625 -1.63 . . . . 1.0 113.196 -170.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 21.8 Cg_exo -63.39 112.6 1.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.16 1.907 . . . . 1.0 108.44 171.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -113.06 160.94 17.64 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.994 -172.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -98.9 125.99 44.46 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.091 -1.077 . . . . 1.0 108.091 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.545 HD13 ' SD ' ' A' ' 44' ' ' MET . 1.3 tm? -127.32 141.1 51.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.26 111.38 23.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.884 -0.51 . . . . 1.0 110.319 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.68 106.37 5.4 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 115.407 -0.815 . . . . 1.0 111.132 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 29.2 tp -143.24 144.44 32.15 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.563 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.528 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.02 144.29 48.61 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.851 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -114.25 34.54 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.447 0.642 . . . . 1.0 109.531 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 38.4 t -65.14 -45.44 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 C-N-CA 123.839 0.856 . . . . 1.0 112.924 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.38 -80.9 0.1 OUTLIER Glycine 0 C--N 1.313 -0.713 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.902 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -58.98 -32.46 97.56 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.957 2.438 . . . . 1.0 112.429 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.416 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -127.45 41.36 1.61 Allowed Glycine 0 N--CA 1.419 -2.468 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -66.07 76.53 0.09 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.46 3.08 57.57 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.58 24.51 5.09 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.593 -0.804 . . . . 1.0 110.143 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' HB1' ' O ' ' A' ' 20' ' ' GLY . . . -96.07 -77.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -172.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.434 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 8.0 pt20 -125.89 -65.48 0.99 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.229 -0.896 . . . . 1.0 111.919 -169.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.434 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.83 64.71 3.48 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' A' ' 25' ' ' GLN . 43.2 t -108.3 129.9 23.46 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 110.24 -0.282 . . . . 1.0 110.24 -174.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.49 108.25 2.18 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.126 1.884 . . . . 1.0 111.309 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.461 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 59.6 t -117.71 138.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -84.16 155.94 22.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.885 0.698 . . . . 1.0 112.885 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.456 HG22 ' H ' ' A' ' 32' ' ' LEU . 14.2 p -151.3 -178.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.415 -1.266 . . . . 1.0 108.192 -176.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' H ' HG22 ' A' ' 31' ' ' VAL . 12.8 tp -119.1 155.39 31.62 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -64.0 -30.6 71.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.354 0.597 . . . . 1.0 109.649 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 2.7 t -104.81 33.48 3.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.401 -1.272 . . . . 1.0 110.352 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -70.22 -163.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.636 172.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.4 p -140.51 161.91 36.59 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 103.668 -2.716 . . . . 1.0 103.668 167.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 43.8 mm -57.78 -47.74 85.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.371 -0.531 . . . . 1.0 111.741 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.577 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . 21.6 t -65.81 -43.87 87.35 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 123.677 0.611 . . . . 1.0 109.902 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.17 -40.44 97.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.28 0.562 . . . . 1.0 111.356 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -63.92 -40.76 97.22 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.524 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.648 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -62.08 -33.17 73.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 123.674 0.609 . . . . 1.0 110.633 -178.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.36 -46.21 84.41 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 123.589 0.556 . . . . 1.0 110.526 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -66.39 -37.68 85.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.193 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.545 ' SD ' HD13 ' A' ' 11' ' ' LEU . 3.8 mtp -62.61 -43.96 97.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.307 0.575 . . . . 1.0 110.633 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -75.9 -25.66 56.26 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.126 -0.488 . . . . 1.0 112.25 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.47 -29.02 68.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.493 0.663 . . . . 1.0 110.991 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -83.87 -32.68 25.08 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.973 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.0 mt -115.64 -52.9 2.62 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.607 0.718 . . . . 1.0 112.572 -167.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -86.86 -1.31 57.7 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.957 -173.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -78.2 123.32 26.77 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 105.608 -1.997 . . . . 1.0 105.608 170.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.61 -2.94 57.46 Favored Glycine 0 C--N 1.292 -1.893 0 C-N-CA 119.943 -1.122 . . . . 1.0 110.318 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.25 155.08 37.32 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 106.28 -1.748 . . . . 1.0 106.28 176.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HG2' ' CG ' ' A' ' 56' ' ' GLN . 19.7 Cg_endo -60.32 149.71 84.34 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.959 1.773 . . . . 1.0 111.553 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.9 mt -60.47 -38.67 85.0 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.395 0.678 . . . . 1.0 111.187 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 t -65.52 -24.5 67.14 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.672 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.4 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 14.9 mm100 -87.9 -12.43 44.74 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 122.226 -0.297 . . . . 1.0 111.581 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 78.6 mtt180 -79.86 117.66 68.48 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.21 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.41 145.0 75.89 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.667 2.245 . . . . 1.0 112.22 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.516 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.3 t70 -96.65 114.79 65.1 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.06 -13.42 33.89 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.755 2.303 . . . . 1.0 114.444 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.577 ' NH1' ' HB2' ' A' ' 38' ' ' SER . 16.8 mmm180 -73.33 -36.54 66.22 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.312 -0.555 . . . . 1.0 110.896 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 t -96.31 -24.18 16.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.791 -0.641 . . . . 1.0 112.333 -174.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.691 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.6 pp -96.38 162.51 13.46 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.57 0.952 . . . . 1.0 113.57 -174.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 9.9 p-10 -114.71 153.2 30.7 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.468 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 p -120.73 126.94 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.186 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.75 112.55 24.52 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.597 ' NE1' HG12 ' A' ' 101' ' ' VAL . 2.3 t-105 -91.51 122.65 34.28 Favored 'General case' 0 N--CA 1.383 -3.801 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.951 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.458 HH22 HD21 ' A' ' 14' ' ' LEU . 67.5 mtm180 -110.3 90.13 3.23 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-O 123.025 1.393 . . . . 1.0 107.314 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.6 p -79.72 -17.68 53.0 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.061 -1.881 . . . . 1.0 110.553 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.7 -56.95 4.52 Favored Glycine 0 C--N 1.298 -1.565 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.676 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.83 -43.01 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.505 0.557 . . . . 1.0 112.505 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.54 -10.33 21.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.332 0.587 . . . . 1.0 109.541 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.11 -149.96 19.48 Favored Glycine 0 N--CA 1.418 -2.565 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.656 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.449 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 7.2 p80 -105.56 114.0 27.91 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.314 0.578 . . . . 1.0 110.853 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.95 146.74 49.22 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.324 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.5 mm -85.97 115.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.496 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -105.87 143.26 34.25 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.903 0.859 . . . . 1.0 111.768 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.435 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 9.6 m -158.3 146.03 18.26 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 104.238 -2.505 . . . . 1.0 104.238 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -72.82 -36.2 67.47 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.043 -1.063 . . . . 1.0 111.004 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -109.46 91.9 3.83 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.228 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.435 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 5.1 t70 -164.14 -69.38 0.04 OUTLIER 'General case' 0 CA--C 1.486 -1.496 0 CA-C-O 121.865 0.841 . . . . 1.0 111.973 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.0 p -93.18 -2.75 10.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 114.421 -1.263 . . . . 1.0 112.142 -172.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.494 HG21 ' ND2' ' A' ' 94' ' ' ASN . 14.7 t -143.72 25.74 1.62 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.067 0.937 . . . . 1.0 109.466 176.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -98.45 17.14 19.65 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.395 -0.82 . . . . 1.0 111.348 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' HB3' HE21 ' A' ' 87' ' ' GLN . 5.5 mp0 -63.2 112.21 2.57 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.54 0.686 . . . . 1.0 110.55 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 m -90.48 74.43 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-O 122.305 1.05 . . . . 1.0 111.991 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' A' ' 85' ' ' GLU . 8.7 pt20 -124.51 -8.88 7.43 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.386 -1.279 . . . . 1.0 110.239 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.67 -103.53 0.24 Allowed Glycine 0 N--CA 1.407 -3.299 0 C-N-CA 120.455 -0.879 . . . . 1.0 111.427 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.5 mt -89.35 -5.58 57.38 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.351 0.596 . . . . 1.0 110.939 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -85.79 -3.95 59.04 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.022 -0.99 . . . . 1.0 110.555 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -80.4 95.47 6.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.413 -1.699 . . . . 1.0 106.413 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -143.14 170.17 16.23 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.153 -170.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt -110.25 155.93 21.37 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.494 ' ND2' HG21 ' A' ' 83' ' ' THR . 55.7 m-80 -94.24 135.96 35.05 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 119.228 -0.989 . . . . 1.0 110.723 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.558 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.4 p -109.46 172.75 6.67 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 125.115 1.366 . . . . 1.0 108.237 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.0 pp -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.839 -1.145 . . . . 1.0 108.015 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.558 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.62 -25.05 67.79 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.327 -0.851 . . . . 1.0 112.029 177.948 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -59.55 -41.61 90.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -102.08 -3.44 27.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.578 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 68.1 mmtt 46.26 68.52 0.59 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.223 1.009 . . . . 1.0 112.827 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.597 HG12 ' NE1' ' A' ' 67' ' ' TRP . 1.5 m -78.3 148.9 75.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.462 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.66 160.58 34.57 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.071 2.514 . . . . 1.0 111.898 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.19 117.93 9.19 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.01 22.17 9.01 Favored Glycine 0 C--N 1.288 -2.135 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.437 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.406 ' O ' HD21 ' A' ' 11' ' ' LEU . . . -69.09 156.8 38.06 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 176.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.0 m -120.52 130.35 54.21 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.182 0.515 . . . . 1.0 110.687 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 33.8 m -113.74 165.83 8.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.692 -0.803 . . . . 1.0 111.077 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -148.3 120.81 8.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.311 -0.859 . . . . 1.0 108.961 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.528 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -106.17 137.7 43.64 Favored 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.072 -176.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.691 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 29.3 m -126.91 149.77 69.9 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.43 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 73.5 Cg_endo -77.19 63.66 7.76 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 122.858 2.372 . . . . 1.0 113.32 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.401 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 42.1 t 64.28 70.65 0.49 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 122.075 0.941 . . . . 1.0 108.928 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.81 -50.74 2.95 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.152 -0.931 . . . . 1.0 110.198 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.6 t -139.68 50.81 1.75 Allowed 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 110.032 -0.358 . . . . 1.0 110.032 -175.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -65.99 69.14 0.05 Allowed 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.174 1.546 . . . . 1.0 115.174 -175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 63.18 7.16 2.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.48 1.912 . . . . 1.0 113.984 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.4 159.8 28.37 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.359 0 CA-C-N 114.834 -1.076 . . . . 1.0 109.145 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.93 109.18 20.19 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.493 -0.929 . . . . 1.0 108.493 174.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -98.48 120.97 39.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -89.85 140.94 29.11 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.226 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -96.61 95.15 7.76 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 -179.046 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.517 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -90.12 84.42 6.12 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -88.1 8.13 28.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.896 0.855 . . . . 1.0 110.859 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t 73.73 -42.79 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.771 0 C-N-CA 126.054 1.742 . . . . 1.0 114.445 170.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.32 78.42 9.63 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.663 1.22 . . . . 1.0 112.619 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.561 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 m-85 -131.48 -177.01 4.22 Favored 'General case' 0 N--CA 1.405 -2.715 0 N-CA-C 104.544 -2.391 . . . . 1.0 104.544 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -99.78 108.77 53.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 C-N-CA 119.746 -0.782 . . . . 1.0 111.93 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 31.6 Cg_exo -60.66 133.5 48.76 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.691 2.261 . . . . 1.0 110.893 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.9 tp -126.95 156.27 41.79 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.604 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.1 m -99.91 127.28 46.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.43 HD11 ' CZ2' ' A' ' 67' ' ' TRP . 2.3 mm? -126.56 146.88 49.97 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.061 0.545 . . . . 1.0 110.697 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -96.2 117.1 30.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.927 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.67 113.19 18.69 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 27.2 tp -142.67 155.39 44.91 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 -177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.568 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -123.59 140.95 52.48 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.424 -0.511 . . . . 1.0 110.078 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -119.29 36.19 4.56 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.239 0.542 . . . . 1.0 110.444 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 76.4 t -66.08 -46.44 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.028 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.87 -80.56 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 118.761 -1.685 . . . . 1.0 114.553 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.42 -31.29 94.56 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.097 2.531 . . . . 1.0 112.781 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.89 38.37 2.19 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.149 -1.18 . . . . 1.0 110.149 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -65.23 80.3 0.05 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.682 0.753 . . . . 1.0 112.808 -176.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.14 -1.74 65.18 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -113.93 20.6 15.62 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.472 -1.364 . . . . 1.0 110.177 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.24 -82.14 0.18 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.368 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.79 -56.13 0.26 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.65 91.81 1.11 Allowed Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.49 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.29 126.1 30.41 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -74.8 104.53 1.91 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.719 1.613 . . . . 1.0 111.057 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.436 HG13 HE21 ' A' ' 47' ' ' GLN . 22.0 t -110.71 155.78 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -121.64 148.52 44.45 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.436 -0.906 . . . . 1.0 112.76 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG23 HD21 ' A' ' 11' ' ' LEU . 7.6 m -147.91 -174.29 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 125.071 1.349 . . . . 1.0 108.312 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.2 158.63 16.95 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-O 120.544 0.211 . . . . 1.0 110.662 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -32.07 73.14 Favored 'General case' 0 C--O 1.26 1.629 0 O-C-N 124.224 0.953 . . . . 1.0 109.344 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 t -108.97 37.39 2.57 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.856 -1.52 . . . . 1.0 109.791 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.405 ' O ' HG21 ' A' ' 95' ' ' THR . 11.1 p-10 -68.53 -166.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.267 173.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 p -139.95 146.18 38.85 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 26.5 mm -57.17 -29.37 31.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 118.482 0.583 . . . . 1.0 110.863 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -60.99 -50.18 74.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -73.41 -40.36 64.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.34 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.705 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.95 -39.28 90.3 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.469 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.612 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.1 ttmp? -57.48 -41.85 81.48 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -67.28 -51.84 47.97 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.267 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.705 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 87.4 mmm -62.6 -45.96 90.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.337 0.398 . . . . 1.0 110.998 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.9 pp -77.23 -28.5 53.72 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.51 -29.08 64.02 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.459 1.104 . . . . 1.0 112.775 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.436 HE21 HG13 ' A' ' 29' ' ' VAL . 15.1 mm-40 -64.88 -37.27 87.06 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.581 0.705 . . . . 1.0 110.207 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.74 -41.48 8.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.98 0.895 . . . . 1.0 109.828 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -91.81 25.45 2.75 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.341 -1.299 . . . . 1.0 111.429 -175.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -61.99 125.14 22.82 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.63 -4.78 53.99 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.28 124.5 53.43 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.404 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 64.9 Cg_endo -66.37 162.05 38.07 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 123.438 2.759 . . . . 1.0 112.613 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -62.4 -39.62 93.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.769 -175.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 t -64.73 -30.79 71.81 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.195 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -85.49 -26.67 26.14 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.379 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 48.5 mtt180 -65.09 126.79 91.98 Favored Pre-proline 0 C--O 1.245 0.839 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 173.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.82 134.2 58.83 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.846 1.697 . . . . 1.0 112.059 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.494 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 13.4 t70 -91.19 153.61 44.67 Favored Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 114.637 -1.165 . . . . 1.0 109.262 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.494 ' HD2' ' CG ' ' A' ' 59' ' ' ASP . 18.7 Cg_endo -58.06 -17.14 30.06 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.873 2.382 . . . . 1.0 113.286 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -70.94 -20.14 62.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 120.14 -0.624 . . . . 1.0 110.926 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 t -116.4 -15.93 10.89 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 120.483 -0.487 . . . . 1.0 111.562 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.513 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.2 OUTLIER -138.29 162.0 35.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 175.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.503 ' OD2' ' HA ' ' A' ' 112' ' ' CYS . 9.5 m-20 -129.15 165.22 21.72 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.309 -1.367 . . . . 1.0 107.309 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.1 128.92 73.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.616 -0.833 . . . . 1.0 109.859 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -90.23 112.66 24.27 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 106.206 -1.776 . . . . 1.0 106.206 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.43 ' CZ2' HD11 ' A' ' 11' ' ' LEU . 3.4 t-105 -95.08 122.1 37.4 Favored 'General case' 1 N--CA 1.372 -4.325 0 C-N-CA 119.395 -0.922 . . . . 1.0 109.01 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -108.16 89.28 2.95 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.7 t -83.24 -17.7 41.75 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.511 -1.677 . . . . 1.0 109.261 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.13 -58.56 3.17 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 112.728 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.65 -37.16 79.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 122.737 0.415 . . . . 1.0 111.328 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.01 -5.23 30.8 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.777 0.798 . . . . 1.0 109.351 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.12 -140.31 15.01 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.832 -1.077 . . . . 1.0 110.642 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -117.57 120.55 38.4 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.034 0.445 . . . . 1.0 109.915 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.56 146.48 49.66 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -85.01 116.43 28.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.422 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 10.6 mp -108.48 155.86 20.13 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.421 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.5 t -171.58 172.5 5.0 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 115.004 -0.998 . . . . 1.0 108.485 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -81.5 -2.48 49.92 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.859 -1.064 . . . . 1.0 109.438 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -165.08 84.62 0.39 Allowed 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 105.937 -1.875 . . . . 1.0 105.937 168.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 82' ' ' VAL . 4.6 p30 -95.2 -168.1 1.74 Allowed 'General case' 0 CA--C 1.477 -1.831 0 CA-C-O 122.896 1.331 . . . . 1.0 112.63 -173.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 ' H ' ' HB2' ' A' ' 81' ' ' ASP . 12.3 p -62.58 -28.96 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.872 0 CA-C-N 111.798 -2.455 . . . . 1.0 113.042 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.9 t -113.3 1.02 15.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.385 -0.926 . . . . 1.0 111.479 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.3 p -89.69 70.69 7.79 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.469 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 43.0 mt-10 -71.1 122.51 20.24 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.248 -1.342 . . . . 1.0 111.404 -174.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.24 83.05 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 122.352 1.072 . . . . 1.0 110.033 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -135.07 -28.7 1.16 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.183 -1.372 . . . . 1.0 109.739 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.32 137.66 2.38 Favored Glycine 0 N--CA 1.413 -2.843 0 N-CA-C 109.079 -1.608 . . . . 1.0 109.079 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.8 mt 73.38 -15.05 0.57 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.393 1.077 . . . . 1.0 113.079 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 54.2 m-85 -97.56 -3.73 39.13 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.336 0.495 . . . . 1.0 112.336 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -75.33 92.35 2.78 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.437 -0.949 . . . . 1.0 108.437 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -145.87 156.98 43.91 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.38 122.01 38.81 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 170.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -74.56 142.39 44.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 -173.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.5 p -105.06 169.41 8.45 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 124.913 1.285 . . . . 1.0 108.709 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 pp -70.32 -32.73 70.6 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 172.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.416 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -62.13 -29.79 70.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.429 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -65.23 -35.21 80.34 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 92.6 m-85 -98.06 8.66 44.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.89 -0.595 . . . . 1.0 112.189 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 52.99 54.63 10.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.045 . . . . 1.0 111.334 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.8 t -74.86 124.37 89.53 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.779 -177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.0 159.1 27.23 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.525 2.816 . . . . 1.0 112.191 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.39 117.99 10.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.071 -0.513 . . . . 1.0 109.87 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.88 18.3 14.3 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.291 -0.957 . . . . 1.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.01 27.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.027 0.441 . . . . 1.0 110.554 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -115.8 132.06 56.75 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 122.066 -0.397 . . . . 1.0 111.076 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 m -114.03 138.68 43.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.98 135.26 49.68 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.42 0.628 . . . . 1.0 110.773 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.568 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 94.6 mt -95.43 129.26 42.65 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 19.0 m -132.84 142.38 44.52 Favored Pre-proline 0 C--N 1.31 -1.15 0 O-C-N 123.172 0.295 . . . . 1.0 110.284 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.37 79.6 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.14 1.893 . . . . 1.0 110.664 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.513 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 3.1 t 53.55 82.02 0.09 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.931 1.692 . . . . 1.0 111.411 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 114' ' ' THR . 2.7 mm? 69.22 -1.06 2.27 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.155 1.382 . . . . 1.0 110.274 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER 70.0 12.33 7.8 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.371 1.469 . . . . 1.0 109.879 -176.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -140.25 96.71 3.09 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.083 -2.191 . . . . 1.0 105.083 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -136.48 163.2 31.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 114.187 1.18 . . . . 1.0 114.187 -170.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.42 174.01 11.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.581 -2.007 . . . . 1.0 105.581 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.4 82.26 5.93 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.332 -1.358 . . . . 1.0 107.332 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -105.22 141.95 35.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.367 -0.833 . . . . 1.0 112.646 -171.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -156.58 163.08 39.78 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.312 -1.736 . . . . 1.0 106.312 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -135.57 92.82 2.88 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.189 -0.604 . . . . 1.0 111.044 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? . . . . . 0 N--CA 1.421 -1.885 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 174.259 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.7 pttp . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -109.6 40.99 1.76 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 106.715 -1.587 . . . . 1.0 106.715 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -93.07 10.94 29.38 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.667 -1.151 . . . . 1.0 111.265 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.9 t -85.61 104.96 13.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.56 -1.645 . . . . 1.0 106.56 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.64 60.29 5.16 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.152 0.977 . . . . 1.0 113.092 -172.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.478 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 26.8 m-85 -129.98 162.46 28.61 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 105.025 -2.213 . . . . 1.0 105.025 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.458 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 20.1 mmt180 -104.01 108.17 59.17 Favored Pre-proline 0 C--N 1.277 -2.572 0 C-N-CA 119.384 -0.926 . . . . 1.0 111.841 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -59.43 131.45 40.73 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.255 1.97 . . . . 1.0 110.763 175.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -136.41 159.93 40.27 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.085 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.1 m -95.22 131.26 41.46 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 105' ' ' ALA . 27.1 tp -127.66 142.09 51.43 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -99.88 113.35 25.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.784 -0.572 . . . . 1.0 110.604 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.51 112.69 14.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.626 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.437 HD23 ' HA2' ' A' ' 22' ' ' GLY . 31.3 tp -142.01 152.67 43.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.573 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.02 140.2 53.21 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.881 -0.512 . . . . 1.0 110.897 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.42 41.74 3.03 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.622 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.88 -45.2 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 CA-C-N 116.546 -0.297 . . . . 1.0 110.546 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.32 -75.29 0.18 Allowed Glycine 0 C--O 1.22 -0.729 0 C-N-CA 119.777 -1.202 . . . . 1.0 113.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.51 -27.38 76.76 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.53 2.82 . . . . 1.0 113.307 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.69 34.41 2.88 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.68 76.3 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.437 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 114.19 -10.81 22.35 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 173.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -109.88 8.66 24.46 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.948 -0.626 . . . . 1.0 111.613 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.87 -86.54 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.321 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -132.38 -61.69 0.86 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.23 71.31 1.08 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.854 -1.165 . . . . 1.0 110.535 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.34 125.33 38.11 Favored Pre-proline 0 C--N 1.306 -1.323 0 O-C-N 122.898 -0.177 . . . . 1.0 110.818 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.46 101.79 1.54 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.021 1.814 . . . . 1.0 111.757 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.515 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 45.7 t -104.99 155.42 6.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.465 -1.309 . . . . 1.0 107.465 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -102.31 150.04 23.73 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.813 -1.155 . . . . 1.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 32' ' ' LEU . 4.4 p -148.26 -178.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.05 -0.977 . . . . 1.0 108.709 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.434 ' H ' HG23 ' A' ' 31' ' ' VAL . 14.4 mt -110.92 162.29 14.98 Favored 'General case' 0 C--O 1.179 -2.617 0 CA-C-N 118.39 0.541 . . . . 1.0 110.852 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.458 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 18.0 t70 -65.11 -31.3 72.44 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-O 121.407 0.623 . . . . 1.0 110.88 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.437 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 0.7 OUTLIER -102.85 28.6 6.03 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.334 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.684 ' O ' ' HA ' ' A' ' 95' ' ' THR . 17.1 p-10 -67.75 135.54 52.85 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -91.08 157.05 17.46 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 45.0 mm -55.86 -40.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.889 0.376 . . . . 1.0 110.446 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 p -62.8 -43.96 97.43 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.294 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -73.15 -37.69 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 1.0 111.677 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.68 -38.39 89.13 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.37 -41.49 72.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -68.32 -47.75 66.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.261 -0.882 . . . . 1.0 110.846 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.83 -44.6 92.73 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.994 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.0 mmm -64.99 -42.76 94.23 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.567 0.542 . . . . 1.0 110.621 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -74.24 -29.33 61.64 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.818 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.08 -30.89 62.66 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.228 1.011 . . . . 1.0 112.539 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.444 HE21 HG12 ' A' ' 29' ' ' VAL . 14.3 mm-40 -70.38 -37.13 74.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.162 0.506 . . . . 1.0 111.283 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.32 -42.03 9.13 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.124 0.964 . . . . 1.0 109.654 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -97.25 33.47 1.96 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.041 -1.436 . . . . 1.0 109.515 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -55.61 115.88 2.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.104 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.16 -2.73 37.79 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.745 -0.74 . . . . 1.0 112.929 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -80.86 126.43 77.71 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.75 159.71 40.2 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 122.643 2.228 . . . . 1.0 111.683 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.73 -42.17 96.78 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.306 0.643 . . . . 1.0 111.956 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -74.2 -15.43 61.01 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.327 0.491 . . . . 1.0 112.327 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -91.35 -9.86 43.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.412 0.625 . . . . 1.0 110.41 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -84.04 119.34 73.24 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.078 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.98 141.35 83.68 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.365 2.043 . . . . 1.0 111.092 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -93.02 159.77 34.98 Favored Pre-proline 0 C--N 1.311 -1.096 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.343 -175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -76.92 15.15 1.17 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.565 2.177 . . . . 1.0 111.455 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -84.17 -40.35 18.27 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 176.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 68.8 p -94.51 -8.97 36.81 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.702 -1.135 . . . . 1.0 111.167 -172.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.3 pp -143.77 161.72 37.87 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.662 -1.154 . . . . 1.0 109.908 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' OD1' ' HB2' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -115.02 157.7 23.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 -177.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.09 121.87 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -91.55 112.72 24.75 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 105.792 -1.929 . . . . 1.0 105.792 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.617 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -86.49 128.72 34.99 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.906 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.98 89.84 3.18 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.4 m -90.1 -17.07 28.36 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.428 -0.909 . . . . 1.0 109.409 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.25 -46.88 3.48 Favored Glycine 0 C--N 1.309 -0.969 0 CA-C-N 114.998 -1.001 . . . . 1.0 112.306 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.35 -27.06 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.146 0.578 . . . . 1.0 111.439 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.405 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . . . -124.08 4.37 8.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.584 0.707 . . . . 1.0 109.775 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.13 -130.43 10.23 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.882 -1.054 . . . . 1.0 113.55 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.34 123.97 46.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 125.144 1.377 . . . . 1.0 108.665 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -132.05 148.43 52.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 mm -94.55 116.11 35.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.282 -0.567 . . . . 1.0 109.616 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.429 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.1 mp -111.03 158.02 19.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.061 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -158.0 159.7 36.69 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.851 -1.907 . . . . 1.0 105.851 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.518 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 17.7 p-10 -66.71 -53.74 30.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.237 -0.585 . . . . 1.0 110.384 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -131.01 107.08 8.83 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 11.5 t70 -169.49 -84.9 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.721 0.772 . . . . 1.0 111.121 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 2.5 p -74.96 -13.07 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 113.889 -1.505 . . . . 1.0 112.956 -170.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.1 t -120.87 -1.95 9.85 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.554 -0.858 . . . . 1.0 110.744 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 92' ' ' ARG . 19.0 p -100.6 96.69 7.53 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.42 0.629 . . . . 1.0 112.333 -171.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.23 128.88 52.85 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.162 -1.051 . . . . 1.0 108.162 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . 20.3 m -85.52 90.14 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-O 123.462 1.601 . . . . 1.0 109.608 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -118.24 12.98 13.63 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 112.724 -2.035 . . . . 1.0 111.506 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.39 -43.16 1.51 Allowed Glycine 0 CA--C 1.47 -2.722 0 N-CA-C 108.924 -1.67 . . . . 1.0 108.924 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.72 -34.39 78.09 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.467 -1.309 . . . . 1.0 107.467 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.577 ' HA ' ' HA ' ' A' ' 86' ' ' VAL 0.343 55.4 p90 60.71 -59.53 0.08 Allowed 'General case' 0 CA--C 1.479 -1.778 0 C-N-CA 129.426 3.09 . . . . 1.0 115.222 177.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -95.22 125.92 40.18 Favored 'General case' 1 C--N 1.24 -4.162 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.101 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 74.6 mmt-85 -147.82 103.06 3.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.273 0.559 . . . . 1.0 110.642 177.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 89.0 mt -102.83 142.59 33.7 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -73.6 143.21 46.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.646 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -120.58 165.96 14.3 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 124.641 1.176 . . . . 1.0 108.799 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.6 pp -65.39 -28.53 69.33 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.476 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.41 -25.93 68.23 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.483 177.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -64.72 -39.4 93.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.472 ' O ' ' HD1' ' A' ' 99' ' ' TYR . 0.5 OUTLIER -88.5 -19.22 26.72 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 115.506 -0.77 . . . . 1.0 109.79 176.273 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm 53.03 60.83 3.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.77 0.828 . . . . 1.0 110.957 -171.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.617 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.3 m -76.62 150.46 82.0 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 113.185 0.809 . . . . 1.0 113.185 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 162.12 28.41 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 123.501 2.801 . . . . 1.0 111.307 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.19 130.97 45.06 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.611 0.719 . . . . 1.0 109.748 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.42 17.74 44.75 Favored Glycine 0 C--N 1.284 -2.313 0 CA-C-N 114.979 -1.01 . . . . 1.0 111.58 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.439 ' O ' HD11 ' A' ' 11' ' ' LEU . . . -62.64 151.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 43.7 m -108.0 127.65 53.96 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.213 0.53 . . . . 1.0 110.995 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.5 m -109.74 141.36 25.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 176.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.79 52.66 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.703 0.763 . . . . 1.0 110.596 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.573 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.3 tt -95.18 122.91 38.35 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.319 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 13.7 m -128.05 145.39 55.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.15 55.95 5.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.875 2.384 . . . . 1.0 113.511 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 62' ' ' THR . 0.1 OUTLIER 58.96 82.54 0.14 Allowed 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 124.586 1.154 . . . . 1.0 111.233 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.5 mt -122.39 -42.29 2.36 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.806 -1.088 . . . . 1.0 111.584 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -127.87 24.55 6.05 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 114.356 1.243 . . . . 1.0 114.356 -170.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.516 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 34.0 ttpt -69.92 130.42 42.18 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.046 -0.662 . . . . 1.0 111.228 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -54.85 145.45 19.82 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 125.588 1.555 . . . . 1.0 111.413 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.6 160.87 31.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.3 mt -105.4 109.17 21.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.178 0.513 . . . . 1.0 110.831 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -144.04 -27.46 0.52 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.945 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -143.45 86.57 1.9 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.39 0.614 . . . . 1.0 110.385 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -124.78 129.39 50.36 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.543 -1.281 . . . . 1.0 107.543 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 C--N 1.28 -2.438 0 N-CA-C 108.334 -0.987 . . . . 1.0 108.334 176.027 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.394 -3.232 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.545 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 17.8 mmt180 -124.11 115.9 27.41 Favored Pre-proline 0 C--N 1.263 -3.158 0 C-N-CA 119.893 -0.723 . . . . 1.0 111.632 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.38 109.18 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.785 1.657 . . . . 1.0 108.334 168.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 tp -113.04 158.49 20.25 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.212 -0.903 . . . . 1.0 111.001 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 m -103.56 127.61 50.94 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.515 HD23 ' SD ' ' A' ' 44' ' ' MET . 14.8 tp -126.94 139.83 52.77 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -96.72 114.0 25.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.39 114.73 13.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.799 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.549 HD21 ' HA2' ' A' ' 22' ' ' GLY . 12.8 tp -142.14 167.34 22.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.645 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.7 pt? -135.94 144.96 45.73 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -110.94 30.76 6.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.909 0.385 . . . . 1.0 111.034 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' HD3' ' A' ' 111' ' ' PRO . 71.5 t -65.94 -47.79 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.816 0 CA-C-N 115.897 -0.592 . . . . 1.0 112.383 -175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.4 -81.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.2 -1.476 . . . . 1.0 113.819 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.63 -27.67 83.64 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 123.599 2.866 . . . . 1.0 112.821 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.91 37.63 2.02 Favored Glycine 0 N--CA 1.408 -3.173 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.68 48.97 0.09 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.465 0.913 . . . . 1.0 113.465 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.549 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 136.42 -3.78 3.65 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.795 -0.922 . . . . 1.0 110.795 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.02 29.75 2.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.06 0.457 . . . . 1.0 111.597 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.96 -76.03 0.27 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -140.76 -63.83 0.47 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.585 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.19 88.84 0.59 Allowed Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.273 -0.965 . . . . 1.0 111.089 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.6 126.54 28.93 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.86 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.937 1.758 . . . . 1.0 111.86 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.569 HG22 ' HG3' ' A' ' 47' ' ' GLN . 13.9 t -112.34 155.35 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -107.67 144.28 34.97 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 m -142.21 -175.22 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 113.598 -1.637 . . . . 1.0 109.504 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.3 158.88 25.19 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 110.27 -0.27 . . . . 1.0 110.27 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.545 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.1 t70 -66.43 -31.33 72.02 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.6 t -103.27 33.36 3.34 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.872 -1.513 . . . . 1.0 109.491 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.564 ' O ' HG22 ' A' ' 95' ' ' THR . 12.8 p-10 -71.58 -165.76 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.216 -0.902 . . . . 1.0 109.013 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 50.1 p -139.07 157.92 45.11 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 169.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 78' ' ' SER . 39.5 mm -59.22 -41.41 83.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 13.5 m -61.8 -43.47 98.79 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.861 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -69.87 -41.21 75.11 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.207 0.527 . . . . 1.0 111.196 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.701 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.88 -39.16 93.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.51 -40.53 75.16 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.429 176.149 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mt-10 -68.59 -47.9 65.57 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 123.754 0.659 . . . . 1.0 110.778 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -63.58 -44.03 95.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.232 0.333 . . . . 1.0 111.621 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.2 mmm -65.03 -40.85 95.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.47 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.0 pp -74.45 -33.18 62.85 Favored 'General case' 0 C--O 1.188 -2.147 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.098 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -51.6 -31.15 23.82 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 124.951 1.301 . . . . 1.0 112.932 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.569 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.5 mm-40 -69.48 -36.61 76.71 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.722 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 122.044 0.926 . . . . 1.0 110.058 -178.289 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.451 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.776 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.17 138.17 39.47 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.53 117.14 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.446 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -91.34 111.82 23.47 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 105.836 -1.913 . . . . 1.0 105.836 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.631 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.9 t-105 -88.72 126.04 35.14 Favored 'General case' 0 N--CA 1.39 -3.446 0 CA-C-N 115.197 -0.911 . . . . 1.0 108.927 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.86 88.98 2.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 107.057 -1.46 . . . . 1.0 107.057 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 62.7 p -71.33 -27.24 63.24 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.483 -1.235 . . . . 1.0 110.082 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 -57.31 4.84 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.484 -1.235 . . . . 1.0 110.7 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.9 m -64.29 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 120.924 0.393 . . . . 1.0 111.895 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.48 -1.4 30.68 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.557 0.694 . . . . 1.0 110.354 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.71 -119.7 6.31 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 27.8 p-80 -140.42 138.26 34.61 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.604 0.24 . . . . 1.0 110.742 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.0 tp -134.73 144.48 47.76 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.62 118.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.854 -1.165 . . . . 1.0 107.854 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.472 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.2 mp -107.71 157.6 17.97 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.4 0.619 . . . . 1.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 37' ' ' ILE . 13.3 m -157.32 160.32 38.4 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.17 -48.06 77.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.422 -1.874 0 CA-C-O 121.676 0.75 . . . . 1.0 109.14 170.445 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--O 1.245 0.861 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -85.06 142.24 29.69 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.942 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.1 p -107.32 168.39 9.26 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 124.604 1.162 . . . . 1.0 108.53 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.632 HD13 HG22 ' A' ' 101' ' ' VAL . 4.0 pp -72.97 -24.33 60.77 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.064 173.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.8 pt20 -64.36 -26.54 68.51 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.335 176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -66.05 -41.7 90.48 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.6 t80 -80.05 -16.26 55.45 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.653 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 58.78 52.12 6.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.778 0.831 . . . . 1.0 110.983 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.632 HG22 HD13 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -78.36 146.83 71.14 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 113.346 0.869 . . . . 1.0 113.346 -178.088 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.16 158.41 26.63 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 123.481 2.788 . . . . 1.0 112.155 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.55 122.65 18.05 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.437 0.637 . . . . 1.0 109.542 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.68 21.85 10.88 Favored Glycine 0 C--N 1.288 -2.131 0 C-N-CA 120.309 -0.948 . . . . 1.0 110.852 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.62 162.52 28.68 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.4 m -114.52 133.52 55.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 120.783 0.325 . . . . 1.0 110.389 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 11' ' ' LEU . 29.5 m -115.74 136.27 53.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.19 144.55 51.01 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.645 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.13 147.72 46.49 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.825 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 16' ' ' ALA . 27.4 m -132.24 136.17 27.65 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.242 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.538 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.5 Cg_endo -73.5 82.42 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.258 1.972 . . . . 1.0 111.97 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.411 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 4.3 p . . . . . 0 CA--C 1.498 -1.026 0 C-N-CA 125.148 1.379 . . . . 1.0 111.477 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.398 -3.058 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.503 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 23.0 mmt180 -119.3 116.4 33.76 Favored Pre-proline 0 C--N 1.268 -2.961 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.208 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.32 104.82 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 107.35 -1.827 . . . . 1.0 107.35 167.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -110.82 159.72 17.4 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.648 -0.705 . . . . 1.0 111.036 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -108.51 125.95 52.37 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 107' ' ' VAL . 20.0 tp -127.45 141.89 51.55 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.45 114.73 26.43 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 122.405 -0.184 . . . . 1.0 110.857 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.14 119.96 20.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.171 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.67 HD21 ' HA2' ' A' ' 22' ' ' GLY . 13.4 tp -148.46 163.27 37.67 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -129.58 144.12 51.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.017 -0.427 . . . . 1.0 110.079 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -112.85 37.17 3.19 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.913 0.387 . . . . 1.0 111.023 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.85 -44.31 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.314 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.813 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.07 -88.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.4 -1.381 . . . . 1.0 113.888 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.31 -37.82 88.57 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.906 2.404 . . . . 1.0 113.139 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.48 33.74 5.38 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -70.58 48.51 0.11 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.468 0.914 . . . . 1.0 113.468 -176.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.67 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 146.85 -12.38 1.47 Allowed Glycine 0 C--N 1.299 -1.49 0 C-N-CA 120.68 -0.771 . . . . 1.0 112.402 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.88 25.47 5.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.089 0.471 . . . . 1.0 111.432 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.8 -77.38 0.19 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -129.56 -58.77 1.1 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.467 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 75.61 0.61 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 1.0 111.591 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.35 125.18 38.59 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 110.277 -0.268 . . . . 1.0 110.277 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.43 102.07 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.859 1.706 . . . . 1.0 111.045 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 47' ' ' GLN . 15.0 t -111.02 155.06 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.52 143.71 38.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 113.746 1.017 . . . . 1.0 113.746 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.6 -175.19 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 113.74 -1.573 . . . . 1.0 109.165 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.45 157.61 27.9 Favored 'General case' 0 C--O 1.191 -1.988 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.503 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 31.7 t70 -66.06 -31.54 72.47 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.87 0.731 . . . . 1.0 109.124 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.2 t -104.99 37.2 2.22 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 114.034 -1.439 . . . . 1.0 109.552 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 95' ' ' THR . 14.2 p-10 -71.83 -161.44 0.07 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.633 -1.167 . . . . 1.0 109.121 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 65.0 p -143.87 155.16 44.0 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 103.71 -2.7 . . . . 1.0 103.71 167.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mm -57.69 -39.54 70.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 118.614 0.643 . . . . 1.0 110.357 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 m -61.26 -43.95 98.04 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.512 175.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HB3' ' H ' ' A' ' 36' ' ' THR . 51.3 tt0 -68.17 -41.47 81.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.519 0.328 . . . . 1.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.95 -38.66 91.71 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.101 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -40.9 73.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 38' ' ' SER . 45.9 mt-10 -68.71 -51.78 37.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.67 0.606 . . . . 1.0 111.379 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.06 -42.43 99.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.807 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.5 mmm -65.21 -41.06 94.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.25 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.88 -30.47 58.85 Favored 'General case' 0 C--O 1.201 -1.493 0 C-N-CA 120.71 -0.396 . . . . 1.0 112.028 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -53.99 -31.4 50.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.536 1.134 . . . . 1.0 112.438 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.528 ' HG3' HG22 ' A' ' 29' ' ' VAL . 13.6 mm-40 -68.83 -40.06 79.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 1.0 110.551 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.875 0.845 . . . . 1.0 110.855 -174.893 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.752 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB2' HG22 ' A' ' 110' ' ' VAL . 16.7 m-20 -103.48 139.42 38.86 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 120.026 -0.669 . . . . 1.0 111.054 -171.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.61 115.07 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 N-CA-C 106.596 -1.631 . . . . 1.0 106.596 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.392 -3.345 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.635 ' HZ2' HG21 ' A' ' 101' ' ' VAL . 4.6 t-105 -85.93 124.15 32.07 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.505 -1.225 . . . . 1.0 109.327 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -111.5 89.19 2.98 Favored 'General case' 0 N--CA 1.396 -3.127 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.9 p -68.12 -31.59 71.29 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.087 -1.415 . . . . 1.0 109.924 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.55 -50.61 4.36 Favored Glycine 0 C--N 1.303 -1.294 0 CA-C-N 114.359 -1.291 . . . . 1.0 111.343 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.21 -39.95 85.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 122.872 0.469 . . . . 1.0 111.897 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.25 -29.51 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.164 0.507 . . . . 1.0 110.073 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.15 -120.95 3.21 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 10.7 p-80 -136.32 136.75 39.98 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.611 0.243 . . . . 1.0 110.701 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.6 tp -134.94 145.27 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -83.43 117.48 29.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.549 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -110.53 151.2 27.87 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-O 121.306 0.574 . . . . 1.0 110.816 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 m -159.14 161.4 36.28 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 105.203 -2.147 . . . . 1.0 105.203 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -64.7 -37.98 89.45 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.418 -2.07 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.055 172.886 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.243 0.754 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -85.09 138.59 32.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.058 -0.657 . . . . 1.0 111.099 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -113.84 169.04 9.28 Favored 'General case' 0 C--O 1.26 1.637 0 C-N-CA 125.061 1.344 . . . . 1.0 108.489 178.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.657 HD13 HG22 ' A' ' 101' ' ' VAL . 3.8 pp -72.33 -24.34 61.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 118.751 -1.18 . . . . 1.0 109.145 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 5.1 pt20 -63.98 -26.11 68.43 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.705 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -65.25 -40.02 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.44 -15.79 41.83 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.409 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 57.44 51.19 10.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.112 0.965 . . . . 1.0 110.422 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.657 HG22 HD13 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -74.62 148.28 85.27 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.31 157.08 29.48 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.247 2.631 . . . . 1.0 112.743 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.36 120.15 12.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.06 16.87 11.63 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 110.861 -0.895 . . . . 1.0 110.861 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.97 162.67 28.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.044 0.45 . . . . 1.0 110.579 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m -115.98 133.29 56.18 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.38 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 11' ' ' LEU . 27.0 m -120.24 137.94 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 C-N-CA 120.593 -0.443 . . . . 1.0 109.982 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -128.46 139.88 52.11 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.58 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.39 147.52 40.44 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.934 -178.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 64' ' ' ASP . 16.5 m -139.45 151.46 66.84 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.187 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.16 72.66 5.81 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.522 2.148 . . . . 1.0 111.152 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 125.027 1.331 . . . . 1.0 110.399 -175.627 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.504 ' HB2' HD22 ' A' ' 32' ' ' LEU . 76.6 m-85 . . . . . 0 N--CA 1.403 -2.808 0 N-CA-C 105.914 -1.884 . . . . 1.0 105.914 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' H ' ' HB2' ' A' ' 33' ' ' ASP . 38.9 mmt180 -109.25 106.92 59.36 Favored Pre-proline 0 C--N 1.273 -2.74 0 C-N-CA 118.877 -1.129 . . . . 1.0 109.74 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -64.59 111.6 1.72 Allowed 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.87 1.713 . . . . 1.0 108.22 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HB3' HG23 ' A' ' 31' ' ' VAL . 5.8 tp -115.48 159.43 21.19 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-O 121.248 0.547 . . . . 1.0 111.368 -172.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -111.5 132.59 54.39 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -125.05 154.58 41.1 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 123.486 0.714 . . . . 1.0 111.065 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -98.93 106.69 18.98 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.384 -0.825 . . . . 1.0 108.868 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.48 112.92 8.0 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.878 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.442 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.4 tp -144.6 149.98 36.68 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.667 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -122.9 143.84 49.62 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 122.27 -0.269 . . . . 1.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -113.57 29.92 7.63 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.164 0.506 . . . . 1.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.7 t -64.19 -47.03 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 CA-C-N 115.608 -0.724 . . . . 1.0 112.222 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.47 -78.69 0.1 OUTLIER Glycine 0 C--O 1.213 -1.17 0 C-N-CA 119.079 -1.534 . . . . 1.0 113.8 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.0 -28.75 87.76 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 123.012 2.475 . . . . 1.0 113.106 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.56 33.14 3.35 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.19 79.09 0.35 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.442 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 103.86 9.29 37.76 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.9 30.75 0.71 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.406 0.622 . . . . 1.0 110.925 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 -75.37 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.295 -0.562 . . . . 1.0 112.068 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.88 -67.43 0.44 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.964 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 77.23 0.91 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.131 -1.588 . . . . 1.0 109.131 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.49 130.42 23.09 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.428 -0.386 . . . . 1.0 110.541 -173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -72.5 104.51 1.72 Allowed 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.128 1.885 . . . . 1.0 111.431 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 25.5 t -114.04 155.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.247 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -104.6 146.14 29.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.728 0.299 . . . . 1.0 111.542 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -148.74 -174.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 124.79 1.236 . . . . 1.0 109.496 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' HB2' ' A' ' 6' ' ' TYR . 14.0 mt -122.37 167.71 12.96 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 123.049 0.54 . . . . 1.0 110.065 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' A' ' 7' ' ' ARG . 29.7 t70 -65.77 -31.28 72.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.73 -0.841 . . . . 1.0 108.73 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 t -112.94 19.82 16.95 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 114.344 1.238 . . . . 1.0 114.344 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.336 24.6 p-10 -85.22 140.2 31.07 Favored 'General case' 0 N--CA 1.415 -2.211 0 C-N-CA 115.853 -2.339 . . . . 1.0 109.411 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -75.17 166.42 23.68 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.637 -1.165 . . . . 1.0 110.852 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -59.31 -41.1 83.12 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.599 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -59.83 -48.1 83.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -73.11 -44.91 59.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.365 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.13 -36.53 82.08 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.593 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 34.1 ttpt -61.74 -34.9 76.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.679 ' HG3' ' O ' ' A' ' 38' ' ' SER . 61.3 mt-10 -65.85 -46.95 76.58 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.043 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.49 ' HD2' HG12 ' A' ' 31' ' ' VAL . 64.2 mttp -61.8 -41.77 98.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 123.301 0.376 . . . . 1.0 111.408 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.591 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.6 mmt -61.42 -48.56 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.129 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -77.48 -24.52 50.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 16.4 t70 -58.04 -34.08 69.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.771 0.828 . . . . 1.0 111.828 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.54 ' HG3' HG22 ' A' ' 29' ' ' VAL . 77.4 mm-40 -66.36 -31.92 72.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.521 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.496 -1.133 0 CA-C-O 121.011 0.434 . . . . 1.0 111.182 -171.769 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 120.964 0.411 . . . . 1.0 112.001 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' HG23 ' A' ' 110' ' ' VAL . 12.6 p-10 -107.26 166.3 10.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.642 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.56 126.43 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.56 0.695 . . . . 1.0 110.276 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -94.66 113.51 25.31 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 105.636 -1.987 . . . . 1.0 105.636 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.638 ' CE3' HD22 ' A' ' 77' ' ' LEU . 5.0 t-105 -89.85 137.18 32.56 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.742 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.31 88.99 3.04 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 107.327 -1.36 . . . . 1.0 107.327 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 p -72.5 -31.84 65.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.251 1.024 . . . . 1.0 108.731 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.93 -55.1 4.62 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 113.708 -1.587 . . . . 1.0 110.525 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -64.27 -42.3 95.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.476 -0.362 . . . . 1.0 111.54 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.41 -21.44 15.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.217 0.532 . . . . 1.0 109.677 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.21 -130.78 9.95 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.142 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 63.2 m-70 -111.42 122.49 47.98 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 123.322 0.649 . . . . 1.0 109.505 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -134.52 136.89 43.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.1 mm -84.21 123.1 38.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.866 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.638 HD22 ' CE3' ' A' ' 67' ' ' TRP . 9.9 mp -108.58 150.48 27.43 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.483 0.658 . . . . 1.0 111.427 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 m -152.09 150.94 30.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.34 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.2 p30 -74.21 -41.15 61.84 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.839 -0.619 . . . . 1.0 109.9 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.316 -0.877 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.799 178.384 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 70.3 mt . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -90.45 159.87 16.33 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.711 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.2 p -119.21 -178.95 3.7 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.056 0.942 . . . . 1.0 108.503 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -78.71 -19.71 51.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.464 -1.294 . . . . 1.0 109.532 175.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.518 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 5.3 pt20 -66.71 -25.79 66.7 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 120.979 0.418 . . . . 1.0 110.518 176.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -62.16 -35.33 78.47 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -97.25 -16.43 20.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.334 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.52 59.59 4.05 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.703 0.801 . . . . 1.0 110.282 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.8 m -73.98 146.8 85.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 119.909 -0.716 . . . . 1.0 112.139 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.56 162.46 35.65 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.793 2.328 . . . . 1.0 112.074 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.06 128.82 37.49 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.642 -0.708 . . . . 1.0 109.37 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.33 25.27 40.34 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.55 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.94 160.19 31.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.984 0.421 . . . . 1.0 110.205 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.5 m -110.78 134.16 52.73 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.121 0.486 . . . . 1.0 110.232 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.573 HG21 ' SD ' ' A' ' 44' ' ' MET . 16.1 m -113.25 155.76 14.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 176.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -135.01 130.05 35.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 172.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.667 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 mp -102.33 130.71 49.13 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.04 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.404 HG23 ' OD1' ' A' ' 64' ' ' ASP . 15.9 m -134.57 149.48 71.06 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.5 82.21 2.54 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 121.939 1.76 . . . . 1.0 112.4 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.419 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 8.7 p . . . . . 0 CA--C 1.505 -0.769 0 C-N-CA 125.148 1.379 . . . . 1.0 111.18 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 33.1 p90 . . . . . 0 N--CA 1.383 -3.824 0 N-CA-C 107.664 -1.236 . . . . 1.0 107.664 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.54 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 18.7 mmt180 -130.33 113.84 17.05 Favored Pre-proline 0 C--N 1.255 -3.535 0 N-CA-C 105.944 -1.872 . . . . 1.0 105.944 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.6 Cg_exo -49.4 115.92 2.01 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.781 1.654 . . . . 1.0 108.875 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 tp -124.13 155.87 37.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.209 0.528 . . . . 1.0 112.151 -170.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.6 m -105.79 128.8 53.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 107' ' ' VAL . 17.7 tp -127.43 142.58 51.38 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 25.8 t-20 -96.03 116.06 28.38 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.33 -0.248 . . . . 1.0 110.33 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.541 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -75.69 121.75 22.96 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.034 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.722 HD21 ' HA2' ' A' ' 22' ' ' GLY . 27.6 tp -151.5 168.12 25.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.611 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 2.1 pt? -136.11 145.06 45.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.123 0.569 . . . . 1.0 109.655 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.18 30.62 7.16 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.027 0.442 . . . . 1.0 110.52 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.404 HG22 ' HD3' ' A' ' 111' ' ' PRO . 50.9 t -64.91 -46.78 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.273 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.75 -81.92 0.08 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 118.511 -1.804 . . . . 1.0 114.66 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.15 -32.28 94.34 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.4 2.733 . . . . 1.0 112.679 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.48 42.36 1.42 Allowed Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.33 39.8 0.05 OUTLIER 'General case' 0 C--O 1.244 0.768 0 N-CA-C 114.057 1.132 . . . . 1.0 114.057 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.722 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 154.16 -20.53 0.65 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.06 57.4 1.7 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.189 0.995 . . . . 1.0 110.333 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.07 -83.08 0.53 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.363 -1.29 . . . . 1.0 111.324 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 7.0 pt20 -111.62 -59.51 1.97 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.609 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 60.05 71.65 0.74 Allowed Glycine 0 CA--C 1.519 0.33 0 O-C-N 123.694 0.621 . . . . 1.0 112.05 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -108.57 127.59 27.16 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 122.656 -0.32 . . . . 1.0 110.218 -174.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.37 110.73 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.687 1.591 . . . . 1.0 111.584 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.581 HG22 ' HG3' ' A' ' 47' ' ' GLN . 21.9 t -116.13 155.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.901 -1.045 . . . . 1.0 108.267 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -106.22 145.3 31.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 114.085 1.143 . . . . 1.0 114.085 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.41 -175.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 113.515 -1.675 . . . . 1.0 108.766 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.1 mt -117.3 158.23 24.73 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 24.4 t70 -66.95 -29.71 69.64 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.801 0.688 . . . . 1.0 109.475 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.72 34.07 2.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.426 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -74.61 -166.39 0.44 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.756 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.6 p -137.29 153.9 50.21 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 168.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 40.0 mm -57.87 -40.0 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.857 0.361 . . . . 1.0 110.103 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.3 p -62.47 -43.88 97.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.122 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -71.6 -41.43 68.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.84 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.09 -37.7 88.39 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.604 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -55.66 -41.52 73.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 176.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' SER . 34.3 mt-10 -71.17 -45.63 63.08 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.284 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -63.37 -43.65 97.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.941 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.5 mmm -64.89 -41.48 95.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.701 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 ' HE2' ' A' ' 41' ' ' LYS . 3.9 pp -75.62 -28.37 58.81 Favored 'General case' 0 C--O 1.198 -1.616 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.846 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.54 -32.53 65.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.874 0.87 . . . . 1.0 112.245 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' A' ' 29' ' ' VAL . 16.7 mm-40 -69.81 -39.79 76.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.231 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.512 -0.516 0 CA-C-O 122.05 0.928 . . . . 1.0 110.496 -174.611 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 107.155 -1.424 . . . . 1.0 107.155 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 8.2 p-10 -107.3 150.16 27.0 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 -169.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.86 121.93 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.563 -1.198 . . . . 1.0 108.939 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.18 112.16 23.94 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.63 ' CE2' HG11 ' A' ' 101' ' ' VAL . 4.2 t-105 -87.26 124.19 33.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.49 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.63 88.19 2.69 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 106.853 -1.536 . . . . 1.0 106.853 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.7 p -72.16 -31.61 66.11 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.143 -1.389 . . . . 1.0 109.895 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.03 3.76 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 114.166 -1.379 . . . . 1.0 110.421 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -64.04 -38.04 81.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 122.911 0.485 . . . . 1.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.32 3.18 18.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.741 0.781 . . . . 1.0 110.143 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.51 -121.54 6.52 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.951 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.6 p-80 -134.78 134.87 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.85 0.357 . . . . 1.0 111.185 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.9 tp -134.02 146.12 50.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mm -83.13 118.69 31.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.554 HD22 ' CE3' ' A' ' 67' ' ' TRP . 11.0 mp -111.68 159.99 17.69 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.959 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -160.38 162.08 33.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' HB2' HD22 ' A' ' 93' ' ' LEU . 14.5 p-10 -62.52 -42.1 99.29 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.416 -2.126 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.454 172.255 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 79' ' ' ASP . 93.2 mt . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.19 144.93 28.64 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.159 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -111.46 165.61 11.84 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 125.078 1.351 . . . . 1.0 108.049 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.638 HD13 HG22 ' A' ' 101' ' ' VAL . 4.4 pp -72.1 -22.86 61.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.63 -1.228 . . . . 1.0 109.322 173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.505 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.6 pt20 -64.64 -25.93 68.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.053 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -63.23 -35.82 81.59 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -90.14 -15.86 30.72 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.331 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 57.66 54.28 6.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.773 0.829 . . . . 1.0 110.826 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.638 HG22 HD13 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -81.44 146.87 58.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.111 0.782 . . . . 1.0 113.111 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.41 157.99 29.2 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.187 2.591 . . . . 1.0 112.093 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.87 123.39 20.03 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.509 0.671 . . . . 1.0 109.956 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.82 19.7 11.65 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.68 162.64 28.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.498 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 84.9 m -115.35 131.06 57.05 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.659 0.266 . . . . 1.0 110.965 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 11' ' ' LEU . 27.1 m -115.2 136.49 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 N-CA-C 109.948 -0.39 . . . . 1.0 109.948 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.6 141.22 49.61 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.611 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.89 150.65 44.41 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.878 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.45 156.39 78.89 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HD3' HG22 ' A' ' 17' ' ' VAL . 73.3 Cg_endo -81.21 75.13 5.14 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.054 1.836 . . . . 1.0 111.781 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.522 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 20.1 p . . . . . 0 C--O 1.242 0.702 0 C-N-CA 125.019 1.327 . . . . 1.0 110.854 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 m-85 . . . . . 0 N--CA 1.418 -2.061 0 N-CA-C 103.769 -2.678 . . . . 1.0 103.769 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -98.86 111.12 59.83 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 119.526 1.057 . . . . 1.0 111.243 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 38.8 Cg_exo -61.16 140.23 88.07 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.561 2.174 . . . . 1.0 111.03 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 10' ' ' THR . 5.7 tp -138.92 161.69 36.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 59.8 m -107.98 126.83 53.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.226 -1.028 . . . . 1.0 108.226 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.497 HD11 HG13 ' A' ' 107' ' ' VAL . 30.6 tp -127.29 138.0 52.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 27.7 t-20 -90.48 120.43 31.57 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.283 -0.261 . . . . 1.0 111.447 -174.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.08 119.6 25.65 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.774 HD21 ' HA2' ' A' ' 22' ' ' GLY . 36.3 tp -146.67 151.9 37.99 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -114.23 139.51 49.33 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 176.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.41 50.1 0.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.037 0.446 . . . . 1.0 110.769 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.435 HG22 ' HD3' ' A' ' 111' ' ' PRO . 39.7 t -65.92 -46.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.546 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.21 -94.55 0.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.299 -0.953 . . . . 1.0 112.705 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.1 -28.23 73.9 Favored 'Trans proline' 0 N--CA 1.484 0.964 0 C-N-CA 123.251 2.634 . . . . 1.0 112.47 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.41 32.21 5.66 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 110.879 -0.888 . . . . 1.0 110.879 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -74.14 29.03 0.08 Allowed 'General case' 0 C--O 1.246 0.921 0 C-N-CA 123.446 0.698 . . . . 1.0 112.545 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.774 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -176.99 -40.13 0.06 OUTLIER Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 120.572 -0.823 . . . . 1.0 112.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.37 4.3 46.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.6 -73.85 0.12 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 113.73 1.011 . . . . 1.0 113.73 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -129.91 -61.8 0.98 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.443 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.49 62.92 5.71 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.7 t -95.24 126.02 47.9 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 115.58 -0.31 . . . . 1.0 110.334 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -73.74 90.86 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.216 1.944 . . . . 1.0 110.291 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 47' ' ' GLN . 12.7 t -93.91 154.73 3.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -108.7 152.13 25.23 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 32' ' ' LEU . 7.2 p -159.18 177.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.944 -172.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.507 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 31.4 mt -108.62 158.16 17.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.623 0.725 . . . . 1.0 110.999 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 -32.75 73.86 Favored 'General case' 0 C--O 1.282 2.805 0 C-N-CA 124.9 1.28 . . . . 1.0 111.422 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.9 t -98.78 13.18 33.25 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.006 -0.997 . . . . 1.0 111.715 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.507 ' OD2' ' HB2' ' A' ' 32' ' ' LEU . 1.7 m-20 -73.24 133.82 44.1 Favored 'General case' 0 CA--C 1.47 -2.097 0 C-N-CA 119.655 -0.818 . . . . 1.0 109.21 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 39' ' ' GLN . 70.8 p -81.28 171.14 15.2 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 107.554 -1.276 . . . . 1.0 107.554 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 78' ' ' SER . 36.7 mm -60.2 -43.47 93.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 118.134 0.424 . . . . 1.0 110.197 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -67.36 -40.22 85.77 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-O 121.774 0.797 . . . . 1.0 110.707 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 14.7 tt0 -66.9 -32.52 73.84 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.485 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.279 -0.418 . . . . 1.0 111.045 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.5 mmmp? -56.52 -33.95 66.55 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.225 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 17.9 pt-20 -54.43 -50.44 67.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 124.288 0.992 . . . . 1.0 110.273 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.5 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 30.6 mmmt -77.27 -36.59 54.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -47.83 84.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.186 0.517 . . . . 1.0 110.462 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 41' ' ' LYS 0.266 0.8 OUTLIER -78.75 -23.37 45.4 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 112.419 0.526 . . . . 1.0 112.419 176.602 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.63 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.5 t70 -50.65 -29.69 11.68 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 125.025 1.33 . . . . 1.0 112.684 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.434 ' HG3' HG22 ' A' ' 29' ' ' VAL . 12.1 mm-40 -75.31 -17.97 60.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.359 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.994 0.902 . . . . 1.0 109.853 179.178 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.6 pp . . . . . 0 N--CA 1.418 -2.043 0 N-CA-C 106.569 -1.641 . . . . 1.0 106.569 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HB3' HG23 ' A' ' 76' ' ' ILE . 4.6 m-20 -103.83 156.96 17.41 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 120.406 -0.518 . . . . 1.0 110.145 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.76 117.92 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.54 0.686 . . . . 1.0 109.557 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -92.7 118.03 30.62 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-O 121.459 0.647 . . . . 1.0 109.937 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 16.9 t90 -82.7 119.65 24.58 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.603 -1.18 . . . . 1.0 108.491 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.01 89.22 3.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 120.952 0.406 . . . . 1.0 109.911 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.4 p -91.43 -23.1 20.13 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.893 0.854 . . . . 1.0 109.029 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.67 -52.27 4.43 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.009 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.02 -38.12 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.045 0.45 . . . . 1.0 111.492 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.79 -3.09 36.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.726 0.774 . . . . 1.0 109.589 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.39 -144.11 17.03 Favored Glycine 0 N--CA 1.416 -2.683 0 CA-C-N 114.883 -1.053 . . . . 1.0 110.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.622 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.4 p80 -133.48 115.27 14.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.028 0.531 . . . . 1.0 109.705 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.42 144.47 49.48 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.676 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 64' ' ' ASP . 29.4 mm -83.46 117.69 29.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.79 146.44 28.98 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.3 -0.864 . . . . 1.0 109.817 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.403 ' HA ' HG21 ' A' ' 37' ' ' ILE . 26.7 t -161.88 166.15 26.68 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.257 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.65 -27.41 65.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 178.104 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 106.887 -1.523 . . . . 1.0 106.887 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 36' ' ' THR . 65.8 m-80 -87.27 137.77 32.05 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.786 -0.765 . . . . 1.0 111.994 -173.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p -105.42 168.98 8.73 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 124.054 0.941 . . . . 1.0 109.312 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.01 -33.18 71.69 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.351 -0.94 . . . . 1.0 108.81 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.57 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 pt20 -65.65 -26.09 67.65 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.576 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -65.57 -35.62 81.36 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.992 0.425 . . . . 1.0 110.422 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.94 -8.09 21.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.199 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 52.47 68.45 0.82 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.454 1.101 . . . . 1.0 112.312 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.471 HG12 ' CE2' ' A' ' 67' ' ' TRP . 2.7 m -78.33 136.7 60.46 Favored Pre-proline 0 N--CA 1.433 -1.285 0 C-N-CA 119.941 -0.704 . . . . 1.0 109.124 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.3 160.54 48.56 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.256 1.97 . . . . 1.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -64.68 124.38 21.76 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.58 25.49 38.79 Favored Glycine 0 C--N 1.303 -1.281 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.798 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.23 36.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.818 0.342 . . . . 1.0 111.039 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 51.1 m -107.97 123.89 49.32 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.055 0.455 . . . . 1.0 110.962 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.497 HG13 HD11 ' A' ' 11' ' ' LEU . 33.4 m -121.15 138.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.446 -0.946 . . . . 1.0 108.446 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -125.72 138.45 53.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.999 0.428 . . . . 1.0 112.019 -176.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.59 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.2 mp -96.39 126.88 41.9 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 30.1 m -116.21 140.13 26.05 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 116.761 -0.199 . . . . 1.0 110.692 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 17' ' ' VAL . 60.0 Cg_endo -72.81 85.06 1.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.633 2.222 . . . . 1.0 112.027 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.216 -0.678 0 C-N-CA 125.874 1.67 . . . . 1.0 113.141 177.115 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.506 ' HB2' HD13 ' A' ' 32' ' ' LEU . 21.9 m-85 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 103.655 -2.72 . . . . 1.0 103.655 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -100.38 109.56 57.32 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 118.729 -1.188 . . . . 1.0 111.578 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 33.7 Cg_exo -62.53 139.17 74.65 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 122.357 2.038 . . . . 1.0 110.607 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 96' ' ' LEU . 6.1 tp -135.12 158.81 43.41 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 116.278 -0.419 . . . . 1.0 109.916 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -100.24 128.5 46.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.517 HD11 HG13 ' A' ' 107' ' ' VAL . 22.2 tp -127.82 138.74 52.82 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 25.9 t-20 -91.51 116.89 29.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 122.165 -0.334 . . . . 1.0 110.573 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.84 118.59 21.76 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.606 0.566 . . . . 1.0 109.564 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.633 HD21 ' HA2' ' A' ' 22' ' ' GLY . 33.8 tp -151.41 158.22 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.7 144.34 48.83 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.9 38.79 3.22 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.654 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 ' HD3' ' A' ' 111' ' ' PRO . 54.4 t -66.22 -44.39 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 115.707 -0.679 . . . . 1.0 111.671 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.33 -78.56 0.2 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.902 -1.142 . . . . 1.0 112.611 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.5 -25.94 76.03 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.236 2.624 . . . . 1.0 111.95 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -133.49 41.67 1.45 Allowed Glycine 0 N--CA 1.416 -2.665 0 N-CA-C 110.068 -1.213 . . . . 1.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -71.75 24.22 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.115 0.783 . . . . 1.0 113.115 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.633 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 169.83 -38.54 0.2 Allowed Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.808 -177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.02 21.68 2.25 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.179 0.514 . . . . 1.0 111.769 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.99 -78.25 0.35 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.74 0.644 . . . . 1.0 112.74 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -125.32 -64.67 1.06 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.863 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.08 63.38 4.79 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 t -93.64 126.08 51.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.94 100.33 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.552 1.501 . . . . 1.0 109.738 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 47' ' ' GLN . 11.3 t -108.32 156.85 8.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -119.3 152.77 36.16 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 40' ' ' ALA . 9.5 p -158.26 169.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 6' ' ' TYR . 15.1 mt -89.95 157.72 17.72 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.35 -32.44 71.27 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-N 114.624 -1.171 . . . . 1.0 110.056 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 23.2 t -101.7 12.54 36.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.775 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 N--CA 1.409 -2.506 0 C-N-CA 118.601 -1.239 . . . . 1.0 108.032 171.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.2 p -80.51 174.33 11.71 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.15 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.3 -42.25 86.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 p -63.79 -45.38 89.96 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 121.986 0.898 . . . . 1.0 111.047 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.47 -16.06 58.96 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.253 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.436 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -85.43 -31.49 22.83 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.042 168.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.629 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.9 mmmp? -56.41 -39.86 73.73 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 3.1 pt-20 -58.41 -44.92 89.21 Favored 'General case' 0 N--CA 1.416 -2.159 0 O-C-N 124.333 1.021 . . . . 1.0 111.966 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 28.3 mmmt -72.86 -39.57 66.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.868 1.062 . . . . 1.0 113.868 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.5 mmt -61.27 -46.92 88.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.322 0.582 . . . . 1.0 110.639 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.4 pp -77.45 -24.07 50.35 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.128 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.6 t70 -50.65 -35.57 31.32 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.132 1.373 . . . . 1.0 112.334 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 29' ' ' VAL . 10.5 mm-40 -71.73 -32.93 68.26 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.194 0.521 . . . . 1.0 111.62 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.309 -1.178 0 CA-C-O 122.01 0.909 . . . . 1.0 109.674 -176.549 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.614 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.3 pp . . . . . 0 N--CA 1.412 -2.343 0 N-CA-C 104.599 -2.371 . . . . 1.0 104.599 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 76' ' ' ILE . 18.6 m-20 -122.85 152.82 40.36 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.541 -0.864 . . . . 1.0 109.332 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 p -119.27 120.94 65.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.728 -0.789 . . . . 1.0 109.522 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.13 116.3 28.7 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.556 0.693 . . . . 1.0 109.667 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.667 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 15.8 t90 -82.29 119.27 23.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.668 -1.151 . . . . 1.0 108.042 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.412 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 85.0 mtm180 -123.11 89.06 3.04 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.5 p -88.77 -20.13 25.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.033 0.92 . . . . 1.0 108.932 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.87 -54.5 4.05 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 114.629 -1.168 . . . . 1.0 111.85 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 m -64.49 -42.11 94.28 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 111.587 0.217 . . . . 1.0 111.587 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.5 -9.41 47.43 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.722 0.773 . . . . 1.0 109.028 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.11 13.75 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 114.507 -1.224 . . . . 1.0 111.321 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.667 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.0 p80 -138.4 118.29 13.29 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 123.722 0.809 . . . . 1.0 110.06 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.25 145.17 48.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.405 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' A' ' 64' ' ' ASP . 28.6 mm -88.46 111.49 22.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.098 0.475 . . . . 1.0 109.789 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.6 151.69 20.89 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.289 -0.869 . . . . 1.0 110.347 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.1 t -162.68 165.46 25.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 6.4 p-10 -71.67 -31.0 66.32 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 N--CA 1.422 -1.828 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 177.27 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 98.2 mt . . . . . 0 C--O 1.245 0.834 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -89.93 139.09 30.94 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 119.894 -0.722 . . . . 1.0 111.013 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.5 p -111.39 171.13 7.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 124.007 0.923 . . . . 1.0 108.599 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.533 HD13 HD22 ' A' ' 9' ' ' LEU . 3.1 pp -68.52 -30.59 69.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.557 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.1 pt20 -64.35 -26.32 68.42 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.987 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -65.76 -39.96 91.56 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 120.981 0.42 . . . . 1.0 110.376 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.38 -7.21 24.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.521 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 51.75 61.55 3.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.923 1.289 . . . . 1.0 113.143 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 67' ' ' TRP . 3.0 m -70.98 136.87 84.91 Favored Pre-proline 0 N--CA 1.438 -1.032 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.13 160.21 50.8 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.545 2.163 . . . . 1.0 111.326 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -66.45 117.96 9.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.712 0.768 . . . . 1.0 109.891 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.41 22.94 20.59 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.712 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.31 152.47 45.39 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 27.7 m -108.56 123.46 48.95 Favored 'General case' 0 C--N 1.279 -2.47 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.253 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.517 HG13 HD11 ' A' ' 11' ' ' LEU . 33.9 m -121.66 155.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -138.45 137.02 36.8 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.307 -0.557 . . . . 1.0 112.003 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.6 mp -94.97 132.67 39.57 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.224 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 16' ' ' ALA . 31.9 m -129.26 137.64 31.41 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.056 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HD3' HG22 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -70.23 86.3 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.227 1.951 . . . . 1.0 111.065 177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.614 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 21.0 p . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 1.0 112.467 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.4 m-85 . . . . . 0 N--CA 1.393 -3.283 0 N-CA-C 102.928 -2.99 . . . . 1.0 102.928 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 23.2 mmt180 -104.66 111.05 65.17 Favored Pre-proline 0 C--N 1.273 -2.757 0 C-N-CA 117.233 -1.787 . . . . 1.0 114.673 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 19.6 Cg_exo -65.69 121.78 9.25 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.383 2.056 . . . . 1.0 109.173 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 9.5 tp -114.9 159.79 20.28 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.374 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m -99.36 124.26 44.33 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 31' ' ' VAL . 2.8 mm? -125.69 144.08 50.76 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.24 0.616 . . . . 1.0 110.179 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -92.67 113.8 26.18 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.441 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -74.25 107.94 6.73 Favored 'General case' 0 C--O 1.253 1.273 0 C-N-CA 123.313 0.645 . . . . 1.0 110.166 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 ' HA2' ' A' ' 22' ' ' GLY . 25.7 tp -142.11 158.95 43.16 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -128.5 143.63 51.01 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 110' ' ' VAL . . . -109.71 36.33 3.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.902 0.382 . . . . 1.0 111.184 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.59 -45.15 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 112.556 0.576 . . . . 1.0 112.556 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.42 -81.97 0.14 Allowed Glycine 0 C--N 1.31 -0.885 0 C-N-CA 119.656 -1.259 . . . . 1.0 112.469 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.59 -24.39 77.88 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.995 2.464 . . . . 1.0 112.584 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.57 27.16 5.81 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.4 68.0 2.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.767 0.794 . . . . 1.0 112.445 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.629 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 127.05 -15.68 6.48 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.27 27.65 6.19 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.98 -0.61 . . . . 1.0 112.273 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.82 -93.21 0.07 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.154 0.502 . . . . 1.0 110.583 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 5.8 pt20 -114.56 -62.7 1.56 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.791 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.408 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 71.13 75.0 0.66 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.215 -1.154 . . . . 1.0 110.215 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.1 127.79 26.46 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 110.244 -0.28 . . . . 1.0 110.244 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.02 108.07 2.51 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.708 1.605 . . . . 1.0 110.675 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 ' HA ' ' A' ' 44' ' ' MET . 60.6 t -114.98 139.16 42.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 96.6 mttt -100.54 139.0 36.84 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.856 -0.738 . . . . 1.0 110.339 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG12 HD23 ' A' ' 11' ' ' LEU . 11.2 p -144.16 159.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.87 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.4 156.16 24.31 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.855 0.836 . . . . 1.0 112.697 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.7 -31.65 72.6 Favored 'General case' 0 C--O 1.27 2.16 0 CA-C-N 113.674 -1.603 . . . . 1.0 108.81 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 18.5 t -85.18 -8.64 58.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 113.533 -1.667 . . . . 1.0 111.947 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.88 133.29 45.34 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.72 0.771 . . . . 1.0 109.714 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.0 p -81.93 177.62 8.75 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.446 -1.252 . . . . 1.0 109.875 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.632 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 37.8 mm -60.82 -46.64 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 119.259 -0.401 . . . . 1.0 110.298 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 40.1 m -60.98 -47.72 85.13 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.833 0.708 . . . . 1.0 111.341 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -64.87 -42.84 94.51 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.204 0.526 . . . . 1.0 110.608 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.41 -35.64 81.08 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.414 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -60.95 -40.06 91.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 38' ' ' SER . 40.6 mt-10 -65.3 -49.54 69.12 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.054 -0.976 . . . . 1.0 110.605 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.99 -40.92 95.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.465 0.542 . . . . 1.0 112.465 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.6 mmm -65.3 -43.53 90.8 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.71 -27.08 58.08 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -55.6 -28.16 53.52 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.801 1.24 . . . . 1.0 113.072 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.645 ' HG3' HG22 ' A' ' 29' ' ' VAL . 6.8 mm100 -69.11 -31.32 69.94 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.282 0.563 . . . . 1.0 110.489 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.432 -1.339 0 CA-C-N 115.914 -0.585 . . . . 1.0 112.347 -174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 111' ' ' PRO 0.291 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 . . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -119.94 152.29 37.63 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.9 0.381 . . . . 1.0 111.204 -173.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -123.61 132.13 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.055 0 C-N-CA 120.026 -0.67 . . . . 1.0 109.365 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 40.9 mt-10 -89.6 112.49 23.72 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.534 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.2 t-105 -91.45 118.27 30.41 Favored 'General case' 1 N--CA 1.374 -4.273 0 C-N-CA 119.299 -0.96 . . . . 1.0 108.525 178.21 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -104.46 88.72 3.02 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 106.241 -1.763 . . . . 1.0 106.241 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -90.12 -16.38 29.71 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.561 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.05 -51.16 3.48 Favored Glycine 0 C--N 1.291 -1.962 0 CA-C-N 114.764 -1.107 . . . . 1.0 111.836 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.29 -38.88 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.023 0.529 . . . . 1.0 110.976 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.78 7.24 30.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.932 0.872 . . . . 1.0 108.82 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.33 -132.43 12.66 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 114.168 -1.378 . . . . 1.0 110.925 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 4.5 p80 -117.06 101.3 8.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.81 0.814 . . . . 1.0 109.296 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.68 143.9 34.12 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.049 -174.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.428 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 20.0 mm -88.43 109.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 75' ' ' LEU . 9.0 mp -99.9 144.22 29.21 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.47 -0.786 . . . . 1.0 112.62 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 37' ' ' ILE . 53.3 m -153.99 146.55 24.11 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.293 -2.114 . . . . 1.0 105.293 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.53 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 0.5 OUTLIER -74.45 -40.67 61.78 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.557 -0.857 . . . . 1.0 110.702 175.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 112.259 0.466 . . . . 1.0 112.259 179.426 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 79' ' ' ASP . 67.2 mt . . . . . 0 N--CA 1.433 -1.313 0 N-CA-C 106.948 -1.501 . . . . 1.0 106.948 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.53 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 38.5 m-80 -89.66 139.8 30.2 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.332 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.73 171.3 8.3 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 124.043 0.937 . . . . 1.0 109.406 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 101' ' ' VAL . 2.1 pp -71.96 -27.43 62.78 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 6.1 pt20 -63.74 -25.76 68.34 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 115.789 -0.642 . . . . 1.0 112.584 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -64.19 -45.8 86.74 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -93.04 -3.76 53.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.37 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 13.5 mmtm 43.44 67.92 0.58 Allowed 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 124.96 1.304 . . . . 1.0 113.046 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.534 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.8 m -74.81 148.24 84.78 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 114.703 -1.135 . . . . 1.0 111.566 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.8 164.24 33.99 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.338 2.692 . . . . 1.0 112.924 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.09 116.4 6.45 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.74 24.94 12.37 Favored Glycine 0 C--N 1.303 -1.269 0 C-N-CA 119.283 -1.437 . . . . 1.0 112.11 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.15 164.2 26.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.9 m -113.26 130.67 56.18 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.663 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.46 135.37 50.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -130.82 130.57 43.82 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.542 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 3.9 pp -113.45 144.74 42.31 Favored 'General case' 0 C--N 1.262 -3.199 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.258 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 16' ' ' ALA . 13.7 m -133.64 130.73 20.94 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.156 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 49.7 Cg_endo -70.49 84.09 0.79 Allowed 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.555 2.17 . . . . 1.0 111.485 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.653 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 4.8 p . . . . . 0 CA--C 1.505 -0.764 0 C-N-CA 125.544 1.538 . . . . 1.0 112.374 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 50.3 m-85 . . . . . 0 N--CA 1.384 -3.769 0 N-CA-C 100.733 -3.803 . . . . 1.0 100.733 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 27.3 mmt180 -107.43 111.24 63.1 Favored Pre-proline 0 C--N 1.268 -2.948 0 C-N-CA 116.902 -1.919 . . . . 1.0 112.53 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 16.1 Cg_exo -68.45 111.09 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.2 1.933 . . . . 1.0 107.742 173.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 10' ' ' THR . 3.7 tp -106.73 154.9 20.29 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.626 -0.716 . . . . 1.0 111.162 -172.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 17.9 m -88.09 119.14 28.18 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 106.679 -1.6 . . . . 1.0 106.679 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.58 HD11 HG13 ' A' ' 107' ' ' VAL . 1.0 OUTLIER -127.92 140.26 52.11 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.394 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -102.18 120.16 39.99 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.732 -0.605 . . . . 1.0 111.052 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.555 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.53 108.38 14.12 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.306 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.511 HD21 ' HA2' ' A' ' 22' ' ' GLY . 25.4 tp -141.67 159.83 41.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -130.02 143.79 50.98 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.693 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -109.69 39.85 2.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.839 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.43 HG22 ' HD3' ' A' ' 111' ' ' PRO . 46.6 t -65.26 -45.44 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.91 -79.46 0.19 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.823 -1.18 . . . . 1.0 112.142 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.31 -31.51 89.11 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.788 2.325 . . . . 1.0 112.378 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.98 27.95 7.55 Favored Glycine 0 N--CA 1.432 -1.598 0 C-N-CA 121.0 -0.619 . . . . 1.0 111.67 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.49 76.03 5.0 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.47 0.652 . . . . 1.0 111.665 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.511 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 124.57 -15.16 7.61 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 110.446 -1.061 . . . . 1.0 110.446 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.65 29.93 6.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.722 -0.739 . . . . 1.0 111.606 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.2 -90.39 0.19 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.301 -0.56 . . . . 1.0 110.95 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HB2' HG23 ' A' ' 27' ' ' VAL . 11.2 pt20 -111.76 -56.07 2.43 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.654 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.01 65.74 3.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.395 -0.682 . . . . 1.0 111.395 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 25' ' ' GLN . 34.8 t -110.41 124.23 33.78 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.44 -174.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.26 104.3 1.88 Allowed 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.245 1.963 . . . . 1.0 110.822 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 42.9 t -109.29 155.63 10.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.19 137.4 40.51 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.881 0.848 . . . . 1.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.76 157.81 23.63 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 114.299 -1.319 . . . . 1.0 108.082 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.74 155.86 18.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.402 0.62 . . . . 1.0 112.245 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 31.9 t70 -64.6 -30.79 71.82 Favored 'General case' 0 C--O 1.267 1.991 0 CA-C-N 114.559 -1.2 . . . . 1.0 109.189 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 5.8 t -88.82 -0.16 57.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.877 -1.511 . . . . 1.0 111.565 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.33 135.41 40.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.694 . . . . 1.0 109.402 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.44 HG21 HD12 ' A' ' 93' ' ' LEU . 81.0 p -81.78 174.67 11.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.569 -1.196 . . . . 1.0 109.579 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 36.5 mm -60.54 -44.39 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.329 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -62.21 -47.29 85.12 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.135 0.897 . . . . 1.0 110.045 178.005 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -65.47 -41.28 93.53 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.785 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.329 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.22 -38.01 89.51 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 177.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' SER . 37.3 mt-10 -65.83 -45.22 83.09 Favored 'General case' 0 C--O 1.205 -1.245 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.83 -176.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.01 -41.71 98.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.698 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 72.4 mmm -65.63 -42.5 91.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.035 0.445 . . . . 1.0 110.625 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.27 -29.9 57.62 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.848 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.2 -28.61 58.9 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.924 1.69 . . . . 1.0 113.031 -172.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 29' ' ' VAL . 16.9 mm100 -66.39 -34.72 78.59 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.099 0.476 . . . . 1.0 110.877 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.6 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.778 -173.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.451 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.32 151.71 29.39 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 120.652 0.263 . . . . 1.0 110.8 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 77' ' ' LEU . 12.5 p -121.28 130.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 C-N-CA 119.581 -0.847 . . . . 1.0 111.219 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 35.9 mt-10 -90.41 113.12 24.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.564 -2.013 . . . . 1.0 105.564 172.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.58 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -89.61 120.69 31.12 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -113.45 89.1 3.0 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.578 -1.268 . . . . 1.0 107.578 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.4 p -81.86 -19.76 40.33 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.863 -1.062 . . . . 1.0 109.676 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.46 -50.26 4.31 Favored Glycine 0 C--N 1.308 -1.023 0 CA-C-N 114.572 -1.195 . . . . 1.0 112.002 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.45 -37.84 81.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 1.0 111.432 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.59 -7.2 22.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.759 0.79 . . . . 1.0 109.395 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 -121.5 6.82 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.99 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.3 p80 -135.24 120.35 18.8 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.264 0.554 . . . . 1.0 111.055 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.12 149.41 44.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 21.7 mm -88.81 114.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.6 mp -110.37 143.5 40.53 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.293 0.568 . . . . 1.0 111.63 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' HG21 ' A' ' 37' ' ' ILE . 27.4 m -161.09 155.84 23.64 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.639 ' HB2' HD22 ' A' ' 93' ' ' LEU . 2.7 p-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.988 -0.685 . . . . 1.0 111.418 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 N--CA 1.439 -1.015 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -176.06 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.639 HD22 ' HB2' ' A' ' 79' ' ' ASP . 79.9 mt . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -99.16 140.94 32.58 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.563 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 2.0 p -112.35 173.88 6.15 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.328 0.651 . . . . 1.0 109.736 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 101' ' ' VAL . 3.3 pp -75.67 -26.0 57.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.105 -1.038 . . . . 1.0 109.175 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.579 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.5 pt20 -66.2 -25.63 67.02 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -61.34 -41.57 97.26 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -97.18 -8.41 30.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.935 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 100' ' ' LYS 0.275 8.6 mmtm 46.15 75.92 0.11 Allowed 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 125.278 1.431 . . . . 1.0 113.773 -176.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.1 m -84.7 150.19 55.76 Favored Pre-proline 0 C--N 1.285 -2.23 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.206 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.09 165.1 19.5 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 123.515 2.81 . . . . 1.0 112.567 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 119.66 11.01 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.399 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.72 19.01 12.63 Favored Glycine 0 C--N 1.29 -2.008 0 C-N-CA 120.7 -0.762 . . . . 1.0 111.405 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.98 155.67 37.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.198 0.523 . . . . 1.0 110.207 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.8 m -118.49 131.36 56.25 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.045 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 11' ' ' LEU . 33.7 m -112.98 139.29 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.48 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -125.19 120.89 32.59 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.575 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.3 pp -106.35 141.97 36.8 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.771 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 16' ' ' ALA . 18.4 m -133.29 137.09 28.44 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.547 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.2 Cg_endo -73.89 84.09 1.51 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.166 1.911 . . . . 1.0 111.614 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.451 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.4 p . . . . . 0 CA--C 1.506 -0.725 0 C-N-CA 125.066 1.346 . . . . 1.0 110.338 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CG ' ' HB2' ' A' ' 34' ' ' CYS . 65.8 m-85 . . . . . 0 N--CA 1.395 -3.219 0 N-CA-C 104.921 -2.252 . . . . 1.0 104.921 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.514 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 17.7 mmt180 -116.06 111.3 42.88 Favored Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 117.492 -1.683 . . . . 1.0 113.778 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 23.2 Cg_exo -64.47 104.65 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.967 1.778 . . . . 1.0 108.866 171.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -107.59 161.41 14.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.983 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -105.4 130.24 53.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 31' ' ' VAL . 1.9 mm? -124.37 148.12 47.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 123.514 0.726 . . . . 1.0 110.704 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -93.06 111.21 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.364 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.16 115.13 15.58 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.68 0.613 . . . . 1.0 109.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 32.2 tp -147.73 155.43 41.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.512 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.64 144.44 48.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.73 30.29 7.45 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.625 0.726 . . . . 1.0 109.469 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.69 -47.1 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 115.023 -0.989 . . . . 1.0 112.691 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.93 -86.36 0.07 OUTLIER Glycine 0 C--O 1.22 -0.768 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.906 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.7 -30.53 85.33 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.151 2.567 . . . . 1.0 113.019 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.06 29.92 6.3 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.445 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.35 83.24 1.42 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.581 0.705 . . . . 1.0 112.063 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.579 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 99.53 3.99 56.16 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -135.73 26.45 3.36 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.382 -0.909 . . . . 1.0 110.605 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.03 -95.44 0.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.72 -60.26 1.47 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 112.753 0.649 . . . . 1.0 112.753 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.26 0.6 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.525 -1.321 . . . . 1.0 109.969 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.0 130.13 23.49 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 122.821 -0.223 . . . . 1.0 110.711 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.25 109.39 1.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.132 1.888 . . . . 1.0 111.28 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 44' ' ' MET . 58.1 t -120.08 138.58 50.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 123.538 0.735 . . . . 1.0 109.144 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -102.95 155.89 18.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.129 0.49 . . . . 1.0 112.195 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 32' ' ' LEU . 5.2 p -158.06 -175.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.542 ' H ' HG22 ' A' ' 31' ' ' VAL . 13.2 tp -109.19 158.52 17.73 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 119.267 0.94 . . . . 1.0 108.632 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 27.1 t70 -62.26 -29.99 70.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 123.429 0.692 . . . . 1.0 109.495 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB2' ' CG ' ' A' ' 6' ' ' TYR . 12.2 t -99.25 31.02 3.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.903 -1.499 . . . . 1.0 110.392 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.657 ' O ' HG22 ' A' ' 95' ' ' THR . 11.7 p-10 -68.49 -165.56 0.06 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.549 0.69 . . . . 1.0 109.149 171.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 p -141.6 161.59 37.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.857 -2.645 . . . . 1.0 103.857 167.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.684 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 44.5 mm -58.57 -46.09 90.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.741 -0.783 . . . . 1.0 110.557 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 36.7 t -63.52 -46.74 84.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 124.016 0.822 . . . . 1.0 110.37 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -64.82 -41.46 95.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.041 0.448 . . . . 1.0 111.426 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -64.32 -39.59 94.22 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.57 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.3 -35.33 79.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.625 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.0 mt-10 -64.44 -45.96 85.21 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.771 0.669 . . . . 1.0 110.062 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.808 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.813 ' HA ' HG11 ' A' ' 29' ' ' VAL . 13.3 mtp -63.59 -42.42 98.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.6 pp -74.72 -26.88 60.11 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.243 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.45 -32.91 73.85 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.414 0.626 . . . . 1.0 111.596 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HG3' HG22 ' A' ' 29' ' ' VAL . 14.5 mm-40 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.676 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 CA--C 1.503 -0.846 0 CA-C-O 121.833 0.825 . . . . 1.0 112.256 -169.056 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 112.167 0.432 . . . . 1.0 112.167 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 7.6 p-10 -117.18 157.38 26.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.28 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 3.6 p -122.61 127.17 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.254 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -91.91 112.93 25.06 Favored 'General case' 0 N--CA 1.399 -2.997 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.467 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -93.18 122.18 35.3 Favored 'General case' 1 N--CA 1.377 -4.089 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.991 -177.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.483 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 88.0 mtm180 -112.56 89.81 3.17 Favored 'General case' 0 N--CA 1.389 -3.508 0 CA-C-O 122.601 1.191 . . . . 1.0 108.243 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 19.0 p -84.66 -16.89 40.31 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.64 -1.618 . . . . 1.0 109.232 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.29 -54.66 4.31 Favored Glycine 0 C--N 1.293 -1.846 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.239 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.4 HG22 ' HD3' ' A' ' 102' ' ' PRO . 33.9 m -62.3 -42.25 94.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.039 0.447 . . . . 1.0 111.126 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.04 -10.21 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.468 0.652 . . . . 1.0 109.318 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.77 -143.01 16.23 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.83 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 3.5 p80 -116.55 112.21 21.01 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.574 0.702 . . . . 1.0 109.623 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.05 144.96 48.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.825 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -85.2 115.65 27.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.721 -1.215 . . . . 1.0 107.721 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.8 mp -103.66 140.56 37.41 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.886 0.851 . . . . 1.0 111.338 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 m -152.39 148.15 27.13 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' HD22 ' A' ' 93' ' ' LEU . 7.4 p-10 -70.96 -41.19 71.39 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.899 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--N 1.311 -1.085 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 176.078 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 79' ' ' ASP . 75.8 mt . . . . . 0 C--O 1.239 0.503 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -81.34 136.57 35.75 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.51 -0.876 . . . . 1.0 110.765 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.2 p -106.75 171.71 7.22 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 124.791 1.236 . . . . 1.0 109.334 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 101' ' ' VAL . 2.7 pp -71.57 -28.53 63.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.588 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.0 pt20 -64.93 -25.64 67.97 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.921 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -61.62 -41.72 97.87 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.03 -4.36 30.11 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.518 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 65.2 mmtt 43.49 68.16 0.55 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.738 1.215 . . . . 1.0 112.227 -177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.467 HG11 ' NE1' ' A' ' 67' ' ' TRP . 2.9 m -75.57 149.01 83.44 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 114.915 -1.038 . . . . 1.0 111.636 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD3' HG22 ' A' ' 71' ' ' VAL . 91.8 Cg_endo -73.74 162.98 38.36 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 122.828 2.352 . . . . 1.0 112.697 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.76 116.86 6.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.502 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.83 35.09 8.53 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 119.981 -1.105 . . . . 1.0 111.509 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 69' ' ' SER . . . -74.03 162.89 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -108.9 123.83 49.69 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.524 -0.47 . . . . 1.0 111.156 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.503 HG21 ' SD ' ' A' ' 44' ' ' MET . 5.9 m -104.79 144.83 14.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -139.85 132.86 29.47 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.512 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 1.6 pt? -118.13 143.49 46.44 Favored 'General case' 0 C--N 1.269 -2.934 0 C-N-CA 120.326 -0.55 . . . . 1.0 110.379 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 14.6 m -124.26 164.87 27.36 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.81 56.32 4.61 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.497 2.132 . . . . 1.0 111.472 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.523 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 5.2 t . . . . . 0 CA--C 1.516 -0.34 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.488 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.534 ' HB2' HD22 ' A' ' 32' ' ' LEU . 11.7 m-85 . . . . . 0 N--CA 1.415 -2.189 0 N-CA-C 105.149 -2.167 . . . . 1.0 105.149 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 33.9 mmt180 -109.6 110.96 59.54 Favored Pre-proline 0 C--N 1.278 -2.542 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.765 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.16 100.1 0.21 Allowed 'Trans proline' 0 C--O 1.245 0.843 0 N-CA-C 107.859 -1.631 . . . . 1.0 107.859 167.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.45 130.2 55.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 -171.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 m -89.36 129.45 35.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 31' ' ' VAL . 1.7 mm? -120.95 147.51 45.36 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 123.343 0.657 . . . . 1.0 110.366 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -90.92 108.5 19.89 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.38 109.19 7.67 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.026 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.702 HD21 ' HA2' ' A' ' 22' ' ' GLY . 30.8 tp -137.52 166.59 23.53 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -131.38 143.93 50.84 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . . . -114.96 38.75 3.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.517 HG22 ' HD3' ' A' ' 111' ' ' PRO . 47.8 t -66.63 -44.48 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.52 -88.2 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 119.123 -1.513 . . . . 1.0 113.713 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.88 -29.35 82.37 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 123.253 2.635 . . . . 1.0 113.546 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.45 24.99 10.05 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 84.6 0.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.354 0.597 . . . . 1.0 111.826 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.702 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 115.33 -5.72 21.41 Favored Glycine 0 CA--C 1.487 -1.687 0 CA-C-N 115.163 -0.926 . . . . 1.0 111.271 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.63 19.13 3.9 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.264 -0.468 . . . . 1.0 112.082 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.99 -92.37 0.09 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 10.7 pt20 -110.04 -59.18 1.96 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.461 0.541 . . . . 1.0 112.461 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.7 69.7 1.25 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.89 127.01 30.25 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.99 -0.105 . . . . 1.0 110.743 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.48 107.43 2.29 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 121.862 1.708 . . . . 1.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 44' ' ' MET . 83.7 t -119.95 140.09 45.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.17 -0.923 . . . . 1.0 109.586 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -104.73 146.31 29.13 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.081 -0.648 . . . . 1.0 111.808 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 HD23 ' A' ' 11' ' ' LEU . 15.3 m -141.94 171.21 11.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 124.241 1.017 . . . . 1.0 109.08 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 6' ' ' TYR . 11.5 mt -88.37 159.15 18.17 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.118 0.485 . . . . 1.0 111.267 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.472 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 37.5 t70 -61.93 -30.75 71.11 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 115.049 -0.978 . . . . 1.0 108.505 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.5 t -96.12 6.08 49.63 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 114.25 -1.341 . . . . 1.0 113.365 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.4 m-20 -70.19 134.91 48.56 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.531 HG22 HD11 ' A' ' 93' ' ' LEU . 49.3 p -79.75 166.88 21.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.12 -44.59 91.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.89 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.6 p -61.84 -47.32 85.57 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 48.9 mt-30 -72.01 -38.23 69.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.975 0.732 . . . . 1.0 112.975 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.4 -39.96 85.59 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -62.51 -33.66 75.33 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.2 mt-10 -65.36 -48.64 72.25 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.086 0.866 . . . . 1.0 110.208 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 41.4 mmtm -60.83 -44.35 97.05 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.78 ' HA ' HG11 ' A' ' 29' ' ' VAL . 9.3 mtp -64.94 -41.97 95.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.751 -1.113 . . . . 1.0 112.288 -178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -76.02 -32.91 59.61 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.765 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.44 -29.78 70.16 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.508 0.723 . . . . 1.0 112.049 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.533 HE21 HG13 ' A' ' 29' ' ' VAL . 11.3 mm-40 -67.54 -39.18 85.02 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.607 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.441 -0.884 0 CA-C-N 115.639 -0.709 . . . . 1.0 112.468 -169.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 120.571 0.224 . . . . 1.0 110.682 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.472 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 9.7 m-20 -108.89 151.63 26.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.925 -1.139 . . . . 1.0 107.925 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.16 128.52 75.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 119.807 -0.757 . . . . 1.0 109.482 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 41.9 mt-10 -89.74 112.47 23.77 Favored 'General case' 0 CA--C 1.457 -2.615 0 N-CA-C 105.612 -1.995 . . . . 1.0 105.612 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.589 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -91.25 117.27 29.5 Favored 'General case' 1 N--CA 1.367 -4.625 0 C-N-CA 119.273 -0.971 . . . . 1.0 108.501 177.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -102.8 88.25 3.15 Favored 'General case' 0 N--CA 1.394 -3.245 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.1 p -83.65 -14.4 51.96 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.824 -1.535 . . . . 1.0 110.34 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.53 -57.73 3.77 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.765 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.2 -43.73 98.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.28 0.632 . . . . 1.0 111.766 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.37 -8.54 21.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.299 0.571 . . . . 1.0 110.347 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.41 -149.38 19.43 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.9 p80 -105.91 108.87 20.6 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.498 0.666 . . . . 1.0 111.299 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.03 146.42 36.74 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.368 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.406 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 25.4 mm -87.87 99.27 8.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -89.34 156.37 18.76 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.564 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.3 t -160.84 164.41 31.37 Favored 'General case' 0 CA--C 1.465 -2.303 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -63.58 -37.21 86.45 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.714 0.634 . . . . 1.0 110.079 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.445 -0.707 0 O-C-N 123.107 0.254 . . . . 1.0 110.846 -178.392 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.531 HD11 HG22 ' A' ' 36' ' ' THR . 3.0 tm? . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 106.449 -1.685 . . . . 1.0 106.449 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.6 m-80 -96.74 139.59 32.57 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.929 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -129.39 176.45 7.95 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 125.855 1.662 . . . . 1.0 106.821 175.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 101' ' ' VAL . 3.0 pp -73.32 -25.31 60.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.237 -1.385 . . . . 1.0 108.944 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.571 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 5.1 pt20 -66.36 -24.73 66.55 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.31 -40.71 91.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -103.45 2.58 33.93 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 30.9 mmmt 40.76 64.09 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.401 1.08 . . . . 1.0 112.097 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.589 HG11 ' CE2' ' A' ' 67' ' ' TRP . 2.1 m -68.74 150.95 97.49 Favored Pre-proline 0 C--N 1.294 -1.833 0 CA-C-N 115.539 -0.755 . . . . 1.0 111.786 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.12 155.83 37.92 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.154 1.903 . . . . 1.0 111.462 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.95 124.5 22.7 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.654 0.74 . . . . 1.0 110.208 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.99 22.23 23.58 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.092 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.408 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . . . -71.08 164.42 25.62 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.911 0.386 . . . . 1.0 109.993 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.3 m -111.56 130.55 55.7 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.282 -0.567 . . . . 1.0 110.767 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.63 HG21 ' SD ' ' A' ' 44' ' ' MET . 27.5 m -114.13 139.49 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.49 138.94 49.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.1 pp -108.89 139.55 43.57 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.548 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 36.0 m -130.42 130.92 23.08 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.569 -0.741 . . . . 1.0 109.511 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.517 ' HD3' HG22 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -68.67 78.72 0.68 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.791 2.327 . . . . 1.0 112.458 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.472 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 43.6 t . . . . . 0 C--O 1.246 0.887 0 C-N-CA 124.781 1.232 . . . . 1.0 111.132 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 89.3 m-85 . . . . . 0 N--CA 1.397 -3.108 0 N-CA-C 105.905 -1.887 . . . . 1.0 105.905 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.436 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 59.4 mmt-85 -104.31 114.57 64.12 Favored Pre-proline 0 C--N 1.271 -2.809 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.409 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.02 111.69 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.39 2.06 . . . . 1.0 108.938 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.36 127.97 54.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -171.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -88.49 122.31 31.83 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.462 HD11 HG13 ' A' ' 107' ' ' VAL . 16.5 tp -126.97 138.99 53.36 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -97.64 119.54 36.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.847 -0.533 . . . . 1.0 110.835 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.01 121.11 23.79 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.504 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -149.19 169.53 20.51 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.448 0.299 . . . . 1.0 110.437 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.811 HD22 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -127.26 144.58 51.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.419 0.288 . . . . 1.0 110.692 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -124.12 39.79 3.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.126 0.489 . . . . 1.0 110.555 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.439 HG22 ' HD3' ' A' ' 111' ' ' PRO . 78.1 t -61.47 -46.33 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 C-N-CA 123.302 0.641 . . . . 1.0 110.728 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.99 -94.39 0.12 Allowed Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.387 -0.911 . . . . 1.0 112.204 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.46 -32.85 88.91 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.42 2.746 . . . . 1.0 113.543 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.49 ' O ' HD21 ' A' ' 15' ' ' LEU . . . -110.45 25.58 15.12 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.887 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.88 79.8 0.12 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.387 0.613 . . . . 1.0 111.78 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -5.33 3.08 Favored Glycine 0 N--CA 1.423 -2.19 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.32 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.63 18.53 21.32 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.178 0.807 . . . . 1.0 113.178 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.811 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -79.58 -76.91 0.19 Allowed 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.897 -0.721 . . . . 1.0 112.141 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.527 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.0 pt20 -138.41 -53.1 0.61 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.261 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 59.94 8.55 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 25' ' ' GLN . 35.4 t -114.71 126.99 27.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.261 -0.469 . . . . 1.0 110.552 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.45 103.36 1.73 Allowed 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.97 1.78 . . . . 1.0 110.562 175.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.516 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 57.7 t -102.16 153.81 5.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -109.57 139.61 44.37 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.314 -0.955 . . . . 1.0 111.433 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.57 174.63 12.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.095 -1.411 . . . . 1.0 108.239 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 32' ' ' LEU . 12.1 mt -104.59 159.73 15.52 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.542 0.687 . . . . 1.0 110.637 175.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 38.5 t70 -59.67 -29.87 68.37 Favored 'General case' 0 C--O 1.272 2.249 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.952 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 45.8 t -82.6 -12.01 58.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.753 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.03 132.67 47.02 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.435 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 44.3 p -78.32 172.55 13.44 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 94' ' ' ASN . 43.7 mm -60.37 -45.61 96.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.926 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.3 t -66.39 -41.92 88.64 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 44.4 tt0 -66.31 -34.38 77.86 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.993 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -81.67 -38.48 25.83 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 122.307 -0.245 . . . . 1.0 111.518 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -60.51 -35.51 76.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.916 0.388 . . . . 1.0 110.34 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -66.48 -41.23 89.27 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.391 -0.822 . . . . 1.0 109.905 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 46.7 mmtm -63.6 -41.49 98.33 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.834 0.709 . . . . 1.0 111.861 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.589 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 86.1 mmm -60.96 -45.94 92.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.146 0.498 . . . . 1.0 110.627 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.5 -25.33 50.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.681 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 24.9 t70 -56.94 -28.83 62.56 Favored 'General case' 0 C--O 1.203 -1.371 0 C-N-CA 125.374 1.47 . . . . 1.0 112.145 -174.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.493 HE21 HG13 ' A' ' 29' ' ' VAL . 14.1 mm-40 -65.78 -33.92 76.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.067 0.46 . . . . 1.0 111.082 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.308 -1.219 0 CA-C-O 121.881 0.848 . . . . 1.0 109.127 -178.478 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.633 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.4 pp . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 7.7 m-20 -105.83 151.53 24.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.6 124.53 71.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.428 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.63 112.28 24.14 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.586 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -93.28 125.82 38.08 Favored 'General case' 1 N--CA 1.374 -4.225 0 CA-C-N 114.554 -1.203 . . . . 1.0 109.165 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.29 89.39 3.05 Favored 'General case' 0 N--CA 1.395 -3.203 0 N-CA-C 106.672 -1.603 . . . . 1.0 106.672 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.8 p -79.0 -22.56 45.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.339 -1.301 . . . . 1.0 109.393 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.16 -45.72 3.5 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.837 -1.074 . . . . 1.0 112.163 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.55 -39.45 85.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.023 0.439 . . . . 1.0 111.062 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.22 -9.41 16.89 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.447 0.641 . . . . 1.0 109.937 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.07 -126.17 8.82 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.212 -0.904 . . . . 1.0 111.51 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -120.28 118.32 30.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.238 0.542 . . . . 1.0 110.204 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.66 151.91 45.92 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 9.8 mm -98.34 120.3 47.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.469 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.432 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.7 mp -111.99 163.32 14.38 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.459 ' HA ' HG21 ' A' ' 37' ' ' ILE . 8.2 t -167.58 163.03 14.57 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.234 -2.506 . . . . 1.0 104.234 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 21.3 p-10 -93.68 -3.25 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 117.9 -1.52 . . . . 1.0 111.033 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 170.963 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 79.3 mt . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.468 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 93.8 m-20 -89.6 141.02 28.98 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -107.27 173.29 6.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 124.448 1.099 . . . . 1.0 109.704 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.461 HD13 HG22 ' A' ' 101' ' ' VAL . 3.9 pp -72.66 -25.41 61.26 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.303 -0.959 . . . . 1.0 108.783 173.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.0 pt20 -66.68 -25.34 66.51 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.22 0.533 . . . . 1.0 110.904 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -64.4 -37.73 88.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -104.55 -1.78 26.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.934 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 49.71 66.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.837 1.255 . . . . 1.0 112.997 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.1 m -85.27 150.71 55.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.636 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.19 155.89 22.61 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.844 2.362 . . . . 1.0 111.926 175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.0 122.17 17.16 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.52 10.34 13.24 Favored Glycine 0 C--N 1.285 -2.264 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -69.89 162.3 28.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.288 0.566 . . . . 1.0 111.069 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.9 m -120.92 132.71 55.11 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.462 HG13 HD11 ' A' ' 11' ' ' LEU . 29.6 m -115.73 135.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.506 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -120.38 137.54 54.24 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.656 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.5 tt -97.92 126.86 43.52 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.974 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 64' ' ' ASP . 33.9 m -127.88 127.1 23.96 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HD3' HG22 ' A' ' 17' ' ' VAL . 43.9 Cg_endo -70.35 82.02 0.91 Allowed 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 122.355 2.037 . . . . 1.0 111.823 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.633 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.7 p . . . . . 0 N--CA 1.493 1.688 0 C-N-CA 126.038 1.735 . . . . 1.0 111.026 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 34' ' ' CYS . 74.8 m-85 . . . . . 0 N--CA 1.401 -2.918 0 N-CA-C 105.261 -2.126 . . . . 1.0 105.261 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -113.39 114.63 47.78 Favored Pre-proline 0 C--N 1.273 -2.721 0 C-N-CA 118.111 -1.436 . . . . 1.0 113.287 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 124.98 16.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.247 1.964 . . . . 1.0 109.098 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tp -122.18 161.81 22.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.801 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m -109.48 128.44 55.17 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.1 mt -126.66 149.99 49.22 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.751 0.82 . . . . 1.0 111.011 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -94.62 116.05 28.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.74 120.59 24.83 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.814 HD21 ' HA2' ' A' ' 22' ' ' GLY . 31.0 tp -151.64 152.32 32.67 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.636 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.1 pt? -122.13 143.03 49.79 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.728 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -117.25 32.41 6.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.363 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.18 -45.32 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 C-N-CA 123.572 0.749 . . . . 1.0 111.814 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.64 -87.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.363 -1.398 . . . . 1.0 113.475 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.33 -30.76 88.22 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.954 2.436 . . . . 1.0 113.171 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.3 26.08 11.64 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.694 -0.765 . . . . 1.0 111.547 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.7 82.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.814 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 103.05 0.12 48.04 Favored Glycine 0 CA--C 1.48 -2.14 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.41 22.04 3.7 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.664 -0.768 . . . . 1.0 111.242 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.66 -69.33 0.62 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.189 -0.459 . . . . 1.0 112.129 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -148.41 -51.77 0.17 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.7 -177.063 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.0 68.19 1.73 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.508 -1.037 . . . . 1.0 110.508 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 25' ' ' GLN . 22.4 t -103.37 127.34 29.87 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.94 108.45 2.72 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 C-N-CA 121.623 1.549 . . . . 1.0 111.624 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG13 ' NE2' ' A' ' 47' ' ' GLN . 44.1 t -106.23 154.83 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.985 -1.007 . . . . 1.0 108.729 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.84 143.96 34.18 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.324 0.583 . . . . 1.0 110.769 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.48 166.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 tp -100.4 156.83 17.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.05 -30.29 70.88 Favored 'General case' 0 C--O 1.268 2.033 0 CA-C-O 121.473 0.654 . . . . 1.0 109.596 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.617 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -90.82 1.56 56.83 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.355 -176.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.17 136.24 46.4 Favored 'General case' 0 CA--C 1.48 -1.734 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.014 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.36 168.81 17.15 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.759 HG21 ' HA ' ' A' ' 78' ' ' SER . 42.1 mm -61.59 -42.23 93.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 120.799 -0.361 . . . . 1.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -61.68 -43.72 98.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 121.109 -0.237 . . . . 1.0 110.547 177.323 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.447 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 27.0 mt-30 -67.33 -39.33 85.81 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 123.461 0.476 . . . . 1.0 111.238 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.66 -39.1 91.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.09 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.2 mptm? -56.93 -40.28 76.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 176.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' SER . 41.3 mt-10 -65.43 -53.81 37.65 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.42 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.27 -40.86 96.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.319 0.859 . . . . 1.0 113.319 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.667 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.5 mmm -64.04 -46.42 84.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.441 . . . . 1.0 110.406 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.7 pp -76.7 -25.19 53.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.13 -29.66 58.18 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.461 1.104 . . . . 1.0 112.67 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' NE2' HG13 ' A' ' 29' ' ' VAL . 27.7 mt-30 -69.25 -31.36 69.86 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.884 -0.327 . . . . 1.0 111.315 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 121.93 0.871 . . . . 1.0 108.713 -178.633 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.542 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 2.2 pp . . . . . 0 N--CA 1.409 -2.483 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' H ' ' H ' ' A' ' 112' ' ' CYS . 53.6 m-20 -112.91 169.5 8.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 1.0 108.329 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.62 129.21 75.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 C-N-CA 119.791 -0.764 . . . . 1.0 108.962 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 10.3 pt-20 -91.49 111.89 23.58 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.159 -1.793 . . . . 1.0 106.159 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 2.5 t-105 -89.99 126.06 35.61 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.164 -1.38 . . . . 1.0 110.054 -174.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.47 88.97 2.85 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.7 p -91.9 -14.15 30.09 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.826 -1.534 . . . . 1.0 110.907 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.52 -52.53 4.38 Favored Glycine 0 C--N 1.303 -1.279 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.793 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.88 -38.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 122.669 0.388 . . . . 1.0 111.394 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.69 1.97 21.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.57 0.7 . . . . 1.0 109.665 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.23 -129.47 10.6 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 19.4 p-80 -110.73 112.73 24.8 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.317 0.579 . . . . 1.0 110.069 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.43 140.19 53.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -79.14 115.06 20.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.481 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.5 mp -109.79 148.36 31.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.763 0.792 . . . . 1.0 112.351 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.759 ' HA ' HG21 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -164.12 157.05 17.7 Favored 'General case' 0 CA--C 1.467 -2.216 0 C-N-CA 125.805 1.642 . . . . 1.0 107.082 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 21.6 p-10 -73.69 -38.33 64.91 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 123.293 0.371 . . . . 1.0 111.399 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 C--N 1.316 -0.882 0 C-N-CA 120.592 -0.443 . . . . 1.0 112.014 -178.878 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.433 -1.306 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 37' ' ' ILE . 41.5 m-80 -82.44 140.16 33.57 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.851 -0.74 . . . . 1.0 109.52 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -114.64 174.74 5.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.528 HD13 HG22 ' A' ' 101' ' ' VAL . 2.4 pp -73.09 -29.59 63.05 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.235 -0.986 . . . . 1.0 108.368 173.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.617 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.0 pt20 -65.76 -24.48 66.96 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.024 -0.535 . . . . 1.0 112.17 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -59.9 -44.23 94.38 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 108.971 -0.751 . . . . 1.0 108.971 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -96.65 -10.28 27.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.569 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 64.7 mmtt 53.0 73.16 0.37 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.259 1.024 . . . . 1.0 113.121 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.2 m -83.08 147.99 55.42 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.958 . . . . 1.0 110.838 177.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.54 159.57 35.65 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.56 2.173 . . . . 1.0 112.911 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.77 121.54 15.26 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 121.764 0.792 . . . . 1.0 109.415 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.96 9.72 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.232 -0.985 . . . . 1.0 111.177 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.61 163.04 27.75 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.941 0.401 . . . . 1.0 110.315 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -115.61 131.33 56.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.835 0.35 . . . . 1.0 110.426 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.07 138.07 46.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.524 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -126.38 128.03 46.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.187 0.518 . . . . 1.0 110.593 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.636 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.3 mp -92.71 127.15 38.1 Favored 'General case' 0 C--N 1.269 -2.928 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.033 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 16' ' ' ALA . 17.3 m -128.94 154.01 80.21 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.13 74.09 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.224 1.949 . . . . 1.0 110.633 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.542 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.266 0 C-N-CA 125.486 1.514 . . . . 1.0 111.836 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' A' ' 32' ' ' LEU . 73.0 m-85 . . . . . 0 N--CA 1.403 -2.775 0 N-CA-C 105.461 -2.051 . . . . 1.0 105.461 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.537 ' H ' ' HB2' ' A' ' 33' ' ' ASP . 31.5 mmt180 -104.98 104.28 45.9 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 119.444 -0.903 . . . . 1.0 109.313 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' A' ' 32' ' ' LEU . 18.7 Cg_exo -65.81 105.18 0.76 Allowed 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 174.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HB3' HG23 ' A' ' 31' ' ' VAL . 4.3 tp -110.37 162.08 15.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-O 121.626 0.727 . . . . 1.0 112.334 -168.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -112.79 129.92 56.26 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.383 -1.281 . . . . 1.0 108.387 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 11' ' ' LEU . 25.7 mt -126.26 149.86 48.81 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.287 0.565 . . . . 1.0 111.258 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 26.6 t-20 -98.03 107.45 19.93 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.286 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.94 111.21 6.16 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 123.903 0.752 . . . . 1.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 30.4 tp -145.23 146.77 31.84 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.407 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.86 143.91 49.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -113.15 29.64 7.82 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.193 0.521 . . . . 1.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.474 HG22 ' HD3' ' A' ' 111' ' ' PRO . 53.2 t -64.9 -47.15 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 123.857 0.863 . . . . 1.0 112.56 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.85 -75.6 0.11 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.611 -1.281 . . . . 1.0 113.773 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.9 -26.44 80.97 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 123.68 2.92 . . . . 1.0 113.057 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.43 39.31 1.59 Allowed Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.751 -1.339 . . . . 1.0 109.751 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -63.75 80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.193 1.183 . . . . 1.0 114.193 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.35 39.96 Favored Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 110.403 -1.079 . . . . 1.0 110.403 172.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -157.05 38.07 0.3 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.612 0.72 . . . . 1.0 110.427 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' H ' HD11 ' A' ' 14' ' ' LEU . . . -95.63 -77.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.811 -0.631 . . . . 1.0 112.546 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.403 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 1.6 pt20 -127.13 -59.14 1.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.418 -172.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 69.56 68.37 1.66 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -99.34 131.25 25.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.666 -0.267 . . . . 1.0 110.561 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.14 103.36 1.49 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.917 1.745 . . . . 1.0 111.597 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.56 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 37.5 t -110.38 155.36 11.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.23 -0.895 . . . . 1.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.22 144.76 31.17 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.16 0.505 . . . . 1.0 112.177 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.541 HG12 ' HD2' ' A' ' 43' ' ' LYS . 2.6 m -147.64 -176.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.69 -1.141 . . . . 1.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 6' ' ' TYR . 29.5 mt -121.45 174.35 6.81 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.641 0.734 . . . . 1.0 110.097 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.537 ' HB2' ' H ' ' A' ' 7' ' ' ARG . 28.8 t70 -66.18 -32.3 73.65 Favored 'General case' 0 C--O 1.265 1.881 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.607 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.9 t -103.46 2.78 34.16 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.417 1.636 . . . . 1.0 115.417 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.393 0.2 OUTLIER -79.08 141.92 36.93 Favored 'General case' 0 CA--C 1.467 -2.245 0 C-N-CA 115.969 -2.293 . . . . 1.0 111.607 172.475 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.2 p -77.24 170.15 17.06 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.527 -1.67 . . . . 1.0 110.217 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.5 mm -59.64 -42.9 89.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.615 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.8 p -61.59 -46.99 87.49 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 123.431 0.457 . . . . 1.0 111.401 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.77 -42.54 63.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.114 0.483 . . . . 1.0 111.558 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.63 -37.4 82.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.716 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.528 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 32.9 ttpt -59.29 -38.31 79.9 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.444 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 38' ' ' SER . 63.5 mt-10 -66.9 -40.0 87.59 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.402 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HD2' HG12 ' A' ' 31' ' ' VAL . 64.6 mttp -63.92 -40.93 97.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 121.335 -0.146 . . . . 1.0 111.05 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.56 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.1 mmt -61.82 -49.35 76.65 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.739 0.65 . . . . 1.0 110.601 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -76.64 -23.08 53.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 30.7 t70 -55.27 -30.82 60.87 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.247 1.019 . . . . 1.0 111.567 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.6 mm100 -67.96 -30.93 70.34 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.845 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.497 -1.088 0 CA-C-O 121.091 0.472 . . . . 1.0 111.46 -171.981 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.9 pp . . . . . 0 C--O 1.248 1.002 0 CA-C-O 120.92 0.39 . . . . 1.0 111.181 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.5 162.71 15.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.305 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.14 127.06 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.302 0.572 . . . . 1.0 110.472 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.45 113.21 25.31 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 105.132 -2.173 . . . . 1.0 105.132 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.564 ' CE3' HD22 ' A' ' 77' ' ' LEU . 4.9 t-105 -91.55 133.54 35.44 Favored 'General case' 0 N--CA 1.403 -2.806 0 CA-C-N 115.39 -0.823 . . . . 1.0 111.912 -173.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -117.08 88.69 2.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 106.446 -1.687 . . . . 1.0 106.446 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 71.3 p -73.48 -31.99 64.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.785 -1.098 . . . . 1.0 110.763 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.14 -50.99 4.35 Favored Glycine 0 C--N 1.303 -1.282 0 CA-C-N 114.566 -1.197 . . . . 1.0 111.365 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.8 -41.28 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.524 0.329 . . . . 1.0 111.703 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.4 -40.04 5.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.275 -1.009 . . . . 1.0 108.275 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.16 -130.16 6.76 Favored Glycine 0 N--CA 1.426 -2.021 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.042 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 88.9 m-70 -100.94 118.86 37.8 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.544 0.737 . . . . 1.0 110.652 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.35 134.43 39.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 mm -79.72 118.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -109.98 152.27 26.09 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.234 0.54 . . . . 1.0 111.4 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -154.92 148.99 25.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 p-10 -66.25 -44.14 84.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.422 -1.858 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.935 178.48 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.0 mt . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 120.709 0.29 . . . . 1.0 110.938 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -103.42 146.21 28.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.211 -0.45 . . . . 1.0 109.847 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.544 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -109.23 171.84 7.2 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -77.02 -17.55 58.74 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.585 -1.246 . . . . 1.0 109.43 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.544 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 5.2 pt20 -66.67 -26.42 67.03 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.896 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -64.07 -40.99 97.47 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 2.0 t80 -88.74 -16.14 32.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.604 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.35 57.91 5.42 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.103 0.961 . . . . 1.0 111.01 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -74.31 144.22 81.04 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.208 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.06 158.49 41.95 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.878 2.385 . . . . 1.0 111.861 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.451 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . 6.0 p-10 -66.49 119.2 11.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.812 0.815 . . . . 1.0 109.827 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.99 20.33 10.72 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.417 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.88 162.12 29.93 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.867 0.365 . . . . 1.0 110.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 76.1 m -115.24 132.3 56.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.093 0.473 . . . . 1.0 110.667 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 13.5 m -113.22 156.89 14.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -139.26 124.87 19.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.232 0.539 . . . . 1.0 109.598 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.628 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.7 mp -101.32 131.38 47.4 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.234 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 17.5 m -130.2 147.96 67.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HD3' HG22 ' A' ' 17' ' ' VAL . 77.7 Cg_endo -83.07 82.96 2.03 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 121.769 1.646 . . . . 1.0 111.741 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.499 -0.999 0 C-N-CA 125.227 1.411 . . . . 1.0 111.247 179.216 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.574 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 47.0 m-85 . . . . . 0 N--CA 1.391 -3.42 0 N-CA-C 103.355 -2.831 . . . . 1.0 103.355 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.451 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 19.2 mmt180 -101.21 110.66 61.99 Favored Pre-proline 0 C--N 1.264 -3.126 0 C-N-CA 118.805 -1.158 . . . . 1.0 111.746 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -60.44 119.83 7.23 Favored 'Trans proline' 0 CA--C 1.508 -0.825 0 C-N-CA 122.397 2.064 . . . . 1.0 108.617 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -114.94 128.41 56.27 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 -171.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.2 m -87.37 120.3 28.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.506 HD23 ' SD ' ' A' ' 44' ' ' MET . 16.3 tp -124.65 142.84 51.08 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -98.76 117.07 32.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.106 -0.371 . . . . 1.0 110.814 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -75.92 116.93 17.11 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.148 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 25.7 tp -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.695 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -128.65 141.21 51.42 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.955 -0.465 . . . . 1.0 110.741 176.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.63 54.0 0.82 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.234 0.54 . . . . 1.0 110.933 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG22 ' HD3' ' A' ' 111' ' ' PRO . 46.5 t -67.71 -43.21 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.604 0.716 . . . . 1.0 109.865 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.94 -84.59 0.14 Allowed Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.94 -32.82 76.42 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.792 2.328 . . . . 1.0 112.142 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.65 18.58 50.11 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 121.32 -0.467 . . . . 1.0 112.152 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -77.79 64.42 3.04 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.449 0.642 . . . . 1.0 111.924 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.54 -29.34 1.89 Allowed Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -94.31 17.99 11.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.122 0.487 . . . . 1.0 111.187 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.07 -83.31 0.08 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -143.7 -62.8 0.39 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.569 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.86 72.57 0.95 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.38 126.72 27.62 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.34 -0.43 . . . . 1.0 110.264 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.36 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 121.737 1.625 . . . . 1.0 111.496 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.517 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 40.6 t -110.61 142.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.117 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.48 140.7 29.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.283 0.563 . . . . 1.0 111.765 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 9' ' ' LEU . 13.7 m -141.33 172.86 9.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 9.8 mt -107.95 158.4 17.39 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.421 0.629 . . . . 1.0 111.483 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.451 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.2 t70 -59.22 -30.83 68.52 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.03 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.9 t -88.6 -3.61 58.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.501 -1.227 . . . . 1.0 112.277 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -73.23 132.34 43.06 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.191 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 p -74.55 172.08 12.66 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -59.94 -44.99 95.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 117.993 0.36 . . . . 1.0 111.198 -177.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.437 ' HB2' ' OD1' ' A' ' 79' ' ' ASP . 4.0 t -71.87 -35.97 69.94 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.955 -1.098 . . . . 1.0 110.519 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.79 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 46.4 tt0 -68.25 -38.02 81.39 Favored 'General case' 0 C--O 1.206 -1.226 0 C-N-CA 123.136 0.574 . . . . 1.0 111.007 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -73.69 -39.75 64.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.539 -0.726 . . . . 1.0 110.596 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.22 -35.91 72.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.316 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.79 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 3.7 pt-20 -68.41 -40.44 81.27 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.919 -176.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.549 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 44.9 mmtm -63.99 -41.45 97.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 124.186 0.929 . . . . 1.0 110.245 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.1 mmm -61.59 -48.59 80.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.694 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.4 pp -77.28 -24.72 50.98 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 112.579 0.585 . . . . 1.0 112.579 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -52.89 -28.92 25.4 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.092 1.357 . . . . 1.0 112.076 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.446 HE21 HG13 ' A' ' 29' ' ' VAL . 12.2 mm-40 -66.76 -36.83 83.34 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.45 0.643 . . . . 1.0 110.348 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.315 -0.895 0 CA-C-O 121.696 0.76 . . . . 1.0 109.545 -177.448 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.616 HD13 ' HG ' ' A' ' 109' ' ' LEU . 4.5 pp . . . . . 0 C--O 1.192 -1.962 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.08 152.45 33.58 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.487 -1.301 . . . . 1.0 107.487 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 77' ' ' LEU . 8.4 p -115.75 125.94 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 118.825 -1.15 . . . . 1.0 110.137 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -93.87 113.11 25.06 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.357 -1.349 . . . . 1.0 107.357 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.611 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.5 t-105 -93.61 124.49 37.63 Favored 'General case' 0 N--CA 1.388 -3.549 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.97 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -109.96 89.57 3.06 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 p -84.59 -13.47 51.6 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.054 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.06 -55.87 3.94 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.42 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.03 -40.93 90.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.003 0.521 . . . . 1.0 111.293 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.35 -10.76 26.99 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.694 0.759 . . . . 1.0 109.03 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.35 -128.23 9.5 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.083 -0.962 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 3.8 p80 -130.65 108.19 9.72 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.298 0.571 . . . . 1.0 109.836 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.68 151.71 36.7 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.0 mm -94.07 120.68 43.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 10.4 mp -111.22 165.18 12.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.525 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -167.06 157.72 11.67 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 105.141 -2.17 . . . . 1.0 105.141 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 9.3 p-10 -78.51 -19.72 52.35 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.42 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 173.964 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 94.3 mt . . . . . 0 C--O 1.251 1.154 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 37' ' ' ILE . 82.7 m-20 -98.58 140.58 32.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.207 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.548 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -111.39 173.1 6.5 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.991 1.316 . . . . 1.0 108.921 177.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 101' ' ' VAL . 3.9 pp -72.21 -22.8 61.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 119.136 -1.025 . . . . 1.0 109.49 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.548 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 5.4 pt20 -65.77 -26.47 67.73 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.327 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -66.7 -40.68 88.6 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 88.1 m-85 -97.47 -1.33 44.41 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.652 -0.703 . . . . 1.0 111.61 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? 48.53 63.61 2.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.034 1.334 . . . . 1.0 113.589 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.611 HG11 ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -84.52 146.29 46.81 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 119.075 -1.05 . . . . 1.0 112.601 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.14 158.08 23.41 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.026 2.484 . . . . 1.0 111.827 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.07 122.46 17.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.4 14.59 12.7 Favored Glycine 0 C--N 1.287 -2.151 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.971 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -71.3 162.68 29.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.269 0.557 . . . . 1.0 110.697 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.4 m -123.04 134.5 54.29 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.309 -0.405 . . . . 1.0 109.92 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.425 HG11 HD21 ' A' ' 11' ' ' LEU . 27.2 m -115.38 138.81 44.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.461 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -126.13 135.17 51.37 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.528 0.68 . . . . 1.0 110.539 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.695 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 tt -100.04 125.8 46.15 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.315 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 16' ' ' ALA . 32.2 m -119.54 130.45 24.84 Favored Pre-proline 0 C--N 1.316 -0.883 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.094 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.5 Cg_endo -75.15 86.35 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.344 2.029 . . . . 1.0 111.699 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.528 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 18.7 p . . . . . 0 N--CA 1.492 1.638 0 C-N-CA 125.833 1.653 . . . . 1.0 113.714 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 N--CA 1.406 -2.628 0 N-CA-C 103.481 -2.785 . . . . 1.0 103.481 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.507 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 33.6 mmt180 -108.52 111.61 61.23 Favored Pre-proline 0 C--N 1.267 -3.004 0 C-N-CA 119.362 -0.935 . . . . 1.0 112.301 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.38 109.51 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.144 1.896 . . . . 1.0 109.57 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 10' ' ' THR . 4.6 tp -112.85 156.02 23.64 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.026 -174.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.439 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 47.3 m -96.51 128.59 43.58 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 ' SD ' ' A' ' 44' ' ' MET . 29.0 tp -127.37 143.73 51.17 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 27.6 t-20 -97.68 113.47 25.23 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.03 -0.419 . . . . 1.0 110.966 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . . . -76.16 115.98 16.41 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.811 -0.632 . . . . 1.0 110.167 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.642 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.7 tp -147.81 154.81 40.95 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.681 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.66 143.67 50.61 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.731 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -116.36 33.29 5.63 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.329 0.585 . . . . 1.0 110.368 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.78 -46.23 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 C-N-CA 123.645 0.778 . . . . 1.0 111.918 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.29 -77.47 0.14 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 119.295 -1.431 . . . . 1.0 113.684 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.45 -35.06 97.08 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.761 2.307 . . . . 1.0 112.141 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.39 36.63 3.22 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -68.39 74.46 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.79 1.033 . . . . 1.0 113.79 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.642 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 105.6 -5.58 40.73 Favored Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 110.14 -1.184 . . . . 1.0 110.14 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -119.9 16.61 12.6 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.244 -0.978 . . . . 1.0 111.371 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.81 -75.31 0.17 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -148.53 -58.06 0.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.965 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 75.54 1.18 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 13' ' ' ALA . 18.3 t -92.9 126.51 51.2 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.419 . . . . 1.0 110.723 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.18 99.06 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.941 1.76 . . . . 1.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 47' ' ' GLN . 16.4 t -109.6 156.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -123.01 151.32 41.98 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.811 -1.156 . . . . 1.0 112.021 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 32' ' ' LEU . 5.1 p -151.34 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.812 -1.181 . . . . 1.0 107.812 -175.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' H ' HG22 ' A' ' 31' ' ' VAL . 19.7 mt -100.56 160.55 14.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-N 118.755 0.707 . . . . 1.0 111.195 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 19.6 t70 -64.62 -31.08 72.14 Favored 'General case' 0 C--O 1.251 1.159 0 O-C-N 124.025 0.828 . . . . 1.0 108.857 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -108.61 39.52 1.98 Allowed 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.013 -1.449 . . . . 1.0 110.168 -177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.627 ' O ' HG22 ' A' ' 95' ' ' THR . 11.9 p-10 -66.89 -164.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.33 170.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 p -142.01 153.46 44.28 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 168.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -56.55 -40.68 70.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 118.122 0.419 . . . . 1.0 111.316 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -62.59 -43.02 99.85 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.62 176.454 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 45.7 mt-30 -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.974 0.416 . . . . 1.0 111.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.02 -38.19 90.17 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.27 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 38' ' ' SER . 28.7 tptp -55.56 -41.89 73.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.7 mt-10 -68.13 -48.52 65.18 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.259 -0.882 . . . . 1.0 110.625 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 34.9 mmtp -65.33 -42.54 92.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.128 0.788 . . . . 1.0 113.128 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 83.2 mmm -63.94 -42.84 97.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.863 0.363 . . . . 1.0 110.577 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.77 -25.63 56.63 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.0 111.682 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.2 t70 -53.02 -31.45 41.29 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.858 1.263 . . . . 1.0 112.224 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.58 ' HG3' HG22 ' A' ' 29' ' ' VAL . 13.7 mm-40 -71.32 -38.27 71.71 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.147 0.498 . . . . 1.0 111.401 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 CA--C 1.497 -1.076 0 CA-C-O 122.072 0.939 . . . . 1.0 108.912 -175.875 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.1 pp . . . . . 0 N--CA 1.427 -1.619 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 1.7 m-20 -107.8 141.09 39.89 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.89 114.31 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 C-N-CA 118.352 -1.339 . . . . 1.0 108.054 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -91.0 112.67 24.66 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 107.614 -1.254 . . . . 1.0 107.614 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CZ2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -83.42 127.52 33.76 Favored 'General case' 0 N--CA 1.385 -3.683 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.723 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.59 89.01 3.03 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.456 -0.793 . . . . 1.0 109.562 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.407 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 53.0 m -97.05 -17.56 19.92 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.683 0.754 . . . . 1.0 109.335 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.95 -46.0 3.5 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.505 -1.225 . . . . 1.0 112.411 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.6 -44.93 97.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-O 120.89 0.376 . . . . 1.0 110.989 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . . . -102.46 0.59 34.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.057 0.932 . . . . 1.0 108.703 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.68 -127.75 8.09 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.282 -1.327 . . . . 1.0 113.236 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 9.3 m170 -115.73 118.46 33.11 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.382 1.073 . . . . 1.0 109.294 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.98 139.04 48.51 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.68 118.29 31.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.29 -0.564 . . . . 1.0 109.638 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -108.49 159.59 16.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.474 0.654 . . . . 1.0 111.44 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 m -165.81 162.75 18.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 12.6 p-10 -66.08 -38.76 89.08 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--N 1.305 -1.347 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 175.846 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.2 mt . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -90.71 141.14 29.1 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.974 -0.691 . . . . 1.0 109.826 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.8 p -121.97 171.49 8.9 Favored 'General case' 0 C--O 1.266 1.922 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 101' ' ' VAL . 3.2 pp -66.8 -29.94 70.01 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.96 . . . . 1.0 108.979 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.549 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 2.5 pt20 -67.83 -26.09 65.88 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.533 177.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -64.13 -41.36 97.24 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' HG12 ' A' ' 101' ' ' VAL . 3.1 t80 -83.45 -18.62 38.0 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.733 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 10.6 mmmm 52.15 60.7 3.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.947 0.899 . . . . 1.0 110.788 -171.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.655 HG11 ' CZ2' ' A' ' 67' ' ' TRP . 1.6 m -74.23 149.78 87.16 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.65 -0.705 . . . . 1.0 112.575 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.3 164.03 31.59 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.142 2.561 . . . . 1.0 111.742 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.408 ' HA ' HD11 ' A' ' 9' ' ' LEU . 5.0 p-10 -65.65 129.01 38.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.366 0.603 . . . . 1.0 109.712 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.27 40.64 Favored Glycine 0 C--N 1.295 -1.727 0 C-N-CA 120.623 -0.799 . . . . 1.0 111.999 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -64.42 154.87 34.36 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 120.716 0.293 . . . . 1.0 111.018 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 98.9 m -107.45 132.52 53.11 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.988 0.423 . . . . 1.0 111.345 -176.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.5 m -113.0 142.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.33 136.57 53.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.578 0.704 . . . . 1.0 110.581 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.681 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.0 tt -102.68 124.47 48.29 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 115.191 -0.913 . . . . 1.0 109.184 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 26.3 m -129.03 144.25 51.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.01 51.54 3.69 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 122.934 2.422 . . . . 1.0 114.002 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.51 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.495 -1.161 0 C-N-CA 124.495 1.118 . . . . 1.0 111.095 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.644 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 m-85 . . . . . 0 N--CA 1.407 -2.577 0 N-CA-C 101.202 -3.629 . . . . 1.0 101.202 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 34.9 mmt180 -98.01 108.24 45.41 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 121.063 1.756 . . . . 1.0 111.22 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 15.4 Cg_exo -69.58 120.07 6.94 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.106 1.871 . . . . 1.0 108.469 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tp -117.87 158.34 25.02 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.223 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -98.34 125.56 43.51 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.54 HD11 HG13 ' A' ' 107' ' ' VAL . 18.5 tp -127.21 142.03 51.59 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.724 -1.213 . . . . 1.0 107.724 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 29.2 t-20 -94.94 122.0 37.13 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.916 -0.49 . . . . 1.0 111.25 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.48 113.31 20.14 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.494 -0.776 . . . . 1.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 33.2 tp -146.61 151.71 37.73 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.912 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.678 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -120.82 140.45 51.72 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.93 42.79 2.1 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.035 0.445 . . . . 1.0 110.901 -174.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.552 HG22 ' HD3' ' A' ' 111' ' ' PRO . 82.7 t -65.2 -46.34 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-N 115.461 -0.791 . . . . 1.0 111.825 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.85 -80.35 0.15 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.239 -0.981 . . . . 1.0 112.986 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.62 -30.95 79.61 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.947 2.432 . . . . 1.0 112.829 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -126.38 41.49 1.63 Allowed Glycine 0 N--CA 1.408 -3.23 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -75.67 31.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.14 0.576 . . . . 1.0 112.195 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.549 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 168.35 -41.28 0.23 Allowed Glycine 0 C--N 1.3 -1.45 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.74 10.11 19.4 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.195 0.521 . . . . 1.0 112.093 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLY . . . -76.16 -68.54 0.57 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.472 0.653 . . . . 1.0 112.603 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.2 pt20 -131.24 -69.51 0.63 Allowed 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.793 -172.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.35 64.33 4.49 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.329 -0.708 . . . . 1.0 111.329 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 25' ' ' GLN . 19.2 t -107.95 125.82 31.2 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -175.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.46 104.93 1.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.63 1.553 . . . . 1.0 110.575 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 47' ' ' GLN . 17.1 t -107.61 156.01 8.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.95 148.06 34.57 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.392 -0.923 . . . . 1.0 110.561 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' CB ' ' A' ' 40' ' ' ALA . 13.9 p -158.55 163.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.393 -0.821 . . . . 1.0 108.974 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.416 ' HB2' ' CG ' ' A' ' 35' ' ' ASP . 18.3 mt -86.05 158.2 19.89 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.739 0.78 . . . . 1.0 112.423 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 30.2 t70 -64.24 -32.03 73.46 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-N 113.904 -1.498 . . . . 1.0 109.289 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.0 t -95.29 6.56 48.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.548 -1.66 . . . . 1.0 111.239 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.416 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 95.2 m-20 -85.54 144.79 27.71 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 119.399 -0.92 . . . . 1.0 108.656 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 p -83.56 169.96 14.87 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.444 -0.798 . . . . 1.0 109.328 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 94' ' ' ASN . 44.2 mm -61.52 -43.44 96.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 117.752 0.251 . . . . 1.0 110.457 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -63.88 -40.76 97.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.22 0.533 . . . . 1.0 110.655 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.663 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 41.1 tt0 -75.78 -25.0 56.03 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.797 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -82.3 -37.6 25.55 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 121.701 -0.624 . . . . 1.0 111.098 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.71 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 2.5 mmmp? -57.64 -36.2 71.51 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.646 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 11.3 pt-20 -62.54 -45.8 91.31 Favored 'General case' 0 N--CA 1.414 -2.239 0 O-C-N 124.154 0.909 . . . . 1.0 110.925 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 29.2 mmmt -70.72 -38.59 73.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.4 mmt -59.58 -49.01 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.363 0.602 . . . . 1.0 109.532 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 2.4 pp -78.11 -23.9 47.69 Favored 'General case' 0 C--O 1.197 -1.709 0 CA-C-N 115.604 -0.726 . . . . 1.0 112.659 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 20.1 t70 -50.18 -34.69 23.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.11 1.364 . . . . 1.0 112.366 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.514 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.7 mm-40 -67.36 -29.96 69.64 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.744 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 C--N 1.315 -0.907 0 CA-C-O 121.717 0.77 . . . . 1.0 110.581 -177.022 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.643 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.2 pp . . . . . 0 N--CA 1.415 -2.222 0 N-CA-C 106.589 -1.634 . . . . 1.0 106.589 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' HB3' HG23 ' A' ' 76' ' ' ILE . 21.5 m-20 -102.93 154.12 19.54 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.13 112.77 41.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -91.34 122.32 33.85 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.771 0.796 . . . . 1.0 110.342 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 17.8 t90 -82.73 116.87 22.27 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.787 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 49.5 mtm105 -122.95 90.43 3.29 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 p -88.01 -20.47 25.77 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.74 -54.41 4.12 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.191 -1.368 . . . . 1.0 111.657 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.48 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 123.773 0.829 . . . . 1.0 111.498 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.94 -15.12 20.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.821 0.344 . . . . 1.0 110.673 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.67 -158.63 15.58 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 111.465 -0.654 . . . . 1.0 111.465 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.4 p80 -136.43 120.58 17.79 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.156 0.582 . . . . 1.0 110.861 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -127.39 148.78 50.27 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.421 -174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' A' ' 64' ' ' ASP . 27.9 mm -84.9 116.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 120.87 0.367 . . . . 1.0 110.194 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.448 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 11.1 mp -106.51 148.64 27.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.937 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.0 t -164.04 161.97 22.86 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -71.38 -30.21 65.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 N--CA 1.409 -2.504 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 178.357 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.432 -1.336 0 N-CA-C 106.448 -1.686 . . . . 1.0 106.448 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.418 ' O ' HG12 ' A' ' 37' ' ' ILE . 78.5 m-20 -84.92 141.49 30.35 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.969 -173.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.552 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -105.67 172.49 6.77 Favored 'General case' 0 N--CA 1.425 -1.69 0 C-N-CA 123.731 0.813 . . . . 1.0 108.917 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.406 HD13 HG22 ' A' ' 101' ' ' VAL . 3.2 pp -71.25 -27.31 63.37 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.503 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.552 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 3.9 pt20 -65.83 -25.25 67.13 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.439 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -65.32 -35.39 80.86 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.448 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 87.4 m-85 -103.32 -11.8 17.67 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.918 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 54.0 69.3 0.73 Allowed 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.615 1.166 . . . . 1.0 112.649 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 11' ' ' LEU . 2.5 m -78.97 137.8 57.31 Favored Pre-proline 0 N--CA 1.434 -1.239 0 C-N-CA 120.041 -0.664 . . . . 1.0 109.471 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.25 160.39 49.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.315 2.01 . . . . 1.0 111.171 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.84 125.73 25.76 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.884 -0.727 . . . . 1.0 110.293 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 21.74 39.52 Favored Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.881 -1.054 . . . . 1.0 111.164 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.92 155.54 39.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.783 0.325 . . . . 1.0 110.403 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 99.0 m -107.01 125.83 51.54 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.108 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 11' ' ' LEU . 35.2 m -121.66 137.06 56.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -122.82 135.13 54.43 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.662 0.744 . . . . 1.0 112.826 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 11.0 mp -90.14 124.09 34.53 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.322 -0.853 . . . . 1.0 109.549 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 23.6 m -125.54 134.7 26.07 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.433 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HD3' HG22 ' A' ' 17' ' ' VAL . 40.2 Cg_endo -68.69 86.15 0.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.525 2.15 . . . . 1.0 111.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.643 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 23.3 p . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 125.541 1.537 . . . . 1.0 111.715 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.563 ' HB2' HD22 ' A' ' 32' ' ' LEU . 41.7 m-85 . . . . . 0 N--CA 1.404 -2.773 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 26.3 mmt180 -110.26 105.03 56.82 Favored Pre-proline 0 C--N 1.272 -2.774 0 C-N-CA 118.773 -1.171 . . . . 1.0 110.547 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.87 118.44 5.33 Favored 'Trans proline' 0 C--O 1.25 1.093 0 N-CA-C 108.504 -1.383 . . . . 1.0 108.504 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER -119.13 131.68 55.91 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 -172.527 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -87.12 128.74 35.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 31' ' ' VAL . 1.1 mm? -122.82 147.35 46.64 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.064 0.946 . . . . 1.0 109.996 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -89.95 110.94 21.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.49 109.45 7.98 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 123.489 0.493 . . . . 1.0 109.78 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.9 tp -138.56 160.77 38.74 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.318 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -125.73 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.21 33.92 4.99 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.921 0.391 . . . . 1.0 110.597 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG22 ' CD ' ' A' ' 111' ' ' PRO . 47.1 t -63.79 -47.66 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 115.849 -0.614 . . . . 1.0 112.392 -174.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.73 -85.14 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.63 -33.78 93.03 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 122.998 2.466 . . . . 1.0 113.072 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.05 29.63 6.99 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -76.24 75.98 3.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.397 0.617 . . . . 1.0 111.985 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 121.2 -7.91 10.55 Favored Glycine 0 CA--C 1.488 -1.629 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.391 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -128.76 28.3 5.38 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.234 0.54 . . . . 1.0 111.27 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 -88.78 0.18 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.449 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.457 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 8.9 pt20 -117.62 -58.49 2.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.243 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 65.97 71.81 0.84 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 -175.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.3 t -103.97 126.98 30.28 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.626 -0.287 . . . . 1.0 110.432 -173.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.21 106.51 2.18 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.963 1.775 . . . . 1.0 111.581 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 44' ' ' MET . 79.4 t -116.1 155.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.95 -1.13 . . . . 1.0 107.95 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -125.69 144.3 50.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 11' ' ' LEU . 16.0 m -139.72 170.31 15.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.571 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 6' ' ' TYR . 14.7 mt -84.52 159.64 20.66 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.043 0.449 . . . . 1.0 111.454 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 24.5 t70 -62.65 -30.89 71.71 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-N 115.286 -0.87 . . . . 1.0 108.834 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 10.0 t -95.27 6.11 49.92 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.048 -1.433 . . . . 1.0 112.562 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -71.24 132.51 45.06 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 174.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.478 ' CG2' HD11 ' A' ' 93' ' ' LEU . 69.8 p -79.26 167.26 21.19 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -60.11 -43.32 92.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.541 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.669 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -61.04 -47.13 87.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 123.32 0.387 . . . . 1.0 110.745 177.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 47.5 mt-30 -71.24 -40.23 71.16 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.6 -39.78 84.77 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.108 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -61.96 -34.66 76.54 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.718 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.669 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.9 mt-10 -64.46 -46.23 84.01 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 124.412 1.07 . . . . 1.0 110.073 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 39.2 mmtm -62.94 -46.61 86.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.662 0.744 . . . . 1.0 109.051 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 107' ' ' VAL . 7.2 mtp -65.3 -40.34 93.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.444 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.55 -33.18 64.58 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.514 -0.474 . . . . 1.0 111.123 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.1 -33.95 75.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.606 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 19.0 mm-40 -67.08 -30.88 71.04 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.52 -0.764 . . . . 1.0 111.584 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.41 HD22 HE22 ' A' ' 25' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.432 -1.33 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.501 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.2 pp . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 120.876 0.369 . . . . 1.0 111.437 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 4.9 m-20 -107.81 150.64 26.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.53 128.89 75.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 120.108 -0.637 . . . . 1.0 109.5 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 33.7 mt-10 -90.93 112.97 25.06 Favored 'General case' 0 CA--C 1.462 -2.407 0 N-CA-C 106.119 -1.808 . . . . 1.0 106.119 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.613 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -91.34 119.16 31.13 Favored 'General case' 1 N--CA 1.37 -4.448 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -108.98 89.48 3.01 Favored 'General case' 0 N--CA 1.394 -3.225 0 N-CA-C 106.738 -1.579 . . . . 1.0 106.738 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.2 p -83.95 -12.49 55.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 113.797 -1.547 . . . . 1.0 110.906 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.4 -60.97 3.58 Favored Glycine 0 C--N 1.302 -1.325 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.695 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.279 0.631 . . . . 1.0 112.049 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.12 -6.52 31.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.58 0.705 . . . . 1.0 109.751 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.35 -153.72 26.68 Favored Glycine 0 N--CA 1.414 -2.831 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.24 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -101.01 117.0 34.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.489 0.662 . . . . 1.0 111.678 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.92 146.75 45.5 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.772 -1.103 . . . . 1.0 108.069 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 22.0 mm -89.76 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.8 159.47 15.79 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.669 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 3.3 t -167.95 165.74 13.59 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 105.789 -1.93 . . . . 1.0 105.789 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' HD22 ' A' ' 93' ' ' LEU . 11.3 p-10 -63.0 -39.54 95.06 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 N--CA 1.44 -0.956 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.253 -179.432 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD11 ' CG2' ' A' ' 36' ' ' THR . 3.3 tm? . . . . . 0 CA--C 1.56 1.331 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.0 m-80 -101.97 137.9 39.64 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 119.533 -0.867 . . . . 1.0 112.03 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.415 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -126.77 175.3 8.11 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.579 -1.637 . . . . 1.0 106.579 174.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.543 HD13 HG22 ' A' ' 101' ' ' VAL . 2.3 pp -72.42 -28.02 62.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.104 -1.438 . . . . 1.0 108.334 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.549 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 4.4 pt20 -66.86 -24.31 66.12 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.513 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -57.61 -40.95 80.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.217 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -107.62 8.92 29.38 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.011 0.745 . . . . 1.0 113.011 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.549 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 31.2 mmmt 38.02 65.13 0.61 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.207 1.403 . . . . 1.0 112.745 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.613 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -67.71 149.69 98.16 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 115.058 -0.973 . . . . 1.0 112.003 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.58 155.5 40.31 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.422 2.081 . . . . 1.0 111.228 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 8.3 p-10 -66.05 127.62 32.85 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 177.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.82 20.72 27.9 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.087 -1.054 . . . . 1.0 110.934 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . . . -71.65 163.95 26.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 1.0 110.129 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.6 m -112.01 131.15 55.58 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.854 -0.529 . . . . 1.0 111.452 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.607 HG21 ' SD ' ' A' ' 44' ' ' MET . 17.3 m -117.07 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -129.0 137.83 51.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.572 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.2 pp -109.85 143.83 39.19 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.891 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 35.0 m -131.8 125.54 20.4 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.427 ' CD ' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -70.49 80.7 1.07 Allowed 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.458 2.105 . . . . 1.0 112.067 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.447 -0.608 0 CA-C-N 114.877 -1.056 . . . . 1.0 110.597 178.223 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.5 m-85 . . . . . 0 N--CA 1.399 -2.989 0 N-CA-C 105.427 -2.064 . . . . 1.0 105.427 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 38.0 mmt180 -109.12 111.03 60.54 Favored Pre-proline 0 C--N 1.283 -2.308 0 C-N-CA 117.625 -1.63 . . . . 1.0 113.196 -170.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 21.8 Cg_exo -63.39 112.6 1.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.16 1.907 . . . . 1.0 108.44 171.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -113.06 160.94 17.64 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.994 -172.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -98.9 125.99 44.46 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.091 -1.077 . . . . 1.0 108.091 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.592 HD12 ' SD ' ' A' ' 44' ' ' MET . 1.3 tm? -127.32 141.1 51.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -97.26 111.38 23.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.884 -0.51 . . . . 1.0 110.319 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.68 106.37 5.4 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 115.407 -0.815 . . . . 1.0 111.132 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.52 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.2 tp -143.24 144.44 32.15 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.563 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.02 144.29 48.61 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.851 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -114.25 34.54 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.447 0.642 . . . . 1.0 109.531 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.499 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 38.4 t -65.14 -45.44 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 C-N-CA 123.839 0.856 . . . . 1.0 112.924 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.38 -80.9 0.1 OUTLIER Glycine 0 C--N 1.313 -0.713 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.902 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -58.98 -32.46 97.56 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.957 2.438 . . . . 1.0 112.429 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.45 41.36 1.61 Allowed Glycine 0 N--CA 1.419 -2.468 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -66.07 76.53 0.09 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 98.46 3.08 57.57 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.58 24.51 5.09 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.593 -0.804 . . . . 1.0 110.143 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.07 -77.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.0 pt20 -125.89 -65.48 0.99 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.229 -0.896 . . . . 1.0 111.919 -169.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.83 64.71 3.48 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 25' ' ' GLN . 43.2 t -108.3 129.9 23.46 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 110.24 -0.282 . . . . 1.0 110.24 -174.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.49 108.25 2.18 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.126 1.884 . . . . 1.0 111.309 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 44' ' ' MET . 59.6 t -117.71 138.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -84.16 155.94 22.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.885 0.698 . . . . 1.0 112.885 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 32' ' ' LEU . 14.2 p -151.3 -178.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.415 -1.266 . . . . 1.0 108.192 -176.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 31' ' ' VAL . 12.8 tp -119.1 155.39 31.62 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 30.5 t70 -64.0 -30.6 71.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.354 0.597 . . . . 1.0 109.649 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 t -104.81 33.48 3.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.401 -1.272 . . . . 1.0 110.352 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.597 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -70.22 -163.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.636 172.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.4 p -140.51 161.91 36.59 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 103.668 -2.716 . . . . 1.0 103.668 167.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.659 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 43.8 mm -57.78 -47.74 85.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.371 -0.531 . . . . 1.0 111.741 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 t -65.81 -43.87 87.35 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 123.677 0.611 . . . . 1.0 109.902 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -63.17 -40.44 97.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.28 0.562 . . . . 1.0 111.356 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -63.92 -40.76 97.22 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.524 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -62.08 -33.17 73.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 123.674 0.609 . . . . 1.0 110.633 -178.494 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.36 -46.21 84.41 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 123.589 0.556 . . . . 1.0 110.526 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -66.39 -37.68 85.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.193 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.746 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.8 mtp -62.61 -43.96 97.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.307 0.575 . . . . 1.0 110.633 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -75.9 -25.66 56.26 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.126 -0.488 . . . . 1.0 112.25 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.47 -29.02 68.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.493 0.663 . . . . 1.0 110.991 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG3' HG13 ' A' ' 29' ' ' VAL . 11.0 mm-40 -83.87 -32.68 25.08 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.973 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 CA--C 1.497 -1.084 0 CA-C-O 121.607 0.718 . . . . 1.0 112.572 -167.538 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.705 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.6 pp . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 113.57 0.952 . . . . 1.0 113.57 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.71 153.2 30.7 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.468 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 p -120.73 126.94 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.186 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.75 112.55 24.52 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.548 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -91.51 122.65 34.28 Favored 'General case' 0 N--CA 1.383 -3.801 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.951 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.516 HH22 HD23 ' A' ' 14' ' ' LEU . 67.5 mtm180 -110.3 90.13 3.23 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-O 123.025 1.393 . . . . 1.0 107.314 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.6 p -79.72 -17.68 53.0 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.061 -1.881 . . . . 1.0 110.553 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.7 -56.95 4.52 Favored Glycine 0 C--N 1.298 -1.565 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.676 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.83 -43.01 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.505 0.557 . . . . 1.0 112.505 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.54 -10.33 21.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.332 0.587 . . . . 1.0 109.541 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.11 -149.96 19.48 Favored Glycine 0 N--CA 1.418 -2.565 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.656 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 7.2 p80 -105.56 114.0 27.91 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.314 0.578 . . . . 1.0 110.853 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.95 146.74 49.22 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.324 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.5 mm -85.97 115.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -105.87 143.26 34.25 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.903 0.859 . . . . 1.0 111.768 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.425 ' HA ' HG21 ' A' ' 37' ' ' ILE . 9.6 m -158.3 146.03 18.26 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 104.238 -2.505 . . . . 1.0 104.238 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 5.2 p-10 -72.82 -36.2 67.47 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.043 -1.063 . . . . 1.0 111.004 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.432 -1.339 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.228 176.706 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 C--O 1.24 0.597 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.423 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 55.7 m-80 -94.24 135.96 35.05 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 119.228 -0.989 . . . . 1.0 110.723 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.4 p -109.46 172.75 6.67 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 125.115 1.366 . . . . 1.0 108.237 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 101' ' ' VAL . 3.0 pp -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.839 -1.145 . . . . 1.0 108.015 171.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.571 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 3.4 pt20 -64.62 -25.05 67.79 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.327 -0.851 . . . . 1.0 112.029 177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -59.55 -41.61 90.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -102.08 -3.44 27.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.578 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 68.1 mmtt 46.26 68.52 0.59 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.223 1.009 . . . . 1.0 112.827 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.548 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -78.3 148.9 75.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.462 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.66 160.58 34.57 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.071 2.514 . . . . 1.0 111.898 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.19 117.93 9.19 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.01 22.17 9.01 Favored Glycine 0 C--N 1.288 -2.135 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.437 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.09 156.8 38.06 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.0 m -120.52 130.35 54.21 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.182 0.515 . . . . 1.0 110.687 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.503 ' CG1' HD11 ' A' ' 11' ' ' LEU . 33.8 m -113.74 165.83 8.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.692 -0.803 . . . . 1.0 111.077 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -148.3 120.81 8.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.311 -0.859 . . . . 1.0 108.961 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.594 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -106.17 137.7 43.64 Favored 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.072 -176.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.705 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 29.3 m -126.91 149.77 69.9 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.43 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 73.5 Cg_endo -77.19 63.66 7.76 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 122.858 2.372 . . . . 1.0 113.32 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.1 t . . . . . 0 C--O 1.243 0.759 0 CA-C-O 122.075 0.941 . . . . 1.0 108.928 -179.166 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.559 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 m-85 . . . . . 0 N--CA 1.405 -2.715 0 N-CA-C 104.544 -2.391 . . . . 1.0 104.544 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -99.78 108.77 53.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 C-N-CA 119.746 -0.782 . . . . 1.0 111.93 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 31.6 Cg_exo -60.66 133.5 48.76 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.691 2.261 . . . . 1.0 110.893 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 96' ' ' LEU . 4.9 tp -126.95 156.27 41.79 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.604 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.1 m -99.91 127.28 46.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 HG22 ' A' ' 31' ' ' VAL . 2.3 mm? -126.56 146.88 49.97 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.061 0.545 . . . . 1.0 110.697 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -96.2 117.1 30.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.927 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.67 113.19 18.69 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 27.2 tp -142.67 155.39 44.91 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 -177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.632 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -123.59 140.95 52.48 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.424 -0.511 . . . . 1.0 110.078 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -119.29 36.19 4.56 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.239 0.542 . . . . 1.0 110.444 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 111' ' ' PRO . 76.4 t -66.08 -46.44 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.028 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.87 -80.56 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 118.761 -1.685 . . . . 1.0 114.553 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.42 -31.29 94.56 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.097 2.531 . . . . 1.0 112.781 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.89 38.37 2.19 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.149 -1.18 . . . . 1.0 110.149 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -65.23 80.3 0.05 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.682 0.753 . . . . 1.0 112.808 -176.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.57 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 95.14 -1.74 65.18 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -113.93 20.6 15.62 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.472 -1.364 . . . . 1.0 110.177 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.24 -82.14 0.18 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.368 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.79 -56.13 0.26 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.65 91.81 1.11 Allowed Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.49 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.29 126.1 30.41 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -74.8 104.53 1.91 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.719 1.613 . . . . 1.0 111.057 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.491 HG13 HE21 ' A' ' 47' ' ' GLN . 22.0 t -110.71 155.78 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -121.64 148.52 44.45 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.436 -0.906 . . . . 1.0 112.76 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 11' ' ' LEU . 7.6 m -147.91 -174.29 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 125.071 1.349 . . . . 1.0 108.312 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.2 mt -107.2 158.63 16.95 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-O 120.544 0.211 . . . . 1.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -32.07 73.14 Favored 'General case' 0 C--O 1.26 1.629 0 O-C-N 124.224 0.953 . . . . 1.0 109.344 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 t -108.97 37.39 2.57 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.856 -1.52 . . . . 1.0 109.791 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 95' ' ' THR . 11.1 p-10 -68.53 -166.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.267 173.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 p -139.95 146.18 38.85 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.591 HG21 ' HA ' ' A' ' 78' ' ' SER . 26.5 mm -57.17 -29.37 31.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 118.482 0.583 . . . . 1.0 110.863 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -60.99 -50.18 74.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -73.41 -40.36 64.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.34 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.95 -39.28 90.3 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.469 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.1 ttmp? -57.48 -41.85 81.48 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -67.28 -51.84 47.97 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.267 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HD3' HG12 ' A' ' 31' ' ' VAL . 53.3 mtpt -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 87.4 mmm -62.6 -45.96 90.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.337 0.398 . . . . 1.0 110.998 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.9 pp -77.23 -28.5 53.72 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.51 -29.08 64.02 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.459 1.104 . . . . 1.0 112.775 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.491 HE21 HG13 ' A' ' 29' ' ' VAL . 15.1 mm-40 -64.88 -37.27 87.06 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.581 0.705 . . . . 1.0 110.207 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.317 -0.842 0 CA-C-O 121.98 0.895 . . . . 1.0 109.828 -177.627 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.621 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 112' ' ' CYS . 9.5 m-20 -129.15 165.22 21.72 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.309 -1.367 . . . . 1.0 107.309 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.1 128.92 73.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.616 -0.833 . . . . 1.0 109.859 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -90.23 112.66 24.27 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 106.206 -1.776 . . . . 1.0 106.206 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.602 ' HZ2' HG11 ' A' ' 101' ' ' VAL . 3.4 t-105 -95.08 122.1 37.4 Favored 'General case' 1 N--CA 1.372 -4.325 0 C-N-CA 119.395 -0.922 . . . . 1.0 109.01 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -108.16 89.28 2.95 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.7 t -83.24 -17.7 41.75 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.511 -1.677 . . . . 1.0 109.261 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.13 -58.56 3.17 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 112.728 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.65 -37.16 79.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 122.737 0.415 . . . . 1.0 111.328 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.01 -5.23 30.8 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.777 0.798 . . . . 1.0 109.351 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.12 -140.31 15.01 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.832 -1.077 . . . . 1.0 110.642 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -117.57 120.55 38.4 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.034 0.445 . . . . 1.0 109.915 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.56 146.48 49.66 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -85.01 116.43 28.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.432 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.6 mp -108.48 155.86 20.13 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.421 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 37' ' ' ILE . 7.5 t -171.58 172.5 5.0 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 115.004 -0.998 . . . . 1.0 108.485 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -81.5 -2.48 49.92 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.859 -1.064 . . . . 1.0 109.438 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 105.937 -1.875 . . . . 1.0 105.937 168.05 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.42 -1.959 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -74.56 142.39 44.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 -173.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.5 p -105.06 169.41 8.45 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 124.913 1.285 . . . . 1.0 108.709 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 9' ' ' LEU . 4.1 pp -70.32 -32.73 70.6 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 172.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.0 pt20 -62.13 -29.79 70.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.429 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -65.23 -35.21 80.34 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -98.06 8.66 44.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.89 -0.595 . . . . 1.0 112.189 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 52.99 54.63 10.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.045 . . . . 1.0 111.334 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.602 HG11 ' HZ2' ' A' ' 67' ' ' TRP . 40.8 t -74.86 124.37 89.53 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.779 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.0 159.1 27.23 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.525 2.816 . . . . 1.0 112.191 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.39 117.99 10.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.071 -0.513 . . . . 1.0 109.87 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.88 18.3 14.3 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.291 -0.957 . . . . 1.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.01 27.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.027 0.441 . . . . 1.0 110.554 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -115.8 132.06 56.75 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 122.066 -0.397 . . . . 1.0 111.076 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 m -114.03 138.68 43.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.98 135.26 49.68 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.42 0.628 . . . . 1.0 110.773 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.632 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 94.6 mt -95.43 129.26 42.65 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 19.0 m -132.84 142.38 44.52 Favored Pre-proline 0 C--N 1.31 -1.15 0 O-C-N 123.172 0.295 . . . . 1.0 110.284 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -72.37 79.6 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.14 1.893 . . . . 1.0 110.664 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.621 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 3.1 t . . . . . 0 C--N 1.323 -0.547 0 C-N-CA 125.931 1.692 . . . . 1.0 111.411 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.483 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 26.8 m-85 . . . . . 0 N--CA 1.406 -2.657 0 N-CA-C 105.025 -2.213 . . . . 1.0 105.025 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.519 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 20.1 mmt180 -104.01 108.17 59.17 Favored Pre-proline 0 C--N 1.277 -2.572 0 C-N-CA 119.384 -0.926 . . . . 1.0 111.841 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -59.43 131.45 40.73 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.255 1.97 . . . . 1.0 110.763 175.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -136.41 159.93 40.27 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.085 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.1 m -95.22 131.26 41.46 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.41 HD23 ' SD ' ' A' ' 44' ' ' MET . 27.1 tp -127.66 142.09 51.43 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -99.88 113.35 25.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.784 -0.572 . . . . 1.0 110.604 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -77.51 112.69 14.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.626 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.517 HD21 ' HA2' ' A' ' 22' ' ' GLY . 31.3 tp -142.01 152.67 43.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.684 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.02 140.2 53.21 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.881 -0.512 . . . . 1.0 110.897 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.42 41.74 3.03 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.622 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.88 -45.2 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 CA-C-N 116.546 -0.297 . . . . 1.0 110.546 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.32 -75.29 0.18 Allowed Glycine 0 C--O 1.22 -0.729 0 C-N-CA 119.777 -1.202 . . . . 1.0 113.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.51 -27.38 76.76 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.53 2.82 . . . . 1.0 113.307 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.69 34.41 2.88 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.68 76.3 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.517 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 114.19 -10.81 22.35 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 173.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -109.88 8.66 24.46 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.948 -0.626 . . . . 1.0 111.613 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.87 -86.54 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.321 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -132.38 -61.69 0.86 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.23 71.31 1.08 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.854 -1.165 . . . . 1.0 110.535 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.34 125.33 38.11 Favored Pre-proline 0 C--N 1.306 -1.323 0 O-C-N 122.898 -0.177 . . . . 1.0 110.818 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.46 101.79 1.54 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.021 1.814 . . . . 1.0 111.757 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 45.7 t -104.99 155.42 6.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.465 -1.309 . . . . 1.0 107.465 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -102.31 150.04 23.73 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.813 -1.155 . . . . 1.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 32' ' ' LEU . 4.4 p -148.26 -178.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.05 -0.977 . . . . 1.0 108.709 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 31' ' ' VAL . 14.4 mt -110.92 162.29 14.98 Favored 'General case' 0 C--O 1.179 -2.617 0 CA-C-N 118.39 0.541 . . . . 1.0 110.852 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.519 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 18.0 t70 -65.11 -31.3 72.44 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-O 121.407 0.623 . . . . 1.0 110.88 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -102.85 28.6 6.03 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.334 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.66 ' O ' ' HA ' ' A' ' 95' ' ' THR . 17.1 p-10 -67.75 135.54 52.85 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -91.08 157.05 17.46 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 45.0 mm -55.86 -40.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.889 0.376 . . . . 1.0 110.446 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 p -62.8 -43.96 97.43 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.294 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -73.15 -37.69 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 1.0 111.677 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.68 -38.39 89.13 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.37 -41.49 72.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -68.32 -47.75 66.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.261 -0.882 . . . . 1.0 110.846 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.83 -44.6 92.73 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.994 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.0 mmm -64.99 -42.76 94.23 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.567 0.542 . . . . 1.0 110.621 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -74.24 -29.33 61.64 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.818 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.08 -30.89 62.66 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.228 1.011 . . . . 1.0 112.539 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.47 HE21 HG13 ' A' ' 29' ' ' VAL . 14.3 mm-40 -70.38 -37.13 74.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.162 0.506 . . . . 1.0 111.283 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.504 -0.822 0 CA-C-O 122.124 0.964 . . . . 1.0 109.654 -176.384 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.3 pp . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 109.908 -0.404 . . . . 1.0 109.908 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 0.1 OUTLIER -115.02 157.7 23.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 -177.36 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.09 121.87 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -91.55 112.72 24.75 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 105.792 -1.929 . . . . 1.0 105.792 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.606 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -86.49 128.72 34.99 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.906 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.98 89.84 3.18 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.4 m -90.1 -17.07 28.36 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.428 -0.909 . . . . 1.0 109.409 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.25 -46.88 3.48 Favored Glycine 0 C--N 1.309 -0.969 0 CA-C-N 114.998 -1.001 . . . . 1.0 112.306 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.35 -27.06 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.146 0.578 . . . . 1.0 111.439 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.496 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . . . -124.08 4.37 8.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.584 0.707 . . . . 1.0 109.775 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.13 -130.43 10.23 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.882 -1.054 . . . . 1.0 113.55 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.34 123.97 46.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 125.144 1.377 . . . . 1.0 108.665 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -132.05 148.43 52.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 mm -94.55 116.11 35.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.282 -0.567 . . . . 1.0 109.616 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.488 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.1 mp -111.03 158.02 19.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.061 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -158.0 159.7 36.69 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.851 -1.907 . . . . 1.0 105.851 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 17.7 p-10 -66.71 -53.74 30.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.237 -0.585 . . . . 1.0 110.384 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--N 1.294 -1.807 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.141 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 89.0 mt . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -73.6 143.21 46.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.646 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -120.58 165.96 14.3 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 124.641 1.176 . . . . 1.0 108.799 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.457 HD13 HG22 ' A' ' 101' ' ' VAL . 2.6 pp -65.39 -28.53 69.33 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.476 173.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.507 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 3.9 pt20 -64.41 -25.93 68.23 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.483 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -64.72 -39.4 93.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -88.5 -19.22 26.72 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 115.506 -0.77 . . . . 1.0 109.79 176.273 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 9.3 mmmm 53.03 60.83 3.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.77 0.828 . . . . 1.0 110.957 -171.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.3 m -76.62 150.46 82.0 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 113.185 0.809 . . . . 1.0 113.185 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 162.12 28.41 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 123.501 2.801 . . . . 1.0 111.307 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.19 130.97 45.06 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.611 0.719 . . . . 1.0 109.748 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.42 17.74 44.75 Favored Glycine 0 C--N 1.284 -2.313 0 CA-C-N 114.979 -1.01 . . . . 1.0 111.58 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.64 151.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 43.7 m -108.0 127.65 53.96 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.213 0.53 . . . . 1.0 110.995 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.402 HG13 HD11 ' A' ' 11' ' ' LEU . 31.5 m -109.74 141.36 25.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.79 52.66 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.703 0.763 . . . . 1.0 110.596 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.684 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.3 tt -95.18 122.91 38.35 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.319 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 13.7 m -128.05 145.39 55.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.15 55.95 5.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.875 2.384 . . . . 1.0 113.511 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.488 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.51 -0.585 0 C-N-CA 124.586 1.154 . . . . 1.0 111.233 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp . . . . . 0 C--O 1.236 0.387 0 CA-C-O 121.093 0.473 . . . . 1.0 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.7 100.19 10.84 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -127.09 88.56 2.83 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.809 -1.182 . . . . 1.0 107.809 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.7 p -122.26 7.65 5.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-O 122.001 0.905 . . . . 1.0 110.118 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -89.82 61.53 5.4 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.48 1.133 . . . . 1.0 110.446 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.86 161.59 39.64 Favored 'General case' 0 N--CA 1.394 -3.232 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.545 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 17.8 mmt180 -124.11 115.9 27.41 Favored Pre-proline 0 C--N 1.263 -3.158 0 C-N-CA 119.893 -0.723 . . . . 1.0 111.632 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.38 109.18 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.785 1.657 . . . . 1.0 108.334 168.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 tp -113.04 158.49 20.25 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.212 -0.903 . . . . 1.0 111.001 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 m -103.56 127.61 50.94 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.515 HD23 ' SD ' ' A' ' 44' ' ' MET . 14.8 tp -126.94 139.83 52.77 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -96.72 114.0 25.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 -177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.39 114.73 13.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.799 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.549 HD21 ' HA2' ' A' ' 22' ' ' GLY . 12.8 tp -142.14 167.34 22.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.645 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.7 pt? -135.94 144.96 45.73 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -110.94 30.76 6.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.909 0.385 . . . . 1.0 111.034 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' HD3' ' A' ' 111' ' ' PRO . 71.5 t -65.94 -47.79 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.816 0 CA-C-N 115.897 -0.592 . . . . 1.0 112.383 -175.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.4 -81.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.2 -1.476 . . . . 1.0 113.819 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.63 -27.67 83.64 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 123.599 2.866 . . . . 1.0 112.821 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.91 37.63 2.02 Favored Glycine 0 N--CA 1.408 -3.173 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.68 48.97 0.09 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.465 0.913 . . . . 1.0 113.465 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.549 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 136.42 -3.78 3.65 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.795 -0.922 . . . . 1.0 110.795 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.02 29.75 2.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.06 0.457 . . . . 1.0 111.597 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.96 -76.03 0.27 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -140.76 -63.83 0.47 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.585 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.19 88.84 0.59 Allowed Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.273 -0.965 . . . . 1.0 111.089 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.6 126.54 28.93 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.86 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.937 1.758 . . . . 1.0 111.86 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.569 HG22 ' HG3' ' A' ' 47' ' ' GLN . 13.9 t -112.34 155.35 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -107.67 144.28 34.97 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 m -142.21 -175.22 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 113.598 -1.637 . . . . 1.0 109.504 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.3 158.88 25.19 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 110.27 -0.27 . . . . 1.0 110.27 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.545 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.1 t70 -66.43 -31.33 72.02 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.6 t -103.27 33.36 3.34 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.872 -1.513 . . . . 1.0 109.491 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.564 ' O ' HG22 ' A' ' 95' ' ' THR . 12.8 p-10 -71.58 -165.76 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.216 -0.902 . . . . 1.0 109.013 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 50.1 p -139.07 157.92 45.11 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 169.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 78' ' ' SER . 39.5 mm -59.22 -41.41 83.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 13.5 m -61.8 -43.47 98.79 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.861 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -69.87 -41.21 75.11 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.207 0.527 . . . . 1.0 111.196 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.701 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.88 -39.16 93.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.51 -40.53 75.16 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.429 176.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mt-10 -68.59 -47.9 65.57 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 123.754 0.659 . . . . 1.0 110.778 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -63.58 -44.03 95.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.232 0.333 . . . . 1.0 111.621 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.2 mmm -65.03 -40.85 95.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.47 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.533 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 4.0 pp -74.45 -33.18 62.85 Favored 'General case' 0 C--O 1.188 -2.147 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.098 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -51.6 -31.15 23.82 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 124.951 1.301 . . . . 1.0 112.932 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.569 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.5 mm-40 -69.48 -36.61 76.71 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.722 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -97.32 -39.33 9.28 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 122.044 0.926 . . . . 1.0 110.058 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.533 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 25.3 m-85 -96.48 32.51 2.0 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 125.469 1.508 . . . . 1.0 109.676 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -53.55 119.43 4.87 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.63 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.4 -6.06 49.37 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.092 -0.575 . . . . 1.0 112.527 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.9 t -77.89 122.9 86.22 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-O 120.718 0.294 . . . . 1.0 111.365 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -66.84 165.43 25.92 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.707 2.938 . . . . 1.0 112.285 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.13 -42.8 99.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.535 0.569 . . . . 1.0 112.535 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.4 t -66.26 -23.09 66.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.939 0.4 . . . . 1.0 111.803 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -89.02 -25.27 22.08 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 111.779 0.289 . . . . 1.0 111.779 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 77.4 mtt180 -66.21 116.71 36.07 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 21.7 Cg_exo -66.31 140.33 58.04 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.621 2.214 . . . . 1.0 113.094 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.47 142.25 57.81 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HA ' HD13 ' A' ' 63' ' ' LEU . 60.8 Cg_endo -70.11 9.29 0.67 Allowed 'Trans proline' 0 N--CA 1.483 0.867 0 C-N-CA 123.174 2.583 . . . . 1.0 113.699 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -94.56 -31.29 13.96 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.412 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 12.8 t -90.96 -23.2 20.51 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 121.33 0.586 . . . . 1.0 110.606 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -126.14 147.93 49.51 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 172.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.17 138.17 39.47 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.53 117.14 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.446 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -91.34 111.82 23.47 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 105.836 -1.913 . . . . 1.0 105.836 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.631 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.9 t-105 -88.72 126.04 35.14 Favored 'General case' 0 N--CA 1.39 -3.446 0 CA-C-N 115.197 -0.911 . . . . 1.0 108.927 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.86 88.98 2.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 107.057 -1.46 . . . . 1.0 107.057 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 62.7 p -71.33 -27.24 63.24 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.483 -1.235 . . . . 1.0 110.082 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 -57.31 4.84 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.484 -1.235 . . . . 1.0 110.7 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.9 m -64.29 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 120.924 0.393 . . . . 1.0 111.895 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.48 -1.4 30.68 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.557 0.694 . . . . 1.0 110.354 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.71 -119.7 6.31 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 27.8 p-80 -140.42 138.26 34.61 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.604 0.24 . . . . 1.0 110.742 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.0 tp -134.73 144.48 47.76 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 115' ' ' LYS . 28.5 mm -81.62 118.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.854 -1.165 . . . . 1.0 107.854 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.472 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.2 mp -107.71 157.6 17.97 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.4 0.619 . . . . 1.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 37' ' ' ILE . 13.3 m -157.32 160.32 38.4 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.17 -48.06 77.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -126.59 111.02 13.85 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.676 0.75 . . . . 1.0 109.14 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.3 -82.92 0.63 Allowed 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 122.66 1.219 . . . . 1.0 108.105 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.6 p -76.4 -19.73 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.558 0 CA-C-N 112.962 -1.926 . . . . 1.0 108.655 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.9 p -98.25 6.93 46.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.12 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 t -76.02 -4.6 42.14 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.371 -0.832 . . . . 1.0 110.522 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -76.1 118.33 18.74 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.49 0.662 . . . . 1.0 110.392 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.39 91.69 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -143.03 -19.59 0.65 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.426 -1.261 . . . . 1.0 110.602 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.98 -112.67 0.26 Allowed Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 110.273 -1.131 . . . . 1.0 110.273 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 pp -87.97 -3.88 58.87 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -63.25 -30.69 71.78 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -64.79 105.83 1.08 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -156.99 143.61 18.33 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.615 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.9 mt -77.59 138.81 39.36 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -85.06 142.24 29.69 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.942 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.1 p -107.32 168.39 9.26 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 124.604 1.162 . . . . 1.0 108.53 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.632 HD13 HG22 ' A' ' 101' ' ' VAL . 4.0 pp -72.97 -24.33 60.77 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.064 173.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.8 pt20 -64.36 -26.54 68.51 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.335 176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -66.05 -41.7 90.48 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.6 t80 -80.05 -16.26 55.45 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.653 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 58.78 52.12 6.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.778 0.831 . . . . 1.0 110.983 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.632 HG22 HD13 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -78.36 146.83 71.14 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 113.346 0.869 . . . . 1.0 113.346 -178.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.16 158.41 26.63 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 123.481 2.788 . . . . 1.0 112.155 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.55 122.65 18.05 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.437 0.637 . . . . 1.0 109.542 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.68 21.85 10.88 Favored Glycine 0 C--N 1.288 -2.131 0 C-N-CA 120.309 -0.948 . . . . 1.0 110.852 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.62 162.52 28.68 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.4 m -114.52 133.52 55.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 120.783 0.325 . . . . 1.0 110.389 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 11' ' ' LEU . 29.5 m -115.74 136.27 53.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.19 144.55 51.01 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.645 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.13 147.72 46.49 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.825 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 16' ' ' ALA . 27.4 m -132.24 136.17 27.65 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.242 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.538 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.5 Cg_endo -73.5 82.42 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.258 1.972 . . . . 1.0 111.97 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 62' ' ' THR . 4.3 p 45.68 66.95 0.81 Allowed 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 125.148 1.379 . . . . 1.0 111.477 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 113' ' ' LEU . 1.1 tm? -113.71 -50.77 2.82 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 114.676 -1.147 . . . . 1.0 110.839 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.0 t -144.89 71.79 1.31 Allowed 'General case' 0 N--CA 1.412 -2.332 0 CA-C-O 122.014 0.911 . . . . 1.0 113.264 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HA ' HG21 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -78.97 65.87 4.27 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.218 -0.993 . . . . 1.0 109.699 172.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -80.02 102.75 9.46 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.04 -170.74 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 114.573 -1.194 . . . . 1.0 108.918 -173.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 pp -59.73 137.11 58.14 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.519 0.676 . . . . 1.0 110.001 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -118.8 161.99 19.22 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.487 -0.779 . . . . 1.0 109.885 -174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.96 114.24 21.1 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 122.156 0.979 . . . . 1.0 109.961 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -163.14 127.26 2.92 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 . . . . . 0 N--CA 1.422 -1.843 0 C-N-CA 120.196 -0.602 . . . . 1.0 109.873 177.783 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 120.769 0.319 . . . . 1.0 110.613 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -123.35 76.0 1.36 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.073 -1.084 . . . . 1.0 108.073 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -85.35 81.87 8.58 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.635 -1.166 . . . . 1.0 109.748 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 p -138.73 80.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-O 122.234 1.016 . . . . 1.0 111.36 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.06 74.11 1.28 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 122.813 1.292 . . . . 1.0 109.618 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -145.23 165.04 29.52 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 114.317 -1.31 . . . . 1.0 108.842 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.503 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 23.0 mmt180 -119.3 116.4 33.76 Favored Pre-proline 0 C--N 1.268 -2.961 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.208 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.32 104.82 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 107.35 -1.827 . . . . 1.0 107.35 167.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -110.82 159.72 17.4 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.648 -0.705 . . . . 1.0 111.036 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -108.51 125.95 52.37 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 107' ' ' VAL . 20.0 tp -127.45 141.89 51.55 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.45 114.73 26.43 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 122.405 -0.184 . . . . 1.0 110.857 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.14 119.96 20.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.171 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.67 HD21 ' HA2' ' A' ' 22' ' ' GLY . 13.4 tp -148.46 163.27 37.67 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -129.58 144.12 51.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.017 -0.427 . . . . 1.0 110.079 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -112.85 37.17 3.19 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.913 0.387 . . . . 1.0 111.023 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.85 -44.31 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.314 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.813 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.07 -88.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.4 -1.381 . . . . 1.0 113.888 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.31 -37.82 88.57 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.906 2.404 . . . . 1.0 113.139 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.48 33.74 5.38 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -70.58 48.51 0.11 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.468 0.914 . . . . 1.0 113.468 -176.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.67 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 146.85 -12.38 1.47 Allowed Glycine 0 C--N 1.299 -1.49 0 C-N-CA 120.68 -0.771 . . . . 1.0 112.402 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.88 25.47 5.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.089 0.471 . . . . 1.0 111.432 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.8 -77.38 0.19 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -129.56 -58.77 1.1 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.467 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 75.61 0.61 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 1.0 111.591 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.35 125.18 38.59 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 110.277 -0.268 . . . . 1.0 110.277 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.43 102.07 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.859 1.706 . . . . 1.0 111.045 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 47' ' ' GLN . 15.0 t -111.02 155.06 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.52 143.71 38.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 113.746 1.017 . . . . 1.0 113.746 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.6 -175.19 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 113.74 -1.573 . . . . 1.0 109.165 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.45 157.61 27.9 Favored 'General case' 0 C--O 1.191 -1.988 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.503 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 31.7 t70 -66.06 -31.54 72.47 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.87 0.731 . . . . 1.0 109.124 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.2 t -104.99 37.2 2.22 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 114.034 -1.439 . . . . 1.0 109.552 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 95' ' ' THR . 14.2 p-10 -71.83 -161.44 0.07 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.633 -1.167 . . . . 1.0 109.121 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 65.0 p -143.87 155.16 44.0 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 103.71 -2.7 . . . . 1.0 103.71 167.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mm -57.69 -39.54 70.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 118.614 0.643 . . . . 1.0 110.357 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 m -61.26 -43.95 98.04 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.512 175.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HB3' ' H ' ' A' ' 36' ' ' THR . 51.3 tt0 -68.17 -41.47 81.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.519 0.328 . . . . 1.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.95 -38.66 91.71 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.101 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -40.9 73.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 38' ' ' SER . 45.9 mt-10 -68.71 -51.78 37.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.67 0.606 . . . . 1.0 111.379 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.06 -42.43 99.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.807 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.5 mmm -65.21 -41.06 94.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.25 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.88 -30.47 58.85 Favored 'General case' 0 C--O 1.201 -1.493 0 C-N-CA 120.71 -0.396 . . . . 1.0 112.028 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' ' HE3' ' A' ' 50' ' ' LYS . 25.7 t70 -53.99 -31.4 50.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.536 1.134 . . . . 1.0 112.438 -173.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.528 ' HG3' HG22 ' A' ' 29' ' ' VAL . 13.6 mm-40 -68.83 -40.06 79.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 1.0 110.551 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -95.82 -41.86 8.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.875 0.845 . . . . 1.0 110.855 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -95.74 28.65 2.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 125.39 1.476 . . . . 1.0 110.046 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 46' ' ' ASP . 4.5 tppp? -51.31 123.7 10.21 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.453 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.84 1.21 34.26 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.687 -0.768 . . . . 1.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 t -89.45 121.0 69.67 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.69 167.75 18.46 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 123.416 2.744 . . . . 1.0 111.683 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.97 -42.7 98.85 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.496 0.554 . . . . 1.0 112.496 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 t -70.81 -20.62 62.56 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.159 0.504 . . . . 1.0 111.473 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -88.92 -6.78 57.04 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.738 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -82.18 117.01 66.84 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 108.493 -0.928 . . . . 1.0 108.493 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.7 143.68 75.28 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.777 2.318 . . . . 1.0 113.342 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.61 135.39 64.57 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.133 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HA ' HD13 ' A' ' 63' ' ' LEU . 57.5 Cg_endo -71.06 12.35 0.46 Allowed 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.322 2.681 . . . . 1.0 112.962 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -93.53 -13.38 27.86 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.031 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.1 t -117.42 -2.97 11.44 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.792 0.33 . . . . 1.0 111.88 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.575 HD13 ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -142.51 151.8 42.02 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 174.251 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' OD1' ' HD2' ' A' ' 115' ' ' LYS . 16.7 m-20 -103.48 139.42 38.86 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 120.026 -0.669 . . . . 1.0 111.054 -171.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.61 115.07 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 N-CA-C 106.596 -1.631 . . . . 1.0 106.596 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.426 ' HB2' HG21 ' A' ' 114' ' ' THR . 43.5 tt0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.392 -3.345 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.635 ' HZ2' HG21 ' A' ' 101' ' ' VAL . 4.6 t-105 -85.93 124.15 32.07 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.505 -1.225 . . . . 1.0 109.327 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -111.5 89.19 2.98 Favored 'General case' 0 N--CA 1.396 -3.127 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.9 p -68.12 -31.59 71.29 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.087 -1.415 . . . . 1.0 109.924 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.55 -50.61 4.36 Favored Glycine 0 C--N 1.303 -1.294 0 CA-C-N 114.359 -1.291 . . . . 1.0 111.343 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.21 -39.95 85.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 122.872 0.469 . . . . 1.0 111.897 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.25 -29.51 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.164 0.507 . . . . 1.0 110.073 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.15 -120.95 3.21 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 10.7 p-80 -136.32 136.75 39.98 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.611 0.243 . . . . 1.0 110.701 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.6 tp -134.94 145.27 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -83.43 117.48 29.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.549 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -110.53 151.2 27.87 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-O 121.306 0.574 . . . . 1.0 110.816 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 m -159.14 161.4 36.28 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 105.203 -2.147 . . . . 1.0 105.203 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -64.7 -37.98 89.45 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 14.2 pt-20 -125.35 112.41 16.3 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.055 172.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 30.2 t70 -134.9 -87.26 0.38 Allowed 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.402 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 8.2 p -72.84 -23.14 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.4 0 CA-C-N 113.479 -1.691 . . . . 1.0 108.408 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.401 HG23 HG13 ' A' ' 82' ' ' VAL . 7.3 p -99.47 4.19 45.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.696 -1.593 . . . . 1.0 111.109 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.58 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 35.4 t -67.2 -17.92 65.03 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.796 -0.638 . . . . 1.0 112.65 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.51 137.29 34.65 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.674 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -118.11 94.15 2.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -151.81 -14.11 0.19 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.309 -0.86 . . . . 1.0 112.435 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.94 -109.24 0.24 Allowed Glycine 0 N--CA 1.424 -2.115 0 C-N-CA 120.304 -0.951 . . . . 1.0 111.287 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.25 -9.65 59.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.263 0.554 . . . . 1.0 112.193 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -64.2 -46.61 83.16 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 115.102 -0.954 . . . . 1.0 112.974 -176.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -68.22 106.1 2.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.355 0.598 . . . . 1.0 111.927 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -164.26 144.53 8.01 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 92.6 mt -75.32 142.12 43.27 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -85.09 138.59 32.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.058 -0.657 . . . . 1.0 111.099 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -113.84 169.04 9.28 Favored 'General case' 0 C--O 1.26 1.637 0 C-N-CA 125.061 1.344 . . . . 1.0 108.489 178.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.657 HD13 HG22 ' A' ' 101' ' ' VAL . 3.8 pp -72.33 -24.34 61.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 118.751 -1.18 . . . . 1.0 109.145 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 5.1 pt20 -63.98 -26.11 68.43 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.705 176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -65.25 -40.02 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.44 -15.79 41.83 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.409 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 57.44 51.19 10.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.112 0.965 . . . . 1.0 110.422 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.657 HG22 HD13 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -74.62 148.28 85.27 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.31 157.08 29.48 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.247 2.631 . . . . 1.0 112.743 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.36 120.15 12.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.06 16.87 11.63 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 110.861 -0.895 . . . . 1.0 110.861 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.97 162.67 28.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.044 0.45 . . . . 1.0 110.579 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 26.3 m -115.98 133.29 56.18 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.38 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 11' ' ' LEU . 27.0 m -120.24 137.94 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 C-N-CA 120.593 -0.443 . . . . 1.0 109.982 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -128.46 139.88 52.11 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 177.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.58 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.39 147.52 40.44 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.934 -178.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.566 HG21 ' H ' ' A' ' 114' ' ' THR . 16.5 m -139.45 151.46 66.84 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.187 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.16 72.66 5.81 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.522 2.148 . . . . 1.0 111.152 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 p 45.49 76.85 0.09 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.027 1.331 . . . . 1.0 110.399 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.08 -40.12 0.32 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 113.353 0.871 . . . . 1.0 113.353 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.566 ' H ' HG21 ' A' ' 110' ' ' VAL . 6.3 t -98.23 10.79 39.77 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.688 0.756 . . . . 1.0 112.045 -170.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HD2' ' OD1' ' A' ' 64' ' ' ASP . 20.5 ptmt -81.84 114.96 20.81 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.916 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -95.94 104.79 16.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.957 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.27 147.61 6.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.935 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.44 148.65 44.87 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.123 0.487 . . . . 1.0 111.568 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -100.22 169.41 9.16 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.0 124.47 32.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.87 106.83 11.22 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.56 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 C--N 1.284 -2.25 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 176.109 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 59.1 tptt . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.79 134.26 3.68 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 106.635 -1.617 . . . . 1.0 106.635 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -81.86 77.51 8.68 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.849 0.833 . . . . 1.0 112.179 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.8 t -119.45 81.1 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-N 114.429 -1.26 . . . . 1.0 107.999 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -126.84 82.79 2.11 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 122.517 1.151 . . . . 1.0 108.522 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.504 ' HB2' HD22 ' A' ' 32' ' ' LEU . 76.6 m-85 -126.14 -178.12 4.2 Favored 'General case' 0 N--CA 1.403 -2.808 0 N-CA-C 105.914 -1.884 . . . . 1.0 105.914 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' H ' ' HB2' ' A' ' 33' ' ' ASP . 38.9 mmt180 -109.25 106.92 59.36 Favored Pre-proline 0 C--N 1.273 -2.74 0 C-N-CA 118.877 -1.129 . . . . 1.0 109.74 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -64.59 111.6 1.72 Allowed 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.87 1.713 . . . . 1.0 108.22 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HB3' HG23 ' A' ' 31' ' ' VAL . 5.8 tp -115.48 159.43 21.19 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-O 121.248 0.547 . . . . 1.0 111.368 -172.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -111.5 132.59 54.39 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -125.05 154.58 41.1 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 123.486 0.714 . . . . 1.0 111.065 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -98.93 106.69 18.98 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.384 -0.825 . . . . 1.0 108.868 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.48 112.92 8.0 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.878 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.442 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.4 tp -144.6 149.98 36.68 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.667 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -122.9 143.84 49.62 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 122.27 -0.269 . . . . 1.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -113.57 29.92 7.63 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.164 0.506 . . . . 1.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.7 t -64.19 -47.03 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 CA-C-N 115.608 -0.724 . . . . 1.0 112.222 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.47 -78.69 0.1 OUTLIER Glycine 0 C--O 1.213 -1.17 0 C-N-CA 119.079 -1.534 . . . . 1.0 113.8 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.0 -28.75 87.76 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 123.012 2.475 . . . . 1.0 113.106 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.56 33.14 3.35 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.19 79.09 0.35 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 103.86 9.29 37.76 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.9 30.75 0.71 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.406 0.622 . . . . 1.0 110.925 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 -75.37 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.295 -0.562 . . . . 1.0 112.068 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.88 -67.43 0.44 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.964 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 77.23 0.91 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.131 -1.588 . . . . 1.0 109.131 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.49 130.42 23.09 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.428 -0.386 . . . . 1.0 110.541 -173.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -72.5 104.51 1.72 Allowed 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.128 1.885 . . . . 1.0 111.431 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 25.5 t -114.04 155.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.247 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -104.6 146.14 29.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.728 0.299 . . . . 1.0 111.542 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -148.74 -174.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 124.79 1.236 . . . . 1.0 109.496 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' HB2' ' A' ' 6' ' ' TYR . 14.0 mt -122.37 167.71 12.96 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 123.049 0.54 . . . . 1.0 110.065 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' A' ' 7' ' ' ARG . 29.7 t70 -65.77 -31.28 72.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.73 -0.841 . . . . 1.0 108.73 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 t -112.94 19.82 16.95 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 114.344 1.238 . . . . 1.0 114.344 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.336 24.6 p-10 -85.22 140.2 31.07 Favored 'General case' 0 N--CA 1.415 -2.211 0 C-N-CA 115.853 -2.339 . . . . 1.0 109.411 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -75.17 166.42 23.68 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.637 -1.165 . . . . 1.0 110.852 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -59.31 -41.1 83.12 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.599 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -59.83 -48.1 83.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -73.11 -44.91 59.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.365 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.13 -36.53 82.08 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.593 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 34.1 ttpt -61.74 -34.9 76.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.679 ' HG3' ' O ' ' A' ' 38' ' ' SER . 61.3 mt-10 -65.85 -46.95 76.58 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.043 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.49 ' HD2' HG12 ' A' ' 31' ' ' VAL . 64.2 mttp -61.8 -41.77 98.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 123.301 0.376 . . . . 1.0 111.408 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.591 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.6 mmt -61.42 -48.56 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.129 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -77.48 -24.52 50.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.776 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 16.4 t70 -58.04 -34.08 69.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.771 0.828 . . . . 1.0 111.828 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.54 ' HG3' HG22 ' A' ' 29' ' ' VAL . 77.4 mm-40 -66.36 -31.92 72.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.521 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.09 -43.39 8.14 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.011 0.434 . . . . 1.0 111.182 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 46' ' ' ASP . 1.1 p90 -75.39 -11.67 60.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.824 -0.625 . . . . 1.0 112.069 -175.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -57.74 114.76 2.43 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.6 5.93 66.38 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.91 -0.586 . . . . 1.0 112.438 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG22 ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -100.98 147.83 34.24 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD2' HG22 ' A' ' 52' ' ' VAL . 17.8 Cg_endo -60.33 154.57 51.94 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.015 2.477 . . . . 1.0 112.27 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.41 -43.23 96.93 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.344 0.658 . . . . 1.0 112.057 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -69.45 -17.27 63.62 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -89.39 -15.4 33.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.307 0.575 . . . . 1.0 110.433 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 94.1 mtt180 -76.9 135.16 67.65 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.881 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.07 151.24 61.4 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 122.468 2.112 . . . . 1.0 110.999 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -91.23 102.95 6.33 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 116.224 -0.443 . . . . 1.0 109.908 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.21 -24.12 72.55 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.239 1.959 . . . . 1.0 112.86 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -68.79 -22.21 64.29 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.516 0.562 . . . . 1.0 112.516 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -119.02 17.27 13.31 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.942 0.401 . . . . 1.0 110.868 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.7 OUTLIER -126.95 143.16 51.36 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 119.838 -0.745 . . . . 1.0 112.001 -179.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' HG23 ' A' ' 110' ' ' VAL . 12.6 p-10 -107.26 166.3 10.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.642 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.56 126.43 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.56 0.695 . . . . 1.0 110.276 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -94.66 113.51 25.31 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 105.636 -1.987 . . . . 1.0 105.636 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.638 ' CE3' HD22 ' A' ' 77' ' ' LEU . 5.0 t-105 -89.85 137.18 32.56 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.742 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.31 88.99 3.04 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 107.327 -1.36 . . . . 1.0 107.327 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 p -72.5 -31.84 65.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.251 1.024 . . . . 1.0 108.731 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.93 -55.1 4.62 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 113.708 -1.587 . . . . 1.0 110.525 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -64.27 -42.3 95.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.476 -0.362 . . . . 1.0 111.54 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.41 -21.44 15.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.217 0.532 . . . . 1.0 109.677 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.21 -130.78 9.95 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.142 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 63.2 m-70 -111.42 122.49 47.98 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 123.322 0.649 . . . . 1.0 109.505 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -134.52 136.89 43.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 115' ' ' LYS . 16.1 mm -84.21 123.1 38.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.866 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.638 HD22 ' CE3' ' A' ' 67' ' ' TRP . 9.9 mp -108.58 150.48 27.43 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.483 0.658 . . . . 1.0 111.427 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.515 ' OG ' HG12 ' A' ' 82' ' ' VAL . 10.9 m -152.09 150.94 30.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.34 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.2 p30 -74.21 -41.15 61.84 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.839 -0.619 . . . . 1.0 109.9 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -153.05 63.63 0.77 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.799 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 78' ' ' SER . 11.2 m-20 -143.92 -103.84 0.12 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.243 -0.583 . . . . 1.0 112.433 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.515 HG12 ' OG ' ' A' ' 78' ' ' SER . 8.9 p -68.39 -41.39 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.617 0.969 . . . . 1.0 113.617 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.58 HG23 ' ND2' ' A' ' 94' ' ' ASN . 9.1 t -97.19 16.51 19.61 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.894 0.854 . . . . 1.0 110.535 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 m -128.15 112.99 15.15 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.896 -1.15 . . . . 1.0 107.896 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -76.2 114.0 14.38 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.56 0.695 . . . . 1.0 110.287 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -103.87 77.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 123.208 1.48 . . . . 1.0 110.1 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -141.22 21.3 2.25 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.525 -1.671 . . . . 1.0 109.99 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.18 -140.51 7.41 Favored Glycine 1 N--CA 1.385 -4.722 0 N-CA-C 108.586 -1.806 . . . . 1.0 108.586 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.726 ' H ' HD23 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -79.84 4.71 15.71 Favored 'General case' 0 C--N 1.262 -3.21 0 C-N-CA 124.272 1.029 . . . . 1.0 111.229 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -77.05 -14.36 59.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.905 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -67.85 105.33 1.94 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 153.41 42.75 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.315 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 70.3 mt -79.66 129.99 34.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.58 ' ND2' HG23 ' A' ' 83' ' ' THR . 68.5 m-80 -90.45 159.87 16.33 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.711 -177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.2 p -119.21 -178.95 3.7 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.056 0.942 . . . . 1.0 108.503 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -78.71 -19.71 51.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.464 -1.294 . . . . 1.0 109.532 175.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.518 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 5.3 pt20 -66.71 -25.79 66.7 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 120.979 0.418 . . . . 1.0 110.518 176.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -62.16 -35.33 78.47 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -97.25 -16.43 20.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.334 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.52 59.59 4.05 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.703 0.801 . . . . 1.0 110.282 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.8 m -73.98 146.8 85.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 119.909 -0.716 . . . . 1.0 112.139 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.56 162.46 35.65 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.793 2.328 . . . . 1.0 112.074 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.06 128.82 37.49 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.642 -0.708 . . . . 1.0 109.37 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.33 25.27 40.34 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.55 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.94 160.19 31.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.984 0.421 . . . . 1.0 110.205 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.5 m -110.78 134.16 52.73 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.121 0.486 . . . . 1.0 110.232 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.573 HG21 ' SD ' ' A' ' 44' ' ' MET . 16.1 m -113.25 155.76 14.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 176.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -135.01 130.05 35.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 172.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.667 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 mp -102.33 130.71 49.13 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.04 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.428 HG21 HG22 ' A' ' 114' ' ' THR . 15.9 m -134.57 149.48 71.06 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.5 82.21 2.54 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 121.939 1.76 . . . . 1.0 112.4 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.419 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 8.7 p 49.6 57.87 6.05 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 125.148 1.379 . . . . 1.0 111.18 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.82 -48.92 3.31 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.92 -1.036 . . . . 1.0 112.641 -172.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.428 HG22 HG21 ' A' ' 110' ' ' VAL . 11.6 t -122.12 23.63 9.81 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 113.913 1.079 . . . . 1.0 113.913 -170.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 18.5 pttp -79.55 18.74 0.7 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.611 0.72 . . . . 1.0 112.67 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -85.5 155.43 21.22 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.627 -1.619 . . . . 1.0 106.627 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 m -68.85 139.92 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.43 -162.31 1.0 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.34 -1.726 . . . . 1.0 106.34 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -66.42 112.89 4.28 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 108.315 -0.995 . . . . 1.0 108.315 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -82.78 85.23 7.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.426 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -116.69 95.71 5.16 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 . . . . . 0 C--N 1.302 -1.484 0 N-CA-C 108.254 -1.017 . . . . 1.0 108.254 -177.268 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp . . . . . 0 CA--C 1.509 -0.604 0 N-CA-C 110.224 -0.287 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -130.17 88.48 2.66 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -84.66 81.98 8.62 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.451 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 2.4 p -114.39 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.157 -0.929 . . . . 1.0 112.413 -175.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.84 42.16 2.47 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.067 -1.457 . . . . 1.0 107.067 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 33.1 p90 -139.3 156.07 47.29 Favored 'General case' 0 N--CA 1.383 -3.824 0 CA-C-N 113.272 -1.786 . . . . 1.0 107.664 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.54 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 18.7 mmt180 -130.33 113.84 17.05 Favored Pre-proline 0 C--N 1.255 -3.535 0 N-CA-C 105.944 -1.872 . . . . 1.0 105.944 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.6 Cg_exo -49.4 115.92 2.01 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.781 1.654 . . . . 1.0 108.875 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 tp -124.13 155.87 37.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.209 0.528 . . . . 1.0 112.151 -170.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.6 m -105.79 128.8 53.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 107' ' ' VAL . 17.7 tp -127.43 142.58 51.38 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 25.8 t-20 -96.03 116.06 28.38 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.33 -0.248 . . . . 1.0 110.33 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.541 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -75.69 121.75 22.96 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.034 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.722 HD21 ' HA2' ' A' ' 22' ' ' GLY . 27.6 tp -151.5 168.12 25.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.611 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 2.1 pt? -136.11 145.06 45.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.123 0.569 . . . . 1.0 109.655 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.18 30.62 7.16 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.027 0.442 . . . . 1.0 110.52 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.404 HG22 ' HD3' ' A' ' 111' ' ' PRO . 50.9 t -64.91 -46.78 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.273 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.75 -81.92 0.08 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 118.511 -1.804 . . . . 1.0 114.66 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.15 -32.28 94.34 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.4 2.733 . . . . 1.0 112.679 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.48 42.36 1.42 Allowed Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.33 39.8 0.05 OUTLIER 'General case' 0 C--O 1.244 0.768 0 N-CA-C 114.057 1.132 . . . . 1.0 114.057 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.722 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 154.16 -20.53 0.65 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.06 57.4 1.7 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.189 0.995 . . . . 1.0 110.333 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.07 -83.08 0.53 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.363 -1.29 . . . . 1.0 111.324 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 7.0 pt20 -111.62 -59.51 1.97 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.609 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 60.05 71.65 0.74 Allowed Glycine 0 CA--C 1.519 0.33 0 O-C-N 123.694 0.621 . . . . 1.0 112.05 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -108.57 127.59 27.16 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 122.656 -0.32 . . . . 1.0 110.218 -174.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.37 110.73 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.687 1.591 . . . . 1.0 111.584 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.581 HG22 ' HG3' ' A' ' 47' ' ' GLN . 21.9 t -116.13 155.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.901 -1.045 . . . . 1.0 108.267 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -106.22 145.3 31.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 114.085 1.143 . . . . 1.0 114.085 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.41 -175.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 113.515 -1.675 . . . . 1.0 108.766 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.1 mt -117.3 158.23 24.73 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 24.4 t70 -66.95 -29.71 69.64 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.801 0.688 . . . . 1.0 109.475 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.72 34.07 2.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.426 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -74.61 -166.39 0.44 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.756 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.6 p -137.29 153.9 50.21 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 168.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 40.0 mm -57.87 -40.0 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.857 0.361 . . . . 1.0 110.103 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.3 p -62.47 -43.88 97.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.122 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -71.6 -41.43 68.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.84 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.09 -37.7 88.39 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.604 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -55.66 -41.52 73.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 176.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' SER . 34.3 mt-10 -71.17 -45.63 63.08 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.284 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -63.37 -43.65 97.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.941 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.5 mmm -64.89 -41.48 95.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.701 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 ' HE2' ' A' ' 41' ' ' LYS . 3.9 pp -75.62 -28.37 58.81 Favored 'General case' 0 C--O 1.198 -1.616 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.846 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.54 -32.53 65.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.874 0.87 . . . . 1.0 112.245 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' A' ' 29' ' ' VAL . 16.7 mm-40 -69.81 -39.79 76.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.231 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.5 -46.28 7.06 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.05 0.928 . . . . 1.0 110.496 -174.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -93.51 29.79 1.9 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 113.893 -1.503 . . . . 1.0 110.087 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -49.87 116.51 1.84 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.872 -1.058 . . . . 1.0 109.847 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.6 -9.29 19.51 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.579 -0.819 . . . . 1.0 111.758 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.33 115.78 61.93 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.74 169.28 16.4 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.274 2.649 . . . . 1.0 112.357 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.24 -40.97 92.14 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.759 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -68.1 -20.66 64.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.968 -0.56 . . . . 1.0 112.247 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -100.55 -3.87 29.77 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.256 0.836 . . . . 1.0 113.256 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -82.38 126.96 72.76 Favored Pre-proline 0 C--N 1.31 -1.127 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.419 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.28 144.21 45.59 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.417 2.078 . . . . 1.0 111.919 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' O ' HG22 ' A' ' 62' ' ' THR . 19.5 m-20 -89.68 140.53 28.08 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HA ' HD13 ' A' ' 63' ' ' LEU . 74.3 Cg_endo -70.64 12.97 0.37 Allowed 'Trans proline' 0 N--CA 1.48 0.683 0 C-N-CA 123.654 2.903 . . . . 1.0 114.159 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -89.61 -23.18 22.0 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 173.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 14.1 t -104.33 -13.4 16.14 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.687 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -138.15 146.71 43.09 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.155 -1.424 . . . . 1.0 107.155 173.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 8.2 p-10 -107.3 150.16 27.0 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 -169.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.86 121.93 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.563 -1.198 . . . . 1.0 108.939 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.18 112.16 23.94 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.63 ' CE2' HG11 ' A' ' 101' ' ' VAL . 4.2 t-105 -87.26 124.19 33.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.49 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.63 88.19 2.69 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 106.853 -1.536 . . . . 1.0 106.853 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.7 p -72.16 -31.61 66.11 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.143 -1.389 . . . . 1.0 109.895 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.03 3.76 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 114.166 -1.379 . . . . 1.0 110.421 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -64.04 -38.04 81.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 122.911 0.485 . . . . 1.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.32 3.18 18.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.741 0.781 . . . . 1.0 110.143 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.51 -121.54 6.52 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.951 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.6 p-80 -134.78 134.87 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.85 0.357 . . . . 1.0 111.185 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.9 tp -134.02 146.12 50.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.562 HG21 ' HA ' ' A' ' 115' ' ' LYS . 28.2 mm -83.13 118.69 31.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.554 HD22 ' CE3' ' A' ' 67' ' ' TRP . 11.0 mp -111.68 159.99 17.69 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.959 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -160.38 162.08 33.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' HB2' HD22 ' A' ' 93' ' ' LEU . 14.5 p-10 -62.52 -42.1 99.29 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -132.71 119.46 20.39 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.454 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -140.19 -79.38 0.29 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-O 122.283 1.04 . . . . 1.0 108.316 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.07 -22.42 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.064 0 CA-C-N 113.283 -1.781 . . . . 1.0 109.075 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.2 p -99.87 1.61 43.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.349 -1.296 . . . . 1.0 110.178 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.4 t -71.78 -17.38 62.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.34 0.59 . . . . 1.0 110.255 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.89 112.1 11.94 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.29 -0.868 . . . . 1.0 109.88 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -98.65 89.19 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -129.11 -18.68 3.67 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 114.8 -1.091 . . . . 1.0 110.702 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.17 -116.04 0.37 Allowed Glycine 0 N--CA 1.407 -3.274 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pp -81.2 -5.86 58.21 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 113.591 0.959 . . . . 1.0 113.591 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -67.47 -28.41 67.84 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -64.88 94.03 0.12 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.802 0.334 . . . . 1.0 110.55 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -167.71 155.05 8.47 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 79' ' ' ASP . 93.2 mt -77.12 148.93 35.74 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -84.19 144.93 28.64 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.159 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -111.46 165.61 11.84 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 125.078 1.351 . . . . 1.0 108.049 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.638 HD13 HG22 ' A' ' 101' ' ' VAL . 4.4 pp -72.1 -22.86 61.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.63 -1.228 . . . . 1.0 109.322 173.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.505 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.6 pt20 -64.64 -25.93 68.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.053 175.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -63.23 -35.82 81.59 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -90.14 -15.86 30.72 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.331 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 57.66 54.28 6.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.773 0.829 . . . . 1.0 110.826 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.638 HG22 HD13 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -81.44 146.87 58.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.111 0.782 . . . . 1.0 113.111 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.41 157.99 29.2 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.187 2.591 . . . . 1.0 112.093 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.87 123.39 20.03 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.509 0.671 . . . . 1.0 109.956 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.82 19.7 11.65 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.68 162.64 28.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.498 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 84.9 m -115.35 131.06 57.05 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.659 0.266 . . . . 1.0 110.965 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 11' ' ' LEU . 27.1 m -115.2 136.49 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 N-CA-C 109.948 -0.39 . . . . 1.0 109.948 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.6 141.22 49.61 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.611 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.89 150.65 44.41 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.878 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 114' ' ' THR . 14.9 m -134.45 156.39 78.89 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HD3' HG22 ' A' ' 17' ' ' VAL . 73.3 Cg_endo -81.21 75.13 5.14 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.054 1.836 . . . . 1.0 111.781 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 62' ' ' THR . 20.1 p 50.31 69.38 0.63 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 125.019 1.327 . . . . 1.0 110.854 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.25 -49.27 1.09 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -173.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.481 HG22 HG21 ' A' ' 110' ' ' VAL . 13.5 t -108.73 19.69 19.39 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.644 -0.822 . . . . 1.0 111.529 -172.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 76' ' ' ILE . 21.4 ptmt -77.25 86.12 3.69 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 122.111 0.958 . . . . 1.0 113.414 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -141.7 113.33 7.75 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.702 -1.135 . . . . 1.0 109.378 175.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.48 -176.15 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.281 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.17 138.27 26.25 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.738 0.649 . . . . 1.0 111.537 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -86.89 154.31 20.95 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.116 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.77 122.21 39.47 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.716 -1.216 . . . . 1.0 107.716 174.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -142.85 111.95 6.56 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.971 -174.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 . . . . . 0 N--CA 1.423 -1.805 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 177.685 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.553 ' HG3' ' OD2' ' A' ' 35' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.48 -1.749 0 CA-C-O 121.449 0.642 . . . . 1.0 110.353 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -130.64 142.61 50.45 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 104.104 -2.554 . . . . 1.0 104.104 170.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.42 74.78 8.41 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 122.527 1.156 . . . . 1.0 112.348 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 m -136.31 -177.26 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.01 -1.45 . . . . 1.0 108.257 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -98.97 96.81 8.08 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.926 0.87 . . . . 1.0 112.531 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 m-85 -128.83 -176.64 3.91 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 103.769 -2.678 . . . . 1.0 103.769 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -98.86 111.12 59.83 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 119.526 1.057 . . . . 1.0 111.243 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 38.8 Cg_exo -61.16 140.23 88.07 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.561 2.174 . . . . 1.0 111.03 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 10' ' ' THR . 5.7 tp -138.92 161.69 36.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 59.8 m -107.98 126.83 53.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.226 -1.028 . . . . 1.0 108.226 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD11 HG13 ' A' ' 107' ' ' VAL . 30.6 tp -127.29 138.0 52.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 27.7 t-20 -90.48 120.43 31.57 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.283 -0.261 . . . . 1.0 111.447 -174.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.08 119.6 25.65 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.774 HD21 ' HA2' ' A' ' 22' ' ' GLY . 36.3 tp -146.67 151.9 37.99 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -114.23 139.51 49.33 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 176.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.41 50.1 0.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.037 0.446 . . . . 1.0 110.769 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.435 HG22 ' HD3' ' A' ' 111' ' ' PRO . 39.7 t -65.92 -46.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.546 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.21 -94.55 0.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.299 -0.953 . . . . 1.0 112.705 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.1 -28.23 73.9 Favored 'Trans proline' 0 N--CA 1.484 0.964 0 C-N-CA 123.251 2.634 . . . . 1.0 112.47 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.41 32.21 5.66 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 110.879 -0.888 . . . . 1.0 110.879 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -74.14 29.03 0.08 Allowed 'General case' 0 C--O 1.246 0.921 0 C-N-CA 123.446 0.698 . . . . 1.0 112.545 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.774 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -176.99 -40.13 0.06 OUTLIER Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 120.572 -0.823 . . . . 1.0 112.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.37 4.3 46.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.6 -73.85 0.12 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 113.73 1.011 . . . . 1.0 113.73 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -129.91 -61.8 0.98 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.443 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.49 62.92 5.71 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.7 t -95.24 126.02 47.9 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 115.58 -0.31 . . . . 1.0 110.334 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -73.74 90.86 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.216 1.944 . . . . 1.0 110.291 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 47' ' ' GLN . 12.7 t -93.91 154.73 3.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -108.7 152.13 25.23 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 32' ' ' LEU . 7.2 p -159.18 177.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.944 -172.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.507 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 31.4 mt -108.62 158.16 17.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.623 0.725 . . . . 1.0 110.999 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 -32.75 73.86 Favored 'General case' 0 C--O 1.282 2.805 0 C-N-CA 124.9 1.28 . . . . 1.0 111.422 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.9 t -98.78 13.18 33.25 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.006 -0.997 . . . . 1.0 111.715 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.553 ' OD2' ' HG3' ' A' ' 1' ' ' LYS . 1.7 m-20 -73.24 133.82 44.1 Favored 'General case' 0 CA--C 1.47 -2.097 0 C-N-CA 119.655 -0.818 . . . . 1.0 109.21 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 39' ' ' GLN . 70.8 p -81.28 171.14 15.2 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 107.554 -1.276 . . . . 1.0 107.554 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 78' ' ' SER . 36.7 mm -60.2 -43.47 93.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 118.134 0.424 . . . . 1.0 110.197 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -67.36 -40.22 85.77 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-O 121.774 0.797 . . . . 1.0 110.707 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 4.4 tt0 -66.9 -32.52 73.84 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.485 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.279 -0.418 . . . . 1.0 111.045 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.5 mmmp? -56.52 -33.95 66.55 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.225 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 17.9 pt-20 -54.43 -50.44 67.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 124.288 0.992 . . . . 1.0 110.273 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.5 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 30.6 mmmt -77.27 -36.59 54.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -47.83 84.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.186 0.517 . . . . 1.0 110.462 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.616 ' HB2' ' CD1' ' A' ' 49' ' ' TYR 0.266 0.8 OUTLIER -78.75 -23.37 45.4 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 112.419 0.526 . . . . 1.0 112.419 176.602 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.63 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.5 t70 -50.65 -29.69 11.68 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 125.025 1.33 . . . . 1.0 112.684 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.434 ' HG3' HG22 ' A' ' 29' ' ' VAL . 12.1 mm-40 -75.31 -17.97 60.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.359 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.36 -30.99 6.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.994 0.902 . . . . 1.0 109.853 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.616 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 32.1 m-85 -98.37 20.02 13.37 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.909 -1.041 . . . . 1.0 111.401 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.13 118.97 9.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.99 -14.1 21.7 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 110.472 -1.051 . . . . 1.0 110.472 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.3 t -97.98 133.1 23.56 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HG2' ' CG ' ' A' ' 56' ' ' GLN . 25.7 Cg_endo -61.98 156.62 48.31 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.86 2.374 . . . . 1.0 112.01 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.71 -41.41 97.56 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.436 0.694 . . . . 1.0 112.001 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 t -66.59 -24.51 66.34 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.059 0.457 . . . . 1.0 111.629 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 16.2 mm100 -86.51 -14.59 42.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.005 0.431 . . . . 1.0 111.905 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -73.98 123.27 89.12 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.165 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.52 147.75 94.67 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.422 2.748 . . . . 1.0 114.04 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -83.38 160.29 59.85 Favored Pre-proline 0 C--N 1.315 -0.893 0 C-N-CA 124.388 1.075 . . . . 1.0 110.891 -176.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.55 8.02 4.86 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.655 2.237 . . . . 1.0 112.099 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -95.0 -21.56 18.52 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.931 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 3.8 t -92.91 -15.54 26.23 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.297 0.57 . . . . 1.0 110.348 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.6 pp -145.64 149.79 35.14 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.569 -1.641 . . . . 1.0 106.569 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HB3' HG23 ' A' ' 76' ' ' ILE . 4.6 m-20 -103.83 156.96 17.41 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 120.406 -0.518 . . . . 1.0 110.145 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.76 117.92 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.54 0.686 . . . . 1.0 109.557 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -92.7 118.03 30.62 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-O 121.459 0.647 . . . . 1.0 109.937 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 16.9 t90 -82.7 119.65 24.58 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.603 -1.18 . . . . 1.0 108.491 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.01 89.22 3.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 120.952 0.406 . . . . 1.0 109.911 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.4 p -91.43 -23.1 20.13 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.893 0.854 . . . . 1.0 109.029 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.67 -52.27 4.43 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.009 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.02 -38.12 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.045 0.45 . . . . 1.0 111.492 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.79 -3.09 36.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.726 0.774 . . . . 1.0 109.589 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.39 -144.11 17.03 Favored Glycine 0 N--CA 1.416 -2.683 0 CA-C-N 114.883 -1.053 . . . . 1.0 110.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.622 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.4 p80 -133.48 115.27 14.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.028 0.531 . . . . 1.0 109.705 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.42 144.47 49.48 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.676 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 64' ' ' ASP . 29.4 mm -83.46 117.69 29.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.79 146.44 28.98 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.3 -0.864 . . . . 1.0 109.817 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.403 ' HA ' HG21 ' A' ' 37' ' ' ILE . 26.7 t -161.88 166.15 26.68 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.257 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.65 -27.41 65.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.37 81.44 1.78 Allowed 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 82' ' ' VAL . 3.0 p30 -102.17 -89.63 0.37 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.637 0.732 . . . . 1.0 112.574 -175.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.424 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 5.0 p -102.69 -14.1 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 C-N-CA 125.041 1.336 . . . . 1.0 108.746 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 16.7 p -87.48 -7.66 57.37 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.153 -0.93 . . . . 1.0 108.653 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.6 p -53.15 -44.9 68.17 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 125.205 1.402 . . . . 1.0 113.976 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -74.71 118.98 18.29 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.828 -0.804 . . . . 1.0 108.828 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 90' ' ' PHE . 2.5 p -143.27 114.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-O 121.651 0.739 . . . . 1.0 112.546 -170.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -102.84 -26.12 13.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.779 -1.101 . . . . 1.0 109.314 172.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -114.99 -100.31 2.31 Favored Glycine 1 N--CA 1.396 -4.021 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.539 ' HB2' HH21 ' A' ' 92' ' ' ARG . 1.1 pp -127.42 24.66 6.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.372 0.606 . . . . 1.0 110.515 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.437 ' H ' HG23 ' A' ' 86' ' ' VAL . 66.1 m-85 -62.59 -38.46 90.22 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 115.009 1.485 . . . . 1.0 115.009 -176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' THR . 43.9 ttp180 -72.08 93.47 1.41 Allowed 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.191 -1.004 . . . . 1.0 112.204 -176.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.539 HH21 ' HB2' ' A' ' 89' ' ' LEU . 28.8 mmt180 -113.86 137.76 51.22 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.324 -1.361 . . . . 1.0 107.324 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.9 mt -66.65 135.62 54.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.887 -1.523 . . . . 1.0 106.887 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 36' ' ' THR . 65.8 m-80 -87.27 137.77 32.05 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.786 -0.765 . . . . 1.0 111.994 -173.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p -105.42 168.98 8.73 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 124.054 0.941 . . . . 1.0 109.312 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.01 -33.18 71.69 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.351 -0.94 . . . . 1.0 108.81 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.57 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 pt20 -65.65 -26.09 67.65 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.576 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -65.57 -35.62 81.36 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.992 0.425 . . . . 1.0 110.422 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.94 -8.09 21.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.199 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 52.47 68.45 0.82 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.454 1.101 . . . . 1.0 112.312 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.471 HG12 ' CE2' ' A' ' 67' ' ' TRP . 2.7 m -78.33 136.7 60.46 Favored Pre-proline 0 N--CA 1.433 -1.285 0 C-N-CA 119.941 -0.704 . . . . 1.0 109.124 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.3 160.54 48.56 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.256 1.97 . . . . 1.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -64.68 124.38 21.76 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.58 25.49 38.79 Favored Glycine 0 C--N 1.303 -1.281 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.798 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.23 36.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.818 0.342 . . . . 1.0 111.039 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 51.1 m -107.97 123.89 49.32 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.055 0.455 . . . . 1.0 110.962 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.497 HG13 HD11 ' A' ' 11' ' ' LEU . 33.4 m -121.15 138.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.446 -0.946 . . . . 1.0 108.446 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -125.72 138.45 53.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.999 0.428 . . . . 1.0 112.019 -176.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.59 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.2 mp -96.39 126.88 41.9 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 30.1 m -116.21 140.13 26.05 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 116.761 -0.199 . . . . 1.0 110.692 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 17' ' ' VAL . 60.0 Cg_endo -72.81 85.06 1.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.633 2.222 . . . . 1.0 112.027 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 116' ' ' HIS . 20.3 p 50.15 93.97 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.874 1.67 . . . . 1.0 113.141 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 114' ' ' THR . 1.7 mm? 64.4 9.87 5.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.595 1.158 . . . . 1.0 110.768 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER 70.68 11.41 7.22 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 126.22 1.808 . . . . 1.0 111.829 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -149.35 107.68 3.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.633 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 51.8 t-80 -62.87 95.61 0.08 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.945 0.72 . . . . 1.0 112.945 -173.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.0 163.51 37.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.53 109.11 20.51 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 74.6 ttt180 -138.49 145.77 41.2 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 53.3 mm-40 -77.79 172.42 13.46 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -79.8 78.33 6.39 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.817 0.818 . . . . 1.0 109.519 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 106.689 -1.597 . . . . 1.0 106.689 179.434 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.542 ' NZ ' ' HB2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.493 -1.234 0 N-CA-C 110.233 -0.284 . . . . 1.0 110.233 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -144.64 71.41 1.3 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.347 -2.094 . . . . 1.0 105.347 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -73.03 81.99 1.24 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 122.877 1.323 . . . . 1.0 114.31 -170.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.3 m -123.95 -163.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 112.958 -1.928 . . . . 1.0 106.404 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -88.21 93.01 9.37 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.833 0.825 . . . . 1.0 112.433 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.506 ' HB2' HD13 ' A' ' 32' ' ' LEU . 21.9 m-85 -137.87 -176.89 4.58 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 103.655 -2.72 . . . . 1.0 103.655 175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -100.38 109.56 57.32 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 118.729 -1.188 . . . . 1.0 111.578 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 33.7 Cg_exo -62.53 139.17 74.65 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 122.357 2.038 . . . . 1.0 110.607 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 96' ' ' LEU . 6.1 tp -135.12 158.81 43.41 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 116.278 -0.419 . . . . 1.0 109.916 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -100.24 128.5 46.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.517 HD11 HG13 ' A' ' 107' ' ' VAL . 22.2 tp -127.82 138.74 52.82 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 25.9 t-20 -91.51 116.89 29.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 122.165 -0.334 . . . . 1.0 110.573 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.84 118.59 21.76 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.606 0.566 . . . . 1.0 109.564 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.633 HD21 ' HA2' ' A' ' 22' ' ' GLY . 33.8 tp -151.41 158.22 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.7 144.34 48.83 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.9 38.79 3.22 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.654 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 ' HD3' ' A' ' 111' ' ' PRO . 54.4 t -66.22 -44.39 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 115.707 -0.679 . . . . 1.0 111.671 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.33 -78.56 0.2 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.902 -1.142 . . . . 1.0 112.611 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.5 -25.94 76.03 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.236 2.624 . . . . 1.0 111.95 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -133.49 41.67 1.45 Allowed Glycine 0 N--CA 1.416 -2.665 0 N-CA-C 110.068 -1.213 . . . . 1.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -71.75 24.22 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.115 0.783 . . . . 1.0 113.115 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.633 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 169.83 -38.54 0.2 Allowed Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.808 -177.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.02 21.68 2.25 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.179 0.514 . . . . 1.0 111.769 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.99 -78.25 0.35 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.74 0.644 . . . . 1.0 112.74 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -125.32 -64.67 1.06 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.863 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.08 63.38 4.79 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 t -93.64 126.08 51.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.94 100.33 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.552 1.501 . . . . 1.0 109.738 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 47' ' ' GLN . 11.3 t -108.32 156.85 8.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -119.3 152.77 36.16 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 40' ' ' ALA . 9.5 p -158.26 169.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 6' ' ' TYR . 15.1 mt -89.95 157.72 17.72 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.35 -32.44 71.27 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-N 114.624 -1.171 . . . . 1.0 110.056 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 23.2 t -101.7 12.54 36.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.775 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 N--CA 1.409 -2.506 0 C-N-CA 118.601 -1.239 . . . . 1.0 108.032 171.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.2 p -80.51 174.33 11.71 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.15 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.3 -42.25 86.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 p -63.79 -45.38 89.96 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 121.986 0.898 . . . . 1.0 111.047 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -77.47 -16.06 58.96 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.253 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.436 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -85.43 -31.49 22.83 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.042 168.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.629 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.9 mmmp? -56.41 -39.86 73.73 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 3.1 pt-20 -58.41 -44.92 89.21 Favored 'General case' 0 N--CA 1.416 -2.159 0 O-C-N 124.333 1.021 . . . . 1.0 111.966 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 28.3 mmmt -72.86 -39.57 66.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.868 1.062 . . . . 1.0 113.868 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.5 mmt -61.27 -46.92 88.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.322 0.582 . . . . 1.0 110.639 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.4 pp -77.45 -24.07 50.35 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.128 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.6 t70 -50.65 -35.57 31.32 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.132 1.373 . . . . 1.0 112.334 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 29' ' ' VAL . 10.5 mm-40 -71.73 -32.93 68.26 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.194 0.521 . . . . 1.0 111.62 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.51 -45.55 7.37 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.01 0.909 . . . . 1.0 109.674 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 88.3 m-85 -95.34 27.63 3.24 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.065 -1.425 . . . . 1.0 110.639 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 46' ' ' ASP . 1.1 tppp? -58.76 121.7 11.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.226 0.536 . . . . 1.0 109.897 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.78 -20.24 9.4 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 110.131 -1.188 . . . . 1.0 110.131 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.3 t -82.63 125.71 75.21 Favored Pre-proline 0 N--CA 1.443 -0.796 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.21 160.34 42.61 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.566 2.177 . . . . 1.0 111.813 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.4 tp -60.68 -38.52 85.24 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.249 0.62 . . . . 1.0 111.438 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 t -66.85 -18.28 65.3 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.857 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -97.58 -11.18 23.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 120.688 -0.405 . . . . 1.0 112.027 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.444 ' HD3' HD11 ' A' ' 45' ' ' LEU . 75.3 mtt180 -77.15 110.09 11.13 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 110.304 -0.258 . . . . 1.0 110.304 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.98 154.25 52.84 Favored 'Trans proline' 0 C--O 1.256 1.394 0 C-N-CA 123.459 2.772 . . . . 1.0 115.475 -172.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.8 154.57 93.3 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.485 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -91.42 23.12 0.63 Allowed 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 123.388 2.725 . . . . 1.0 112.624 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -94.78 -28.51 15.23 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.0 t -91.06 1.41 57.11 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.134 0.969 . . . . 1.0 109.991 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.614 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.3 pp -145.39 161.88 38.61 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 104.599 -2.371 . . . . 1.0 104.599 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 76' ' ' ILE . 18.6 m-20 -122.85 152.82 40.36 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.541 -0.864 . . . . 1.0 109.332 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 p -119.27 120.94 65.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.728 -0.789 . . . . 1.0 109.522 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.13 116.3 28.7 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.556 0.693 . . . . 1.0 109.667 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.667 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 15.8 t90 -82.29 119.27 23.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.668 -1.151 . . . . 1.0 108.042 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.412 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 85.0 mtm180 -123.11 89.06 3.04 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.5 p -88.77 -20.13 25.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.033 0.92 . . . . 1.0 108.932 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.87 -54.5 4.05 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 114.629 -1.168 . . . . 1.0 111.85 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 m -64.49 -42.11 94.28 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 111.587 0.217 . . . . 1.0 111.587 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.5 -9.41 47.43 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.722 0.773 . . . . 1.0 109.028 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.11 13.75 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 114.507 -1.224 . . . . 1.0 111.321 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.667 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.0 p80 -138.4 118.29 13.29 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 123.722 0.809 . . . . 1.0 110.06 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.25 145.17 48.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.405 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' A' ' 64' ' ' ASP . 28.6 mm -88.46 111.49 22.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.098 0.475 . . . . 1.0 109.789 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.6 151.69 20.89 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.289 -0.869 . . . . 1.0 110.347 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 23.1 t -162.68 165.46 25.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 6.4 p-10 -71.67 -31.0 66.32 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 37.7 tt0 -138.16 84.49 2.04 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 3.3 p30 -102.4 -90.43 0.36 Allowed 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.742 0.782 . . . . 1.0 112.64 -174.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.442 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 4.9 p -102.58 -19.02 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.503 0 CA-C-N 113.803 -1.544 . . . . 1.0 108.022 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 21.4 p -79.99 -8.99 59.65 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.916 -1.038 . . . . 1.0 109.643 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.425 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 53.0 p -56.13 -42.35 76.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.528 1.131 . . . . 1.0 113.167 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.71 124.25 23.48 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.55 123.37 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-O 121.668 0.747 . . . . 1.0 112.53 -171.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -101.27 -27.01 13.43 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.081 -0.963 . . . . 1.0 109.659 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.23 -87.97 0.57 Allowed Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 120.155 -1.021 . . . . 1.0 112.469 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -127.03 14.69 7.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.943 0.401 . . . . 1.0 111.634 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -61.54 -36.92 81.93 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.879 1.066 . . . . 1.0 113.879 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 83' ' ' THR . 42.2 ttp180 -77.03 114.17 15.54 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 119.708 -0.797 . . . . 1.0 113.022 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -137.7 146.98 44.42 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 98.2 mt -70.39 142.39 52.09 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -89.93 139.09 30.94 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 119.894 -0.722 . . . . 1.0 111.013 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.5 p -111.39 171.13 7.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 124.007 0.923 . . . . 1.0 108.599 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.533 HD13 HD22 ' A' ' 9' ' ' LEU . 3.1 pp -68.52 -30.59 69.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.557 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.1 pt20 -64.35 -26.32 68.42 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.987 178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -65.76 -39.96 91.56 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 120.981 0.42 . . . . 1.0 110.376 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.38 -7.21 24.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.521 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 51.75 61.55 3.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.923 1.289 . . . . 1.0 113.143 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 67' ' ' TRP . 3.0 m -70.98 136.87 84.91 Favored Pre-proline 0 N--CA 1.438 -1.032 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.13 160.21 50.8 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.545 2.163 . . . . 1.0 111.326 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -66.45 117.96 9.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.712 0.768 . . . . 1.0 109.891 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.41 22.94 20.59 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.712 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.31 152.47 45.39 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 27.7 m -108.56 123.46 48.95 Favored 'General case' 0 C--N 1.279 -2.47 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.253 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.517 HG13 HD11 ' A' ' 11' ' ' LEU . 33.9 m -121.66 155.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -138.45 137.02 36.8 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.307 -0.557 . . . . 1.0 112.003 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.6 mp -94.97 132.67 39.57 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.224 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 16' ' ' ALA . 31.9 m -129.26 137.64 31.41 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.056 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HD3' HG22 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -70.23 86.3 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.227 1.951 . . . . 1.0 111.065 177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.614 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 21.0 p 50.4 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 1.0 112.467 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 114' ' ' THR . 2.2 mm? 58.04 23.69 10.31 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.775 1.23 . . . . 1.0 110.218 -176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER 67.38 13.68 9.42 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.8 1.64 . . . . 1.0 112.545 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -124.18 104.81 9.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -72.19 93.15 1.42 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.635 0.731 . . . . 1.0 111.526 -174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.25 163.88 34.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.92 -1.036 . . . . 1.0 108.349 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.14 106.0 13.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.429 -1.693 . . . . 1.0 106.429 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 67.0 ttt180 -136.76 134.75 37.43 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.985 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 51.0 mm-40 -74.48 175.19 7.99 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -76.98 72.18 3.52 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 122.001 0.905 . . . . 1.0 109.636 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 106.759 -1.571 . . . . 1.0 106.759 -178.891 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 111.783 0.29 . . . . 1.0 111.783 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 135.91 54.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 108.698 -0.852 . . . . 1.0 108.698 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -81.7 -1.55 47.29 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.489 0.662 . . . . 1.0 111.794 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.38 97.27 4.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 115.188 -0.915 . . . . 1.0 109.43 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -108.08 79.38 1.26 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.966 0.889 . . . . 1.0 112.777 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.4 m-85 -123.4 178.5 5.13 Favored 'General case' 0 N--CA 1.393 -3.283 0 N-CA-C 102.928 -2.99 . . . . 1.0 102.928 172.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 23.2 mmt180 -104.66 111.05 65.17 Favored Pre-proline 0 C--N 1.273 -2.757 0 C-N-CA 117.233 -1.787 . . . . 1.0 114.673 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 19.6 Cg_exo -65.69 121.78 9.25 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.383 2.056 . . . . 1.0 109.173 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 9.5 tp -114.9 159.79 20.28 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.374 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m -99.36 124.26 44.33 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 31' ' ' VAL . 2.8 mm? -125.69 144.08 50.76 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.24 0.616 . . . . 1.0 110.179 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -92.67 113.8 26.18 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -74.25 107.94 6.73 Favored 'General case' 0 C--O 1.253 1.273 0 C-N-CA 123.313 0.645 . . . . 1.0 110.166 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 ' HA2' ' A' ' 22' ' ' GLY . 25.7 tp -142.11 158.95 43.16 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -128.5 143.63 51.01 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 110' ' ' VAL . . . -109.71 36.33 3.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.902 0.382 . . . . 1.0 111.184 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.59 -45.15 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 112.556 0.576 . . . . 1.0 112.556 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.42 -81.97 0.14 Allowed Glycine 0 C--N 1.31 -0.885 0 C-N-CA 119.656 -1.259 . . . . 1.0 112.469 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.59 -24.39 77.88 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.995 2.464 . . . . 1.0 112.584 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.57 27.16 5.81 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.4 68.0 2.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.767 0.794 . . . . 1.0 112.445 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.629 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 127.05 -15.68 6.48 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.27 27.65 6.19 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.98 -0.61 . . . . 1.0 112.273 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.82 -93.21 0.07 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.154 0.502 . . . . 1.0 110.583 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 5.8 pt20 -114.56 -62.7 1.56 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.791 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.408 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 71.13 75.0 0.66 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.215 -1.154 . . . . 1.0 110.215 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.1 127.79 26.46 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 110.244 -0.28 . . . . 1.0 110.244 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.02 108.07 2.51 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.708 1.605 . . . . 1.0 110.675 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 ' HA ' ' A' ' 44' ' ' MET . 60.6 t -114.98 139.16 42.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 96.6 mttt -100.54 139.0 36.84 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.856 -0.738 . . . . 1.0 110.339 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG12 HD23 ' A' ' 11' ' ' LEU . 11.2 p -144.16 159.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.87 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.4 156.16 24.31 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.855 0.836 . . . . 1.0 112.697 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.7 -31.65 72.6 Favored 'General case' 0 C--O 1.27 2.16 0 CA-C-N 113.674 -1.603 . . . . 1.0 108.81 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 18.5 t -85.18 -8.64 58.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 113.533 -1.667 . . . . 1.0 111.947 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.88 133.29 45.34 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.72 0.771 . . . . 1.0 109.714 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.0 p -81.93 177.62 8.75 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.446 -1.252 . . . . 1.0 109.875 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.632 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 37.8 mm -60.82 -46.64 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 119.259 -0.401 . . . . 1.0 110.298 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 40.1 m -60.98 -47.72 85.13 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.833 0.708 . . . . 1.0 111.341 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -64.87 -42.84 94.51 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.204 0.526 . . . . 1.0 110.608 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.41 -35.64 81.08 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.414 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -60.95 -40.06 91.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 38' ' ' SER . 40.6 mt-10 -65.3 -49.54 69.12 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.054 -0.976 . . . . 1.0 110.605 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.99 -40.92 95.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.465 0.542 . . . . 1.0 112.465 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.6 mmm -65.3 -43.53 90.8 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 4.4 pp -75.71 -27.08 58.08 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.364 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -55.6 -28.16 53.52 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.801 1.24 . . . . 1.0 113.072 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.645 ' HG3' HG22 ' A' ' 29' ' ' VAL . 6.8 mm100 -69.11 -31.32 69.94 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.282 0.563 . . . . 1.0 110.489 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.7 -26.32 7.03 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.914 -0.585 . . . . 1.0 112.347 -174.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 82.0 m-85 -102.94 31.68 4.08 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -55.62 121.13 8.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.09 -0.959 . . . . 1.0 110.584 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.87 -5.82 51.03 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.053 -0.594 . . . . 1.0 112.22 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.46 123.45 68.19 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 95.9 Cg_endo -73.26 163.7 37.26 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 123.551 2.834 . . . . 1.0 112.748 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -60.23 -40.09 88.96 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.343 0.657 . . . . 1.0 111.14 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.5 t -64.15 -17.48 63.52 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.06 -30.27 12.78 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.222 -0.591 . . . . 1.0 110.155 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 88.4 mtt180 -66.5 147.41 98.97 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.5 145.16 91.83 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 121.799 1.666 . . . . 1.0 109.802 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.483 ' OD2' ' HB2' ' A' ' 61' ' ' ARG . 31.4 t70 -70.36 117.21 52.68 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.08 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . 28.0 Cg_endo -62.97 -20.24 71.06 Favored 'Trans proline' 0 C--O 1.223 -0.241 0 C-N-CA 123.013 2.476 . . . . 1.0 114.117 -173.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.483 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 28.9 mtp-105 -72.55 -35.61 68.04 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 59' ' ' ASP . 1.8 t -87.2 -25.08 24.21 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.217 0.821 . . . . 1.0 113.217 -174.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 60' ' ' PRO 0.291 0.0 OUTLIER -98.77 161.66 13.53 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 119.619 -0.832 . . . . 1.0 110.011 176.09 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -119.94 152.29 37.63 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.9 0.381 . . . . 1.0 111.204 -173.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -123.61 132.13 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.055 0 C-N-CA 120.026 -0.67 . . . . 1.0 109.365 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 40.9 mt-10 -89.6 112.49 23.72 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.534 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.2 t-105 -91.45 118.27 30.41 Favored 'General case' 1 N--CA 1.374 -4.273 0 C-N-CA 119.299 -0.96 . . . . 1.0 108.525 178.21 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -104.46 88.72 3.02 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 106.241 -1.763 . . . . 1.0 106.241 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -90.12 -16.38 29.71 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.561 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.05 -51.16 3.48 Favored Glycine 0 C--N 1.291 -1.962 0 CA-C-N 114.764 -1.107 . . . . 1.0 111.836 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.29 -38.88 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.023 0.529 . . . . 1.0 110.976 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.78 7.24 30.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.932 0.872 . . . . 1.0 108.82 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.33 -132.43 12.66 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 114.168 -1.378 . . . . 1.0 110.925 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 4.5 p80 -117.06 101.3 8.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.81 0.814 . . . . 1.0 109.296 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.68 143.9 34.12 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.049 -174.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.428 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 20.0 mm -88.43 109.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 75' ' ' LEU . 9.0 mp -99.9 144.22 29.21 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.47 -0.786 . . . . 1.0 112.62 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 37' ' ' ILE . 53.3 m -153.99 146.55 24.11 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.293 -2.114 . . . . 1.0 105.293 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.53 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 0.5 OUTLIER -74.45 -40.67 61.78 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.557 -0.857 . . . . 1.0 110.702 175.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -130.79 89.5 2.76 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.259 0.466 . . . . 1.0 112.259 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 10.8 m-20 -154.89 -151.85 0.37 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.449 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 9.1 p -54.57 -28.49 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 123.903 0.881 . . . . 1.0 111.29 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 t -83.52 3.11 33.77 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.219 0.608 . . . . 1.0 110.964 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 t -117.07 98.18 6.33 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.529 -0.915 . . . . 1.0 108.529 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.64 130.64 55.98 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.61 -1.255 . . . . 1.0 107.61 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 91' ' ' ARG . 15.0 p -143.49 118.89 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.954 0 CA-C-O 121.967 0.889 . . . . 1.0 112.078 -175.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -80.63 -33.85 35.46 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.73 -1.123 . . . . 1.0 110.545 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.5 -90.13 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.264 -0.735 . . . . 1.0 111.264 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pp -105.9 3.82 28.94 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.051 0.453 . . . . 1.0 111.292 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -62.02 -42.83 99.59 Favored 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 123.841 0.856 . . . . 1.0 111.97 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.615 ' H ' HG23 ' A' ' 86' ' ' VAL . 2.9 tpm_? -135.93 153.45 51.43 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.012 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 92' ' ' ARG . 1.9 tpm_? -131.22 -67.86 0.69 Allowed 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 174.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 79' ' ' ASP . 67.2 mt -132.41 161.81 32.69 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 106.948 -1.501 . . . . 1.0 106.948 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.53 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 38.5 m-80 -89.66 139.8 30.2 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.332 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.73 171.3 8.3 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 124.043 0.937 . . . . 1.0 109.406 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 101' ' ' VAL . 2.1 pp -71.96 -27.43 62.78 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 6.1 pt20 -63.74 -25.76 68.34 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 115.789 -0.642 . . . . 1.0 112.584 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -64.19 -45.8 86.74 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -93.04 -3.76 53.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.37 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 13.5 mmtm 43.44 67.92 0.58 Allowed 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 124.96 1.304 . . . . 1.0 113.046 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.534 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.8 m -74.81 148.24 84.78 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 114.703 -1.135 . . . . 1.0 111.566 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.8 164.24 33.99 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.338 2.692 . . . . 1.0 112.924 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.09 116.4 6.45 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.74 24.94 12.37 Favored Glycine 0 C--N 1.303 -1.269 0 C-N-CA 119.283 -1.437 . . . . 1.0 112.11 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.15 164.2 26.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.9 m -113.26 130.67 56.18 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.663 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.46 135.37 50.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -130.82 130.57 43.82 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.542 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 3.9 pp -113.45 144.74 42.31 Favored 'General case' 0 C--N 1.262 -3.199 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.258 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 16' ' ' ALA . 13.7 m -133.64 130.73 20.94 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.156 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 49.7 Cg_endo -70.49 84.09 0.79 Allowed 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.555 2.17 . . . . 1.0 111.485 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.653 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 4.8 p 52.47 76.91 0.17 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 125.544 1.538 . . . . 1.0 112.374 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.1 -53.22 1.84 Allowed 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.447 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 t -108.68 8.37 26.91 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.051 0.929 . . . . 1.0 111.664 -173.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 3.5 tmmm? -123.66 90.12 3.22 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -148.87 -169.44 3.37 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.902 -1.888 . . . . 1.0 105.902 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.01 140.53 17.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.6 mt -76.46 135.84 39.39 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.042 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -64.55 -32.91 74.76 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.825 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -83.4 85.81 7.17 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.812 0.815 . . . . 1.0 109.84 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -145.5 88.26 1.84 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.948 -1.501 . . . . 1.0 106.948 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 118.542 -0.742 . . . . 1.0 109.281 -175.392 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 121.403 0.62 . . . . 1.0 110.003 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.453 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -131.73 164.45 25.94 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.948 -1.131 . . . . 1.0 107.948 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.14 67.15 9.61 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 123.069 1.414 . . . . 1.0 108.915 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.22 20.39 5.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 114.19 -1.368 . . . . 1.0 109.203 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -89.59 54.37 2.87 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 123.009 1.385 . . . . 1.0 110.331 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 50.3 m-85 -133.05 -178.93 5.19 Favored 'General case' 0 N--CA 1.384 -3.769 0 N-CA-C 100.733 -3.803 . . . . 1.0 100.733 175.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 27.3 mmt180 -107.43 111.24 63.1 Favored Pre-proline 0 C--N 1.268 -2.948 0 C-N-CA 116.902 -1.919 . . . . 1.0 112.53 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 16.1 Cg_exo -68.45 111.09 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.2 1.933 . . . . 1.0 107.742 173.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 10' ' ' THR . 3.7 tp -106.73 154.9 20.29 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.626 -0.716 . . . . 1.0 111.162 -172.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 17.9 m -88.09 119.14 28.18 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 106.679 -1.6 . . . . 1.0 106.679 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.58 HD11 HG13 ' A' ' 107' ' ' VAL . 1.0 OUTLIER -127.92 140.26 52.11 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -102.18 120.16 39.99 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.732 -0.605 . . . . 1.0 111.052 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.555 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.53 108.38 14.12 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.306 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.511 HD21 ' HA2' ' A' ' 22' ' ' GLY . 25.4 tp -141.67 159.83 41.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -130.02 143.79 50.98 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.693 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -109.69 39.85 2.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.839 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.43 HG22 ' HD3' ' A' ' 111' ' ' PRO . 46.6 t -65.26 -45.44 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.91 -79.46 0.19 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.823 -1.18 . . . . 1.0 112.142 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.31 -31.51 89.11 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.788 2.325 . . . . 1.0 112.378 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.98 27.95 7.55 Favored Glycine 0 N--CA 1.432 -1.598 0 C-N-CA 121.0 -0.619 . . . . 1.0 111.67 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.49 76.03 5.0 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.47 0.652 . . . . 1.0 111.665 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.511 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 124.57 -15.16 7.61 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 110.446 -1.061 . . . . 1.0 110.446 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.65 29.93 6.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.722 -0.739 . . . . 1.0 111.606 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.2 -90.39 0.19 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.301 -0.56 . . . . 1.0 110.95 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HB2' HG23 ' A' ' 27' ' ' VAL . 11.2 pt20 -111.76 -56.07 2.43 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.654 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.01 65.74 3.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.395 -0.682 . . . . 1.0 111.395 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 25' ' ' GLN . 34.8 t -110.41 124.23 33.78 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.44 -174.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.26 104.3 1.88 Allowed 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.245 1.963 . . . . 1.0 110.822 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 42.9 t -109.29 155.63 10.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.19 137.4 40.51 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.881 0.848 . . . . 1.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.76 157.81 23.63 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 114.299 -1.319 . . . . 1.0 108.082 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.74 155.86 18.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.402 0.62 . . . . 1.0 112.245 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 31.9 t70 -64.6 -30.79 71.82 Favored 'General case' 0 C--O 1.267 1.991 0 CA-C-N 114.559 -1.2 . . . . 1.0 109.189 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 5.8 t -88.82 -0.16 57.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.877 -1.511 . . . . 1.0 111.565 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.33 135.41 40.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.694 . . . . 1.0 109.402 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.44 HG21 HD12 ' A' ' 93' ' ' LEU . 81.0 p -81.78 174.67 11.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.569 -1.196 . . . . 1.0 109.579 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 36.5 mm -60.54 -44.39 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.329 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -62.21 -47.29 85.12 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.135 0.897 . . . . 1.0 110.045 178.005 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -65.47 -41.28 93.53 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.785 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.329 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.22 -38.01 89.51 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 177.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' SER . 37.3 mt-10 -65.83 -45.22 83.09 Favored 'General case' 0 C--O 1.205 -1.245 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.83 -176.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.01 -41.71 98.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.698 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 72.4 mmm -65.63 -42.5 91.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.035 0.445 . . . . 1.0 110.625 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.447 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 4.5 pp -76.27 -29.9 57.62 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.848 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.2 -28.61 58.9 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.924 1.69 . . . . 1.0 113.031 -172.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 29' ' ' VAL . 16.9 mm100 -66.39 -34.72 78.59 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.099 0.476 . . . . 1.0 110.877 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.33 -32.39 5.3 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.778 -173.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 89.9 m-85 -92.0 25.38 2.85 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 123.241 0.617 . . . . 1.0 109.507 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -58.76 118.24 5.49 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.04 -5.86 21.95 Favored Glycine 0 C--N 1.3 -1.459 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.0 t -93.12 116.17 66.09 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 108.925 -0.768 . . . . 1.0 108.925 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 76.9 Cg_endo -69.74 164.18 35.48 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.071 2.514 . . . . 1.0 111.634 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 3.1 tm? -60.62 -40.84 93.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 122.825 0.45 . . . . 1.0 110.227 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 t -63.83 -18.22 63.91 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.723 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -98.78 -25.18 14.74 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.958 -0.464 . . . . 1.0 109.988 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 85.8 mtt180 -65.72 142.99 98.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.25 144.56 95.61 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 122.269 1.98 . . . . 1.0 111.913 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 62' ' ' THR . 7.7 t70 -75.07 126.96 87.51 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.166 -1.05 . . . . 1.0 108.166 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . 55.9 Cg_endo -68.7 -6.75 18.65 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 122.755 2.303 . . . . 1.0 114.492 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -94.34 -17.91 22.11 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.037 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 59' ' ' ASP . 5.5 t -91.47 -8.06 48.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.411 0.624 . . . . 1.0 110.939 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -135.26 144.09 46.66 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 173.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.32 151.71 29.39 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 120.652 0.263 . . . . 1.0 110.8 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 77' ' ' LEU . 12.5 p -121.28 130.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 C-N-CA 119.581 -0.847 . . . . 1.0 111.219 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 35.9 mt-10 -90.41 113.12 24.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.564 -2.013 . . . . 1.0 105.564 172.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.58 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -89.61 120.69 31.12 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -113.45 89.1 3.0 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.578 -1.268 . . . . 1.0 107.578 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.4 p -81.86 -19.76 40.33 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.863 -1.062 . . . . 1.0 109.676 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.46 -50.26 4.31 Favored Glycine 0 C--N 1.308 -1.023 0 CA-C-N 114.572 -1.195 . . . . 1.0 112.002 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.45 -37.84 81.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 1.0 111.432 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.59 -7.2 22.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.759 0.79 . . . . 1.0 109.395 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 -121.5 6.82 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.99 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.3 p80 -135.24 120.35 18.8 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.264 0.554 . . . . 1.0 111.055 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.12 149.41 44.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 21.7 mm -88.81 114.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.6 mp -110.37 143.5 40.53 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.293 0.568 . . . . 1.0 111.63 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 27.4 m -161.09 155.84 23.64 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.639 ' HB2' HD22 ' A' ' 93' ' ' LEU . 2.7 p-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.988 -0.685 . . . . 1.0 111.418 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.618 ' HA ' ' CB ' ' A' ' 84' ' ' SER . 47.5 mt-10 -129.46 65.61 1.47 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 4.2 m-20 -141.09 -109.39 0.14 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.55 0.944 . . . . 1.0 113.55 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.94 -29.94 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 114.297 1.221 . . . . 1.0 114.297 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 t -123.06 20.62 9.89 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.321 0.581 . . . . 1.0 109.923 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.618 ' CB ' ' HA ' ' A' ' 80' ' ' GLU . 38.8 t -115.31 94.29 4.66 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 119.402 -0.919 . . . . 1.0 113.422 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -143.18 134.01 25.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 104.673 -2.343 . . . . 1.0 104.673 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG23 ' H ' ' A' ' 91' ' ' ARG . 5.3 p -139.91 126.64 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 CA-C-O 122.099 0.952 . . . . 1.0 111.877 -171.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -64.8 -37.3 87.15 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.331 -1.758 . . . . 1.0 111.091 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.71 -77.34 0.05 OUTLIER Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -111.69 4.96 18.92 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -61.89 -50.53 71.83 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.48 0.548 . . . . 1.0 112.48 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.572 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -139.85 121.07 14.83 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 116.992 -0.094 . . . . 1.0 111.048 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -93.9 -61.89 1.45 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.639 HD22 ' HB2' ' A' ' 79' ' ' ASP . 79.9 mt -137.4 169.4 17.84 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 175.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -99.16 140.94 32.58 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.563 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 2.0 p -112.35 173.88 6.15 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.328 0.651 . . . . 1.0 109.736 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 101' ' ' VAL . 3.3 pp -75.67 -26.0 57.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.105 -1.038 . . . . 1.0 109.175 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.579 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.5 pt20 -66.2 -25.63 67.02 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -61.34 -41.57 97.26 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -97.18 -8.41 30.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.935 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 100' ' ' LYS 0.275 8.6 mmtm 46.15 75.92 0.11 Allowed 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 125.278 1.431 . . . . 1.0 113.773 -176.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.1 m -84.7 150.19 55.76 Favored Pre-proline 0 C--N 1.285 -2.23 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.206 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.09 165.1 19.5 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 123.515 2.81 . . . . 1.0 112.567 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 119.66 11.01 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.399 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.72 19.01 12.63 Favored Glycine 0 C--N 1.29 -2.008 0 C-N-CA 120.7 -0.762 . . . . 1.0 111.405 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.98 155.67 37.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.198 0.523 . . . . 1.0 110.207 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.8 m -118.49 131.36 56.25 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.045 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 11' ' ' LEU . 33.7 m -112.98 139.29 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.48 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -125.19 120.89 32.59 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.575 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.3 pp -106.35 141.97 36.8 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.771 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 113' ' ' LEU . 18.4 m -133.29 137.09 28.44 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.547 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.2 Cg_endo -73.89 84.09 1.51 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.166 1.911 . . . . 1.0 111.614 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.451 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.4 p 52.34 61.6 3.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 125.066 1.346 . . . . 1.0 110.338 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -110.89 -48.25 3.15 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.648 -173.191 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.7 t -112.78 7.76 18.61 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.662 -1.215 . . . . 1.0 111.974 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -126.71 115.65 19.74 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.827 -1.079 . . . . 1.0 108.193 173.659 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -144.46 -163.88 1.79 Allowed 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.237 -1.764 . . . . 1.0 106.237 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.5 143.88 14.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.869 -1.53 . . . . 1.0 106.869 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.0 114.83 1.9 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 -172.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -72.05 -23.35 61.36 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.985 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -86.38 68.25 10.16 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 121.982 0.896 . . . . 1.0 109.635 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -145.05 92.54 2.28 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.419 -1.264 . . . . 1.0 107.728 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 . . . . . 0 C--N 1.295 -1.786 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -178.945 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 CA--C 1.498 -1.03 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp 56.44 30.38 16.95 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.001 0.813 . . . . 1.0 110.984 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -76.0 -17.29 59.75 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 122.222 1.01 . . . . 1.0 109.771 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 6' ' ' TYR . 11.0 m -130.47 130.79 65.3 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 CA-C-N 113.372 -1.74 . . . . 1.0 107.285 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -100.58 82.87 2.51 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 122.503 1.144 . . . . 1.0 112.618 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.432 ' CD2' ' HB ' ' A' ' 4' ' ' VAL . 65.8 m-85 -126.58 -177.84 4.15 Favored 'General case' 0 N--CA 1.395 -3.219 0 N-CA-C 104.921 -2.252 . . . . 1.0 104.921 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.514 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 17.7 mmt180 -116.06 111.3 42.88 Favored Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 117.492 -1.683 . . . . 1.0 113.778 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 23.2 Cg_exo -64.47 104.65 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.967 1.778 . . . . 1.0 108.866 171.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -107.59 161.41 14.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.983 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -105.4 130.24 53.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 31' ' ' VAL . 1.9 mm? -124.37 148.12 47.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 123.514 0.726 . . . . 1.0 110.704 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -93.06 111.21 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.364 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.16 115.13 15.58 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.68 0.613 . . . . 1.0 109.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 32.2 tp -147.73 155.43 41.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.512 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.64 144.44 48.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.73 30.29 7.45 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.625 0.726 . . . . 1.0 109.469 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.69 -47.1 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 115.023 -0.989 . . . . 1.0 112.691 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.93 -86.36 0.07 OUTLIER Glycine 0 C--O 1.22 -0.768 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.906 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.7 -30.53 85.33 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.151 2.567 . . . . 1.0 113.019 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.06 29.92 6.3 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.445 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.35 83.24 1.42 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.581 0.705 . . . . 1.0 112.063 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.579 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 99.53 3.99 56.16 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -135.73 26.45 3.36 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.382 -0.909 . . . . 1.0 110.605 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.03 -95.44 0.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.72 -60.26 1.47 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 112.753 0.649 . . . . 1.0 112.753 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.26 0.6 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.525 -1.321 . . . . 1.0 109.969 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.0 130.13 23.49 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 122.821 -0.223 . . . . 1.0 110.711 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.25 109.39 1.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.132 1.888 . . . . 1.0 111.28 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 44' ' ' MET . 58.1 t -120.08 138.58 50.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 123.538 0.735 . . . . 1.0 109.144 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -102.95 155.89 18.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.129 0.49 . . . . 1.0 112.195 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 32' ' ' LEU . 5.2 p -158.06 -175.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.542 ' H ' HG22 ' A' ' 31' ' ' VAL . 13.2 tp -109.19 158.52 17.73 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 119.267 0.94 . . . . 1.0 108.632 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 27.1 t70 -62.26 -29.99 70.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 123.429 0.692 . . . . 1.0 109.495 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB2' ' CG ' ' A' ' 6' ' ' TYR . 12.2 t -99.25 31.02 3.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.903 -1.499 . . . . 1.0 110.392 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.657 ' O ' HG22 ' A' ' 95' ' ' THR . 11.7 p-10 -68.49 -165.56 0.06 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.549 0.69 . . . . 1.0 109.149 171.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 p -141.6 161.59 37.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.857 -2.645 . . . . 1.0 103.857 167.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.684 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 44.5 mm -58.57 -46.09 90.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.741 -0.783 . . . . 1.0 110.557 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 36.7 t -63.52 -46.74 84.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 124.016 0.822 . . . . 1.0 110.37 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -64.82 -41.46 95.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.041 0.448 . . . . 1.0 111.426 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -64.32 -39.59 94.22 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.57 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.3 -35.33 79.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.625 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.0 mt-10 -64.44 -45.96 85.21 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.771 0.669 . . . . 1.0 110.062 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.808 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.813 ' HA ' HG11 ' A' ' 29' ' ' VAL . 13.3 mtp -63.59 -42.42 98.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.6 pp -74.72 -26.88 60.11 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.243 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 50' ' ' LYS . 23.8 t70 -62.45 -32.91 73.85 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.414 0.626 . . . . 1.0 111.596 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HG3' HG22 ' A' ' 29' ' ' VAL . 14.5 mm-40 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.676 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.63 -54.41 2.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.833 0.825 . . . . 1.0 112.256 -169.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -91.33 -4.8 55.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.695 -1.139 . . . . 1.0 111.789 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 46' ' ' ASP . 6.0 tmmm? -77.46 121.21 23.52 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.922 -1.51 . . . . 1.0 106.922 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.61 -7.8 56.05 Favored Glycine 0 C--N 1.306 -1.097 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.796 HG22 ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -81.59 160.65 63.9 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 107.132 -1.432 . . . . 1.0 107.132 177.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.796 ' HD2' HG22 ' A' ' 52' ' ' VAL . 15.8 Cg_endo -56.85 150.96 51.41 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 121.741 1.627 . . . . 1.0 111.37 176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.5 mt -59.88 -40.37 88.48 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.351 0.66 . . . . 1.0 112.113 -171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -69.69 -14.26 62.71 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.098 0.475 . . . . 1.0 111.56 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 93.0 mm-40 -95.63 -8.81 33.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.756 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.14 111.65 35.07 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 93.9 Cg_endo -76.92 155.39 34.2 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.019 2.479 . . . . 1.0 112.676 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -94.44 114.77 64.21 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.758 -0.656 . . . . 1.0 109.973 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.32 -3.68 14.22 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.947 2.432 . . . . 1.0 113.433 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -91.03 -21.82 21.07 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.502 -0.479 . . . . 1.0 111.025 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -105.69 -24.58 12.5 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.357 0.502 . . . . 1.0 112.357 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp -94.62 162.16 13.9 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.167 0.432 . . . . 1.0 112.167 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 7.6 p-10 -117.18 157.38 26.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.28 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 3.6 p -122.61 127.17 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.254 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -91.91 112.93 25.06 Favored 'General case' 0 N--CA 1.399 -2.997 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.467 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -93.18 122.18 35.3 Favored 'General case' 1 N--CA 1.377 -4.089 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.991 -177.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.483 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 88.0 mtm180 -112.56 89.81 3.17 Favored 'General case' 0 N--CA 1.389 -3.508 0 CA-C-O 122.601 1.191 . . . . 1.0 108.243 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 19.0 p -84.66 -16.89 40.31 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.64 -1.618 . . . . 1.0 109.232 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.29 -54.66 4.31 Favored Glycine 0 C--N 1.293 -1.846 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.239 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.4 HG22 ' HD3' ' A' ' 102' ' ' PRO . 33.9 m -62.3 -42.25 94.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.039 0.447 . . . . 1.0 111.126 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.04 -10.21 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.468 0.652 . . . . 1.0 109.318 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.77 -143.01 16.23 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.83 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 3.5 p80 -116.55 112.21 21.01 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.574 0.702 . . . . 1.0 109.623 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.05 144.96 48.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.825 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 116' ' ' HIS . 28.7 mm -85.2 115.65 27.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.721 -1.215 . . . . 1.0 107.721 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.466 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.8 mp -103.66 140.56 37.41 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.886 0.851 . . . . 1.0 111.338 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.4 m -152.39 148.15 27.13 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' HD22 ' A' ' 93' ' ' LEU . 7.4 p-10 -70.96 -41.19 71.39 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.899 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.93 96.07 6.29 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 31.8 t70 -161.79 -89.29 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.945 0.878 . . . . 1.0 112.82 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.533 HG12 HD21 ' A' ' 94' ' ' ASN . 1.6 p -87.41 -2.5 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 CA-C-N 114.433 -1.258 . . . . 1.0 112.358 -171.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 92' ' ' ARG . 15.2 t -137.28 19.1 2.95 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 119.878 -0.729 . . . . 1.0 110.174 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.1 p -89.15 10.82 20.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.589 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -56.79 117.29 3.78 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.793 -0.639 . . . . 1.0 111.168 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 m -88.89 64.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 122.522 1.153 . . . . 1.0 110.969 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -101.89 0.66 35.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.418 -1.265 . . . . 1.0 110.184 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.89 -100.69 0.24 Allowed Glycine 0 N--CA 1.4 -3.765 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.3 mt -102.88 5.31 38.46 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.7 0.762 . . . . 1.0 111.148 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -91.9 0.53 57.48 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.03 -0.987 . . . . 1.0 111.624 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -67.35 93.99 0.36 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 106.278 -1.749 . . . . 1.0 106.278 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 83' ' ' THR . 51.5 ttp180 -133.88 157.37 46.13 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.439 -169.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 79' ' ' ASP . 75.8 mt -95.66 148.66 22.31 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.533 HD21 HG12 ' A' ' 82' ' ' VAL . 53.5 m-80 -81.34 136.57 35.75 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.51 -0.876 . . . . 1.0 110.765 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.2 p -106.75 171.71 7.22 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 124.791 1.236 . . . . 1.0 109.334 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 101' ' ' VAL . 2.7 pp -71.57 -28.53 63.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.588 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.0 pt20 -64.93 -25.64 67.97 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.921 176.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -61.62 -41.72 97.87 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.03 -4.36 30.11 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.518 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 65.2 mmtt 43.49 68.16 0.55 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.738 1.215 . . . . 1.0 112.227 -177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.467 HG11 ' NE1' ' A' ' 67' ' ' TRP . 2.9 m -75.57 149.01 83.44 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 114.915 -1.038 . . . . 1.0 111.636 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD3' HG22 ' A' ' 71' ' ' VAL . 91.8 Cg_endo -73.74 162.98 38.36 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 122.828 2.352 . . . . 1.0 112.697 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.76 116.86 6.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.502 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.83 35.09 8.53 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 119.981 -1.105 . . . . 1.0 111.509 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 69' ' ' SER . . . -74.03 162.89 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -108.9 123.83 49.69 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.524 -0.47 . . . . 1.0 111.156 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.503 HG21 ' SD ' ' A' ' 44' ' ' MET . 5.9 m -104.79 144.83 14.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -139.85 132.86 29.47 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.512 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 1.6 pt? -118.13 143.49 46.44 Favored 'General case' 0 C--N 1.269 -2.934 0 C-N-CA 120.326 -0.55 . . . . 1.0 110.379 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 14.6 m -124.26 164.87 27.36 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.81 56.32 4.61 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.497 2.132 . . . . 1.0 111.472 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.569 ' SG ' ' HD3' ' A' ' 115' ' ' LYS . 5.2 t 63.43 82.75 0.17 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.488 -175.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -128.83 -45.79 1.28 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.499 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.9 t -127.45 36.55 4.37 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.142 0.496 . . . . 1.0 110.429 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.569 ' HD3' ' SG ' ' A' ' 112' ' ' CYS . 53.5 pttt -50.57 14.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.873 2.545 . . . . 1.0 117.873 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 76' ' ' ILE . 8.7 t-160 68.72 14.59 9.0 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 124.063 0.945 . . . . 1.0 112.237 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.3 m -152.25 148.4 14.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 106.674 -1.602 . . . . 1.0 106.674 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 pp -142.73 164.35 30.34 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.034 -0.666 . . . . 1.0 112.336 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -133.8 134.82 43.33 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -71.45 133.68 46.05 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.328 0.393 . . . . 1.0 110.534 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -95.3 96.02 8.87 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.447 -1.316 . . . . 1.0 107.447 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 C--N 1.284 -2.257 0 N-CA-C 106.723 -1.584 . . . . 1.0 106.723 -178.705 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 CA--C 1.499 -0.992 0 N-CA-C 106.234 -1.765 . . . . 1.0 106.234 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -78.24 68.45 4.27 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.989 1.376 . . . . 1.0 110.028 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -88.58 11.12 18.17 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 113.645 -1.616 . . . . 1.0 109.163 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.0 t 65.97 66.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.245 -1.343 . . . . 1.0 111.356 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -104.84 32.2 4.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.444 -1.253 . . . . 1.0 109.101 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.534 ' HB2' HD22 ' A' ' 32' ' ' LEU . 11.7 m-85 -116.23 173.35 6.64 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 105.149 -2.167 . . . . 1.0 105.149 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 33.9 mmt180 -109.6 110.96 59.54 Favored Pre-proline 0 C--N 1.278 -2.542 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.765 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.16 100.1 0.21 Allowed 'Trans proline' 0 C--O 1.245 0.843 0 N-CA-C 107.859 -1.631 . . . . 1.0 107.859 167.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.45 130.2 55.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 -171.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 m -89.36 129.45 35.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 31' ' ' VAL . 1.7 mm? -120.95 147.51 45.36 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 123.343 0.657 . . . . 1.0 110.366 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -90.92 108.5 19.89 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.38 109.19 7.67 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.026 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.702 HD21 ' HA2' ' A' ' 22' ' ' GLY . 30.8 tp -137.52 166.59 23.53 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -131.38 143.93 50.84 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . . . -114.96 38.75 3.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG22 ' HD3' ' A' ' 111' ' ' PRO . 47.8 t -66.63 -44.48 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.52 -88.2 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 119.123 -1.513 . . . . 1.0 113.713 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.88 -29.35 82.37 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 123.253 2.635 . . . . 1.0 113.546 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.45 24.99 10.05 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 84.6 0.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.354 0.597 . . . . 1.0 111.826 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.702 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 115.33 -5.72 21.41 Favored Glycine 0 CA--C 1.487 -1.687 0 CA-C-N 115.163 -0.926 . . . . 1.0 111.271 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.63 19.13 3.9 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.264 -0.468 . . . . 1.0 112.082 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.99 -92.37 0.09 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 10.7 pt20 -110.04 -59.18 1.96 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.461 0.541 . . . . 1.0 112.461 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.7 69.7 1.25 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.89 127.01 30.25 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.99 -0.105 . . . . 1.0 110.743 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.48 107.43 2.29 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 121.862 1.708 . . . . 1.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 44' ' ' MET . 83.7 t -119.95 140.09 45.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.17 -0.923 . . . . 1.0 109.586 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -104.73 146.31 29.13 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.081 -0.648 . . . . 1.0 111.808 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 HD23 ' A' ' 11' ' ' LEU . 15.3 m -141.94 171.21 11.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 124.241 1.017 . . . . 1.0 109.08 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 6' ' ' TYR . 11.5 mt -88.37 159.15 18.17 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.118 0.485 . . . . 1.0 111.267 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.472 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 37.5 t70 -61.93 -30.75 71.11 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 115.049 -0.978 . . . . 1.0 108.505 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.5 t -96.12 6.08 49.63 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 114.25 -1.341 . . . . 1.0 113.365 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.4 m-20 -70.19 134.91 48.56 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.531 HG22 HD11 ' A' ' 93' ' ' LEU . 49.3 p -79.75 166.88 21.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.12 -44.59 91.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.89 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.6 p -61.84 -47.32 85.57 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 48.9 mt-30 -72.01 -38.23 69.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.975 0.732 . . . . 1.0 112.975 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.4 -39.96 85.59 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -62.51 -33.66 75.33 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.2 mt-10 -65.36 -48.64 72.25 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.086 0.866 . . . . 1.0 110.208 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 41.4 mmtm -60.83 -44.35 97.05 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.78 ' HA ' HG11 ' A' ' 29' ' ' VAL . 9.3 mtp -64.94 -41.97 95.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.751 -1.113 . . . . 1.0 112.288 -178.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -76.02 -32.91 59.61 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.765 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' O ' ' HE3' ' A' ' 50' ' ' LYS . 38.1 t70 -61.44 -29.78 70.16 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.508 0.723 . . . . 1.0 112.049 -174.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.533 HE21 HG13 ' A' ' 29' ' ' VAL . 11.3 mm-40 -67.54 -39.18 85.02 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.607 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.68 -19.15 13.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.639 -0.709 . . . . 1.0 112.468 -169.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -98.15 14.77 26.47 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 46' ' ' ASP . 4.6 tppp? -64.84 126.59 28.44 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.435 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.76 -19.1 39.38 Favored Glycine 0 C--N 1.314 -0.675 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.5 t -93.45 133.8 27.72 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 107.827 -1.175 . . . . 1.0 107.827 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.469 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 47.4 Cg_endo -63.75 153.0 77.98 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.779 2.32 . . . . 1.0 111.626 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.92 -37.46 82.39 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.085 0.554 . . . . 1.0 111.311 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.1 t -64.0 -23.83 67.48 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.837 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -96.14 -26.39 15.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.54 -0.464 . . . . 1.0 110.524 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 80.7 mtt180 -63.9 139.05 97.57 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.89 136.72 67.74 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 121.309 1.339 . . . . 1.0 110.959 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 62' ' ' THR . 10.6 t70 -87.34 125.19 66.58 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.566 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 39.8 Cg_endo -66.22 -17.0 53.8 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.127 2.551 . . . . 1.0 113.851 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -91.27 -11.05 39.24 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 120.976 0.417 . . . . 1.0 111.162 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 59' ' ' ASP . 14.5 t -113.66 9.75 17.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.07 0.462 . . . . 1.0 110.281 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp -132.34 161.72 32.85 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.682 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.472 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 9.7 m-20 -108.89 151.63 26.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.925 -1.139 . . . . 1.0 107.925 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.16 128.52 75.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 119.807 -0.757 . . . . 1.0 109.482 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 41.9 mt-10 -89.74 112.47 23.77 Favored 'General case' 0 CA--C 1.457 -2.615 0 N-CA-C 105.612 -1.995 . . . . 1.0 105.612 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.589 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -91.25 117.27 29.5 Favored 'General case' 1 N--CA 1.367 -4.625 0 C-N-CA 119.273 -0.971 . . . . 1.0 108.501 177.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -102.8 88.25 3.15 Favored 'General case' 0 N--CA 1.394 -3.245 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.1 p -83.65 -14.4 51.96 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.824 -1.535 . . . . 1.0 110.34 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.53 -57.73 3.77 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.765 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.2 -43.73 98.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.28 0.632 . . . . 1.0 111.766 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.37 -8.54 21.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.299 0.571 . . . . 1.0 110.347 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.41 -149.38 19.43 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.9 p80 -105.91 108.87 20.6 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.498 0.666 . . . . 1.0 111.299 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.03 146.42 36.74 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.368 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.406 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 25.4 mm -87.87 99.27 8.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -89.34 156.37 18.76 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.564 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.3 t -160.84 164.41 31.37 Favored 'General case' 0 CA--C 1.465 -2.303 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -63.58 -37.21 86.45 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.714 0.634 . . . . 1.0 110.079 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.418 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 2.6 tm-20 -163.67 88.91 0.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 123.107 0.254 . . . . 1.0 110.846 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -152.63 -142.94 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.058 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.48 -33.16 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 p -85.3 4.52 34.61 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.759 0.79 . . . . 1.0 112.706 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.418 ' OG ' ' HA ' ' A' ' 80' ' ' GLU . 75.5 m -85.84 9.92 15.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.353 -0.84 . . . . 1.0 110.95 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 62.83 30.5 16.64 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 123.048 1.404 . . . . 1.0 110.038 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.76 85.19 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.262 -3.239 0 CA-C-N 113.333 -1.758 . . . . 1.0 112.796 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.83 -25.83 6.68 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 113.853 -1.521 . . . . 1.0 108.576 170.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.29 -111.42 0.29 Allowed Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.31 -10.58 59.51 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 112.932 0.715 . . . . 1.0 112.932 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -79.51 -0.47 33.42 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.473 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -65.88 125.43 25.37 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.334 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -136.97 -172.51 3.2 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.614 0.721 . . . . 1.0 112.848 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.531 HD11 HG22 ' A' ' 36' ' ' THR . 3.0 tm? -102.72 138.22 39.9 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.247 1.819 . . . . 1.0 106.449 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.6 m-80 -96.74 139.59 32.57 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.929 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -129.39 176.45 7.95 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 125.855 1.662 . . . . 1.0 106.821 175.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 101' ' ' VAL . 3.0 pp -73.32 -25.31 60.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.237 -1.385 . . . . 1.0 108.944 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.571 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 5.1 pt20 -66.36 -24.73 66.55 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.31 -40.71 91.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -103.45 2.58 33.93 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 30.9 mmmt 40.76 64.09 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.401 1.08 . . . . 1.0 112.097 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.589 HG11 ' CE2' ' A' ' 67' ' ' TRP . 2.1 m -68.74 150.95 97.49 Favored Pre-proline 0 C--N 1.294 -1.833 0 CA-C-N 115.539 -0.755 . . . . 1.0 111.786 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.12 155.83 37.92 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.154 1.903 . . . . 1.0 111.462 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.95 124.5 22.7 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.654 0.74 . . . . 1.0 110.208 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.99 22.23 23.58 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.092 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.408 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . . . -71.08 164.42 25.62 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.911 0.386 . . . . 1.0 109.993 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 79.3 m -111.56 130.55 55.7 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.282 -0.567 . . . . 1.0 110.767 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.63 HG21 ' SD ' ' A' ' 44' ' ' MET . 27.5 m -114.13 139.49 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.49 138.94 49.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.1 pp -108.89 139.55 43.57 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.548 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 36.0 m -130.42 130.92 23.08 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.569 -0.741 . . . . 1.0 109.511 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.517 ' HD3' HG22 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -68.67 78.72 0.68 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.791 2.327 . . . . 1.0 112.458 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 62' ' ' THR . 43.6 t 57.08 83.76 0.1 Allowed 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.781 1.232 . . . . 1.0 111.132 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 114' ' ' THR . 3.1 mm? 62.76 22.09 13.17 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 125.301 1.44 . . . . 1.0 110.319 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER 68.06 13.13 9.05 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 113.365 -1.743 . . . . 1.0 112.682 177.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 115' ' ' LYS . 11.4 mmpt? -88.3 91.77 8.91 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.538 -0.912 . . . . 1.0 108.538 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -88.93 102.19 14.82 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.308 -0.86 . . . . 1.0 109.67 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.7 m -125.16 166.98 19.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 114.451 -1.249 . . . . 1.0 108.667 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.7 78.66 6.26 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.003 -0.739 . . . . 1.0 109.003 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -70.8 -42.59 70.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.447 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -81.79 97.94 8.23 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.56 -0.745 . . . . 1.0 111.308 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -163.03 160.06 24.08 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.691 -1.596 . . . . 1.0 106.691 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? . . . . . 0 C--N 1.27 -2.853 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 177.437 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 4.2 mppt? -146.72 178.12 8.56 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.117 -1.438 . . . . 1.0 107.117 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -84.1 88.93 7.2 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.039 -1.838 . . . . 1.0 106.039 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.79 87.69 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.168 -0.923 . . . . 1.0 113.063 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.21 31.01 4.93 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 124.089 1.899 . . . . 1.0 106.069 167.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 89.3 m-85 -134.89 -177.66 4.73 Favored 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 111.732 -2.485 . . . . 1.0 105.905 -172.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.436 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 59.4 mmt-85 -104.31 114.57 64.12 Favored Pre-proline 0 C--N 1.271 -2.809 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.409 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.02 111.69 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.39 2.06 . . . . 1.0 108.938 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.36 127.97 54.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -171.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -88.49 122.31 31.83 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.462 HD11 HG13 ' A' ' 107' ' ' VAL . 16.5 tp -126.97 138.99 53.36 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -97.64 119.54 36.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.847 -0.533 . . . . 1.0 110.835 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.01 121.11 23.79 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.504 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -149.19 169.53 20.51 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.448 0.299 . . . . 1.0 110.437 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.811 HD22 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -127.26 144.58 51.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.419 0.288 . . . . 1.0 110.692 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -124.12 39.79 3.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.126 0.489 . . . . 1.0 110.555 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.439 HG22 ' HD3' ' A' ' 111' ' ' PRO . 78.1 t -61.47 -46.33 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 C-N-CA 123.302 0.641 . . . . 1.0 110.728 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.99 -94.39 0.12 Allowed Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.387 -0.911 . . . . 1.0 112.204 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.46 -32.85 88.91 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.42 2.746 . . . . 1.0 113.543 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' O ' HD21 ' A' ' 15' ' ' LEU . . . -110.45 25.58 15.12 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.887 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.88 79.8 0.12 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.387 0.613 . . . . 1.0 111.78 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -5.33 3.08 Favored Glycine 0 N--CA 1.423 -2.19 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.32 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.63 18.53 21.32 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.178 0.807 . . . . 1.0 113.178 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.811 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -79.58 -76.91 0.19 Allowed 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.897 -0.721 . . . . 1.0 112.141 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.527 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.0 pt20 -138.41 -53.1 0.61 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.261 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 59.94 8.55 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 25' ' ' GLN . 35.4 t -114.71 126.99 27.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.261 -0.469 . . . . 1.0 110.552 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.45 103.36 1.73 Allowed 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.97 1.78 . . . . 1.0 110.562 175.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.516 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 57.7 t -102.16 153.81 5.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -109.57 139.61 44.37 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.314 -0.955 . . . . 1.0 111.433 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.57 174.63 12.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.095 -1.411 . . . . 1.0 108.239 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 32' ' ' LEU . 12.1 mt -104.59 159.73 15.52 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.542 0.687 . . . . 1.0 110.637 175.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 38.5 t70 -59.67 -29.87 68.37 Favored 'General case' 0 C--O 1.272 2.249 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.952 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 45.8 t -82.6 -12.01 58.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.753 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.03 132.67 47.02 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.435 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 44.3 p -78.32 172.55 13.44 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 94' ' ' ASN . 43.7 mm -60.37 -45.61 96.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.926 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.3 t -66.39 -41.92 88.64 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 44.4 tt0 -66.31 -34.38 77.86 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.993 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -81.67 -38.48 25.83 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 122.307 -0.245 . . . . 1.0 111.518 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -60.51 -35.51 76.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.916 0.388 . . . . 1.0 110.34 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -66.48 -41.23 89.27 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.391 -0.822 . . . . 1.0 109.905 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 46.7 mmtm -63.6 -41.49 98.33 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.834 0.709 . . . . 1.0 111.861 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.589 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 86.1 mmm -60.96 -45.94 92.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.146 0.498 . . . . 1.0 110.627 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.5 -25.33 50.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.681 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 24.9 t70 -56.94 -28.83 62.56 Favored 'General case' 0 C--O 1.203 -1.371 0 C-N-CA 125.374 1.47 . . . . 1.0 112.145 -174.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.493 HE21 HG13 ' A' ' 29' ' ' VAL . 14.1 mm-40 -65.78 -33.92 76.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.067 0.46 . . . . 1.0 111.082 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.33 -42.05 8.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.881 0.848 . . . . 1.0 109.127 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -101.72 35.73 2.25 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.116 -1.402 . . . . 1.0 111.062 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -57.0 118.97 5.51 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.98 -1.009 . . . . 1.0 109.768 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.77 -11.42 38.37 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 120.766 -0.73 . . . . 1.0 112.355 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.91 129.13 71.67 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 58.0 Cg_endo -67.23 156.7 65.14 Favored 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.75 2.3 . . . . 1.0 112.431 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.52 -38.59 87.92 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.963 0.505 . . . . 1.0 111.56 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 t -62.7 -24.02 67.45 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 121.074 0.464 . . . . 1.0 111.299 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 -88.22 -24.51 23.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.922 0.391 . . . . 1.0 110.308 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 58.2 mtt180 -74.1 121.21 84.66 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.17 141.32 96.49 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.491 2.128 . . . . 1.0 112.347 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -90.1 150.54 43.57 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 115.558 -0.746 . . . . 1.0 112.466 -174.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.15 7.92 2.7 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.683 2.255 . . . . 1.0 110.894 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.84 -16.96 24.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.11 173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 t -117.39 -2.72 11.5 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.427 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.633 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.4 pp -149.48 155.45 40.39 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 7.7 m-20 -105.83 151.53 24.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.6 124.53 71.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.428 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.63 112.28 24.14 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.586 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -93.28 125.82 38.08 Favored 'General case' 1 N--CA 1.374 -4.225 0 CA-C-N 114.554 -1.203 . . . . 1.0 109.165 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.29 89.39 3.05 Favored 'General case' 0 N--CA 1.395 -3.203 0 N-CA-C 106.672 -1.603 . . . . 1.0 106.672 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.8 p -79.0 -22.56 45.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.339 -1.301 . . . . 1.0 109.393 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.16 -45.72 3.5 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.837 -1.074 . . . . 1.0 112.163 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.55 -39.45 85.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.023 0.439 . . . . 1.0 111.062 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.22 -9.41 16.89 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.447 0.641 . . . . 1.0 109.937 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.07 -126.17 8.82 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.212 -0.904 . . . . 1.0 111.51 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -120.28 118.32 30.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.238 0.542 . . . . 1.0 110.204 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.66 151.91 45.92 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 9.8 mm -98.34 120.3 47.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.469 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.432 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.7 mp -111.99 163.32 14.38 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.459 ' HA ' HG21 ' A' ' 37' ' ' ILE . 8.2 t -167.58 163.03 14.57 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.234 -2.506 . . . . 1.0 104.234 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 21.3 p-10 -93.68 -3.25 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 117.9 -1.52 . . . . 1.0 111.033 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -138.56 75.08 1.5 Allowed 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' A' ' 83' ' ' THR . 17.9 m-20 -80.75 -172.18 3.52 Favored 'General case' 0 CA--C 1.478 -1.805 0 CA-C-N 115.03 -0.986 . . . . 1.0 109.834 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.95 -27.66 39.13 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 114.881 -1.054 . . . . 1.0 109.92 172.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 81' ' ' ASP . 9.0 t -81.27 -2.5 49.17 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.637 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 76.8 p -80.24 86.57 5.62 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.235 1.016 . . . . 1.0 109.711 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -81.69 118.3 22.72 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.545 0.688 . . . . 1.0 111.75 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 t -97.56 84.06 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 -177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -152.05 4.44 0.4 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.547 -1.206 . . . . 1.0 111.671 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.67 85.21 0.17 Allowed Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 119.246 -1.454 . . . . 1.0 113.169 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.4 mt 73.44 -17.37 0.43 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.516 1.526 . . . . 1.0 114.178 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -64.84 -31.55 72.83 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.264 0.554 . . . . 1.0 109.759 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -71.45 113.27 8.31 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.04 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -150.53 158.95 44.73 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.86 -1.163 . . . . 1.0 107.86 172.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 79.3 mt -79.88 139.48 37.12 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.468 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 93.8 m-20 -89.6 141.02 28.98 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -107.27 173.29 6.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 124.448 1.099 . . . . 1.0 109.704 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.461 HD13 HG22 ' A' ' 101' ' ' VAL . 3.9 pp -72.66 -25.41 61.26 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.303 -0.959 . . . . 1.0 108.783 173.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.0 pt20 -66.68 -25.34 66.51 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.22 0.533 . . . . 1.0 110.904 173.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -64.4 -37.73 88.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -104.55 -1.78 26.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.934 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 49.71 66.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.837 1.255 . . . . 1.0 112.997 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.1 m -85.27 150.71 55.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.636 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.19 155.89 22.61 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.844 2.362 . . . . 1.0 111.926 175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.0 122.17 17.16 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.52 10.34 13.24 Favored Glycine 0 C--N 1.285 -2.264 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -69.89 162.3 28.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.288 0.566 . . . . 1.0 111.069 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.9 m -120.92 132.71 55.11 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.462 HG13 HD11 ' A' ' 11' ' ' LEU . 29.6 m -115.73 135.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.506 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -120.38 137.54 54.24 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.656 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.5 tt -97.92 126.86 43.52 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.974 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 64' ' ' ASP . 33.9 m -127.88 127.1 23.96 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HD3' HG22 ' A' ' 17' ' ' VAL . 43.9 Cg_endo -70.35 82.02 0.91 Allowed 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 122.355 2.037 . . . . 1.0 111.823 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.633 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.7 p 50.93 29.85 4.79 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 126.038 1.735 . . . . 1.0 111.026 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -69.1 -41.63 77.21 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 113.859 -1.519 . . . . 1.0 112.984 -172.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.0 t -111.23 -0.22 16.54 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 114.403 1.26 . . . . 1.0 114.403 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 48.02 74.1 0.18 Allowed 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 124.184 0.994 . . . . 1.0 113.483 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -103.22 4.53 36.82 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.78 1.276 . . . . 1.0 109.881 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.3 132.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.426 0 CA-C-N 112.9 -1.955 . . . . 1.0 109.144 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.8 mt -134.86 106.19 6.76 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.456 ' HD3' ' H ' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -137.36 -7.44 1.75 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.144 -0.935 . . . . 1.0 109.642 -175.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -82.17 -169.92 2.64 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.065 -1.425 . . . . 1.0 111.349 -176.138 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.3 t30 72.62 25.62 2.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.59 1.186 . . . . 1.0 109.299 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.566 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.0 pm0 . . . . . 0 C--O 1.252 1.209 0 CA-C-N 114.959 -1.019 . . . . 1.0 110.135 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.9 tttm . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.463 0.649 . . . . 1.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -120.84 150.4 41.09 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.466 -0.788 . . . . 1.0 109.604 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.03 2.21 56.49 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.904 0.859 . . . . 1.0 110.406 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 6' ' ' TYR . 34.5 m -125.35 132.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 CA-C-N 114.735 -1.12 . . . . 1.0 108.514 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -108.76 78.68 1.17 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.414 1.102 . . . . 1.0 111.222 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 34' ' ' CYS . 74.8 m-85 -128.01 -178.57 4.57 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 105.261 -2.126 . . . . 1.0 105.261 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -113.39 114.63 47.78 Favored Pre-proline 0 C--N 1.273 -2.721 0 C-N-CA 118.111 -1.436 . . . . 1.0 113.287 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 124.98 16.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.247 1.964 . . . . 1.0 109.098 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tp -122.18 161.81 22.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.801 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m -109.48 128.44 55.17 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.1 mt -126.66 149.99 49.22 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.751 0.82 . . . . 1.0 111.011 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -94.62 116.05 28.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.74 120.59 24.83 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.814 HD21 ' HA2' ' A' ' 22' ' ' GLY . 31.0 tp -151.64 152.32 32.67 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.636 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.1 pt? -122.13 143.03 49.79 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.728 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -117.25 32.41 6.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.363 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.18 -45.32 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 C-N-CA 123.572 0.749 . . . . 1.0 111.814 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.64 -87.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.363 -1.398 . . . . 1.0 113.475 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.33 -30.76 88.22 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.954 2.436 . . . . 1.0 113.171 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.3 26.08 11.64 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.694 -0.765 . . . . 1.0 111.547 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.7 82.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.814 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 103.05 0.12 48.04 Favored Glycine 0 CA--C 1.48 -2.14 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.41 22.04 3.7 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.664 -0.768 . . . . 1.0 111.242 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.66 -69.33 0.62 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.189 -0.459 . . . . 1.0 112.129 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -148.41 -51.77 0.17 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.7 -177.063 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.0 68.19 1.73 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.508 -1.037 . . . . 1.0 110.508 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 25' ' ' GLN . 22.4 t -103.37 127.34 29.87 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.94 108.45 2.72 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 C-N-CA 121.623 1.549 . . . . 1.0 111.624 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG13 ' NE2' ' A' ' 47' ' ' GLN . 44.1 t -106.23 154.83 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.985 -1.007 . . . . 1.0 108.729 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.84 143.96 34.18 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.324 0.583 . . . . 1.0 110.769 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.48 166.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 tp -100.4 156.83 17.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.05 -30.29 70.88 Favored 'General case' 0 C--O 1.268 2.033 0 CA-C-O 121.473 0.654 . . . . 1.0 109.596 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.617 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -90.82 1.56 56.83 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.355 -176.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.17 136.24 46.4 Favored 'General case' 0 CA--C 1.48 -1.734 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.014 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.36 168.81 17.15 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.759 HG21 ' HA ' ' A' ' 78' ' ' SER . 42.1 mm -61.59 -42.23 93.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 120.799 -0.361 . . . . 1.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -61.68 -43.72 98.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 121.109 -0.237 . . . . 1.0 110.547 177.323 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.447 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 27.0 mt-30 -67.33 -39.33 85.81 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 123.461 0.476 . . . . 1.0 111.238 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.66 -39.1 91.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.09 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.2 mptm? -56.93 -40.28 76.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 176.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' SER . 41.3 mt-10 -65.43 -53.81 37.65 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.42 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.27 -40.86 96.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.319 0.859 . . . . 1.0 113.319 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.667 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.5 mmm -64.04 -46.42 84.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.441 . . . . 1.0 110.406 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.7 pp -76.7 -25.19 53.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.13 -29.66 58.18 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.461 1.104 . . . . 1.0 112.67 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' NE2' HG13 ' A' ' 29' ' ' VAL . 27.7 mt-30 -69.25 -31.36 69.86 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.884 -0.327 . . . . 1.0 111.315 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -92.55 -40.11 10.98 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.93 0.871 . . . . 1.0 108.713 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -94.15 28.02 2.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.491 -1.232 . . . . 1.0 110.665 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -59.41 126.77 28.99 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.438 -0.801 . . . . 1.0 110.39 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.24 -11.55 57.01 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.771 -0.931 . . . . 1.0 110.771 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -97.48 116.86 65.91 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 59.2 Cg_endo -68.38 161.09 46.28 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.536 2.157 . . . . 1.0 111.06 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.3 -39.33 90.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.519 0.2 . . . . 1.0 111.436 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 t -62.85 -26.49 68.79 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.665 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -85.94 -19.35 30.58 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.549 0.69 . . . . 1.0 109.907 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HD3' HD11 ' A' ' 45' ' ' LEU . 78.2 mtt180 -84.16 154.53 63.59 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.55 161.66 45.02 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.064 1.842 . . . . 1.0 110.706 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -64.0 128.88 93.52 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 109.541 -0.54 . . . . 1.0 109.541 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.27 -5.11 16.6 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.378 2.052 . . . . 1.0 114.683 -175.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.4 -6.81 43.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.093 0.406 . . . . 1.0 111.24 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.2 p -72.96 -23.67 60.69 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.145 -1.057 . . . . 1.0 108.145 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.542 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 2.2 pp -117.95 148.7 41.94 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 113.813 -1.54 . . . . 1.0 109.43 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' H ' ' H ' ' A' ' 112' ' ' CYS . 53.6 m-20 -112.91 169.5 8.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 1.0 108.329 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.62 129.21 75.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 C-N-CA 119.791 -0.764 . . . . 1.0 108.962 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 10.3 pt-20 -91.49 111.89 23.58 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.159 -1.793 . . . . 1.0 106.159 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 2.5 t-105 -89.99 126.06 35.61 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.164 -1.38 . . . . 1.0 110.054 -174.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.47 88.97 2.85 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.7 p -91.9 -14.15 30.09 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.826 -1.534 . . . . 1.0 110.907 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.52 -52.53 4.38 Favored Glycine 0 C--N 1.303 -1.279 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.793 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.88 -38.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 122.669 0.388 . . . . 1.0 111.394 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.69 1.97 21.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.57 0.7 . . . . 1.0 109.665 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.23 -129.47 10.6 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 19.4 p-80 -110.73 112.73 24.8 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.317 0.579 . . . . 1.0 110.069 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.43 140.19 53.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -79.14 115.06 20.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.481 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.5 mp -109.79 148.36 31.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.763 0.792 . . . . 1.0 112.351 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.759 ' HA ' HG21 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -164.12 157.05 17.7 Favored 'General case' 0 CA--C 1.467 -2.216 0 C-N-CA 125.805 1.642 . . . . 1.0 107.082 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 21.6 p-10 -73.69 -38.33 64.91 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 123.293 0.371 . . . . 1.0 111.399 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -153.78 88.05 1.25 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.592 -0.443 . . . . 1.0 112.014 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 11.2 t70 -173.29 -92.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.556 0.693 . . . . 1.0 110.996 171.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.487 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 9.3 p -65.95 -28.23 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 114.406 -1.27 . . . . 1.0 110.548 -175.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.6 p -89.54 -20.2 24.08 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.821 -1.082 . . . . 1.0 110.757 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 t -89.15 88.46 7.55 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 121.696 0.76 . . . . 1.0 111.33 -172.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 47.2 mt-10 -104.45 117.63 34.64 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 173.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.8 m -79.09 68.53 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 114.041 1.126 . . . . 1.0 114.041 -171.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -105.74 -13.13 15.64 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.222 -1.353 . . . . 1.0 109.58 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.78 -90.18 0.11 Allowed Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 120.637 -0.792 . . . . 1.0 112.285 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -71.46 -6.8 43.12 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 114.288 1.218 . . . . 1.0 114.288 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 49.1 m-85 -87.12 -2.52 58.69 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.202 -0.599 . . . . 1.0 112.309 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -84.85 91.63 8.06 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.13 -1.434 . . . . 1.0 107.13 170.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 173.58 157.44 0.13 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.98 138.08 39.41 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 37' ' ' ILE . 41.5 m-80 -82.44 140.16 33.57 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.851 -0.74 . . . . 1.0 109.52 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -114.64 174.74 5.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.528 HD13 HG22 ' A' ' 101' ' ' VAL . 2.4 pp -73.09 -29.59 63.05 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.235 -0.986 . . . . 1.0 108.368 173.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.617 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.0 pt20 -65.76 -24.48 66.96 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.024 -0.535 . . . . 1.0 112.17 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -59.9 -44.23 94.38 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 108.971 -0.751 . . . . 1.0 108.971 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -96.65 -10.28 27.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.569 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 64.7 mmtt 53.0 73.16 0.37 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.259 1.024 . . . . 1.0 113.121 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.2 m -83.08 147.99 55.42 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.958 . . . . 1.0 110.838 177.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.54 159.57 35.65 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.56 2.173 . . . . 1.0 112.911 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.77 121.54 15.26 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 121.764 0.792 . . . . 1.0 109.415 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.96 9.72 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.232 -0.985 . . . . 1.0 111.177 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.61 163.04 27.75 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.941 0.401 . . . . 1.0 110.315 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -115.61 131.33 56.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.835 0.35 . . . . 1.0 110.426 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.07 138.07 46.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.524 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -126.38 128.03 46.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.187 0.518 . . . . 1.0 110.593 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.636 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.3 mp -92.71 127.15 38.1 Favored 'General case' 0 C--N 1.269 -2.928 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.033 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 16' ' ' ALA . 17.3 m -128.94 154.01 80.21 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.13 74.09 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.224 1.949 . . . . 1.0 110.633 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.542 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER 58.85 17.86 5.62 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.486 1.514 . . . . 1.0 111.836 -179.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 74.79 -39.67 0.42 Allowed 'General case' 0 C--N 1.349 0.576 0 C-N-CA 125.589 1.555 . . . . 1.0 108.627 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.533 ' H ' ' C ' ' A' ' 112' ' ' CYS . 12.7 t -117.08 117.63 30.14 Favored 'General case' 1 N--CA 1.376 -4.172 0 CA-C-N 114.179 -1.373 . . . . 1.0 107.334 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 11.4 mptt -63.4 -40.24 96.69 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.259 -1.791 . . . . 1.0 114.652 -166.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -99.41 100.04 11.03 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.404 -0.918 . . . . 1.0 110.704 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.411 ' CG1' HG23 ' A' ' 114' ' ' THR . 15.9 m -136.16 166.1 27.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.714 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 pp -110.19 144.77 38.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -132.7 107.35 8.33 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.135 0.493 . . . . 1.0 109.839 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -90.24 162.49 15.2 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.895 -1.521 . . . . 1.0 106.895 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -79.9 64.72 4.84 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.607 0.717 . . . . 1.0 112.031 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 . . . . . 0 N--CA 1.439 -0.977 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 177.948 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 CA--C 1.5 -0.956 0 N-CA-C 111.903 0.335 . . . . 1.0 111.903 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 132.28 54.08 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.046 0.45 . . . . 1.0 110.59 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -99.12 25.84 6.42 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.19 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 t -80.59 68.91 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 115.092 -0.958 . . . . 1.0 110.57 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -129.45 84.54 2.23 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.631 -1.168 . . . . 1.0 108.051 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' A' ' 32' ' ' LEU . 73.0 m-85 -130.57 -178.53 4.82 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 105.461 -2.051 . . . . 1.0 105.461 -176.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.537 ' H ' ' HB2' ' A' ' 33' ' ' ASP . 31.5 mmt180 -104.98 104.28 45.9 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 119.444 -0.903 . . . . 1.0 109.313 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' A' ' 32' ' ' LEU . 18.7 Cg_exo -65.81 105.18 0.76 Allowed 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 174.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HB3' HG23 ' A' ' 31' ' ' VAL . 4.3 tp -110.37 162.08 15.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-O 121.626 0.727 . . . . 1.0 112.334 -168.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -112.79 129.92 56.26 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.383 -1.281 . . . . 1.0 108.387 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 11' ' ' LEU . 25.7 mt -126.26 149.86 48.81 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.287 0.565 . . . . 1.0 111.258 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 26.6 t-20 -98.03 107.45 19.93 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.286 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.94 111.21 6.16 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 123.903 0.752 . . . . 1.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 30.4 tp -145.23 146.77 31.84 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.407 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.86 143.91 49.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -113.15 29.64 7.82 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.193 0.521 . . . . 1.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.474 HG22 ' HD3' ' A' ' 111' ' ' PRO . 53.2 t -64.9 -47.15 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 123.857 0.863 . . . . 1.0 112.56 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.85 -75.6 0.11 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.611 -1.281 . . . . 1.0 113.773 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.9 -26.44 80.97 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 123.68 2.92 . . . . 1.0 113.057 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.43 39.31 1.59 Allowed Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.751 -1.339 . . . . 1.0 109.751 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -63.75 80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.193 1.183 . . . . 1.0 114.193 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.35 39.96 Favored Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 110.403 -1.079 . . . . 1.0 110.403 172.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -157.05 38.07 0.3 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.612 0.72 . . . . 1.0 110.427 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' H ' HD11 ' A' ' 14' ' ' LEU . . . -95.63 -77.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.811 -0.631 . . . . 1.0 112.546 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.403 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 1.6 pt20 -127.13 -59.14 1.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.418 -172.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 69.56 68.37 1.66 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -99.34 131.25 25.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.666 -0.267 . . . . 1.0 110.561 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.14 103.36 1.49 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.917 1.745 . . . . 1.0 111.597 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.56 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 37.5 t -110.38 155.36 11.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.23 -0.895 . . . . 1.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.22 144.76 31.17 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.16 0.505 . . . . 1.0 112.177 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.541 HG12 ' HD2' ' A' ' 43' ' ' LYS . 2.6 m -147.64 -176.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.69 -1.141 . . . . 1.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 6' ' ' TYR . 29.5 mt -121.45 174.35 6.81 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.641 0.734 . . . . 1.0 110.097 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.537 ' HB2' ' H ' ' A' ' 7' ' ' ARG . 28.8 t70 -66.18 -32.3 73.65 Favored 'General case' 0 C--O 1.265 1.881 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.607 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.9 t -103.46 2.78 34.16 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.417 1.636 . . . . 1.0 115.417 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.393 0.2 OUTLIER -79.08 141.92 36.93 Favored 'General case' 0 CA--C 1.467 -2.245 0 C-N-CA 115.969 -2.293 . . . . 1.0 111.607 172.475 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.2 p -77.24 170.15 17.06 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.527 -1.67 . . . . 1.0 110.217 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.5 mm -59.64 -42.9 89.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.615 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.8 p -61.59 -46.99 87.49 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 123.431 0.457 . . . . 1.0 111.401 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.77 -42.54 63.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.114 0.483 . . . . 1.0 111.558 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.63 -37.4 82.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.716 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.528 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 32.9 ttpt -59.29 -38.31 79.9 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.444 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 38' ' ' SER . 63.5 mt-10 -66.9 -40.0 87.59 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.402 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HD2' HG12 ' A' ' 31' ' ' VAL . 64.6 mttp -63.92 -40.93 97.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 121.335 -0.146 . . . . 1.0 111.05 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.56 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.1 mmt -61.82 -49.35 76.65 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.739 0.65 . . . . 1.0 110.601 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -76.64 -23.08 53.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.757 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 30.7 t70 -55.27 -30.82 60.87 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.247 1.019 . . . . 1.0 111.567 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.6 mm100 -67.96 -30.93 70.34 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.845 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.88 -41.66 7.92 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.091 0.472 . . . . 1.0 111.46 -171.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.757 ' CE2' ' HA ' ' A' ' 46' ' ' ASP . 1.2 p90 -78.85 -11.12 59.98 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.903 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 13.9 tppt? -59.51 114.79 2.88 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.74 9.93 70.76 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.274 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.585 HG22 ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -97.33 147.94 33.7 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.585 ' HD2' HG22 ' A' ' 52' ' ' VAL . 18.7 Cg_endo -56.91 149.08 63.41 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.912 2.408 . . . . 1.0 112.067 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.7 -41.2 97.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.401 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 t -66.56 -21.49 66.15 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 112.307 0.484 . . . . 1.0 112.307 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -85.57 -23.9 27.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.018 0.437 . . . . 1.0 110.643 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -62.81 118.84 45.83 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.593 -177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 80.1 Cg_endo -72.36 159.93 48.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.082 2.522 . . . . 1.0 111.942 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -93.06 102.01 6.41 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.733 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 58' ' ' PRO . 34.4 Cg_exo -61.54 -33.41 87.45 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.989 2.46 . . . . 1.0 112.017 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -61.06 -30.17 70.17 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.273 -0.876 . . . . 1.0 113.116 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 14.7 t -101.56 2.15 38.69 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.449 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.9 pp -111.66 155.22 23.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.92 0.39 . . . . 1.0 111.181 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 11.2 p-10 -113.5 162.71 15.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.305 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.14 127.06 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.302 0.572 . . . . 1.0 110.472 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.45 113.21 25.31 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 105.132 -2.173 . . . . 1.0 105.132 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.564 ' CE3' HD22 ' A' ' 77' ' ' LEU . 4.9 t-105 -91.55 133.54 35.44 Favored 'General case' 0 N--CA 1.403 -2.806 0 CA-C-N 115.39 -0.823 . . . . 1.0 111.912 -173.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -117.08 88.69 2.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 106.446 -1.687 . . . . 1.0 106.446 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 71.3 p -73.48 -31.99 64.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.785 -1.098 . . . . 1.0 110.763 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.14 -50.99 4.35 Favored Glycine 0 C--N 1.303 -1.282 0 CA-C-N 114.566 -1.197 . . . . 1.0 111.365 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.8 -41.28 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.524 0.329 . . . . 1.0 111.703 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.4 -40.04 5.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.275 -1.009 . . . . 1.0 108.275 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.16 -130.16 6.76 Favored Glycine 0 N--CA 1.426 -2.021 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.042 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 88.9 m-70 -100.94 118.86 37.8 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.544 0.737 . . . . 1.0 110.652 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.35 134.43 39.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 115' ' ' LYS . 28.1 mm -79.72 118.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -109.98 152.27 26.09 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.234 0.54 . . . . 1.0 111.4 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.405 ' OG ' HG12 ' A' ' 82' ' ' VAL . 6.6 m -154.92 148.99 25.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 p-10 -66.25 -44.14 84.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.478 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 43.2 tt0 -157.5 88.6 1.0 Allowed 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.935 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 3.4 t70 -159.5 -81.21 0.05 Allowed 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 119.628 -0.829 . . . . 1.0 112.208 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 7.3 p -93.96 -34.0 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.323 0 CA-C-N 114.36 -1.291 . . . . 1.0 112.617 -171.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.501 HG23 ' ND2' ' A' ' 94' ' ' ASN . 2.8 t -106.12 20.35 19.09 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.315 1.055 . . . . 1.0 109.277 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.478 ' OG ' ' HA ' ' A' ' 80' ' ' GLU . 5.8 m -132.91 121.67 23.2 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 105.589 -2.004 . . . . 1.0 105.589 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -75.94 91.58 3.05 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.449 1.119 . . . . 1.0 111.078 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 p -102.64 85.58 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.1 0 CA-C-N 114.247 -1.342 . . . . 1.0 109.705 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -149.79 20.49 0.9 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 113.101 -1.863 . . . . 1.0 108.139 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.81 -160.86 32.81 Favored Glycine 1 N--CA 1.372 -5.622 0 N-CA-C 107.553 -2.219 . . . . 1.0 107.553 -175.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.767 ' H ' HD23 ' A' ' 89' ' ' LEU . 1.8 pt? -74.22 9.49 1.62 Allowed 'General case' 0 C--N 1.26 -3.292 0 C-N-CA 124.176 0.99 . . . . 1.0 112.314 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 61.8 m-85 -87.04 -0.62 56.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -66.06 116.45 7.19 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.252 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -144.86 160.63 40.98 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.934 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.0 mt -81.76 148.04 29.12 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.938 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.501 ' ND2' HG23 ' A' ' 83' ' ' THR . 58.2 m-80 -103.42 146.21 28.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.211 -0.45 . . . . 1.0 109.847 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.544 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -109.23 171.84 7.2 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -77.02 -17.55 58.74 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.585 -1.246 . . . . 1.0 109.43 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.544 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 5.2 pt20 -66.67 -26.42 67.03 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.896 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -64.07 -40.99 97.47 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 2.0 t80 -88.74 -16.14 32.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.604 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.35 57.91 5.42 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.103 0.961 . . . . 1.0 111.01 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -74.31 144.22 81.04 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.208 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.06 158.49 41.95 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.878 2.385 . . . . 1.0 111.861 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.451 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . 6.0 p-10 -66.49 119.2 11.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.812 0.815 . . . . 1.0 109.827 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.99 20.33 10.72 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.417 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.88 162.12 29.93 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.867 0.365 . . . . 1.0 110.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 76.1 m -115.24 132.3 56.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.093 0.473 . . . . 1.0 110.667 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 13.5 m -113.22 156.89 14.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -139.26 124.87 19.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.232 0.539 . . . . 1.0 109.598 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.628 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.7 mp -101.32 131.38 47.4 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.234 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 17.5 m -130.2 147.96 67.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HD3' HG22 ' A' ' 17' ' ' VAL . 77.7 Cg_endo -83.07 82.96 2.03 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 121.769 1.646 . . . . 1.0 111.741 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.629 ' HB3' ' O ' ' A' ' 62' ' ' THR . 12.6 p 52.18 64.59 1.79 Allowed 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 125.227 1.411 . . . . 1.0 111.247 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -113.84 -49.75 2.86 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 114.676 -1.147 . . . . 1.0 112.833 -174.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.1 t -131.19 37.96 3.69 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.067 -1.053 . . . . 1.0 113.294 -171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 18.4 pttp -78.96 73.12 5.51 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.898 1.332 . . . . 1.0 112.658 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -158.5 133.48 8.42 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 103.677 -2.712 . . . . 1.0 103.677 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.1 m -69.21 135.89 27.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 C-N-CA 119.284 -0.967 . . . . 1.0 112.302 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.2 mt -117.95 122.13 42.45 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.877 -1.527 . . . . 1.0 106.877 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 55.26 77.44 0.22 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.937 0.875 . . . . 1.0 110.296 -175.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -84.41 95.17 8.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.008 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -144.38 121.07 11.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.893 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 C--N 1.289 -2.033 0 N-CA-C 108.34 -0.985 . . . . 1.0 108.34 177.99 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 3.0 mppt? -77.23 164.78 25.28 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -81.16 86.35 6.2 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.591 -1.633 . . . . 1.0 106.591 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 t -87.58 74.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-O 121.741 0.782 . . . . 1.0 112.472 -173.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.91 30.03 4.05 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 124.27 1.986 . . . . 1.0 107.121 166.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.574 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 47.0 m-85 -110.28 -178.58 3.55 Favored 'General case' 0 N--CA 1.391 -3.42 0 N-CA-C 103.355 -2.831 . . . . 1.0 103.355 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.451 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 19.2 mmt180 -101.21 110.66 61.99 Favored Pre-proline 0 C--N 1.264 -3.126 0 C-N-CA 118.805 -1.158 . . . . 1.0 111.746 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -60.44 119.83 7.23 Favored 'Trans proline' 0 CA--C 1.508 -0.825 0 C-N-CA 122.397 2.064 . . . . 1.0 108.617 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -114.94 128.41 56.27 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 -171.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.2 m -87.37 120.3 28.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.506 HD23 ' SD ' ' A' ' 44' ' ' MET . 16.3 tp -124.65 142.84 51.08 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -98.76 117.07 32.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.106 -0.371 . . . . 1.0 110.814 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -75.92 116.93 17.11 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.148 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 25.7 tp -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.695 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -128.65 141.21 51.42 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.955 -0.465 . . . . 1.0 110.741 176.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.63 54.0 0.82 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.234 0.54 . . . . 1.0 110.933 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG22 ' HD3' ' A' ' 111' ' ' PRO . 46.5 t -67.71 -43.21 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.604 0.716 . . . . 1.0 109.865 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.94 -84.59 0.14 Allowed Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.94 -32.82 76.42 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.792 2.328 . . . . 1.0 112.142 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.65 18.58 50.11 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 121.32 -0.467 . . . . 1.0 112.152 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -77.79 64.42 3.04 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.449 0.642 . . . . 1.0 111.924 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.54 -29.34 1.89 Allowed Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -94.31 17.99 11.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.122 0.487 . . . . 1.0 111.187 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.07 -83.31 0.08 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -143.7 -62.8 0.39 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.569 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.86 72.57 0.95 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.38 126.72 27.62 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.34 -0.43 . . . . 1.0 110.264 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.36 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 121.737 1.625 . . . . 1.0 111.496 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.517 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 40.6 t -110.61 142.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.117 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.48 140.7 29.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.283 0.563 . . . . 1.0 111.765 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 9' ' ' LEU . 13.7 m -141.33 172.86 9.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 9.8 mt -107.95 158.4 17.39 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.421 0.629 . . . . 1.0 111.483 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.451 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.2 t70 -59.22 -30.83 68.52 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.03 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.9 t -88.6 -3.61 58.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.501 -1.227 . . . . 1.0 112.277 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -73.23 132.34 43.06 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 p -74.55 172.08 12.66 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -59.94 -44.99 95.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 117.993 0.36 . . . . 1.0 111.198 -177.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.437 ' HB2' ' OD1' ' A' ' 79' ' ' ASP . 4.0 t -71.87 -35.97 69.94 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.955 -1.098 . . . . 1.0 110.519 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.79 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 46.4 tt0 -68.25 -38.02 81.39 Favored 'General case' 0 C--O 1.206 -1.226 0 C-N-CA 123.136 0.574 . . . . 1.0 111.007 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -73.69 -39.75 64.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.539 -0.726 . . . . 1.0 110.596 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.646 ' HE2' ' O ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -58.22 -35.91 72.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.316 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.79 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 3.7 pt-20 -68.41 -40.44 81.27 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.919 -176.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.549 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 44.9 mmtm -63.99 -41.45 97.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 124.186 0.929 . . . . 1.0 110.245 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.1 mmm -61.59 -48.59 80.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.694 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.4 pp -77.28 -24.72 50.98 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 112.579 0.585 . . . . 1.0 112.579 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -52.89 -28.92 25.4 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.092 1.357 . . . . 1.0 112.076 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.446 HE21 HG13 ' A' ' 29' ' ' VAL . 12.2 mm-40 -66.76 -36.83 83.34 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.45 0.643 . . . . 1.0 110.348 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -95.16 -41.69 8.96 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.696 0.76 . . . . 1.0 109.545 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -95.46 30.91 2.11 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.413 -1.267 . . . . 1.0 110.877 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -56.6 122.94 13.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.565 -0.743 . . . . 1.0 109.71 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.67 -17.85 27.61 Favored Glycine 0 C--N 1.313 -0.728 0 N-CA-C 111.324 -0.711 . . . . 1.0 111.324 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.4 t -85.53 128.59 58.48 Favored Pre-proline 0 C--N 1.315 -0.932 0 C-N-CA 122.937 0.495 . . . . 1.0 110.301 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.522 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 75.2 Cg_endo -70.35 161.56 45.55 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.26 2.64 . . . . 1.0 112.008 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.607 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 51.6 tp -61.21 -40.06 92.57 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -176.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -64.36 -26.07 68.31 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.557 0.218 . . . . 1.0 111.308 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -85.61 -19.17 31.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.939 0.4 . . . . 1.0 110.145 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.607 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 83.9 mtt180 -73.92 114.2 30.43 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 107.435 -1.32 . . . . 1.0 107.435 175.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.646 ' O ' ' HE2' ' A' ' 41' ' ' LYS . 39.4 Cg_exo -53.35 133.48 53.15 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 122.489 2.126 . . . . 1.0 112.638 -172.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 61' ' ' ARG . 24.3 m-20 -83.42 146.45 50.59 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.118 -0.946 . . . . 1.0 110.959 -176.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HG2' ' NH1' ' A' ' 61' ' ' ARG . 32.5 Cg_endo -70.45 20.85 0.2 Allowed 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 122.955 2.437 . . . . 1.0 112.491 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 59' ' ' ASP . 4.2 mpt_? -86.09 -34.58 20.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 169.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.577 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 4.8 t -95.04 -20.38 19.38 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.572 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.616 HD13 ' HG ' ' A' ' 109' ' ' LEU . 4.5 pp -134.82 161.55 34.88 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.08 152.45 33.58 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.487 -1.301 . . . . 1.0 107.487 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 77' ' ' LEU . 8.4 p -115.75 125.94 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 118.825 -1.15 . . . . 1.0 110.137 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -93.87 113.11 25.06 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.357 -1.349 . . . . 1.0 107.357 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.611 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.5 t-105 -93.61 124.49 37.63 Favored 'General case' 0 N--CA 1.388 -3.549 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.97 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -109.96 89.57 3.06 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 p -84.59 -13.47 51.6 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.054 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.06 -55.87 3.94 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.42 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.03 -40.93 90.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.003 0.521 . . . . 1.0 111.293 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.35 -10.76 26.99 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.694 0.759 . . . . 1.0 109.03 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.35 -128.23 9.5 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.083 -0.962 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 3.8 p80 -130.65 108.19 9.72 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.298 0.571 . . . . 1.0 109.836 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.68 151.71 36.7 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.0 mm -94.07 120.68 43.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 10.4 mp -111.22 165.18 12.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.525 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -167.06 157.72 11.67 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 105.141 -2.17 . . . . 1.0 105.141 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 9.3 p-10 -78.51 -19.72 52.35 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.42 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.6 ' OE2' ' HD3' ' A' ' 91' ' ' ARG . 47.1 mt-10 -132.35 78.53 1.81 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.504 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.6 m-20 -80.88 -171.95 3.44 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 122.5 1.143 . . . . 1.0 110.328 -178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.18 -24.57 35.5 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.728 0 CA-C-N 114.434 -1.257 . . . . 1.0 109.468 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.496 HG22 ' HB2' ' A' ' 81' ' ' ASP . 3.7 t -80.4 -7.24 59.03 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 115.657 -0.701 . . . . 1.0 111.05 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 p -94.63 81.06 3.84 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.026 -1.102 . . . . 1.0 108.026 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.98 124.57 24.1 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.463 -0.79 . . . . 1.0 112.842 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 t -105.32 87.35 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 106.779 -1.563 . . . . 1.0 106.779 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -155.91 5.74 0.2 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.188 -0.915 . . . . 1.0 112.103 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.06 79.84 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 119.771 -1.205 . . . . 1.0 113.186 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.4 mt 70.47 -6.35 1.2 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.866 1.266 . . . . 1.0 113.444 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -79.94 -5.57 55.89 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.001 -0.545 . . . . 1.0 112.043 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.6 ' HD3' ' OE2' ' A' ' 80' ' ' GLU . 2.4 tmm_? -75.53 130.53 39.01 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -155.88 177.46 11.38 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 94.3 mt -110.15 149.27 30.31 Favored 'General case' 0 C--O 1.251 1.154 0 O-C-N 123.925 0.766 . . . . 1.0 109.477 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 37' ' ' ILE . 82.7 m-20 -98.58 140.58 32.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.207 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.548 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -111.39 173.1 6.5 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.991 1.316 . . . . 1.0 108.921 177.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 101' ' ' VAL . 3.9 pp -72.21 -22.8 61.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 119.136 -1.025 . . . . 1.0 109.49 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.548 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 5.4 pt20 -65.77 -26.47 67.73 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.327 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -66.7 -40.68 88.6 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 88.1 m-85 -97.47 -1.33 44.41 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.652 -0.703 . . . . 1.0 111.61 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? 48.53 63.61 2.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.034 1.334 . . . . 1.0 113.589 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.611 HG11 ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -84.52 146.29 46.81 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 119.075 -1.05 . . . . 1.0 112.601 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.14 158.08 23.41 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.026 2.484 . . . . 1.0 111.827 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.07 122.46 17.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.4 14.59 12.7 Favored Glycine 0 C--N 1.287 -2.151 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.971 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -71.3 162.68 29.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.269 0.557 . . . . 1.0 110.697 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 97.4 m -123.04 134.5 54.29 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.309 -0.405 . . . . 1.0 109.92 -176.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.425 HG11 HD21 ' A' ' 11' ' ' LEU . 27.2 m -115.38 138.81 44.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.461 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -126.13 135.17 51.37 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.528 0.68 . . . . 1.0 110.539 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.695 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 tt -100.04 125.8 46.15 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.315 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 16' ' ' ALA . 32.2 m -119.54 130.45 24.84 Favored Pre-proline 0 C--N 1.316 -0.883 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.094 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.5 Cg_endo -75.15 86.35 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.344 2.029 . . . . 1.0 111.699 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.628 ' HA ' ' NH2' ' A' ' 119' ' ' ARG . 18.7 p 56.09 17.21 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.833 1.653 . . . . 1.0 113.714 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -40.97 82.9 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -172.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 110' ' ' VAL . 14.9 t -114.62 2.41 14.51 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 115.561 1.689 . . . . 1.0 115.561 -168.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.459 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 2.3 mptp? 42.48 73.45 0.14 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 114.664 1.357 . . . . 1.0 114.664 175.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -98.21 -0.93 43.21 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 123.11 1.433 . . . . 1.0 110.229 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 81' ' ' ASP . 26.7 m -131.13 148.29 32.95 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.854 0 CA-C-N 112.13 -2.305 . . . . 1.0 105.597 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 95.2 mt -109.98 115.82 30.49 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.75 -0.78 . . . . 1.0 111.451 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.628 ' NH2' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -120.48 -32.55 4.05 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.553 -1.203 . . . . 1.0 108.366 177.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pm0 -78.06 143.35 37.51 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.743 -1.117 . . . . 1.0 108.021 176.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 73.56 82.69 0.12 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.51 1.131 . . . . 1.0 108.186 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 . . . . . 0 C--N 1.297 -1.695 0 CA-C-N 115.435 -0.802 . . . . 1.0 111.11 -175.021 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -115.09 37.67 3.43 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.53 86.21 6.98 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.439 -1.255 . . . . 1.0 108.904 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.61 104.16 16.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.022 -0.99 . . . . 1.0 108.847 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.54 44.95 1.2 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.204 1.002 . . . . 1.0 111.006 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -131.01 156.28 45.4 Favored 'General case' 0 N--CA 1.406 -2.628 0 N-CA-C 103.481 -2.785 . . . . 1.0 103.481 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.507 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 33.6 mmt180 -108.52 111.61 61.23 Favored Pre-proline 0 C--N 1.267 -3.004 0 C-N-CA 119.362 -0.935 . . . . 1.0 112.301 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.38 109.51 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.144 1.896 . . . . 1.0 109.57 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 10' ' ' THR . 4.6 tp -112.85 156.02 23.64 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.026 -174.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.439 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 47.3 m -96.51 128.59 43.58 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 ' SD ' ' A' ' 44' ' ' MET . 29.0 tp -127.37 143.73 51.17 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 27.6 t-20 -97.68 113.47 25.23 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.03 -0.419 . . . . 1.0 110.966 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . . . -76.16 115.98 16.41 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.811 -0.632 . . . . 1.0 110.167 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.642 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.7 tp -147.81 154.81 40.95 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.681 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.66 143.67 50.61 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.731 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -116.36 33.29 5.63 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.329 0.585 . . . . 1.0 110.368 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.78 -46.23 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 C-N-CA 123.645 0.778 . . . . 1.0 111.918 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.29 -77.47 0.14 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 119.295 -1.431 . . . . 1.0 113.684 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.45 -35.06 97.08 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.761 2.307 . . . . 1.0 112.141 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.39 36.63 3.22 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -68.39 74.46 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.79 1.033 . . . . 1.0 113.79 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.642 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 105.6 -5.58 40.73 Favored Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 110.14 -1.184 . . . . 1.0 110.14 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -119.9 16.61 12.6 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.244 -0.978 . . . . 1.0 111.371 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.81 -75.31 0.17 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -148.53 -58.06 0.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.965 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 75.54 1.18 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 13' ' ' ALA . 18.3 t -92.9 126.51 51.2 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.419 . . . . 1.0 110.723 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.18 99.06 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.941 1.76 . . . . 1.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 47' ' ' GLN . 16.4 t -109.6 156.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -123.01 151.32 41.98 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.811 -1.156 . . . . 1.0 112.021 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 32' ' ' LEU . 5.1 p -151.34 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.812 -1.181 . . . . 1.0 107.812 -175.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' H ' HG22 ' A' ' 31' ' ' VAL . 19.7 mt -100.56 160.55 14.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-N 118.755 0.707 . . . . 1.0 111.195 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 19.6 t70 -64.62 -31.08 72.14 Favored 'General case' 0 C--O 1.251 1.159 0 O-C-N 124.025 0.828 . . . . 1.0 108.857 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 8.2 t -108.61 39.52 1.98 Allowed 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.013 -1.449 . . . . 1.0 110.168 -177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.627 ' O ' HG22 ' A' ' 95' ' ' THR . 11.9 p-10 -66.89 -164.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.33 170.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 p -142.01 153.46 44.28 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 168.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -56.55 -40.68 70.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 118.122 0.419 . . . . 1.0 111.316 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -62.59 -43.02 99.85 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.62 176.454 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 45.7 mt-30 -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.974 0.416 . . . . 1.0 111.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.02 -38.19 90.17 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.27 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 38' ' ' SER . 28.7 tptp -55.56 -41.89 73.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.7 mt-10 -68.13 -48.52 65.18 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.259 -0.882 . . . . 1.0 110.625 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 34.9 mmtp -65.33 -42.54 92.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.128 0.788 . . . . 1.0 113.128 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 83.2 mmm -63.94 -42.84 97.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.863 0.363 . . . . 1.0 110.577 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.77 -25.63 56.63 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.0 111.682 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.2 t70 -53.02 -31.45 41.29 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.858 1.263 . . . . 1.0 112.224 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.58 ' HG3' HG22 ' A' ' 29' ' ' VAL . 13.7 mm-40 -71.32 -38.27 71.71 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.147 0.498 . . . . 1.0 111.401 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.97 -43.32 12.45 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 122.072 0.939 . . . . 1.0 108.912 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -95.77 32.13 1.92 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.769 -1.56 . . . . 1.0 109.636 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -50.6 117.66 2.59 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.994 -1.003 . . . . 1.0 111.331 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.47 -9.41 22.13 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.777 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.03 124.57 70.34 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 50.3 Cg_endo -66.99 160.96 44.76 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 122.877 2.384 . . . . 1.0 111.277 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.43 -41.78 97.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.859 -174.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 t -63.13 -23.87 67.64 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 112.446 0.535 . . . . 1.0 112.446 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.447 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 10.1 tt0 -93.2 -10.24 36.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.077 0.465 . . . . 1.0 111.732 -175.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 88.8 mtt180 -76.6 128.45 81.99 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 111.972 0.36 . . . . 1.0 111.972 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.61 142.86 66.14 Favored 'Trans proline' 0 C--O 1.26 1.608 0 C-N-CA 123.231 2.621 . . . . 1.0 113.678 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.26 156.98 88.81 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 115.185 -0.916 . . . . 1.0 111.694 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.56 12.87 2.51 Favored 'Trans proline' 0 C--O 1.203 -1.243 0 C-N-CA 123.068 2.512 . . . . 1.0 111.489 174.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.478 ' NH1' ' HB3' ' A' ' 80' ' ' GLU . 9.7 mmm180 -74.23 -39.46 63.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.329 0.585 . . . . 1.0 111.832 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 82.0 p -81.85 -12.69 58.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.084 -0.962 . . . . 1.0 112.218 -171.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.1 pp -136.25 164.21 28.61 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.385 -1.279 . . . . 1.0 109.245 -176.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 1.7 m-20 -107.8 141.09 39.89 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.89 114.31 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 C-N-CA 118.352 -1.339 . . . . 1.0 108.054 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -91.0 112.67 24.66 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 107.614 -1.254 . . . . 1.0 107.614 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CZ2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -83.42 127.52 33.76 Favored 'General case' 0 N--CA 1.385 -3.683 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.723 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.59 89.01 3.03 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.456 -0.793 . . . . 1.0 109.562 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.407 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 53.0 m -97.05 -17.56 19.92 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.683 0.754 . . . . 1.0 109.335 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.95 -46.0 3.5 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.505 -1.225 . . . . 1.0 112.411 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.6 -44.93 97.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-O 120.89 0.376 . . . . 1.0 110.989 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . . . -102.46 0.59 34.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.057 0.932 . . . . 1.0 108.703 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.68 -127.75 8.09 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.282 -1.327 . . . . 1.0 113.236 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 9.3 m170 -115.73 118.46 33.11 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.382 1.073 . . . . 1.0 109.294 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.98 139.04 48.51 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.484 HG21 ' HA ' ' A' ' 115' ' ' LYS . 25.6 mm -84.68 118.29 31.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.29 -0.564 . . . . 1.0 109.638 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -108.49 159.59 16.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.474 0.654 . . . . 1.0 111.44 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 39.2 m -165.81 162.75 18.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 12.6 p-10 -66.08 -38.76 89.08 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.478 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 45.9 tt0 -135.04 126.65 28.89 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 37.8 t70 -157.31 -99.23 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.653 0.74 . . . . 1.0 111.861 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -102.17 -25.47 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 CA-C-N 114.83 -1.077 . . . . 1.0 112.621 -171.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 t -94.19 -6.12 45.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.319 0.581 . . . . 1.0 110.534 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 p -98.25 73.41 2.17 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.445 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.15 135.86 33.14 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . 15.9 m -104.37 89.38 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-O 122.23 1.014 . . . . 1.0 110.813 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -139.54 5.62 2.24 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.474 -1.239 . . . . 1.0 111.046 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.78 -60.32 0.21 Allowed Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.143 -1.027 . . . . 1.0 111.55 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.51 -38.37 89.49 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.117 0.96 . . . . 1.0 108.57 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 86' ' ' VAL 0.295 52.8 p90 60.74 -52.05 0.1 Allowed 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 130.427 3.491 . . . . 1.0 115.416 176.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -100.88 119.39 38.62 Favored 'General case' 1 C--N 1.236 -4.363 0 CA-C-N 115.666 -0.697 . . . . 1.0 109.622 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.6 mmt-85 -143.99 89.35 2.03 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.455 0.645 . . . . 1.0 111.118 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.2 mt -76.07 147.92 38.31 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.724 -1.125 . . . . 1.0 109.099 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -90.71 141.14 29.1 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.974 -0.691 . . . . 1.0 109.826 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.8 p -121.97 171.49 8.9 Favored 'General case' 0 C--O 1.266 1.922 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 101' ' ' VAL . 3.2 pp -66.8 -29.94 70.01 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.96 . . . . 1.0 108.979 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.549 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 2.5 pt20 -67.83 -26.09 65.88 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.533 177.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -64.13 -41.36 97.24 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' HG12 ' A' ' 101' ' ' VAL . 3.1 t80 -83.45 -18.62 38.0 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.733 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 10.6 mmmm 52.15 60.7 3.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.947 0.899 . . . . 1.0 110.788 -171.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.655 HG11 ' CZ2' ' A' ' 67' ' ' TRP . 1.6 m -74.23 149.78 87.16 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.65 -0.705 . . . . 1.0 112.575 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.3 164.03 31.59 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.142 2.561 . . . . 1.0 111.742 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.408 ' HA ' HD11 ' A' ' 9' ' ' LEU . 5.0 p-10 -65.65 129.01 38.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.366 0.603 . . . . 1.0 109.712 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.27 40.64 Favored Glycine 0 C--N 1.295 -1.727 0 C-N-CA 120.623 -0.799 . . . . 1.0 111.999 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -64.42 154.87 34.36 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 120.716 0.293 . . . . 1.0 111.018 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 98.9 m -107.45 132.52 53.11 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.988 0.423 . . . . 1.0 111.345 -176.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.5 m -113.0 142.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.33 136.57 53.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.578 0.704 . . . . 1.0 110.581 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.681 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.0 tt -102.68 124.47 48.29 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 115.191 -0.913 . . . . 1.0 109.184 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 26.3 m -129.03 144.25 51.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.01 51.54 3.69 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 122.934 2.422 . . . . 1.0 114.002 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 62' ' ' THR . 0.1 OUTLIER 64.03 84.32 0.15 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 124.495 1.118 . . . . 1.0 111.095 -178.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.21 -55.05 2.54 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 114.304 -1.317 . . . . 1.0 110.71 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.5 t -135.55 37.41 2.9 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 113.861 1.06 . . . . 1.0 113.861 -170.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HA ' HG21 ' A' ' 76' ' ' ILE . 37.5 ttpt -74.34 131.23 40.95 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.249 -0.981 . . . . 1.0 109.965 175.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -53.14 128.61 28.35 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.539 -1.21 . . . . 1.0 111.968 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.0 m -109.55 155.04 10.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.34 80.69 8.11 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.462 0.649 . . . . 1.0 110.039 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -90.85 -20.58 22.12 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.111 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -129.39 108.04 9.97 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 121.326 0.584 . . . . 1.0 111.233 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -130.49 88.79 2.68 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.786 -1.19 . . . . 1.0 107.786 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 -177.349 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? . . . . . 0 CA--C 1.484 -1.558 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.625 ' O ' HD11 ' A' ' 32' ' ' LEU . 35.1 mtmm -133.65 108.38 8.52 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.318 -1.364 . . . . 1.0 107.318 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -82.01 74.03 9.01 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.564 1.173 . . . . 1.0 110.716 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.92 -171.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 113.489 -1.687 . . . . 1.0 107.463 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -101.08 91.3 4.49 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.242 1.02 . . . . 1.0 112.347 -174.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.644 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 m-85 -137.55 -175.89 4.22 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 101.202 -3.629 . . . . 1.0 101.202 175.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 34.9 mmt180 -98.01 108.24 45.41 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 121.063 1.756 . . . . 1.0 111.22 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 15.4 Cg_exo -69.58 120.07 6.94 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.106 1.871 . . . . 1.0 108.469 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tp -117.87 158.34 25.02 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.223 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -98.34 125.56 43.51 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.54 HD11 HG13 ' A' ' 107' ' ' VAL . 18.5 tp -127.21 142.03 51.59 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.724 -1.213 . . . . 1.0 107.724 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 29.2 t-20 -94.94 122.0 37.13 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.916 -0.49 . . . . 1.0 111.25 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.48 113.31 20.14 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.494 -0.776 . . . . 1.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 33.2 tp -146.61 151.71 37.73 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.912 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.678 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -120.82 140.45 51.72 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.93 42.79 2.1 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.035 0.445 . . . . 1.0 110.901 -174.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.552 HG22 ' HD3' ' A' ' 111' ' ' PRO . 82.7 t -65.2 -46.34 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-N 115.461 -0.791 . . . . 1.0 111.825 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.85 -80.35 0.15 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.239 -0.981 . . . . 1.0 112.986 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.62 -30.95 79.61 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.947 2.432 . . . . 1.0 112.829 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -126.38 41.49 1.63 Allowed Glycine 0 N--CA 1.408 -3.23 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -75.67 31.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.14 0.576 . . . . 1.0 112.195 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.549 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 168.35 -41.28 0.23 Allowed Glycine 0 C--N 1.3 -1.45 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.74 10.11 19.4 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.195 0.521 . . . . 1.0 112.093 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLY . . . -76.16 -68.54 0.57 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.472 0.653 . . . . 1.0 112.603 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.2 pt20 -131.24 -69.51 0.63 Allowed 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.793 -172.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.35 64.33 4.49 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.329 -0.708 . . . . 1.0 111.329 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 25' ' ' GLN . 19.2 t -107.95 125.82 31.2 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -175.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.46 104.93 1.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.63 1.553 . . . . 1.0 110.575 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 47' ' ' GLN . 17.1 t -107.61 156.01 8.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.95 148.06 34.57 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.392 -0.923 . . . . 1.0 110.561 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' CB ' ' A' ' 40' ' ' ALA . 13.9 p -158.55 163.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.393 -0.821 . . . . 1.0 108.974 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD11 ' O ' ' A' ' 2' ' ' LYS . 18.3 mt -86.05 158.2 19.89 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.739 0.78 . . . . 1.0 112.423 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 30.2 t70 -64.24 -32.03 73.46 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-N 113.904 -1.498 . . . . 1.0 109.289 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.0 t -95.29 6.56 48.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.548 -1.66 . . . . 1.0 111.239 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.416 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 95.2 m-20 -85.54 144.79 27.71 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 119.399 -0.92 . . . . 1.0 108.656 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 p -83.56 169.96 14.87 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.444 -0.798 . . . . 1.0 109.328 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 94' ' ' ASN . 44.2 mm -61.52 -43.44 96.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 117.752 0.251 . . . . 1.0 110.457 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -63.88 -40.76 97.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.22 0.533 . . . . 1.0 110.655 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.663 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 8.1 tt0 -75.78 -25.0 56.03 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.797 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -82.3 -37.6 25.55 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 121.701 -0.624 . . . . 1.0 111.098 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.71 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 2.5 mmmp? -57.64 -36.2 71.51 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.646 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 11.3 pt-20 -62.54 -45.8 91.31 Favored 'General case' 0 N--CA 1.414 -2.239 0 O-C-N 124.154 0.909 . . . . 1.0 110.925 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 29.2 mmmt -70.72 -38.59 73.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.4 mmt -59.58 -49.01 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.363 0.602 . . . . 1.0 109.532 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 2.4 pp -78.11 -23.9 47.69 Favored 'General case' 0 C--O 1.197 -1.709 0 CA-C-N 115.604 -0.726 . . . . 1.0 112.659 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 20.1 t70 -50.18 -34.69 23.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.11 1.364 . . . . 1.0 112.366 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.514 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.7 mm-40 -67.36 -29.96 69.64 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.744 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.83 -38.74 7.28 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.717 0.77 . . . . 1.0 110.581 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 25.3 m-85 -88.44 16.17 6.83 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.232 1.013 . . . . 1.0 111.652 -177.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -64.91 116.28 6.21 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.61 -14.25 15.01 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 110.006 -1.238 . . . . 1.0 110.006 -175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.5 t -105.23 130.72 22.62 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.723 -0.843 . . . . 1.0 108.723 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 60.2 Cg_endo -67.35 161.71 41.95 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.055 2.503 . . . . 1.0 112.444 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.5 tp -61.68 -36.42 80.81 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.369 0.667 . . . . 1.0 111.865 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 t -63.06 -29.55 70.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.889 0.476 . . . . 1.0 111.256 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.5 -23.08 24.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.809 0.338 . . . . 1.0 111.443 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 70.5 mtt180 -67.0 121.67 79.12 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.091 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HB2' HD21 ' A' ' 63' ' ' LEU . 35.7 Cg_exo -59.88 140.57 93.67 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.163 2.575 . . . . 1.0 113.429 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 44.6 m-20 -89.16 155.0 49.56 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.706 -0.679 . . . . 1.0 111.274 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.482 ' HG2' ' OD1' ' A' ' 79' ' ' ASP . 62.8 Cg_endo -81.19 2.23 8.72 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.329 2.019 . . . . 1.0 112.778 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -93.78 -7.07 44.52 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.889 -0.507 . . . . 1.0 111.557 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 t -118.63 -13.11 9.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.945 0.878 . . . . 1.0 109.978 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.643 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.2 pp -140.92 147.93 39.62 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 106.589 -1.634 . . . . 1.0 106.589 174.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' HB3' HG23 ' A' ' 76' ' ' ILE . 21.5 m-20 -102.93 154.12 19.54 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.13 112.77 41.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -91.34 122.32 33.85 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.771 0.796 . . . . 1.0 110.342 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 17.8 t90 -82.73 116.87 22.27 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.787 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 49.5 mtm105 -122.95 90.43 3.29 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 p -88.01 -20.47 25.77 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.74 -54.41 4.12 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.191 -1.368 . . . . 1.0 111.657 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.48 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 123.773 0.829 . . . . 1.0 111.498 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.94 -15.12 20.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.821 0.344 . . . . 1.0 110.673 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.67 -158.63 15.58 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 111.465 -0.654 . . . . 1.0 111.465 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.4 p80 -136.43 120.58 17.79 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.156 0.582 . . . . 1.0 110.861 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -127.39 148.78 50.27 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.421 -174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' A' ' 64' ' ' ASP . 27.9 mm -84.9 116.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 120.87 0.367 . . . . 1.0 110.194 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.448 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 11.1 mp -106.51 148.64 27.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.937 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 32.0 t -164.04 161.97 22.86 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 175.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD1' ' HG2' ' A' ' 60' ' ' PRO . 4.1 p-10 -71.38 -30.21 65.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.529 ' HG2' ' CB ' ' A' ' 84' ' ' SER . 33.9 tt0 -139.33 83.2 1.93 Allowed 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 1.7 p30 -102.09 -89.08 0.37 Allowed 'General case' 0 CA--C 1.478 -1.801 0 CA-C-O 121.594 0.712 . . . . 1.0 112.291 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.04 -16.55 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.215 0 CA-C-N 114.458 -1.246 . . . . 1.0 107.998 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 14.0 p -85.45 -3.0 58.72 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.52 -1.218 . . . . 1.0 108.546 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.529 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 78.1 p -59.47 -34.55 72.69 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.314 -1.312 . . . . 1.0 112.483 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.01 125.6 29.43 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.167 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 91' ' ' ARG . 3.1 p -151.32 124.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.592 0 CA-C-O 121.576 0.703 . . . . 1.0 111.257 -174.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -102.62 -30.11 11.14 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.118 -0.946 . . . . 1.0 108.903 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.64 -97.51 1.37 Allowed Glycine 0 N--CA 1.404 -3.474 0 C-N-CA 120.015 -1.088 . . . . 1.0 111.274 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -120.91 6.49 10.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -62.89 -29.87 71.1 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 115.65 1.722 . . . . 1.0 115.65 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 83' ' ' THR . 49.0 ttp180 -65.86 118.01 9.08 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.625 -0.83 . . . . 1.0 110.68 177.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -132.63 147.05 52.33 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.05 132.47 38.94 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.448 -1.686 . . . . 1.0 106.448 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.418 ' O ' HG12 ' A' ' 37' ' ' ILE . 78.5 m-20 -84.92 141.49 30.35 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.969 -173.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.552 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -105.67 172.49 6.77 Favored 'General case' 0 N--CA 1.425 -1.69 0 C-N-CA 123.731 0.813 . . . . 1.0 108.917 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.406 HD13 HG22 ' A' ' 101' ' ' VAL . 3.2 pp -71.25 -27.31 63.37 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.503 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.552 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 3.9 pt20 -65.83 -25.25 67.13 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.439 177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -65.32 -35.39 80.86 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.448 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 87.4 m-85 -103.32 -11.8 17.67 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.918 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 54.0 69.3 0.73 Allowed 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.615 1.166 . . . . 1.0 112.649 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 11' ' ' LEU . 2.5 m -78.97 137.8 57.31 Favored Pre-proline 0 N--CA 1.434 -1.239 0 C-N-CA 120.041 -0.664 . . . . 1.0 109.471 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.25 160.39 49.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.315 2.01 . . . . 1.0 111.171 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.84 125.73 25.76 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.884 -0.727 . . . . 1.0 110.293 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 21.74 39.52 Favored Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.881 -1.054 . . . . 1.0 111.164 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.92 155.54 39.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.783 0.325 . . . . 1.0 110.403 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 99.0 m -107.01 125.83 51.54 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.108 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 11' ' ' LEU . 35.2 m -121.66 137.06 56.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 176.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -122.82 135.13 54.43 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.662 0.744 . . . . 1.0 112.826 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 11.0 mp -90.14 124.09 34.53 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.322 -0.853 . . . . 1.0 109.549 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 23.6 m -125.54 134.7 26.07 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.433 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HD3' HG22 ' A' ' 17' ' ' VAL . 40.2 Cg_endo -68.69 86.15 0.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.525 2.15 . . . . 1.0 111.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.643 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 23.3 p 49.35 77.3 0.11 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.541 1.537 . . . . 1.0 111.715 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 114' ' ' THR . 3.0 mm? 69.8 12.62 8.01 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 125.019 1.328 . . . . 1.0 110.0 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER 75.03 12.84 3.38 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.874 1.669 . . . . 1.0 112.42 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -120.63 99.85 6.78 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 114.289 -1.323 . . . . 1.0 107.551 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -72.24 100.88 2.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.131 -175.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.3 164.58 31.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.938 -1.504 . . . . 1.0 106.938 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.75 92.84 8.71 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.737 -0.785 . . . . 1.0 109.62 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 73.3 ttt180 -123.75 140.46 52.97 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.877 -1.056 . . . . 1.0 109.504 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 70.0 mm-40 -75.31 162.18 28.64 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -73.84 88.35 1.8 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.63 0.728 . . . . 1.0 110.393 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 N--CA 1.435 -1.178 0 C-N-CA 126.126 1.77 . . . . 1.0 106.86 177.756 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -152.2 101.06 2.67 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.918 0.866 . . . . 1.0 108.71 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -103.52 17.66 23.6 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.65 -1.159 . . . . 1.0 109.933 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.1 t 66.43 66.53 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 122.713 1.244 . . . . 1.0 109.578 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.56 27.58 9.23 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.784 -1.553 . . . . 1.0 107.582 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.563 ' HB2' HD22 ' A' ' 32' ' ' LEU . 41.7 m-85 -125.65 163.62 22.37 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 26.3 mmt180 -110.26 105.03 56.82 Favored Pre-proline 0 C--N 1.272 -2.774 0 C-N-CA 118.773 -1.171 . . . . 1.0 110.547 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.87 118.44 5.33 Favored 'Trans proline' 0 C--O 1.25 1.093 0 N-CA-C 108.504 -1.383 . . . . 1.0 108.504 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER -119.13 131.68 55.91 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 -172.527 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -87.12 128.74 35.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 31' ' ' VAL . 1.1 mm? -122.82 147.35 46.64 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.064 0.946 . . . . 1.0 109.996 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -89.95 110.94 21.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.49 109.45 7.98 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 123.489 0.493 . . . . 1.0 109.78 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.9 tp -138.56 160.77 38.74 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.318 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -125.73 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.21 33.92 4.99 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.921 0.391 . . . . 1.0 110.597 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.428 ' HA ' ' OG1' ' A' ' 114' ' ' THR . 47.1 t -63.79 -47.66 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 115.849 -0.614 . . . . 1.0 112.392 -174.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.73 -85.14 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.63 -33.78 93.03 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 122.998 2.466 . . . . 1.0 113.072 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.05 29.63 6.99 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -76.24 75.98 3.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.397 0.617 . . . . 1.0 111.985 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 121.2 -7.91 10.55 Favored Glycine 0 CA--C 1.488 -1.629 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.391 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -128.76 28.3 5.38 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.234 0.54 . . . . 1.0 111.27 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 -88.78 0.18 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.449 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.457 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 8.9 pt20 -117.62 -58.49 2.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.243 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 65.97 71.81 0.84 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 -175.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.3 t -103.97 126.98 30.28 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.626 -0.287 . . . . 1.0 110.432 -173.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.21 106.51 2.18 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.963 1.775 . . . . 1.0 111.581 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 44' ' ' MET . 79.4 t -116.1 155.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.95 -1.13 . . . . 1.0 107.95 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -125.69 144.3 50.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 11' ' ' LEU . 16.0 m -139.72 170.31 15.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.571 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 6' ' ' TYR . 14.7 mt -84.52 159.64 20.66 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.043 0.449 . . . . 1.0 111.454 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 24.5 t70 -62.65 -30.89 71.71 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-N 115.286 -0.87 . . . . 1.0 108.834 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 10.0 t -95.27 6.11 49.92 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.048 -1.433 . . . . 1.0 112.562 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -71.24 132.51 45.06 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 174.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.478 ' CG2' HD11 ' A' ' 93' ' ' LEU . 69.8 p -79.26 167.26 21.19 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -60.11 -43.32 92.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.541 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.669 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -61.04 -47.13 87.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 123.32 0.387 . . . . 1.0 110.745 177.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 47.5 mt-30 -71.24 -40.23 71.16 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.6 -39.78 84.77 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.108 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -61.96 -34.66 76.54 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.718 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.669 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.9 mt-10 -64.46 -46.23 84.01 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 124.412 1.07 . . . . 1.0 110.073 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 39.2 mmtm -62.94 -46.61 86.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.662 0.744 . . . . 1.0 109.051 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 107' ' ' VAL . 7.2 mtp -65.3 -40.34 93.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.444 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.55 -33.18 64.58 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.514 -0.474 . . . . 1.0 111.123 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.1 -33.95 75.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.606 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 19.0 mm-40 -67.08 -30.88 71.04 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.52 -0.764 . . . . 1.0 111.584 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.41 HD22 HE22 ' A' ' 25' ' ' GLN . 0.7 OUTLIER -108.62 -28.04 9.51 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.501 -173.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.77 13.68 21.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.181 0.515 . . . . 1.0 110.307 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -61.89 126.02 25.87 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.301 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.53 -20.02 28.08 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.75 131.85 23.0 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 51.2 Cg_endo -65.12 154.39 73.7 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.481 2.12 . . . . 1.0 111.591 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.7 tp -59.21 -39.51 82.89 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.763 0.425 . . . . 1.0 111.769 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -63.42 -23.95 67.62 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -94.16 -24.47 17.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.35 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 89.4 mtt180 -65.77 145.68 99.02 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.61 142.88 96.02 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 121.919 1.746 . . . . 1.0 110.423 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.437 ' OD2' ' HB2' ' A' ' 61' ' ' ARG . 19.8 t70 -77.35 117.28 64.33 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.599 -0.273 . . . . 1.0 110.666 -177.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 40.4 Cg_endo -68.16 -13.62 38.47 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.183 2.589 . . . . 1.0 113.15 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 98.4 mtt180 -93.73 -10.93 32.66 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.287 -176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.8 -21.15 11.33 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.037 0.446 . . . . 1.0 111.498 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.2 pp -88.54 162.93 16.13 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.437 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 4.9 m-20 -107.81 150.64 26.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.53 128.89 75.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 120.108 -0.637 . . . . 1.0 109.5 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 33.7 mt-10 -90.93 112.97 25.06 Favored 'General case' 0 CA--C 1.462 -2.407 0 N-CA-C 106.119 -1.808 . . . . 1.0 106.119 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.613 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -91.34 119.16 31.13 Favored 'General case' 1 N--CA 1.37 -4.448 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -108.98 89.48 3.01 Favored 'General case' 0 N--CA 1.394 -3.225 0 N-CA-C 106.738 -1.579 . . . . 1.0 106.738 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.2 p -83.95 -12.49 55.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 113.797 -1.547 . . . . 1.0 110.906 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.4 -60.97 3.58 Favored Glycine 0 C--N 1.302 -1.325 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.695 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.279 0.631 . . . . 1.0 112.049 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.12 -6.52 31.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.58 0.705 . . . . 1.0 109.751 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.35 -153.72 26.68 Favored Glycine 0 N--CA 1.414 -2.831 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.24 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -101.01 117.0 34.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.489 0.662 . . . . 1.0 111.678 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.92 146.75 45.5 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.772 -1.103 . . . . 1.0 108.069 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 22.0 mm -89.76 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.8 159.47 15.79 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.669 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 3.3 t -167.95 165.74 13.59 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 105.789 -1.93 . . . . 1.0 105.789 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' HD22 ' A' ' 93' ' ' LEU . 11.3 p-10 -63.0 -39.54 95.06 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' CD ' ' HE ' ' A' ' 91' ' ' ARG . 3.0 tm-20 -163.47 95.2 0.82 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.253 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -150.56 -98.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.729 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.46 -44.94 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 114.034 1.124 . . . . 1.0 114.034 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -84.44 7.95 18.01 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.046 0.927 . . . . 1.0 112.084 -175.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 80' ' ' GLU . 49.5 m -74.45 15.8 0.32 Allowed 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.718 -1.128 . . . . 1.0 113.189 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' OE1' ' HD3' ' A' ' 92' ' ' ARG . 60.4 mt-10 56.15 23.35 6.88 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.647 1.213 . . . . 1.0 111.438 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.0 70.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 113.426 -1.715 . . . . 1.0 112.0 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -99.15 -11.29 21.51 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.154 -1.384 . . . . 1.0 108.799 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.52 -114.74 0.51 Allowed Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 108.262 -1.935 . . . . 1.0 108.262 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.46 -2.65 58.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.471 0.653 . . . . 1.0 111.876 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -80.44 12.43 3.02 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.889 0.852 . . . . 1.0 110.657 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HE ' ' CD ' ' A' ' 80' ' ' GLU . 75.4 ttt180 -65.34 116.42 6.65 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.117 -1.402 . . . . 1.0 109.202 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.459 ' HD3' ' OE1' ' A' ' 85' ' ' GLU . 83.9 mtp180 -131.61 157.73 42.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.343 0.592 . . . . 1.0 112.402 -173.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD11 ' CG2' ' A' ' 36' ' ' THR . 3.3 tm? -72.51 144.73 47.9 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 125.201 1.4 . . . . 1.0 108.296 175.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.0 m-80 -101.97 137.9 39.64 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 119.533 -0.867 . . . . 1.0 112.03 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.415 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -126.77 175.3 8.11 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.579 -1.637 . . . . 1.0 106.579 174.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.543 HD13 HG22 ' A' ' 101' ' ' VAL . 2.3 pp -72.42 -28.02 62.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.104 -1.438 . . . . 1.0 108.334 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.549 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 4.4 pt20 -66.86 -24.31 66.12 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.513 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -57.61 -40.95 80.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.217 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -107.62 8.92 29.38 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.011 0.745 . . . . 1.0 113.011 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.549 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 31.2 mmmt 38.02 65.13 0.61 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.207 1.403 . . . . 1.0 112.745 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.613 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -67.71 149.69 98.16 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 115.058 -0.973 . . . . 1.0 112.003 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.58 155.5 40.31 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.422 2.081 . . . . 1.0 111.228 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 8.3 p-10 -66.05 127.62 32.85 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 177.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.82 20.72 27.9 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.087 -1.054 . . . . 1.0 110.934 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . . . -71.65 163.95 26.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 1.0 110.129 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.6 m -112.01 131.15 55.58 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.854 -0.529 . . . . 1.0 111.452 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.607 HG21 ' SD ' ' A' ' 44' ' ' MET . 17.3 m -117.07 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -129.0 137.83 51.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.572 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.2 pp -109.85 143.83 39.19 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.891 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 35.0 m -131.8 125.54 20.4 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.427 ' CD ' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -70.49 80.7 1.07 Allowed 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.458 2.105 . . . . 1.0 112.067 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.3 t 63.25 83.04 0.17 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.877 -1.056 . . . . 1.0 110.597 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.505 ' O ' HG22 ' A' ' 114' ' ' THR . 2.7 mm? 62.75 14.3 7.17 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 125.144 1.378 . . . . 1.0 110.723 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER 67.76 14.49 9.48 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.077 1.351 . . . . 1.0 110.88 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 115' ' ' LYS . 11.4 mmpt? -82.85 99.54 9.79 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.596 -1.184 . . . . 1.0 110.649 -175.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -84.07 96.45 8.9 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.1 172.16 16.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.661 -1.154 . . . . 1.0 108.868 -174.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.97 74.21 5.49 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.825 -0.805 . . . . 1.0 108.825 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -83.07 -51.17 7.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.306 0.574 . . . . 1.0 109.967 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.1 97.22 10.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.756 -0.657 . . . . 1.0 109.243 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -159.29 159.03 33.54 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 106.307 -1.738 . . . . 1.0 106.307 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? . . . . . 0 C--N 1.273 -2.755 0 CA-C-O 118.383 -0.817 . . . . 1.0 109.846 177.558 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 CA--C 1.509 -0.604 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp 56.02 37.21 28.6 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.863 0.84 . . . . 1.0 110.69 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -81.89 -6.21 58.91 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 122.428 1.109 . . . . 1.0 109.587 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 m -135.13 153.47 34.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 CA-C-N 113.469 -1.696 . . . . 1.0 106.585 176.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -114.23 105.07 12.74 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 122.075 0.941 . . . . 1.0 111.99 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.5 m-85 -123.17 -178.5 3.99 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 105.427 -2.064 . . . . 1.0 105.427 175.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 38.0 mmt180 -109.12 111.03 60.54 Favored Pre-proline 0 C--N 1.283 -2.308 0 C-N-CA 117.625 -1.63 . . . . 1.0 113.196 -170.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 21.8 Cg_exo -63.39 112.6 1.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.16 1.907 . . . . 1.0 108.44 171.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -113.06 160.94 17.64 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.994 -172.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -98.9 125.99 44.46 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.091 -1.077 . . . . 1.0 108.091 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD12 ' SD ' ' A' ' 44' ' ' MET . 1.3 tm? -127.32 141.1 51.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -97.26 111.38 23.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.884 -0.51 . . . . 1.0 110.319 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.68 106.37 5.4 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 115.407 -0.815 . . . . 1.0 111.132 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.52 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.2 tp -143.24 144.44 32.15 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.563 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.02 144.29 48.61 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.851 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -114.25 34.54 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.447 0.642 . . . . 1.0 109.531 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.499 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 38.4 t -65.14 -45.44 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 C-N-CA 123.839 0.856 . . . . 1.0 112.924 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.38 -80.9 0.1 OUTLIER Glycine 0 C--N 1.313 -0.713 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.902 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -58.98 -32.46 97.56 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.957 2.438 . . . . 1.0 112.429 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.45 41.36 1.61 Allowed Glycine 0 N--CA 1.419 -2.468 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -66.07 76.53 0.09 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 98.46 3.08 57.57 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.58 24.51 5.09 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.593 -0.804 . . . . 1.0 110.143 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.07 -77.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.0 pt20 -125.89 -65.48 0.99 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.229 -0.896 . . . . 1.0 111.919 -169.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.83 64.71 3.48 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 25' ' ' GLN . 43.2 t -108.3 129.9 23.46 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 110.24 -0.282 . . . . 1.0 110.24 -174.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.49 108.25 2.18 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.126 1.884 . . . . 1.0 111.309 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 44' ' ' MET . 59.6 t -117.71 138.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -84.16 155.94 22.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.885 0.698 . . . . 1.0 112.885 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 32' ' ' LEU . 14.2 p -151.3 -178.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.415 -1.266 . . . . 1.0 108.192 -176.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 31' ' ' VAL . 12.8 tp -119.1 155.39 31.62 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 30.5 t70 -64.0 -30.6 71.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.354 0.597 . . . . 1.0 109.649 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.7 t -104.81 33.48 3.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.401 -1.272 . . . . 1.0 110.352 -175.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.597 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -70.22 -163.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.636 172.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.4 p -140.51 161.91 36.59 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 103.668 -2.716 . . . . 1.0 103.668 167.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.659 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 43.8 mm -57.78 -47.74 85.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.371 -0.531 . . . . 1.0 111.741 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.584 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . 21.6 t -65.81 -43.87 87.35 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 123.677 0.611 . . . . 1.0 109.902 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -63.17 -40.44 97.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.28 0.562 . . . . 1.0 111.356 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -63.92 -40.76 97.22 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.524 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -62.08 -33.17 73.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 123.674 0.609 . . . . 1.0 110.633 -178.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.36 -46.21 84.41 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 123.589 0.556 . . . . 1.0 110.526 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -66.39 -37.68 85.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.193 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.746 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.8 mtp -62.61 -43.96 97.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.307 0.575 . . . . 1.0 110.633 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 49' ' ' TYR . 4.6 pp -75.9 -25.66 56.26 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.126 -0.488 . . . . 1.0 112.25 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.47 -29.02 68.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.493 0.663 . . . . 1.0 110.991 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG3' HG13 ' A' ' 29' ' ' VAL . 11.0 mm-40 -83.87 -32.68 25.08 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.973 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.0 mt -115.64 -52.9 2.62 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.607 0.718 . . . . 1.0 112.572 -167.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 95.1 m-85 -86.86 -1.31 57.7 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.957 -173.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 50' ' ' LYS . 3.7 tmmm? -78.2 123.32 26.77 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 105.608 -1.997 . . . . 1.0 105.608 170.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.61 -2.94 57.46 Favored Glycine 0 C--N 1.292 -1.893 0 C-N-CA 119.943 -1.122 . . . . 1.0 110.318 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -98.25 155.08 37.32 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 106.28 -1.748 . . . . 1.0 106.28 176.274 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HD2' HG22 ' A' ' 52' ' ' VAL . 19.7 Cg_endo -60.32 149.71 84.34 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.959 1.773 . . . . 1.0 111.553 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.9 mt -60.47 -38.67 85.0 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.395 0.678 . . . . 1.0 111.187 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 t -65.52 -24.5 67.14 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.672 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.441 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 84.0 mm-40 -87.9 -12.43 44.74 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 122.226 -0.297 . . . . 1.0 111.581 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 78.6 mtt180 -79.86 117.66 68.48 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.21 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 20.6 Cg_exo -66.41 145.0 75.89 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.667 2.245 . . . . 1.0 112.22 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.3 t70 -96.65 114.79 65.1 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.06 -13.42 33.89 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.755 2.303 . . . . 1.0 114.444 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH1' ' HB2' ' A' ' 38' ' ' SER . 16.8 mmm180 -73.33 -36.54 66.22 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.312 -0.555 . . . . 1.0 110.896 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 t -96.31 -24.18 16.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.791 -0.641 . . . . 1.0 112.333 -174.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.705 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.6 pp -96.38 162.51 13.46 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.57 0.952 . . . . 1.0 113.57 -174.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 9.9 p-10 -114.71 153.2 30.7 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.468 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 p -120.73 126.94 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.186 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.75 112.55 24.52 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.548 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -91.51 122.65 34.28 Favored 'General case' 0 N--CA 1.383 -3.801 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.951 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.516 HH22 HD23 ' A' ' 14' ' ' LEU . 67.5 mtm180 -110.3 90.13 3.23 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-O 123.025 1.393 . . . . 1.0 107.314 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.6 p -79.72 -17.68 53.0 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.061 -1.881 . . . . 1.0 110.553 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.7 -56.95 4.52 Favored Glycine 0 C--N 1.298 -1.565 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.676 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.83 -43.01 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.505 0.557 . . . . 1.0 112.505 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.54 -10.33 21.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.332 0.587 . . . . 1.0 109.541 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.11 -149.96 19.48 Favored Glycine 0 N--CA 1.418 -2.565 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.656 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 7.2 p80 -105.56 114.0 27.91 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.314 0.578 . . . . 1.0 110.853 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.95 146.74 49.22 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.324 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.404 HG21 ' HA ' ' A' ' 115' ' ' LYS . 29.5 mm -85.97 115.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 176.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -105.87 143.26 34.25 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.903 0.859 . . . . 1.0 111.768 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 9.6 m -158.3 146.03 18.26 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 104.238 -2.505 . . . . 1.0 104.238 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 5.2 p-10 -72.82 -36.2 67.47 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.043 -1.063 . . . . 1.0 111.004 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -109.46 91.9 3.83 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.228 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 5.1 t70 -164.14 -69.38 0.04 OUTLIER 'General case' 0 CA--C 1.486 -1.496 0 CA-C-O 121.865 0.841 . . . . 1.0 111.973 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.556 HG12 HD21 ' A' ' 94' ' ' ASN . 5.0 p -93.18 -2.75 10.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 114.421 -1.263 . . . . 1.0 112.142 -172.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.511 HG22 ' ND2' ' A' ' 94' ' ' ASN . 14.7 t -143.72 25.74 1.62 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.067 0.937 . . . . 1.0 109.466 176.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -98.45 17.14 19.65 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.395 -0.82 . . . . 1.0 111.348 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -63.2 112.21 2.57 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.54 0.686 . . . . 1.0 110.55 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 m -90.48 74.43 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-O 122.305 1.05 . . . . 1.0 111.991 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -124.51 -8.88 7.43 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.386 -1.279 . . . . 1.0 110.239 178.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.67 -103.53 0.24 Allowed Glycine 0 N--CA 1.407 -3.299 0 C-N-CA 120.455 -0.879 . . . . 1.0 111.427 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.5 mt -89.35 -5.58 57.38 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.351 0.596 . . . . 1.0 110.939 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -85.79 -3.95 59.04 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.022 -0.99 . . . . 1.0 110.555 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -80.4 95.47 6.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.413 -1.699 . . . . 1.0 106.413 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -143.14 170.17 16.23 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.153 -170.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt -110.25 155.93 21.37 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.556 HD21 HG12 ' A' ' 82' ' ' VAL . 55.7 m-80 -94.24 135.96 35.05 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 119.228 -0.989 . . . . 1.0 110.723 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.4 p -109.46 172.75 6.67 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 125.115 1.366 . . . . 1.0 108.237 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 101' ' ' VAL . 3.0 pp -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.839 -1.145 . . . . 1.0 108.015 171.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.571 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 3.4 pt20 -64.62 -25.05 67.79 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.327 -0.851 . . . . 1.0 112.029 177.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -59.55 -41.61 90.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -102.08 -3.44 27.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.578 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 68.1 mmtt 46.26 68.52 0.59 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.223 1.009 . . . . 1.0 112.827 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -78.3 148.9 75.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.462 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.66 160.58 34.57 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.071 2.514 . . . . 1.0 111.898 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.19 117.93 9.19 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.01 22.17 9.01 Favored Glycine 0 C--N 1.288 -2.135 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.437 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.09 156.8 38.06 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.0 m -120.52 130.35 54.21 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.182 0.515 . . . . 1.0 110.687 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.503 ' CG1' HD11 ' A' ' 11' ' ' LEU . 33.8 m -113.74 165.83 8.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.692 -0.803 . . . . 1.0 111.077 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -148.3 120.81 8.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.311 -0.859 . . . . 1.0 108.961 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.594 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -106.17 137.7 43.64 Favored 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.072 -176.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.705 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 29.3 m -126.91 149.77 69.9 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.43 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 73.5 Cg_endo -77.19 63.66 7.76 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 122.858 2.372 . . . . 1.0 113.32 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.1 t 64.28 70.65 0.49 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 122.075 0.941 . . . . 1.0 108.928 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.81 -50.74 2.95 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.152 -0.931 . . . . 1.0 110.198 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.6 t -139.68 50.81 1.75 Allowed 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 110.032 -0.358 . . . . 1.0 110.032 -175.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 63.3 pttt -65.99 69.14 0.05 Allowed 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.174 1.546 . . . . 1.0 115.174 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 63.18 7.16 2.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.48 1.912 . . . . 1.0 113.984 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.4 159.8 28.37 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.359 0 CA-C-N 114.834 -1.076 . . . . 1.0 109.145 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -108.93 109.18 20.19 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.493 -0.929 . . . . 1.0 108.493 174.354 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -98.48 120.97 39.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -89.85 140.94 29.11 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.226 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -96.61 95.15 7.76 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 -179.046 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.517 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -90.12 84.42 6.12 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -88.1 8.13 28.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.896 0.855 . . . . 1.0 110.859 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t 73.73 -42.79 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.771 0 C-N-CA 126.054 1.742 . . . . 1.0 114.445 170.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.32 78.42 9.63 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.663 1.22 . . . . 1.0 112.619 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.559 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 m-85 -131.48 -177.01 4.22 Favored 'General case' 0 N--CA 1.405 -2.715 0 N-CA-C 104.544 -2.391 . . . . 1.0 104.544 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -99.78 108.77 53.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 C-N-CA 119.746 -0.782 . . . . 1.0 111.93 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 31.6 Cg_exo -60.66 133.5 48.76 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.691 2.261 . . . . 1.0 110.893 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 96' ' ' LEU . 4.9 tp -126.95 156.27 41.79 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.604 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.1 m -99.91 127.28 46.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 HG22 ' A' ' 31' ' ' VAL . 2.3 mm? -126.56 146.88 49.97 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.061 0.545 . . . . 1.0 110.697 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -96.2 117.1 30.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.927 178.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.67 113.19 18.69 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 27.2 tp -142.67 155.39 44.91 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 -177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.632 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -123.59 140.95 52.48 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.424 -0.511 . . . . 1.0 110.078 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -119.29 36.19 4.56 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.239 0.542 . . . . 1.0 110.444 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 111' ' ' PRO . 76.4 t -66.08 -46.44 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.028 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.87 -80.56 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 118.761 -1.685 . . . . 1.0 114.553 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.42 -31.29 94.56 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.097 2.531 . . . . 1.0 112.781 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.89 38.37 2.19 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.149 -1.18 . . . . 1.0 110.149 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -65.23 80.3 0.05 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.682 0.753 . . . . 1.0 112.808 -176.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.57 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 95.14 -1.74 65.18 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -113.93 20.6 15.62 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.472 -1.364 . . . . 1.0 110.177 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.24 -82.14 0.18 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.368 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.79 -56.13 0.26 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.65 91.81 1.11 Allowed Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.49 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.29 126.1 30.41 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -74.8 104.53 1.91 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.719 1.613 . . . . 1.0 111.057 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG13 HE21 ' A' ' 47' ' ' GLN . 22.0 t -110.71 155.78 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -121.64 148.52 44.45 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.436 -0.906 . . . . 1.0 112.76 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 11' ' ' LEU . 7.6 m -147.91 -174.29 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 125.071 1.349 . . . . 1.0 108.312 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.2 mt -107.2 158.63 16.95 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-O 120.544 0.211 . . . . 1.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -32.07 73.14 Favored 'General case' 0 C--O 1.26 1.629 0 O-C-N 124.224 0.953 . . . . 1.0 109.344 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 t -108.97 37.39 2.57 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.856 -1.52 . . . . 1.0 109.791 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 95' ' ' THR . 11.1 p-10 -68.53 -166.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.267 173.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 p -139.95 146.18 38.85 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.591 HG21 ' HA ' ' A' ' 78' ' ' SER . 26.5 mm -57.17 -29.37 31.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 118.482 0.583 . . . . 1.0 110.863 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -60.99 -50.18 74.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -73.41 -40.36 64.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.34 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.95 -39.28 90.3 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.469 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.1 ttmp? -57.48 -41.85 81.48 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -67.28 -51.84 47.97 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.267 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HD3' HG12 ' A' ' 31' ' ' VAL . 53.3 mtpt -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 87.4 mmm -62.6 -45.96 90.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.337 0.398 . . . . 1.0 110.998 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.9 pp -77.23 -28.5 53.72 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.51 -29.08 64.02 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.459 1.104 . . . . 1.0 112.775 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.491 HE21 HG13 ' A' ' 29' ' ' VAL . 15.1 mm-40 -64.88 -37.27 87.06 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.581 0.705 . . . . 1.0 110.207 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.74 -41.48 8.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.98 0.895 . . . . 1.0 109.828 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 79.8 m-85 -91.81 25.45 2.75 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.341 -1.299 . . . . 1.0 111.429 -175.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -61.99 125.14 22.82 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.63 -4.78 53.99 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.28 124.5 53.43 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -66.37 162.05 38.07 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 123.438 2.759 . . . . 1.0 112.613 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -62.4 -39.62 93.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.769 -175.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 t -64.73 -30.79 71.81 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.195 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -85.49 -26.67 26.14 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.379 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 48.5 mtt180 -65.09 126.79 91.98 Favored Pre-proline 0 C--O 1.245 0.839 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 173.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 31.2 Cg_exo -58.82 134.2 58.83 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.846 1.697 . . . . 1.0 112.059 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.468 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 13.4 t70 -91.19 153.61 44.67 Favored Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 114.637 -1.165 . . . . 1.0 109.262 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 18.7 Cg_endo -58.06 -17.14 30.06 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.873 2.382 . . . . 1.0 113.286 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -70.94 -20.14 62.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 120.14 -0.624 . . . . 1.0 110.926 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 t -116.4 -15.93 10.89 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 120.483 -0.487 . . . . 1.0 111.562 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.621 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.2 OUTLIER -138.29 162.0 35.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 175.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 112' ' ' CYS . 9.5 m-20 -129.15 165.22 21.72 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.309 -1.367 . . . . 1.0 107.309 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.1 128.92 73.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.616 -0.833 . . . . 1.0 109.859 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -90.23 112.66 24.27 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 106.206 -1.776 . . . . 1.0 106.206 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.602 ' HZ2' HG11 ' A' ' 101' ' ' VAL . 3.4 t-105 -95.08 122.1 37.4 Favored 'General case' 1 N--CA 1.372 -4.325 0 C-N-CA 119.395 -0.922 . . . . 1.0 109.01 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -108.16 89.28 2.95 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.7 t -83.24 -17.7 41.75 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.511 -1.677 . . . . 1.0 109.261 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.13 -58.56 3.17 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 112.728 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.65 -37.16 79.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 122.737 0.415 . . . . 1.0 111.328 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.01 -5.23 30.8 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.777 0.798 . . . . 1.0 109.351 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.12 -140.31 15.01 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.832 -1.077 . . . . 1.0 110.642 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -117.57 120.55 38.4 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.034 0.445 . . . . 1.0 109.915 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.56 146.48 49.66 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -85.01 116.43 28.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.432 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.6 mp -108.48 155.86 20.13 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.421 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 37' ' ' ILE . 7.5 t -171.58 172.5 5.0 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 115.004 -0.998 . . . . 1.0 108.485 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -81.5 -2.48 49.92 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.859 -1.064 . . . . 1.0 109.438 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -165.08 84.62 0.39 Allowed 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 105.937 -1.875 . . . . 1.0 105.937 168.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' HB2' ' H ' ' A' ' 82' ' ' VAL . 4.6 p30 -95.2 -168.1 1.74 Allowed 'General case' 0 CA--C 1.477 -1.831 0 CA-C-O 122.896 1.331 . . . . 1.0 112.63 -173.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.406 ' H ' ' HB2' ' A' ' 81' ' ' ASP . 12.3 p -62.58 -28.96 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.872 0 CA-C-N 111.798 -2.455 . . . . 1.0 113.042 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.9 t -113.3 1.02 15.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.385 -0.926 . . . . 1.0 111.479 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.3 p -89.69 70.69 7.79 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 43.0 mt-10 -71.1 122.51 20.24 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.248 -1.342 . . . . 1.0 111.404 -174.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.24 83.05 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 122.352 1.072 . . . . 1.0 110.033 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -135.07 -28.7 1.16 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.183 -1.372 . . . . 1.0 109.739 178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.32 137.66 2.38 Favored Glycine 0 N--CA 1.413 -2.843 0 N-CA-C 109.079 -1.608 . . . . 1.0 109.079 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.8 mt 73.38 -15.05 0.57 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.393 1.077 . . . . 1.0 113.079 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 54.2 m-85 -97.56 -3.73 39.13 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.336 0.495 . . . . 1.0 112.336 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -75.33 92.35 2.78 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.437 -0.949 . . . . 1.0 108.437 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -145.87 156.98 43.91 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.38 122.01 38.81 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 170.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -74.56 142.39 44.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 -173.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.5 p -105.06 169.41 8.45 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 124.913 1.285 . . . . 1.0 108.709 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 9' ' ' LEU . 4.1 pp -70.32 -32.73 70.6 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 172.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 4.0 pt20 -62.13 -29.79 70.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.429 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -65.23 -35.21 80.34 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -98.06 8.66 44.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.89 -0.595 . . . . 1.0 112.189 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 52.99 54.63 10.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.045 . . . . 1.0 111.334 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.602 HG11 ' HZ2' ' A' ' 67' ' ' TRP . 40.8 t -74.86 124.37 89.53 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.779 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.0 159.1 27.23 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.525 2.816 . . . . 1.0 112.191 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.39 117.99 10.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.071 -0.513 . . . . 1.0 109.87 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.88 18.3 14.3 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.291 -0.957 . . . . 1.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.01 27.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.027 0.441 . . . . 1.0 110.554 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 30.9 m -115.8 132.06 56.75 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 122.066 -0.397 . . . . 1.0 111.076 -173.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 m -114.03 138.68 43.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.98 135.26 49.68 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.42 0.628 . . . . 1.0 110.773 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.632 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 94.6 mt -95.43 129.26 42.65 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 19.0 m -132.84 142.38 44.52 Favored Pre-proline 0 C--N 1.31 -1.15 0 O-C-N 123.172 0.295 . . . . 1.0 110.284 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -72.37 79.6 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.14 1.893 . . . . 1.0 110.664 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.621 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 3.1 t 53.55 82.02 0.09 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.931 1.692 . . . . 1.0 111.411 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 114' ' ' THR . 2.7 mm? 69.22 -1.06 2.27 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.155 1.382 . . . . 1.0 110.274 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER 70.0 12.33 7.8 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.371 1.469 . . . . 1.0 109.879 -176.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -140.25 96.71 3.09 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.083 -2.191 . . . . 1.0 105.083 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 112' ' ' CYS . 29.5 p-80 -136.48 163.2 31.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 114.187 1.18 . . . . 1.0 114.187 -170.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.42 174.01 11.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.581 -2.007 . . . . 1.0 105.581 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.4 82.26 5.93 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.332 -1.358 . . . . 1.0 107.332 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -105.22 141.95 35.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.367 -0.833 . . . . 1.0 112.646 -171.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -156.58 163.08 39.78 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.312 -1.736 . . . . 1.0 106.312 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -135.57 92.82 2.88 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.189 -0.604 . . . . 1.0 111.044 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? . . . . . 0 N--CA 1.421 -1.885 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 174.259 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.7 pttp . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -109.6 40.99 1.76 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 106.715 -1.587 . . . . 1.0 106.715 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -93.07 10.94 29.38 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.667 -1.151 . . . . 1.0 111.265 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.9 t -85.61 104.96 13.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.56 -1.645 . . . . 1.0 106.56 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -82.64 60.29 5.16 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.152 0.977 . . . . 1.0 113.092 -172.236 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.483 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 26.8 m-85 -129.98 162.46 28.61 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 105.025 -2.213 . . . . 1.0 105.025 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.519 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 20.1 mmt180 -104.01 108.17 59.17 Favored Pre-proline 0 C--N 1.277 -2.572 0 C-N-CA 119.384 -0.926 . . . . 1.0 111.841 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -59.43 131.45 40.73 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.255 1.97 . . . . 1.0 110.763 175.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -136.41 159.93 40.27 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.085 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.1 m -95.22 131.26 41.46 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.41 HD23 ' SD ' ' A' ' 44' ' ' MET . 27.1 tp -127.66 142.09 51.43 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -99.88 113.35 25.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.784 -0.572 . . . . 1.0 110.604 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -77.51 112.69 14.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.626 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.517 HD21 ' HA2' ' A' ' 22' ' ' GLY . 31.3 tp -142.01 152.67 43.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.684 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.02 140.2 53.21 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.881 -0.512 . . . . 1.0 110.897 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.42 41.74 3.03 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.622 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.88 -45.2 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 CA-C-N 116.546 -0.297 . . . . 1.0 110.546 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.32 -75.29 0.18 Allowed Glycine 0 C--O 1.22 -0.729 0 C-N-CA 119.777 -1.202 . . . . 1.0 113.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.51 -27.38 76.76 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.53 2.82 . . . . 1.0 113.307 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.69 34.41 2.88 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.68 76.3 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 114.19 -10.81 22.35 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 173.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -109.88 8.66 24.46 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.948 -0.626 . . . . 1.0 111.613 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.87 -86.54 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.321 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -132.38 -61.69 0.86 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.23 71.31 1.08 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.854 -1.165 . . . . 1.0 110.535 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.34 125.33 38.11 Favored Pre-proline 0 C--N 1.306 -1.323 0 O-C-N 122.898 -0.177 . . . . 1.0 110.818 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.46 101.79 1.54 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.021 1.814 . . . . 1.0 111.757 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 45.7 t -104.99 155.42 6.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.465 -1.309 . . . . 1.0 107.465 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -102.31 150.04 23.73 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.813 -1.155 . . . . 1.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 32' ' ' LEU . 4.4 p -148.26 -178.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.05 -0.977 . . . . 1.0 108.709 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 31' ' ' VAL . 14.4 mt -110.92 162.29 14.98 Favored 'General case' 0 C--O 1.179 -2.617 0 CA-C-N 118.39 0.541 . . . . 1.0 110.852 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.519 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 18.0 t70 -65.11 -31.3 72.44 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-O 121.407 0.623 . . . . 1.0 110.88 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -102.85 28.6 6.03 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.334 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.66 ' O ' ' HA ' ' A' ' 95' ' ' THR . 17.1 p-10 -67.75 135.54 52.85 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -91.08 157.05 17.46 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 45.0 mm -55.86 -40.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.889 0.376 . . . . 1.0 110.446 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 p -62.8 -43.96 97.43 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.294 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -73.15 -37.69 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 1.0 111.677 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.68 -38.39 89.13 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.37 -41.49 72.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -68.32 -47.75 66.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.261 -0.882 . . . . 1.0 110.846 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.83 -44.6 92.73 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.994 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.0 mmm -64.99 -42.76 94.23 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.567 0.542 . . . . 1.0 110.621 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -74.24 -29.33 61.64 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.818 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.08 -30.89 62.66 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.228 1.011 . . . . 1.0 112.539 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.47 HE21 HG13 ' A' ' 29' ' ' VAL . 14.3 mm-40 -70.38 -37.13 74.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.162 0.506 . . . . 1.0 111.283 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.32 -42.03 9.13 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.124 0.964 . . . . 1.0 109.654 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -97.25 33.47 1.96 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.041 -1.436 . . . . 1.0 109.515 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -55.61 115.88 2.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.104 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.16 -2.73 37.79 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.745 -0.74 . . . . 1.0 112.929 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -80.86 126.43 77.71 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 56' ' ' GLN . 31.4 Cg_endo -63.75 159.71 40.2 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 122.643 2.228 . . . . 1.0 111.683 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.73 -42.17 96.78 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.306 0.643 . . . . 1.0 111.956 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -74.2 -15.43 61.01 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.327 0.491 . . . . 1.0 112.327 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 10.1 tt0 -91.35 -9.86 43.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.412 0.625 . . . . 1.0 110.41 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -84.04 119.34 73.24 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.078 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.98 141.35 83.68 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.365 2.043 . . . . 1.0 111.092 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 61' ' ' ARG . 29.1 m-20 -93.02 159.77 34.98 Favored Pre-proline 0 C--N 1.311 -1.096 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.343 -175.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -76.92 15.15 1.17 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.565 2.177 . . . . 1.0 111.455 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.43 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 10.9 mmm180 -84.17 -40.35 18.27 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 68.8 p -94.51 -8.97 36.81 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.702 -1.135 . . . . 1.0 111.167 -172.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.3 pp -143.77 161.72 37.87 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.662 -1.154 . . . . 1.0 109.908 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.532 ' OD1' ' HB2' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -115.02 157.7 23.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 -177.36 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.09 121.87 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -91.55 112.72 24.75 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 105.792 -1.929 . . . . 1.0 105.792 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.606 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -86.49 128.72 34.99 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.906 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.98 89.84 3.18 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.4 m -90.1 -17.07 28.36 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.428 -0.909 . . . . 1.0 109.409 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.25 -46.88 3.48 Favored Glycine 0 C--N 1.309 -0.969 0 CA-C-N 114.998 -1.001 . . . . 1.0 112.306 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.35 -27.06 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.146 0.578 . . . . 1.0 111.439 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.496 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . . . -124.08 4.37 8.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.584 0.707 . . . . 1.0 109.775 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.13 -130.43 10.23 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.882 -1.054 . . . . 1.0 113.55 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.34 123.97 46.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 125.144 1.377 . . . . 1.0 108.665 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -132.05 148.43 52.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 mm -94.55 116.11 35.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.282 -0.567 . . . . 1.0 109.616 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.488 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.1 mp -111.03 158.02 19.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.061 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -158.0 159.7 36.69 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.851 -1.907 . . . . 1.0 105.851 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 17.7 p-10 -66.71 -53.74 30.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.237 -0.585 . . . . 1.0 110.384 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -131.01 107.08 8.83 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 11.5 t70 -169.49 -84.9 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.721 0.772 . . . . 1.0 111.121 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.48 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 2.5 p -74.96 -13.07 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 113.889 -1.505 . . . . 1.0 112.956 -170.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.1 t -120.87 -1.95 9.85 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.554 -0.858 . . . . 1.0 110.744 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 92' ' ' ARG . 19.0 p -100.6 96.69 7.53 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.42 0.629 . . . . 1.0 112.333 -171.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.23 128.88 52.85 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.162 -1.051 . . . . 1.0 108.162 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . 20.3 m -85.52 90.14 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-O 123.462 1.601 . . . . 1.0 109.608 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -118.24 12.98 13.63 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 112.724 -2.035 . . . . 1.0 111.506 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.39 -43.16 1.51 Allowed Glycine 0 CA--C 1.47 -2.722 0 N-CA-C 108.924 -1.67 . . . . 1.0 108.924 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.72 -34.39 78.09 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.467 -1.309 . . . . 1.0 107.467 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 86' ' ' VAL 0.343 55.4 p90 60.71 -59.53 0.08 Allowed 'General case' 0 CA--C 1.479 -1.778 0 C-N-CA 129.426 3.09 . . . . 1.0 115.222 177.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -95.22 125.92 40.18 Favored 'General case' 1 C--N 1.24 -4.162 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.101 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 74.6 mmt-85 -147.82 103.06 3.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.273 0.559 . . . . 1.0 110.642 177.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 89.0 mt -102.83 142.59 33.7 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -73.6 143.21 46.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.646 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -120.58 165.96 14.3 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 124.641 1.176 . . . . 1.0 108.799 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.457 HD13 HG22 ' A' ' 101' ' ' VAL . 2.6 pp -65.39 -28.53 69.33 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.476 173.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.507 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 3.9 pt20 -64.41 -25.93 68.23 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.483 177.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -64.72 -39.4 93.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -88.5 -19.22 26.72 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 115.506 -0.77 . . . . 1.0 109.79 176.273 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 9.3 mmmm 53.03 60.83 3.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.77 0.828 . . . . 1.0 110.957 -171.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.3 m -76.62 150.46 82.0 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 113.185 0.809 . . . . 1.0 113.185 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 162.12 28.41 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 123.501 2.801 . . . . 1.0 111.307 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.19 130.97 45.06 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.611 0.719 . . . . 1.0 109.748 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.42 17.74 44.75 Favored Glycine 0 C--N 1.284 -2.313 0 CA-C-N 114.979 -1.01 . . . . 1.0 111.58 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.64 151.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 43.7 m -108.0 127.65 53.96 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.213 0.53 . . . . 1.0 110.995 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.402 HG13 HD11 ' A' ' 11' ' ' LEU . 31.5 m -109.74 141.36 25.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.79 52.66 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.703 0.763 . . . . 1.0 110.596 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.684 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.3 tt -95.18 122.91 38.35 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.319 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 13.7 m -128.05 145.39 55.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.15 55.95 5.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.875 2.384 . . . . 1.0 113.511 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 62' ' ' THR . 0.1 OUTLIER 58.96 82.54 0.14 Allowed 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 124.586 1.154 . . . . 1.0 111.233 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.5 mt -122.39 -42.29 2.36 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.806 -1.088 . . . . 1.0 111.584 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -127.87 24.55 6.05 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 114.356 1.243 . . . . 1.0 114.356 -170.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 34.0 ttpt -69.92 130.42 42.18 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.046 -0.662 . . . . 1.0 111.228 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -54.85 145.45 19.82 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 125.588 1.555 . . . . 1.0 111.413 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.6 160.87 31.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.3 mt -105.4 109.17 21.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.178 0.513 . . . . 1.0 110.831 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -144.04 -27.46 0.52 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.945 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -143.45 86.57 1.9 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.39 0.614 . . . . 1.0 110.385 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -124.78 129.39 50.36 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.543 -1.281 . . . . 1.0 107.543 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 C--N 1.28 -2.438 0 N-CA-C 108.334 -0.987 . . . . 1.0 108.334 176.027 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.394 -3.232 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.545 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 17.8 mmt180 -124.11 115.9 27.41 Favored Pre-proline 0 C--N 1.263 -3.158 0 C-N-CA 119.893 -0.723 . . . . 1.0 111.632 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.38 109.18 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.785 1.657 . . . . 1.0 108.334 168.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 tp -113.04 158.49 20.25 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.212 -0.903 . . . . 1.0 111.001 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 m -103.56 127.61 50.94 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.515 HD23 ' SD ' ' A' ' 44' ' ' MET . 14.8 tp -126.94 139.83 52.77 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.49 HD22 HG23 ' A' ' 106' ' ' THR . 6.4 t30 -96.72 114.0 25.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.39 114.73 13.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.799 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.549 HD21 ' HA2' ' A' ' 22' ' ' GLY . 12.8 tp -142.14 167.34 22.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.645 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.7 pt? -135.94 144.96 45.73 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -110.94 30.76 6.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.909 0.385 . . . . 1.0 111.034 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' HD3' ' A' ' 111' ' ' PRO . 71.5 t -65.94 -47.79 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.816 0 CA-C-N 115.897 -0.592 . . . . 1.0 112.383 -175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.4 -81.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.2 -1.476 . . . . 1.0 113.819 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.63 -27.67 83.64 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 123.599 2.866 . . . . 1.0 112.821 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.91 37.63 2.02 Favored Glycine 0 N--CA 1.408 -3.173 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.68 48.97 0.09 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.465 0.913 . . . . 1.0 113.465 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.549 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 136.42 -3.78 3.65 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.795 -0.922 . . . . 1.0 110.795 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.02 29.75 2.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.06 0.457 . . . . 1.0 111.597 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.96 -76.03 0.27 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -140.76 -63.83 0.47 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.585 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.19 88.84 0.59 Allowed Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.273 -0.965 . . . . 1.0 111.089 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.6 126.54 28.93 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.86 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.937 1.758 . . . . 1.0 111.86 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.569 HG22 ' HG3' ' A' ' 47' ' ' GLN . 13.9 t -112.34 155.35 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -107.67 144.28 34.97 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 m -142.21 -175.22 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 113.598 -1.637 . . . . 1.0 109.504 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.3 158.88 25.19 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 110.27 -0.27 . . . . 1.0 110.27 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.545 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.1 t70 -66.43 -31.33 72.02 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.6 t -103.27 33.36 3.34 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.872 -1.513 . . . . 1.0 109.491 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.564 ' O ' HG22 ' A' ' 95' ' ' THR . 12.8 p-10 -71.58 -165.76 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.216 -0.902 . . . . 1.0 109.013 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 50.1 p -139.07 157.92 45.11 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 169.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 78' ' ' SER . 39.5 mm -59.22 -41.41 83.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 13.5 m -61.8 -43.47 98.79 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.861 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.87 -41.21 75.11 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.207 0.527 . . . . 1.0 111.196 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.701 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.88 -39.16 93.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.489 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.51 -40.53 75.16 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.429 176.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mt-10 -68.59 -47.9 65.57 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 123.754 0.659 . . . . 1.0 110.778 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -63.58 -44.03 95.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.232 0.333 . . . . 1.0 111.621 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.2 mmm -65.03 -40.85 95.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.47 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.0 pp -74.45 -33.18 62.85 Favored 'General case' 0 C--O 1.188 -2.147 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.098 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -51.6 -31.15 23.82 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 124.951 1.301 . . . . 1.0 112.932 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.569 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.5 mm-40 -69.48 -36.61 76.71 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.722 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 122.044 0.926 . . . . 1.0 110.058 -178.289 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.451 ' CD2' ' HB2' ' A' ' 109' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.423 -1.776 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.17 138.17 39.47 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.53 117.14 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.446 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -91.34 111.82 23.47 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 105.836 -1.913 . . . . 1.0 105.836 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.631 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.9 t-105 -88.72 126.04 35.14 Favored 'General case' 0 N--CA 1.39 -3.446 0 CA-C-N 115.197 -0.911 . . . . 1.0 108.927 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.86 88.98 2.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 107.057 -1.46 . . . . 1.0 107.057 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 62.7 p -71.33 -27.24 63.24 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.483 -1.235 . . . . 1.0 110.082 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 -57.31 4.84 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.484 -1.235 . . . . 1.0 110.7 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.9 m -64.29 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 120.924 0.393 . . . . 1.0 111.895 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.48 -1.4 30.68 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.557 0.694 . . . . 1.0 110.354 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.71 -119.7 6.31 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 27.8 p-80 -140.42 138.26 34.61 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.604 0.24 . . . . 1.0 110.742 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.0 tp -134.73 144.48 47.76 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.5 mm -81.62 118.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.854 -1.165 . . . . 1.0 107.854 174.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.472 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.2 mp -107.71 157.6 17.97 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.4 0.619 . . . . 1.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 37' ' ' ILE . 13.3 m -157.32 160.32 38.4 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.17 -48.06 77.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 N--CA 1.422 -1.874 0 CA-C-O 121.676 0.75 . . . . 1.0 109.14 170.445 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--O 1.245 0.861 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -85.06 142.24 29.69 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.942 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.1 p -107.32 168.39 9.26 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 124.604 1.162 . . . . 1.0 108.53 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.632 HD13 HG22 ' A' ' 101' ' ' VAL . 4.0 pp -72.97 -24.33 60.77 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.064 173.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.36 -26.54 68.51 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.335 176.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -66.05 -41.7 90.48 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.6 t80 -80.05 -16.26 55.45 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.653 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 58.78 52.12 6.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.778 0.831 . . . . 1.0 110.983 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.632 HG22 HD13 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -78.36 146.83 71.14 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 113.346 0.869 . . . . 1.0 113.346 -178.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.16 158.41 26.63 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 123.481 2.788 . . . . 1.0 112.155 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.55 122.65 18.05 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.437 0.637 . . . . 1.0 109.542 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.68 21.85 10.88 Favored Glycine 0 C--N 1.288 -2.131 0 C-N-CA 120.309 -0.948 . . . . 1.0 110.852 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.62 162.52 28.68 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.49 HG23 HD22 ' A' ' 12' ' ' ASN . 87.4 m -114.52 133.52 55.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 120.783 0.325 . . . . 1.0 110.389 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 11' ' ' LEU . 29.5 m -115.74 136.27 53.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.19 144.55 51.01 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.645 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.13 147.72 46.49 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.825 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 16' ' ' ALA . 27.4 m -132.24 136.17 27.65 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.242 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.538 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.5 Cg_endo -73.5 82.42 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.258 1.972 . . . . 1.0 111.97 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.411 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 4.3 p . . . . . 0 CA--C 1.498 -1.026 0 C-N-CA 125.148 1.379 . . . . 1.0 111.477 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.398 -3.058 0 N-CA-C 108.842 -0.799 . . . . 1.0 108.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.503 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 23.0 mmt180 -119.3 116.4 33.76 Favored Pre-proline 0 C--N 1.268 -2.961 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.208 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.32 104.82 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 107.35 -1.827 . . . . 1.0 107.35 167.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -110.82 159.72 17.4 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.648 -0.705 . . . . 1.0 111.036 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -108.51 125.95 52.37 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 107' ' ' VAL . 20.0 tp -127.45 141.89 51.55 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.419 HD22 HG23 ' A' ' 106' ' ' THR . 6.1 t30 -96.45 114.73 26.43 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 122.405 -0.184 . . . . 1.0 110.857 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.14 119.96 20.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.171 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.67 HD21 ' HA2' ' A' ' 22' ' ' GLY . 13.4 tp -148.46 163.27 37.67 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -129.58 144.12 51.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.017 -0.427 . . . . 1.0 110.079 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -112.85 37.17 3.19 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.913 0.387 . . . . 1.0 111.023 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.85 -44.31 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.314 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.813 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.07 -88.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.4 -1.381 . . . . 1.0 113.888 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.31 -37.82 88.57 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.906 2.404 . . . . 1.0 113.139 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.48 33.74 5.38 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -70.58 48.51 0.11 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.468 0.914 . . . . 1.0 113.468 -176.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.67 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 146.85 -12.38 1.47 Allowed Glycine 0 C--N 1.299 -1.49 0 C-N-CA 120.68 -0.771 . . . . 1.0 112.402 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.88 25.47 5.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.089 0.471 . . . . 1.0 111.432 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.8 -77.38 0.19 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -129.56 -58.77 1.1 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.467 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 75.61 0.61 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 1.0 111.591 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.35 125.18 38.59 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 110.277 -0.268 . . . . 1.0 110.277 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.43 102.07 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.859 1.706 . . . . 1.0 111.045 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 47' ' ' GLN . 15.0 t -111.02 155.06 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.52 143.71 38.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 113.746 1.017 . . . . 1.0 113.746 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.6 -175.19 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 113.74 -1.573 . . . . 1.0 109.165 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.45 157.61 27.9 Favored 'General case' 0 C--O 1.191 -1.988 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.503 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 31.7 t70 -66.06 -31.54 72.47 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.87 0.731 . . . . 1.0 109.124 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.2 t -104.99 37.2 2.22 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 114.034 -1.439 . . . . 1.0 109.552 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 95' ' ' THR . 14.2 p-10 -71.83 -161.44 0.07 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.633 -1.167 . . . . 1.0 109.121 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 65.0 p -143.87 155.16 44.0 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 103.71 -2.7 . . . . 1.0 103.71 167.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mm -57.69 -39.54 70.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 118.614 0.643 . . . . 1.0 110.357 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 m -61.26 -43.95 98.04 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.512 175.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HB3' ' H ' ' A' ' 36' ' ' THR . 9.3 tt0 -68.17 -41.47 81.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.519 0.328 . . . . 1.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.95 -38.66 91.71 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.101 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -40.9 73.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 38' ' ' SER . 45.9 mt-10 -68.71 -51.78 37.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.67 0.606 . . . . 1.0 111.379 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.06 -42.43 99.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.807 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.5 mmm -65.21 -41.06 94.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.25 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.88 -30.47 58.85 Favored 'General case' 0 C--O 1.201 -1.493 0 C-N-CA 120.71 -0.396 . . . . 1.0 112.028 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -53.99 -31.4 50.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.536 1.134 . . . . 1.0 112.438 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.528 ' HG3' HG22 ' A' ' 29' ' ' VAL . 13.6 mm-40 -68.83 -40.06 79.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 1.0 110.551 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.875 0.845 . . . . 1.0 110.855 -174.893 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.752 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB2' HG22 ' A' ' 110' ' ' VAL . 16.7 m-20 -103.48 139.42 38.86 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 120.026 -0.669 . . . . 1.0 111.054 -171.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.61 115.07 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 N-CA-C 106.596 -1.631 . . . . 1.0 106.596 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.392 -3.345 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.635 ' HZ2' HG21 ' A' ' 101' ' ' VAL . 4.6 t-105 -85.93 124.15 32.07 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.505 -1.225 . . . . 1.0 109.327 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -111.5 89.19 2.98 Favored 'General case' 0 N--CA 1.396 -3.127 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.9 p -68.12 -31.59 71.29 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.087 -1.415 . . . . 1.0 109.924 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.55 -50.61 4.36 Favored Glycine 0 C--N 1.303 -1.294 0 CA-C-N 114.359 -1.291 . . . . 1.0 111.343 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.21 -39.95 85.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 122.872 0.469 . . . . 1.0 111.897 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.25 -29.51 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.164 0.507 . . . . 1.0 110.073 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.15 -120.95 3.21 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 10.7 p-80 -136.32 136.75 39.98 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.611 0.243 . . . . 1.0 110.701 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.6 tp -134.94 145.27 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -83.43 117.48 29.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.549 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -110.53 151.2 27.87 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-O 121.306 0.574 . . . . 1.0 110.816 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 m -159.14 161.4 36.28 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 105.203 -2.147 . . . . 1.0 105.203 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -64.7 -37.98 89.45 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 N--CA 1.418 -2.07 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.055 172.886 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 C--O 1.243 0.754 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -85.09 138.59 32.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.058 -0.657 . . . . 1.0 111.099 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -113.84 169.04 9.28 Favored 'General case' 0 C--O 1.26 1.637 0 C-N-CA 125.061 1.344 . . . . 1.0 108.489 178.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.657 HD13 HG22 ' A' ' 101' ' ' VAL . 3.8 pp -72.33 -24.34 61.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 118.751 -1.18 . . . . 1.0 109.145 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -63.98 -26.11 68.43 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.705 176.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -65.25 -40.02 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.44 -15.79 41.83 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.409 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 57.44 51.19 10.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.112 0.965 . . . . 1.0 110.422 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.657 HG22 HD13 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -74.62 148.28 85.27 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.31 157.08 29.48 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.247 2.631 . . . . 1.0 112.743 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.36 120.15 12.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.06 16.87 11.63 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 110.861 -0.895 . . . . 1.0 110.861 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.97 162.67 28.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.044 0.45 . . . . 1.0 110.579 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.419 HG23 HD22 ' A' ' 12' ' ' ASN . 26.3 m -115.98 133.29 56.18 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.38 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 11' ' ' LEU . 27.0 m -120.24 137.94 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 C-N-CA 120.593 -0.443 . . . . 1.0 109.982 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -128.46 139.88 52.11 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.58 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.39 147.52 40.44 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.934 -178.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 64' ' ' ASP . 16.5 m -139.45 151.46 66.84 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.187 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.16 72.66 5.81 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.522 2.148 . . . . 1.0 111.152 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 p . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 125.027 1.331 . . . . 1.0 110.399 -175.627 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.504 ' HB2' HD22 ' A' ' 32' ' ' LEU . 76.6 m-85 . . . . . 0 N--CA 1.403 -2.808 0 N-CA-C 105.914 -1.884 . . . . 1.0 105.914 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' H ' ' HB2' ' A' ' 33' ' ' ASP . 38.9 mmt180 -109.25 106.92 59.36 Favored Pre-proline 0 C--N 1.273 -2.74 0 C-N-CA 118.877 -1.129 . . . . 1.0 109.74 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -64.59 111.6 1.72 Allowed 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.87 1.713 . . . . 1.0 108.22 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HB3' HG23 ' A' ' 31' ' ' VAL . 5.8 tp -115.48 159.43 21.19 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-O 121.248 0.547 . . . . 1.0 111.368 -172.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -111.5 132.59 54.39 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -125.05 154.58 41.1 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 123.486 0.714 . . . . 1.0 111.065 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -98.93 106.69 18.98 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.384 -0.825 . . . . 1.0 108.868 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.48 112.92 8.0 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.878 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.442 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.4 tp -144.6 149.98 36.68 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.667 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -122.9 143.84 49.62 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 122.27 -0.269 . . . . 1.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -113.57 29.92 7.63 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.164 0.506 . . . . 1.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.7 t -64.19 -47.03 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 CA-C-N 115.608 -0.724 . . . . 1.0 112.222 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.47 -78.69 0.1 OUTLIER Glycine 0 C--O 1.213 -1.17 0 C-N-CA 119.079 -1.534 . . . . 1.0 113.8 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.0 -28.75 87.76 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 123.012 2.475 . . . . 1.0 113.106 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.56 33.14 3.35 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.19 79.09 0.35 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.442 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 103.86 9.29 37.76 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.9 30.75 0.71 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.406 0.622 . . . . 1.0 110.925 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 -75.37 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.295 -0.562 . . . . 1.0 112.068 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.88 -67.43 0.44 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.964 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 77.23 0.91 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.131 -1.588 . . . . 1.0 109.131 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.49 130.42 23.09 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.428 -0.386 . . . . 1.0 110.541 -173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -72.5 104.51 1.72 Allowed 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.128 1.885 . . . . 1.0 111.431 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 25.5 t -114.04 155.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.247 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -104.6 146.14 29.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.728 0.299 . . . . 1.0 111.542 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -148.74 -174.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 124.79 1.236 . . . . 1.0 109.496 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' HB2' ' A' ' 6' ' ' TYR . 14.0 mt -122.37 167.71 12.96 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 123.049 0.54 . . . . 1.0 110.065 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' A' ' 7' ' ' ARG . 29.7 t70 -65.77 -31.28 72.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.73 -0.841 . . . . 1.0 108.73 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 t -112.94 19.82 16.95 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 114.344 1.238 . . . . 1.0 114.344 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.336 24.6 p-10 -85.22 140.2 31.07 Favored 'General case' 0 N--CA 1.415 -2.211 0 C-N-CA 115.853 -2.339 . . . . 1.0 109.411 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -75.17 166.42 23.68 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.637 -1.165 . . . . 1.0 110.852 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -59.31 -41.1 83.12 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.599 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -59.83 -48.1 83.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -73.11 -44.91 59.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.365 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.13 -36.53 82.08 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.593 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 34.1 ttpt -61.74 -34.9 76.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.679 ' HG3' ' O ' ' A' ' 38' ' ' SER . 61.3 mt-10 -65.85 -46.95 76.58 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.043 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.49 ' HD2' HG12 ' A' ' 31' ' ' VAL . 64.2 mttp -61.8 -41.77 98.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 123.301 0.376 . . . . 1.0 111.408 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.591 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.6 mmt -61.42 -48.56 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.129 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -77.48 -24.52 50.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 16.4 t70 -58.04 -34.08 69.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.771 0.828 . . . . 1.0 111.828 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.54 ' HG3' HG22 ' A' ' 29' ' ' VAL . 77.4 mm-40 -66.36 -31.92 72.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.521 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 CA--C 1.496 -1.133 0 CA-C-O 121.011 0.434 . . . . 1.0 111.182 -171.769 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.7 OUTLIER . . . . . 0 C--O 1.251 1.178 0 CA-C-O 120.964 0.411 . . . . 1.0 112.001 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' HG23 ' A' ' 110' ' ' VAL . 12.6 p-10 -107.26 166.3 10.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.642 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.56 126.43 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.56 0.695 . . . . 1.0 110.276 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -94.66 113.51 25.31 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 105.636 -1.987 . . . . 1.0 105.636 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.638 ' CE3' HD22 ' A' ' 77' ' ' LEU . 5.0 t-105 -89.85 137.18 32.56 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.742 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.31 88.99 3.04 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 107.327 -1.36 . . . . 1.0 107.327 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 p -72.5 -31.84 65.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.251 1.024 . . . . 1.0 108.731 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.93 -55.1 4.62 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 113.708 -1.587 . . . . 1.0 110.525 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -64.27 -42.3 95.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.476 -0.362 . . . . 1.0 111.54 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.41 -21.44 15.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.217 0.532 . . . . 1.0 109.677 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.21 -130.78 9.95 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.142 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 63.2 m-70 -111.42 122.49 47.98 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 123.322 0.649 . . . . 1.0 109.505 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -134.52 136.89 43.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.1 mm -84.21 123.1 38.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.866 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.638 HD22 ' CE3' ' A' ' 67' ' ' TRP . 9.9 mp -108.58 150.48 27.43 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.483 0.658 . . . . 1.0 111.427 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.9 m -152.09 150.94 30.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.34 -177.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.2 p30 -74.21 -41.15 61.84 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.839 -0.619 . . . . 1.0 109.9 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.316 -0.877 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.799 178.384 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 70.3 mt . . . . . 0 N--CA 1.43 -1.442 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -90.45 159.87 16.33 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.711 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.2 p -119.21 -178.95 3.7 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.056 0.942 . . . . 1.0 108.503 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -78.71 -19.71 51.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.464 -1.294 . . . . 1.0 109.532 175.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.518 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -66.71 -25.79 66.7 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 120.979 0.418 . . . . 1.0 110.518 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -62.16 -35.33 78.47 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -97.25 -16.43 20.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.334 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.52 59.59 4.05 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.703 0.801 . . . . 1.0 110.282 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.8 m -73.98 146.8 85.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 119.909 -0.716 . . . . 1.0 112.139 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.56 162.46 35.65 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.793 2.328 . . . . 1.0 112.074 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.06 128.82 37.49 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.642 -0.708 . . . . 1.0 109.37 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.33 25.27 40.34 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.55 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.94 160.19 31.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.984 0.421 . . . . 1.0 110.205 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.5 m -110.78 134.16 52.73 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.121 0.486 . . . . 1.0 110.232 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.573 HG21 ' SD ' ' A' ' 44' ' ' MET . 16.1 m -113.25 155.76 14.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 176.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -135.01 130.05 35.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 172.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.667 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 mp -102.33 130.71 49.13 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.04 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.404 HG23 ' OD1' ' A' ' 64' ' ' ASP . 15.9 m -134.57 149.48 71.06 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.5 82.21 2.54 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 121.939 1.76 . . . . 1.0 112.4 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.419 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 8.7 p . . . . . 0 CA--C 1.505 -0.769 0 C-N-CA 125.148 1.379 . . . . 1.0 111.18 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 33.1 p90 . . . . . 0 N--CA 1.383 -3.824 0 N-CA-C 107.664 -1.236 . . . . 1.0 107.664 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.54 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 18.7 mmt180 -130.33 113.84 17.05 Favored Pre-proline 0 C--N 1.255 -3.535 0 N-CA-C 105.944 -1.872 . . . . 1.0 105.944 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.6 Cg_exo -49.4 115.92 2.01 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.781 1.654 . . . . 1.0 108.875 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 tp -124.13 155.87 37.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.209 0.528 . . . . 1.0 112.151 -170.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.6 m -105.79 128.8 53.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 107' ' ' VAL . 17.7 tp -127.43 142.58 51.38 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 5.5 t30 -96.03 116.06 28.38 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.33 -0.248 . . . . 1.0 110.33 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.541 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -75.69 121.75 22.96 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.034 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.722 HD21 ' HA2' ' A' ' 22' ' ' GLY . 27.6 tp -151.5 168.12 25.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.611 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 2.1 pt? -136.11 145.06 45.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.123 0.569 . . . . 1.0 109.655 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.18 30.62 7.16 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.027 0.442 . . . . 1.0 110.52 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.404 HG22 ' HD3' ' A' ' 111' ' ' PRO . 50.9 t -64.91 -46.78 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.273 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.75 -81.92 0.08 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 118.511 -1.804 . . . . 1.0 114.66 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.15 -32.28 94.34 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.4 2.733 . . . . 1.0 112.679 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.48 42.36 1.42 Allowed Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.33 39.8 0.05 OUTLIER 'General case' 0 C--O 1.244 0.768 0 N-CA-C 114.057 1.132 . . . . 1.0 114.057 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.722 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 154.16 -20.53 0.65 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.06 57.4 1.7 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.189 0.995 . . . . 1.0 110.333 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.07 -83.08 0.53 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.363 -1.29 . . . . 1.0 111.324 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 7.0 pt20 -111.62 -59.51 1.97 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.609 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 60.05 71.65 0.74 Allowed Glycine 0 CA--C 1.519 0.33 0 O-C-N 123.694 0.621 . . . . 1.0 112.05 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -108.57 127.59 27.16 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 122.656 -0.32 . . . . 1.0 110.218 -174.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.37 110.73 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.687 1.591 . . . . 1.0 111.584 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.581 HG22 ' HG3' ' A' ' 47' ' ' GLN . 21.9 t -116.13 155.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.901 -1.045 . . . . 1.0 108.267 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -106.22 145.3 31.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 114.085 1.143 . . . . 1.0 114.085 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.41 -175.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 113.515 -1.675 . . . . 1.0 108.766 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.1 mt -117.3 158.23 24.73 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 24.4 t70 -66.95 -29.71 69.64 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.801 0.688 . . . . 1.0 109.475 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.72 34.07 2.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.426 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -74.61 -166.39 0.44 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.756 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.6 p -137.29 153.9 50.21 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 168.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 40.0 mm -57.87 -40.0 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.857 0.361 . . . . 1.0 110.103 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.3 p -62.47 -43.88 97.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.122 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.6 -41.43 68.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.84 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.09 -37.7 88.39 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.604 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -55.66 -41.52 73.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 176.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' SER . 34.3 mt-10 -71.17 -45.63 63.08 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.284 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -63.37 -43.65 97.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.941 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.5 mmm -64.89 -41.48 95.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.701 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 ' HE2' ' A' ' 41' ' ' LYS . 3.9 pp -75.62 -28.37 58.81 Favored 'General case' 0 C--O 1.198 -1.616 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.846 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.54 -32.53 65.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.874 0.87 . . . . 1.0 112.245 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' A' ' 29' ' ' VAL . 16.7 mm-40 -69.81 -39.79 76.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.231 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 CA--C 1.512 -0.516 0 CA-C-O 122.05 0.928 . . . . 1.0 110.496 -174.611 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 107.155 -1.424 . . . . 1.0 107.155 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 8.2 p-10 -107.3 150.16 27.0 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 -169.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.86 121.93 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.563 -1.198 . . . . 1.0 108.939 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.18 112.16 23.94 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.63 ' CE2' HG11 ' A' ' 101' ' ' VAL . 4.2 t-105 -87.26 124.19 33.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.49 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.63 88.19 2.69 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 106.853 -1.536 . . . . 1.0 106.853 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.7 p -72.16 -31.61 66.11 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.143 -1.389 . . . . 1.0 109.895 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.03 3.76 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 114.166 -1.379 . . . . 1.0 110.421 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -64.04 -38.04 81.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 122.911 0.485 . . . . 1.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.32 3.18 18.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.741 0.781 . . . . 1.0 110.143 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.51 -121.54 6.52 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.951 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.6 p-80 -134.78 134.87 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.85 0.357 . . . . 1.0 111.185 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.9 tp -134.02 146.12 50.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.2 mm -83.13 118.69 31.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.554 HD22 ' CE3' ' A' ' 67' ' ' TRP . 11.0 mp -111.68 159.99 17.69 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.959 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -160.38 162.08 33.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' HB2' HD22 ' A' ' 93' ' ' LEU . 14.5 p-10 -62.52 -42.1 99.29 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.416 -2.126 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.454 172.255 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 79' ' ' ASP . 93.2 mt . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.19 144.93 28.64 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.159 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -111.46 165.61 11.84 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 125.078 1.351 . . . . 1.0 108.049 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.638 HD13 HG22 ' A' ' 101' ' ' VAL . 4.4 pp -72.1 -22.86 61.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.63 -1.228 . . . . 1.0 109.322 173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.505 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.64 -25.93 68.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.053 175.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -63.23 -35.82 81.59 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -90.14 -15.86 30.72 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.331 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 57.66 54.28 6.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.773 0.829 . . . . 1.0 110.826 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.638 HG22 HD13 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -81.44 146.87 58.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.111 0.782 . . . . 1.0 113.111 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.41 157.99 29.2 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.187 2.591 . . . . 1.0 112.093 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.87 123.39 20.03 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.509 0.671 . . . . 1.0 109.956 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.82 19.7 11.65 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.68 162.64 28.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.498 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 84.9 m -115.35 131.06 57.05 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.659 0.266 . . . . 1.0 110.965 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 11' ' ' LEU . 27.1 m -115.2 136.49 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 N-CA-C 109.948 -0.39 . . . . 1.0 109.948 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.6 141.22 49.61 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.611 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.89 150.65 44.41 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.878 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.45 156.39 78.89 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HD3' HG22 ' A' ' 17' ' ' VAL . 73.3 Cg_endo -81.21 75.13 5.14 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.054 1.836 . . . . 1.0 111.781 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.522 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 20.1 p . . . . . 0 C--O 1.242 0.702 0 C-N-CA 125.019 1.327 . . . . 1.0 110.854 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 m-85 . . . . . 0 N--CA 1.418 -2.061 0 N-CA-C 103.769 -2.678 . . . . 1.0 103.769 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -98.86 111.12 59.83 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 119.526 1.057 . . . . 1.0 111.243 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 38.8 Cg_exo -61.16 140.23 88.07 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.561 2.174 . . . . 1.0 111.03 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 10' ' ' THR . 5.7 tp -138.92 161.69 36.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 59.8 m -107.98 126.83 53.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.226 -1.028 . . . . 1.0 108.226 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.497 HD11 HG13 ' A' ' 107' ' ' VAL . 30.6 tp -127.29 138.0 52.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 7.1 t30 -90.48 120.43 31.57 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.283 -0.261 . . . . 1.0 111.447 -174.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.08 119.6 25.65 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.774 HD21 ' HA2' ' A' ' 22' ' ' GLY . 36.3 tp -146.67 151.9 37.99 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -114.23 139.51 49.33 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 176.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.41 50.1 0.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.037 0.446 . . . . 1.0 110.769 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.435 HG22 ' HD3' ' A' ' 111' ' ' PRO . 39.7 t -65.92 -46.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.546 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.21 -94.55 0.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.299 -0.953 . . . . 1.0 112.705 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.1 -28.23 73.9 Favored 'Trans proline' 0 N--CA 1.484 0.964 0 C-N-CA 123.251 2.634 . . . . 1.0 112.47 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.41 32.21 5.66 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 110.879 -0.888 . . . . 1.0 110.879 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -74.14 29.03 0.08 Allowed 'General case' 0 C--O 1.246 0.921 0 C-N-CA 123.446 0.698 . . . . 1.0 112.545 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.774 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -176.99 -40.13 0.06 OUTLIER Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 120.572 -0.823 . . . . 1.0 112.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.37 4.3 46.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.6 -73.85 0.12 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 113.73 1.011 . . . . 1.0 113.73 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -129.91 -61.8 0.98 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.443 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.49 62.92 5.71 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.7 t -95.24 126.02 47.9 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 115.58 -0.31 . . . . 1.0 110.334 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -73.74 90.86 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.216 1.944 . . . . 1.0 110.291 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 47' ' ' GLN . 12.7 t -93.91 154.73 3.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -108.7 152.13 25.23 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 32' ' ' LEU . 7.2 p -159.18 177.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.944 -172.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.507 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 31.4 mt -108.62 158.16 17.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.623 0.725 . . . . 1.0 110.999 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 -32.75 73.86 Favored 'General case' 0 C--O 1.282 2.805 0 C-N-CA 124.9 1.28 . . . . 1.0 111.422 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.9 t -98.78 13.18 33.25 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.006 -0.997 . . . . 1.0 111.715 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.507 ' OD2' ' HB2' ' A' ' 32' ' ' LEU . 1.7 m-20 -73.24 133.82 44.1 Favored 'General case' 0 CA--C 1.47 -2.097 0 C-N-CA 119.655 -0.818 . . . . 1.0 109.21 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 39' ' ' GLN . 70.8 p -81.28 171.14 15.2 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 107.554 -1.276 . . . . 1.0 107.554 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 78' ' ' SER . 36.7 mm -60.2 -43.47 93.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 118.134 0.424 . . . . 1.0 110.197 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -67.36 -40.22 85.77 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-O 121.774 0.797 . . . . 1.0 110.707 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 4.4 tt0 -66.9 -32.52 73.84 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.485 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.279 -0.418 . . . . 1.0 111.045 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.5 mmmp? -56.52 -33.95 66.55 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.225 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 17.9 pt-20 -54.43 -50.44 67.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 124.288 0.992 . . . . 1.0 110.273 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.5 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 30.6 mmmt -77.27 -36.59 54.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -47.83 84.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.186 0.517 . . . . 1.0 110.462 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 41' ' ' LYS 0.266 0.8 OUTLIER -78.75 -23.37 45.4 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 112.419 0.526 . . . . 1.0 112.419 176.602 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.63 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.5 t70 -50.65 -29.69 11.68 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 125.025 1.33 . . . . 1.0 112.684 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.434 ' HG3' HG22 ' A' ' 29' ' ' VAL . 12.1 mm-40 -75.31 -17.97 60.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.359 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 121.994 0.902 . . . . 1.0 109.853 179.178 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.6 pp . . . . . 0 N--CA 1.418 -2.043 0 N-CA-C 106.569 -1.641 . . . . 1.0 106.569 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HB3' HG23 ' A' ' 76' ' ' ILE . 4.6 m-20 -103.83 156.96 17.41 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 120.406 -0.518 . . . . 1.0 110.145 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.76 117.92 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.54 0.686 . . . . 1.0 109.557 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -92.7 118.03 30.62 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-O 121.459 0.647 . . . . 1.0 109.937 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 16.9 t90 -82.7 119.65 24.58 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.603 -1.18 . . . . 1.0 108.491 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.01 89.22 3.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 120.952 0.406 . . . . 1.0 109.911 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.4 p -91.43 -23.1 20.13 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.893 0.854 . . . . 1.0 109.029 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.67 -52.27 4.43 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.009 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.02 -38.12 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.045 0.45 . . . . 1.0 111.492 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.79 -3.09 36.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.726 0.774 . . . . 1.0 109.589 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.39 -144.11 17.03 Favored Glycine 0 N--CA 1.416 -2.683 0 CA-C-N 114.883 -1.053 . . . . 1.0 110.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.622 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.4 p80 -133.48 115.27 14.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.028 0.531 . . . . 1.0 109.705 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.42 144.47 49.48 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.676 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 64' ' ' ASP . 29.4 mm -83.46 117.69 29.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.79 146.44 28.98 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.3 -0.864 . . . . 1.0 109.817 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.403 ' HA ' HG21 ' A' ' 37' ' ' ILE . 26.7 t -161.88 166.15 26.68 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.257 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.65 -27.41 65.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 . . . . . 0 N--CA 1.415 -2.195 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 178.104 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 106.887 -1.523 . . . . 1.0 106.887 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 36' ' ' THR . 65.8 m-80 -87.27 137.77 32.05 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.786 -0.765 . . . . 1.0 111.994 -173.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p -105.42 168.98 8.73 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 124.054 0.941 . . . . 1.0 109.312 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.01 -33.18 71.69 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.351 -0.94 . . . . 1.0 108.81 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.57 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 pt20 -65.65 -26.09 67.65 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.576 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -65.57 -35.62 81.36 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.992 0.425 . . . . 1.0 110.422 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.94 -8.09 21.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.199 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 52.47 68.45 0.82 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.454 1.101 . . . . 1.0 112.312 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.471 HG12 ' CE2' ' A' ' 67' ' ' TRP . 2.7 m -78.33 136.7 60.46 Favored Pre-proline 0 N--CA 1.433 -1.285 0 C-N-CA 119.941 -0.704 . . . . 1.0 109.124 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.3 160.54 48.56 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.256 1.97 . . . . 1.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -64.68 124.38 21.76 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.58 25.49 38.79 Favored Glycine 0 C--N 1.303 -1.281 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.798 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.23 36.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.818 0.342 . . . . 1.0 111.039 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 51.1 m -107.97 123.89 49.32 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.055 0.455 . . . . 1.0 110.962 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.497 HG13 HD11 ' A' ' 11' ' ' LEU . 33.4 m -121.15 138.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.446 -0.946 . . . . 1.0 108.446 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -125.72 138.45 53.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.999 0.428 . . . . 1.0 112.019 -176.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.59 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.2 mp -96.39 126.88 41.9 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 30.1 m -116.21 140.13 26.05 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 116.761 -0.199 . . . . 1.0 110.692 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 17' ' ' VAL . 60.0 Cg_endo -72.81 85.06 1.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.633 2.222 . . . . 1.0 112.027 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 20.3 p . . . . . 0 C--O 1.216 -0.678 0 C-N-CA 125.874 1.67 . . . . 1.0 113.141 177.115 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.506 ' HB2' HD13 ' A' ' 32' ' ' LEU . 21.9 m-85 . . . . . 0 N--CA 1.425 -1.709 0 N-CA-C 103.655 -2.72 . . . . 1.0 103.655 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -100.38 109.56 57.32 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 118.729 -1.188 . . . . 1.0 111.578 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 33.7 Cg_exo -62.53 139.17 74.65 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 122.357 2.038 . . . . 1.0 110.607 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 96' ' ' LEU . 6.1 tp -135.12 158.81 43.41 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 116.278 -0.419 . . . . 1.0 109.916 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -100.24 128.5 46.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.517 HD11 HG13 ' A' ' 107' ' ' VAL . 22.2 tp -127.82 138.74 52.82 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 5.2 t30 -91.51 116.89 29.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 122.165 -0.334 . . . . 1.0 110.573 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.84 118.59 21.76 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.606 0.566 . . . . 1.0 109.564 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.633 HD21 ' HA2' ' A' ' 22' ' ' GLY . 33.8 tp -151.41 158.22 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.7 144.34 48.83 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.9 38.79 3.22 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.654 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 ' HD3' ' A' ' 111' ' ' PRO . 54.4 t -66.22 -44.39 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 115.707 -0.679 . . . . 1.0 111.671 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.33 -78.56 0.2 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.902 -1.142 . . . . 1.0 112.611 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.5 -25.94 76.03 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.236 2.624 . . . . 1.0 111.95 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -133.49 41.67 1.45 Allowed Glycine 0 N--CA 1.416 -2.665 0 N-CA-C 110.068 -1.213 . . . . 1.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -71.75 24.22 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.115 0.783 . . . . 1.0 113.115 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.633 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 169.83 -38.54 0.2 Allowed Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.808 -177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.02 21.68 2.25 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.179 0.514 . . . . 1.0 111.769 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.99 -78.25 0.35 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.74 0.644 . . . . 1.0 112.74 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -125.32 -64.67 1.06 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.863 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.08 63.38 4.79 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 t -93.64 126.08 51.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.94 100.33 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.552 1.501 . . . . 1.0 109.738 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 47' ' ' GLN . 11.3 t -108.32 156.85 8.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -119.3 152.77 36.16 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 40' ' ' ALA . 9.5 p -158.26 169.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 6' ' ' TYR . 15.1 mt -89.95 157.72 17.72 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.35 -32.44 71.27 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-N 114.624 -1.171 . . . . 1.0 110.056 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 23.2 t -101.7 12.54 36.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.775 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 N--CA 1.409 -2.506 0 C-N-CA 118.601 -1.239 . . . . 1.0 108.032 171.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.2 p -80.51 174.33 11.71 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.15 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.3 -42.25 86.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 p -63.79 -45.38 89.96 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 121.986 0.898 . . . . 1.0 111.047 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.47 -16.06 58.96 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.253 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.436 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -85.43 -31.49 22.83 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.042 168.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.629 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.9 mmmp? -56.41 -39.86 73.73 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 3.1 pt-20 -58.41 -44.92 89.21 Favored 'General case' 0 N--CA 1.416 -2.159 0 O-C-N 124.333 1.021 . . . . 1.0 111.966 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 28.3 mmmt -72.86 -39.57 66.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.868 1.062 . . . . 1.0 113.868 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.5 mmt -61.27 -46.92 88.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.322 0.582 . . . . 1.0 110.639 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.4 pp -77.45 -24.07 50.35 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.128 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.6 t70 -50.65 -35.57 31.32 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.132 1.373 . . . . 1.0 112.334 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 29' ' ' VAL . 10.5 mm-40 -71.73 -32.93 68.26 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.194 0.521 . . . . 1.0 111.62 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.309 -1.178 0 CA-C-O 122.01 0.909 . . . . 1.0 109.674 -176.549 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.614 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.3 pp . . . . . 0 N--CA 1.412 -2.343 0 N-CA-C 104.599 -2.371 . . . . 1.0 104.599 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 76' ' ' ILE . 18.6 m-20 -122.85 152.82 40.36 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.541 -0.864 . . . . 1.0 109.332 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 p -119.27 120.94 65.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.728 -0.789 . . . . 1.0 109.522 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.13 116.3 28.7 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.556 0.693 . . . . 1.0 109.667 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.667 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 15.8 t90 -82.29 119.27 23.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.668 -1.151 . . . . 1.0 108.042 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.412 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 85.0 mtm180 -123.11 89.06 3.04 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.5 p -88.77 -20.13 25.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.033 0.92 . . . . 1.0 108.932 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.87 -54.5 4.05 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 114.629 -1.168 . . . . 1.0 111.85 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 m -64.49 -42.11 94.28 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 111.587 0.217 . . . . 1.0 111.587 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.5 -9.41 47.43 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.722 0.773 . . . . 1.0 109.028 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.11 13.75 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 114.507 -1.224 . . . . 1.0 111.321 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.667 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.0 p80 -138.4 118.29 13.29 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 123.722 0.809 . . . . 1.0 110.06 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.25 145.17 48.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.405 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' A' ' 64' ' ' ASP . 28.6 mm -88.46 111.49 22.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.098 0.475 . . . . 1.0 109.789 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.6 151.69 20.89 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.289 -0.869 . . . . 1.0 110.347 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.1 t -162.68 165.46 25.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 6.4 p-10 -71.67 -31.0 66.32 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 N--CA 1.422 -1.828 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 177.27 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 98.2 mt . . . . . 0 C--O 1.245 0.834 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -89.93 139.09 30.94 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 119.894 -0.722 . . . . 1.0 111.013 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.5 p -111.39 171.13 7.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 124.007 0.923 . . . . 1.0 108.599 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.533 HD13 HD22 ' A' ' 9' ' ' LEU . 3.1 pp -68.52 -30.59 69.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.557 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.35 -26.32 68.42 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.987 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -65.76 -39.96 91.56 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 120.981 0.42 . . . . 1.0 110.376 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.38 -7.21 24.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.521 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 51.75 61.55 3.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.923 1.289 . . . . 1.0 113.143 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 67' ' ' TRP . 3.0 m -70.98 136.87 84.91 Favored Pre-proline 0 N--CA 1.438 -1.032 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.13 160.21 50.8 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.545 2.163 . . . . 1.0 111.326 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -66.45 117.96 9.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.712 0.768 . . . . 1.0 109.891 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.41 22.94 20.59 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.712 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.31 152.47 45.39 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 27.7 m -108.56 123.46 48.95 Favored 'General case' 0 C--N 1.279 -2.47 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.253 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.517 HG13 HD11 ' A' ' 11' ' ' LEU . 33.9 m -121.66 155.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -138.45 137.02 36.8 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.307 -0.557 . . . . 1.0 112.003 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.6 mp -94.97 132.67 39.57 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.224 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 16' ' ' ALA . 31.9 m -129.26 137.64 31.41 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.056 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HD3' HG22 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -70.23 86.3 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.227 1.951 . . . . 1.0 111.065 177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.614 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 21.0 p . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 1.0 112.467 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.4 m-85 . . . . . 0 N--CA 1.393 -3.283 0 N-CA-C 102.928 -2.99 . . . . 1.0 102.928 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 23.2 mmt180 -104.66 111.05 65.17 Favored Pre-proline 0 C--N 1.273 -2.757 0 C-N-CA 117.233 -1.787 . . . . 1.0 114.673 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 19.6 Cg_exo -65.69 121.78 9.25 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.383 2.056 . . . . 1.0 109.173 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 9.5 tp -114.9 159.79 20.28 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.374 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m -99.36 124.26 44.33 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 31' ' ' VAL . 2.8 mm? -125.69 144.08 50.76 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.24 0.616 . . . . 1.0 110.179 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -92.67 113.8 26.18 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.441 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -74.25 107.94 6.73 Favored 'General case' 0 C--O 1.253 1.273 0 C-N-CA 123.313 0.645 . . . . 1.0 110.166 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 ' HA2' ' A' ' 22' ' ' GLY . 25.7 tp -142.11 158.95 43.16 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -128.5 143.63 51.01 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 110' ' ' VAL . . . -109.71 36.33 3.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.902 0.382 . . . . 1.0 111.184 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.59 -45.15 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 112.556 0.576 . . . . 1.0 112.556 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.42 -81.97 0.14 Allowed Glycine 0 C--N 1.31 -0.885 0 C-N-CA 119.656 -1.259 . . . . 1.0 112.469 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.59 -24.39 77.88 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.995 2.464 . . . . 1.0 112.584 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.57 27.16 5.81 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.4 68.0 2.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.767 0.794 . . . . 1.0 112.445 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.629 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 127.05 -15.68 6.48 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.27 27.65 6.19 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.98 -0.61 . . . . 1.0 112.273 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.82 -93.21 0.07 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.154 0.502 . . . . 1.0 110.583 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 5.8 pt20 -114.56 -62.7 1.56 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.791 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.408 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 71.13 75.0 0.66 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.215 -1.154 . . . . 1.0 110.215 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.1 127.79 26.46 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 110.244 -0.28 . . . . 1.0 110.244 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.02 108.07 2.51 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.708 1.605 . . . . 1.0 110.675 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 ' HA ' ' A' ' 44' ' ' MET . 60.6 t -114.98 139.16 42.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 96.6 mttt -100.54 139.0 36.84 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.856 -0.738 . . . . 1.0 110.339 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG12 HD23 ' A' ' 11' ' ' LEU . 11.2 p -144.16 159.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.87 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.4 156.16 24.31 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.855 0.836 . . . . 1.0 112.697 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.7 -31.65 72.6 Favored 'General case' 0 C--O 1.27 2.16 0 CA-C-N 113.674 -1.603 . . . . 1.0 108.81 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 18.5 t -85.18 -8.64 58.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 113.533 -1.667 . . . . 1.0 111.947 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.88 133.29 45.34 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.72 0.771 . . . . 1.0 109.714 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.0 p -81.93 177.62 8.75 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.446 -1.252 . . . . 1.0 109.875 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.632 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 37.8 mm -60.82 -46.64 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 119.259 -0.401 . . . . 1.0 110.298 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 40.1 m -60.98 -47.72 85.13 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.833 0.708 . . . . 1.0 111.341 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -64.87 -42.84 94.51 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.204 0.526 . . . . 1.0 110.608 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.41 -35.64 81.08 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.414 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -60.95 -40.06 91.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 38' ' ' SER . 40.6 mt-10 -65.3 -49.54 69.12 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.054 -0.976 . . . . 1.0 110.605 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.99 -40.92 95.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.465 0.542 . . . . 1.0 112.465 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.6 mmm -65.3 -43.53 90.8 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.71 -27.08 58.08 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.364 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -55.6 -28.16 53.52 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.801 1.24 . . . . 1.0 113.072 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.645 ' HG3' HG22 ' A' ' 29' ' ' VAL . 71.4 mm-40 -69.11 -31.32 69.94 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.282 0.563 . . . . 1.0 110.489 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.432 -1.339 0 CA-C-N 115.914 -0.585 . . . . 1.0 112.347 -174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.445 ' HB2' ' HA ' ' A' ' 111' ' ' PRO 0.291 0.0 OUTLIER . . . . . 0 CA--C 1.502 -0.872 0 N-CA-C 110.011 -0.366 . . . . 1.0 110.011 . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -119.94 152.29 37.63 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.9 0.381 . . . . 1.0 111.204 -173.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -123.61 132.13 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.055 0 C-N-CA 120.026 -0.67 . . . . 1.0 109.365 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 40.9 mt-10 -89.6 112.49 23.72 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.534 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.2 t-105 -91.45 118.27 30.41 Favored 'General case' 1 N--CA 1.374 -4.273 0 C-N-CA 119.299 -0.96 . . . . 1.0 108.525 178.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -104.46 88.72 3.02 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 106.241 -1.763 . . . . 1.0 106.241 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -90.12 -16.38 29.71 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.561 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.05 -51.16 3.48 Favored Glycine 0 C--N 1.291 -1.962 0 CA-C-N 114.764 -1.107 . . . . 1.0 111.836 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.29 -38.88 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.023 0.529 . . . . 1.0 110.976 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.78 7.24 30.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.932 0.872 . . . . 1.0 108.82 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.33 -132.43 12.66 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 114.168 -1.378 . . . . 1.0 110.925 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 4.5 p80 -117.06 101.3 8.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.81 0.814 . . . . 1.0 109.296 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.68 143.9 34.12 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.049 -174.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.428 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 20.0 mm -88.43 109.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 75' ' ' LEU . 9.0 mp -99.9 144.22 29.21 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.47 -0.786 . . . . 1.0 112.62 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 37' ' ' ILE . 53.3 m -153.99 146.55 24.11 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.293 -2.114 . . . . 1.0 105.293 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.53 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 0.5 OUTLIER -74.45 -40.67 61.78 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.557 -0.857 . . . . 1.0 110.702 175.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 . . . . . 0 C--N 1.325 -0.486 0 N-CA-C 112.259 0.466 . . . . 1.0 112.259 179.426 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 79' ' ' ASP . 67.2 mt . . . . . 0 N--CA 1.433 -1.313 0 N-CA-C 106.948 -1.501 . . . . 1.0 106.948 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.53 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 38.5 m-80 -89.66 139.8 30.2 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.332 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.73 171.3 8.3 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 124.043 0.937 . . . . 1.0 109.406 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 101' ' ' VAL . 2.1 pp -71.96 -27.43 62.78 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 6.1 pt20 -63.74 -25.76 68.34 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 115.789 -0.642 . . . . 1.0 112.584 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -64.19 -45.8 86.74 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -93.04 -3.76 53.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.37 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 13.5 mmtm 43.44 67.92 0.58 Allowed 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 124.96 1.304 . . . . 1.0 113.046 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.534 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.8 m -74.81 148.24 84.78 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 114.703 -1.135 . . . . 1.0 111.566 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.8 164.24 33.99 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.338 2.692 . . . . 1.0 112.924 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.09 116.4 6.45 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.74 24.94 12.37 Favored Glycine 0 C--N 1.303 -1.269 0 C-N-CA 119.283 -1.437 . . . . 1.0 112.11 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.15 164.2 26.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.9 m -113.26 130.67 56.18 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.663 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.46 135.37 50.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -130.82 130.57 43.82 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.542 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 3.9 pp -113.45 144.74 42.31 Favored 'General case' 0 C--N 1.262 -3.199 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.258 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 16' ' ' ALA . 13.7 m -133.64 130.73 20.94 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.156 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 49.7 Cg_endo -70.49 84.09 0.79 Allowed 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.555 2.17 . . . . 1.0 111.485 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.653 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 4.8 p . . . . . 0 CA--C 1.505 -0.764 0 C-N-CA 125.544 1.538 . . . . 1.0 112.374 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 50.3 m-85 . . . . . 0 N--CA 1.384 -3.769 0 N-CA-C 100.733 -3.803 . . . . 1.0 100.733 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 27.3 mmt180 -107.43 111.24 63.1 Favored Pre-proline 0 C--N 1.268 -2.948 0 C-N-CA 116.902 -1.919 . . . . 1.0 112.53 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 16.1 Cg_exo -68.45 111.09 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.2 1.933 . . . . 1.0 107.742 173.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 10' ' ' THR . 3.7 tp -106.73 154.9 20.29 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.626 -0.716 . . . . 1.0 111.162 -172.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 17.9 m -88.09 119.14 28.18 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 106.679 -1.6 . . . . 1.0 106.679 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.58 HD11 HG13 ' A' ' 107' ' ' VAL . 1.0 OUTLIER -127.92 140.26 52.11 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -102.18 120.16 39.99 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.732 -0.605 . . . . 1.0 111.052 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.555 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.53 108.38 14.12 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.306 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.511 HD21 ' HA2' ' A' ' 22' ' ' GLY . 25.4 tp -141.67 159.83 41.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -130.02 143.79 50.98 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.693 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -109.69 39.85 2.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.839 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.43 HG22 ' HD3' ' A' ' 111' ' ' PRO . 46.6 t -65.26 -45.44 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.91 -79.46 0.19 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.823 -1.18 . . . . 1.0 112.142 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.31 -31.51 89.11 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.788 2.325 . . . . 1.0 112.378 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.98 27.95 7.55 Favored Glycine 0 N--CA 1.432 -1.598 0 C-N-CA 121.0 -0.619 . . . . 1.0 111.67 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.49 76.03 5.0 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.47 0.652 . . . . 1.0 111.665 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.511 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 124.57 -15.16 7.61 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 110.446 -1.061 . . . . 1.0 110.446 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.65 29.93 6.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.722 -0.739 . . . . 1.0 111.606 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.2 -90.39 0.19 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.301 -0.56 . . . . 1.0 110.95 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HB2' HG23 ' A' ' 27' ' ' VAL . 11.2 pt20 -111.76 -56.07 2.43 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.654 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.01 65.74 3.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.395 -0.682 . . . . 1.0 111.395 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 25' ' ' GLN . 34.8 t -110.41 124.23 33.78 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.44 -174.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.26 104.3 1.88 Allowed 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.245 1.963 . . . . 1.0 110.822 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 42.9 t -109.29 155.63 10.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.19 137.4 40.51 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.881 0.848 . . . . 1.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.76 157.81 23.63 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 114.299 -1.319 . . . . 1.0 108.082 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.74 155.86 18.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.402 0.62 . . . . 1.0 112.245 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 31.9 t70 -64.6 -30.79 71.82 Favored 'General case' 0 C--O 1.267 1.991 0 CA-C-N 114.559 -1.2 . . . . 1.0 109.189 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 5.8 t -88.82 -0.16 57.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.877 -1.511 . . . . 1.0 111.565 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.33 135.41 40.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.694 . . . . 1.0 109.402 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.44 HG21 HD12 ' A' ' 93' ' ' LEU . 81.0 p -81.78 174.67 11.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.569 -1.196 . . . . 1.0 109.579 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 36.5 mm -60.54 -44.39 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.329 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -62.21 -47.29 85.12 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.135 0.897 . . . . 1.0 110.045 178.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -65.47 -41.28 93.53 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.785 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.329 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.22 -38.01 89.51 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 177.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' SER . 37.3 mt-10 -65.83 -45.22 83.09 Favored 'General case' 0 C--O 1.205 -1.245 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.83 -176.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.01 -41.71 98.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.698 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 72.4 mmm -65.63 -42.5 91.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.035 0.445 . . . . 1.0 110.625 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 pp -76.27 -29.9 57.62 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.848 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.2 -28.61 58.9 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.924 1.69 . . . . 1.0 113.031 -172.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 29' ' ' VAL . 88.3 mm-40 -66.39 -34.72 78.59 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.099 0.476 . . . . 1.0 110.877 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.427 -1.6 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.778 -173.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.451 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.32 151.71 29.39 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 120.652 0.263 . . . . 1.0 110.8 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 77' ' ' LEU . 12.5 p -121.28 130.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 C-N-CA 119.581 -0.847 . . . . 1.0 111.219 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 35.9 mt-10 -90.41 113.12 24.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.564 -2.013 . . . . 1.0 105.564 172.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.58 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -89.61 120.69 31.12 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -113.45 89.1 3.0 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.578 -1.268 . . . . 1.0 107.578 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.4 p -81.86 -19.76 40.33 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.863 -1.062 . . . . 1.0 109.676 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.46 -50.26 4.31 Favored Glycine 0 C--N 1.308 -1.023 0 CA-C-N 114.572 -1.195 . . . . 1.0 112.002 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.45 -37.84 81.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 1.0 111.432 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.59 -7.2 22.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.759 0.79 . . . . 1.0 109.395 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 -121.5 6.82 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.99 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.3 p80 -135.24 120.35 18.8 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.264 0.554 . . . . 1.0 111.055 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.12 149.41 44.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 21.7 mm -88.81 114.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.6 mp -110.37 143.5 40.53 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.293 0.568 . . . . 1.0 111.63 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.452 ' HA ' HG21 ' A' ' 37' ' ' ILE . 27.4 m -161.09 155.84 23.64 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.639 ' HB2' HD22 ' A' ' 93' ' ' LEU . 2.7 p-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.988 -0.685 . . . . 1.0 111.418 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 . . . . . 0 N--CA 1.439 -1.015 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -176.06 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.639 HD22 ' HB2' ' A' ' 79' ' ' ASP . 79.9 mt . . . . . 0 N--CA 1.441 -0.886 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -99.16 140.94 32.58 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.563 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 2.0 p -112.35 173.88 6.15 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.328 0.651 . . . . 1.0 109.736 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 101' ' ' VAL . 3.3 pp -75.67 -26.0 57.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.105 -1.038 . . . . 1.0 109.175 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.579 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.5 pt20 -66.2 -25.63 67.02 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -61.34 -41.57 97.26 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -97.18 -8.41 30.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.935 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 100' ' ' LYS 0.275 8.6 mmtm 46.15 75.92 0.11 Allowed 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 125.278 1.431 . . . . 1.0 113.773 -176.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.1 m -84.7 150.19 55.76 Favored Pre-proline 0 C--N 1.285 -2.23 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.206 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.09 165.1 19.5 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 123.515 2.81 . . . . 1.0 112.567 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 119.66 11.01 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.399 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.72 19.01 12.63 Favored Glycine 0 C--N 1.29 -2.008 0 C-N-CA 120.7 -0.762 . . . . 1.0 111.405 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.98 155.67 37.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.198 0.523 . . . . 1.0 110.207 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.8 m -118.49 131.36 56.25 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.045 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 11' ' ' LEU . 33.7 m -112.98 139.29 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.48 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -125.19 120.89 32.59 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.575 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.3 pp -106.35 141.97 36.8 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.771 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 16' ' ' ALA . 18.4 m -133.29 137.09 28.44 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.547 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.2 Cg_endo -73.89 84.09 1.51 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.166 1.911 . . . . 1.0 111.614 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.451 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.4 p . . . . . 0 CA--C 1.506 -0.725 0 C-N-CA 125.066 1.346 . . . . 1.0 110.338 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CG ' ' HB2' ' A' ' 34' ' ' CYS . 65.8 m-85 . . . . . 0 N--CA 1.395 -3.219 0 N-CA-C 104.921 -2.252 . . . . 1.0 104.921 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.514 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 17.7 mmt180 -116.06 111.3 42.88 Favored Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 117.492 -1.683 . . . . 1.0 113.778 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 23.2 Cg_exo -64.47 104.65 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.967 1.778 . . . . 1.0 108.866 171.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -107.59 161.41 14.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.983 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -105.4 130.24 53.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 31' ' ' VAL . 1.9 mm? -124.37 148.12 47.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 123.514 0.726 . . . . 1.0 110.704 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.06 111.21 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.364 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.16 115.13 15.58 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.68 0.613 . . . . 1.0 109.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 32.2 tp -147.73 155.43 41.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.512 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.64 144.44 48.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.73 30.29 7.45 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.625 0.726 . . . . 1.0 109.469 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.69 -47.1 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 115.023 -0.989 . . . . 1.0 112.691 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.93 -86.36 0.07 OUTLIER Glycine 0 C--O 1.22 -0.768 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.906 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.7 -30.53 85.33 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.151 2.567 . . . . 1.0 113.019 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.06 29.92 6.3 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.445 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.35 83.24 1.42 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.581 0.705 . . . . 1.0 112.063 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.579 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 99.53 3.99 56.16 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -135.73 26.45 3.36 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.382 -0.909 . . . . 1.0 110.605 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.03 -95.44 0.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.72 -60.26 1.47 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 112.753 0.649 . . . . 1.0 112.753 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.26 0.6 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.525 -1.321 . . . . 1.0 109.969 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.0 130.13 23.49 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 122.821 -0.223 . . . . 1.0 110.711 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.25 109.39 1.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.132 1.888 . . . . 1.0 111.28 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 44' ' ' MET . 58.1 t -120.08 138.58 50.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 123.538 0.735 . . . . 1.0 109.144 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -102.95 155.89 18.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.129 0.49 . . . . 1.0 112.195 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 32' ' ' LEU . 5.2 p -158.06 -175.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.542 ' H ' HG22 ' A' ' 31' ' ' VAL . 13.2 tp -109.19 158.52 17.73 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 119.267 0.94 . . . . 1.0 108.632 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 27.1 t70 -62.26 -29.99 70.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 123.429 0.692 . . . . 1.0 109.495 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB2' ' CG ' ' A' ' 6' ' ' TYR . 12.2 t -99.25 31.02 3.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.903 -1.499 . . . . 1.0 110.392 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.657 ' O ' HG22 ' A' ' 95' ' ' THR . 11.7 p-10 -68.49 -165.56 0.06 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.549 0.69 . . . . 1.0 109.149 171.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 p -141.6 161.59 37.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.857 -2.645 . . . . 1.0 103.857 167.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.684 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 44.5 mm -58.57 -46.09 90.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.741 -0.783 . . . . 1.0 110.557 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 36.7 t -63.52 -46.74 84.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 124.016 0.822 . . . . 1.0 110.37 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -64.82 -41.46 95.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.041 0.448 . . . . 1.0 111.426 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -64.32 -39.59 94.22 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.57 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.3 -35.33 79.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.625 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.0 mt-10 -64.44 -45.96 85.21 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.771 0.669 . . . . 1.0 110.062 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.808 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.813 ' HA ' HG11 ' A' ' 29' ' ' VAL . 13.3 mtp -63.59 -42.42 98.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.6 pp -74.72 -26.88 60.11 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.243 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -62.45 -32.91 73.85 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.414 0.626 . . . . 1.0 111.596 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HG3' HG22 ' A' ' 29' ' ' VAL . 14.5 mm-40 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.676 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 CA--C 1.503 -0.846 0 CA-C-O 121.833 0.825 . . . . 1.0 112.256 -169.056 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 112.167 0.432 . . . . 1.0 112.167 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 7.6 p-10 -117.18 157.38 26.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.28 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 3.6 p -122.61 127.17 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.254 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -91.91 112.93 25.06 Favored 'General case' 0 N--CA 1.399 -2.997 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.467 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -93.18 122.18 35.3 Favored 'General case' 1 N--CA 1.377 -4.089 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.991 -177.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.483 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 88.0 mtm180 -112.56 89.81 3.17 Favored 'General case' 0 N--CA 1.389 -3.508 0 CA-C-O 122.601 1.191 . . . . 1.0 108.243 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 19.0 p -84.66 -16.89 40.31 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.64 -1.618 . . . . 1.0 109.232 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.29 -54.66 4.31 Favored Glycine 0 C--N 1.293 -1.846 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.239 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.4 HG22 ' HD3' ' A' ' 102' ' ' PRO . 33.9 m -62.3 -42.25 94.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.039 0.447 . . . . 1.0 111.126 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.04 -10.21 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.468 0.652 . . . . 1.0 109.318 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.77 -143.01 16.23 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.83 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 3.5 p80 -116.55 112.21 21.01 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.574 0.702 . . . . 1.0 109.623 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.05 144.96 48.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.825 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.7 mm -85.2 115.65 27.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.721 -1.215 . . . . 1.0 107.721 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.8 mp -103.66 140.56 37.41 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.886 0.851 . . . . 1.0 111.338 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.4 m -152.39 148.15 27.13 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' HD22 ' A' ' 93' ' ' LEU . 7.4 p-10 -70.96 -41.19 71.39 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.899 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 . . . . . 0 C--N 1.311 -1.085 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 176.078 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 79' ' ' ASP . 75.8 mt . . . . . 0 C--O 1.239 0.503 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -81.34 136.57 35.75 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.51 -0.876 . . . . 1.0 110.765 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.2 p -106.75 171.71 7.22 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 124.791 1.236 . . . . 1.0 109.334 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 101' ' ' VAL . 2.7 pp -71.57 -28.53 63.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.588 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.93 -25.64 67.97 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.921 176.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -61.62 -41.72 97.87 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.03 -4.36 30.11 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.518 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 65.2 mmtt 43.49 68.16 0.55 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.738 1.215 . . . . 1.0 112.227 -177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.467 HG11 ' NE1' ' A' ' 67' ' ' TRP . 2.9 m -75.57 149.01 83.44 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 114.915 -1.038 . . . . 1.0 111.636 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD3' HG22 ' A' ' 71' ' ' VAL . 91.8 Cg_endo -73.74 162.98 38.36 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 122.828 2.352 . . . . 1.0 112.697 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.76 116.86 6.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.502 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.83 35.09 8.53 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 119.981 -1.105 . . . . 1.0 111.509 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 69' ' ' SER . . . -74.03 162.89 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -108.9 123.83 49.69 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.524 -0.47 . . . . 1.0 111.156 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.503 HG21 ' SD ' ' A' ' 44' ' ' MET . 5.9 m -104.79 144.83 14.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -139.85 132.86 29.47 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.512 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 1.6 pt? -118.13 143.49 46.44 Favored 'General case' 0 C--N 1.269 -2.934 0 C-N-CA 120.326 -0.55 . . . . 1.0 110.379 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 14.6 m -124.26 164.87 27.36 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.81 56.32 4.61 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.497 2.132 . . . . 1.0 111.472 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.523 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 5.2 t . . . . . 0 CA--C 1.516 -0.34 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.488 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.534 ' HB2' HD22 ' A' ' 32' ' ' LEU . 11.7 m-85 . . . . . 0 N--CA 1.415 -2.189 0 N-CA-C 105.149 -2.167 . . . . 1.0 105.149 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.472 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 33.9 mmt180 -109.6 110.96 59.54 Favored Pre-proline 0 C--N 1.278 -2.542 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.765 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.16 100.1 0.21 Allowed 'Trans proline' 0 C--O 1.245 0.843 0 N-CA-C 107.859 -1.631 . . . . 1.0 107.859 167.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.45 130.2 55.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 -171.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 m -89.36 129.45 35.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 31' ' ' VAL . 1.7 mm? -120.95 147.51 45.36 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 123.343 0.657 . . . . 1.0 110.366 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.408 HD22 HG23 ' A' ' 106' ' ' THR . 7.3 t30 -90.92 108.5 19.89 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.38 109.19 7.67 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.026 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.702 HD21 ' HA2' ' A' ' 22' ' ' GLY . 30.8 tp -137.52 166.59 23.53 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -131.38 143.93 50.84 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . . . -114.96 38.75 3.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.517 HG22 ' HD3' ' A' ' 111' ' ' PRO . 47.8 t -66.63 -44.48 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.52 -88.2 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 119.123 -1.513 . . . . 1.0 113.713 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.88 -29.35 82.37 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 123.253 2.635 . . . . 1.0 113.546 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.45 24.99 10.05 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 84.6 0.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.354 0.597 . . . . 1.0 111.826 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.702 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 115.33 -5.72 21.41 Favored Glycine 0 CA--C 1.487 -1.687 0 CA-C-N 115.163 -0.926 . . . . 1.0 111.271 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.63 19.13 3.9 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.264 -0.468 . . . . 1.0 112.082 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.99 -92.37 0.09 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 10.7 pt20 -110.04 -59.18 1.96 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.461 0.541 . . . . 1.0 112.461 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.7 69.7 1.25 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.89 127.01 30.25 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.99 -0.105 . . . . 1.0 110.743 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.48 107.43 2.29 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 121.862 1.708 . . . . 1.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 44' ' ' MET . 83.7 t -119.95 140.09 45.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.17 -0.923 . . . . 1.0 109.586 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -104.73 146.31 29.13 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.081 -0.648 . . . . 1.0 111.808 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 HD23 ' A' ' 11' ' ' LEU . 15.3 m -141.94 171.21 11.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 124.241 1.017 . . . . 1.0 109.08 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 6' ' ' TYR . 11.5 mt -88.37 159.15 18.17 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.118 0.485 . . . . 1.0 111.267 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.472 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 37.5 t70 -61.93 -30.75 71.11 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 115.049 -0.978 . . . . 1.0 108.505 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.5 t -96.12 6.08 49.63 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 114.25 -1.341 . . . . 1.0 113.365 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.4 m-20 -70.19 134.91 48.56 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.531 HG22 HD11 ' A' ' 93' ' ' LEU . 49.3 p -79.75 166.88 21.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.12 -44.59 91.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.89 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.6 p -61.84 -47.32 85.57 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 48.9 mt-30 -72.01 -38.23 69.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.975 0.732 . . . . 1.0 112.975 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.4 -39.96 85.59 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -62.51 -33.66 75.33 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.2 mt-10 -65.36 -48.64 72.25 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.086 0.866 . . . . 1.0 110.208 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 41.4 mmtm -60.83 -44.35 97.05 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.78 ' HA ' HG11 ' A' ' 29' ' ' VAL . 9.3 mtp -64.94 -41.97 95.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.751 -1.113 . . . . 1.0 112.288 -178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -76.02 -32.91 59.61 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.765 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -61.44 -29.78 70.16 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.508 0.723 . . . . 1.0 112.049 -174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.533 HE21 HG13 ' A' ' 29' ' ' VAL . 11.3 mm-40 -67.54 -39.18 85.02 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.607 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.441 -0.884 0 CA-C-N 115.639 -0.709 . . . . 1.0 112.468 -169.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 120.571 0.224 . . . . 1.0 110.682 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.472 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 9.7 m-20 -108.89 151.63 26.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.925 -1.139 . . . . 1.0 107.925 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.16 128.52 75.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 119.807 -0.757 . . . . 1.0 109.482 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 41.9 mt-10 -89.74 112.47 23.77 Favored 'General case' 0 CA--C 1.457 -2.615 0 N-CA-C 105.612 -1.995 . . . . 1.0 105.612 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.589 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -91.25 117.27 29.5 Favored 'General case' 1 N--CA 1.367 -4.625 0 C-N-CA 119.273 -0.971 . . . . 1.0 108.501 177.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -102.8 88.25 3.15 Favored 'General case' 0 N--CA 1.394 -3.245 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.1 p -83.65 -14.4 51.96 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.824 -1.535 . . . . 1.0 110.34 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.53 -57.73 3.77 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.765 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.2 -43.73 98.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.28 0.632 . . . . 1.0 111.766 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.37 -8.54 21.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.299 0.571 . . . . 1.0 110.347 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.41 -149.38 19.43 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.9 p80 -105.91 108.87 20.6 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.498 0.666 . . . . 1.0 111.299 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.03 146.42 36.74 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.368 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.406 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 25.4 mm -87.87 99.27 8.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -89.34 156.37 18.76 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.564 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.3 t -160.84 164.41 31.37 Favored 'General case' 0 CA--C 1.465 -2.303 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -63.58 -37.21 86.45 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.714 0.634 . . . . 1.0 110.079 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 . . . . . 0 N--CA 1.445 -0.707 0 O-C-N 123.107 0.254 . . . . 1.0 110.846 -178.392 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.531 HD11 HG22 ' A' ' 36' ' ' THR . 3.0 tm? . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 106.449 -1.685 . . . . 1.0 106.449 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.6 m-80 -96.74 139.59 32.57 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.929 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -129.39 176.45 7.95 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 125.855 1.662 . . . . 1.0 106.821 175.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 101' ' ' VAL . 3.0 pp -73.32 -25.31 60.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.237 -1.385 . . . . 1.0 108.944 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.571 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 5.1 pt20 -66.36 -24.73 66.55 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.31 -40.71 91.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -103.45 2.58 33.93 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 30.9 mmmt 40.76 64.09 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.401 1.08 . . . . 1.0 112.097 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.589 HG11 ' CE2' ' A' ' 67' ' ' TRP . 2.1 m -68.74 150.95 97.49 Favored Pre-proline 0 C--N 1.294 -1.833 0 CA-C-N 115.539 -0.755 . . . . 1.0 111.786 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.12 155.83 37.92 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.154 1.903 . . . . 1.0 111.462 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.95 124.5 22.7 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.654 0.74 . . . . 1.0 110.208 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.99 22.23 23.58 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.092 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.408 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . . . -71.08 164.42 25.62 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.911 0.386 . . . . 1.0 109.993 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.408 HG23 HD22 ' A' ' 12' ' ' ASN . 79.3 m -111.56 130.55 55.7 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.282 -0.567 . . . . 1.0 110.767 -173.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.63 HG21 ' SD ' ' A' ' 44' ' ' MET . 27.5 m -114.13 139.49 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.49 138.94 49.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.1 pp -108.89 139.55 43.57 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.548 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 36.0 m -130.42 130.92 23.08 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.569 -0.741 . . . . 1.0 109.511 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.517 ' HD3' HG22 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -68.67 78.72 0.68 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.791 2.327 . . . . 1.0 112.458 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.472 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 43.6 t . . . . . 0 C--O 1.246 0.887 0 C-N-CA 124.781 1.232 . . . . 1.0 111.132 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 89.3 m-85 . . . . . 0 N--CA 1.397 -3.108 0 N-CA-C 105.905 -1.887 . . . . 1.0 105.905 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.436 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 59.4 mmt-85 -104.31 114.57 64.12 Favored Pre-proline 0 C--N 1.271 -2.809 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.409 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.02 111.69 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.39 2.06 . . . . 1.0 108.938 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.36 127.97 54.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -171.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -88.49 122.31 31.83 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.462 HD11 HG13 ' A' ' 107' ' ' VAL . 16.5 tp -126.97 138.99 53.36 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -97.64 119.54 36.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.847 -0.533 . . . . 1.0 110.835 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.01 121.11 23.79 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.504 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -149.19 169.53 20.51 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.448 0.299 . . . . 1.0 110.437 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.811 HD22 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -127.26 144.58 51.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.419 0.288 . . . . 1.0 110.692 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -124.12 39.79 3.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.126 0.489 . . . . 1.0 110.555 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.439 HG22 ' HD3' ' A' ' 111' ' ' PRO . 78.1 t -61.47 -46.33 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 C-N-CA 123.302 0.641 . . . . 1.0 110.728 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.99 -94.39 0.12 Allowed Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.387 -0.911 . . . . 1.0 112.204 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.46 -32.85 88.91 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.42 2.746 . . . . 1.0 113.543 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.49 ' O ' HD21 ' A' ' 15' ' ' LEU . . . -110.45 25.58 15.12 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.887 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.88 79.8 0.12 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.387 0.613 . . . . 1.0 111.78 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -5.33 3.08 Favored Glycine 0 N--CA 1.423 -2.19 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.32 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.63 18.53 21.32 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.178 0.807 . . . . 1.0 113.178 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.811 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -79.58 -76.91 0.19 Allowed 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.897 -0.721 . . . . 1.0 112.141 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.527 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.0 pt20 -138.41 -53.1 0.61 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.261 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 59.94 8.55 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 25' ' ' GLN . 35.4 t -114.71 126.99 27.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.261 -0.469 . . . . 1.0 110.552 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.45 103.36 1.73 Allowed 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.97 1.78 . . . . 1.0 110.562 175.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.516 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 57.7 t -102.16 153.81 5.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -109.57 139.61 44.37 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.314 -0.955 . . . . 1.0 111.433 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.57 174.63 12.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.095 -1.411 . . . . 1.0 108.239 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 32' ' ' LEU . 12.1 mt -104.59 159.73 15.52 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.542 0.687 . . . . 1.0 110.637 175.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 38.5 t70 -59.67 -29.87 68.37 Favored 'General case' 0 C--O 1.272 2.249 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.952 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 45.8 t -82.6 -12.01 58.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.753 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.03 132.67 47.02 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.435 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 44.3 p -78.32 172.55 13.44 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 94' ' ' ASN . 43.7 mm -60.37 -45.61 96.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.926 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.3 t -66.39 -41.92 88.64 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 8.4 tt0 -66.31 -34.38 77.86 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.993 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -81.67 -38.48 25.83 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 122.307 -0.245 . . . . 1.0 111.518 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -60.51 -35.51 76.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.916 0.388 . . . . 1.0 110.34 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -66.48 -41.23 89.27 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.391 -0.822 . . . . 1.0 109.905 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 46.7 mmtm -63.6 -41.49 98.33 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.834 0.709 . . . . 1.0 111.861 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.589 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 86.1 mmm -60.96 -45.94 92.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.146 0.498 . . . . 1.0 110.627 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.5 -25.33 50.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.681 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 24.9 t70 -56.94 -28.83 62.56 Favored 'General case' 0 C--O 1.203 -1.371 0 C-N-CA 125.374 1.47 . . . . 1.0 112.145 -174.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.493 HE21 HG13 ' A' ' 29' ' ' VAL . 14.1 mm-40 -65.78 -33.92 76.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.067 0.46 . . . . 1.0 111.082 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? . . . . . 0 C--N 1.308 -1.219 0 CA-C-O 121.881 0.848 . . . . 1.0 109.127 -178.478 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.633 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.4 pp . . . . . 0 N--CA 1.432 -1.353 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 7.7 m-20 -105.83 151.53 24.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.6 124.53 71.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.428 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.63 112.28 24.14 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.586 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -93.28 125.82 38.08 Favored 'General case' 1 N--CA 1.374 -4.225 0 CA-C-N 114.554 -1.203 . . . . 1.0 109.165 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.29 89.39 3.05 Favored 'General case' 0 N--CA 1.395 -3.203 0 N-CA-C 106.672 -1.603 . . . . 1.0 106.672 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.8 p -79.0 -22.56 45.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.339 -1.301 . . . . 1.0 109.393 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.16 -45.72 3.5 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.837 -1.074 . . . . 1.0 112.163 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.55 -39.45 85.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.023 0.439 . . . . 1.0 111.062 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.22 -9.41 16.89 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.447 0.641 . . . . 1.0 109.937 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.07 -126.17 8.82 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.212 -0.904 . . . . 1.0 111.51 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -120.28 118.32 30.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.238 0.542 . . . . 1.0 110.204 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.66 151.91 45.92 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 9.8 mm -98.34 120.3 47.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.469 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.432 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.7 mp -111.99 163.32 14.38 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.459 ' HA ' HG21 ' A' ' 37' ' ' ILE . 8.2 t -167.58 163.03 14.57 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.234 -2.506 . . . . 1.0 104.234 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 21.3 p-10 -93.68 -3.25 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 117.9 -1.52 . . . . 1.0 111.033 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 . . . . . 0 N--CA 1.427 -1.582 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 170.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 79.3 mt . . . . . 0 N--CA 1.425 -1.69 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.468 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 93.8 m-20 -89.6 141.02 28.98 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -107.27 173.29 6.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 124.448 1.099 . . . . 1.0 109.704 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.461 HD13 HG22 ' A' ' 101' ' ' VAL . 3.9 pp -72.66 -25.41 61.26 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.303 -0.959 . . . . 1.0 108.783 173.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -66.68 -25.34 66.51 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.22 0.533 . . . . 1.0 110.904 173.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -64.4 -37.73 88.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -104.55 -1.78 26.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.934 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 49.71 66.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.837 1.255 . . . . 1.0 112.997 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.1 m -85.27 150.71 55.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.636 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.19 155.89 22.61 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.844 2.362 . . . . 1.0 111.926 175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.0 122.17 17.16 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.52 10.34 13.24 Favored Glycine 0 C--N 1.285 -2.264 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -69.89 162.3 28.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.288 0.566 . . . . 1.0 111.069 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.9 m -120.92 132.71 55.11 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.462 HG13 HD11 ' A' ' 11' ' ' LEU . 29.6 m -115.73 135.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.506 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -120.38 137.54 54.24 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.656 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.5 tt -97.92 126.86 43.52 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.974 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 64' ' ' ASP . 33.9 m -127.88 127.1 23.96 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HD3' HG22 ' A' ' 17' ' ' VAL . 43.9 Cg_endo -70.35 82.02 0.91 Allowed 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 122.355 2.037 . . . . 1.0 111.823 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.633 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.7 p . . . . . 0 N--CA 1.493 1.688 0 C-N-CA 126.038 1.735 . . . . 1.0 111.026 178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 34' ' ' CYS . 74.8 m-85 . . . . . 0 N--CA 1.401 -2.918 0 N-CA-C 105.261 -2.126 . . . . 1.0 105.261 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -113.39 114.63 47.78 Favored Pre-proline 0 C--N 1.273 -2.721 0 C-N-CA 118.111 -1.436 . . . . 1.0 113.287 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 124.98 16.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.247 1.964 . . . . 1.0 109.098 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tp -122.18 161.81 22.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.801 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m -109.48 128.44 55.17 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.1 mt -126.66 149.99 49.22 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.751 0.82 . . . . 1.0 111.011 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -94.62 116.05 28.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.74 120.59 24.83 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.814 HD21 ' HA2' ' A' ' 22' ' ' GLY . 31.0 tp -151.64 152.32 32.67 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.636 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.1 pt? -122.13 143.03 49.79 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.728 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -117.25 32.41 6.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.363 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.18 -45.32 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 C-N-CA 123.572 0.749 . . . . 1.0 111.814 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.64 -87.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.363 -1.398 . . . . 1.0 113.475 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.33 -30.76 88.22 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.954 2.436 . . . . 1.0 113.171 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.3 26.08 11.64 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.694 -0.765 . . . . 1.0 111.547 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.7 82.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.814 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 103.05 0.12 48.04 Favored Glycine 0 CA--C 1.48 -2.14 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.41 22.04 3.7 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.664 -0.768 . . . . 1.0 111.242 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.66 -69.33 0.62 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.189 -0.459 . . . . 1.0 112.129 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -148.41 -51.77 0.17 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.7 -177.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.0 68.19 1.73 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.508 -1.037 . . . . 1.0 110.508 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 25' ' ' GLN . 22.4 t -103.37 127.34 29.87 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.94 108.45 2.72 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 C-N-CA 121.623 1.549 . . . . 1.0 111.624 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.467 HG13 ' NE2' ' A' ' 47' ' ' GLN . 44.1 t -106.23 154.83 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.985 -1.007 . . . . 1.0 108.729 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.84 143.96 34.18 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.324 0.583 . . . . 1.0 110.769 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.48 166.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 tp -100.4 156.83 17.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.05 -30.29 70.88 Favored 'General case' 0 C--O 1.268 2.033 0 CA-C-O 121.473 0.654 . . . . 1.0 109.596 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.617 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -90.82 1.56 56.83 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.355 -176.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.17 136.24 46.4 Favored 'General case' 0 CA--C 1.48 -1.734 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.014 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.36 168.81 17.15 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.759 HG21 ' HA ' ' A' ' 78' ' ' SER . 42.1 mm -61.59 -42.23 93.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 120.799 -0.361 . . . . 1.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -61.68 -43.72 98.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 121.109 -0.237 . . . . 1.0 110.547 177.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.447 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 27.0 mt-30 -67.33 -39.33 85.81 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 123.461 0.476 . . . . 1.0 111.238 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.66 -39.1 91.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.09 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.2 mptm? -56.93 -40.28 76.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 176.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' SER . 41.3 mt-10 -65.43 -53.81 37.65 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.42 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.27 -40.86 96.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.319 0.859 . . . . 1.0 113.319 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.667 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.5 mmm -64.04 -46.42 84.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.441 . . . . 1.0 110.406 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.7 pp -76.7 -25.19 53.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.13 -29.66 58.18 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.461 1.104 . . . . 1.0 112.67 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.467 ' NE2' HG13 ' A' ' 29' ' ' VAL . 27.7 mt-30 -69.25 -31.36 69.86 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.884 -0.327 . . . . 1.0 111.315 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 C--N 1.318 -0.772 0 CA-C-O 121.93 0.871 . . . . 1.0 108.713 -178.633 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.542 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 2.2 pp . . . . . 0 N--CA 1.409 -2.483 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' H ' ' H ' ' A' ' 112' ' ' CYS . 53.6 m-20 -112.91 169.5 8.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 1.0 108.329 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.62 129.21 75.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 C-N-CA 119.791 -0.764 . . . . 1.0 108.962 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 10.3 pt-20 -91.49 111.89 23.58 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.159 -1.793 . . . . 1.0 106.159 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 2.5 t-105 -89.99 126.06 35.61 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.164 -1.38 . . . . 1.0 110.054 -174.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.47 88.97 2.85 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.7 p -91.9 -14.15 30.09 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.826 -1.534 . . . . 1.0 110.907 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.52 -52.53 4.38 Favored Glycine 0 C--N 1.303 -1.279 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.793 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.88 -38.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 122.669 0.388 . . . . 1.0 111.394 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.69 1.97 21.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.57 0.7 . . . . 1.0 109.665 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.23 -129.47 10.6 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 19.4 p-80 -110.73 112.73 24.8 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.317 0.579 . . . . 1.0 110.069 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.43 140.19 53.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -79.14 115.06 20.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.481 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.5 mp -109.79 148.36 31.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.763 0.792 . . . . 1.0 112.351 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.759 ' HA ' HG21 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -164.12 157.05 17.7 Favored 'General case' 0 CA--C 1.467 -2.216 0 C-N-CA 125.805 1.642 . . . . 1.0 107.082 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 21.6 p-10 -73.69 -38.33 64.91 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 123.293 0.371 . . . . 1.0 111.399 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 C--N 1.316 -0.882 0 C-N-CA 120.592 -0.443 . . . . 1.0 112.014 -178.878 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt . . . . . 0 N--CA 1.433 -1.306 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 37' ' ' ILE . 41.5 m-80 -82.44 140.16 33.57 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.851 -0.74 . . . . 1.0 109.52 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -114.64 174.74 5.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.528 HD13 HG22 ' A' ' 101' ' ' VAL . 2.4 pp -73.09 -29.59 63.05 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.235 -0.986 . . . . 1.0 108.368 173.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.617 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.0 pt20 -65.76 -24.48 66.96 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.024 -0.535 . . . . 1.0 112.17 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -59.9 -44.23 94.38 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 108.971 -0.751 . . . . 1.0 108.971 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -96.65 -10.28 27.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.569 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 64.7 mmtt 53.0 73.16 0.37 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.259 1.024 . . . . 1.0 113.121 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.2 m -83.08 147.99 55.42 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.958 . . . . 1.0 110.838 177.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.54 159.57 35.65 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.56 2.173 . . . . 1.0 112.911 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.77 121.54 15.26 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 121.764 0.792 . . . . 1.0 109.415 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.96 9.72 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.232 -0.985 . . . . 1.0 111.177 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.61 163.04 27.75 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.941 0.401 . . . . 1.0 110.315 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -115.61 131.33 56.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.835 0.35 . . . . 1.0 110.426 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.07 138.07 46.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.524 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -126.38 128.03 46.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.187 0.518 . . . . 1.0 110.593 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.636 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.3 mp -92.71 127.15 38.1 Favored 'General case' 0 C--N 1.269 -2.928 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.033 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 16' ' ' ALA . 17.3 m -128.94 154.01 80.21 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.13 74.09 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.224 1.949 . . . . 1.0 110.633 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.542 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.266 0 C-N-CA 125.486 1.514 . . . . 1.0 111.836 -179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' A' ' 32' ' ' LEU . 73.0 m-85 . . . . . 0 N--CA 1.403 -2.775 0 N-CA-C 105.461 -2.051 . . . . 1.0 105.461 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.537 ' H ' ' HB2' ' A' ' 33' ' ' ASP . 31.5 mmt180 -104.98 104.28 45.9 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 119.444 -0.903 . . . . 1.0 109.313 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' A' ' 32' ' ' LEU . 18.7 Cg_exo -65.81 105.18 0.76 Allowed 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 174.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HB3' HG23 ' A' ' 31' ' ' VAL . 4.3 tp -110.37 162.08 15.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-O 121.626 0.727 . . . . 1.0 112.334 -168.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -112.79 129.92 56.26 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.383 -1.281 . . . . 1.0 108.387 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 11' ' ' LEU . 25.7 mt -126.26 149.86 48.81 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.287 0.565 . . . . 1.0 111.258 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 8.7 t30 -98.03 107.45 19.93 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.286 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.94 111.21 6.16 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 123.903 0.752 . . . . 1.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 30.4 tp -145.23 146.77 31.84 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.407 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.86 143.91 49.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -113.15 29.64 7.82 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.193 0.521 . . . . 1.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.474 HG22 ' HD3' ' A' ' 111' ' ' PRO . 53.2 t -64.9 -47.15 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 123.857 0.863 . . . . 1.0 112.56 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.85 -75.6 0.11 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.611 -1.281 . . . . 1.0 113.773 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.9 -26.44 80.97 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 123.68 2.92 . . . . 1.0 113.057 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.43 39.31 1.59 Allowed Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.751 -1.339 . . . . 1.0 109.751 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -63.75 80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.193 1.183 . . . . 1.0 114.193 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.35 39.96 Favored Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 110.403 -1.079 . . . . 1.0 110.403 172.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -157.05 38.07 0.3 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.612 0.72 . . . . 1.0 110.427 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' H ' HD11 ' A' ' 14' ' ' LEU . . . -95.63 -77.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.811 -0.631 . . . . 1.0 112.546 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.403 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 1.6 pt20 -127.13 -59.14 1.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.418 -172.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 69.56 68.37 1.66 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -99.34 131.25 25.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.666 -0.267 . . . . 1.0 110.561 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.14 103.36 1.49 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.917 1.745 . . . . 1.0 111.597 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.56 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 37.5 t -110.38 155.36 11.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.23 -0.895 . . . . 1.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.22 144.76 31.17 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.16 0.505 . . . . 1.0 112.177 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.541 HG12 ' HD2' ' A' ' 43' ' ' LYS . 2.6 m -147.64 -176.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.69 -1.141 . . . . 1.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 6' ' ' TYR . 29.5 mt -121.45 174.35 6.81 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.641 0.734 . . . . 1.0 110.097 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.537 ' HB2' ' H ' ' A' ' 7' ' ' ARG . 28.8 t70 -66.18 -32.3 73.65 Favored 'General case' 0 C--O 1.265 1.881 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.607 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.446 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 3.9 t -103.46 2.78 34.16 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.417 1.636 . . . . 1.0 115.417 -169.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.393 0.2 OUTLIER -79.08 141.92 36.93 Favored 'General case' 0 CA--C 1.467 -2.245 0 C-N-CA 115.969 -2.293 . . . . 1.0 111.607 172.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.2 p -77.24 170.15 17.06 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.527 -1.67 . . . . 1.0 110.217 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.5 mm -59.64 -42.9 89.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.615 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.8 p -61.59 -46.99 87.49 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 123.431 0.457 . . . . 1.0 111.401 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.77 -42.54 63.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.114 0.483 . . . . 1.0 111.558 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.63 -37.4 82.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.716 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.528 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 32.9 ttpt -59.29 -38.31 79.9 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.444 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 38' ' ' SER . 63.5 mt-10 -66.9 -40.0 87.59 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.402 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HD2' HG12 ' A' ' 31' ' ' VAL . 64.6 mttp -63.92 -40.93 97.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 121.335 -0.146 . . . . 1.0 111.05 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.56 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.1 mmt -61.82 -49.35 76.65 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.739 0.65 . . . . 1.0 110.601 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -76.64 -23.08 53.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 30.7 t70 -55.27 -30.82 60.87 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.247 1.019 . . . . 1.0 111.567 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG3' HG22 ' A' ' 29' ' ' VAL . 78.0 mm-40 -67.96 -30.93 70.34 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.845 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.497 -1.088 0 CA-C-O 121.091 0.472 . . . . 1.0 111.46 -171.981 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.9 pp . . . . . 0 C--O 1.248 1.002 0 CA-C-O 120.92 0.39 . . . . 1.0 111.181 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.5 162.71 15.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.305 -176.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.14 127.06 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.302 0.572 . . . . 1.0 110.472 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.45 113.21 25.31 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 105.132 -2.173 . . . . 1.0 105.132 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.564 ' CE3' HD22 ' A' ' 77' ' ' LEU . 4.9 t-105 -91.55 133.54 35.44 Favored 'General case' 0 N--CA 1.403 -2.806 0 CA-C-N 115.39 -0.823 . . . . 1.0 111.912 -173.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -117.08 88.69 2.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 106.446 -1.687 . . . . 1.0 106.446 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 71.3 p -73.48 -31.99 64.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.785 -1.098 . . . . 1.0 110.763 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.14 -50.99 4.35 Favored Glycine 0 C--N 1.303 -1.282 0 CA-C-N 114.566 -1.197 . . . . 1.0 111.365 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.8 -41.28 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.524 0.329 . . . . 1.0 111.703 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.4 -40.04 5.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.275 -1.009 . . . . 1.0 108.275 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.16 -130.16 6.76 Favored Glycine 0 N--CA 1.426 -2.021 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.042 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 88.9 m-70 -100.94 118.86 37.8 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.544 0.737 . . . . 1.0 110.652 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.35 134.43 39.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 28.1 mm -79.72 118.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -109.98 152.27 26.09 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.234 0.54 . . . . 1.0 111.4 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.6 m -154.92 148.99 25.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 p-10 -66.25 -44.14 84.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 N--CA 1.422 -1.858 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.935 178.48 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.0 mt . . . . . 0 N--CA 1.447 -0.623 0 CA-C-O 120.709 0.29 . . . . 1.0 110.938 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -103.42 146.21 28.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.211 -0.45 . . . . 1.0 109.847 177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.544 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -109.23 171.84 7.2 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -77.02 -17.55 58.74 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.585 -1.246 . . . . 1.0 109.43 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.544 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -66.67 -26.42 67.03 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.896 173.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -64.07 -40.99 97.47 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 2.0 t80 -88.74 -16.14 32.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.604 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.35 57.91 5.42 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.103 0.961 . . . . 1.0 111.01 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -74.31 144.22 81.04 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.208 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.06 158.49 41.95 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.878 2.385 . . . . 1.0 111.861 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.451 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . 6.0 p-10 -66.49 119.2 11.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.812 0.815 . . . . 1.0 109.827 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.99 20.33 10.72 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.417 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.88 162.12 29.93 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.867 0.365 . . . . 1.0 110.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 76.1 m -115.24 132.3 56.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.093 0.473 . . . . 1.0 110.667 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 13.5 m -113.22 156.89 14.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -139.26 124.87 19.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.232 0.539 . . . . 1.0 109.598 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.628 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.7 mp -101.32 131.38 47.4 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.234 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 17.5 m -130.2 147.96 67.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HD3' HG22 ' A' ' 17' ' ' VAL . 77.7 Cg_endo -83.07 82.96 2.03 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 121.769 1.646 . . . . 1.0 111.741 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 12.6 p . . . . . 0 CA--C 1.499 -0.999 0 C-N-CA 125.227 1.411 . . . . 1.0 111.247 179.216 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.574 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 47.0 m-85 . . . . . 0 N--CA 1.391 -3.42 0 N-CA-C 103.355 -2.831 . . . . 1.0 103.355 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.451 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 19.2 mmt180 -101.21 110.66 61.99 Favored Pre-proline 0 C--N 1.264 -3.126 0 C-N-CA 118.805 -1.158 . . . . 1.0 111.746 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -60.44 119.83 7.23 Favored 'Trans proline' 0 CA--C 1.508 -0.825 0 C-N-CA 122.397 2.064 . . . . 1.0 108.617 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -114.94 128.41 56.27 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 -171.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.2 m -87.37 120.3 28.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.506 HD23 ' SD ' ' A' ' 44' ' ' MET . 16.3 tp -124.65 142.84 51.08 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.52 HD22 HG23 ' A' ' 106' ' ' THR . 8.1 t30 -98.76 117.07 32.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.106 -0.371 . . . . 1.0 110.814 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -75.92 116.93 17.11 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.148 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 25.7 tp -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.695 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -128.65 141.21 51.42 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.955 -0.465 . . . . 1.0 110.741 176.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.63 54.0 0.82 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.234 0.54 . . . . 1.0 110.933 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 HG22 ' HD3' ' A' ' 111' ' ' PRO . 46.5 t -67.71 -43.21 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.604 0.716 . . . . 1.0 109.865 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.94 -84.59 0.14 Allowed Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.94 -32.82 76.42 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.792 2.328 . . . . 1.0 112.142 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.65 18.58 50.11 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 121.32 -0.467 . . . . 1.0 112.152 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -77.79 64.42 3.04 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.449 0.642 . . . . 1.0 111.924 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.54 -29.34 1.89 Allowed Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -94.31 17.99 11.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.122 0.487 . . . . 1.0 111.187 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.07 -83.31 0.08 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -143.7 -62.8 0.39 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.569 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.86 72.57 0.95 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.38 126.72 27.62 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.34 -0.43 . . . . 1.0 110.264 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.36 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 121.737 1.625 . . . . 1.0 111.496 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.517 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 40.6 t -110.61 142.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.117 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.48 140.7 29.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.283 0.563 . . . . 1.0 111.765 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 9' ' ' LEU . 13.7 m -141.33 172.86 9.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 9.8 mt -107.95 158.4 17.39 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.421 0.629 . . . . 1.0 111.483 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.451 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.2 t70 -59.22 -30.83 68.52 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.03 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.9 t -88.6 -3.61 58.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.501 -1.227 . . . . 1.0 112.277 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -73.23 132.34 43.06 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 p -74.55 172.08 12.66 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -59.94 -44.99 95.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 117.993 0.36 . . . . 1.0 111.198 -177.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.437 ' HB2' ' OD1' ' A' ' 79' ' ' ASP . 4.0 t -71.87 -35.97 69.94 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.955 -1.098 . . . . 1.0 110.519 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.79 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 9.1 tt0 -68.25 -38.02 81.39 Favored 'General case' 0 C--O 1.206 -1.226 0 C-N-CA 123.136 0.574 . . . . 1.0 111.007 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -73.69 -39.75 64.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.539 -0.726 . . . . 1.0 110.596 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.22 -35.91 72.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.316 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.79 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 3.7 pt-20 -68.41 -40.44 81.27 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.919 -176.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.549 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 44.9 mmtm -63.99 -41.45 97.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 124.186 0.929 . . . . 1.0 110.245 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.1 mmm -61.59 -48.59 80.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.694 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.4 pp -77.28 -24.72 50.98 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 112.579 0.585 . . . . 1.0 112.579 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -52.89 -28.92 25.4 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.092 1.357 . . . . 1.0 112.076 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.446 HE21 HG13 ' A' ' 29' ' ' VAL . 12.2 mm-40 -66.76 -36.83 83.34 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.45 0.643 . . . . 1.0 110.348 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--N 1.315 -0.895 0 CA-C-O 121.696 0.76 . . . . 1.0 109.545 -177.448 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.616 HD13 ' HG ' ' A' ' 109' ' ' LEU . 4.5 pp . . . . . 0 C--O 1.192 -1.962 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.08 152.45 33.58 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.487 -1.301 . . . . 1.0 107.487 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 77' ' ' LEU . 8.4 p -115.75 125.94 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 118.825 -1.15 . . . . 1.0 110.137 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -93.87 113.11 25.06 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.357 -1.349 . . . . 1.0 107.357 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.611 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.5 t-105 -93.61 124.49 37.63 Favored 'General case' 0 N--CA 1.388 -3.549 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.97 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -109.96 89.57 3.06 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 p -84.59 -13.47 51.6 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.054 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.06 -55.87 3.94 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.42 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.03 -40.93 90.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.003 0.521 . . . . 1.0 111.293 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.35 -10.76 26.99 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.694 0.759 . . . . 1.0 109.03 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.35 -128.23 9.5 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.083 -0.962 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 3.8 p80 -130.65 108.19 9.72 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.298 0.571 . . . . 1.0 109.836 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.68 151.71 36.7 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.0 mm -94.07 120.68 43.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 10.4 mp -111.22 165.18 12.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.525 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -167.06 157.72 11.67 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 105.141 -2.17 . . . . 1.0 105.141 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 9.3 p-10 -78.51 -19.72 52.35 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.42 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 C--N 1.304 -1.409 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 173.964 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 94.3 mt . . . . . 0 C--O 1.251 1.154 0 N-CA-C 109.477 -0.564 . . . . 1.0 109.477 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 37' ' ' ILE . 82.7 m-20 -98.58 140.58 32.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.207 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.548 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -111.39 173.1 6.5 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.991 1.316 . . . . 1.0 108.921 177.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 101' ' ' VAL . 3.9 pp -72.21 -22.8 61.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 119.136 -1.025 . . . . 1.0 109.49 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.548 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.77 -26.47 67.73 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.327 175.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -66.7 -40.68 88.6 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.487 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 88.1 m-85 -97.47 -1.33 44.41 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.652 -0.703 . . . . 1.0 111.61 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? 48.53 63.61 2.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.034 1.334 . . . . 1.0 113.589 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.611 HG11 ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -84.52 146.29 46.81 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 119.075 -1.05 . . . . 1.0 112.601 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.14 158.08 23.41 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.026 2.484 . . . . 1.0 111.827 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.07 122.46 17.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.4 14.59 12.7 Favored Glycine 0 C--N 1.287 -2.151 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.971 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -71.3 162.68 29.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.269 0.557 . . . . 1.0 110.697 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.52 HG23 HD22 ' A' ' 12' ' ' ASN . 97.4 m -123.04 134.5 54.29 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.309 -0.405 . . . . 1.0 109.92 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.425 HG11 HD21 ' A' ' 11' ' ' LEU . 27.2 m -115.38 138.81 44.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.461 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -126.13 135.17 51.37 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.528 0.68 . . . . 1.0 110.539 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.695 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 tt -100.04 125.8 46.15 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.315 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 16' ' ' ALA . 32.2 m -119.54 130.45 24.84 Favored Pre-proline 0 C--N 1.316 -0.883 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.094 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.5 Cg_endo -75.15 86.35 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.344 2.029 . . . . 1.0 111.699 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.528 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 18.7 p . . . . . 0 N--CA 1.492 1.638 0 C-N-CA 125.833 1.653 . . . . 1.0 113.714 177.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 . . . . . 0 N--CA 1.406 -2.628 0 N-CA-C 103.481 -2.785 . . . . 1.0 103.481 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.507 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 33.6 mmt180 -108.52 111.61 61.23 Favored Pre-proline 0 C--N 1.267 -3.004 0 C-N-CA 119.362 -0.935 . . . . 1.0 112.301 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.38 109.51 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.144 1.896 . . . . 1.0 109.57 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 10' ' ' THR . 4.6 tp -112.85 156.02 23.64 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.026 -174.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.439 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 47.3 m -96.51 128.59 43.58 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 ' SD ' ' A' ' 44' ' ' MET . 29.0 tp -127.37 143.73 51.17 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 7.3 t30 -97.68 113.47 25.23 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.03 -0.419 . . . . 1.0 110.966 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . . . -76.16 115.98 16.41 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.811 -0.632 . . . . 1.0 110.167 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.642 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.7 tp -147.81 154.81 40.95 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.681 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.66 143.67 50.61 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.731 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -116.36 33.29 5.63 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.329 0.585 . . . . 1.0 110.368 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.78 -46.23 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 C-N-CA 123.645 0.778 . . . . 1.0 111.918 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.29 -77.47 0.14 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 119.295 -1.431 . . . . 1.0 113.684 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.45 -35.06 97.08 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.761 2.307 . . . . 1.0 112.141 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.39 36.63 3.22 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -68.39 74.46 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.79 1.033 . . . . 1.0 113.79 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.642 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 105.6 -5.58 40.73 Favored Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 110.14 -1.184 . . . . 1.0 110.14 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -119.9 16.61 12.6 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.244 -0.978 . . . . 1.0 111.371 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.81 -75.31 0.17 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -148.53 -58.06 0.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.965 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 75.54 1.18 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 13' ' ' ALA . 18.3 t -92.9 126.51 51.2 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.419 . . . . 1.0 110.723 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.18 99.06 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.941 1.76 . . . . 1.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 47' ' ' GLN . 16.4 t -109.6 156.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -123.01 151.32 41.98 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.811 -1.156 . . . . 1.0 112.021 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 32' ' ' LEU . 5.1 p -151.34 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.812 -1.181 . . . . 1.0 107.812 -175.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.496 ' H ' HG22 ' A' ' 31' ' ' VAL . 19.7 mt -100.56 160.55 14.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-N 118.755 0.707 . . . . 1.0 111.195 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 19.6 t70 -64.62 -31.08 72.14 Favored 'General case' 0 C--O 1.251 1.159 0 O-C-N 124.025 0.828 . . . . 1.0 108.857 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 8.2 t -108.61 39.52 1.98 Allowed 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.013 -1.449 . . . . 1.0 110.168 -177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.627 ' O ' HG22 ' A' ' 95' ' ' THR . 11.9 p-10 -66.89 -164.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.33 170.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 p -142.01 153.46 44.28 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 168.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -56.55 -40.68 70.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 118.122 0.419 . . . . 1.0 111.316 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -62.59 -43.02 99.85 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.62 176.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 45.7 mt-30 -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.974 0.416 . . . . 1.0 111.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.02 -38.19 90.17 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.27 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 38' ' ' SER . 28.7 tptp -55.56 -41.89 73.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.7 mt-10 -68.13 -48.52 65.18 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.259 -0.882 . . . . 1.0 110.625 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 34.9 mmtp -65.33 -42.54 92.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.128 0.788 . . . . 1.0 113.128 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 83.2 mmm -63.94 -42.84 97.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.863 0.363 . . . . 1.0 110.577 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.77 -25.63 56.63 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.0 111.682 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.2 t70 -53.02 -31.45 41.29 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.858 1.263 . . . . 1.0 112.224 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.58 ' HG3' HG22 ' A' ' 29' ' ' VAL . 13.7 mm-40 -71.32 -38.27 71.71 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.147 0.498 . . . . 1.0 111.401 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 CA--C 1.497 -1.076 0 CA-C-O 122.072 0.939 . . . . 1.0 108.912 -175.875 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.1 pp . . . . . 0 N--CA 1.427 -1.619 0 N-CA-C 109.245 -0.65 . . . . 1.0 109.245 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 1.7 m-20 -107.8 141.09 39.89 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.89 114.31 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 C-N-CA 118.352 -1.339 . . . . 1.0 108.054 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -91.0 112.67 24.66 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 107.614 -1.254 . . . . 1.0 107.614 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CZ2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -83.42 127.52 33.76 Favored 'General case' 0 N--CA 1.385 -3.683 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.723 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.59 89.01 3.03 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.456 -0.793 . . . . 1.0 109.562 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.407 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 53.0 m -97.05 -17.56 19.92 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.683 0.754 . . . . 1.0 109.335 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.95 -46.0 3.5 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.505 -1.225 . . . . 1.0 112.411 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.6 -44.93 97.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-O 120.89 0.376 . . . . 1.0 110.989 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . . . -102.46 0.59 34.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.057 0.932 . . . . 1.0 108.703 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.68 -127.75 8.09 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.282 -1.327 . . . . 1.0 113.236 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 9.3 m170 -115.73 118.46 33.11 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.382 1.073 . . . . 1.0 109.294 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.98 139.04 48.51 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.68 118.29 31.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.29 -0.564 . . . . 1.0 109.638 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -108.49 159.59 16.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.474 0.654 . . . . 1.0 111.44 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 39.2 m -165.81 162.75 18.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 12.6 p-10 -66.08 -38.76 89.08 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--N 1.305 -1.347 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 175.846 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.2 mt . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 109.099 -0.704 . . . . 1.0 109.099 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -90.71 141.14 29.1 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.974 -0.691 . . . . 1.0 109.826 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.8 p -121.97 171.49 8.9 Favored 'General case' 0 C--O 1.266 1.922 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 101' ' ' VAL . 3.2 pp -66.8 -29.94 70.01 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.96 . . . . 1.0 108.979 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.549 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -67.83 -26.09 65.88 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.533 177.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -64.13 -41.36 97.24 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' HG12 ' A' ' 101' ' ' VAL . 3.1 t80 -83.45 -18.62 38.0 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.733 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 10.6 mmmm 52.15 60.7 3.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.947 0.899 . . . . 1.0 110.788 -171.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.655 HG11 ' CZ2' ' A' ' 67' ' ' TRP . 1.6 m -74.23 149.78 87.16 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.65 -0.705 . . . . 1.0 112.575 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.3 164.03 31.59 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.142 2.561 . . . . 1.0 111.742 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.408 ' HA ' HD11 ' A' ' 9' ' ' LEU . 5.0 p-10 -65.65 129.01 38.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.366 0.603 . . . . 1.0 109.712 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.27 40.64 Favored Glycine 0 C--N 1.295 -1.727 0 C-N-CA 120.623 -0.799 . . . . 1.0 111.999 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -64.42 154.87 34.36 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 120.716 0.293 . . . . 1.0 111.018 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 98.9 m -107.45 132.52 53.11 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.988 0.423 . . . . 1.0 111.345 -176.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.5 m -113.0 142.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.33 136.57 53.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.578 0.704 . . . . 1.0 110.581 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.681 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.0 tt -102.68 124.47 48.29 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 115.191 -0.913 . . . . 1.0 109.184 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 26.3 m -129.03 144.25 51.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.01 51.54 3.69 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 122.934 2.422 . . . . 1.0 114.002 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.51 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.495 -1.161 0 C-N-CA 124.495 1.118 . . . . 1.0 111.095 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.644 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 m-85 . . . . . 0 N--CA 1.407 -2.577 0 N-CA-C 101.202 -3.629 . . . . 1.0 101.202 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 34.9 mmt180 -98.01 108.24 45.41 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 121.063 1.756 . . . . 1.0 111.22 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 15.4 Cg_exo -69.58 120.07 6.94 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.106 1.871 . . . . 1.0 108.469 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tp -117.87 158.34 25.02 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.223 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -98.34 125.56 43.51 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.54 HD11 HG13 ' A' ' 107' ' ' VAL . 18.5 tp -127.21 142.03 51.59 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.724 -1.213 . . . . 1.0 107.724 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 10.8 t30 -94.94 122.0 37.13 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.916 -0.49 . . . . 1.0 111.25 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.48 113.31 20.14 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.494 -0.776 . . . . 1.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 33.2 tp -146.61 151.71 37.73 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.912 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.678 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -120.82 140.45 51.72 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.93 42.79 2.1 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.035 0.445 . . . . 1.0 110.901 -174.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.552 HG22 ' HD3' ' A' ' 111' ' ' PRO . 82.7 t -65.2 -46.34 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-N 115.461 -0.791 . . . . 1.0 111.825 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.85 -80.35 0.15 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.239 -0.981 . . . . 1.0 112.986 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.62 -30.95 79.61 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.947 2.432 . . . . 1.0 112.829 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -126.38 41.49 1.63 Allowed Glycine 0 N--CA 1.408 -3.23 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -75.67 31.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.14 0.576 . . . . 1.0 112.195 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.549 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 168.35 -41.28 0.23 Allowed Glycine 0 C--N 1.3 -1.45 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.74 10.11 19.4 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.195 0.521 . . . . 1.0 112.093 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLY . . . -76.16 -68.54 0.57 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.472 0.653 . . . . 1.0 112.603 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HB2' HG23 ' A' ' 27' ' ' VAL . 1.1 pt20 -131.24 -69.51 0.63 Allowed 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.793 -172.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.35 64.33 4.49 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.329 -0.708 . . . . 1.0 111.329 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 25' ' ' GLN . 19.2 t -107.95 125.82 31.2 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -175.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.46 104.93 1.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.63 1.553 . . . . 1.0 110.575 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 47' ' ' GLN . 17.1 t -107.61 156.01 8.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.95 148.06 34.57 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.392 -0.923 . . . . 1.0 110.561 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' CB ' ' A' ' 40' ' ' ALA . 13.9 p -158.55 163.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.393 -0.821 . . . . 1.0 108.974 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.416 ' HB2' ' CG ' ' A' ' 35' ' ' ASP . 18.3 mt -86.05 158.2 19.89 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.739 0.78 . . . . 1.0 112.423 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 30.2 t70 -64.24 -32.03 73.46 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-N 113.904 -1.498 . . . . 1.0 109.289 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 53.0 t -95.29 6.56 48.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.548 -1.66 . . . . 1.0 111.239 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.416 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 95.2 m-20 -85.54 144.79 27.71 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 119.399 -0.92 . . . . 1.0 108.656 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 p -83.56 169.96 14.87 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.444 -0.798 . . . . 1.0 109.328 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 94' ' ' ASN . 44.2 mm -61.52 -43.44 96.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 117.752 0.251 . . . . 1.0 110.457 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -63.88 -40.76 97.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.22 0.533 . . . . 1.0 110.655 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.663 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 8.1 tt0 -75.78 -25.0 56.03 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.797 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -82.3 -37.6 25.55 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 121.701 -0.624 . . . . 1.0 111.098 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.71 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 2.5 mmmp? -57.64 -36.2 71.51 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.646 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 11.3 pt-20 -62.54 -45.8 91.31 Favored 'General case' 0 N--CA 1.414 -2.239 0 O-C-N 124.154 0.909 . . . . 1.0 110.925 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 29.2 mmmt -70.72 -38.59 73.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.4 mmt -59.58 -49.01 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.363 0.602 . . . . 1.0 109.532 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 2.4 pp -78.11 -23.9 47.69 Favored 'General case' 0 C--O 1.197 -1.709 0 CA-C-N 115.604 -0.726 . . . . 1.0 112.659 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 20.1 t70 -50.18 -34.69 23.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.11 1.364 . . . . 1.0 112.366 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.514 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.7 mm-40 -67.36 -29.96 69.64 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.744 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 C--N 1.315 -0.907 0 CA-C-O 121.717 0.77 . . . . 1.0 110.581 -177.022 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.643 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.2 pp . . . . . 0 N--CA 1.415 -2.222 0 N-CA-C 106.589 -1.634 . . . . 1.0 106.589 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.45 ' HB3' HG23 ' A' ' 76' ' ' ILE . 21.5 m-20 -102.93 154.12 19.54 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.13 112.77 41.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -91.34 122.32 33.85 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.771 0.796 . . . . 1.0 110.342 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 17.8 t90 -82.73 116.87 22.27 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.787 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 49.5 mtm105 -122.95 90.43 3.29 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 p -88.01 -20.47 25.77 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.74 -54.41 4.12 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.191 -1.368 . . . . 1.0 111.657 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.48 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 123.773 0.829 . . . . 1.0 111.498 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.94 -15.12 20.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.821 0.344 . . . . 1.0 110.673 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.67 -158.63 15.58 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 111.465 -0.654 . . . . 1.0 111.465 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.4 p80 -136.43 120.58 17.79 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.156 0.582 . . . . 1.0 110.861 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -127.39 148.78 50.27 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.421 -174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' A' ' 64' ' ' ASP . 27.9 mm -84.9 116.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 120.87 0.367 . . . . 1.0 110.194 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.448 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 11.1 mp -106.51 148.64 27.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.937 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 32.0 t -164.04 161.97 22.86 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -71.38 -30.21 65.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 177.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 N--CA 1.409 -2.504 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 178.357 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.432 -1.336 0 N-CA-C 106.448 -1.686 . . . . 1.0 106.448 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.418 ' O ' HG12 ' A' ' 37' ' ' ILE . 78.5 m-20 -84.92 141.49 30.35 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.969 -173.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.552 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -105.67 172.49 6.77 Favored 'General case' 0 N--CA 1.425 -1.69 0 C-N-CA 123.731 0.813 . . . . 1.0 108.917 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.406 HD13 HG22 ' A' ' 101' ' ' VAL . 3.2 pp -71.25 -27.31 63.37 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.503 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.552 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -65.83 -25.25 67.13 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.439 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -65.32 -35.39 80.86 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.448 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 87.4 m-85 -103.32 -11.8 17.67 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.918 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 54.0 69.3 0.73 Allowed 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.615 1.166 . . . . 1.0 112.649 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 11' ' ' LEU . 2.5 m -78.97 137.8 57.31 Favored Pre-proline 0 N--CA 1.434 -1.239 0 C-N-CA 120.041 -0.664 . . . . 1.0 109.471 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.25 160.39 49.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.315 2.01 . . . . 1.0 111.171 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.84 125.73 25.76 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.884 -0.727 . . . . 1.0 110.293 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 21.74 39.52 Favored Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.881 -1.054 . . . . 1.0 111.164 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.92 155.54 39.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.783 0.325 . . . . 1.0 110.403 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 99.0 m -107.01 125.83 51.54 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.108 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 11' ' ' LEU . 35.2 m -121.66 137.06 56.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -122.82 135.13 54.43 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.662 0.744 . . . . 1.0 112.826 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 11.0 mp -90.14 124.09 34.53 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.322 -0.853 . . . . 1.0 109.549 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 23.6 m -125.54 134.7 26.07 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.433 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HD3' HG22 ' A' ' 17' ' ' VAL . 40.2 Cg_endo -68.69 86.15 0.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.525 2.15 . . . . 1.0 111.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.643 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 23.3 p . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 125.541 1.537 . . . . 1.0 111.715 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.563 ' HB2' HD22 ' A' ' 32' ' ' LEU . 41.7 m-85 . . . . . 0 N--CA 1.404 -2.773 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 26.3 mmt180 -110.26 105.03 56.82 Favored Pre-proline 0 C--N 1.272 -2.774 0 C-N-CA 118.773 -1.171 . . . . 1.0 110.547 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.87 118.44 5.33 Favored 'Trans proline' 0 C--O 1.25 1.093 0 N-CA-C 108.504 -1.383 . . . . 1.0 108.504 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER -119.13 131.68 55.91 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 -172.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -87.12 128.74 35.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 31' ' ' VAL . 1.1 mm? -122.82 147.35 46.64 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.064 0.946 . . . . 1.0 109.996 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -89.95 110.94 21.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.49 109.45 7.98 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 123.489 0.493 . . . . 1.0 109.78 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.9 tp -138.56 160.77 38.74 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.318 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -125.73 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.21 33.92 4.99 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.921 0.391 . . . . 1.0 110.597 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.427 HG22 ' CD ' ' A' ' 111' ' ' PRO . 47.1 t -63.79 -47.66 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 115.849 -0.614 . . . . 1.0 112.392 -174.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.73 -85.14 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.63 -33.78 93.03 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 122.998 2.466 . . . . 1.0 113.072 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.05 29.63 6.99 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -76.24 75.98 3.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.397 0.617 . . . . 1.0 111.985 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 121.2 -7.91 10.55 Favored Glycine 0 CA--C 1.488 -1.629 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.391 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -128.76 28.3 5.38 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.234 0.54 . . . . 1.0 111.27 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 -88.78 0.18 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.449 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.457 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 8.9 pt20 -117.62 -58.49 2.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.243 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.457 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 65.97 71.81 0.84 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 -175.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.3 t -103.97 126.98 30.28 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.626 -0.287 . . . . 1.0 110.432 -173.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.21 106.51 2.18 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.963 1.775 . . . . 1.0 111.581 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 44' ' ' MET . 79.4 t -116.1 155.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.95 -1.13 . . . . 1.0 107.95 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -125.69 144.3 50.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 11' ' ' LEU . 16.0 m -139.72 170.31 15.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.571 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 6' ' ' TYR . 14.7 mt -84.52 159.64 20.66 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.043 0.449 . . . . 1.0 111.454 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 24.5 t70 -62.65 -30.89 71.71 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-N 115.286 -0.87 . . . . 1.0 108.834 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 10.0 t -95.27 6.11 49.92 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.048 -1.433 . . . . 1.0 112.562 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -71.24 132.51 45.06 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 174.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.478 ' CG2' HD11 ' A' ' 93' ' ' LEU . 69.8 p -79.26 167.26 21.19 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -60.11 -43.32 92.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.541 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.669 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -61.04 -47.13 87.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 123.32 0.387 . . . . 1.0 110.745 177.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 47.5 mt-30 -71.24 -40.23 71.16 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.6 -39.78 84.77 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.108 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -61.96 -34.66 76.54 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.718 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.669 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.9 mt-10 -64.46 -46.23 84.01 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 124.412 1.07 . . . . 1.0 110.073 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 39.2 mmtm -62.94 -46.61 86.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.662 0.744 . . . . 1.0 109.051 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 107' ' ' VAL . 7.2 mtp -65.3 -40.34 93.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.444 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.55 -33.18 64.58 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.514 -0.474 . . . . 1.0 111.123 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.1 -33.95 75.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.606 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 19.0 mm-40 -67.08 -30.88 71.04 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.52 -0.764 . . . . 1.0 111.584 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.41 HD22 HE22 ' A' ' 25' ' ' GLN . 0.7 OUTLIER . . . . . 0 N--CA 1.432 -1.33 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.501 -173.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.2 pp . . . . . 0 N--CA 1.44 -0.951 0 CA-C-O 120.876 0.369 . . . . 1.0 111.437 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 4.9 m-20 -107.81 150.64 26.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.53 128.89 75.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 120.108 -0.637 . . . . 1.0 109.5 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 33.7 mt-10 -90.93 112.97 25.06 Favored 'General case' 0 CA--C 1.462 -2.407 0 N-CA-C 106.119 -1.808 . . . . 1.0 106.119 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.613 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -91.34 119.16 31.13 Favored 'General case' 1 N--CA 1.37 -4.448 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -108.98 89.48 3.01 Favored 'General case' 0 N--CA 1.394 -3.225 0 N-CA-C 106.738 -1.579 . . . . 1.0 106.738 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.2 p -83.95 -12.49 55.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 113.797 -1.547 . . . . 1.0 110.906 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.4 -60.97 3.58 Favored Glycine 0 C--N 1.302 -1.325 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.695 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.279 0.631 . . . . 1.0 112.049 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.12 -6.52 31.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.58 0.705 . . . . 1.0 109.751 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.35 -153.72 26.68 Favored Glycine 0 N--CA 1.414 -2.831 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.24 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -101.01 117.0 34.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.489 0.662 . . . . 1.0 111.678 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.92 146.75 45.5 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.772 -1.103 . . . . 1.0 108.069 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 22.0 mm -89.76 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.8 159.47 15.79 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.669 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 3.3 t -167.95 165.74 13.59 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 105.789 -1.93 . . . . 1.0 105.789 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' HD22 ' A' ' 93' ' ' LEU . 11.3 p-10 -63.0 -39.54 95.06 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 . . . . . 0 N--CA 1.44 -0.956 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.253 -179.432 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.478 HD11 ' CG2' ' A' ' 36' ' ' THR . 3.3 tm? . . . . . 0 CA--C 1.56 1.331 0 N-CA-C 108.296 -1.001 . . . . 1.0 108.296 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.0 m-80 -101.97 137.9 39.64 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 119.533 -0.867 . . . . 1.0 112.03 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.415 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -126.77 175.3 8.11 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.579 -1.637 . . . . 1.0 106.579 174.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.543 HD13 HG22 ' A' ' 101' ' ' VAL . 2.3 pp -72.42 -28.02 62.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.104 -1.438 . . . . 1.0 108.334 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.549 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 4.4 pt20 -66.86 -24.31 66.12 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.513 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -57.61 -40.95 80.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.217 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -107.62 8.92 29.38 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.011 0.745 . . . . 1.0 113.011 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.549 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 31.2 mmmt 38.02 65.13 0.61 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.207 1.403 . . . . 1.0 112.745 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.613 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -67.71 149.69 98.16 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 115.058 -0.973 . . . . 1.0 112.003 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.58 155.5 40.31 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.422 2.081 . . . . 1.0 111.228 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 8.3 p-10 -66.05 127.62 32.85 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 177.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.82 20.72 27.9 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.087 -1.054 . . . . 1.0 110.934 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . . . -71.65 163.95 26.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 1.0 110.129 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.6 m -112.01 131.15 55.58 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.854 -0.529 . . . . 1.0 111.452 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.607 HG21 ' SD ' ' A' ' 44' ' ' MET . 17.3 m -117.07 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -129.0 137.83 51.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.572 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.2 pp -109.85 143.83 39.19 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.891 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 35.0 m -131.8 125.54 20.4 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.427 ' CD ' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -70.49 80.7 1.07 Allowed 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.458 2.105 . . . . 1.0 112.067 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.3 t . . . . . 0 N--CA 1.447 -0.608 0 CA-C-N 114.877 -1.056 . . . . 1.0 110.597 178.223 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.5 m-85 . . . . . 0 N--CA 1.399 -2.989 0 N-CA-C 105.427 -2.064 . . . . 1.0 105.427 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 38.0 mmt180 -109.12 111.03 60.54 Favored Pre-proline 0 C--N 1.283 -2.308 0 C-N-CA 117.625 -1.63 . . . . 1.0 113.196 -170.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 21.8 Cg_exo -63.39 112.6 1.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.16 1.907 . . . . 1.0 108.44 171.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -113.06 160.94 17.64 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.994 -172.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -98.9 125.99 44.46 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.091 -1.077 . . . . 1.0 108.091 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.592 HD12 ' SD ' ' A' ' 44' ' ' MET . 1.3 tm? -127.32 141.1 51.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.26 111.38 23.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.884 -0.51 . . . . 1.0 110.319 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.68 106.37 5.4 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 115.407 -0.815 . . . . 1.0 111.132 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.52 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.2 tp -143.24 144.44 32.15 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.563 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.02 144.29 48.61 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.851 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -114.25 34.54 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.447 0.642 . . . . 1.0 109.531 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.499 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 38.4 t -65.14 -45.44 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 C-N-CA 123.839 0.856 . . . . 1.0 112.924 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.38 -80.9 0.1 OUTLIER Glycine 0 C--N 1.313 -0.713 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.902 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -58.98 -32.46 97.56 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.957 2.438 . . . . 1.0 112.429 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.45 41.36 1.61 Allowed Glycine 0 N--CA 1.419 -2.468 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -66.07 76.53 0.09 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 98.46 3.08 57.57 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.58 24.51 5.09 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.593 -0.804 . . . . 1.0 110.143 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.07 -77.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.0 pt20 -125.89 -65.48 0.99 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.229 -0.896 . . . . 1.0 111.919 -169.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.83 64.71 3.48 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 25' ' ' GLN . 43.2 t -108.3 129.9 23.46 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 110.24 -0.282 . . . . 1.0 110.24 -174.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.49 108.25 2.18 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.126 1.884 . . . . 1.0 111.309 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 44' ' ' MET . 59.6 t -117.71 138.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -84.16 155.94 22.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.885 0.698 . . . . 1.0 112.885 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 32' ' ' LEU . 14.2 p -151.3 -178.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.415 -1.266 . . . . 1.0 108.192 -176.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 31' ' ' VAL . 12.8 tp -119.1 155.39 31.62 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 30.5 t70 -64.0 -30.6 71.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.354 0.597 . . . . 1.0 109.649 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.401 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 2.7 t -104.81 33.48 3.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.401 -1.272 . . . . 1.0 110.352 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.597 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -70.22 -163.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.636 172.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.4 p -140.51 161.91 36.59 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 103.668 -2.716 . . . . 1.0 103.668 167.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.659 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 43.8 mm -57.78 -47.74 85.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.371 -0.531 . . . . 1.0 111.741 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.6 t -65.81 -43.87 87.35 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 123.677 0.611 . . . . 1.0 109.902 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.17 -40.44 97.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.28 0.562 . . . . 1.0 111.356 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -63.92 -40.76 97.22 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.524 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -62.08 -33.17 73.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 123.674 0.609 . . . . 1.0 110.633 -178.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.36 -46.21 84.41 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 123.589 0.556 . . . . 1.0 110.526 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -66.39 -37.68 85.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.193 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.746 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.8 mtp -62.61 -43.96 97.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.307 0.575 . . . . 1.0 110.633 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -75.9 -25.66 56.26 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.126 -0.488 . . . . 1.0 112.25 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.47 -29.02 68.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.493 0.663 . . . . 1.0 110.991 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG3' HG13 ' A' ' 29' ' ' VAL . 11.0 mm-40 -83.87 -32.68 25.08 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.973 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.0 mt . . . . . 0 CA--C 1.497 -1.084 0 CA-C-O 121.607 0.718 . . . . 1.0 112.572 -167.538 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.705 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.6 pp . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 113.57 0.952 . . . . 1.0 113.57 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -114.71 153.2 30.7 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.468 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 p -120.73 126.94 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.186 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.75 112.55 24.52 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.548 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -91.51 122.65 34.28 Favored 'General case' 0 N--CA 1.383 -3.801 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.951 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.516 HH22 HD23 ' A' ' 14' ' ' LEU . 67.5 mtm180 -110.3 90.13 3.23 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-O 123.025 1.393 . . . . 1.0 107.314 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.6 p -79.72 -17.68 53.0 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.061 -1.881 . . . . 1.0 110.553 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.7 -56.95 4.52 Favored Glycine 0 C--N 1.298 -1.565 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.676 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.83 -43.01 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.505 0.557 . . . . 1.0 112.505 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.54 -10.33 21.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.332 0.587 . . . . 1.0 109.541 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.11 -149.96 19.48 Favored Glycine 0 N--CA 1.418 -2.565 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.656 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 7.2 p80 -105.56 114.0 27.91 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.314 0.578 . . . . 1.0 110.853 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.95 146.74 49.22 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.324 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.5 mm -85.97 115.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 176.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.532 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -105.87 143.26 34.25 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.903 0.859 . . . . 1.0 111.768 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.425 ' HA ' HG21 ' A' ' 37' ' ' ILE . 9.6 m -158.3 146.03 18.26 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 104.238 -2.505 . . . . 1.0 104.238 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 5.2 p-10 -72.82 -36.2 67.47 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.043 -1.063 . . . . 1.0 111.004 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 N--CA 1.432 -1.339 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.228 176.706 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 C--O 1.24 0.597 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.423 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 55.7 m-80 -94.24 135.96 35.05 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 119.228 -0.989 . . . . 1.0 110.723 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.4 p -109.46 172.75 6.67 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 125.115 1.366 . . . . 1.0 108.237 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 101' ' ' VAL . 3.0 pp -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.839 -1.145 . . . . 1.0 108.015 171.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.571 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.62 -25.05 67.79 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.327 -0.851 . . . . 1.0 112.029 177.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -59.55 -41.61 90.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -102.08 -3.44 27.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.578 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 68.1 mmtt 46.26 68.52 0.59 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.223 1.009 . . . . 1.0 112.827 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.548 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -78.3 148.9 75.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.462 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.66 160.58 34.57 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.071 2.514 . . . . 1.0 111.898 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.19 117.93 9.19 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.01 22.17 9.01 Favored Glycine 0 C--N 1.288 -2.135 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.437 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.09 156.8 38.06 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.0 m -120.52 130.35 54.21 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.182 0.515 . . . . 1.0 110.687 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.503 ' CG1' HD11 ' A' ' 11' ' ' LEU . 33.8 m -113.74 165.83 8.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.692 -0.803 . . . . 1.0 111.077 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -148.3 120.81 8.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.311 -0.859 . . . . 1.0 108.961 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.594 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -106.17 137.7 43.64 Favored 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.072 -176.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.705 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 29.3 m -126.91 149.77 69.9 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.43 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 73.5 Cg_endo -77.19 63.66 7.76 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 122.858 2.372 . . . . 1.0 113.32 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.1 t . . . . . 0 C--O 1.243 0.759 0 CA-C-O 122.075 0.941 . . . . 1.0 108.928 -179.166 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.559 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 m-85 . . . . . 0 N--CA 1.405 -2.715 0 N-CA-C 104.544 -2.391 . . . . 1.0 104.544 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -99.78 108.77 53.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 C-N-CA 119.746 -0.782 . . . . 1.0 111.93 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 31.6 Cg_exo -60.66 133.5 48.76 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.691 2.261 . . . . 1.0 110.893 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 96' ' ' LEU . 4.9 tp -126.95 156.27 41.79 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.604 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.1 m -99.91 127.28 46.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 HG22 ' A' ' 31' ' ' VAL . 2.3 mm? -126.56 146.88 49.97 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.061 0.545 . . . . 1.0 110.697 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.44 HD22 HG23 ' A' ' 106' ' ' THR . 11.8 t30 -96.2 117.1 30.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.927 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.67 113.19 18.69 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 27.2 tp -142.67 155.39 44.91 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 -177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.632 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -123.59 140.95 52.48 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.424 -0.511 . . . . 1.0 110.078 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -119.29 36.19 4.56 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.239 0.542 . . . . 1.0 110.444 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 111' ' ' PRO . 76.4 t -66.08 -46.44 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.028 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.87 -80.56 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 118.761 -1.685 . . . . 1.0 114.553 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.42 -31.29 94.56 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.097 2.531 . . . . 1.0 112.781 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.89 38.37 2.19 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.149 -1.18 . . . . 1.0 110.149 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -65.23 80.3 0.05 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.682 0.753 . . . . 1.0 112.808 -176.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.57 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 95.14 -1.74 65.18 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -113.93 20.6 15.62 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.472 -1.364 . . . . 1.0 110.177 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.24 -82.14 0.18 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.368 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.79 -56.13 0.26 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.65 91.81 1.11 Allowed Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.49 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.29 126.1 30.41 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -74.8 104.53 1.91 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.719 1.613 . . . . 1.0 111.057 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.491 HG13 HE21 ' A' ' 47' ' ' GLN . 22.0 t -110.71 155.78 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -121.64 148.52 44.45 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.436 -0.906 . . . . 1.0 112.76 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 11' ' ' LEU . 7.6 m -147.91 -174.29 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 125.071 1.349 . . . . 1.0 108.312 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.2 mt -107.2 158.63 16.95 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-O 120.544 0.211 . . . . 1.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -32.07 73.14 Favored 'General case' 0 C--O 1.26 1.629 0 O-C-N 124.224 0.953 . . . . 1.0 109.344 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 t -108.97 37.39 2.57 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.856 -1.52 . . . . 1.0 109.791 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 95' ' ' THR . 11.1 p-10 -68.53 -166.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.267 173.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 p -139.95 146.18 38.85 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.591 HG21 ' HA ' ' A' ' 78' ' ' SER . 26.5 mm -57.17 -29.37 31.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 118.482 0.583 . . . . 1.0 110.863 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -60.99 -50.18 74.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -73.41 -40.36 64.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.34 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.95 -39.28 90.3 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.469 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.1 ttmp? -57.48 -41.85 81.48 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -67.28 -51.84 47.97 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.267 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HD3' HG12 ' A' ' 31' ' ' VAL . 53.3 mtpt -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 87.4 mmm -62.6 -45.96 90.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.337 0.398 . . . . 1.0 110.998 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.9 pp -77.23 -28.5 53.72 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.51 -29.08 64.02 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.459 1.104 . . . . 1.0 112.775 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.491 HE21 HG13 ' A' ' 29' ' ' VAL . 15.1 mm-40 -64.88 -37.27 87.06 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.581 0.705 . . . . 1.0 110.207 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? . . . . . 0 C--N 1.317 -0.842 0 CA-C-O 121.98 0.895 . . . . 1.0 109.828 -177.627 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.621 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.43 -1.472 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 112' ' ' CYS . 9.5 m-20 -129.15 165.22 21.72 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.309 -1.367 . . . . 1.0 107.309 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.1 128.92 73.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.616 -0.833 . . . . 1.0 109.859 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -90.23 112.66 24.27 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 106.206 -1.776 . . . . 1.0 106.206 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.602 ' HZ2' HG11 ' A' ' 101' ' ' VAL . 3.4 t-105 -95.08 122.1 37.4 Favored 'General case' 1 N--CA 1.372 -4.325 0 C-N-CA 119.395 -0.922 . . . . 1.0 109.01 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -108.16 89.28 2.95 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.7 t -83.24 -17.7 41.75 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.511 -1.677 . . . . 1.0 109.261 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.13 -58.56 3.17 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 112.728 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.65 -37.16 79.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 122.737 0.415 . . . . 1.0 111.328 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.01 -5.23 30.8 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.777 0.798 . . . . 1.0 109.351 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.12 -140.31 15.01 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.832 -1.077 . . . . 1.0 110.642 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -117.57 120.55 38.4 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.034 0.445 . . . . 1.0 109.915 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.56 146.48 49.66 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -85.01 116.43 28.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.432 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.6 mp -108.48 155.86 20.13 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.421 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 37' ' ' ILE . 7.5 t -171.58 172.5 5.0 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 115.004 -0.998 . . . . 1.0 108.485 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -81.5 -2.48 49.92 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.859 -1.064 . . . . 1.0 109.438 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.432 -1.352 0 N-CA-C 105.937 -1.875 . . . . 1.0 105.937 168.05 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.42 -1.959 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -74.56 142.39 44.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 -173.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.5 p -105.06 169.41 8.45 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 124.913 1.285 . . . . 1.0 108.709 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 9' ' ' LEU . 4.1 pp -70.32 -32.73 70.6 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 172.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -62.13 -29.79 70.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.429 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -65.23 -35.21 80.34 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -98.06 8.66 44.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.89 -0.595 . . . . 1.0 112.189 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 52.99 54.63 10.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.045 . . . . 1.0 111.334 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.602 HG11 ' HZ2' ' A' ' 67' ' ' TRP . 40.8 t -74.86 124.37 89.53 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.779 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.0 159.1 27.23 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.525 2.816 . . . . 1.0 112.191 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.39 117.99 10.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.071 -0.513 . . . . 1.0 109.87 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.88 18.3 14.3 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.291 -0.957 . . . . 1.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.01 27.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.027 0.441 . . . . 1.0 110.554 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.44 HG23 HD22 ' A' ' 12' ' ' ASN . 30.9 m -115.8 132.06 56.75 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 122.066 -0.397 . . . . 1.0 111.076 -173.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 m -114.03 138.68 43.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.98 135.26 49.68 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.42 0.628 . . . . 1.0 110.773 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.632 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 94.6 mt -95.43 129.26 42.65 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 19.0 m -132.84 142.38 44.52 Favored Pre-proline 0 C--N 1.31 -1.15 0 O-C-N 123.172 0.295 . . . . 1.0 110.284 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -72.37 79.6 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.14 1.893 . . . . 1.0 110.664 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.621 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 3.1 t . . . . . 0 C--N 1.323 -0.547 0 C-N-CA 125.931 1.692 . . . . 1.0 111.411 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.483 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 26.8 m-85 . . . . . 0 N--CA 1.406 -2.657 0 N-CA-C 105.025 -2.213 . . . . 1.0 105.025 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.519 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 20.1 mmt180 -104.01 108.17 59.17 Favored Pre-proline 0 C--N 1.277 -2.572 0 C-N-CA 119.384 -0.926 . . . . 1.0 111.841 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -59.43 131.45 40.73 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.255 1.97 . . . . 1.0 110.763 175.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -136.41 159.93 40.27 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.085 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.1 m -95.22 131.26 41.46 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.41 HD23 ' SD ' ' A' ' 44' ' ' MET . 27.1 tp -127.66 142.09 51.43 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -99.88 113.35 25.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.784 -0.572 . . . . 1.0 110.604 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -77.51 112.69 14.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.626 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.517 HD21 ' HA2' ' A' ' 22' ' ' GLY . 31.3 tp -142.01 152.67 43.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.684 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.02 140.2 53.21 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.881 -0.512 . . . . 1.0 110.897 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.42 41.74 3.03 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.622 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.88 -45.2 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 CA-C-N 116.546 -0.297 . . . . 1.0 110.546 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.32 -75.29 0.18 Allowed Glycine 0 C--O 1.22 -0.729 0 C-N-CA 119.777 -1.202 . . . . 1.0 113.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.51 -27.38 76.76 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.53 2.82 . . . . 1.0 113.307 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.69 34.41 2.88 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.68 76.3 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.517 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 114.19 -10.81 22.35 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 173.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -109.88 8.66 24.46 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.948 -0.626 . . . . 1.0 111.613 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.87 -86.54 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.321 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -132.38 -61.69 0.86 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.23 71.31 1.08 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.854 -1.165 . . . . 1.0 110.535 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.34 125.33 38.11 Favored Pre-proline 0 C--N 1.306 -1.323 0 O-C-N 122.898 -0.177 . . . . 1.0 110.818 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.46 101.79 1.54 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.021 1.814 . . . . 1.0 111.757 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 45.7 t -104.99 155.42 6.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.465 -1.309 . . . . 1.0 107.465 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -102.31 150.04 23.73 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.813 -1.155 . . . . 1.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 32' ' ' LEU . 4.4 p -148.26 -178.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.05 -0.977 . . . . 1.0 108.709 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 31' ' ' VAL . 14.4 mt -110.92 162.29 14.98 Favored 'General case' 0 C--O 1.179 -2.617 0 CA-C-N 118.39 0.541 . . . . 1.0 110.852 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.519 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 18.0 t70 -65.11 -31.3 72.44 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-O 121.407 0.623 . . . . 1.0 110.88 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -102.85 28.6 6.03 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.334 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.66 ' O ' ' HA ' ' A' ' 95' ' ' THR . 17.1 p-10 -67.75 135.54 52.85 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -91.08 157.05 17.46 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 45.0 mm -55.86 -40.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.889 0.376 . . . . 1.0 110.446 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 p -62.8 -43.96 97.43 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.294 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -73.15 -37.69 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 1.0 111.677 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.68 -38.39 89.13 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.37 -41.49 72.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -68.32 -47.75 66.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.261 -0.882 . . . . 1.0 110.846 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.83 -44.6 92.73 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.994 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.0 mmm -64.99 -42.76 94.23 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.567 0.542 . . . . 1.0 110.621 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -74.24 -29.33 61.64 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.818 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.08 -30.89 62.66 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.228 1.011 . . . . 1.0 112.539 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.47 HE21 HG13 ' A' ' 29' ' ' VAL . 14.3 mm-40 -70.38 -37.13 74.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.162 0.506 . . . . 1.0 111.283 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 CA--C 1.504 -0.822 0 CA-C-O 122.124 0.964 . . . . 1.0 109.654 -176.384 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.3 pp . . . . . 0 N--CA 1.439 -0.979 0 N-CA-C 109.908 -0.404 . . . . 1.0 109.908 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.488 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 0.1 OUTLIER -115.02 157.7 23.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 -177.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.09 121.87 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -91.55 112.72 24.75 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 105.792 -1.929 . . . . 1.0 105.792 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.606 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -86.49 128.72 34.99 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.906 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.98 89.84 3.18 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.4 m -90.1 -17.07 28.36 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.428 -0.909 . . . . 1.0 109.409 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.25 -46.88 3.48 Favored Glycine 0 C--N 1.309 -0.969 0 CA-C-N 114.998 -1.001 . . . . 1.0 112.306 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.35 -27.06 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.146 0.578 . . . . 1.0 111.439 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.496 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . . . -124.08 4.37 8.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.584 0.707 . . . . 1.0 109.775 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.13 -130.43 10.23 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.882 -1.054 . . . . 1.0 113.55 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.34 123.97 46.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 125.144 1.377 . . . . 1.0 108.665 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -132.05 148.43 52.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 mm -94.55 116.11 35.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.282 -0.567 . . . . 1.0 109.616 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.488 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.1 mp -111.03 158.02 19.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.061 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -158.0 159.7 36.69 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.851 -1.907 . . . . 1.0 105.851 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 17.7 p-10 -66.71 -53.74 30.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.237 -0.585 . . . . 1.0 110.384 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 . . . . . 0 C--N 1.294 -1.807 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.141 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 89.0 mt . . . . . 0 N--CA 1.432 -1.327 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -73.6 143.21 46.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.646 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -120.58 165.96 14.3 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 124.641 1.176 . . . . 1.0 108.799 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.457 HD13 HG22 ' A' ' 101' ' ' VAL . 2.6 pp -65.39 -28.53 69.33 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.476 173.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.507 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.41 -25.93 68.23 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.483 177.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -64.72 -39.4 93.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -88.5 -19.22 26.72 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 115.506 -0.77 . . . . 1.0 109.79 176.273 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 9.3 mmmm 53.03 60.83 3.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.77 0.828 . . . . 1.0 110.957 -171.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.3 m -76.62 150.46 82.0 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 113.185 0.809 . . . . 1.0 113.185 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 162.12 28.41 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 123.501 2.801 . . . . 1.0 111.307 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.19 130.97 45.06 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.611 0.719 . . . . 1.0 109.748 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.42 17.74 44.75 Favored Glycine 0 C--N 1.284 -2.313 0 CA-C-N 114.979 -1.01 . . . . 1.0 111.58 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.64 151.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 43.7 m -108.0 127.65 53.96 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.213 0.53 . . . . 1.0 110.995 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.402 HG13 HD11 ' A' ' 11' ' ' LEU . 31.5 m -109.74 141.36 25.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.79 52.66 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.703 0.763 . . . . 1.0 110.596 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.684 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.3 tt -95.18 122.91 38.35 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.319 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 13.7 m -128.05 145.39 55.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.15 55.95 5.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.875 2.384 . . . . 1.0 113.511 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.488 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.51 -0.585 0 C-N-CA 124.586 1.154 . . . . 1.0 111.233 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.1 mtpp . . . . . 0 C--O 1.236 0.387 0 CA-C-O 121.093 0.473 . . . . 1.0 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -100.7 100.19 10.84 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.43 -0.952 . . . . 1.0 108.43 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -127.09 88.56 2.83 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.809 -1.182 . . . . 1.0 107.809 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.7 p -122.26 7.65 5.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-O 122.001 0.905 . . . . 1.0 110.118 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -89.82 61.53 5.4 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 122.48 1.133 . . . . 1.0 110.446 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.86 161.59 39.64 Favored 'General case' 0 N--CA 1.394 -3.232 0 N-CA-C 105.965 -1.865 . . . . 1.0 105.965 176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.545 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 17.8 mmt180 -124.11 115.9 27.41 Favored Pre-proline 0 C--N 1.263 -3.158 0 C-N-CA 119.893 -0.723 . . . . 1.0 111.632 -173.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.38 109.18 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.785 1.657 . . . . 1.0 108.334 168.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 tp -113.04 158.49 20.25 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.212 -0.903 . . . . 1.0 111.001 -171.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.6 m -103.56 127.61 50.94 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.521 -1.289 . . . . 1.0 107.521 177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.515 HD23 ' SD ' ' A' ' 44' ' ' MET . 14.8 tp -126.94 139.83 52.77 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 108.97 -0.752 . . . . 1.0 108.97 -177.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.49 HD22 HG23 ' A' ' 106' ' ' THR . 6.4 t30 -96.72 114.0 25.6 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 -177.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.39 114.73 13.1 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.8 -0.636 . . . . 1.0 110.799 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.549 HD21 ' HA2' ' A' ' 22' ' ' GLY . 12.8 tp -142.14 167.34 22.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 108.864 -0.791 . . . . 1.0 108.864 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.645 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.7 pt? -135.94 144.96 45.73 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.792 -0.447 . . . . 1.0 109.792 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -110.94 30.76 6.57 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.909 0.385 . . . . 1.0 111.034 -176.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.538 HG22 ' HD3' ' A' ' 111' ' ' PRO . 71.5 t -65.94 -47.79 84.11 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.816 0 CA-C-N 115.897 -0.592 . . . . 1.0 112.383 -175.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.4 -81.97 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.2 -1.476 . . . . 1.0 113.819 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -58.63 -27.67 83.64 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 C-N-CA 123.599 2.866 . . . . 1.0 112.821 -174.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -131.91 37.63 2.02 Favored Glycine 0 N--CA 1.408 -3.173 0 N-CA-C 110.645 -0.982 . . . . 1.0 110.645 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.68 48.97 0.09 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 113.465 0.913 . . . . 1.0 113.465 -176.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.549 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 136.42 -3.78 3.65 Favored Glycine 0 N--CA 1.43 -1.74 0 N-CA-C 110.795 -0.922 . . . . 1.0 110.795 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -138.02 29.75 2.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.06 0.457 . . . . 1.0 111.597 -177.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.96 -76.03 0.27 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.248 0.462 . . . . 1.0 112.248 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -140.76 -63.83 0.47 Allowed 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.585 -177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.19 88.84 0.59 Allowed Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.273 -0.965 . . . . 1.0 111.089 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 17.1 t -109.6 126.54 28.93 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 -177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -75.86 105.72 2.13 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.937 1.758 . . . . 1.0 111.86 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.569 HG22 ' HG3' ' A' ' 47' ' ' GLN . 13.9 t -112.34 155.35 13.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.335 -0.987 . . . . 1.0 108.335 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -107.67 144.28 34.97 Favored 'General case' 0 CA--C 1.493 -1.229 0 N-CA-C 114.111 1.152 . . . . 1.0 114.111 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 m -142.21 -175.22 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 113.598 -1.637 . . . . 1.0 109.504 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.2 mt -119.3 158.88 25.19 Favored 'General case' 0 C--O 1.189 -2.104 0 N-CA-C 110.27 -0.27 . . . . 1.0 110.27 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.545 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.1 t70 -66.43 -31.33 72.02 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 108.921 -0.77 . . . . 1.0 108.921 177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 53.6 t -103.27 33.36 3.34 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.872 -1.513 . . . . 1.0 109.491 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.564 ' O ' HG22 ' A' ' 95' ' ' THR . 12.8 p-10 -71.58 -165.76 0.17 Allowed 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.216 -0.902 . . . . 1.0 109.013 174.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 50.1 p -139.07 157.92 45.11 Favored 'General case' 0 C--N 1.271 -2.808 0 N-CA-C 104.253 -2.499 . . . . 1.0 104.253 169.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 78' ' ' SER . 39.5 mm -59.22 -41.41 83.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 120.433 -0.507 . . . . 1.0 109.91 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 13.5 m -61.8 -43.47 98.79 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.861 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -69.87 -41.21 75.11 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.207 0.527 . . . . 1.0 111.196 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.701 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.88 -39.16 93.11 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.489 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -56.51 -40.53 75.16 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.546 -0.752 . . . . 1.0 109.429 176.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.573 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mt-10 -68.59 -47.9 65.57 Favored 'General case' 0 C--O 1.206 -1.193 0 O-C-N 123.754 0.659 . . . . 1.0 110.778 -177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -63.58 -44.03 95.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.232 0.333 . . . . 1.0 111.621 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.701 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.2 mmm -65.03 -40.85 95.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.47 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.533 ' HB2' ' CD1' ' A' ' 49' ' ' TYR . 4.0 pp -74.45 -33.18 62.85 Favored 'General case' 0 C--O 1.188 -2.147 0 C-N-CA 120.225 -0.59 . . . . 1.0 112.098 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -51.6 -31.15 23.82 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 124.951 1.301 . . . . 1.0 112.932 -173.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.569 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.5 mm-40 -69.48 -36.61 76.71 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.722 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -97.32 -39.33 9.28 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 122.044 0.926 . . . . 1.0 110.058 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.533 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 25.3 m-85 -96.48 32.51 2.0 Allowed 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 125.469 1.508 . . . . 1.0 109.676 -177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -53.55 119.43 4.87 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.63 175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.4 -6.06 49.37 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.092 -0.575 . . . . 1.0 112.527 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 52.9 t -77.89 122.9 86.22 Favored Pre-proline 0 C--N 1.317 -0.834 0 CA-C-O 120.718 0.294 . . . . 1.0 111.365 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -66.84 165.43 25.92 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.707 2.938 . . . . 1.0 112.285 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.13 -42.8 99.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.535 0.569 . . . . 1.0 112.535 -173.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.4 t -66.26 -23.09 66.34 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.939 0.4 . . . . 1.0 111.803 -176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -89.02 -25.27 22.08 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 111.779 0.289 . . . . 1.0 111.779 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 77.4 mtt180 -66.21 116.71 36.07 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 21.7 Cg_exo -66.31 140.33 58.04 Favored 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.621 2.214 . . . . 1.0 113.094 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -79.47 142.25 57.81 Favored Pre-proline 0 C--N 1.313 -0.991 0 N-CA-C 108.108 -1.071 . . . . 1.0 108.108 176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HA ' HD13 ' A' ' 63' ' ' LEU . 60.8 Cg_endo -70.11 9.29 0.67 Allowed 'Trans proline' 0 N--CA 1.483 0.867 0 C-N-CA 123.174 2.583 . . . . 1.0 113.699 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -94.56 -31.29 13.96 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.412 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.609 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 12.8 t -90.96 -23.2 20.51 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 121.33 0.586 . . . . 1.0 110.606 -178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.462 HD13 ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -126.14 147.93 49.51 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.277 -1.749 . . . . 1.0 106.277 172.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.17 138.17 39.47 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 7.4 p -108.53 117.14 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.066 0 C-N-CA 118.978 -1.089 . . . . 1.0 109.446 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -91.34 111.82 23.47 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 105.836 -1.913 . . . . 1.0 105.836 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.631 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.9 t-105 -88.72 126.04 35.14 Favored 'General case' 0 N--CA 1.39 -3.446 0 CA-C-N 115.197 -0.911 . . . . 1.0 108.927 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -110.86 88.98 2.91 Favored 'General case' 0 N--CA 1.394 -3.265 0 N-CA-C 107.057 -1.46 . . . . 1.0 107.057 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 62.7 p -71.33 -27.24 63.24 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.483 -1.235 . . . . 1.0 110.082 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.89 -57.31 4.84 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.484 -1.235 . . . . 1.0 110.7 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.9 m -64.29 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-O 120.924 0.393 . . . . 1.0 111.895 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.48 -1.4 30.68 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.557 0.694 . . . . 1.0 110.354 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.71 -119.7 6.31 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 110.62 -0.992 . . . . 1.0 110.62 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.573 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 27.8 p-80 -140.42 138.26 34.61 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 120.604 0.24 . . . . 1.0 110.742 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 25.0 tp -134.73 144.48 47.76 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.818 -0.808 . . . . 1.0 108.818 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 115' ' ' LYS . 28.5 mm -81.62 118.98 30.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.854 -1.165 . . . . 1.0 107.854 174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.472 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.2 mp -107.71 157.6 17.97 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 121.4 0.619 . . . . 1.0 110.356 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' HG13 ' A' ' 37' ' ' ILE . 13.3 m -157.32 160.32 38.4 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.451 -1.685 . . . . 1.0 106.451 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -56.17 -48.06 77.06 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 108.373 -0.973 . . . . 1.0 108.373 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -126.59 111.02 13.85 Favored 'General case' 0 N--CA 1.422 -1.874 0 CA-C-O 121.676 0.75 . . . . 1.0 109.14 170.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -116.3 -82.92 0.63 Allowed 'General case' 0 CA--C 1.479 -1.774 0 CA-C-O 122.66 1.219 . . . . 1.0 108.105 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.6 p -76.4 -19.73 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.558 0 CA-C-N 112.962 -1.926 . . . . 1.0 108.655 177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.9 p -98.25 6.93 46.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.12 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.4 t -76.02 -4.6 42.14 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.371 -0.832 . . . . 1.0 110.522 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -76.1 118.33 18.74 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 121.49 0.662 . . . . 1.0 110.392 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.5 t -109.39 91.69 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 N-CA-C 108.595 -0.891 . . . . 1.0 108.595 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -143.03 -19.59 0.65 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.426 -1.261 . . . . 1.0 110.602 178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -166.98 -112.67 0.26 Allowed Glycine 0 N--CA 1.415 -2.758 0 N-CA-C 110.273 -1.131 . . . . 1.0 110.273 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 pp -87.97 -3.88 58.87 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -63.25 -30.69 71.78 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 53.3 ttp180 -64.79 105.83 1.08 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 109.472 -0.566 . . . . 1.0 109.472 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -156.99 143.61 18.33 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.615 -176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 95.9 mt -77.59 138.81 39.36 Favored 'General case' 0 C--O 1.245 0.861 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -85.06 142.24 29.69 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.942 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.1 p -107.32 168.39 9.26 Favored 'General case' 0 N--CA 1.423 -1.804 0 C-N-CA 124.604 1.162 . . . . 1.0 108.53 176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.632 HD13 HG22 ' A' ' 101' ' ' VAL . 4.0 pp -72.97 -24.33 60.77 Favored 'General case' 0 C--N 1.312 -1.057 0 C-N-CA 119.42 -0.912 . . . . 1.0 109.064 173.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.36 -26.54 68.51 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.813 -0.631 . . . . 1.0 111.335 176.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.5 t-160 -66.05 -41.7 90.48 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 1.6 t80 -80.05 -16.26 55.45 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.605 -0.725 . . . . 1.0 110.653 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm 58.78 52.12 6.94 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.778 0.831 . . . . 1.0 110.983 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.632 HG22 HD13 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -78.36 146.83 71.14 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 113.346 0.869 . . . . 1.0 113.346 -178.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.16 158.41 26.63 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 123.481 2.788 . . . . 1.0 112.155 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.55 122.65 18.05 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.437 0.637 . . . . 1.0 109.542 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.68 21.85 10.88 Favored Glycine 0 C--N 1.288 -2.131 0 C-N-CA 120.309 -0.948 . . . . 1.0 110.852 -176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.62 162.52 28.68 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.982 -0.377 . . . . 1.0 109.982 177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.49 HG23 HD22 ' A' ' 12' ' ' ASN . 87.4 m -114.52 133.52 55.72 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 120.783 0.325 . . . . 1.0 110.389 -175.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.461 HG11 HD21 ' A' ' 11' ' ' LEU . 29.5 m -115.74 136.27 53.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 176.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.19 144.55 51.01 Favored 'General case' 0 C--N 1.28 -2.436 0 N-CA-C 108.722 -0.844 . . . . 1.0 108.722 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.645 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.13 147.72 46.49 Favored 'General case' 0 C--N 1.277 -2.558 0 C-N-CA 120.19 -0.604 . . . . 1.0 111.825 -179.401 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.419 HG13 ' HB3' ' A' ' 16' ' ' ALA . 27.4 m -132.24 136.17 27.65 Favored Pre-proline 0 C--N 1.298 -1.655 0 CA-C-N 115.052 -0.977 . . . . 1.0 109.242 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.538 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.5 Cg_endo -73.5 82.42 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 122.258 1.972 . . . . 1.0 111.97 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 62' ' ' THR . 4.3 p 45.68 66.95 0.81 Allowed 'General case' 0 CA--C 1.498 -1.026 0 C-N-CA 125.148 1.379 . . . . 1.0 111.477 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 113' ' ' LEU . 1.1 tm? -113.71 -50.77 2.82 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 114.676 -1.147 . . . . 1.0 110.839 -173.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.0 t -144.89 71.79 1.31 Allowed 'General case' 0 N--CA 1.412 -2.332 0 CA-C-O 122.014 0.911 . . . . 1.0 113.264 -171.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HA ' HG21 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -78.97 65.87 4.27 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 119.218 -0.993 . . . . 1.0 109.699 172.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -80.02 102.75 9.46 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.21 -1.033 . . . . 1.0 108.21 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.04 -170.74 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 CA-C-N 114.573 -1.194 . . . . 1.0 108.918 -173.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.3 pp -59.73 137.11 58.14 Favored 'General case' 0 C--O 1.245 0.832 0 CA-C-O 121.519 0.676 . . . . 1.0 110.001 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -118.8 161.99 19.22 Favored 'General case' 0 C--N 1.287 -2.109 0 CA-C-N 115.487 -0.779 . . . . 1.0 109.885 -174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.96 114.24 21.1 Favored 'General case' 0 N--CA 1.415 -2.183 0 CA-C-O 122.156 0.979 . . . . 1.0 109.961 176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -163.14 127.26 2.92 Favored 'General case' 0 C--N 1.276 -2.589 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 -176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 . . . . . 0 N--CA 1.422 -1.843 0 C-N-CA 120.196 -0.602 . . . . 1.0 109.873 177.783 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 120.769 0.319 . . . . 1.0 110.613 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -123.35 76.0 1.36 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.073 -1.084 . . . . 1.0 108.073 174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -85.35 81.87 8.58 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.635 -1.166 . . . . 1.0 109.748 -175.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.2 p -138.73 80.4 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 CA-C-O 122.234 1.016 . . . . 1.0 111.36 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.06 74.11 1.28 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 122.813 1.292 . . . . 1.0 109.618 173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -145.23 165.04 29.52 Favored 'General case' 0 N--CA 1.398 -3.058 0 CA-C-N 114.317 -1.31 . . . . 1.0 108.842 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.503 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 23.0 mmt180 -119.3 116.4 33.76 Favored Pre-proline 0 C--N 1.268 -2.961 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.208 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -58.32 104.82 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 N-CA-C 107.35 -1.827 . . . . 1.0 107.35 167.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 tp -110.82 159.72 17.4 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.648 -0.705 . . . . 1.0 111.036 -171.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.3 m -108.51 125.95 52.37 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 107.551 -1.277 . . . . 1.0 107.551 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.524 HD21 HG11 ' A' ' 107' ' ' VAL . 20.0 tp -127.45 141.89 51.55 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 -175.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.419 HD22 HG23 ' A' ' 106' ' ' THR . 6.1 t30 -96.45 114.73 26.43 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 122.405 -0.184 . . . . 1.0 110.857 -178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.14 119.96 20.0 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.171 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.67 HD21 ' HA2' ' A' ' 22' ' ' GLY . 13.4 tp -148.46 163.27 37.67 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.227 -1.027 . . . . 1.0 108.227 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.58 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -129.58 144.12 51.13 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 122.017 -0.427 . . . . 1.0 110.079 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -112.85 37.17 3.19 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-O 120.913 0.387 . . . . 1.0 111.023 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 43.8 t -67.85 -44.31 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.314 0 CA-C-N 116.306 -0.406 . . . . 1.0 111.813 -176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.07 -88.64 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.4 -1.381 . . . . 1.0 113.888 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.31 -37.82 88.57 Favored 'Trans proline' 0 N--CA 1.481 0.738 0 C-N-CA 122.906 2.404 . . . . 1.0 113.139 -175.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -113.48 33.74 5.38 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 111.131 -0.788 . . . . 1.0 111.131 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -70.58 48.51 0.11 Allowed 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.468 0.914 . . . . 1.0 113.468 -176.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.67 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 146.85 -12.38 1.47 Allowed Glycine 0 C--N 1.299 -1.49 0 C-N-CA 120.68 -0.771 . . . . 1.0 112.402 -178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -127.88 25.47 5.95 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.089 0.471 . . . . 1.0 111.432 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.8 -77.38 0.19 Allowed 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 113.484 0.92 . . . . 1.0 113.484 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -129.56 -58.77 1.1 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.196 -0.456 . . . . 1.0 111.467 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.84 75.61 0.61 Allowed Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.342 -0.933 . . . . 1.0 111.591 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -101.35 125.18 38.59 Favored Pre-proline 0 C--N 1.308 -1.211 0 N-CA-C 110.277 -0.268 . . . . 1.0 110.277 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.43 102.07 1.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 121.859 1.706 . . . . 1.0 111.045 176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 47' ' ' GLN . 15.0 t -111.02 155.06 12.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.094 -1.076 . . . . 1.0 108.094 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -109.52 143.71 38.79 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 113.746 1.017 . . . . 1.0 113.746 -178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.6 -175.19 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 113.74 -1.573 . . . . 1.0 109.165 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.45 157.61 27.9 Favored 'General case' 0 C--O 1.191 -1.988 0 N-CA-C 110.112 -0.329 . . . . 1.0 110.112 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.503 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 31.7 t70 -66.06 -31.54 72.47 Favored 'General case' 0 C--N 1.31 -1.151 0 O-C-N 123.87 0.731 . . . . 1.0 109.124 177.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 33.2 t -104.99 37.2 2.22 Favored 'General case' 0 C--O 1.246 0.904 0 CA-C-N 114.034 -1.439 . . . . 1.0 109.552 -177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' O ' HG22 ' A' ' 95' ' ' THR . 14.2 p-10 -71.83 -161.44 0.07 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 114.633 -1.167 . . . . 1.0 109.121 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.402 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 65.0 p -143.87 155.16 44.0 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 103.71 -2.7 . . . . 1.0 103.71 167.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 44.2 mm -57.69 -39.54 70.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 118.614 0.643 . . . . 1.0 110.357 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 14.2 m -61.26 -43.95 98.04 Favored 'General case' 0 CA--C 1.558 1.278 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.512 175.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.402 ' HB3' ' H ' ' A' ' 36' ' ' THR . 9.3 tt0 -68.17 -41.47 81.44 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 122.519 0.328 . . . . 1.0 110.74 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.95 -38.66 91.71 Favored 'General case' 0 CA--C 1.498 -1.057 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.101 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.92 -40.9 73.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.209 -0.663 . . . . 1.0 109.209 176.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 38' ' ' SER . 45.9 mt-10 -68.71 -51.78 37.86 Favored 'General case' 0 CA--C 1.5 -0.977 0 O-C-N 123.67 0.606 . . . . 1.0 111.379 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -63.06 -42.43 99.7 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.833 -0.621 . . . . 1.0 111.807 -174.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.5 mmm -65.21 -41.06 94.84 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.25 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.88 -30.47 58.85 Favored 'General case' 0 C--O 1.201 -1.493 0 C-N-CA 120.71 -0.396 . . . . 1.0 112.028 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.414 ' O ' ' HE3' ' A' ' 50' ' ' LYS . 25.7 t70 -53.99 -31.4 50.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.536 1.134 . . . . 1.0 112.438 -173.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.528 ' HG3' HG22 ' A' ' 29' ' ' VAL . 13.6 mm-40 -68.83 -40.06 79.65 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.228 0.537 . . . . 1.0 110.551 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -95.82 -41.86 8.62 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.875 0.845 . . . . 1.0 110.855 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -95.74 28.65 2.95 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 125.39 1.476 . . . . 1.0 110.046 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 46' ' ' ASP . 4.5 tppp? -51.31 123.7 10.21 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.453 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.84 1.21 34.26 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 120.687 -0.768 . . . . 1.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 27.1 t -89.45 121.0 69.67 Favored Pre-proline 0 N--CA 1.436 -1.138 0 N-CA-C 109.156 -0.683 . . . . 1.0 109.156 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.69 167.75 18.46 Favored 'Trans proline' 0 C--O 1.242 0.704 0 C-N-CA 123.416 2.744 . . . . 1.0 111.683 179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.97 -42.7 98.85 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.496 0.554 . . . . 1.0 112.496 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 t -70.81 -20.62 62.56 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.159 0.504 . . . . 1.0 111.473 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -88.92 -6.78 57.04 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.327 -0.549 . . . . 1.0 111.738 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -82.18 117.01 66.84 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 108.493 -0.928 . . . . 1.0 108.493 173.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -65.7 143.68 75.28 Favored 'Trans proline' 0 C--O 1.24 0.609 0 C-N-CA 122.777 2.318 . . . . 1.0 113.342 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -77.61 135.39 64.57 Favored Pre-proline 0 C--N 1.308 -1.2 0 CA-C-N 115.434 -0.803 . . . . 1.0 109.133 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' HA ' HD13 ' A' ' 63' ' ' LEU . 57.5 Cg_endo -71.06 12.35 0.46 Allowed 'Trans proline' 0 N--CA 1.485 0.994 0 C-N-CA 123.322 2.681 . . . . 1.0 112.962 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -93.53 -13.38 27.86 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.031 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.1 t -117.42 -2.97 11.44 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.792 0.33 . . . . 1.0 111.88 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.575 HD13 ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -142.51 151.8 42.02 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 174.251 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.438 ' OD1' ' HD2' ' A' ' 115' ' ' LYS . 16.7 m-20 -103.48 139.42 38.86 Favored 'General case' 0 CA--C 1.476 -1.896 0 C-N-CA 120.026 -0.669 . . . . 1.0 111.054 -171.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.61 115.07 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 N-CA-C 106.596 -1.631 . . . . 1.0 106.596 168.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.426 ' HB2' HG21 ' A' ' 114' ' ' THR . 43.5 tt0 -91.35 112.42 24.33 Favored 'General case' 0 N--CA 1.392 -3.345 0 N-CA-C 105.412 -2.07 . . . . 1.0 105.412 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.635 ' HZ2' HG21 ' A' ' 101' ' ' VAL . 4.6 t-105 -85.93 124.15 32.07 Favored 'General case' 0 N--CA 1.385 -3.721 0 CA-C-N 114.505 -1.225 . . . . 1.0 109.327 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -111.5 89.19 2.98 Favored 'General case' 0 N--CA 1.396 -3.127 0 N-CA-C 106.926 -1.509 . . . . 1.0 106.926 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.9 p -68.12 -31.59 71.29 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.087 -1.415 . . . . 1.0 109.924 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.55 -50.61 4.36 Favored Glycine 0 C--N 1.303 -1.294 0 CA-C-N 114.359 -1.291 . . . . 1.0 111.343 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.8 m -66.21 -39.95 85.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 122.872 0.469 . . . . 1.0 111.897 178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -103.25 -29.51 11.23 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.164 0.507 . . . . 1.0 110.073 178.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 130.15 -120.95 3.21 Favored Glycine 0 N--CA 1.439 -1.131 0 N-CA-C 110.952 -0.859 . . . . 1.0 110.952 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 10.7 p-80 -136.32 136.75 39.98 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.611 0.243 . . . . 1.0 110.701 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 28.6 tp -134.94 145.27 48.02 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 108.83 -0.804 . . . . 1.0 108.83 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 32.0 mm -83.43 117.48 29.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.3 -0.63 . . . . 1.0 109.3 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.549 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -110.53 151.2 27.87 Favored 'General case' 0 N--CA 1.418 -2.056 0 CA-C-O 121.306 0.574 . . . . 1.0 110.816 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.9 m -159.14 161.4 36.28 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 105.203 -2.147 . . . . 1.0 105.203 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -64.7 -37.98 89.45 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.881 -1.155 . . . . 1.0 107.881 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 14.2 pt-20 -125.35 112.41 16.3 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 115.001 -0.999 . . . . 1.0 110.055 172.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 30.2 t70 -134.9 -87.26 0.38 Allowed 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 107.643 -1.243 . . . . 1.0 107.643 176.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.402 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 8.2 p -72.84 -23.14 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.4 0 CA-C-N 113.479 -1.691 . . . . 1.0 108.408 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.401 HG23 HG13 ' A' ' 82' ' ' VAL . 7.3 p -99.47 4.19 45.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 113.696 -1.593 . . . . 1.0 111.109 -178.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.58 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 35.4 t -67.2 -17.92 65.03 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 115.796 -0.638 . . . . 1.0 112.65 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -82.51 137.29 34.65 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 116.003 -0.544 . . . . 1.0 109.674 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.5 t -118.11 94.15 2.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 108.181 -1.044 . . . . 1.0 108.181 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -151.81 -14.11 0.19 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.309 -0.86 . . . . 1.0 112.435 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -176.94 -109.24 0.24 Allowed Glycine 0 N--CA 1.424 -2.115 0 C-N-CA 120.304 -0.951 . . . . 1.0 111.287 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.25 -9.65 59.74 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.263 0.554 . . . . 1.0 112.193 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -64.2 -46.61 83.16 Favored 'General case' 0 C--O 1.207 -1.18 0 CA-C-N 115.102 -0.954 . . . . 1.0 112.974 -176.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -68.22 106.1 2.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.355 0.598 . . . . 1.0 111.927 -178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -164.26 144.53 8.01 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.155 -1.054 . . . . 1.0 108.155 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 92.6 mt -75.32 142.12 43.27 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.643 -0.873 . . . . 1.0 108.643 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -85.09 138.59 32.32 Favored 'General case' 0 C--N 1.312 -1.052 0 C-N-CA 120.058 -0.657 . . . . 1.0 111.099 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 35' ' ' ASP . 0.9 OUTLIER -113.84 169.04 9.28 Favored 'General case' 0 C--O 1.26 1.637 0 C-N-CA 125.061 1.344 . . . . 1.0 108.489 178.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.657 HD13 HG22 ' A' ' 101' ' ' VAL . 3.8 pp -72.33 -24.34 61.28 Favored 'General case' 0 N--CA 1.436 -1.169 0 C-N-CA 118.751 -1.18 . . . . 1.0 109.145 173.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.474 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -63.98 -26.11 68.43 Favored 'General case' 0 C--O 1.214 -0.81 0 CA-C-N 116.262 -0.427 . . . . 1.0 111.705 176.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -65.25 -40.02 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -85.44 -15.79 41.83 Favored 'General case' 0 CA--C 1.554 1.122 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.409 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 57.44 51.19 10.14 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.112 0.965 . . . . 1.0 110.422 -177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.657 HG22 HD13 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -74.62 148.28 85.27 Favored Pre-proline 0 C--O 1.243 0.728 0 N-CA-C 112.953 0.723 . . . . 1.0 112.953 -177.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.31 157.08 29.48 Favored 'Trans proline' 0 C--O 1.245 0.871 0 C-N-CA 123.247 2.631 . . . . 1.0 112.743 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -66.36 120.15 12.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.101 -0.703 . . . . 1.0 109.101 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.06 16.87 11.63 Favored Glycine 0 C--N 1.295 -1.743 0 N-CA-C 110.861 -0.895 . . . . 1.0 110.861 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -70.97 162.67 28.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.044 0.45 . . . . 1.0 110.579 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.419 HG23 HD22 ' A' ' 12' ' ' ASN . 26.3 m -115.98 133.29 56.18 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 116.634 -0.257 . . . . 1.0 110.38 -175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.524 HG11 HD21 ' A' ' 11' ' ' LEU . 27.0 m -120.24 137.94 52.42 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.517 0 C-N-CA 120.593 -0.443 . . . . 1.0 109.982 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -128.46 139.88 52.11 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 177.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.58 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.39 147.52 40.44 Favored 'General case' 0 C--N 1.285 -2.218 0 C-N-CA 120.294 -0.562 . . . . 1.0 111.934 -178.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.566 HG21 ' H ' ' A' ' 114' ' ' THR . 16.5 m -139.45 151.46 66.84 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.339 -0.846 . . . . 1.0 109.187 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.16 72.66 5.81 Favored 'Trans proline' 0 CA--C 1.548 1.217 0 C-N-CA 122.522 2.148 . . . . 1.0 111.152 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 22.7 p 45.49 76.85 0.09 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 125.027 1.331 . . . . 1.0 110.399 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -143.08 -40.12 0.32 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 113.353 0.871 . . . . 1.0 113.353 -170.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.566 ' H ' HG21 ' A' ' 110' ' ' VAL . 6.3 t -98.23 10.79 39.77 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.688 0.756 . . . . 1.0 112.045 -170.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.438 ' HD2' ' OD1' ' A' ' 64' ' ' ASP . 20.5 ptmt -81.84 114.96 20.81 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 115.424 -0.807 . . . . 1.0 109.916 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -95.94 104.79 16.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.738 -0.665 . . . . 1.0 109.957 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.9 m -79.27 147.61 6.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 115.385 -0.825 . . . . 1.0 109.935 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.3 pp -122.44 148.65 44.87 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.123 0.487 . . . . 1.0 111.568 -177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -100.22 169.41 9.16 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.0 124.47 32.48 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.513 -0.921 . . . . 1.0 108.513 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.87 106.83 11.22 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.56 -175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 . . . . . 0 C--N 1.284 -2.25 0 N-CA-C 108.604 -0.887 . . . . 1.0 108.604 176.109 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 59.1 tptt . . . . . 0 CA--C 1.508 -0.669 0 N-CA-C 108.293 -1.003 . . . . 1.0 108.293 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.79 134.26 3.68 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 106.635 -1.617 . . . . 1.0 106.635 173.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -81.86 77.51 8.68 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.849 0.833 . . . . 1.0 112.179 -174.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.8 t -119.45 81.1 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.414 -2.25 0 CA-C-N 114.429 -1.26 . . . . 1.0 107.999 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -126.84 82.79 2.11 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 122.517 1.151 . . . . 1.0 108.522 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.504 ' HB2' HD22 ' A' ' 32' ' ' LEU . 76.6 m-85 -126.14 -178.12 4.2 Favored 'General case' 0 N--CA 1.403 -2.808 0 N-CA-C 105.914 -1.884 . . . . 1.0 105.914 -176.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' H ' ' HB2' ' A' ' 33' ' ' ASP . 38.9 mmt180 -109.25 106.92 59.36 Favored Pre-proline 0 C--N 1.273 -2.74 0 C-N-CA 118.877 -1.129 . . . . 1.0 109.74 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -64.59 111.6 1.72 Allowed 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.87 1.713 . . . . 1.0 108.22 174.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.415 ' HB3' HG23 ' A' ' 31' ' ' VAL . 5.8 tp -115.48 159.43 21.19 Favored 'General case' 0 N--CA 1.417 -2.094 0 CA-C-O 121.248 0.547 . . . . 1.0 111.368 -172.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.2 m -111.5 132.59 54.39 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.228 -1.027 . . . . 1.0 108.228 176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 35.8 mt -125.05 154.58 41.1 Favored 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 123.486 0.714 . . . . 1.0 111.065 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -98.93 106.69 18.98 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 115.384 -0.825 . . . . 1.0 108.868 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.48 112.92 8.0 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.534 -0.757 . . . . 1.0 109.878 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.442 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.4 tp -144.6 149.98 36.68 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.868 -0.79 . . . . 1.0 108.868 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.667 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -122.9 143.84 49.62 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 122.27 -0.269 . . . . 1.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.43 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -113.57 29.92 7.63 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.164 0.506 . . . . 1.0 110.127 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.7 t -64.19 -47.03 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.739 0 CA-C-N 115.608 -0.724 . . . . 1.0 112.222 -176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.47 -78.69 0.1 OUTLIER Glycine 0 C--O 1.213 -1.17 0 C-N-CA 119.079 -1.534 . . . . 1.0 113.8 -178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -60.0 -28.75 87.76 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 123.012 2.475 . . . . 1.0 113.106 -174.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.56 33.14 3.35 Favored Glycine 0 N--CA 1.42 -2.392 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.19 79.09 0.35 Allowed 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 112.738 0.644 . . . . 1.0 112.738 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.442 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 103.86 9.29 37.76 Favored Glycine 0 CA--C 1.485 -1.828 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -149.9 30.75 0.71 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 121.406 0.622 . . . . 1.0 110.925 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.37 -75.37 0.43 Allowed 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.295 -0.562 . . . . 1.0 112.068 -176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.88 -67.43 0.44 Allowed 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.964 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.15 77.23 0.91 Allowed Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 109.131 -1.588 . . . . 1.0 109.131 -175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -105.49 130.42 23.09 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-N 115.428 -0.386 . . . . 1.0 110.541 -173.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -72.5 104.51 1.72 Allowed 'Trans proline' 0 C--O 1.244 0.809 0 C-N-CA 122.128 1.885 . . . . 1.0 111.431 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.591 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 25.5 t -114.04 155.79 15.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.247 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -104.6 146.14 29.33 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 120.728 0.299 . . . . 1.0 111.542 -174.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -148.74 -174.75 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 C-N-CA 124.79 1.236 . . . . 1.0 109.496 -178.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD22 ' HB2' ' A' ' 6' ' ' TYR . 14.0 mt -122.37 167.71 12.96 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 123.049 0.54 . . . . 1.0 110.065 178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.455 ' HB2' ' H ' ' A' ' 7' ' ' ARG . 29.7 t70 -65.77 -31.28 72.17 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.73 -0.841 . . . . 1.0 108.73 175.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.3 t -112.94 19.82 16.95 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 114.344 1.238 . . . . 1.0 114.344 -173.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.336 24.6 p-10 -85.22 140.2 31.07 Favored 'General case' 0 N--CA 1.415 -2.211 0 C-N-CA 115.853 -2.339 . . . . 1.0 109.411 170.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.8 p -75.17 166.42 23.68 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 114.637 -1.165 . . . . 1.0 110.852 -172.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.6 mm -59.31 -41.1 83.12 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.599 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -59.83 -48.1 83.07 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.83 -0.433 . . . . 1.0 109.83 177.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -73.11 -44.91 59.65 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.641 -0.709 . . . . 1.0 112.365 -173.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.13 -36.53 82.08 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.794 -0.639 . . . . 1.0 110.593 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.567 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 34.1 ttpt -61.74 -34.9 76.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.679 ' HG3' ' O ' ' A' ' 38' ' ' SER . 61.3 mt-10 -65.85 -46.95 76.58 Favored 'General case' 0 C--O 1.202 -1.41 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.043 177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.49 ' HD2' HG12 ' A' ' 31' ' ' VAL . 64.2 mttp -61.8 -41.77 98.16 Favored 'General case' 0 CA--C 1.507 -0.7 0 O-C-N 123.301 0.376 . . . . 1.0 111.408 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.591 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.6 mmt -61.42 -48.56 80.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.129 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -77.48 -24.52 50.16 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 112.888 0.699 . . . . 1.0 112.888 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.776 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 16.4 t70 -58.04 -34.08 69.7 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.771 0.828 . . . . 1.0 111.828 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.54 ' HG3' HG22 ' A' ' 29' ' ' VAL . 77.4 mm-40 -66.36 -31.92 72.99 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.494 -0.776 . . . . 1.0 110.521 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -95.09 -43.39 8.14 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.011 0.434 . . . . 1.0 111.182 -171.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 46' ' ' ASP . 1.1 p90 -75.39 -11.67 60.09 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.824 -0.625 . . . . 1.0 112.069 -175.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 tppt? -57.74 114.76 2.43 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 109.966 -0.383 . . . . 1.0 109.966 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.6 5.93 66.38 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.91 -0.586 . . . . 1.0 112.438 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.538 HG22 ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -100.98 147.83 34.24 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 109.721 -0.474 . . . . 1.0 109.721 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' HD2' HG22 ' A' ' 52' ' ' VAL . 17.8 Cg_endo -60.33 154.57 51.94 Favored 'Trans proline' 0 C--N 1.36 1.142 0 C-N-CA 123.015 2.477 . . . . 1.0 112.27 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.41 -43.23 96.93 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 123.344 0.658 . . . . 1.0 112.057 -173.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -69.45 -17.27 63.62 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.22 0.452 . . . . 1.0 112.22 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -89.39 -15.4 33.36 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.307 0.575 . . . . 1.0 110.433 -178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 94.1 mtt180 -76.9 135.16 67.65 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.766 -0.652 . . . . 1.0 110.881 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -71.07 151.24 61.4 Favored 'Trans proline' 0 C--O 1.249 1.039 0 C-N-CA 122.468 2.112 . . . . 1.0 110.999 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -91.23 102.95 6.33 Favored Pre-proline 0 C--N 1.313 -1.007 0 CA-C-N 116.224 -0.443 . . . . 1.0 109.908 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.21 -24.12 72.55 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.239 1.959 . . . . 1.0 112.86 -177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -68.79 -22.21 64.29 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.516 0.562 . . . . 1.0 112.516 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 15.0 t -119.02 17.27 13.31 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 120.942 0.401 . . . . 1.0 110.868 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.419 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.7 OUTLIER -126.95 143.16 51.36 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 119.838 -0.745 . . . . 1.0 112.001 -179.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.404 ' OD1' HG23 ' A' ' 110' ' ' VAL . 12.6 p-10 -107.26 166.3 10.74 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.327 -0.851 . . . . 1.0 110.642 -178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -124.56 126.43 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.805 0 CA-C-O 121.56 0.695 . . . . 1.0 110.276 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -94.66 113.51 25.31 Favored 'General case' 0 N--CA 1.412 -2.361 0 N-CA-C 105.636 -1.987 . . . . 1.0 105.636 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.638 ' CE3' HD22 ' A' ' 77' ' ' LEU . 5.0 t-105 -89.85 137.18 32.56 Favored 'General case' 0 N--CA 1.4 -2.934 0 CA-C-N 115.734 -0.666 . . . . 1.0 111.742 -173.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -120.31 88.99 3.04 Favored 'General case' 0 N--CA 1.413 -2.306 0 N-CA-C 107.327 -1.36 . . . . 1.0 107.327 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.4 p -72.5 -31.84 65.68 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 122.251 1.024 . . . . 1.0 108.731 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.93 -55.1 4.62 Favored Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 113.708 -1.587 . . . . 1.0 110.525 -177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.5 m -64.27 -42.3 95.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.476 -0.362 . . . . 1.0 111.54 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.41 -21.44 15.99 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 121.217 0.532 . . . . 1.0 109.677 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.21 -130.78 9.95 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.142 177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.537 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 63.2 m-70 -111.42 122.49 47.98 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 123.322 0.649 . . . . 1.0 109.505 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -134.52 136.89 43.42 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 106.123 -1.806 . . . . 1.0 106.123 177.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.502 HG21 ' HA ' ' A' ' 115' ' ' LYS . 16.1 mm -84.21 123.1 38.69 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 C-N-CA 119.512 -0.875 . . . . 1.0 108.866 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.638 HD22 ' CE3' ' A' ' 67' ' ' TRP . 9.9 mp -108.58 150.48 27.43 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.483 0.658 . . . . 1.0 111.427 -179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.515 ' OG ' HG12 ' A' ' 82' ' ' VAL . 10.9 m -152.09 150.94 30.47 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.608 -0.724 . . . . 1.0 109.34 -177.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.2 p30 -74.21 -41.15 61.84 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.839 -0.619 . . . . 1.0 109.9 174.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -153.05 63.63 0.77 Allowed 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.098 -0.501 . . . . 1.0 109.799 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB2' ' CB ' ' A' ' 78' ' ' SER . 11.2 m-20 -143.92 -103.84 0.12 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.243 -0.583 . . . . 1.0 112.433 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.515 HG12 ' OG ' ' A' ' 78' ' ' SER . 8.9 p -68.39 -41.39 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 113.617 0.969 . . . . 1.0 113.617 -175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.58 HG23 ' ND2' ' A' ' 94' ' ' ASN . 9.1 t -97.19 16.51 19.61 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.894 0.854 . . . . 1.0 110.535 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 m -128.15 112.99 15.15 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 107.896 -1.15 . . . . 1.0 107.896 177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -76.2 114.0 14.38 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.56 0.695 . . . . 1.0 110.287 177.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.4 p -103.87 77.56 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 123.208 1.48 . . . . 1.0 110.1 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -141.22 21.3 2.25 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.525 -1.671 . . . . 1.0 109.99 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 155.18 -140.51 7.41 Favored Glycine 1 N--CA 1.385 -4.722 0 N-CA-C 108.586 -1.806 . . . . 1.0 108.586 -179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.726 ' H ' HD23 ' A' ' 89' ' ' LEU . 1.0 OUTLIER -79.84 4.71 15.71 Favored 'General case' 0 C--N 1.262 -3.21 0 C-N-CA 124.272 1.029 . . . . 1.0 111.229 -179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -77.05 -14.36 59.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.437 -0.801 . . . . 1.0 109.905 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -67.85 105.33 1.94 Allowed 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.522 -0.918 . . . . 1.0 108.522 176.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 153.41 42.75 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.315 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 70.3 mt -79.66 129.99 34.96 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.58 ' ND2' HG23 ' A' ' 83' ' ' THR . 68.5 m-80 -90.45 159.87 16.33 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.711 -177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.2 p -119.21 -178.95 3.7 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 124.056 0.942 . . . . 1.0 108.503 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.546 HD13 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -78.71 -19.71 51.76 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 118.464 -1.294 . . . . 1.0 109.532 175.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.518 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -66.71 -25.79 66.7 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-O 120.979 0.418 . . . . 1.0 110.518 176.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -62.16 -35.33 78.47 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.898 -0.778 . . . . 1.0 108.898 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -97.25 -16.43 20.36 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.334 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.52 59.59 4.05 Favored 'General case' 0 C--O 1.241 0.618 0 C-N-CA 123.703 0.801 . . . . 1.0 110.282 -174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.8 m -73.98 146.8 85.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 119.909 -0.716 . . . . 1.0 112.139 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -75.56 162.46 35.65 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.793 2.328 . . . . 1.0 112.074 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.06 128.82 37.49 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.642 -0.708 . . . . 1.0 109.37 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.33 25.27 40.34 Favored Glycine 0 N--CA 1.425 -2.058 0 CA-C-N 115.348 -0.842 . . . . 1.0 111.55 178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.94 160.19 31.28 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.984 0.421 . . . . 1.0 110.205 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.5 m -110.78 134.16 52.73 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-O 121.121 0.486 . . . . 1.0 110.232 -175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.573 HG21 ' SD ' ' A' ' 44' ' ' MET . 16.1 m -113.25 155.76 14.38 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.196 0 N-CA-C 108.613 -0.884 . . . . 1.0 108.613 176.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -135.01 130.05 35.08 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 172.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.667 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 mp -102.33 130.71 49.13 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.04 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.428 HG21 HG22 ' A' ' 114' ' ' THR . 15.9 m -134.57 149.48 71.06 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -80.5 82.21 2.54 Favored 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 121.939 1.76 . . . . 1.0 112.4 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.419 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 8.7 p 49.6 57.87 6.05 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 125.148 1.379 . . . . 1.0 111.18 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.82 -48.92 3.31 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 114.92 -1.036 . . . . 1.0 112.641 -172.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.428 HG22 HG21 ' A' ' 110' ' ' VAL . 11.6 t -122.12 23.63 9.81 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 113.913 1.079 . . . . 1.0 113.913 -170.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 82' ' ' VAL . 18.5 pttp -79.55 18.74 0.7 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.611 0.72 . . . . 1.0 112.67 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -85.5 155.43 21.22 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 106.627 -1.619 . . . . 1.0 106.627 173.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.8 m -68.85 139.92 19.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 113.309 0.855 . . . . 1.0 113.309 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 77.2 mt -122.43 -162.31 1.0 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.34 -1.726 . . . . 1.0 106.34 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -66.42 112.89 4.28 Favored 'General case' 0 N--CA 1.413 -2.3 0 N-CA-C 108.315 -0.995 . . . . 1.0 108.315 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -82.78 85.23 7.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.449 -0.796 . . . . 1.0 112.426 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -116.69 95.71 5.16 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.456 -0.942 . . . . 1.0 108.456 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 . . . . . 0 C--N 1.302 -1.484 0 N-CA-C 108.254 -1.017 . . . . 1.0 108.254 -177.268 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.3 mtpp . . . . . 0 CA--C 1.509 -0.604 0 N-CA-C 110.224 -0.287 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -130.17 88.48 2.66 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -84.66 81.98 8.62 Favored 'General case' 0 CA--C 1.49 -1.361 0 N-CA-C 107.652 -1.24 . . . . 1.0 107.652 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.451 ' HA ' ' CE2' ' A' ' 6' ' ' TYR . 2.4 p -114.39 108.24 24.95 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.157 -0.929 . . . . 1.0 112.413 -175.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -136.84 42.16 2.47 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 107.067 -1.457 . . . . 1.0 107.067 173.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 33' ' ' ASP . 33.1 p90 -139.3 156.07 47.29 Favored 'General case' 0 N--CA 1.383 -3.824 0 CA-C-N 113.272 -1.786 . . . . 1.0 107.664 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.54 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 18.7 mmt180 -130.33 113.84 17.05 Favored Pre-proline 0 C--N 1.255 -3.535 0 N-CA-C 105.944 -1.872 . . . . 1.0 105.944 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 7' ' ' ARG . 11.6 Cg_exo -49.4 115.92 2.01 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.781 1.654 . . . . 1.0 108.875 172.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.8 tp -124.13 155.87 37.66 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-O 121.209 0.528 . . . . 1.0 112.151 -170.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.6 m -105.79 128.8 53.95 Favored 'General case' 0 N--CA 1.428 -1.532 0 N-CA-C 107.586 -1.264 . . . . 1.0 107.586 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 HG11 ' A' ' 107' ' ' VAL . 17.7 tp -127.43 142.58 51.38 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 109.666 -0.494 . . . . 1.0 109.666 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.498 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 5.5 t30 -96.03 116.06 28.38 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 110.33 -0.248 . . . . 1.0 110.33 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.541 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -75.69 121.75 22.96 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.034 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.722 HD21 ' HA2' ' A' ' 22' ' ' GLY . 27.6 tp -151.5 168.12 25.9 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 109.249 -0.649 . . . . 1.0 109.249 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.611 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 2.1 pt? -136.11 145.06 45.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.123 0.569 . . . . 1.0 109.655 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -114.18 30.62 7.16 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.027 0.442 . . . . 1.0 110.52 -177.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.404 HG22 ' HD3' ' A' ' 111' ' ' PRO . 50.9 t -64.91 -46.78 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.273 0 N-CA-C 113.152 0.797 . . . . 1.0 113.152 -174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 172.75 -81.92 0.08 OUTLIER Glycine 0 CA--C 1.522 0.472 0 C-N-CA 118.511 -1.804 . . . . 1.0 114.66 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.15 -32.28 94.34 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 123.4 2.733 . . . . 1.0 112.679 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -130.48 42.36 1.42 Allowed Glycine 0 N--CA 1.42 -2.408 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.33 39.8 0.05 OUTLIER 'General case' 0 C--O 1.244 0.768 0 N-CA-C 114.057 1.132 . . . . 1.0 114.057 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.722 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 154.16 -20.53 0.65 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 111.687 -0.565 . . . . 1.0 111.687 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -130.06 57.4 1.7 Allowed 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 122.189 0.995 . . . . 1.0 110.333 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.07 -83.08 0.53 Allowed 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.363 -1.29 . . . . 1.0 111.324 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 7.0 pt20 -111.62 -59.51 1.97 Allowed 'General case' 0 N--CA 1.434 -1.247 0 CA-C-N 115.589 -0.732 . . . . 1.0 111.609 -174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 60.05 71.65 0.74 Allowed Glycine 0 CA--C 1.519 0.33 0 O-C-N 123.694 0.621 . . . . 1.0 112.05 -177.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.4 t -108.57 127.59 27.16 Favored Pre-proline 0 C--N 1.312 -1.046 0 O-C-N 122.656 -0.32 . . . . 1.0 110.218 -174.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -74.37 110.73 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.687 1.591 . . . . 1.0 111.584 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.581 HG22 ' HG3' ' A' ' 47' ' ' GLN . 21.9 t -116.13 155.45 17.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-N 114.901 -1.045 . . . . 1.0 108.267 177.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -106.22 145.3 31.74 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 114.085 1.143 . . . . 1.0 114.085 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -145.41 -175.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 113.515 -1.675 . . . . 1.0 108.766 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.1 mt -117.3 158.23 24.73 Favored 'General case' 0 C--O 1.187 -2.185 0 N-CA-C 109.778 -0.452 . . . . 1.0 109.778 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 24.4 t70 -66.95 -29.71 69.64 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 123.801 0.688 . . . . 1.0 109.475 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.1 t -102.72 34.07 2.96 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.099 -1.41 . . . . 1.0 109.426 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.536 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -74.61 -166.39 0.44 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.238 -0.892 . . . . 1.0 108.756 173.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 63.6 p -137.29 153.9 50.21 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 104.626 -2.361 . . . . 1.0 104.626 168.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.427 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 40.0 mm -57.87 -40.0 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 CA-C-O 120.857 0.361 . . . . 1.0 110.103 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.3 p -62.47 -43.88 97.74 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.99 -0.55 . . . . 1.0 111.122 176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -71.6 -41.43 68.94 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.84 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.09 -37.7 88.39 Favored 'General case' 0 CA--C 1.493 -1.249 0 N-CA-C 109.861 -0.422 . . . . 1.0 109.861 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.604 ' NZ ' ' HG ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -55.66 -41.52 73.76 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 176.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' SER . 34.3 mt-10 -71.17 -45.63 63.08 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 115.641 -0.709 . . . . 1.0 111.284 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -63.37 -43.65 97.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.941 -177.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.5 mmm -64.89 -41.48 95.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.701 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD23 ' HE2' ' A' ' 41' ' ' LYS . 3.9 pp -75.62 -28.37 58.81 Favored 'General case' 0 C--O 1.198 -1.616 0 C-N-CA 120.346 -0.542 . . . . 1.0 111.846 -179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -56.54 -32.53 65.22 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.874 0.87 . . . . 1.0 112.245 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.581 ' HG3' HG22 ' A' ' 29' ' ' VAL . 16.7 mm-40 -69.81 -39.79 76.33 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 116.048 -0.524 . . . . 1.0 111.231 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.5 -46.28 7.06 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-O 122.05 0.928 . . . . 1.0 110.496 -174.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -93.51 29.79 1.9 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 113.893 -1.503 . . . . 1.0 110.087 -177.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -49.87 116.51 1.84 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.872 -1.058 . . . . 1.0 109.847 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.6 -9.29 19.51 Favored Glycine 0 N--CA 1.429 -1.788 0 C-N-CA 120.579 -0.819 . . . . 1.0 111.758 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 54.3 t -84.33 115.78 61.93 Favored Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 108.276 -1.009 . . . . 1.0 108.276 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -67.74 169.28 16.4 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.274 2.649 . . . . 1.0 112.357 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.24 -40.97 92.14 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.759 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -68.1 -20.66 64.95 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.968 -0.56 . . . . 1.0 112.247 -177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -100.55 -3.87 29.77 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 113.256 0.836 . . . . 1.0 113.256 -175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 mtt180 -82.38 126.96 72.76 Favored Pre-proline 0 C--N 1.31 -1.127 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.419 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.28 144.21 45.59 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.417 2.078 . . . . 1.0 111.919 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' O ' HG22 ' A' ' 62' ' ' THR . 19.5 m-20 -89.68 140.53 28.08 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 109.708 -0.479 . . . . 1.0 109.708 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HA ' HD13 ' A' ' 63' ' ' LEU . 74.3 Cg_endo -70.64 12.97 0.37 Allowed 'Trans proline' 0 N--CA 1.48 0.683 0 C-N-CA 123.654 2.903 . . . . 1.0 114.159 -175.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -89.61 -23.18 22.0 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 173.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.595 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 14.1 t -104.33 -13.4 16.14 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 116.238 -0.437 . . . . 1.0 111.687 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -138.15 146.71 43.09 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.155 -1.424 . . . . 1.0 107.155 173.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 8.2 p-10 -107.3 150.16 27.0 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 113.012 0.745 . . . . 1.0 113.012 -169.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.0 p -114.86 121.93 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.554 0 CA-C-N 114.563 -1.198 . . . . 1.0 108.939 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -91.18 112.16 23.94 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.378 -2.082 . . . . 1.0 105.378 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.63 ' CE2' HG11 ' A' ' 101' ' ' VAL . 4.2 t-105 -87.26 124.19 33.07 Favored 'General case' 0 N--CA 1.389 -3.487 0 CA-C-N 114.79 -1.095 . . . . 1.0 109.49 -178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -109.63 88.19 2.69 Favored 'General case' 0 N--CA 1.403 -2.783 0 N-CA-C 106.853 -1.536 . . . . 1.0 106.853 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.7 p -72.16 -31.61 66.11 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 114.143 -1.389 . . . . 1.0 109.895 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 89.64 -54.03 3.76 Favored Glycine 0 N--CA 1.438 -1.186 0 CA-C-N 114.166 -1.379 . . . . 1.0 110.421 -177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -64.04 -38.04 81.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 C-N-CA 122.911 0.485 . . . . 1.0 111.91 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -111.32 3.18 18.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.741 0.781 . . . . 1.0 110.143 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.51 -121.54 6.52 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.843 -1.071 . . . . 1.0 110.951 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.594 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.6 p-80 -134.78 134.87 41.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.85 0.357 . . . . 1.0 111.185 178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.9 tp -134.02 146.12 50.08 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.755 -0.831 . . . . 1.0 108.755 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.562 HG21 ' HA ' ' A' ' 115' ' ' LYS . 28.2 mm -83.13 118.69 31.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.554 HD22 ' CE3' ' A' ' 67' ' ' TRP . 11.0 mp -111.68 159.99 17.69 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.959 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -160.38 162.08 33.26 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 106.051 -1.833 . . . . 1.0 106.051 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' HB2' HD22 ' A' ' 93' ' ' LEU . 14.5 p-10 -62.52 -42.1 99.29 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 108.511 -0.922 . . . . 1.0 108.511 178.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -132.71 119.46 20.39 Favored 'General case' 0 N--CA 1.416 -2.126 0 CA-C-N 115.81 -0.632 . . . . 1.0 109.454 172.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -140.19 -79.38 0.29 Allowed 'General case' 0 CA--C 1.475 -1.939 0 CA-C-O 122.283 1.04 . . . . 1.0 108.316 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -72.07 -22.42 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.064 0 CA-C-N 113.283 -1.781 . . . . 1.0 109.075 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.2 p -99.87 1.61 43.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 CA-C-N 114.349 -1.296 . . . . 1.0 110.178 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.4 t -71.78 -17.38 62.18 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.34 0.59 . . . . 1.0 110.255 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -75.89 112.1 11.94 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.29 -0.868 . . . . 1.0 109.88 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -98.65 89.19 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 108.68 -0.859 . . . . 1.0 108.68 -176.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -129.11 -18.68 3.67 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 114.8 -1.091 . . . . 1.0 110.702 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -171.17 -116.04 0.37 Allowed Glycine 0 N--CA 1.407 -3.274 0 N-CA-C 110.33 -1.108 . . . . 1.0 110.33 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.9 pp -81.2 -5.86 58.21 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 113.591 0.959 . . . . 1.0 113.591 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -67.47 -28.41 67.84 Favored 'General case' 0 C--O 1.21 -1.019 0 N-CA-C 113.122 0.786 . . . . 1.0 113.122 -177.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -64.88 94.03 0.12 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-O 120.802 0.334 . . . . 1.0 110.55 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -167.71 155.05 8.47 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.149 -0.686 . . . . 1.0 109.149 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 79' ' ' ASP . 93.2 mt -77.12 148.93 35.74 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.23 -0.656 . . . . 1.0 109.23 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -84.19 144.93 28.64 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.159 -179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -111.46 165.61 11.84 Favored 'General case' 0 N--CA 1.414 -2.264 0 C-N-CA 125.078 1.351 . . . . 1.0 108.049 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.638 HD13 HG22 ' A' ' 101' ' ' VAL . 4.4 pp -72.1 -22.86 61.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 118.63 -1.228 . . . . 1.0 109.322 173.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.505 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.64 -25.93 68.17 Favored 'General case' 0 C--O 1.214 -0.801 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.053 175.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -63.23 -35.82 81.59 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.222 -0.659 . . . . 1.0 109.222 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -90.14 -15.86 30.72 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.331 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm 57.66 54.28 6.48 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.773 0.829 . . . . 1.0 110.826 -176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.638 HG22 HD13 ' A' ' 96' ' ' LEU . 0.8 OUTLIER -81.44 146.87 58.49 Favored Pre-proline 0 C--N 1.322 -0.626 0 N-CA-C 113.111 0.782 . . . . 1.0 113.111 -178.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.41 157.99 29.2 Favored 'Trans proline' 0 C--O 1.245 0.86 0 C-N-CA 123.187 2.591 . . . . 1.0 112.093 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.87 123.39 20.03 Favored 'General case' 0 CA--C 1.501 -0.937 0 CA-C-O 121.509 0.671 . . . . 1.0 109.956 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.82 19.7 11.65 Favored Glycine 0 C--N 1.286 -2.214 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.68 162.64 28.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.68 -0.489 . . . . 1.0 109.68 177.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.498 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 84.9 m -115.35 131.06 57.05 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.659 0.266 . . . . 1.0 110.965 -174.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.456 HG11 HD21 ' A' ' 11' ' ' LEU . 27.1 m -115.2 136.49 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.509 0 N-CA-C 109.948 -0.39 . . . . 1.0 109.948 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.6 141.22 49.61 Favored 'General case' 0 C--N 1.284 -2.263 0 N-CA-C 108.708 -0.849 . . . . 1.0 108.708 177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.611 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -123.89 150.65 44.41 Favored 'General case' 0 C--N 1.277 -2.548 0 C-N-CA 120.074 -0.651 . . . . 1.0 111.878 -178.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 114' ' ' THR . 14.9 m -134.45 156.39 78.89 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.404 ' HD3' HG22 ' A' ' 17' ' ' VAL . 73.3 Cg_endo -81.21 75.13 5.14 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 122.054 1.836 . . . . 1.0 111.781 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 62' ' ' THR . 20.1 p 50.31 69.38 0.63 Allowed 'General case' 0 C--O 1.242 0.702 0 C-N-CA 125.019 1.327 . . . . 1.0 110.854 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -130.25 -49.27 1.09 Allowed 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 113.747 1.017 . . . . 1.0 113.747 -173.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.481 HG22 HG21 ' A' ' 110' ' ' VAL . 13.5 t -108.73 19.69 19.39 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.644 -0.822 . . . . 1.0 111.529 -172.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.562 ' HA ' HG21 ' A' ' 76' ' ' ILE . 21.4 ptmt -77.25 86.12 3.69 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-O 122.111 0.958 . . . . 1.0 113.414 -178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -141.7 113.33 7.75 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.702 -1.135 . . . . 1.0 109.378 175.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 m -91.48 -176.15 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.281 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.17 138.27 26.25 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 123.738 0.649 . . . . 1.0 111.537 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -86.89 154.31 20.95 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.893 -0.594 . . . . 1.0 111.116 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.77 122.21 39.47 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.716 -1.216 . . . . 1.0 107.716 174.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -142.85 111.95 6.56 Favored 'General case' 0 C--N 1.281 -2.388 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.971 -174.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 pm0 . . . . . 0 N--CA 1.423 -1.805 0 N-CA-C 109.453 -0.573 . . . . 1.0 109.453 177.685 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.553 ' HG3' ' OD2' ' A' ' 35' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.48 -1.749 0 CA-C-O 121.449 0.642 . . . . 1.0 110.353 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -130.64 142.61 50.45 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 104.104 -2.554 . . . . 1.0 104.104 170.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -81.42 74.78 8.41 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 122.527 1.156 . . . . 1.0 112.348 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 m -136.31 -177.26 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 114.01 -1.45 . . . . 1.0 108.257 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -98.97 96.81 8.08 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.926 0.87 . . . . 1.0 112.531 -171.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.549 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.0 m-85 -128.83 -176.64 3.91 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 103.769 -2.678 . . . . 1.0 103.769 175.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -98.86 111.12 59.83 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 119.526 1.057 . . . . 1.0 111.243 -173.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 38.8 Cg_exo -61.16 140.23 88.07 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.561 2.174 . . . . 1.0 111.03 175.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HG ' ' N ' ' A' ' 10' ' ' THR . 5.7 tp -138.92 161.69 36.68 Favored 'General case' 0 N--CA 1.419 -2.021 0 N-CA-C 108.713 -0.847 . . . . 1.0 108.713 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.432 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 59.8 m -107.98 126.83 53.18 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 108.226 -1.028 . . . . 1.0 108.226 175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.497 HD11 HG13 ' A' ' 107' ' ' VAL . 30.6 tp -127.29 138.0 52.97 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 -177.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 7.1 t30 -90.48 120.43 31.57 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.283 -0.261 . . . . 1.0 111.447 -174.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.08 119.6 25.65 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 109.197 -0.668 . . . . 1.0 109.197 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.774 HD21 ' HA2' ' A' ' 22' ' ' GLY . 36.3 tp -146.67 151.9 37.99 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.793 -0.817 . . . . 1.0 108.793 -178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.59 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.5 OUTLIER -114.23 139.51 49.33 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 176.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.41 50.1 0.97 Allowed 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.037 0.446 . . . . 1.0 110.769 -177.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.435 HG22 ' HD3' ' A' ' 111' ' ' PRO . 39.7 t -65.92 -46.33 88.7 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.546 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.21 -94.55 0.1 Allowed Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.299 -0.953 . . . . 1.0 112.705 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -63.1 -28.23 73.9 Favored 'Trans proline' 0 N--CA 1.484 0.964 0 C-N-CA 123.251 2.634 . . . . 1.0 112.47 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.41 32.21 5.66 Favored Glycine 0 N--CA 1.417 -2.588 0 N-CA-C 110.879 -0.888 . . . . 1.0 110.879 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -74.14 29.03 0.08 Allowed 'General case' 0 C--O 1.246 0.921 0 C-N-CA 123.446 0.698 . . . . 1.0 112.545 -177.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.774 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . -176.99 -40.13 0.06 OUTLIER Glycine 0 N--CA 1.427 -1.906 0 C-N-CA 120.572 -0.823 . . . . 1.0 112.457 -175.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.37 4.3 46.76 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.312 0.486 . . . . 1.0 112.312 -175.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.6 -73.85 0.12 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 113.73 1.011 . . . . 1.0 113.73 -173.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -129.91 -61.8 0.98 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.748 -0.66 . . . . 1.0 111.443 -173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.49 62.92 5.71 Favored Glycine 0 CA--C 1.508 -0.385 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.7 t -95.24 126.02 47.9 Favored Pre-proline 0 C--N 1.303 -1.417 0 CA-C-N 115.58 -0.31 . . . . 1.0 110.334 -175.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -73.74 90.86 0.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.216 1.944 . . . . 1.0 110.291 175.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 47' ' ' GLN . 12.7 t -93.91 154.73 3.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 -178.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -108.7 152.13 25.23 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.436 HG22 ' H ' ' A' ' 32' ' ' LEU . 7.2 p -159.18 177.55 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.384 0 CA-C-N 115.17 -0.923 . . . . 1.0 108.944 -172.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.507 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 31.4 mt -108.62 158.16 17.84 Favored 'General case' 0 CA--C 1.499 -0.999 0 CA-C-O 121.623 0.725 . . . . 1.0 110.999 174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 -32.75 73.86 Favored 'General case' 0 C--O 1.282 2.805 0 C-N-CA 124.9 1.28 . . . . 1.0 111.422 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.9 t -98.78 13.18 33.25 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 115.006 -0.997 . . . . 1.0 111.715 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.553 ' OD2' ' HG3' ' A' ' 1' ' ' LYS . 1.7 m-20 -73.24 133.82 44.1 Favored 'General case' 0 CA--C 1.47 -2.097 0 C-N-CA 119.655 -0.818 . . . . 1.0 109.21 174.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.599 ' OG1' ' HB2' ' A' ' 39' ' ' GLN . 70.8 p -81.28 171.14 15.2 Favored 'General case' 0 N--CA 1.404 -2.771 0 N-CA-C 107.554 -1.276 . . . . 1.0 107.554 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.403 HG21 ' HA ' ' A' ' 78' ' ' SER . 36.7 mm -60.2 -43.47 93.3 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 118.134 0.424 . . . . 1.0 110.197 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.0 p -67.36 -40.22 85.77 Favored 'General case' 0 C--O 1.26 1.642 0 CA-C-O 121.774 0.797 . . . . 1.0 110.707 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.738 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 4.4 tt0 -66.9 -32.52 73.84 Favored 'General case' 0 C--O 1.202 -1.443 0 CA-C-N 114.69 -1.141 . . . . 1.0 110.485 -178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 116.279 -0.418 . . . . 1.0 111.045 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.5 mmmp? -56.52 -33.95 66.55 Favored 'General case' 0 CA--C 1.495 -1.16 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.225 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 17.9 pt-20 -54.43 -50.44 67.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 124.288 0.992 . . . . 1.0 110.273 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.5 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 30.6 mmmt -77.27 -36.59 54.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 114.753 1.39 . . . . 1.0 114.753 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -47.83 84.29 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.186 0.517 . . . . 1.0 110.462 -176.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.616 ' HB2' ' CD1' ' A' ' 49' ' ' TYR 0.266 0.8 OUTLIER -78.75 -23.37 45.4 Favored 'General case' 0 C--O 1.206 -1.206 0 N-CA-C 112.419 0.526 . . . . 1.0 112.419 176.602 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.63 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.5 t70 -50.65 -29.69 11.68 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 125.025 1.33 . . . . 1.0 112.684 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.434 ' HG3' HG22 ' A' ' 29' ' ' VAL . 12.1 mm-40 -75.31 -17.97 60.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.359 -178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -112.36 -30.99 6.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.994 0.902 . . . . 1.0 109.853 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.616 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 32.1 m-85 -98.37 20.02 13.37 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.909 -1.041 . . . . 1.0 111.401 -177.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.13 118.97 9.31 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 108.77 -0.826 . . . . 1.0 108.77 175.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.99 -14.1 21.7 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 110.472 -1.051 . . . . 1.0 110.472 -175.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.3 t -97.98 133.1 23.56 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.464 ' HG2' ' CG ' ' A' ' 56' ' ' GLN . 25.7 Cg_endo -61.98 156.62 48.31 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.86 2.374 . . . . 1.0 112.01 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.6 tp -61.71 -41.41 97.56 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 123.436 0.694 . . . . 1.0 112.001 -174.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 t -66.59 -24.51 66.34 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.059 0.457 . . . . 1.0 111.629 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.464 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 16.2 mm100 -86.51 -14.59 42.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.005 0.431 . . . . 1.0 111.905 -176.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 56.9 mtt180 -73.98 123.27 89.12 Favored Pre-proline 0 C--N 1.31 -1.151 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.165 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.52 147.75 94.67 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 123.422 2.748 . . . . 1.0 114.04 -177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -83.38 160.29 59.85 Favored Pre-proline 0 C--N 1.315 -0.893 0 C-N-CA 124.388 1.075 . . . . 1.0 110.891 -176.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -84.55 8.02 4.86 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.655 2.237 . . . . 1.0 112.099 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.5 ptp180 -95.0 -21.56 18.52 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.931 177.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 3.8 t -92.91 -15.54 26.23 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-O 121.297 0.57 . . . . 1.0 110.348 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.496 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.6 pp -145.64 149.79 35.14 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.569 -1.641 . . . . 1.0 106.569 177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HB3' HG23 ' A' ' 76' ' ' ILE . 4.6 m-20 -103.83 156.96 17.41 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 120.406 -0.518 . . . . 1.0 110.145 -172.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 p -117.76 117.92 56.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 121.54 0.686 . . . . 1.0 109.557 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -92.7 118.03 30.62 Favored 'General case' 0 N--CA 1.416 -2.145 0 CA-C-O 121.459 0.647 . . . . 1.0 109.937 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.622 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 16.9 t90 -82.7 119.65 24.58 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.603 -1.18 . . . . 1.0 108.491 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.8 mtm180 -122.01 89.22 3.08 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 120.952 0.406 . . . . 1.0 109.911 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.4 p -91.43 -23.1 20.13 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.893 0.854 . . . . 1.0 109.029 175.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.67 -52.27 4.43 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.993 -1.003 . . . . 1.0 111.009 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.02 -38.12 81.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 121.045 0.45 . . . . 1.0 111.492 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.79 -3.09 36.37 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.726 0.774 . . . . 1.0 109.589 176.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.39 -144.11 17.03 Favored Glycine 0 N--CA 1.416 -2.683 0 CA-C-N 114.883 -1.053 . . . . 1.0 110.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.622 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 8.4 p80 -133.48 115.27 14.57 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 123.028 0.531 . . . . 1.0 109.705 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.3 mt -123.42 144.47 49.48 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.676 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.487 HG23 ' HB3' ' A' ' 64' ' ' ASP . 29.4 mm -83.46 117.69 29.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 109.719 -0.474 . . . . 1.0 109.719 177.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.79 146.44 28.98 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.3 -0.864 . . . . 1.0 109.817 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.403 ' HA ' HG21 ' A' ' 37' ' ' ILE . 26.7 t -161.88 166.15 26.68 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 115.683 -0.689 . . . . 1.0 109.257 176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -69.65 -27.41 65.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.878 -1.156 . . . . 1.0 107.878 176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -141.37 81.44 1.78 Allowed 'General case' 0 N--CA 1.415 -2.195 0 N-CA-C 106.939 -1.504 . . . . 1.0 106.939 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 82' ' ' VAL . 3.0 p30 -102.17 -89.63 0.37 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.637 0.732 . . . . 1.0 112.574 -175.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.424 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 5.0 p -102.69 -14.1 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.33 0 C-N-CA 125.041 1.336 . . . . 1.0 108.746 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 16.7 p -87.48 -7.66 57.37 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.153 -0.93 . . . . 1.0 108.653 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.6 p -53.15 -44.9 68.17 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 125.205 1.402 . . . . 1.0 113.976 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -74.71 118.98 18.29 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.828 -0.804 . . . . 1.0 108.828 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 90' ' ' PHE . 2.5 p -143.27 114.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.876 0 CA-C-O 121.651 0.739 . . . . 1.0 112.546 -170.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -102.84 -26.12 13.25 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 114.779 -1.101 . . . . 1.0 109.314 172.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -114.99 -100.31 2.31 Favored Glycine 1 N--CA 1.396 -4.021 0 N-CA-C 109.903 -1.279 . . . . 1.0 109.903 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.539 ' HB2' HH21 ' A' ' 92' ' ' ARG . 1.1 pp -127.42 24.66 6.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.372 0.606 . . . . 1.0 110.515 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.437 ' H ' HG23 ' A' ' 86' ' ' VAL . 66.1 m-85 -62.59 -38.46 90.22 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 115.009 1.485 . . . . 1.0 115.009 -176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 83' ' ' THR . 43.9 ttp180 -72.08 93.47 1.41 Allowed 'General case' 0 CA--C 1.506 -0.715 0 C-N-CA 119.191 -1.004 . . . . 1.0 112.204 -176.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.539 HH21 ' HB2' ' A' ' 89' ' ' LEU . 28.8 mmt180 -113.86 137.76 51.22 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.324 -1.361 . . . . 1.0 107.324 176.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.9 mt -66.65 135.62 54.35 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 106.887 -1.523 . . . . 1.0 106.887 175.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 36' ' ' THR . 65.8 m-80 -87.27 137.77 32.05 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 119.786 -0.765 . . . . 1.0 111.994 -173.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.5 p -105.42 168.98 8.73 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 124.054 0.941 . . . . 1.0 109.312 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 pp -70.01 -33.18 71.69 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 119.351 -0.94 . . . . 1.0 108.81 174.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.57 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.1 pt20 -65.65 -26.09 67.65 Favored 'General case' 0 C--O 1.211 -0.971 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.576 177.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.0 t-160 -65.57 -35.62 81.36 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-O 120.992 0.425 . . . . 1.0 110.422 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.94 -8.09 21.84 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.199 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 52.47 68.45 0.82 Allowed 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.454 1.101 . . . . 1.0 112.312 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.471 HG12 ' CE2' ' A' ' 67' ' ' TRP . 2.7 m -78.33 136.7 60.46 Favored Pre-proline 0 N--CA 1.433 -1.285 0 C-N-CA 119.941 -0.704 . . . . 1.0 109.124 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -68.3 160.54 48.56 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 122.256 1.97 . . . . 1.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -64.68 124.38 21.76 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.58 25.49 38.79 Favored Glycine 0 C--N 1.303 -1.281 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.798 -178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.24 158.23 36.25 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-O 120.818 0.342 . . . . 1.0 111.039 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.462 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 51.1 m -107.97 123.89 49.32 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-O 121.055 0.455 . . . . 1.0 110.962 -176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.497 HG13 HD11 ' A' ' 11' ' ' LEU . 33.4 m -121.15 138.57 51.11 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 N-CA-C 108.446 -0.946 . . . . 1.0 108.446 176.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.666 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -125.72 138.45 53.88 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 120.999 0.428 . . . . 1.0 112.019 -176.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.59 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.2 mp -96.39 126.88 41.9 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 109.241 -0.651 . . . . 1.0 109.241 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 30.1 m -116.21 140.13 26.05 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 116.761 -0.199 . . . . 1.0 110.692 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.435 ' HD3' HG22 ' A' ' 17' ' ' VAL . 60.0 Cg_endo -72.81 85.06 1.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.633 2.222 . . . . 1.0 112.027 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.633 ' SG ' ' HA ' ' A' ' 116' ' ' HIS . 20.3 p 50.15 93.97 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 125.874 1.67 . . . . 1.0 113.141 177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 114' ' ' THR . 1.7 mm? 64.4 9.87 5.28 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.595 1.158 . . . . 1.0 110.768 179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.7 OUTLIER 70.68 11.41 7.22 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 126.22 1.808 . . . . 1.0 111.829 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -149.35 107.68 3.77 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.633 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 51.8 t-80 -62.87 95.61 0.08 Allowed 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.945 0.72 . . . . 1.0 112.945 -173.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.9 m -134.0 163.51 37.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 107.994 -1.113 . . . . 1.0 107.994 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.53 109.11 20.51 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 74.6 ttt180 -138.49 145.77 41.2 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.479 -0.563 . . . . 1.0 109.479 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 53.3 mm-40 -77.79 172.42 13.46 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.093 -1.077 . . . . 1.0 108.093 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -79.8 78.33 6.39 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.817 0.818 . . . . 1.0 109.519 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 . . . . . 0 N--CA 1.432 -1.339 0 N-CA-C 106.689 -1.597 . . . . 1.0 106.689 179.434 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.542 ' NZ ' ' HB2' ' A' ' 1' ' ' LYS . 0.1 OUTLIER . . . . . 0 CA--C 1.493 -1.234 0 N-CA-C 110.233 -0.284 . . . . 1.0 110.233 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -144.64 71.41 1.3 Allowed 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 105.347 -2.094 . . . . 1.0 105.347 171.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -73.03 81.99 1.24 Allowed 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 122.877 1.323 . . . . 1.0 114.31 -170.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.3 m -123.95 -163.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 112.958 -1.928 . . . . 1.0 106.404 171.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -88.21 93.01 9.37 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.833 0.825 . . . . 1.0 112.433 -173.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.506 ' HB2' HD13 ' A' ' 32' ' ' LEU . 21.9 m-85 -137.87 -176.89 4.58 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 103.655 -2.72 . . . . 1.0 103.655 175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 38.9 mmt180 -100.38 109.56 57.32 Favored Pre-proline 0 C--N 1.295 -1.803 0 C-N-CA 118.729 -1.188 . . . . 1.0 111.578 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 33.7 Cg_exo -62.53 139.17 74.65 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 122.357 2.038 . . . . 1.0 110.607 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 96' ' ' LEU . 6.1 tp -135.12 158.81 43.41 Favored 'General case' 0 N--CA 1.411 -2.389 0 CA-C-N 116.278 -0.419 . . . . 1.0 109.916 -178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -100.24 128.5 46.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.768 -1.197 . . . . 1.0 107.768 176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.517 HD11 HG13 ' A' ' 107' ' ' VAL . 22.2 tp -127.82 138.74 52.82 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.332 -0.988 . . . . 1.0 108.332 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.499 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 5.2 t30 -91.51 116.89 29.23 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 122.165 -0.334 . . . . 1.0 110.573 -176.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.84 118.59 21.76 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 123.606 0.566 . . . . 1.0 109.564 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.633 HD21 ' HA2' ' A' ' 22' ' ' GLY . 33.8 tp -151.41 158.22 43.42 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 109.482 -0.562 . . . . 1.0 109.482 -177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.7 144.34 48.83 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 109.663 -0.495 . . . . 1.0 109.663 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.9 38.79 3.22 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.96 0.41 . . . . 1.0 110.654 -174.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG22 ' HD3' ' A' ' 111' ' ' PRO . 54.4 t -66.22 -44.39 91.41 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.507 0 CA-C-N 115.707 -0.679 . . . . 1.0 111.671 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 154.33 -78.56 0.2 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 119.902 -1.142 . . . . 1.0 112.611 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.5 -25.94 76.03 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.236 2.624 . . . . 1.0 111.95 -175.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 22' ' ' GLY . . . -133.49 41.67 1.45 Allowed Glycine 0 N--CA 1.416 -2.665 0 N-CA-C 110.068 -1.213 . . . . 1.0 110.068 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -71.75 24.22 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 113.115 0.783 . . . . 1.0 113.115 -177.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.633 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 169.83 -38.54 0.2 Allowed Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.898 -0.592 . . . . 1.0 111.808 -177.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.02 21.68 2.25 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.179 0.514 . . . . 1.0 111.769 -176.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -88.99 -78.25 0.35 Allowed 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.74 0.644 . . . . 1.0 112.74 -174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -125.32 -64.67 1.06 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.863 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.08 63.38 4.79 Favored Glycine 0 CA--C 1.507 -0.453 0 N-CA-C 110.767 -0.933 . . . . 1.0 110.767 -177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.4 t -93.64 126.08 51.2 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 109.951 -0.389 . . . . 1.0 109.951 -174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -73.94 100.33 1.27 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.552 1.501 . . . . 1.0 109.738 175.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.575 HG22 ' HG3' ' A' ' 47' ' ' GLN . 11.3 t -108.32 156.85 8.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.358 -0.978 . . . . 1.0 108.358 -178.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -119.3 152.77 36.16 Favored 'General case' 0 C--N 1.29 -2.019 0 C-N-CA 119.555 -0.858 . . . . 1.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.436 HG21 ' HA ' ' A' ' 40' ' ' ALA . 9.5 p -158.26 169.1 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 -177.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 6' ' ' TYR . 15.1 mt -89.95 157.72 17.72 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 112.869 0.692 . . . . 1.0 112.869 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.35 -32.44 71.27 Favored 'General case' 0 C--O 1.267 2.001 0 CA-C-N 114.624 -1.171 . . . . 1.0 110.056 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.474 ' HB3' ' CD2' ' A' ' 6' ' ' TYR . 23.2 t -101.7 12.54 36.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 114.576 -1.193 . . . . 1.0 111.775 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.46 136.47 34.9 Favored 'General case' 0 N--CA 1.409 -2.506 0 C-N-CA 118.601 -1.239 . . . . 1.0 108.032 171.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 28.2 p -80.51 174.33 11.71 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 115.066 -0.97 . . . . 1.0 109.15 -176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 40.5 mm -59.3 -42.25 86.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 109.589 -0.523 . . . . 1.0 109.589 178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.9 p -63.79 -45.38 89.96 Favored 'General case' 0 CA--C 1.554 1.126 0 CA-C-O 121.986 0.898 . . . . 1.0 111.047 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -77.47 -16.06 58.96 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.202 -0.908 . . . . 1.0 112.253 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.436 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -85.43 -31.49 22.83 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 115.694 -0.685 . . . . 1.0 112.042 168.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.629 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 3.9 mmmp? -56.41 -39.86 73.73 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 46' ' ' ASP . 3.1 pt-20 -58.41 -44.92 89.21 Favored 'General case' 0 N--CA 1.416 -2.159 0 O-C-N 124.333 1.021 . . . . 1.0 111.966 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.472 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 28.3 mmmt -72.86 -39.57 66.4 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 113.868 1.062 . . . . 1.0 113.868 176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.5 mmt -61.27 -46.92 88.38 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.322 0.582 . . . . 1.0 110.639 -175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.4 pp -77.45 -24.07 50.35 Favored 'General case' 0 C--O 1.205 -1.248 0 CA-C-N 115.64 -0.709 . . . . 1.0 111.128 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.583 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 28.6 t70 -50.65 -35.57 31.32 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 125.132 1.373 . . . . 1.0 112.334 -175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 29' ' ' VAL . 10.5 mm-40 -71.73 -32.93 68.26 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.194 0.521 . . . . 1.0 111.62 -178.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.51 -45.55 7.37 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.01 0.909 . . . . 1.0 109.674 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 88.3 m-85 -95.34 27.63 3.24 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.065 -1.425 . . . . 1.0 110.639 -174.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 46' ' ' ASP . 1.1 tppp? -58.76 121.7 11.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.226 0.536 . . . . 1.0 109.897 175.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.78 -20.24 9.4 Favored Glycine 0 N--CA 1.426 -2.018 0 N-CA-C 110.131 -1.188 . . . . 1.0 110.131 -175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 75.3 t -82.63 125.71 75.21 Favored Pre-proline 0 N--CA 1.443 -0.796 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.21 160.34 42.61 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 122.566 2.177 . . . . 1.0 111.813 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 54.4 tp -60.68 -38.52 85.24 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 123.249 0.62 . . . . 1.0 111.438 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 t -66.85 -18.28 65.3 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.857 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -97.58 -11.18 23.95 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 120.688 -0.405 . . . . 1.0 112.027 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.444 ' HD3' HD11 ' A' ' 45' ' ' LEU . 75.3 mtt180 -77.15 110.09 11.13 Favored Pre-proline 0 CA--C 1.551 1.007 0 N-CA-C 110.304 -0.258 . . . . 1.0 110.304 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.98 154.25 52.84 Favored 'Trans proline' 0 C--O 1.256 1.394 0 C-N-CA 123.459 2.772 . . . . 1.0 115.475 -172.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -67.8 154.57 93.3 Favored Pre-proline 0 N--CA 1.475 0.788 0 CA-C-N 114.466 -1.243 . . . . 1.0 111.485 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -91.42 23.12 0.63 Allowed 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 123.388 2.725 . . . . 1.0 112.624 177.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -94.78 -28.51 15.23 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.26 0.467 . . . . 1.0 112.26 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.0 t -91.06 1.41 57.11 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 122.134 0.969 . . . . 1.0 109.991 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.614 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.3 pp -145.39 161.88 38.61 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 104.599 -2.371 . . . . 1.0 104.599 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.434 ' HB3' HG23 ' A' ' 76' ' ' ILE . 18.6 m-20 -122.85 152.82 40.36 Favored 'General case' 0 C--N 1.266 -3.04 0 C-N-CA 119.541 -0.864 . . . . 1.0 109.332 -177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.9 p -119.27 120.94 65.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 119.728 -0.789 . . . . 1.0 109.522 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -94.13 116.3 28.7 Favored 'General case' 0 N--CA 1.41 -2.431 0 CA-C-O 121.556 0.693 . . . . 1.0 109.667 -178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.667 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 15.8 t90 -82.29 119.27 23.91 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 114.668 -1.151 . . . . 1.0 108.042 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.412 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 85.0 mtm180 -123.11 89.06 3.04 Favored 'General case' 0 N--CA 1.421 -1.924 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -178.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.5 p -88.77 -20.13 25.15 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 122.033 0.92 . . . . 1.0 108.932 174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 88.87 -54.5 4.05 Favored Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 114.629 -1.168 . . . . 1.0 111.85 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.9 m -64.49 -42.11 94.28 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 N-CA-C 111.587 0.217 . . . . 1.0 111.587 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.5 -9.41 47.43 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-O 121.722 0.773 . . . . 1.0 109.028 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.58 -138.11 13.75 Favored Glycine 0 N--CA 1.416 -2.684 0 CA-C-N 114.507 -1.224 . . . . 1.0 111.321 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.667 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.0 p80 -138.4 118.29 13.29 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 123.722 0.809 . . . . 1.0 110.06 178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.8 mt -123.25 145.17 48.89 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.919 -0.582 . . . . 1.0 110.405 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.434 HG23 ' HB3' ' A' ' 64' ' ' ASP . 28.6 mm -88.46 111.49 22.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-O 121.098 0.475 . . . . 1.0 109.789 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.8 mp -99.6 151.69 20.89 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.289 -0.869 . . . . 1.0 110.347 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 23.1 t -162.68 165.46 25.65 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.021 -1.103 . . . . 1.0 108.021 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 6.4 p-10 -71.67 -31.0 66.32 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.267 -1.012 . . . . 1.0 108.267 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 37.7 tt0 -138.16 84.49 2.04 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 106.201 -1.777 . . . . 1.0 106.201 177.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.507 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 3.3 p30 -102.4 -90.43 0.36 Allowed 'General case' 0 CA--C 1.489 -1.377 0 CA-C-O 121.742 0.782 . . . . 1.0 112.64 -174.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.442 ' H ' ' CG ' ' A' ' 81' ' ' ASP . 4.9 p -102.58 -19.02 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.503 0 CA-C-N 113.803 -1.544 . . . . 1.0 108.022 -176.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 21.4 p -79.99 -8.99 59.65 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.916 -1.038 . . . . 1.0 109.643 178.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.425 ' HB3' ' HG2' ' A' ' 80' ' ' GLU . 53.0 p -56.13 -42.35 76.76 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.528 1.131 . . . . 1.0 113.167 -177.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -69.71 124.25 23.48 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.821 -0.807 . . . . 1.0 108.821 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 2.8 p -153.55 123.37 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-O 121.668 0.747 . . . . 1.0 112.53 -171.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -101.27 -27.01 13.43 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.081 -0.963 . . . . 1.0 109.659 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -128.23 -87.97 0.57 Allowed Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 120.155 -1.021 . . . . 1.0 112.469 -175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.4 pp -127.03 14.69 7.35 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.943 0.401 . . . . 1.0 111.634 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -61.54 -36.92 81.93 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.879 1.066 . . . . 1.0 113.879 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.573 ' HA ' ' O ' ' A' ' 83' ' ' THR . 42.2 ttp180 -77.03 114.17 15.54 Favored 'General case' 0 CA--C 1.493 -1.229 0 C-N-CA 119.708 -0.797 . . . . 1.0 113.022 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -137.7 146.98 44.42 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.767 -1.568 . . . . 1.0 106.767 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.433 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 98.2 mt -70.39 142.39 52.09 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.572 -1.27 . . . . 1.0 107.572 175.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -89.93 139.09 30.94 Favored 'General case' 0 CA--C 1.493 -1.218 0 C-N-CA 119.894 -0.722 . . . . 1.0 111.013 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.557 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.5 p -111.39 171.13 7.66 Favored 'General case' 0 N--CA 1.415 -2.184 0 C-N-CA 124.007 0.923 . . . . 1.0 108.599 176.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.533 HD13 HD22 ' A' ' 9' ' ' LEU . 3.1 pp -68.52 -30.59 69.43 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.507 -0.923 . . . . 1.0 108.507 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.557 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.35 -26.32 68.42 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 115.968 -0.56 . . . . 1.0 111.987 178.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -65.76 -39.96 91.56 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-O 120.981 0.42 . . . . 1.0 110.376 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -100.38 -7.21 24.65 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.521 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp 51.75 61.55 3.16 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.923 1.289 . . . . 1.0 113.143 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.45 HG12 ' CE2' ' A' ' 67' ' ' TRP . 3.0 m -70.98 136.87 84.91 Favored Pre-proline 0 N--CA 1.438 -1.032 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 178.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.13 160.21 50.8 Favored 'Trans proline' 0 C--O 1.239 0.557 0 C-N-CA 122.545 2.163 . . . . 1.0 111.326 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -66.45 117.96 9.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.712 0.768 . . . . 1.0 109.891 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.41 22.94 20.59 Favored Glycine 0 N--CA 1.424 -2.132 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.712 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.31 152.47 45.39 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 110.048 -0.353 . . . . 1.0 110.048 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 27.7 m -108.56 123.46 48.95 Favored 'General case' 0 C--N 1.279 -2.47 0 C-N-CA 120.395 -0.522 . . . . 1.0 110.253 -176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.517 HG13 HD11 ' A' ' 11' ' ' LEU . 33.9 m -121.66 155.17 25.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.017 -1.105 . . . . 1.0 108.017 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -138.45 137.02 36.8 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.307 -0.557 . . . . 1.0 112.003 -177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.6 mp -94.97 132.67 39.57 Favored 'General case' 0 C--N 1.274 -2.685 0 CA-C-N 115.671 -0.695 . . . . 1.0 110.224 -175.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 16' ' ' ALA . 31.9 m -129.26 137.64 31.41 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 116.176 -0.466 . . . . 1.0 110.056 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.451 ' HD3' HG22 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -70.23 86.3 0.65 Allowed 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.227 1.951 . . . . 1.0 111.065 177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.614 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 21.0 p 50.4 85.21 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 1.0 112.467 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' O ' HG22 ' A' ' 114' ' ' THR . 2.2 mm? 58.04 23.69 10.31 Favored 'General case' 0 CA--C 1.502 -0.883 0 C-N-CA 124.775 1.23 . . . . 1.0 110.218 -176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER 67.38 13.68 9.42 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.8 1.64 . . . . 1.0 112.545 178.315 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -124.18 104.81 9.05 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.074 -1.084 . . . . 1.0 108.074 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -72.19 93.15 1.42 Allowed 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.635 0.731 . . . . 1.0 111.526 -174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.25 163.88 34.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 114.92 -1.036 . . . . 1.0 108.349 178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.14 106.0 13.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.429 -1.693 . . . . 1.0 106.429 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 67.0 ttt180 -136.76 134.75 37.43 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.985 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 51.0 mm-40 -74.48 175.19 7.99 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 176.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -76.98 72.18 3.52 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 122.001 0.905 . . . . 1.0 109.636 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 106.759 -1.571 . . . . 1.0 106.759 -178.891 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 111.783 0.29 . . . . 1.0 111.783 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.29 135.91 54.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 108.698 -0.852 . . . . 1.0 108.698 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -81.7 -1.55 47.29 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.489 0.662 . . . . 1.0 111.794 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 p -121.38 97.27 4.82 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 CA-C-N 115.188 -0.915 . . . . 1.0 109.43 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -108.08 79.38 1.26 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.966 0.889 . . . . 1.0 112.777 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.53 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.4 m-85 -123.4 178.5 5.13 Favored 'General case' 0 N--CA 1.393 -3.283 0 N-CA-C 102.928 -2.99 . . . . 1.0 102.928 172.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 23.2 mmt180 -104.66 111.05 65.17 Favored Pre-proline 0 C--N 1.273 -2.757 0 C-N-CA 117.233 -1.787 . . . . 1.0 114.673 -172.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 19.6 Cg_exo -65.69 121.78 9.25 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 122.383 2.056 . . . . 1.0 109.173 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 30' ' ' LYS . 9.5 tp -114.9 159.79 20.28 Favored 'General case' 0 N--CA 1.402 -2.831 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.374 -177.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m -99.36 124.26 44.33 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.165 -0.68 . . . . 1.0 109.165 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 31' ' ' VAL . 2.8 mm? -125.69 144.08 50.76 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 123.24 0.616 . . . . 1.0 110.179 177.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -92.67 113.8 26.18 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 109.949 -0.389 . . . . 1.0 109.949 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.441 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -74.25 107.94 6.73 Favored 'General case' 0 C--O 1.253 1.273 0 C-N-CA 123.313 0.645 . . . . 1.0 110.166 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.629 HD21 ' HA2' ' A' ' 22' ' ' GLY . 25.7 tp -142.11 158.95 43.16 Favored 'General case' 0 N--CA 1.411 -2.407 0 N-CA-C 108.88 -0.785 . . . . 1.0 108.88 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -128.5 143.63 51.01 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 109.157 -0.683 . . . . 1.0 109.157 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB3' HG13 ' A' ' 110' ' ' VAL . . . -109.71 36.33 3.02 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 120.902 0.382 . . . . 1.0 111.184 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -66.59 -45.15 89.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 112.556 0.576 . . . . 1.0 112.556 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 159.42 -81.97 0.14 Allowed Glycine 0 C--N 1.31 -0.885 0 C-N-CA 119.656 -1.259 . . . . 1.0 112.469 -178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.59 -24.39 77.88 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 122.995 2.464 . . . . 1.0 112.584 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -123.57 27.16 5.81 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.965 -0.854 . . . . 1.0 110.965 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.4 68.0 2.69 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.767 0.794 . . . . 1.0 112.445 -175.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.629 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 127.05 -15.68 6.48 Favored Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 110.765 -0.934 . . . . 1.0 110.765 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -126.27 27.65 6.19 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.98 -0.61 . . . . 1.0 112.273 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.82 -93.21 0.07 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.154 0.502 . . . . 1.0 110.583 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 5.8 pt20 -114.56 -62.7 1.56 Allowed 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.005 -0.543 . . . . 1.0 111.791 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.408 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 71.13 75.0 0.66 Allowed Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 110.215 -1.154 . . . . 1.0 110.215 -175.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.9 t -110.1 127.79 26.46 Favored Pre-proline 0 C--N 1.31 -1.124 0 N-CA-C 110.244 -0.28 . . . . 1.0 110.244 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.02 108.07 2.51 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.708 1.605 . . . . 1.0 110.675 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG11 ' HA ' ' A' ' 44' ' ' MET . 60.6 t -114.98 139.16 42.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.649 -0.871 . . . . 1.0 108.649 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 9' ' ' LEU . 96.6 mttt -100.54 139.0 36.84 Favored 'General case' 0 N--CA 1.429 -1.51 0 C-N-CA 119.856 -0.738 . . . . 1.0 110.339 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG12 HD23 ' A' ' 11' ' ' LEU . 11.2 p -144.16 159.09 15.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.87 0 N-CA-C 107.932 -1.136 . . . . 1.0 107.932 -176.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.9 mt -82.4 156.16 24.31 Favored 'General case' 0 CA--C 1.488 -1.428 0 CA-C-O 121.855 0.836 . . . . 1.0 112.697 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.7 -31.65 72.6 Favored 'General case' 0 C--O 1.27 2.16 0 CA-C-N 113.674 -1.603 . . . . 1.0 108.81 177.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.552 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 18.5 t -85.18 -8.64 58.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 113.533 -1.667 . . . . 1.0 111.947 -176.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -71.88 133.29 45.34 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-O 121.72 0.771 . . . . 1.0 109.714 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.0 p -81.93 177.62 8.75 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.446 -1.252 . . . . 1.0 109.875 -178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.632 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 37.8 mm -60.82 -46.64 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 CA-C-O 119.259 -0.401 . . . . 1.0 110.298 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 40.1 m -60.98 -47.72 85.13 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 123.833 0.708 . . . . 1.0 111.341 174.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -64.87 -42.84 94.51 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-O 121.204 0.526 . . . . 1.0 110.608 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.41 -35.64 81.08 Favored 'General case' 0 C--O 1.203 -1.392 0 CA-C-N 116.003 -0.544 . . . . 1.0 111.414 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.1 OUTLIER -60.95 -40.06 91.86 Favored 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 108.393 -0.965 . . . . 1.0 108.393 178.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 38' ' ' SER . 40.6 mt-10 -65.3 -49.54 69.12 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.054 -0.976 . . . . 1.0 110.605 -176.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -64.99 -40.92 95.66 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 112.465 0.542 . . . . 1.0 112.465 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.6 mmm -65.3 -43.53 90.8 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 4.4 pp -75.71 -27.08 58.08 Favored 'General case' 0 C--O 1.203 -1.354 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.364 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -55.6 -28.16 53.52 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.801 1.24 . . . . 1.0 113.072 -175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.645 ' HG3' HG22 ' A' ' 29' ' ' VAL . 71.4 mm-40 -69.11 -31.32 69.94 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.282 0.563 . . . . 1.0 110.489 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.7 -26.32 7.03 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.914 -0.585 . . . . 1.0 112.347 -174.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 82.0 m-85 -102.94 31.68 4.08 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 175.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -55.62 121.13 8.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.09 -0.959 . . . . 1.0 110.584 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.87 -5.82 51.03 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.053 -0.594 . . . . 1.0 112.22 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.7 t -88.46 123.45 68.19 Favored Pre-proline 0 C--N 1.308 -1.229 0 N-CA-C 109.818 -0.438 . . . . 1.0 109.818 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 95.9 Cg_endo -73.26 163.7 37.26 Favored 'Trans proline' 0 C--O 1.243 0.769 0 C-N-CA 123.551 2.834 . . . . 1.0 112.748 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -60.23 -40.09 88.96 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.343 0.657 . . . . 1.0 111.14 -178.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.5 t -64.15 -17.48 63.52 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -98.06 -30.27 12.78 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 120.222 -0.591 . . . . 1.0 110.155 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 88.4 mtt180 -66.5 147.41 98.97 Favored Pre-proline 0 C--O 1.236 0.353 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 177.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.5 145.16 91.83 Favored 'Trans proline' 0 C--O 1.24 0.607 0 C-N-CA 121.799 1.666 . . . . 1.0 109.802 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.483 ' OD2' ' HB2' ' A' ' 61' ' ' ARG . 31.4 t70 -70.36 117.21 52.68 Favored Pre-proline 0 C--N 1.322 -0.601 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.08 -178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . 28.0 Cg_endo -62.97 -20.24 71.06 Favored 'Trans proline' 0 C--O 1.223 -0.241 0 C-N-CA 123.013 2.476 . . . . 1.0 114.117 -173.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.483 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 28.9 mtp-105 -72.55 -35.61 68.04 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 59' ' ' ASP . 1.8 t -87.2 -25.08 24.21 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.217 0.821 . . . . 1.0 113.217 -174.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.561 ' CD1' ' HA ' ' A' ' 60' ' ' PRO 0.291 0.0 OUTLIER -98.77 161.66 13.53 Favored 'General case' 0 CA--C 1.502 -0.872 0 C-N-CA 119.619 -0.832 . . . . 1.0 110.011 176.09 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -119.94 152.29 37.63 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 120.9 0.381 . . . . 1.0 111.204 -173.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 p -123.61 132.13 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.055 0 C-N-CA 120.026 -0.67 . . . . 1.0 109.365 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 40.9 mt-10 -89.6 112.49 23.72 Favored 'General case' 0 N--CA 1.412 -2.351 0 N-CA-C 104.647 -2.353 . . . . 1.0 104.647 172.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.534 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.2 t-105 -91.45 118.27 30.41 Favored 'General case' 1 N--CA 1.374 -4.273 0 C-N-CA 119.299 -0.96 . . . . 1.0 108.525 178.21 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -104.46 88.72 3.02 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 106.241 -1.763 . . . . 1.0 106.241 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 39.9 p -90.12 -16.38 29.71 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 113.845 -1.525 . . . . 1.0 109.561 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.05 -51.16 3.48 Favored Glycine 0 C--N 1.291 -1.962 0 CA-C-N 114.764 -1.107 . . . . 1.0 111.836 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.29 -38.88 83.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.023 0.529 . . . . 1.0 110.976 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.78 7.24 30.22 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.932 0.872 . . . . 1.0 108.82 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 76.33 -132.43 12.66 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 114.168 -1.378 . . . . 1.0 110.925 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 4.5 p80 -117.06 101.3 8.36 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.81 0.814 . . . . 1.0 109.296 177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -106.68 143.9 34.12 Favored 'General case' 0 C--N 1.29 -2.013 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.049 -174.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.428 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 20.0 mm -88.43 109.12 19.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' A' ' 75' ' ' LEU . 9.0 mp -99.9 144.22 29.21 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-N 115.47 -0.786 . . . . 1.0 112.62 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.433 ' HA ' HG21 ' A' ' 37' ' ' ILE . 53.3 m -153.99 146.55 24.11 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 105.293 -2.114 . . . . 1.0 105.293 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.53 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 0.5 OUTLIER -74.45 -40.67 61.78 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.557 -0.857 . . . . 1.0 110.702 175.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -130.79 89.5 2.76 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.259 0.466 . . . . 1.0 112.259 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.449 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 10.8 m-20 -154.89 -151.85 0.37 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.316 -0.994 . . . . 1.0 108.316 173.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.449 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 9.1 p -54.57 -28.49 19.25 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 123.903 0.881 . . . . 1.0 111.29 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 t -83.52 3.11 33.77 Favored 'General case' 0 CA--C 1.559 1.319 0 C-N-CA 123.219 0.608 . . . . 1.0 110.964 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.5 t -117.07 98.18 6.33 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 108.529 -0.915 . . . . 1.0 108.529 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -118.64 130.64 55.98 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.61 -1.255 . . . . 1.0 107.61 177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.615 HG23 ' H ' ' A' ' 91' ' ' ARG . 15.0 p -143.49 118.89 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.954 0 CA-C-O 121.967 0.889 . . . . 1.0 112.078 -175.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -80.63 -33.85 35.46 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 114.73 -1.123 . . . . 1.0 110.545 175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.5 -90.13 0.08 OUTLIER Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 111.264 -0.735 . . . . 1.0 111.264 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.1 pp -105.9 3.82 28.94 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.051 0.453 . . . . 1.0 111.292 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -62.02 -42.83 99.59 Favored 'General case' 0 N--CA 1.425 -1.694 0 C-N-CA 123.841 0.856 . . . . 1.0 111.97 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.615 ' H ' HG23 ' A' ' 86' ' ' VAL . 2.9 tpm_? -135.93 153.45 51.43 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.012 -176.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 92' ' ' ARG . 1.9 tpm_? -131.22 -67.86 0.69 Allowed 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 107.558 -1.275 . . . . 1.0 107.558 174.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' HB2' ' A' ' 79' ' ' ASP . 67.2 mt -132.41 161.81 32.69 Favored 'General case' 0 N--CA 1.433 -1.313 0 N-CA-C 106.948 -1.501 . . . . 1.0 106.948 177.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.53 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 38.5 m-80 -89.66 139.8 30.2 Favored 'General case' 0 CA--C 1.502 -0.903 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.332 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -118.73 171.3 8.3 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 124.043 0.937 . . . . 1.0 109.406 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.492 HD13 HG22 ' A' ' 101' ' ' VAL . 2.1 pp -71.96 -27.43 62.78 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 108.628 -0.878 . . . . 1.0 108.628 176.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.552 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 6.1 pt20 -63.74 -25.76 68.34 Favored 'General case' 0 C--O 1.211 -0.932 0 CA-C-N 115.789 -0.642 . . . . 1.0 112.584 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -64.19 -45.8 86.74 Favored 'General case' 0 C--O 1.223 -0.307 0 N-CA-C 109.609 -0.515 . . . . 1.0 109.609 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -93.04 -3.76 53.72 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.132 -0.486 . . . . 1.0 111.37 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 13.5 mmtm 43.44 67.92 0.58 Allowed 'General case' 0 CA--C 1.493 -1.217 0 C-N-CA 124.96 1.304 . . . . 1.0 113.046 -179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.534 HG11 ' NE1' ' A' ' 67' ' ' TRP . 1.8 m -74.81 148.24 84.78 Favored Pre-proline 0 C--N 1.294 -1.815 0 CA-C-N 114.703 -1.135 . . . . 1.0 111.566 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.8 164.24 33.99 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 123.338 2.692 . . . . 1.0 112.924 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -65.09 116.4 6.45 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 108.491 -0.929 . . . . 1.0 108.491 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.74 24.94 12.37 Favored Glycine 0 C--N 1.303 -1.269 0 C-N-CA 119.283 -1.437 . . . . 1.0 112.11 177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.15 164.2 26.11 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.736 -0.468 . . . . 1.0 109.736 176.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.9 m -113.26 130.67 56.18 Favored 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 120.418 -0.513 . . . . 1.0 110.663 -174.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.5 m -111.46 135.37 50.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -130.82 130.57 43.82 Favored 'General case' 0 C--N 1.28 -2.432 0 N-CA-C 108.971 -0.752 . . . . 1.0 108.971 177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.542 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 3.9 pp -113.45 144.74 42.31 Favored 'General case' 0 C--N 1.262 -3.199 0 C-N-CA 119.984 -0.686 . . . . 1.0 111.258 -175.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG13 ' HB3' ' A' ' 16' ' ' ALA . 13.7 m -133.64 130.73 20.94 Favored Pre-proline 0 N--CA 1.423 -1.786 0 CA-C-N 115.367 -0.833 . . . . 1.0 109.156 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 63' ' ' LEU . 49.7 Cg_endo -70.49 84.09 0.79 Allowed 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.555 2.17 . . . . 1.0 111.485 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.653 ' HA ' ' OD1' ' A' ' 64' ' ' ASP . 4.8 p 52.47 76.91 0.17 Allowed 'General case' 0 CA--C 1.505 -0.764 0 C-N-CA 125.544 1.538 . . . . 1.0 112.374 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -123.1 -53.22 1.84 Allowed 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 115.629 -0.714 . . . . 1.0 111.447 -177.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 5.9 t -108.68 8.37 26.91 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.051 0.929 . . . . 1.0 111.664 -173.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 3.5 tmmm? -123.66 90.12 3.22 Favored 'General case' 0 C--N 1.28 -2.443 0 N-CA-C 107.861 -1.163 . . . . 1.0 107.861 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -148.87 -169.44 3.37 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 105.902 -1.888 . . . . 1.0 105.902 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.01 140.53 17.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 109.205 -0.665 . . . . 1.0 109.205 175.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 93.6 mt -76.46 135.84 39.39 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 116.316 -0.402 . . . . 1.0 111.042 -174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -64.55 -32.91 74.76 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.678 -0.692 . . . . 1.0 110.825 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -83.4 85.81 7.17 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.812 0.815 . . . . 1.0 109.84 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -145.5 88.26 1.84 Allowed 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 106.948 -1.501 . . . . 1.0 106.948 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.6 mm100 . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 118.542 -0.742 . . . . 1.0 109.281 -175.392 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 121.403 0.62 . . . . 1.0 110.003 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.453 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -131.73 164.45 25.94 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 107.948 -1.131 . . . . 1.0 107.948 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.14 67.15 9.61 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 123.069 1.414 . . . . 1.0 108.915 175.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.22 20.39 5.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 CA-C-N 114.19 -1.368 . . . . 1.0 109.203 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -89.59 54.37 2.87 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 123.009 1.385 . . . . 1.0 110.331 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.444 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 50.3 m-85 -133.05 -178.93 5.19 Favored 'General case' 0 N--CA 1.384 -3.769 0 N-CA-C 100.733 -3.803 . . . . 1.0 100.733 175.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.426 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 27.3 mmt180 -107.43 111.24 63.1 Favored Pre-proline 0 C--N 1.268 -2.948 0 C-N-CA 116.902 -1.919 . . . . 1.0 112.53 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 16.1 Cg_exo -68.45 111.09 2.44 Favored 'Trans proline' 0 N--CA 1.445 -1.338 0 C-N-CA 122.2 1.933 . . . . 1.0 107.742 173.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.416 ' HG ' ' N ' ' A' ' 10' ' ' THR . 3.7 tp -106.73 154.9 20.29 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-N 115.626 -0.716 . . . . 1.0 111.162 -172.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.416 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 17.9 m -88.09 119.14 28.18 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 106.679 -1.6 . . . . 1.0 106.679 174.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.58 HD11 HG13 ' A' ' 107' ' ' VAL . 1.0 OUTLIER -127.92 140.26 52.11 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -102.18 120.16 39.99 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.732 -0.605 . . . . 1.0 111.052 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.555 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.53 108.38 14.12 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.306 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.511 HD21 ' HA2' ' A' ' 22' ' ' GLY . 25.4 tp -141.67 159.83 41.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -130.02 143.79 50.98 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 178.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.693 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -109.69 39.85 2.02 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.839 -175.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.43 HG22 ' HD3' ' A' ' 111' ' ' PRO . 46.6 t -65.26 -45.44 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.19 0 N-CA-C 112.058 0.392 . . . . 1.0 112.058 -176.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 153.91 -79.46 0.19 Allowed Glycine 0 N--CA 1.441 -1.013 0 C-N-CA 119.823 -1.18 . . . . 1.0 112.142 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -61.31 -31.51 89.11 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.788 2.325 . . . . 1.0 112.378 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.98 27.95 7.55 Favored Glycine 0 N--CA 1.432 -1.598 0 C-N-CA 121.0 -0.619 . . . . 1.0 111.67 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.49 76.03 5.0 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.47 0.652 . . . . 1.0 111.665 -176.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.511 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 124.57 -15.16 7.61 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 110.446 -1.061 . . . . 1.0 110.446 176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.65 29.93 6.68 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 114.722 -0.739 . . . . 1.0 111.606 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.2 -90.39 0.19 Allowed 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 120.301 -0.56 . . . . 1.0 110.95 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HB2' HG23 ' A' ' 27' ' ' VAL . 11.2 pt20 -111.76 -56.07 2.43 Favored 'General case' 0 N--CA 1.426 -1.652 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.654 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.01 65.74 3.31 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 111.395 -0.682 . . . . 1.0 111.395 -178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 25' ' ' GLN . 34.8 t -110.41 124.23 33.78 Favored Pre-proline 0 C--N 1.303 -1.444 0 CA-C-N 115.559 -0.32 . . . . 1.0 110.44 -174.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.26 104.3 1.88 Allowed 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 122.245 1.963 . . . . 1.0 110.822 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.538 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 42.9 t -109.29 155.63 10.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 108.465 -0.939 . . . . 1.0 108.465 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.19 137.4 40.51 Favored 'General case' 0 N--CA 1.426 -1.63 0 CA-C-O 121.881 0.848 . . . . 1.0 110.618 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.1 p -140.76 157.81 23.63 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 CA-C-N 114.299 -1.319 . . . . 1.0 108.082 -176.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.9 mt -89.74 155.86 18.91 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 121.402 0.62 . . . . 1.0 112.245 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.426 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 31.9 t70 -64.6 -30.79 71.82 Favored 'General case' 0 C--O 1.267 1.991 0 CA-C-N 114.559 -1.2 . . . . 1.0 109.189 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.579 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 5.8 t -88.82 -0.16 57.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 113.877 -1.511 . . . . 1.0 111.565 -177.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -75.33 135.41 40.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.558 0.694 . . . . 1.0 109.402 177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.44 HG21 HD12 ' A' ' 93' ' ' LEU . 81.0 p -81.78 174.67 11.12 Favored 'General case' 0 C--N 1.277 -2.552 0 CA-C-N 114.569 -1.196 . . . . 1.0 109.579 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.614 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 36.5 mm -60.54 -44.39 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 C-N-CA 120.918 -0.313 . . . . 1.0 110.329 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -62.21 -47.29 85.12 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 124.135 0.897 . . . . 1.0 110.045 178.005 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -65.47 -41.28 93.53 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.785 -176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.698 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -63.59 -35.92 82.09 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.737 -0.665 . . . . 1.0 111.329 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.22 -38.01 89.51 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.84 -0.8 . . . . 1.0 108.84 177.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' SER . 37.3 mt-10 -65.83 -45.22 83.09 Favored 'General case' 0 C--O 1.205 -1.245 0 CA-C-N 115.163 -0.926 . . . . 1.0 110.83 -176.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -62.01 -41.71 98.36 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.893 0.331 . . . . 1.0 111.893 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.698 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 72.4 mmm -65.63 -42.5 91.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.035 0.445 . . . . 1.0 110.625 -176.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.447 ' HB2' ' CD2' ' A' ' 49' ' ' TYR . 4.5 pp -76.27 -29.9 57.62 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-N 116.23 -0.441 . . . . 1.0 111.848 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -56.2 -28.61 58.9 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.924 1.69 . . . . 1.0 113.031 -172.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.493 ' HG3' HG22 ' A' ' 29' ' ' VAL . 88.3 mm-40 -66.39 -34.72 78.59 Favored 'General case' 0 CA--C 1.503 -0.85 0 CA-C-O 121.099 0.476 . . . . 1.0 110.877 -176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.33 -32.39 5.3 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.393 -0.821 . . . . 1.0 111.778 -173.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.447 ' CD2' ' HB2' ' A' ' 45' ' ' LEU . 89.9 m-85 -92.0 25.38 2.85 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 123.241 0.617 . . . . 1.0 109.507 178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -58.76 118.24 5.49 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.04 -5.86 21.95 Favored Glycine 0 C--N 1.3 -1.459 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.0 t -93.12 116.17 66.09 Favored Pre-proline 0 N--CA 1.438 -1.057 0 N-CA-C 108.925 -0.768 . . . . 1.0 108.925 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 76.9 Cg_endo -69.74 164.18 35.48 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.071 2.514 . . . . 1.0 111.634 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.424 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 3.1 tm? -60.62 -40.84 93.38 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 122.825 0.45 . . . . 1.0 110.227 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 t -63.83 -18.22 63.91 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.723 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -98.78 -25.18 14.74 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.958 -0.464 . . . . 1.0 109.988 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 85.8 mtt180 -65.72 142.99 98.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -62.25 144.56 95.61 Favored 'Trans proline' 0 C--O 1.239 0.569 0 C-N-CA 122.269 1.98 . . . . 1.0 111.913 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 62' ' ' THR . 7.7 t70 -75.07 126.96 87.51 Favored Pre-proline 0 C--N 1.299 -1.606 0 N-CA-C 108.166 -1.05 . . . . 1.0 108.166 176.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . 55.9 Cg_endo -68.7 -6.75 18.65 Favored 'Trans proline' 0 C--N 1.319 -1.012 0 C-N-CA 122.755 2.303 . . . . 1.0 114.492 -174.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -94.34 -17.91 22.11 Favored 'General case' 0 C--N 1.318 -0.778 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.037 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 59' ' ' ASP . 5.5 t -91.47 -8.06 48.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.411 0.624 . . . . 1.0 110.939 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -135.26 144.09 46.66 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.627 -0.879 . . . . 1.0 108.627 173.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -112.32 151.71 29.39 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-O 120.652 0.263 . . . . 1.0 110.8 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.437 HG12 ' O ' ' A' ' 77' ' ' LEU . 12.5 p -121.28 130.25 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 C-N-CA 119.581 -0.847 . . . . 1.0 111.219 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.52 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 35.9 mt-10 -90.41 113.12 24.97 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.564 -2.013 . . . . 1.0 105.564 172.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.58 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -89.61 120.69 31.12 Favored 'General case' 0 N--CA 1.386 -3.642 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -113.45 89.1 3.0 Favored 'General case' 0 N--CA 1.402 -2.861 0 N-CA-C 107.578 -1.268 . . . . 1.0 107.578 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.4 p -81.86 -19.76 40.33 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.863 -1.062 . . . . 1.0 109.676 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 85.46 -50.26 4.31 Favored Glycine 0 C--N 1.308 -1.023 0 CA-C-N 114.572 -1.195 . . . . 1.0 112.002 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.45 -37.84 81.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.148 0.499 . . . . 1.0 111.432 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.59 -7.2 22.01 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.759 0.79 . . . . 1.0 109.395 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 94.88 -121.5 6.82 Favored Glycine 0 N--CA 1.435 -1.417 0 CA-C-N 114.872 -1.058 . . . . 1.0 110.99 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.3 p80 -135.24 120.35 18.8 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.264 0.554 . . . . 1.0 111.055 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -123.12 149.41 44.54 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 -177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.52 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 21.7 mm -88.81 114.79 27.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 108.666 -0.864 . . . . 1.0 108.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.456 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.6 mp -110.37 143.5 40.53 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.293 0.568 . . . . 1.0 111.63 -177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 27.4 m -161.09 155.84 23.64 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 105.341 -2.096 . . . . 1.0 105.341 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.639 ' HB2' HD22 ' A' ' 93' ' ' LEU . 2.7 p-10 -74.36 -45.61 45.91 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.988 -0.685 . . . . 1.0 111.418 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.618 ' HA ' ' CB ' ' A' ' 84' ' ' SER . 47.5 mt-10 -129.46 65.61 1.47 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 112.934 0.716 . . . . 1.0 112.934 -176.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 4.2 m-20 -141.09 -109.39 0.14 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.55 0.944 . . . . 1.0 113.55 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -59.94 -29.94 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 114.297 1.221 . . . . 1.0 114.297 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.4 t -123.06 20.62 9.89 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.321 0.581 . . . . 1.0 109.923 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.618 ' CB ' ' HA ' ' A' ' 80' ' ' GLU . 38.8 t -115.31 94.29 4.66 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 119.402 -0.919 . . . . 1.0 113.422 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -143.18 134.01 25.35 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 104.673 -2.343 . . . . 1.0 104.673 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG23 ' H ' ' A' ' 91' ' ' ARG . 5.3 p -139.91 126.64 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 CA-C-O 122.099 0.952 . . . . 1.0 111.877 -171.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -64.8 -37.3 87.15 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.331 -1.758 . . . . 1.0 111.091 176.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.71 -77.34 0.05 OUTLIER Glycine 0 N--CA 1.435 -1.424 0 N-CA-C 110.818 -0.913 . . . . 1.0 110.818 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.3 pp -111.69 4.96 18.92 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 113.233 0.827 . . . . 1.0 113.233 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -61.89 -50.53 71.83 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 112.48 0.548 . . . . 1.0 112.48 -175.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.572 ' H ' HG23 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -139.85 121.07 14.83 Favored 'General case' 0 C--O 1.211 -0.971 0 CA-C-N 116.992 -0.094 . . . . 1.0 111.048 179.713 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? -93.9 -61.89 1.45 Allowed 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.409 -0.96 . . . . 1.0 108.409 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.639 HD22 ' HB2' ' A' ' 79' ' ' ASP . 79.9 mt -137.4 169.4 17.84 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 106.722 -1.585 . . . . 1.0 106.722 175.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -99.16 140.94 32.58 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 120.116 -0.634 . . . . 1.0 109.563 177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 2.0 p -112.35 173.88 6.15 Favored 'General case' 0 CA--C 1.499 -1.017 0 C-N-CA 123.328 0.651 . . . . 1.0 109.736 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.526 HD13 HG22 ' A' ' 101' ' ' VAL . 3.3 pp -75.67 -26.0 57.27 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 119.105 -1.038 . . . . 1.0 109.175 174.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.579 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.5 pt20 -66.2 -25.63 67.02 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 111.995 0.369 . . . . 1.0 111.995 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -61.34 -41.57 97.26 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 109.517 -0.549 . . . . 1.0 109.517 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -97.18 -8.41 30.1 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.935 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 100' ' ' LYS 0.275 8.6 mmtm 46.15 75.92 0.11 Allowed 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 125.278 1.431 . . . . 1.0 113.773 -176.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.58 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.1 m -84.7 150.19 55.76 Favored Pre-proline 0 C--N 1.285 -2.23 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.206 178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -81.09 165.1 19.5 Favored 'Trans proline' 0 C--O 1.244 0.794 0 C-N-CA 123.515 2.81 . . . . 1.0 112.567 178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.77 119.66 11.01 Favored 'General case' 0 CA--C 1.497 -1.072 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.399 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.72 19.01 12.63 Favored Glycine 0 C--N 1.29 -2.008 0 C-N-CA 120.7 -0.762 . . . . 1.0 111.405 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.98 155.67 37.98 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.198 0.523 . . . . 1.0 110.207 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 49.8 m -118.49 131.36 56.25 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.045 -174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 11' ' ' LEU . 33.7 m -112.98 139.29 38.9 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 C-N-CA 120.26 -0.576 . . . . 1.0 109.48 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.693 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -125.19 120.89 32.59 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 108.934 -0.765 . . . . 1.0 108.934 175.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.575 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.3 pp -106.35 141.97 36.8 Favored 'General case' 0 C--N 1.257 -3.454 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.771 -174.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 113' ' ' LEU . 18.4 m -133.29 137.09 28.44 Favored Pre-proline 0 N--CA 1.418 -2.063 0 CA-C-N 115.645 -0.707 . . . . 1.0 109.547 -178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.43 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.2 Cg_endo -73.89 84.09 1.51 Allowed 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 122.166 1.911 . . . . 1.0 111.614 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.451 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.4 p 52.34 61.6 3.12 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 125.066 1.346 . . . . 1.0 110.338 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 0.4 OUTLIER -110.89 -48.25 3.15 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.345 -0.843 . . . . 1.0 112.648 -173.191 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.7 t -112.78 7.76 18.61 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.662 -1.215 . . . . 1.0 111.974 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 115' ' ' LYS . 0.9 OUTLIER -126.71 115.65 19.74 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 114.827 -1.079 . . . . 1.0 108.193 173.659 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -144.46 -163.88 1.79 Allowed 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 106.237 -1.764 . . . . 1.0 106.237 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.5 143.88 14.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 106.869 -1.53 . . . . 1.0 106.869 168.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.4 mt -55.0 114.83 1.9 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 -172.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -72.05 -23.35 61.36 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.985 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -86.38 68.25 10.16 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 121.982 0.896 . . . . 1.0 109.635 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -145.05 92.54 2.28 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.419 -1.264 . . . . 1.0 107.728 176.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.3 mm100 . . . . . 0 C--N 1.295 -1.786 0 N-CA-C 108.696 -0.853 . . . . 1.0 108.696 -178.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.4 mttp . . . . . 0 CA--C 1.498 -1.03 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp 56.44 30.38 16.95 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.001 0.813 . . . . 1.0 110.984 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -76.0 -17.29 59.75 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 122.222 1.01 . . . . 1.0 109.771 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.432 ' HB ' ' CD2' ' A' ' 6' ' ' TYR . 11.0 m -130.47 130.79 65.3 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 CA-C-N 113.372 -1.74 . . . . 1.0 107.285 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -100.58 82.87 2.51 Favored 'General case' 0 CA--C 1.478 -1.811 0 CA-C-O 122.503 1.144 . . . . 1.0 112.618 -176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.432 ' CD2' ' HB ' ' A' ' 4' ' ' VAL . 65.8 m-85 -126.58 -177.84 4.15 Favored 'General case' 0 N--CA 1.395 -3.219 0 N-CA-C 104.921 -2.252 . . . . 1.0 104.921 177.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.514 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 17.7 mmt180 -116.06 111.3 42.88 Favored Pre-proline 0 C--N 1.283 -2.32 0 C-N-CA 117.492 -1.683 . . . . 1.0 113.778 -171.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 23.2 Cg_exo -64.47 104.65 0.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 121.967 1.778 . . . . 1.0 108.866 171.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.8 tp -107.59 161.41 14.88 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 115.611 -0.722 . . . . 1.0 109.983 -173.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 m -105.4 130.24 53.54 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.132 -0.692 . . . . 1.0 109.132 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 31' ' ' VAL . 1.9 mm? -124.37 148.12 47.75 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 123.514 0.726 . . . . 1.0 110.704 178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -93.06 111.21 22.77 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 115.535 -0.757 . . . . 1.0 109.364 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.16 115.13 15.58 Favored 'General case' 0 C--N 1.31 -1.109 0 O-C-N 123.68 0.613 . . . . 1.0 109.899 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.615 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 32.2 tp -147.73 155.43 41.71 Favored 'General case' 0 N--CA 1.418 -2.04 0 N-CA-C 108.623 -0.88 . . . . 1.0 108.623 -179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.512 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.64 144.44 48.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.926 -0.398 . . . . 1.0 109.926 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.475 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.73 30.29 7.45 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.625 0.726 . . . . 1.0 109.469 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.69 -47.1 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.632 0 CA-C-N 115.023 -0.989 . . . . 1.0 112.691 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.93 -86.36 0.07 OUTLIER Glycine 0 C--O 1.22 -0.768 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.906 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -61.7 -30.53 85.33 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.151 2.567 . . . . 1.0 113.019 -175.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.06 29.92 6.3 Favored Glycine 0 N--CA 1.429 -1.816 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.445 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.35 83.24 1.42 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.581 0.705 . . . . 1.0 112.063 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.579 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 99.53 3.99 56.16 Favored Glycine 0 CA--C 1.483 -1.94 0 N-CA-C 110.275 -1.13 . . . . 1.0 110.275 176.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -135.73 26.45 3.36 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.382 -0.909 . . . . 1.0 110.605 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.03 -95.44 0.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.124 0.787 . . . . 1.0 113.124 -175.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -123.72 -60.26 1.47 Allowed 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 112.753 0.649 . . . . 1.0 112.753 -174.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.25 79.26 0.6 Allowed Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 119.525 -1.321 . . . . 1.0 109.969 -176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.9 t -106.0 130.13 23.49 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 122.821 -0.223 . . . . 1.0 110.711 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.25 109.39 1.98 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.132 1.888 . . . . 1.0 111.28 177.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 44' ' ' MET . 58.1 t -120.08 138.58 50.18 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 C-N-CA 123.538 0.735 . . . . 1.0 109.144 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -102.95 155.89 18.04 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.129 0.49 . . . . 1.0 112.195 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 32' ' ' LEU . 5.2 p -158.06 -175.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 107.591 -1.262 . . . . 1.0 107.591 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.542 ' H ' HG22 ' A' ' 31' ' ' VAL . 13.2 tp -109.19 158.52 17.73 Favored 'General case' 0 C--O 1.206 -1.222 0 CA-C-N 119.267 0.94 . . . . 1.0 108.632 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 27.1 t70 -62.26 -29.99 70.8 Favored 'General case' 0 C--O 1.252 1.208 0 C-N-CA 123.429 0.692 . . . . 1.0 109.495 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HB2' ' CG ' ' A' ' 6' ' ' TYR . 12.2 t -99.25 31.02 3.23 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.903 -1.499 . . . . 1.0 110.392 -176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.657 ' O ' HG22 ' A' ' 95' ' ' THR . 11.7 p-10 -68.49 -165.56 0.06 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.549 0.69 . . . . 1.0 109.149 171.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.0 p -141.6 161.59 37.55 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.857 -2.645 . . . . 1.0 103.857 167.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.684 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 44.5 mm -58.57 -46.09 90.18 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 C-N-CA 119.741 -0.783 . . . . 1.0 110.557 -178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 36.7 t -63.52 -46.74 84.68 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 124.016 0.822 . . . . 1.0 110.37 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -64.82 -41.46 95.74 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.041 0.448 . . . . 1.0 111.426 -175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -64.32 -39.59 94.22 Favored 'General case' 0 CA--C 1.483 -1.622 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.57 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.684 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -63.3 -35.33 79.99 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.253 -0.579 . . . . 1.0 109.625 -179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.537 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.0 mt-10 -64.44 -45.96 85.21 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.771 0.669 . . . . 1.0 110.062 -178.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -67.51 -41.7 84.03 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.808 179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.813 ' HA ' HG11 ' A' ' 29' ' ' VAL . 13.3 mtp -63.59 -42.42 98.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.249 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.6 pp -74.72 -26.88 60.11 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 120.447 -0.501 . . . . 1.0 111.243 178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 50' ' ' LYS . 23.8 t70 -62.45 -32.91 73.85 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.414 0.626 . . . . 1.0 111.596 -179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HG3' HG22 ' A' ' 29' ' ' VAL . 14.5 mm-40 -70.55 -29.66 66.18 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.676 -178.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.8 mt -116.63 -54.41 2.44 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 121.833 0.825 . . . . 1.0 112.256 -169.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -91.33 -4.8 55.45 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 114.695 -1.139 . . . . 1.0 111.789 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 46' ' ' ASP . 6.0 tmmm? -77.46 121.21 23.52 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 106.922 -1.51 . . . . 1.0 106.922 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.61 -7.8 56.05 Favored Glycine 0 C--N 1.306 -1.097 0 N-CA-C 110.811 -0.916 . . . . 1.0 110.811 -175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.796 HG22 ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -81.59 160.65 63.9 Favored Pre-proline 0 CA--C 1.551 1.018 0 N-CA-C 107.132 -1.432 . . . . 1.0 107.132 177.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.796 ' HD2' HG22 ' A' ' 52' ' ' VAL . 15.8 Cg_endo -56.85 150.96 51.41 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 121.741 1.627 . . . . 1.0 111.37 176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.5 mt -59.88 -40.37 88.48 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 123.351 0.66 . . . . 1.0 112.113 -171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -69.69 -14.26 62.71 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.098 0.475 . . . . 1.0 111.56 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.473 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 18.7 mm100 -95.63 -8.81 33.81 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.464 -0.334 . . . . 1.0 110.756 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.14 111.65 35.07 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.286 -0.635 . . . . 1.0 109.286 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HB2' ' CD2' ' A' ' 63' ' ' LEU . 93.9 Cg_endo -76.92 155.39 34.2 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.019 2.479 . . . . 1.0 112.676 -176.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -94.44 114.77 64.21 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 115.758 -0.656 . . . . 1.0 109.973 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.32 -3.68 14.22 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 122.947 2.432 . . . . 1.0 113.433 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -91.03 -21.82 21.07 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.502 -0.479 . . . . 1.0 111.025 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.9 t -105.69 -24.58 12.5 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.357 0.502 . . . . 1.0 112.357 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.702 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp -94.62 162.16 13.9 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 112.167 0.432 . . . . 1.0 112.167 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 7.6 p-10 -117.18 157.38 26.07 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.28 -178.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 3.6 p -122.61 127.17 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.169 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.254 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -91.91 112.93 25.06 Favored 'General case' 0 N--CA 1.399 -2.997 0 N-CA-C 106.406 -1.702 . . . . 1.0 106.406 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.467 ' NE1' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -93.18 122.18 35.3 Favored 'General case' 1 N--CA 1.377 -4.089 0 CA-C-N 114.67 -1.15 . . . . 1.0 108.991 -177.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.483 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 88.0 mtm180 -112.56 89.81 3.17 Favored 'General case' 0 N--CA 1.389 -3.508 0 CA-C-O 122.601 1.191 . . . . 1.0 108.243 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.436 ' HA ' ' HB1' ' A' ' 105' ' ' ALA . 19.0 p -84.66 -16.89 40.31 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 113.64 -1.618 . . . . 1.0 109.232 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.29 -54.66 4.31 Favored Glycine 0 C--N 1.293 -1.846 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.239 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.4 HG22 ' HD3' ' A' ' 102' ' ' PRO . 33.9 m -62.3 -42.25 94.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.039 0.447 . . . . 1.0 111.126 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.04 -10.21 31.52 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.468 0.652 . . . . 1.0 109.318 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.77 -143.01 16.23 Favored Glycine 0 N--CA 1.425 -2.048 0 CA-C-N 115.089 -0.96 . . . . 1.0 110.83 -179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.483 ' CB ' ' HG2' ' A' ' 68' ' ' ARG . 3.5 p80 -116.55 112.21 21.01 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.574 0.702 . . . . 1.0 109.623 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.05 144.96 48.59 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.439 -0.801 . . . . 1.0 109.825 -175.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 116' ' ' HIS . 28.7 mm -85.2 115.65 27.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 107.721 -1.215 . . . . 1.0 107.721 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.466 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.8 mp -103.66 140.56 37.41 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.886 0.851 . . . . 1.0 111.338 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 47.4 m -152.39 148.15 27.13 Favored 'General case' 0 C--N 1.274 -2.696 0 N-CA-C 106.258 -1.756 . . . . 1.0 106.258 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.605 ' HB2' HD22 ' A' ' 93' ' ' LEU . 7.4 p-10 -70.96 -41.19 71.39 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.06 -0.656 . . . . 1.0 110.899 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -104.93 96.07 6.29 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 108.567 -0.901 . . . . 1.0 108.567 176.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 31.8 t70 -161.79 -89.29 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.044 0 CA-C-O 121.945 0.878 . . . . 1.0 112.82 -178.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.533 HG12 HD21 ' A' ' 94' ' ' ASN . 1.6 p -87.41 -2.5 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 CA-C-N 114.433 -1.258 . . . . 1.0 112.358 -171.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 92' ' ' ARG . 15.2 t -137.28 19.1 2.95 Favored 'General case' 0 C--N 1.29 -1.987 0 C-N-CA 119.878 -0.729 . . . . 1.0 110.174 177.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.1 p -89.15 10.82 20.54 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.928 -0.578 . . . . 1.0 111.589 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -56.79 117.29 3.78 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.793 -0.639 . . . . 1.0 111.168 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.0 m -88.89 64.51 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 CA-C-O 122.522 1.153 . . . . 1.0 110.969 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -101.89 0.66 35.84 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.418 -1.265 . . . . 1.0 110.184 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.89 -100.69 0.24 Allowed Glycine 0 N--CA 1.4 -3.765 0 N-CA-C 110.436 -1.066 . . . . 1.0 110.436 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.3 mt -102.88 5.31 38.46 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 121.7 0.762 . . . . 1.0 111.148 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -91.9 0.53 57.48 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.03 -0.987 . . . . 1.0 111.624 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -67.35 93.99 0.36 Allowed 'General case' 0 C--O 1.243 0.747 0 N-CA-C 106.278 -1.749 . . . . 1.0 106.278 171.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.534 ' O ' HG23 ' A' ' 83' ' ' THR . 51.5 ttp180 -133.88 157.37 46.13 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.439 -169.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 79' ' ' ASP . 75.8 mt -95.66 148.66 22.31 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.533 HD21 HG12 ' A' ' 82' ' ' VAL . 53.5 m-80 -81.34 136.57 35.75 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 119.51 -0.876 . . . . 1.0 110.765 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.2 p -106.75 171.71 7.22 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 124.791 1.236 . . . . 1.0 109.334 177.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.447 HD13 HG22 ' A' ' 101' ' ' VAL . 2.7 pp -71.57 -28.53 63.91 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.588 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -64.93 -25.64 67.97 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.493 -0.776 . . . . 1.0 111.921 176.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -61.62 -41.72 97.87 Favored 'General case' 0 C--O 1.219 -0.547 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -100.03 -4.36 30.11 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.714 -0.675 . . . . 1.0 111.518 177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 65.2 mmtt 43.49 68.16 0.55 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.738 1.215 . . . . 1.0 112.227 -177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.467 HG11 ' NE1' ' A' ' 67' ' ' TRP . 2.9 m -75.57 149.01 83.44 Favored Pre-proline 0 C--N 1.304 -1.403 0 CA-C-N 114.915 -1.038 . . . . 1.0 111.636 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.4 ' HD3' HG22 ' A' ' 71' ' ' VAL . 91.8 Cg_endo -73.74 162.98 38.36 Favored 'Trans proline' 0 C--O 1.251 1.166 0 C-N-CA 122.828 2.352 . . . . 1.0 112.697 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -64.76 116.86 6.72 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.317 -0.856 . . . . 1.0 109.502 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 88.83 35.09 8.53 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 119.981 -1.105 . . . . 1.0 111.509 -179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' A' ' 69' ' ' SER . . . -74.03 162.89 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.767 -0.457 . . . . 1.0 109.767 175.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.1 m -108.9 123.83 49.69 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.524 -0.47 . . . . 1.0 111.156 -174.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.503 HG21 ' SD ' ' A' ' 44' ' ' MET . 5.9 m -104.79 144.83 14.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 N-CA-C 108.693 -0.855 . . . . 1.0 108.693 174.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -139.85 132.86 29.47 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 108.863 -0.791 . . . . 1.0 108.863 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.512 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 1.6 pt? -118.13 143.49 46.44 Favored 'General case' 0 C--N 1.269 -2.934 0 C-N-CA 120.326 -0.55 . . . . 1.0 110.379 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.702 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 14.6 m -124.26 164.87 27.36 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 108.477 -0.934 . . . . 1.0 108.477 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -84.81 56.32 4.61 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.497 2.132 . . . . 1.0 111.472 -176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.569 ' SG ' ' HD3' ' A' ' 115' ' ' LYS . 5.2 t 63.43 82.75 0.17 Allowed 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.162 -0.926 . . . . 1.0 109.488 -175.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -128.83 -45.79 1.28 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 120.165 -0.614 . . . . 1.0 111.499 -177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.9 t -127.45 36.55 4.37 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.142 0.496 . . . . 1.0 110.429 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.569 ' HD3' ' SG ' ' A' ' 112' ' ' CYS . 53.5 pttt -50.57 14.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.873 2.545 . . . . 1.0 117.873 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.421 ' HB2' ' HB ' ' A' ' 76' ' ' ILE . 8.7 t-160 68.72 14.59 9.0 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 124.063 0.945 . . . . 1.0 112.237 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.3 m -152.25 148.4 14.38 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.499 0 N-CA-C 106.674 -1.602 . . . . 1.0 106.674 176.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.9 pp -142.73 164.35 30.34 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 120.034 -0.666 . . . . 1.0 112.336 -177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -133.8 134.82 43.33 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.782 -1.192 . . . . 1.0 107.782 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -71.45 133.68 46.05 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 123.328 0.393 . . . . 1.0 110.534 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -95.3 96.02 8.87 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.447 -1.316 . . . . 1.0 107.447 177.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 . . . . . 0 C--N 1.284 -2.257 0 N-CA-C 106.723 -1.584 . . . . 1.0 106.723 -178.705 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt . . . . . 0 CA--C 1.499 -0.992 0 N-CA-C 106.234 -1.765 . . . . 1.0 106.234 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -78.24 68.45 4.27 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 122.989 1.376 . . . . 1.0 110.028 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -88.58 11.12 18.17 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 113.645 -1.616 . . . . 1.0 109.163 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.0 t 65.97 66.41 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.245 -1.343 . . . . 1.0 111.356 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -104.84 32.2 4.3 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.444 -1.253 . . . . 1.0 109.101 178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.534 ' HB2' HD22 ' A' ' 32' ' ' LEU . 11.7 m-85 -116.23 173.35 6.64 Favored 'General case' 0 C--N 1.277 -2.575 0 N-CA-C 105.149 -2.167 . . . . 1.0 105.149 -175.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.472 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 33.9 mmt180 -109.6 110.96 59.54 Favored Pre-proline 0 C--N 1.278 -2.542 0 C-N-CA 119.736 -0.786 . . . . 1.0 110.765 -179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -62.16 100.1 0.21 Allowed 'Trans proline' 0 C--O 1.245 0.843 0 N-CA-C 107.859 -1.631 . . . . 1.0 107.859 167.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.45 130.2 55.25 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 -171.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.3 m -89.36 129.45 35.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 109.969 -0.382 . . . . 1.0 109.969 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 31' ' ' VAL . 1.7 mm? -120.95 147.51 45.36 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 123.343 0.657 . . . . 1.0 110.366 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.408 HD22 HG23 ' A' ' 106' ' ' THR . 7.3 t30 -90.92 108.5 19.89 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 108.759 -0.83 . . . . 1.0 108.759 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.38 109.19 7.67 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.776 -0.647 . . . . 1.0 111.026 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.702 HD21 ' HA2' ' A' ' 22' ' ' GLY . 30.8 tp -137.52 166.59 23.53 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 109.002 -0.74 . . . . 1.0 109.002 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.604 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -131.38 143.93 50.84 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HB3' ' CG1' ' A' ' 110' ' ' VAL . . . -114.96 38.75 3.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.517 HG22 ' HD3' ' A' ' 111' ' ' PRO . 47.8 t -66.63 -44.48 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.032 0 N-CA-C 112.83 0.678 . . . . 1.0 112.83 -175.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.52 -88.2 0.09 OUTLIER Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 119.123 -1.513 . . . . 1.0 113.713 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.88 -29.35 82.37 Favored 'Trans proline' 0 N--CA 1.485 0.985 0 C-N-CA 123.253 2.635 . . . . 1.0 113.546 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -115.45 24.99 10.05 Favored Glycine 0 N--CA 1.427 -1.92 0 N-CA-C 110.943 -0.863 . . . . 1.0 110.943 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.1 84.6 0.72 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.354 0.597 . . . . 1.0 111.826 -177.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.702 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 115.33 -5.72 21.41 Favored Glycine 0 CA--C 1.487 -1.687 0 CA-C-N 115.163 -0.926 . . . . 1.0 111.271 173.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -133.63 19.13 3.9 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.264 -0.468 . . . . 1.0 112.082 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -84.99 -92.37 0.09 Allowed 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.72 1.007 . . . . 1.0 113.72 -172.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 10.7 pt20 -110.04 -59.18 1.96 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 112.461 0.541 . . . . 1.0 112.461 -173.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.412 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.7 69.7 1.25 Allowed Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.62 -0.592 . . . . 1.0 111.62 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.3 t -103.89 127.01 30.25 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.99 -0.105 . . . . 1.0 110.743 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -72.48 107.43 2.29 Favored 'Trans proline' 0 C--O 1.244 0.795 0 C-N-CA 121.862 1.708 . . . . 1.0 111.36 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.78 HG11 ' HA ' ' A' ' 44' ' ' MET . 83.7 t -119.95 140.09 45.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.17 -0.923 . . . . 1.0 109.586 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -104.73 146.31 29.13 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.081 -0.648 . . . . 1.0 111.808 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG22 HD23 ' A' ' 11' ' ' LEU . 15.3 m -141.94 171.21 11.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 124.241 1.017 . . . . 1.0 109.08 176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.534 HD22 ' HB2' ' A' ' 6' ' ' TYR . 11.5 mt -88.37 159.15 18.17 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 121.118 0.485 . . . . 1.0 111.267 176.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.472 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 37.5 t70 -61.93 -30.75 71.11 Favored 'General case' 0 C--O 1.269 2.11 0 CA-C-N 115.049 -0.978 . . . . 1.0 108.505 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.463 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 1.5 t -96.12 6.08 49.63 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 114.25 -1.341 . . . . 1.0 113.365 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.4 m-20 -70.19 134.91 48.56 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 107.293 -1.373 . . . . 1.0 107.293 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.531 HG22 HD11 ' A' ' 93' ' ' LEU . 49.3 p -79.75 166.88 21.32 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 108.125 -1.065 . . . . 1.0 108.125 -177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.12 -44.59 91.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 120.36 -0.536 . . . . 1.0 111.89 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.662 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 3.6 p -61.84 -47.32 85.57 Favored 'General case' 0 N--CA 1.428 -1.534 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.842 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.505 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 48.9 mt-30 -72.01 -38.23 69.65 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 112.975 0.732 . . . . 1.0 112.975 -176.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.4 -39.96 85.59 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 0.3 OUTLIER -62.51 -33.66 75.33 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 109.538 -0.542 . . . . 1.0 109.538 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.662 ' HG3' ' O ' ' A' ' 38' ' ' SER . 44.2 mt-10 -65.36 -48.64 72.25 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 124.086 0.866 . . . . 1.0 110.208 178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 41.4 mmtm -60.83 -44.35 97.05 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 109.045 -0.724 . . . . 1.0 109.045 -176.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.78 ' HA ' HG11 ' A' ' 29' ' ' VAL . 9.3 mtp -64.94 -41.97 95.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 114.751 -1.113 . . . . 1.0 112.288 -178.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 pp -76.02 -32.91 59.61 Favored 'General case' 0 C--O 1.213 -0.833 0 C-N-CA 120.428 -0.509 . . . . 1.0 111.765 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' O ' ' HE3' ' A' ' 50' ' ' LYS . 38.1 t70 -61.44 -29.78 70.16 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 123.508 0.723 . . . . 1.0 112.049 -174.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.533 HE21 HG13 ' A' ' 29' ' ' VAL . 11.3 mm-40 -67.54 -39.18 85.02 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.607 -177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.68 -19.15 13.28 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.639 -0.709 . . . . 1.0 112.468 -169.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -98.15 14.77 26.47 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.182 -0.673 . . . . 1.0 109.182 175.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.46 ' HE3' ' O ' ' A' ' 46' ' ' ASP . 4.6 tppp? -64.84 126.59 28.44 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.363 -0.835 . . . . 1.0 109.435 177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.76 -19.1 39.38 Favored Glycine 0 C--N 1.314 -0.675 0 N-CA-C 109.508 -1.437 . . . . 1.0 109.508 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.5 t -93.45 133.8 27.72 Favored Pre-proline 0 N--CA 1.436 -1.154 0 N-CA-C 107.827 -1.175 . . . . 1.0 107.827 177.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.469 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 47.4 Cg_endo -63.75 153.0 77.98 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.779 2.32 . . . . 1.0 111.626 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.5 tp -60.92 -37.46 82.39 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 123.085 0.554 . . . . 1.0 111.311 -176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.1 t -64.0 -23.83 67.48 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.837 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -96.14 -26.39 15.49 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.54 -0.464 . . . . 1.0 110.524 -178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 80.7 mtt180 -63.9 139.05 97.57 Favored Pre-proline 0 C--O 1.235 0.32 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.89 136.72 67.74 Favored 'Trans proline' 0 C--O 1.242 0.698 0 C-N-CA 121.309 1.339 . . . . 1.0 110.959 177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.588 ' HB3' HG22 ' A' ' 62' ' ' THR . 10.6 t70 -87.34 125.19 66.58 Favored Pre-proline 0 C--N 1.303 -1.447 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.566 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.423 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 39.8 Cg_endo -66.22 -17.0 53.8 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 123.127 2.551 . . . . 1.0 113.851 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -91.27 -11.05 39.24 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-O 120.976 0.417 . . . . 1.0 111.162 -176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.588 HG22 ' HB3' ' A' ' 59' ' ' ASP . 14.5 t -113.66 9.75 17.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.07 0.462 . . . . 1.0 110.281 176.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.9 pp -132.34 161.72 32.85 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.682 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.472 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 9.7 m-20 -108.89 151.63 26.01 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.925 -1.139 . . . . 1.0 107.925 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.16 128.52 75.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 C-N-CA 119.807 -0.757 . . . . 1.0 109.482 175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.406 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 41.9 mt-10 -89.74 112.47 23.77 Favored 'General case' 0 CA--C 1.457 -2.615 0 N-CA-C 105.612 -1.995 . . . . 1.0 105.612 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.589 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -91.25 117.27 29.5 Favored 'General case' 1 N--CA 1.367 -4.625 0 C-N-CA 119.273 -0.971 . . . . 1.0 108.501 177.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 91.6 mtt180 -102.8 88.25 3.15 Favored 'General case' 0 N--CA 1.394 -3.245 0 N-CA-C 105.963 -1.866 . . . . 1.0 105.963 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 59.1 p -83.65 -14.4 51.96 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.824 -1.535 . . . . 1.0 110.34 -175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.53 -57.73 3.77 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 115.126 -0.943 . . . . 1.0 111.765 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.2 -43.73 98.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.28 0.632 . . . . 1.0 111.766 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.37 -8.54 21.08 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.299 0.571 . . . . 1.0 110.347 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.41 -149.38 19.43 Favored Glycine 0 N--CA 1.423 -2.171 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.557 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 1.9 p80 -105.91 108.87 20.6 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.498 0.666 . . . . 1.0 111.299 179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -111.03 146.42 36.74 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.988 -1.006 . . . . 1.0 109.368 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.406 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 25.4 mm -87.87 99.27 8.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.363 -0.606 . . . . 1.0 109.363 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mp -89.34 156.37 18.76 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.716 -0.675 . . . . 1.0 110.564 -177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 5.3 t -160.84 164.41 31.37 Favored 'General case' 0 CA--C 1.465 -2.303 0 N-CA-C 106.454 -1.684 . . . . 1.0 106.454 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -63.58 -37.21 86.45 Favored 'General case' 0 C--N 1.288 -2.097 0 O-C-N 123.714 0.634 . . . . 1.0 110.079 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.418 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 2.6 tm-20 -163.67 88.91 0.57 Allowed 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 123.107 0.254 . . . . 1.0 110.846 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -152.63 -142.94 0.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.058 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 10.2 p -58.48 -33.16 47.35 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 N-CA-C 113.345 0.868 . . . . 1.0 113.345 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 p -85.3 4.52 34.61 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.759 0.79 . . . . 1.0 112.706 -177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.418 ' OG ' ' HA ' ' A' ' 80' ' ' GLU . 75.5 m -85.84 9.92 15.28 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.353 -0.84 . . . . 1.0 110.95 177.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 62.83 30.5 16.64 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 123.048 1.404 . . . . 1.0 110.038 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.9 p -71.76 85.19 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.262 -3.239 0 CA-C-N 113.333 -1.758 . . . . 1.0 112.796 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -117.83 -25.83 6.68 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 113.853 -1.521 . . . . 1.0 108.576 170.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.29 -111.42 0.29 Allowed Glycine 0 N--CA 1.416 -2.661 0 N-CA-C 109.309 -1.516 . . . . 1.0 109.309 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.6 pp -76.31 -10.58 59.51 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 112.932 0.715 . . . . 1.0 112.932 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -79.51 -0.47 33.42 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 116.035 -0.53 . . . . 1.0 111.473 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -65.88 125.43 25.37 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.334 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -136.97 -172.51 3.2 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.614 0.721 . . . . 1.0 112.848 -178.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.531 HD11 HG22 ' A' ' 36' ' ' THR . 3.0 tm? -102.72 138.22 39.9 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 126.247 1.819 . . . . 1.0 106.449 178.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.6 m-80 -96.74 139.59 32.57 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 118.399 -1.32 . . . . 1.0 112.929 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.439 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -129.39 176.45 7.95 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 125.855 1.662 . . . . 1.0 106.821 175.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.494 HD13 HG22 ' A' ' 101' ' ' VAL . 3.0 pp -73.32 -25.31 60.59 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.237 -1.385 . . . . 1.0 108.944 174.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.571 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 5.1 pt20 -66.36 -24.73 66.55 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 113.204 0.816 . . . . 1.0 113.204 177.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -60.31 -40.71 91.5 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 109.315 -0.624 . . . . 1.0 109.315 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -103.45 2.58 33.93 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.47 0.915 . . . . 1.0 113.47 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 30.9 mmmt 40.76 64.09 1.03 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.401 1.08 . . . . 1.0 112.097 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.589 HG11 ' CE2' ' A' ' 67' ' ' TRP . 2.1 m -68.74 150.95 97.49 Favored Pre-proline 0 C--N 1.294 -1.833 0 CA-C-N 115.539 -0.755 . . . . 1.0 111.786 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -76.12 155.83 37.92 Favored 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 122.154 1.903 . . . . 1.0 111.462 175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -65.95 124.5 22.7 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.654 0.74 . . . . 1.0 110.208 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.99 22.23 23.58 Favored Glycine 0 N--CA 1.431 -1.658 0 CA-C-N 115.328 -0.851 . . . . 1.0 112.092 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.408 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . . . -71.08 164.42 25.62 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.911 0.386 . . . . 1.0 109.993 177.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.408 HG23 HD22 ' A' ' 12' ' ' ASN . 79.3 m -111.56 130.55 55.7 Favored 'General case' 0 C--N 1.288 -2.072 0 C-N-CA 120.282 -0.567 . . . . 1.0 110.767 -173.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.63 HG21 ' SD ' ' A' ' 44' ' ' MET . 27.5 m -114.13 139.49 39.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 109.144 -0.687 . . . . 1.0 109.144 176.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -131.49 138.94 49.19 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 109.389 -0.597 . . . . 1.0 109.389 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.604 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.1 pp -108.89 139.55 43.57 Favored 'General case' 0 C--N 1.274 -2.681 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.548 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 36.0 m -130.42 130.92 23.08 Favored Pre-proline 0 C--N 1.306 -1.319 0 CA-C-N 115.569 -0.741 . . . . 1.0 109.511 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.517 ' HD3' HG22 ' A' ' 17' ' ' VAL . 42.4 Cg_endo -68.67 78.72 0.68 Allowed 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.791 2.327 . . . . 1.0 112.458 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 62' ' ' THR . 43.6 t 57.08 83.76 0.1 Allowed 'General case' 0 C--O 1.246 0.887 0 C-N-CA 124.781 1.232 . . . . 1.0 111.132 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 114' ' ' THR . 3.1 mm? 62.76 22.09 13.17 Favored 'General case' 0 CA--C 1.483 -1.624 0 C-N-CA 125.301 1.44 . . . . 1.0 110.319 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER 68.06 13.13 9.05 Favored 'General case' 0 C--O 1.249 1.065 0 CA-C-N 113.365 -1.743 . . . . 1.0 112.682 177.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' HE2' ' HA ' ' A' ' 115' ' ' LYS . 11.4 mmpt? -88.3 91.77 8.91 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.538 -0.912 . . . . 1.0 108.538 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -88.93 102.19 14.82 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 115.308 -0.86 . . . . 1.0 109.67 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.7 m -125.16 166.98 19.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 114.451 -1.249 . . . . 1.0 108.667 -177.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.7 78.66 6.26 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.003 -0.739 . . . . 1.0 109.003 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -70.8 -42.59 70.09 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.544 -0.753 . . . . 1.0 110.447 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -81.79 97.94 8.23 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.56 -0.745 . . . . 1.0 111.308 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -163.03 160.06 24.08 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 106.691 -1.596 . . . . 1.0 106.691 176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? . . . . . 0 C--N 1.27 -2.853 0 N-CA-C 109.169 -0.678 . . . . 1.0 109.169 177.437 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 4.2 mppt? -146.72 178.12 8.56 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.117 -1.438 . . . . 1.0 107.117 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -84.1 88.93 7.2 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.039 -1.838 . . . . 1.0 106.039 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.7 t -91.79 87.69 2.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.168 -0.923 . . . . 1.0 113.063 -171.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -129.21 31.01 4.93 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 124.089 1.899 . . . . 1.0 106.069 167.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.578 ' CD1' ' HB2' ' A' ' 34' ' ' CYS . 89.3 m-85 -134.89 -177.66 4.73 Favored 'General case' 0 N--CA 1.397 -3.108 0 CA-C-N 111.732 -2.485 . . . . 1.0 105.905 -172.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.436 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 59.4 mmt-85 -104.31 114.57 64.12 Favored Pre-proline 0 C--N 1.271 -2.809 0 C-N-CA 120.068 -0.653 . . . . 1.0 111.409 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.02 111.69 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.39 2.06 . . . . 1.0 108.938 171.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.36 127.97 54.75 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 108.898 -0.779 . . . . 1.0 108.898 -171.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.0 m -88.49 122.31 31.83 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.36 -1.348 . . . . 1.0 107.36 176.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.462 HD11 HG13 ' A' ' 107' ' ' VAL . 16.5 tp -126.97 138.99 53.36 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -97.64 119.54 36.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.847 -0.533 . . . . 1.0 110.835 -178.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.01 121.11 23.79 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 116.596 -0.275 . . . . 1.0 110.504 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -149.19 169.53 20.51 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 122.448 0.299 . . . . 1.0 110.437 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.811 HD22 ' HB2' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -127.26 144.58 51.02 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 122.419 0.288 . . . . 1.0 110.692 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.511 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -124.12 39.79 3.88 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-O 121.126 0.489 . . . . 1.0 110.555 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.439 HG22 ' HD3' ' A' ' 111' ' ' PRO . 78.1 t -61.47 -46.33 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.18 0 C-N-CA 123.302 0.641 . . . . 1.0 110.728 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 161.99 -94.39 0.12 Allowed Glycine 0 N--CA 1.433 -1.553 0 C-N-CA 120.387 -0.911 . . . . 1.0 112.204 176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.46 -32.85 88.91 Favored 'Trans proline' 0 N--CA 1.475 0.415 0 C-N-CA 123.42 2.746 . . . . 1.0 113.543 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.49 ' O ' HD21 ' A' ' 15' ' ' LEU . . . -110.45 25.58 15.12 Favored Glycine 0 N--CA 1.415 -2.763 0 C-N-CA 120.733 -0.746 . . . . 1.0 111.887 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.88 79.8 0.12 Allowed 'General case' 0 C--O 1.243 0.719 0 CA-C-O 121.387 0.613 . . . . 1.0 111.78 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 138.82 -5.33 3.08 Favored Glycine 0 N--CA 1.423 -2.19 0 CA-C-N 115.387 -0.824 . . . . 1.0 112.32 177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -107.63 18.53 21.32 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 113.178 0.807 . . . . 1.0 113.178 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.811 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -79.58 -76.91 0.19 Allowed 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 119.897 -0.721 . . . . 1.0 112.141 -176.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.527 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.0 pt20 -138.41 -53.1 0.61 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.261 -176.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 62.55 59.94 8.55 Favored Glycine 0 CA--C 1.496 -1.097 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.527 HG23 ' HB2' ' A' ' 25' ' ' GLN . 35.4 t -114.71 126.99 27.25 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 115.261 -0.469 . . . . 1.0 110.552 -175.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.45 103.36 1.73 Allowed 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.97 1.78 . . . . 1.0 110.562 175.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.516 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 57.7 t -102.16 153.81 5.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 106.944 -1.502 . . . . 1.0 106.944 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -109.57 139.61 44.37 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 119.314 -0.955 . . . . 1.0 111.433 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 m -135.57 174.63 12.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-N 114.095 -1.411 . . . . 1.0 108.239 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.443 ' HA ' HD23 ' A' ' 32' ' ' LEU . 12.1 mt -104.59 159.73 15.52 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 121.542 0.687 . . . . 1.0 110.637 175.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' A' ' 6' ' ' TYR . 38.5 t70 -59.67 -29.87 68.37 Favored 'General case' 0 C--O 1.272 2.249 0 CA-C-N 114.43 -1.259 . . . . 1.0 109.952 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.578 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 45.8 t -82.6 -12.01 58.0 Favored 'General case' 0 C--O 1.246 0.908 0 CA-C-N 113.959 -1.473 . . . . 1.0 112.753 -177.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.03 132.67 47.02 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.046 -1.094 . . . . 1.0 108.046 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.435 ' H ' ' HB3' ' A' ' 39' ' ' GLN . 44.3 p -78.32 172.55 13.44 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.19 -1.041 . . . . 1.0 108.19 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 94' ' ' ASN . 43.7 mm -60.37 -45.61 96.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.926 -177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.3 t -66.39 -41.92 88.64 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.578 -0.527 . . . . 1.0 109.578 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 8.4 tt0 -66.31 -34.38 77.86 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.599 -0.728 . . . . 1.0 110.993 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -81.67 -38.48 25.83 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 122.307 -0.245 . . . . 1.0 111.518 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -60.51 -35.51 76.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.916 0.388 . . . . 1.0 110.34 177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 43' ' ' LYS . 0.0 OUTLIER -66.48 -41.23 89.27 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 115.391 -0.822 . . . . 1.0 109.905 179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 46.7 mmtm -63.6 -41.49 98.33 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.834 0.709 . . . . 1.0 111.861 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.589 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 86.1 mmm -60.96 -45.94 92.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.146 0.498 . . . . 1.0 110.627 -177.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.5 pp -77.5 -25.33 50.27 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.148 -0.478 . . . . 1.0 111.681 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 24.9 t70 -56.94 -28.83 62.56 Favored 'General case' 0 C--O 1.203 -1.371 0 C-N-CA 125.374 1.47 . . . . 1.0 112.145 -174.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.493 HE21 HG13 ' A' ' 29' ' ' VAL . 14.1 mm-40 -65.78 -33.92 76.96 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.067 0.46 . . . . 1.0 111.082 -179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -96.33 -42.05 8.34 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.881 0.848 . . . . 1.0 109.127 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -101.72 35.73 2.25 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.116 -1.402 . . . . 1.0 111.062 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -57.0 118.97 5.51 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.98 -1.009 . . . . 1.0 109.768 175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.77 -11.42 38.37 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 120.766 -0.73 . . . . 1.0 112.355 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 53.5 t -79.91 129.13 71.67 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 109.565 -0.532 . . . . 1.0 109.565 177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.461 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 58.0 Cg_endo -67.23 156.7 65.14 Favored 'Trans proline' 0 C--O 1.243 0.741 0 C-N-CA 122.75 2.3 . . . . 1.0 112.431 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.9 tp -61.52 -38.59 87.92 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 122.963 0.505 . . . . 1.0 111.56 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.9 t -62.7 -24.02 67.45 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 121.074 0.464 . . . . 1.0 111.299 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.596 ' HA ' HE21 ' A' ' 56' ' ' GLN . 0.1 OUTLIER -88.22 -24.51 23.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.922 0.391 . . . . 1.0 110.308 178.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 58.2 mtt180 -74.1 121.21 84.66 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 108.698 -0.853 . . . . 1.0 108.698 176.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.17 141.32 96.49 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.491 2.128 . . . . 1.0 112.347 -177.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -90.1 150.54 43.57 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 115.558 -0.746 . . . . 1.0 112.466 -174.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -75.15 7.92 2.7 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.683 2.255 . . . . 1.0 110.894 173.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.84 -16.96 24.68 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.11 173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.4 t -117.39 -2.72 11.5 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.526 -0.761 . . . . 1.0 110.427 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.633 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.4 pp -149.48 155.45 40.39 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 109.122 -0.696 . . . . 1.0 109.122 177.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 7.7 m-20 -105.83 151.53 24.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 106.753 -1.573 . . . . 1.0 106.753 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.6 124.53 71.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.982 0 C-N-CA 119.17 -1.012 . . . . 1.0 108.428 172.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.63 112.28 24.14 Favored 'General case' 0 N--CA 1.4 -2.93 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.586 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.4 t-105 -93.28 125.82 38.08 Favored 'General case' 1 N--CA 1.374 -4.225 0 CA-C-N 114.554 -1.203 . . . . 1.0 109.165 -177.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -112.29 89.39 3.05 Favored 'General case' 0 N--CA 1.395 -3.203 0 N-CA-C 106.672 -1.603 . . . . 1.0 106.672 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.8 p -79.0 -22.56 45.32 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.339 -1.301 . . . . 1.0 109.393 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 83.16 -45.72 3.5 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.837 -1.074 . . . . 1.0 112.163 -179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.3 m -63.55 -39.45 85.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.023 0.439 . . . . 1.0 111.062 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -106.22 -9.41 16.89 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.447 0.641 . . . . 1.0 109.937 176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.07 -126.17 8.82 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.212 -0.904 . . . . 1.0 111.51 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -120.28 118.32 30.12 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.238 0.542 . . . . 1.0 110.204 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.66 151.91 45.92 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.517 -1.29 . . . . 1.0 107.517 -176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.447 ' CG2' ' HB3' ' A' ' 64' ' ' ASP . 9.8 mm -98.34 120.3 47.48 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 C-N-CA 119.341 -0.944 . . . . 1.0 108.469 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.432 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.7 mp -111.99 163.32 14.38 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 112.673 0.62 . . . . 1.0 112.673 -177.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.459 ' HA ' HG21 ' A' ' 37' ' ' ILE . 8.2 t -167.58 163.03 14.57 Favored 'General case' 0 CA--C 1.48 -1.737 0 N-CA-C 104.234 -2.506 . . . . 1.0 104.234 175.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 21.3 p-10 -93.68 -3.25 52.73 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 117.9 -1.52 . . . . 1.0 111.033 176.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -138.56 75.08 1.5 Allowed 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.438 -1.319 . . . . 1.0 107.438 170.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' A' ' 83' ' ' THR . 17.9 m-20 -80.75 -172.18 3.52 Favored 'General case' 0 CA--C 1.478 -1.805 0 CA-C-N 115.03 -0.986 . . . . 1.0 109.834 -175.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.95 -27.66 39.13 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-N 114.881 -1.054 . . . . 1.0 109.92 172.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 81' ' ' ASP . 9.0 t -81.27 -2.5 49.17 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 115.916 -0.584 . . . . 1.0 111.637 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 76.8 p -80.24 86.57 5.62 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 122.235 1.016 . . . . 1.0 109.711 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -81.69 118.3 22.72 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.545 0.688 . . . . 1.0 111.75 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 t -97.56 84.06 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 -177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.05 4.44 0.4 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.547 -1.206 . . . . 1.0 111.671 -177.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.67 85.21 0.17 Allowed Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 119.246 -1.454 . . . . 1.0 113.169 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.4 mt 73.44 -17.37 0.43 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 125.516 1.526 . . . . 1.0 114.178 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -64.84 -31.55 72.83 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.264 0.554 . . . . 1.0 109.759 177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -71.45 113.27 8.31 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.04 175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -150.53 158.95 44.73 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.86 -1.163 . . . . 1.0 107.86 172.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 79.3 mt -79.88 139.48 37.12 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.468 ' H ' ' HA ' ' A' ' 79' ' ' ASP . 93.8 m-20 -89.6 141.02 28.98 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 109.983 -0.377 . . . . 1.0 109.983 -177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.492 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.9 OUTLIER -107.27 173.29 6.39 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 124.448 1.099 . . . . 1.0 109.704 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.461 HD13 HG22 ' A' ' 101' ' ' VAL . 3.9 pp -72.66 -25.41 61.26 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 119.303 -0.959 . . . . 1.0 108.783 173.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.492 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -66.68 -25.34 66.51 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 121.22 0.533 . . . . 1.0 110.904 173.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 31.4 t60 -64.4 -37.73 88.53 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -104.55 -1.78 26.08 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.934 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? 49.71 66.71 1.05 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.837 1.255 . . . . 1.0 112.997 179.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.586 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.1 m -85.27 150.71 55.29 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 120.029 -0.668 . . . . 1.0 111.636 177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -80.19 155.89 22.61 Favored 'Trans proline' 0 C--O 1.243 0.775 0 C-N-CA 122.844 2.362 . . . . 1.0 111.926 175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.0 122.17 17.16 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 109.116 -0.698 . . . . 1.0 109.116 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.52 10.34 13.24 Favored Glycine 0 C--N 1.285 -2.264 0 N-CA-C 110.389 -1.084 . . . . 1.0 110.389 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.414 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -69.89 162.3 28.26 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.288 0.566 . . . . 1.0 111.069 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 58.9 m -120.92 132.71 55.11 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.886 -0.413 . . . . 1.0 109.886 -176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.462 HG13 HD11 ' A' ' 11' ' ' LEU . 29.6 m -115.73 135.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.506 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.511 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -120.38 137.54 54.24 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-N 115.774 -0.648 . . . . 1.0 110.87 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.656 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.5 tt -97.92 126.86 43.52 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.324 -0.853 . . . . 1.0 109.974 -176.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 64' ' ' ASP . 33.9 m -127.88 127.1 23.96 Favored Pre-proline 0 N--CA 1.435 -1.199 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HD3' HG22 ' A' ' 17' ' ' VAL . 43.9 Cg_endo -70.35 82.02 0.91 Allowed 'Trans proline' 0 C--O 1.238 0.481 0 C-N-CA 122.355 2.037 . . . . 1.0 111.823 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.633 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 27.7 p 50.93 29.85 4.79 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 126.038 1.735 . . . . 1.0 111.026 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 113' ' ' LEU . 0.6 OUTLIER -69.1 -41.63 77.21 Favored 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 113.859 -1.519 . . . . 1.0 112.984 -172.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.0 t -111.23 -0.22 16.54 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 114.403 1.26 . . . . 1.0 114.403 -169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? 48.02 74.1 0.18 Allowed 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 124.184 0.994 . . . . 1.0 113.483 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -103.22 4.53 36.82 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 122.78 1.276 . . . . 1.0 109.881 173.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 m -117.3 132.17 67.86 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.426 0 CA-C-N 112.9 -1.955 . . . . 1.0 109.144 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.8 mt -134.86 106.19 6.76 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.433 -0.951 . . . . 1.0 108.433 -177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.456 ' HD3' ' H ' ' A' ' 119' ' ' ARG . 0.3 OUTLIER -137.36 -7.44 1.75 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.144 -0.935 . . . . 1.0 109.642 -175.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.625 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 0.9 OUTLIER -82.17 -169.92 2.64 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 114.065 -1.425 . . . . 1.0 111.349 -176.138 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 22.3 t30 72.62 25.62 2.6 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.59 1.186 . . . . 1.0 109.299 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.566 ' OE1' ' HA ' ' A' ' 120' ' ' GLU . 6.0 pm0 . . . . . 0 C--O 1.252 1.209 0 CA-C-N 114.959 -1.019 . . . . 1.0 110.135 178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 62.9 tttm . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 121.463 0.649 . . . . 1.0 110.226 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -120.84 150.4 41.09 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.466 -0.788 . . . . 1.0 109.604 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -91.03 2.21 56.49 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.904 0.859 . . . . 1.0 110.406 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 6' ' ' TYR . 34.5 m -125.35 132.16 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 CA-C-N 114.735 -1.12 . . . . 1.0 108.514 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -108.76 78.68 1.17 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 122.414 1.102 . . . . 1.0 111.222 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' CG ' ' HB2' ' A' ' 34' ' ' CYS . 74.8 m-85 -128.01 -178.57 4.57 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 105.261 -2.126 . . . . 1.0 105.261 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -113.39 114.63 47.78 Favored Pre-proline 0 C--N 1.273 -2.721 0 C-N-CA 118.111 -1.436 . . . . 1.0 113.287 -168.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.44 124.98 16.67 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.247 1.964 . . . . 1.0 109.098 171.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.5 tp -122.18 161.81 22.51 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.771 -0.65 . . . . 1.0 109.801 -174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.1 m -109.48 128.44 55.17 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 39.1 mt -126.66 149.99 49.22 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 123.751 0.82 . . . . 1.0 111.011 178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -94.62 116.05 28.29 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.119 -0.697 . . . . 1.0 109.119 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.74 120.59 24.83 Favored 'General case' 0 CA--C 1.487 -1.454 0 N-CA-C 109.109 -0.7 . . . . 1.0 109.109 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.814 HD21 ' HA2' ' A' ' 22' ' ' GLY . 31.0 tp -151.64 152.32 32.67 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 108.537 -0.912 . . . . 1.0 108.537 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.636 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.1 pt? -122.13 143.03 49.79 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.728 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -117.25 32.41 6.18 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.121 -0.491 . . . . 1.0 110.363 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.7 t -65.18 -45.32 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.393 0 C-N-CA 123.572 0.749 . . . . 1.0 111.814 -178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.64 -87.99 0.08 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 119.363 -1.398 . . . . 1.0 113.475 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -61.33 -30.76 88.22 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 122.954 2.436 . . . . 1.0 113.171 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.3 26.08 11.64 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.694 -0.765 . . . . 1.0 111.547 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -69.7 82.6 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.093 0.775 . . . . 1.0 113.093 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.814 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 103.05 0.12 48.04 Favored Glycine 0 CA--C 1.48 -2.14 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 174.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -134.41 22.04 3.7 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.664 -0.768 . . . . 1.0 111.242 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.66 -69.33 0.62 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.189 -0.459 . . . . 1.0 112.129 -176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB2' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -148.41 -51.77 0.17 Allowed 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.121 -0.49 . . . . 1.0 111.7 -177.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.0 68.19 1.73 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.508 -1.037 . . . . 1.0 110.508 -177.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 25' ' ' GLN . 22.4 t -103.37 127.34 29.87 Favored Pre-proline 0 C--N 1.312 -1.051 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -175.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.94 108.45 2.72 Favored 'Trans proline' 0 N--CA 1.44 -1.641 0 C-N-CA 121.623 1.549 . . . . 1.0 111.624 178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.467 HG13 ' NE2' ' A' ' 47' ' ' GLN . 44.1 t -106.23 154.83 7.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.985 -1.007 . . . . 1.0 108.729 179.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -106.84 143.96 34.18 Favored 'General case' 0 CA--C 1.498 -1.052 0 CA-C-O 121.324 0.583 . . . . 1.0 110.769 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.48 166.96 17.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 N-CA-C 107.456 -1.313 . . . . 1.0 107.456 -176.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.2 tp -100.4 156.83 17.04 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 177.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -62.05 -30.29 70.88 Favored 'General case' 0 C--O 1.268 2.033 0 CA-C-O 121.473 0.654 . . . . 1.0 109.596 178.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.617 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -90.82 1.56 56.83 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.001 -1.454 . . . . 1.0 112.355 -176.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.17 136.24 46.4 Favored 'General case' 0 CA--C 1.48 -1.734 0 C-N-CA 119.542 -0.863 . . . . 1.0 109.014 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -82.36 168.81 17.15 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.0 -1.111 . . . . 1.0 108.0 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.759 HG21 ' HA ' ' A' ' 78' ' ' SER . 42.1 mm -61.59 -42.23 93.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 120.799 -0.361 . . . . 1.0 110.48 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.59 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -61.68 -43.72 98.31 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 121.109 -0.237 . . . . 1.0 110.547 177.323 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.447 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 27.0 mt-30 -67.33 -39.33 85.81 Favored 'General case' 0 C--O 1.244 0.785 0 O-C-N 123.461 0.476 . . . . 1.0 111.238 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.66 -39.1 91.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.567 -0.742 . . . . 1.0 111.09 177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.494 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.2 mptm? -56.93 -40.28 76.07 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 176.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' SER . 41.3 mt-10 -65.43 -53.81 37.65 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.622 -0.717 . . . . 1.0 110.42 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.27 -40.86 96.83 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 113.319 0.859 . . . . 1.0 113.319 -175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.667 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 92.5 mmm -64.04 -46.42 84.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.441 . . . . 1.0 110.406 -176.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 4.7 pp -76.7 -25.19 53.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.199 0.444 . . . . 1.0 112.199 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -55.13 -29.66 58.18 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.461 1.104 . . . . 1.0 112.67 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.467 ' NE2' HG13 ' A' ' 29' ' ' VAL . 27.7 mt-30 -69.25 -31.36 69.86 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.884 -0.327 . . . . 1.0 111.315 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -92.55 -40.11 10.98 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.93 0.871 . . . . 1.0 108.713 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -94.15 28.02 2.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 114.491 -1.232 . . . . 1.0 110.665 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -59.41 126.77 28.99 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.438 -0.801 . . . . 1.0 110.39 178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.24 -11.55 57.01 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.771 -0.931 . . . . 1.0 110.771 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -97.48 116.86 65.91 Favored Pre-proline 0 N--CA 1.428 -1.572 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 178.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 59.2 Cg_endo -68.38 161.09 46.28 Favored 'Trans proline' 0 C--O 1.24 0.618 0 C-N-CA 122.536 2.157 . . . . 1.0 111.06 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 51.5 tp -61.3 -39.33 90.06 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.519 0.2 . . . . 1.0 111.436 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 t -62.85 -26.49 68.79 Favored 'General case' 0 CA--C 1.561 1.401 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.665 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -85.94 -19.35 30.58 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.549 0.69 . . . . 1.0 109.907 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.489 ' HD3' HD11 ' A' ' 45' ' ' LEU . 78.2 mtt180 -84.16 154.53 63.59 Favored Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 108.672 -0.862 . . . . 1.0 108.672 176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.55 161.66 45.02 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.064 1.842 . . . . 1.0 110.706 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -64.0 128.88 93.52 Favored Pre-proline 0 C--N 1.315 -0.924 0 N-CA-C 109.541 -0.54 . . . . 1.0 109.541 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.27 -5.11 16.6 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.378 2.052 . . . . 1.0 114.683 -175.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.4 -6.81 43.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 118.093 0.406 . . . . 1.0 111.24 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 82.2 p -72.96 -23.67 60.69 Favored 'General case' 0 CA--C 1.508 -0.665 0 N-CA-C 108.145 -1.057 . . . . 1.0 108.145 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.542 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 2.2 pp -117.95 148.7 41.94 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 113.813 -1.54 . . . . 1.0 109.43 178.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' H ' ' H ' ' A' ' 112' ' ' CYS . 53.6 m-20 -112.91 169.5 8.87 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.329 -0.989 . . . . 1.0 108.329 177.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 p -121.62 129.21 75.73 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 C-N-CA 119.791 -0.764 . . . . 1.0 108.962 178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 10.3 pt-20 -91.49 111.89 23.58 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 106.159 -1.793 . . . . 1.0 106.159 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 2.5 t-105 -89.99 126.06 35.61 Favored 'General case' 0 N--CA 1.389 -3.505 0 CA-C-N 114.164 -1.38 . . . . 1.0 110.054 -174.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -108.47 88.97 2.85 Favored 'General case' 0 N--CA 1.401 -2.889 0 N-CA-C 105.907 -1.886 . . . . 1.0 105.907 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.7 p -91.9 -14.15 30.09 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.826 -1.534 . . . . 1.0 110.907 -176.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.52 -52.53 4.38 Favored Glycine 0 C--N 1.303 -1.279 0 CA-C-N 115.457 -0.792 . . . . 1.0 111.793 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.9 m -63.88 -38.61 82.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 C-N-CA 122.669 0.388 . . . . 1.0 111.394 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -108.69 1.97 21.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.57 0.7 . . . . 1.0 109.665 177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 75.23 -129.47 10.6 Favored Glycine 0 N--CA 1.423 -2.198 0 N-CA-C 109.953 -1.259 . . . . 1.0 109.953 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.637 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 19.4 p-80 -110.73 112.73 24.8 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.317 0.579 . . . . 1.0 110.069 177.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.43 140.19 53.0 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.197 -1.038 . . . . 1.0 108.197 -175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 24.9 mm -79.14 115.06 20.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.481 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.5 mp -109.79 148.36 31.6 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.763 0.792 . . . . 1.0 112.351 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.759 ' HA ' HG21 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -164.12 157.05 17.7 Favored 'General case' 0 CA--C 1.467 -2.216 0 C-N-CA 125.805 1.642 . . . . 1.0 107.082 174.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 21.6 p-10 -73.69 -38.33 64.91 Favored 'General case' 0 C--N 1.276 -2.621 0 O-C-N 123.293 0.371 . . . . 1.0 111.399 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -153.78 88.05 1.25 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 120.592 -0.443 . . . . 1.0 112.014 -178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.487 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 11.2 t70 -173.29 -92.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.556 0.693 . . . . 1.0 110.996 171.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.487 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 9.3 p -65.95 -28.23 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.346 0 CA-C-N 114.406 -1.27 . . . . 1.0 110.548 -175.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.6 p -89.54 -20.2 24.08 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.821 -1.082 . . . . 1.0 110.757 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.4 t -89.15 88.46 7.55 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-O 121.696 0.76 . . . . 1.0 111.33 -172.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.59 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 47.2 mt-10 -104.45 117.63 34.64 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.023 -1.473 . . . . 1.0 107.023 173.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 20.8 m -79.09 68.53 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 114.041 1.126 . . . . 1.0 114.041 -171.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -105.74 -13.13 15.64 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 114.222 -1.353 . . . . 1.0 109.58 175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 158.78 -90.18 0.11 Allowed Glycine 0 N--CA 1.423 -2.204 0 C-N-CA 120.637 -0.792 . . . . 1.0 112.285 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.9 pp -71.46 -6.8 43.12 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 114.288 1.218 . . . . 1.0 114.288 -172.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 49.1 m-85 -87.12 -2.52 58.69 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.202 -0.599 . . . . 1.0 112.309 -178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -84.85 91.63 8.06 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 107.13 -1.434 . . . . 1.0 107.13 170.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 173.58 157.44 0.13 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 106.403 -1.703 . . . . 1.0 106.403 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.4 mt -76.98 138.08 39.41 Favored 'General case' 0 N--CA 1.433 -1.306 0 N-CA-C 107.306 -1.368 . . . . 1.0 107.306 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.501 ' O ' HG12 ' A' ' 37' ' ' ILE . 41.5 m-80 -82.44 140.16 33.57 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.851 -0.74 . . . . 1.0 109.52 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.479 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -114.64 174.74 5.81 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.775 -0.824 . . . . 1.0 108.775 178.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.528 HD13 HG22 ' A' ' 101' ' ' VAL . 2.4 pp -73.09 -29.59 63.05 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.235 -0.986 . . . . 1.0 108.368 173.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.617 ' NE2' ' HA ' ' A' ' 34' ' ' CYS . 5.0 pt20 -65.76 -24.48 66.96 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 116.024 -0.535 . . . . 1.0 112.17 176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -59.9 -44.23 94.38 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 108.971 -0.751 . . . . 1.0 108.971 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -96.65 -10.28 27.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.32 -0.4 . . . . 1.0 111.569 177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.449 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 64.7 mmtt 53.0 73.16 0.37 Allowed 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 124.259 1.024 . . . . 1.0 113.121 -176.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.619 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.2 m -83.08 147.99 55.42 Favored Pre-proline 0 C--N 1.304 -1.389 0 CA-C-N 115.091 -0.958 . . . . 1.0 110.838 177.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -76.54 159.57 35.65 Favored 'Trans proline' 0 C--O 1.249 1.058 0 C-N-CA 122.56 2.173 . . . . 1.0 112.911 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -65.77 121.54 15.26 Favored 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 121.764 0.792 . . . . 1.0 109.415 176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 99.38 24.96 9.72 Favored Glycine 0 C--N 1.289 -2.059 0 C-N-CA 120.232 -0.985 . . . . 1.0 111.177 -178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -75.61 163.04 27.75 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-O 120.941 0.401 . . . . 1.0 110.315 176.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 52.4 m -115.61 131.33 56.97 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 120.835 0.35 . . . . 1.0 110.426 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.07 138.07 46.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.639 -0.504 . . . . 1.0 109.639 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.524 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . . . -126.38 128.03 46.4 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.187 0.518 . . . . 1.0 110.593 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.636 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.3 mp -92.71 127.15 38.1 Favored 'General case' 0 C--N 1.269 -2.928 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.033 -175.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 16' ' ' ALA . 17.3 m -128.94 154.01 80.21 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 108.817 -0.809 . . . . 1.0 108.817 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -71.13 74.09 1.95 Allowed 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.224 1.949 . . . . 1.0 110.633 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.542 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 0.2 OUTLIER 58.85 17.86 5.62 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.486 1.514 . . . . 1.0 111.836 -179.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.7 tm? 74.79 -39.67 0.42 Allowed 'General case' 0 C--N 1.349 0.576 0 C-N-CA 125.589 1.555 . . . . 1.0 108.627 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.533 ' H ' ' C ' ' A' ' 112' ' ' CYS . 12.7 t -117.08 117.63 30.14 Favored 'General case' 1 N--CA 1.376 -4.172 0 CA-C-N 114.179 -1.373 . . . . 1.0 107.334 -179.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.511 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 11.4 mptt -63.4 -40.24 96.69 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.259 -1.791 . . . . 1.0 114.652 -166.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -99.41 100.04 11.03 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 119.404 -0.918 . . . . 1.0 110.704 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.411 ' CG1' HG23 ' A' ' 114' ' ' THR . 15.9 m -136.16 166.1 27.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.714 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 pp -110.19 144.77 38.36 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 174.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -132.7 107.35 8.33 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 121.135 0.493 . . . . 1.0 109.839 178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -90.24 162.49 15.2 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.895 -1.521 . . . . 1.0 106.895 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -79.9 64.72 4.84 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.607 0.717 . . . . 1.0 112.031 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 . . . . . 0 N--CA 1.439 -0.977 0 N-CA-C 107.596 -1.261 . . . . 1.0 107.596 177.948 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 56.7 tptt . . . . . 0 CA--C 1.5 -0.956 0 N-CA-C 111.903 0.335 . . . . 1.0 111.903 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.96 132.28 54.08 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-O 121.046 0.45 . . . . 1.0 110.59 -178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -99.12 25.84 6.42 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.511 -0.768 . . . . 1.0 109.19 -176.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 t -80.59 68.91 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.233 0 CA-C-N 115.092 -0.958 . . . . 1.0 110.57 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -129.45 84.54 2.23 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-N 114.631 -1.168 . . . . 1.0 108.051 173.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.518 ' HB2' HD22 ' A' ' 32' ' ' LEU . 73.0 m-85 -130.57 -178.53 4.82 Favored 'General case' 0 N--CA 1.403 -2.775 0 N-CA-C 105.461 -2.051 . . . . 1.0 105.461 -176.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.537 ' H ' ' HB2' ' A' ' 33' ' ' ASP . 31.5 mmt180 -104.98 104.28 45.9 Favored Pre-proline 0 C--N 1.277 -2.576 0 C-N-CA 119.444 -0.903 . . . . 1.0 109.313 174.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.423 ' HA ' HD23 ' A' ' 32' ' ' LEU . 18.7 Cg_exo -65.81 105.18 0.76 Allowed 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 107.522 -1.761 . . . . 1.0 107.522 174.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HB3' HG23 ' A' ' 31' ' ' VAL . 4.3 tp -110.37 162.08 15.0 Favored 'General case' 0 N--CA 1.411 -2.39 0 CA-C-O 121.626 0.727 . . . . 1.0 112.334 -168.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.7 m -112.79 129.92 56.26 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 114.383 -1.281 . . . . 1.0 108.387 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 11' ' ' LEU . 25.7 mt -126.26 149.86 48.81 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.287 0.565 . . . . 1.0 111.258 176.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 8.7 t30 -98.03 107.45 19.93 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 115.123 -0.944 . . . . 1.0 109.286 178.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.94 111.21 6.16 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 123.903 0.752 . . . . 1.0 109.894 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 30.4 tp -145.23 146.77 31.84 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 115.796 -0.638 . . . . 1.0 109.407 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.628 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.8 pt? -121.86 143.91 49.14 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 110.293 -0.262 . . . . 1.0 110.293 -178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -113.15 29.64 7.82 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.193 0.521 . . . . 1.0 110.388 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.474 HG22 ' HD3' ' A' ' 111' ' ' PRO . 53.2 t -64.9 -47.15 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 C-N-CA 123.857 0.863 . . . . 1.0 112.56 -175.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.85 -75.6 0.11 Allowed Glycine 0 CA--C 1.528 0.866 0 C-N-CA 119.611 -1.281 . . . . 1.0 113.773 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.9 -26.44 80.97 Favored 'Trans proline' 0 N--CA 1.502 1.989 0 C-N-CA 123.68 2.92 . . . . 1.0 113.057 -173.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -138.43 39.31 1.59 Allowed Glycine 0 N--CA 1.419 -2.449 0 N-CA-C 109.751 -1.339 . . . . 1.0 109.751 177.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -63.75 80.37 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 114.193 1.183 . . . . 1.0 114.193 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.81 15.35 39.96 Favored Glycine 0 CA--C 1.482 -2.002 0 N-CA-C 110.403 -1.079 . . . . 1.0 110.403 172.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -157.05 38.07 0.3 Allowed 'General case' 0 N--CA 1.423 -1.797 0 CA-C-O 121.612 0.72 . . . . 1.0 110.427 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' H ' HD11 ' A' ' 14' ' ' LEU . . . -95.63 -77.95 0.47 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.811 -0.631 . . . . 1.0 112.546 -174.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.403 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 1.6 pt20 -127.13 -59.14 1.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.459 -0.791 . . . . 1.0 111.418 -172.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 69.56 68.37 1.66 Allowed Glycine 0 N--CA 1.438 -1.227 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.9 t -99.34 131.25 25.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 CA-C-N 115.666 -0.267 . . . . 1.0 110.561 -173.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.14 103.36 1.49 Allowed 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 121.917 1.745 . . . . 1.0 111.597 177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.56 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 37.5 t -110.38 155.36 11.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 CA-C-N 115.23 -0.895 . . . . 1.0 108.857 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -104.22 144.76 31.17 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.16 0.505 . . . . 1.0 112.177 -174.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.541 HG12 ' HD2' ' A' ' 43' ' ' LYS . 2.6 m -147.64 -176.28 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 114.69 -1.141 . . . . 1.0 108.794 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.518 HD22 ' HB2' ' A' ' 6' ' ' TYR . 29.5 mt -121.45 174.35 6.81 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.641 0.734 . . . . 1.0 110.097 175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.537 ' HB2' ' H ' ' A' ' 7' ' ' ARG . 28.8 t70 -66.18 -32.3 73.65 Favored 'General case' 0 C--O 1.265 1.881 0 CA-C-N 114.725 -1.125 . . . . 1.0 109.607 176.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.446 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 3.9 t -103.46 2.78 34.16 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 115.417 1.636 . . . . 1.0 115.417 -169.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . 0.393 0.2 OUTLIER -79.08 141.92 36.93 Favored 'General case' 0 CA--C 1.467 -2.245 0 C-N-CA 115.969 -2.293 . . . . 1.0 111.607 172.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.2 p -77.24 170.15 17.06 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 113.527 -1.67 . . . . 1.0 110.217 -176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 38.5 mm -59.64 -42.9 89.9 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.543 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.615 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.8 p -61.59 -46.99 87.49 Favored 'General case' 0 N--CA 1.435 -1.215 0 O-C-N 123.431 0.457 . . . . 1.0 111.401 178.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -72.77 -42.54 63.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.114 0.483 . . . . 1.0 111.558 -174.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.63 -37.4 82.43 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.716 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.528 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 32.9 ttpt -59.29 -38.31 79.9 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.27 -0.877 . . . . 1.0 109.444 177.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.615 ' HG3' ' O ' ' A' ' 38' ' ' SER . 63.5 mt-10 -66.9 -40.0 87.59 Favored 'General case' 0 N--CA 1.434 -1.225 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.402 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.541 ' HD2' HG12 ' A' ' 31' ' ' VAL . 64.6 mttp -63.92 -40.93 97.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 121.335 -0.146 . . . . 1.0 111.05 179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.56 ' CE ' ' HB ' ' A' ' 29' ' ' VAL . 1.1 mmt -61.82 -49.35 76.65 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.739 0.65 . . . . 1.0 110.601 -177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.1 pp -76.64 -23.08 53.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 112.989 0.737 . . . . 1.0 112.989 -179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.757 ' HA ' ' CE2' ' A' ' 49' ' ' TYR . 30.7 t70 -55.27 -30.82 60.87 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 124.247 1.019 . . . . 1.0 111.567 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG3' HG22 ' A' ' 29' ' ' VAL . 78.0 mm-40 -67.96 -30.93 70.34 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.61 -0.723 . . . . 1.0 110.845 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.88 -41.66 7.92 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 121.091 0.472 . . . . 1.0 111.46 -171.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.757 ' CE2' ' HA ' ' A' ' 46' ' ' ASP . 1.2 p90 -78.85 -11.12 59.98 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.903 -175.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 46' ' ' ASP . 13.9 tppt? -59.51 114.79 2.88 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 109.851 -0.426 . . . . 1.0 109.851 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.74 9.93 70.76 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.274 178.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.585 HG22 ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -97.33 147.94 33.7 Favored Pre-proline 0 C--N 1.312 -1.058 0 N-CA-C 109.278 -0.638 . . . . 1.0 109.278 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.585 ' HD2' HG22 ' A' ' 52' ' ' VAL . 18.7 Cg_endo -56.91 149.08 63.41 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.912 2.408 . . . . 1.0 112.067 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.7 -41.2 97.26 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.401 -173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 t -66.56 -21.49 66.15 Favored 'General case' 0 CA--C 1.555 1.17 0 N-CA-C 112.307 0.484 . . . . 1.0 112.307 -177.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -85.57 -23.9 27.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.018 0.437 . . . . 1.0 110.643 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -62.81 118.84 45.83 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.723 -0.671 . . . . 1.0 111.593 -177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.566 ' O ' ' HD3' ' A' ' 60' ' ' PRO . 80.1 Cg_endo -72.36 159.93 48.18 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.082 2.522 . . . . 1.0 111.942 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -93.06 102.01 6.41 Favored Pre-proline 0 C--N 1.315 -0.895 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.733 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 58' ' ' PRO . 34.4 Cg_exo -61.54 -33.41 87.45 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.989 2.46 . . . . 1.0 112.017 -178.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -61.06 -30.17 70.17 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.273 -0.876 . . . . 1.0 113.116 -175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.629 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 14.7 t -101.56 2.15 38.69 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 120.53 -0.468 . . . . 1.0 111.449 -176.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.9 pp -111.66 155.22 23.76 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 120.92 0.39 . . . . 1.0 111.181 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.419 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 11.2 p-10 -113.5 162.71 15.82 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.839 -0.619 . . . . 1.0 111.305 -176.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.2 p -125.14 127.06 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.302 0.572 . . . . 1.0 110.472 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -93.45 113.21 25.31 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 105.132 -2.173 . . . . 1.0 105.132 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.564 ' CE3' HD22 ' A' ' 77' ' ' LEU . 4.9 t-105 -91.55 133.54 35.44 Favored 'General case' 0 N--CA 1.403 -2.806 0 CA-C-N 115.39 -0.823 . . . . 1.0 111.912 -173.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -117.08 88.69 2.95 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 106.446 -1.687 . . . . 1.0 106.446 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.51 ' HB3' ' CE2' ' A' ' 99' ' ' TYR . 71.3 p -73.48 -31.99 64.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 114.785 -1.098 . . . . 1.0 110.763 -177.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.14 -50.99 4.35 Favored Glycine 0 C--N 1.303 -1.282 0 CA-C-N 114.566 -1.197 . . . . 1.0 111.365 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.8 -41.28 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 122.524 0.329 . . . . 1.0 111.703 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -105.4 -40.04 5.95 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.275 -1.009 . . . . 1.0 108.275 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 127.16 -130.16 6.76 Favored Glycine 0 N--CA 1.426 -2.021 0 CA-C-N 114.91 -1.041 . . . . 1.0 112.042 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.443 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 88.9 m-70 -100.94 118.86 37.8 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 123.544 0.737 . . . . 1.0 110.652 -177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.35 134.43 39.8 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.083 -1.451 . . . . 1.0 107.083 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.416 HG21 ' HA ' ' A' ' 115' ' ' LYS . 28.1 mm -79.72 118.86 28.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 109.28 -0.637 . . . . 1.0 109.28 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -109.98 152.27 26.09 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.234 0.54 . . . . 1.0 111.4 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.405 ' OG ' HG12 ' A' ' 82' ' ' VAL . 6.6 m -154.92 148.99 25.85 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 -178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 1.3 p-10 -66.25 -44.14 84.55 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.478 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 43.2 tt0 -157.5 88.6 1.0 Allowed 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 115.733 -0.667 . . . . 1.0 109.935 178.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 3.4 t70 -159.5 -81.21 0.05 Allowed 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 119.628 -0.829 . . . . 1.0 112.208 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.429 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 7.3 p -93.96 -34.0 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.323 0 CA-C-N 114.36 -1.291 . . . . 1.0 112.617 -171.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.501 HG23 ' ND2' ' A' ' 94' ' ' ASN . 2.8 t -106.12 20.35 19.09 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.315 1.055 . . . . 1.0 109.277 -178.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.478 ' OG ' ' HA ' ' A' ' 80' ' ' GLU . 5.8 m -132.91 121.67 23.2 Favored 'General case' 0 N--CA 1.402 -2.837 0 N-CA-C 105.589 -2.004 . . . . 1.0 105.589 177.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -75.94 91.58 3.05 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 122.449 1.119 . . . . 1.0 111.078 179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.4 p -102.64 85.58 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.265 -3.1 0 CA-C-N 114.247 -1.342 . . . . 1.0 109.705 -177.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -149.79 20.49 0.9 Allowed 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 113.101 -1.863 . . . . 1.0 108.139 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.81 -160.86 32.81 Favored Glycine 1 N--CA 1.372 -5.622 0 N-CA-C 107.553 -2.219 . . . . 1.0 107.553 -175.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.767 ' H ' HD23 ' A' ' 89' ' ' LEU . 1.8 pt? -74.22 9.49 1.62 Allowed 'General case' 0 C--N 1.26 -3.292 0 C-N-CA 124.176 0.99 . . . . 1.0 112.314 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 61.8 m-85 -87.04 -0.62 56.94 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -66.06 116.45 7.19 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.924 -1.034 . . . . 1.0 110.252 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -144.86 160.63 40.98 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.934 -179.767 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.0 mt -81.76 148.04 29.12 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.052 -0.976 . . . . 1.0 110.938 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.501 ' ND2' HG23 ' A' ' 83' ' ' THR . 58.2 m-80 -103.42 146.21 28.84 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.211 -0.45 . . . . 1.0 109.847 177.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.544 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -109.23 171.84 7.2 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.506 HD13 HG22 ' A' ' 101' ' ' VAL . 4.6 pp -77.02 -17.55 58.74 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.585 -1.246 . . . . 1.0 109.43 175.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.544 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -66.67 -26.42 67.03 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.896 173.616 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -64.07 -40.99 97.47 Favored 'General case' 0 C--O 1.223 -0.295 0 N-CA-C 109.038 -0.727 . . . . 1.0 109.038 178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 69' ' ' SER . 2.0 t80 -88.74 -16.14 32.98 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.63 -0.713 . . . . 1.0 110.604 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm 54.35 57.91 5.42 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.103 0.961 . . . . 1.0 111.01 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.535 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -74.31 144.22 81.04 Favored Pre-proline 0 C--N 1.324 -0.518 0 C-N-CA 119.405 -0.918 . . . . 1.0 111.208 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.06 158.49 41.95 Favored 'Trans proline' 0 C--O 1.246 0.875 0 C-N-CA 122.878 2.385 . . . . 1.0 111.861 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.451 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . 6.0 p-10 -66.49 119.2 11.24 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.812 0.815 . . . . 1.0 109.827 175.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.99 20.33 10.72 Favored Glycine 0 N--CA 1.427 -1.902 0 CA-C-N 115.144 -0.935 . . . . 1.0 111.417 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.88 162.12 29.93 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 120.867 0.365 . . . . 1.0 110.616 178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.419 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 76.1 m -115.24 132.3 56.65 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.093 0.473 . . . . 1.0 110.667 -175.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' LEU . 13.5 m -113.22 156.89 14.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 109.013 -0.736 . . . . 1.0 109.013 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -139.26 124.87 19.41 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.232 0.539 . . . . 1.0 109.598 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.628 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.7 mp -101.32 131.38 47.4 Favored 'General case' 0 C--N 1.267 -2.986 0 CA-C-N 115.574 -0.739 . . . . 1.0 110.234 -174.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 17.5 m -130.2 147.96 67.83 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 108.998 -0.742 . . . . 1.0 108.998 178.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.474 ' HD3' HG22 ' A' ' 17' ' ' VAL . 77.7 Cg_endo -83.07 82.96 2.03 Favored 'Trans proline' 0 N--CA 1.443 -1.488 0 C-N-CA 121.769 1.646 . . . . 1.0 111.741 -177.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.629 ' HB3' ' O ' ' A' ' 62' ' ' THR . 12.6 p 52.18 64.59 1.79 Allowed 'General case' 0 CA--C 1.499 -0.999 0 C-N-CA 125.227 1.411 . . . . 1.0 111.247 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -113.84 -49.75 2.86 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 114.676 -1.147 . . . . 1.0 112.833 -174.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 9.1 t -131.19 37.96 3.69 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.067 -1.053 . . . . 1.0 113.294 -171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 18.4 pttp -78.96 73.12 5.51 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.898 1.332 . . . . 1.0 112.658 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -158.5 133.48 8.42 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 103.677 -2.712 . . . . 1.0 103.677 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.1 m -69.21 135.89 27.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 C-N-CA 119.284 -0.967 . . . . 1.0 112.302 -174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 86.2 mt -117.95 122.13 42.45 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.877 -1.527 . . . . 1.0 106.877 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 55.26 77.44 0.22 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.937 0.875 . . . . 1.0 110.296 -175.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -84.41 95.17 8.69 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.802 -1.09 . . . . 1.0 112.008 -176.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -144.38 121.07 11.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.503 -0.771 . . . . 1.0 109.893 177.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 C--N 1.289 -2.033 0 N-CA-C 108.34 -0.985 . . . . 1.0 108.34 177.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm . . . . . 0 CA--C 1.505 -0.776 0 N-CA-C 108.629 -0.878 . . . . 1.0 108.629 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 3.0 mppt? -77.23 164.78 25.28 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.758 -0.83 . . . . 1.0 108.758 176.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -81.16 86.35 6.2 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.591 -1.633 . . . . 1.0 106.591 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.3 t -87.58 74.99 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.005 0 CA-C-O 121.741 0.782 . . . . 1.0 112.472 -173.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -132.91 30.03 4.05 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 124.27 1.986 . . . . 1.0 107.121 166.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.574 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 47.0 m-85 -110.28 -178.58 3.55 Favored 'General case' 0 N--CA 1.391 -3.42 0 N-CA-C 103.355 -2.831 . . . . 1.0 103.355 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.451 ' H ' ' CB ' ' A' ' 33' ' ' ASP . 19.2 mmt180 -101.21 110.66 61.99 Favored Pre-proline 0 C--N 1.264 -3.126 0 C-N-CA 118.805 -1.158 . . . . 1.0 111.746 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -60.44 119.83 7.23 Favored 'Trans proline' 0 CA--C 1.508 -0.825 0 C-N-CA 122.397 2.064 . . . . 1.0 108.617 172.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.432 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -114.94 128.41 56.27 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 109.15 -0.685 . . . . 1.0 109.15 -171.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.2 m -87.37 120.3 28.53 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.95 -1.5 . . . . 1.0 106.95 173.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.506 HD23 ' SD ' ' A' ' 44' ' ' MET . 16.3 tp -124.65 142.84 51.08 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 109.499 -0.556 . . . . 1.0 109.499 -174.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.52 HD22 HG23 ' A' ' 106' ' ' THR . 8.1 t30 -98.76 117.07 32.42 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 122.106 -0.371 . . . . 1.0 110.814 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -75.92 116.93 17.11 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 116.088 -0.506 . . . . 1.0 110.148 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 25.7 tp -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 109.015 -0.735 . . . . 1.0 109.015 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.695 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -128.65 141.21 51.42 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.955 -0.465 . . . . 1.0 110.741 176.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.489 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -115.63 54.0 0.82 Allowed 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.234 0.54 . . . . 1.0 110.933 -176.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 HG22 ' HD3' ' A' ' 111' ' ' PRO . 46.5 t -67.71 -43.21 86.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.604 0.716 . . . . 1.0 109.865 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 155.94 -84.59 0.14 Allowed Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 179.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.94 -32.82 76.42 Favored 'Trans proline' 0 C--O 1.213 -0.735 0 C-N-CA 122.792 2.328 . . . . 1.0 112.142 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -102.65 18.58 50.11 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 121.32 -0.467 . . . . 1.0 112.152 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -77.79 64.42 3.04 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.449 0.642 . . . . 1.0 111.924 -177.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.54 -29.34 1.89 Allowed Glycine 0 CA--C 1.487 -1.702 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -94.31 17.99 11.85 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.122 0.487 . . . . 1.0 111.187 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -77.07 -83.31 0.08 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.523 0.564 . . . . 1.0 112.523 -176.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -143.7 -62.8 0.39 Allowed 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 116.452 -0.34 . . . . 1.0 111.569 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.86 72.57 0.95 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -178.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.38 126.72 27.62 Favored Pre-proline 0 C--N 1.303 -1.429 0 CA-C-N 115.34 -0.43 . . . . 1.0 110.264 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -76.36 106.12 2.2 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 121.737 1.625 . . . . 1.0 111.496 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.517 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 40.6 t -110.61 142.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 CA-C-N 115.396 -0.82 . . . . 1.0 109.117 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.48 140.7 29.29 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.283 0.563 . . . . 1.0 111.765 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 9' ' ' LEU . 13.7 m -141.33 172.86 9.82 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 CA-C-N 114.399 -1.273 . . . . 1.0 109.06 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.491 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 9.8 mt -107.95 158.4 17.39 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.421 0.629 . . . . 1.0 111.483 176.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.451 ' CB ' ' H ' ' A' ' 7' ' ' ARG . 32.2 t70 -59.22 -30.83 68.52 Favored 'General case' 0 C--O 1.256 1.435 0 CA-C-N 114.44 -1.254 . . . . 1.0 110.03 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.9 t -88.6 -3.61 58.76 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 114.501 -1.227 . . . . 1.0 112.277 -177.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -73.23 132.34 43.06 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 177.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 p -74.55 172.08 12.66 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.024 -0.732 . . . . 1.0 109.024 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.451 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -59.94 -44.99 95.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-N 117.993 0.36 . . . . 1.0 111.198 -177.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.437 ' HB2' ' OD1' ' A' ' 79' ' ' ASP . 4.0 t -71.87 -35.97 69.94 Favored 'General case' 0 C--O 1.251 1.15 0 C-N-CA 118.955 -1.098 . . . . 1.0 110.519 177.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.79 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 9.1 tt0 -68.25 -38.02 81.39 Favored 'General case' 0 C--O 1.206 -1.226 0 C-N-CA 123.136 0.574 . . . . 1.0 111.007 -178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -73.69 -39.75 64.16 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.539 -0.726 . . . . 1.0 110.596 176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.646 ' HE2' ' O ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -58.22 -35.91 72.38 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.26 -0.882 . . . . 1.0 110.316 178.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.79 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 3.7 pt-20 -68.41 -40.44 81.27 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.722 -0.672 . . . . 1.0 109.919 -176.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.549 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 44.9 mmtm -63.99 -41.45 97.49 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 124.186 0.929 . . . . 1.0 110.245 -178.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 85.1 mmm -61.59 -48.59 80.26 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.234 -0.894 . . . . 1.0 110.694 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.4 pp -77.28 -24.72 50.98 Favored 'General case' 0 C--O 1.208 -1.129 0 N-CA-C 112.579 0.585 . . . . 1.0 112.579 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -52.89 -28.92 25.4 Favored 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.092 1.357 . . . . 1.0 112.076 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.446 HE21 HG13 ' A' ' 29' ' ' VAL . 12.2 mm-40 -66.76 -36.83 83.34 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.45 0.643 . . . . 1.0 110.348 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -95.16 -41.69 8.96 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.696 0.76 . . . . 1.0 109.545 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -95.46 30.91 2.11 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 114.413 -1.267 . . . . 1.0 110.877 -176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -56.6 122.94 13.2 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.565 -0.743 . . . . 1.0 109.71 176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.67 -17.85 27.61 Favored Glycine 0 C--N 1.313 -0.728 0 N-CA-C 111.324 -0.711 . . . . 1.0 111.324 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 62.4 t -85.53 128.59 58.48 Favored Pre-proline 0 C--N 1.315 -0.932 0 C-N-CA 122.937 0.495 . . . . 1.0 110.301 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.522 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 75.2 Cg_endo -70.35 161.56 45.55 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.26 2.64 . . . . 1.0 112.008 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.607 ' HA ' ' HD2' ' A' ' 57' ' ' ARG . 51.6 tp -61.21 -40.06 92.57 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -176.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -64.36 -26.07 68.31 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-O 120.557 0.218 . . . . 1.0 111.308 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.641 ' HA ' HE21 ' A' ' 56' ' ' GLN . 0.0 OUTLIER -85.61 -19.17 31.42 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.939 0.4 . . . . 1.0 110.145 179.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.607 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 83.9 mtt180 -73.92 114.2 30.43 Favored Pre-proline 0 N--CA 1.446 -0.657 0 N-CA-C 107.435 -1.32 . . . . 1.0 107.435 175.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.646 ' O ' ' HE2' ' A' ' 41' ' ' LYS . 39.4 Cg_exo -53.35 133.48 53.15 Favored 'Trans proline' 0 C--N 1.362 1.238 0 C-N-CA 122.489 2.126 . . . . 1.0 112.638 -172.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 61' ' ' ARG . 24.3 m-20 -83.42 146.45 50.59 Favored Pre-proline 0 C--N 1.295 -1.797 0 CA-C-N 115.118 -0.946 . . . . 1.0 110.959 -176.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HG2' ' NH1' ' A' ' 61' ' ' ARG . 32.5 Cg_endo -70.45 20.85 0.2 Allowed 'Trans proline' 0 CA--C 1.559 1.766 0 C-N-CA 122.955 2.437 . . . . 1.0 112.491 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 59' ' ' ASP . 4.2 mpt_? -86.09 -34.58 20.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.202 -0.666 . . . . 1.0 109.202 169.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.577 ' O ' ' HB3' ' A' ' 112' ' ' CYS . 4.8 t -95.04 -20.38 19.38 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.579 -0.737 . . . . 1.0 110.572 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.616 HD13 ' HG ' ' A' ' 109' ' ' LEU . 4.5 pp -134.82 161.55 34.88 Favored 'General case' 0 C--O 1.192 -1.962 0 N-CA-C 109.094 -0.706 . . . . 1.0 109.094 -177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -116.08 152.45 33.58 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.487 -1.301 . . . . 1.0 107.487 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 77' ' ' LEU . 8.4 p -115.75 125.94 73.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 118.825 -1.15 . . . . 1.0 110.137 177.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -93.87 113.11 25.06 Favored 'General case' 0 N--CA 1.412 -2.326 0 N-CA-C 107.357 -1.349 . . . . 1.0 107.357 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.611 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.5 t-105 -93.61 124.49 37.63 Favored 'General case' 0 N--CA 1.388 -3.549 0 CA-C-N 115.011 -0.995 . . . . 1.0 108.97 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -109.96 89.57 3.06 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 106.959 -1.497 . . . . 1.0 106.959 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.8 p -84.59 -13.47 51.6 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 114.435 -1.257 . . . . 1.0 110.054 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.06 -55.87 3.94 Favored Glycine 0 C--N 1.305 -1.165 0 CA-C-N 115.149 -0.932 . . . . 1.0 112.42 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.03 -40.93 90.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 123.003 0.521 . . . . 1.0 111.293 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.35 -10.76 26.99 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.694 0.759 . . . . 1.0 109.03 176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.35 -128.23 9.5 Favored Glycine 0 N--CA 1.425 -2.079 0 CA-C-N 115.083 -0.962 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 3.8 p80 -130.65 108.19 9.72 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 121.298 0.571 . . . . 1.0 109.836 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.4 mp -117.68 151.71 36.7 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.562 -0.903 . . . . 1.0 108.562 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.0 mm -94.07 120.68 43.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 10.4 mp -111.22 165.18 12.14 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.525 -177.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.2 t -167.06 157.72 11.67 Favored 'General case' 0 CA--C 1.485 -1.539 0 N-CA-C 105.141 -2.17 . . . . 1.0 105.141 174.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.613 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 9.3 p-10 -78.51 -19.72 52.35 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.123 -1.031 . . . . 1.0 110.42 177.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.6 ' OE2' ' HD3' ' A' ' 91' ' ' ARG . 47.1 mt-10 -132.35 78.53 1.81 Allowed 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.504 ' HA ' HG12 ' A' ' 117' ' ' VAL . 17.6 m-20 -80.88 -171.95 3.44 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-O 122.5 1.143 . . . . 1.0 110.328 -178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.18 -24.57 35.5 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.728 0 CA-C-N 114.434 -1.257 . . . . 1.0 109.468 171.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.496 HG22 ' HB2' ' A' ' 81' ' ' ASP . 3.7 t -80.4 -7.24 59.03 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 115.657 -0.701 . . . . 1.0 111.05 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 52.8 p -94.63 81.06 3.84 Favored 'General case' 0 N--CA 1.427 -1.59 0 N-CA-C 108.026 -1.102 . . . . 1.0 108.026 174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -68.98 124.57 24.1 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.463 -0.79 . . . . 1.0 112.842 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.8 t -105.32 87.35 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 106.779 -1.563 . . . . 1.0 106.779 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.91 5.74 0.2 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.188 -0.915 . . . . 1.0 112.103 -175.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.06 79.84 0.06 OUTLIER Glycine 0 N--CA 1.436 -1.346 0 C-N-CA 119.771 -1.205 . . . . 1.0 113.186 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.4 mt 70.47 -6.35 1.2 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 124.866 1.266 . . . . 1.0 113.444 174.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -79.94 -5.57 55.89 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.001 -0.545 . . . . 1.0 112.043 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.6 ' HD3' ' OE2' ' A' ' 80' ' ' GLU . 2.4 tmm_? -75.53 130.53 39.01 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 -179.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -155.88 177.46 11.38 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 94.3 mt -110.15 149.27 30.31 Favored 'General case' 0 C--O 1.251 1.154 0 O-C-N 123.925 0.766 . . . . 1.0 109.477 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.451 ' O ' HG12 ' A' ' 37' ' ' ILE . 82.7 m-20 -98.58 140.58 32.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.207 178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.548 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -111.39 173.1 6.5 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 124.991 1.316 . . . . 1.0 108.921 177.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.52 HD13 HG22 ' A' ' 101' ' ' VAL . 3.9 pp -72.21 -22.8 61.21 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 119.136 -1.025 . . . . 1.0 109.49 174.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.548 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.2 OUTLIER -65.77 -26.47 67.73 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.33 -0.396 . . . . 1.0 111.327 175.153 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -66.7 -40.68 88.6 Favored 'General case' 0 C--O 1.213 -0.842 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.487 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 88.1 m-85 -97.47 -1.33 44.41 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.652 -0.703 . . . . 1.0 111.61 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? 48.53 63.61 2.02 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.034 1.334 . . . . 1.0 113.589 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.611 HG11 ' CE2' ' A' ' 67' ' ' TRP . 0.9 OUTLIER -84.52 146.29 46.81 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 119.075 -1.05 . . . . 1.0 112.601 179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.14 158.08 23.41 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 123.026 2.484 . . . . 1.0 111.827 176.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.07 122.46 17.45 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.801 -0.815 . . . . 1.0 108.801 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.4 14.59 12.7 Favored Glycine 0 C--N 1.287 -2.151 0 CA-C-N 115.047 -0.979 . . . . 1.0 110.971 -178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -71.3 162.68 29.04 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.269 0.557 . . . . 1.0 110.697 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.52 HG23 HD22 ' A' ' 12' ' ' ASN . 97.4 m -123.04 134.5 54.29 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.309 -0.405 . . . . 1.0 109.92 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.425 HG11 HD21 ' A' ' 11' ' ' LEU . 27.2 m -115.38 138.81 44.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.461 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -126.13 135.17 51.37 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-O 121.528 0.68 . . . . 1.0 110.539 178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.695 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.4 tt -100.04 125.8 46.15 Favored 'General case' 0 C--N 1.266 -3.037 0 CA-C-N 115.288 -0.869 . . . . 1.0 109.315 -176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 16' ' ' ALA . 32.2 m -119.54 130.45 24.84 Favored Pre-proline 0 C--N 1.316 -0.883 0 C-N-CA 120.913 -0.315 . . . . 1.0 111.094 178.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' A' ' 17' ' ' VAL . 59.5 Cg_endo -75.15 86.35 1.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.344 2.029 . . . . 1.0 111.699 -178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.628 ' HA ' ' NH2' ' A' ' 119' ' ' ARG . 18.7 p 56.09 17.21 2.57 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 125.833 1.653 . . . . 1.0 113.714 177.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.01 -40.97 82.9 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 115.161 1.541 . . . . 1.0 115.161 -172.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 110' ' ' VAL . 14.9 t -114.62 2.41 14.51 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 115.561 1.689 . . . . 1.0 115.561 -168.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.459 ' HA ' ' NH1' ' A' ' 119' ' ' ARG . 2.3 mptp? 42.48 73.45 0.14 Allowed 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 114.664 1.357 . . . . 1.0 114.664 175.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 -98.21 -0.93 43.21 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 123.11 1.433 . . . . 1.0 110.229 174.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.504 HG12 ' HA ' ' A' ' 81' ' ' ASP . 26.7 m -131.13 148.29 32.95 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.854 0 CA-C-N 112.13 -2.305 . . . . 1.0 105.597 174.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 95.2 mt -109.98 115.82 30.49 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.75 -0.78 . . . . 1.0 111.451 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.628 ' NH2' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -120.48 -32.55 4.05 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.553 -1.203 . . . . 1.0 108.366 177.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 120' ' ' GLU . 1.5 pm0 -78.06 143.35 37.51 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 114.743 -1.117 . . . . 1.0 108.021 176.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 7.0 t30 73.56 82.69 0.12 Allowed 'General case' 0 N--CA 1.484 1.258 0 O-C-N 124.51 1.131 . . . . 1.0 108.186 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 . . . . . 0 C--N 1.297 -1.695 0 CA-C-N 115.435 -0.802 . . . . 1.0 111.11 -175.021 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 113.084 0.772 . . . . 1.0 113.084 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -115.09 37.67 3.43 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.263 -1.014 . . . . 1.0 108.263 177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.53 86.21 6.98 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.439 -1.255 . . . . 1.0 108.904 -176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 48.6 t -116.61 104.16 16.18 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.022 -0.99 . . . . 1.0 108.847 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.54 44.95 1.2 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 122.204 1.002 . . . . 1.0 111.006 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -131.01 156.28 45.4 Favored 'General case' 0 N--CA 1.406 -2.628 0 N-CA-C 103.481 -2.785 . . . . 1.0 103.481 178.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.507 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 33.6 mmt180 -108.52 111.61 61.23 Favored Pre-proline 0 C--N 1.267 -3.004 0 C-N-CA 119.362 -0.935 . . . . 1.0 112.301 -173.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -61.38 109.51 0.75 Allowed 'Trans proline' 0 C--O 1.245 0.85 0 C-N-CA 122.144 1.896 . . . . 1.0 109.57 173.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 10' ' ' THR . 4.6 tp -112.85 156.02 23.64 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 115.534 -0.757 . . . . 1.0 110.026 -174.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.439 ' N ' ' HG ' ' A' ' 9' ' ' LEU . 47.3 m -96.51 128.59 43.58 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 107.711 -1.218 . . . . 1.0 107.711 178.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 ' SD ' ' A' ' 44' ' ' MET . 29.0 tp -127.37 143.73 51.17 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 -176.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 7.3 t30 -97.68 113.47 25.23 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 122.03 -0.419 . . . . 1.0 110.966 -176.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' A' ' 27' ' ' VAL . . . -76.16 115.98 16.41 Favored 'General case' 0 C--O 1.249 1.029 0 CA-C-N 115.811 -0.632 . . . . 1.0 110.167 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.642 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.7 tp -147.81 154.81 40.95 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 -178.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.681 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.66 143.67 50.61 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 120.637 -0.425 . . . . 1.0 110.731 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -116.36 33.29 5.63 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.329 0.585 . . . . 1.0 110.368 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.3 t -64.78 -46.23 92.7 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 C-N-CA 123.645 0.778 . . . . 1.0 111.918 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.29 -77.47 0.14 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 119.295 -1.431 . . . . 1.0 113.684 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -59.45 -35.06 97.08 Favored 'Trans proline' 0 C--N 1.362 1.267 0 C-N-CA 122.761 2.307 . . . . 1.0 112.141 -175.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -121.39 36.63 3.22 Favored Glycine 0 N--CA 1.424 -2.156 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -68.39 74.46 0.24 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.79 1.033 . . . . 1.0 113.79 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.642 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 105.6 -5.58 40.73 Favored Glycine 0 CA--C 1.486 -1.78 0 N-CA-C 110.14 -1.184 . . . . 1.0 110.14 175.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -119.9 16.61 12.6 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.244 -0.978 . . . . 1.0 111.371 -176.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.81 -75.31 0.17 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 112.132 0.419 . . . . 1.0 112.132 -175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -148.53 -58.06 0.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.965 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.52 75.54 1.18 Allowed Glycine 0 N--CA 1.44 -1.089 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 13' ' ' ALA . 18.3 t -92.9 126.51 51.2 Favored Pre-proline 0 C--N 1.309 -1.187 0 CA-C-N 115.361 -0.419 . . . . 1.0 110.723 -173.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.18 99.06 1.22 Allowed 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 121.941 1.76 . . . . 1.0 110.751 175.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 47' ' ' GLN . 16.4 t -109.6 156.1 10.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 N-CA-C 107.292 -1.373 . . . . 1.0 107.292 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -123.01 151.32 41.98 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 118.811 -1.156 . . . . 1.0 112.021 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG22 ' H ' ' A' ' 32' ' ' LEU . 5.1 p -151.34 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 N-CA-C 107.812 -1.181 . . . . 1.0 107.812 -175.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.496 ' H ' HG22 ' A' ' 31' ' ' VAL . 19.7 mt -100.56 160.55 14.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-N 118.755 0.707 . . . . 1.0 111.195 -177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 19.6 t70 -64.62 -31.08 72.14 Favored 'General case' 0 C--O 1.251 1.159 0 O-C-N 124.025 0.828 . . . . 1.0 108.857 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.442 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 8.2 t -108.61 39.52 1.98 Allowed 'General case' 0 N--CA 1.426 -1.674 0 CA-C-N 114.013 -1.449 . . . . 1.0 110.168 -177.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.627 ' O ' HG22 ' A' ' 95' ' ' THR . 11.9 p-10 -66.89 -164.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.02 -0.991 . . . . 1.0 109.33 170.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 76.8 p -142.01 153.46 44.28 Favored 'General case' 0 C--N 1.272 -2.775 0 N-CA-C 104.854 -2.276 . . . . 1.0 104.854 168.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 45.8 mm -56.55 -40.68 70.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 118.122 0.419 . . . . 1.0 111.316 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.565 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -62.59 -43.02 99.85 Favored 'General case' 0 CA--C 1.557 1.243 0 CA-C-N 116.473 -0.331 . . . . 1.0 111.62 176.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 45.7 mt-30 -73.16 -37.58 66.51 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.974 0.416 . . . . 1.0 111.575 -179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -64.02 -38.19 90.17 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.27 176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.4 ' HB3' ' O ' ' A' ' 38' ' ' SER . 28.7 tptp -55.56 -41.89 73.89 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.684 -0.858 . . . . 1.0 108.684 175.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.7 mt-10 -68.13 -48.52 65.18 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.259 -0.882 . . . . 1.0 110.625 -178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 46' ' ' ASP . 34.9 mmtp -65.33 -42.54 92.8 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.128 0.788 . . . . 1.0 113.128 -177.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 83.2 mmm -63.94 -42.84 97.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.863 0.363 . . . . 1.0 110.577 -177.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.2 pp -75.77 -25.63 56.63 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-O 120.776 0.322 . . . . 1.0 111.682 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 43' ' ' LYS . 4.2 t70 -53.02 -31.45 41.29 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.858 1.263 . . . . 1.0 112.224 -177.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.58 ' HG3' HG22 ' A' ' 29' ' ' VAL . 13.7 mm-40 -71.32 -38.27 71.71 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.147 0.498 . . . . 1.0 111.401 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.97 -43.32 12.45 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 122.072 0.939 . . . . 1.0 108.912 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -95.77 32.13 1.92 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 113.769 -1.56 . . . . 1.0 109.636 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -50.6 117.66 2.59 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.994 -1.003 . . . . 1.0 111.331 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.47 -9.41 22.13 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 115.584 -0.735 . . . . 1.0 111.777 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 55.4 t -86.03 124.57 70.34 Favored Pre-proline 0 C--N 1.308 -1.219 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 50.3 Cg_endo -66.99 160.96 44.76 Favored 'Trans proline' 0 C--O 1.246 0.894 0 C-N-CA 122.877 2.384 . . . . 1.0 111.277 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.43 -41.78 97.71 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.859 -174.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 t -63.13 -23.87 67.64 Favored 'General case' 0 CA--C 1.56 1.345 0 N-CA-C 112.446 0.535 . . . . 1.0 112.446 -179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.447 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 10.1 tt0 -93.2 -10.24 36.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.077 0.465 . . . . 1.0 111.732 -175.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 88.8 mtt180 -76.6 128.45 81.99 Favored Pre-proline 0 C--N 1.314 -0.958 0 N-CA-C 111.972 0.36 . . . . 1.0 111.972 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -66.61 142.86 66.14 Favored 'Trans proline' 0 C--O 1.26 1.608 0 C-N-CA 123.231 2.621 . . . . 1.0 113.678 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.26 156.98 88.81 Favored Pre-proline 0 N--CA 1.471 0.612 0 CA-C-N 115.185 -0.916 . . . . 1.0 111.694 -176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -89.56 12.87 2.51 Favored 'Trans proline' 0 C--O 1.203 -1.243 0 C-N-CA 123.068 2.512 . . . . 1.0 111.489 174.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.478 ' NH1' ' HB3' ' A' ' 80' ' ' GLU . 9.7 mmm180 -74.23 -39.46 63.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.329 0.585 . . . . 1.0 111.832 178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 82.0 p -81.85 -12.69 58.36 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.084 -0.962 . . . . 1.0 112.218 -171.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.1 pp -136.25 164.21 28.61 Favored 'General case' 0 C--N 1.282 -2.358 0 CA-C-N 114.385 -1.279 . . . . 1.0 109.245 -176.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.51 ' OD1' ' HA ' ' A' ' 112' ' ' CYS . 1.7 m-20 -107.8 141.09 39.89 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.157 -1.053 . . . . 1.0 108.157 -177.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.8 p -103.89 114.31 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 C-N-CA 118.352 -1.339 . . . . 1.0 108.054 171.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -91.0 112.67 24.66 Favored 'General case' 0 N--CA 1.414 -2.263 0 N-CA-C 107.614 -1.254 . . . . 1.0 107.614 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.655 ' CZ2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -83.42 127.52 33.76 Favored 'General case' 0 N--CA 1.385 -3.683 0 CA-C-N 115.448 -0.797 . . . . 1.0 109.723 -178.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.59 89.01 3.03 Favored 'General case' 0 N--CA 1.422 -1.837 0 CA-C-N 115.456 -0.793 . . . . 1.0 109.562 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.407 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 53.0 m -97.05 -17.56 19.92 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.683 0.754 . . . . 1.0 109.335 176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.95 -46.0 3.5 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.505 -1.225 . . . . 1.0 112.411 179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.6 -44.93 97.87 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.704 0 CA-C-O 120.89 0.376 . . . . 1.0 110.989 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.507 ' HB3' ' CZ ' ' A' ' 99' ' ' TYR . . . -102.46 0.59 34.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 122.057 0.932 . . . . 1.0 108.703 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.68 -127.75 8.09 Favored Glycine 0 N--CA 1.42 -2.388 0 CA-C-N 114.282 -1.327 . . . . 1.0 113.236 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 9.3 m170 -115.73 118.46 33.11 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 124.382 1.073 . . . . 1.0 109.294 -178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.98 139.04 48.51 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.484 HG21 ' HA ' ' A' ' 115' ' ' LYS . 25.6 mm -84.68 118.29 31.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 120.29 -0.564 . . . . 1.0 109.638 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.0 mp -108.49 159.59 16.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.474 0.654 . . . . 1.0 111.44 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 39.2 m -165.81 162.75 18.67 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.567 -1.642 . . . . 1.0 106.567 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 12.6 p-10 -66.08 -38.76 89.08 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.682 -0.488 . . . . 1.0 109.682 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.478 ' HB3' ' NH1' ' A' ' 61' ' ' ARG . 45.9 tt0 -135.04 126.65 28.89 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.46 -1.311 . . . . 1.0 107.46 175.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 37.8 t70 -157.31 -99.23 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.653 0.74 . . . . 1.0 111.861 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 p -102.17 -25.47 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 CA-C-N 114.83 -1.077 . . . . 1.0 112.621 -171.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 t -94.19 -6.12 45.49 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 121.319 0.581 . . . . 1.0 110.534 -176.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.3 p -98.25 73.41 2.17 Favored 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 115.687 -0.688 . . . . 1.0 110.445 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -87.15 135.86 33.14 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.052 -1.092 . . . . 1.0 108.052 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.616 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . 15.9 m -104.37 89.38 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-O 122.23 1.014 . . . . 1.0 110.813 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -139.54 5.62 2.24 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.474 -1.239 . . . . 1.0 111.046 179.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.78 -60.32 0.21 Allowed Glycine 0 CA--C 1.501 -0.813 0 C-N-CA 120.143 -1.027 . . . . 1.0 111.55 177.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 98.8 mt -65.51 -38.37 89.49 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 122.117 0.96 . . . . 1.0 108.57 176.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 86' ' ' VAL 0.295 52.8 p90 60.74 -52.05 0.1 Allowed 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 130.427 3.491 . . . . 1.0 115.416 176.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -100.88 119.39 38.62 Favored 'General case' 1 C--N 1.236 -4.363 0 CA-C-N 115.666 -0.697 . . . . 1.0 109.622 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 61.6 mmt-85 -143.99 89.35 2.03 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.455 0.645 . . . . 1.0 111.118 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 88.2 mt -76.07 147.92 38.31 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.724 -1.125 . . . . 1.0 109.099 178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -90.71 141.14 29.1 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.974 -0.691 . . . . 1.0 109.826 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.8 p -121.97 171.49 8.9 Favored 'General case' 0 C--O 1.266 1.922 0 N-CA-C 107.915 -1.143 . . . . 1.0 107.915 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.576 HD13 HG22 ' A' ' 101' ' ' VAL . 3.2 pp -66.8 -29.94 70.01 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.96 . . . . 1.0 108.979 171.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.549 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -67.83 -26.09 65.88 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.533 177.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.6 t60 -64.13 -41.36 97.24 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.528 ' CD1' HG12 ' A' ' 101' ' ' VAL . 3.1 t80 -83.45 -18.62 38.0 Favored 'General case' 0 CA--C 1.558 1.283 0 CA-C-N 115.489 -0.778 . . . . 1.0 109.733 175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.485 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 10.6 mmmm 52.15 60.7 3.64 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.947 0.899 . . . . 1.0 110.788 -171.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.655 HG11 ' CZ2' ' A' ' 67' ' ' TRP . 1.6 m -74.23 149.78 87.16 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.65 -0.705 . . . . 1.0 112.575 -176.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.3 164.03 31.59 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 123.142 2.561 . . . . 1.0 111.742 174.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.408 ' HA ' HD11 ' A' ' 9' ' ' LEU . 5.0 p-10 -65.65 129.01 38.24 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.366 0.603 . . . . 1.0 109.712 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.36 24.27 40.64 Favored Glycine 0 C--N 1.295 -1.727 0 C-N-CA 120.623 -0.799 . . . . 1.0 111.999 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -64.42 154.87 34.36 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 120.716 0.293 . . . . 1.0 111.018 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 98.9 m -107.45 132.52 53.11 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 120.988 0.423 . . . . 1.0 111.345 -176.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.5 m -113.0 142.63 24.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 109.055 -0.72 . . . . 1.0 109.055 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.33 136.57 53.62 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.578 0.704 . . . . 1.0 110.581 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.681 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 10.0 tt -102.68 124.47 48.29 Favored 'General case' 0 C--N 1.275 -2.666 0 CA-C-N 115.191 -0.913 . . . . 1.0 109.184 -177.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.559 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 26.3 m -129.03 144.25 51.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -78.01 51.54 3.69 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 122.934 2.422 . . . . 1.0 114.002 -174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 62' ' ' THR . 0.1 OUTLIER 64.03 84.32 0.15 Allowed 'General case' 0 CA--C 1.495 -1.161 0 C-N-CA 124.495 1.118 . . . . 1.0 111.095 -178.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.21 -55.05 2.54 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 114.304 -1.317 . . . . 1.0 110.71 -177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.5 t -135.55 37.41 2.9 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 113.861 1.06 . . . . 1.0 113.861 -170.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.484 ' HA ' HG21 ' A' ' 76' ' ' ILE . 37.5 ttpt -74.34 131.23 40.95 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.249 -0.981 . . . . 1.0 109.965 175.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -53.14 128.61 28.35 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.539 -1.21 . . . . 1.0 111.968 -176.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.0 m -109.55 155.04 10.82 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.018 -1.105 . . . . 1.0 108.018 177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.5 mt -87.34 80.69 8.11 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.462 0.649 . . . . 1.0 110.039 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -90.85 -20.58 22.12 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.361 -0.836 . . . . 1.0 110.111 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -129.39 108.04 9.97 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-O 121.326 0.584 . . . . 1.0 111.233 -174.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -130.49 88.79 2.68 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.786 -1.19 . . . . 1.0 107.786 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 . . . . . 0 C--N 1.307 -1.277 0 N-CA-C 108.673 -0.862 . . . . 1.0 108.673 -177.349 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? . . . . . 0 CA--C 1.484 -1.558 0 N-CA-C 108.235 -1.024 . . . . 1.0 108.235 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.625 ' O ' HD11 ' A' ' 32' ' ' LEU . 35.1 mtmm -133.65 108.38 8.52 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.318 -1.364 . . . . 1.0 107.318 176.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -82.01 74.03 9.01 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 122.564 1.173 . . . . 1.0 110.716 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.92 -171.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 CA-C-N 113.489 -1.687 . . . . 1.0 107.463 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -101.08 91.3 4.49 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.242 1.02 . . . . 1.0 112.347 -174.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.644 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 18.0 m-85 -137.55 -175.89 4.22 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 101.202 -3.629 . . . . 1.0 101.202 175.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 34.9 mmt180 -98.01 108.24 45.41 Favored Pre-proline 0 C--N 1.29 -2.013 0 CA-C-N 121.063 1.756 . . . . 1.0 111.22 -173.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.644 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 15.4 Cg_exo -69.58 120.07 6.94 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 C-N-CA 122.106 1.871 . . . . 1.0 108.469 175.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.2 tp -117.87 158.34 25.02 Favored 'General case' 0 C--N 1.27 -2.869 0 CA-C-N 115.804 -0.634 . . . . 1.0 110.223 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.3 m -98.34 125.56 43.51 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 107.584 -1.265 . . . . 1.0 107.584 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.54 HD11 HG13 ' A' ' 107' ' ' VAL . 18.5 tp -127.21 142.03 51.59 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 107.724 -1.213 . . . . 1.0 107.724 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.451 ' HB3' ' HA ' ' A' ' 106' ' ' THR . 10.8 t30 -94.94 122.0 37.13 Favored 'General case' 0 C--N 1.295 -1.787 0 O-C-N 121.916 -0.49 . . . . 1.0 111.25 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.48 113.31 20.14 Favored 'General case' 0 CA--C 1.493 -1.225 0 CA-C-N 115.494 -0.776 . . . . 1.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 33.2 tp -146.61 151.71 37.73 Favored 'General case' 0 N--CA 1.418 -2.062 0 CA-C-N 116.112 -0.495 . . . . 1.0 109.912 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.678 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.5 pt? -120.82 140.45 51.72 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.087 -0.709 . . . . 1.0 109.087 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.572 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.93 42.79 2.1 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.035 0.445 . . . . 1.0 110.901 -174.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.552 HG22 ' HD3' ' A' ' 111' ' ' PRO . 82.7 t -65.2 -46.34 91.17 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.517 0 CA-C-N 115.461 -0.791 . . . . 1.0 111.825 -177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 160.85 -80.35 0.15 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.239 -0.981 . . . . 1.0 112.986 -179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -62.62 -30.95 79.61 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.947 2.432 . . . . 1.0 112.829 -177.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 24' ' ' ALA . . . -126.38 41.49 1.63 Allowed Glycine 0 N--CA 1.408 -3.23 0 N-CA-C 109.497 -1.441 . . . . 1.0 109.497 178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -75.67 31.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 123.14 0.576 . . . . 1.0 112.195 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.549 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 168.35 -41.28 0.23 Allowed Glycine 0 C--N 1.3 -1.45 0 N-CA-C 111.34 -0.704 . . . . 1.0 111.34 -176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.74 10.11 19.4 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.195 0.521 . . . . 1.0 112.093 -177.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLY . . . -76.16 -68.54 0.57 Allowed 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.472 0.653 . . . . 1.0 112.603 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.46 ' HB2' HG23 ' A' ' 27' ' ' VAL . 1.1 pt20 -131.24 -69.51 0.63 Allowed 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 115.209 -0.905 . . . . 1.0 110.793 -172.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 57.35 64.33 4.49 Favored Glycine 0 N--CA 1.462 0.399 0 N-CA-C 111.329 -0.708 . . . . 1.0 111.329 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 25' ' ' GLN . 19.2 t -107.95 125.82 31.2 Favored Pre-proline 0 C--N 1.301 -1.504 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -175.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -73.46 104.93 1.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.63 1.553 . . . . 1.0 110.575 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 47' ' ' GLN . 17.1 t -107.61 156.01 8.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 108.222 -1.029 . . . . 1.0 108.222 -178.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -111.95 148.06 34.57 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.392 -0.923 . . . . 1.0 110.561 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' CB ' ' A' ' 40' ' ' ALA . 13.9 p -158.55 163.81 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.393 -0.821 . . . . 1.0 108.974 -176.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD11 ' O ' ' A' ' 2' ' ' LYS . 18.3 mt -86.05 158.2 19.89 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-O 121.739 0.78 . . . . 1.0 112.423 178.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.47 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 30.2 t70 -64.24 -32.03 73.46 Favored 'General case' 0 C--O 1.255 1.358 0 CA-C-N 113.904 -1.498 . . . . 1.0 109.289 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.414 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 53.0 t -95.29 6.56 48.7 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 113.548 -1.66 . . . . 1.0 111.239 -175.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.416 ' CG ' ' HB2' ' A' ' 32' ' ' LEU . 95.2 m-20 -85.54 144.79 27.71 Favored 'General case' 0 N--CA 1.417 -2.078 0 C-N-CA 119.399 -0.92 . . . . 1.0 108.656 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.7 p -83.56 169.96 14.87 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.444 -0.798 . . . . 1.0 109.328 -175.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 94' ' ' ASN . 44.2 mm -61.52 -43.44 96.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 117.752 0.251 . . . . 1.0 110.457 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.4 p -63.88 -40.76 97.27 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.22 0.533 . . . . 1.0 110.655 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.663 ' O ' ' HG2' ' A' ' 42' ' ' GLU . 8.1 tt0 -75.78 -25.0 56.03 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.797 -178.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.496 ' CB ' HG21 ' A' ' 31' ' ' VAL . . . -82.3 -37.6 25.55 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 121.701 -0.624 . . . . 1.0 111.098 173.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.71 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 2.5 mmmp? -57.64 -36.2 71.51 Favored 'General case' 0 CA--C 1.488 -1.439 0 CA-C-N 115.813 -0.631 . . . . 1.0 110.646 179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 39' ' ' GLN . 11.3 pt-20 -62.54 -45.8 91.31 Favored 'General case' 0 N--CA 1.414 -2.239 0 O-C-N 124.154 0.909 . . . . 1.0 110.925 -177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HA ' ' HD2' ' A' ' 43' ' ' LYS . 29.2 mmmt -70.72 -38.59 73.62 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.4 mmt -59.58 -49.01 79.43 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.363 0.602 . . . . 1.0 109.532 -176.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.71 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 2.4 pp -78.11 -23.9 47.69 Favored 'General case' 0 C--O 1.197 -1.709 0 CA-C-N 115.604 -0.726 . . . . 1.0 112.659 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.618 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 20.1 t70 -50.18 -34.69 23.42 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 125.11 1.364 . . . . 1.0 112.366 -176.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.514 ' HG3' HG22 ' A' ' 29' ' ' VAL . 11.7 mm-40 -67.36 -29.96 69.64 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.744 -178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -102.83 -38.74 7.28 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.717 0.77 . . . . 1.0 110.581 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.511 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 25.3 m-85 -88.44 16.17 6.83 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 124.232 1.013 . . . . 1.0 111.652 -177.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -64.91 116.28 6.21 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.015 -1.106 . . . . 1.0 108.015 175.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.61 -14.25 15.01 Favored Glycine 0 C--N 1.307 -1.028 0 N-CA-C 110.006 -1.238 . . . . 1.0 110.006 -175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.5 t -105.23 130.72 22.62 Favored Pre-proline 0 C--N 1.316 -0.863 0 N-CA-C 108.723 -0.843 . . . . 1.0 108.723 178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 60.2 Cg_endo -67.35 161.71 41.95 Favored 'Trans proline' 0 C--O 1.244 0.812 0 C-N-CA 123.055 2.503 . . . . 1.0 112.444 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 46.5 tp -61.68 -36.42 80.81 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 123.369 0.667 . . . . 1.0 111.865 -175.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.4 t -63.06 -29.55 70.9 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 122.889 0.476 . . . . 1.0 111.256 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -87.5 -23.08 24.53 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 120.809 0.338 . . . . 1.0 111.443 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 70.5 mtt180 -67.0 121.67 79.12 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.091 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.433 ' HB2' HD21 ' A' ' 63' ' ' LEU . 35.7 Cg_exo -59.88 140.57 93.67 Favored 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 123.163 2.575 . . . . 1.0 113.429 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 44.6 m-20 -89.16 155.0 49.56 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.706 -0.679 . . . . 1.0 111.274 -176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.482 ' HG2' ' OD1' ' A' ' 79' ' ' ASP . 62.8 Cg_endo -81.19 2.23 8.72 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.329 2.019 . . . . 1.0 112.778 178.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -93.78 -7.07 44.52 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.889 -0.507 . . . . 1.0 111.557 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.4 t -118.63 -13.11 9.66 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.945 0.878 . . . . 1.0 109.978 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.643 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 4.2 pp -140.92 147.93 39.62 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 106.589 -1.634 . . . . 1.0 106.589 174.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.45 ' HB3' HG23 ' A' ' 76' ' ' ILE . 21.5 m-20 -102.93 154.12 19.54 Favored 'General case' 0 C--N 1.267 -3.019 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 -174.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.9 p -115.13 112.77 41.32 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.06 -1.089 . . . . 1.0 108.06 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -91.34 122.32 33.85 Favored 'General case' 0 N--CA 1.415 -2.189 0 CA-C-O 121.771 0.796 . . . . 1.0 110.342 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 74' ' ' HIS . 17.8 t90 -82.73 116.87 22.27 Favored 'General case' 0 C--N 1.269 -2.918 0 CA-C-N 114.496 -1.229 . . . . 1.0 108.787 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.434 ' HG2' ' CB ' ' A' ' 74' ' ' HIS . 49.5 mtm105 -122.95 90.43 3.29 Favored 'General case' 0 N--CA 1.417 -2.08 0 N-CA-C 109.387 -0.597 . . . . 1.0 109.387 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 p -88.01 -20.47 25.77 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 175.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.74 -54.41 4.12 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 114.191 -1.368 . . . . 1.0 111.657 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.5 m -63.48 -40.43 89.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 C-N-CA 123.773 0.829 . . . . 1.0 111.498 -179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.94 -15.12 20.26 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.821 0.344 . . . . 1.0 110.673 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 120.67 -158.63 15.58 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 111.465 -0.654 . . . . 1.0 111.465 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.664 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 6.4 p80 -136.43 120.58 17.79 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 123.156 0.582 . . . . 1.0 110.861 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.0 mt -127.39 148.78 50.27 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.421 -174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' A' ' 64' ' ' ASP . 27.9 mm -84.9 116.95 29.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 120.87 0.367 . . . . 1.0 110.194 178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.448 ' HG ' ' CE1' ' A' ' 99' ' ' TYR . 11.1 mp -106.51 148.64 27.97 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.937 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 32.0 t -164.04 161.97 22.86 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.647 -0.872 . . . . 1.0 108.647 175.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.482 ' OD1' ' HG2' ' A' ' 60' ' ' PRO . 4.1 p-10 -71.38 -30.21 65.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 177.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.529 ' HG2' ' CB ' ' A' ' 84' ' ' SER . 33.9 tt0 -139.33 83.2 1.93 Allowed 'General case' 0 N--CA 1.409 -2.504 0 N-CA-C 106.161 -1.792 . . . . 1.0 106.161 178.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 1.7 p30 -102.09 -89.08 0.37 Allowed 'General case' 0 CA--C 1.478 -1.801 0 CA-C-O 121.594 0.712 . . . . 1.0 112.291 -176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.04 -16.55 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.215 0 CA-C-N 114.458 -1.246 . . . . 1.0 107.998 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 91' ' ' ARG . 14.0 p -85.45 -3.0 58.72 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-N 114.52 -1.218 . . . . 1.0 108.546 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.529 ' CB ' ' HG2' ' A' ' 80' ' ' GLU . 78.1 p -59.47 -34.55 72.69 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.314 -1.312 . . . . 1.0 112.483 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -76.01 125.6 29.43 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.063 -0.971 . . . . 1.0 109.167 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 91' ' ' ARG . 3.1 p -151.32 124.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.592 0 CA-C-O 121.576 0.703 . . . . 1.0 111.257 -174.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -102.62 -30.11 11.14 Favored 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.118 -0.946 . . . . 1.0 108.903 172.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.64 -97.51 1.37 Allowed Glycine 0 N--CA 1.404 -3.474 0 C-N-CA 120.015 -1.088 . . . . 1.0 111.274 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 pp -120.91 6.49 10.39 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 112.597 0.592 . . . . 1.0 112.597 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -62.89 -29.87 71.1 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 115.65 1.722 . . . . 1.0 115.65 -171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 83' ' ' THR . 49.0 ttp180 -65.86 118.01 9.08 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.625 -0.83 . . . . 1.0 110.68 177.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -132.63 147.05 52.33 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 107.167 -1.42 . . . . 1.0 107.167 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.05 132.47 38.94 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.448 -1.686 . . . . 1.0 106.448 173.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.418 ' O ' HG12 ' A' ' 37' ' ' ILE . 78.5 m-20 -84.92 141.49 30.35 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.969 -173.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.552 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 1.3 p -105.67 172.49 6.77 Favored 'General case' 0 N--CA 1.425 -1.69 0 C-N-CA 123.731 0.813 . . . . 1.0 108.917 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.406 HD13 HG22 ' A' ' 101' ' ' VAL . 3.2 pp -71.25 -27.31 63.37 Favored 'General case' 0 N--CA 1.437 -1.088 0 C-N-CA 118.735 -1.186 . . . . 1.0 108.503 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.552 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.0 OUTLIER -65.83 -25.25 67.13 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.439 177.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -65.32 -35.39 80.86 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 109.508 -0.553 . . . . 1.0 109.508 -178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.448 ' CE1' ' HG ' ' A' ' 77' ' ' LEU . 87.4 m-85 -103.32 -11.8 17.67 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.927 -0.579 . . . . 1.0 110.918 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 30.9 mmtp 54.0 69.3 0.73 Allowed 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 124.615 1.166 . . . . 1.0 112.649 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.448 HG21 HD13 ' A' ' 11' ' ' LEU . 2.5 m -78.97 137.8 57.31 Favored Pre-proline 0 N--CA 1.434 -1.239 0 C-N-CA 120.041 -0.664 . . . . 1.0 109.471 177.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.25 160.39 49.06 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.315 2.01 . . . . 1.0 111.171 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -64.84 125.73 25.76 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 119.884 -0.727 . . . . 1.0 110.293 178.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 89.54 21.74 39.52 Favored Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.881 -1.054 . . . . 1.0 111.164 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.92 155.54 39.77 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.783 0.325 . . . . 1.0 110.403 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 12' ' ' ASN . 99.0 m -107.01 125.83 51.54 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.108 -177.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 11' ' ' LEU . 35.2 m -121.66 137.06 56.55 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 176.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -122.82 135.13 54.43 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.662 0.744 . . . . 1.0 112.826 -174.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.678 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 11.0 mp -90.14 124.09 34.53 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.322 -0.853 . . . . 1.0 109.549 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 23.6 m -125.54 134.7 26.07 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 116.672 -0.24 . . . . 1.0 110.433 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.552 ' HD3' HG22 ' A' ' 17' ' ' VAL . 40.2 Cg_endo -68.69 86.15 0.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.525 2.15 . . . . 1.0 111.18 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.643 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 23.3 p 49.35 77.3 0.11 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.541 1.537 . . . . 1.0 111.715 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 114' ' ' THR . 3.0 mm? 69.8 12.62 8.01 Favored 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 125.019 1.328 . . . . 1.0 110.0 -178.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER 75.03 12.84 3.38 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.874 1.669 . . . . 1.0 112.42 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -120.63 99.85 6.78 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-N 114.289 -1.323 . . . . 1.0 107.551 176.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -72.24 100.88 2.7 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.131 -175.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.3 164.58 31.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 N-CA-C 106.938 -1.504 . . . . 1.0 106.938 176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.6 mt -85.75 92.84 8.71 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 119.737 -0.785 . . . . 1.0 109.62 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 120' ' ' GLU . 73.3 ttt180 -123.75 140.46 52.97 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.877 -1.056 . . . . 1.0 109.504 -178.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 119' ' ' ARG . 70.0 mm-40 -75.31 162.18 28.64 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 176.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -73.84 88.35 1.8 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.63 0.728 . . . . 1.0 110.393 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 . . . . . 0 N--CA 1.435 -1.178 0 C-N-CA 126.126 1.77 . . . . 1.0 106.86 177.756 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 108.001 -1.111 . . . . 1.0 108.001 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -152.2 101.06 2.67 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.918 0.866 . . . . 1.0 108.71 174.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -103.52 17.66 23.6 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 114.65 -1.159 . . . . 1.0 109.933 -174.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.1 t 66.43 66.53 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 CA-C-O 122.713 1.244 . . . . 1.0 109.578 -175.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -115.56 27.58 9.23 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 113.784 -1.553 . . . . 1.0 107.582 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.563 ' HB2' HD22 ' A' ' 32' ' ' LEU . 41.7 m-85 -125.65 163.62 22.37 Favored 'General case' 0 C--N 1.263 -3.19 0 N-CA-C 104.422 -2.436 . . . . 1.0 104.422 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 33' ' ' ASP . 26.3 mmt180 -110.26 105.03 56.82 Favored Pre-proline 0 C--N 1.272 -2.774 0 C-N-CA 118.773 -1.171 . . . . 1.0 110.547 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.87 118.44 5.33 Favored 'Trans proline' 0 C--O 1.25 1.093 0 N-CA-C 108.504 -1.383 . . . . 1.0 108.504 172.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 103' ' ' ASP . 0.8 OUTLIER -119.13 131.68 55.91 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.352 -0.981 . . . . 1.0 108.352 -172.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.8 m -87.12 128.74 35.11 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.723 -0.473 . . . . 1.0 109.723 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 31' ' ' VAL . 1.1 mm? -122.82 147.35 46.64 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 124.064 0.946 . . . . 1.0 109.996 178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -89.95 110.94 21.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.986 -0.746 . . . . 1.0 108.986 177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.49 109.45 7.98 Favored 'General case' 0 C--O 1.249 1.045 0 O-C-N 123.489 0.493 . . . . 1.0 109.78 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.9 tp -138.56 160.77 38.74 Favored 'General case' 0 N--CA 1.413 -2.297 0 CA-C-N 115.578 -0.737 . . . . 1.0 109.318 -175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.572 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.6 pt? -125.73 143.43 51.05 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.718 -0.475 . . . . 1.0 109.718 177.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 108' ' ' ALA . . . -114.21 33.92 4.99 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.921 0.391 . . . . 1.0 110.597 -177.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.428 ' HA ' ' OG1' ' A' ' 114' ' ' THR . 47.1 t -63.79 -47.66 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.428 0 CA-C-N 115.849 -0.614 . . . . 1.0 112.392 -174.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.73 -85.14 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.439 -1.362 . . . . 1.0 113.201 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.63 -33.78 93.03 Favored 'Trans proline' 0 N--CA 1.481 0.749 0 C-N-CA 122.998 2.466 . . . . 1.0 113.072 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -116.05 29.63 6.99 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 15' ' ' LEU . . . -76.24 75.98 3.05 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.397 0.617 . . . . 1.0 111.985 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.557 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 121.2 -7.91 10.55 Favored Glycine 0 CA--C 1.488 -1.629 0 CA-C-N 115.409 -0.814 . . . . 1.0 111.391 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -128.76 28.3 5.38 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.234 0.54 . . . . 1.0 111.27 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.43 -88.78 0.18 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.449 -177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.457 ' HG3' ' H ' ' A' ' 26' ' ' GLY . 8.9 pt20 -117.62 -58.49 2.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 116.047 -0.524 . . . . 1.0 112.243 -175.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.457 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 65.97 71.81 0.84 Allowed Glycine 0 C--N 1.34 0.777 0 N-CA-C 110.863 -0.895 . . . . 1.0 110.863 -175.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.3 t -103.97 126.98 30.28 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 115.626 -0.287 . . . . 1.0 110.432 -173.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.21 106.51 2.18 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 121.963 1.775 . . . . 1.0 111.581 178.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 44' ' ' MET . 79.4 t -116.1 155.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.95 -1.13 . . . . 1.0 107.95 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -125.69 144.3 50.66 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.357 0.873 . . . . 1.0 113.357 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 11' ' ' LEU . 16.0 m -139.72 170.31 15.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.015 -0.993 . . . . 1.0 109.571 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.563 HD22 ' HB2' ' A' ' 6' ' ' TYR . 14.7 mt -84.52 159.64 20.66 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.043 0.449 . . . . 1.0 111.454 177.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 7' ' ' ARG . 24.5 t70 -62.65 -30.89 71.71 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-N 115.286 -0.87 . . . . 1.0 108.834 178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.545 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 10.0 t -95.27 6.11 49.92 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 114.048 -1.433 . . . . 1.0 112.562 -177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -71.24 132.51 45.06 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 107.337 -1.357 . . . . 1.0 107.337 174.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.478 ' CG2' HD11 ' A' ' 93' ' ' LEU . 69.8 p -79.26 167.26 21.19 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 -179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 94' ' ' ASN . 48.7 mm -60.11 -43.32 92.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 120.237 -0.585 . . . . 1.0 111.541 -179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.669 ' O ' ' HG3' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -61.04 -47.13 87.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 O-C-N 123.32 0.387 . . . . 1.0 110.745 177.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.422 ' O ' ' HG2' ' A' ' 43' ' ' LYS . 47.5 mt-30 -71.24 -40.23 71.16 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.215 0.45 . . . . 1.0 112.215 -176.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -67.6 -39.78 84.77 Favored 'General case' 0 CA--C 1.488 -1.415 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.108 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.458 ' HE2' ' HA ' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -61.96 -34.66 76.54 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 115.93 -0.577 . . . . 1.0 109.718 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.669 ' HG3' ' O ' ' A' ' 38' ' ' SER . 42.9 mt-10 -64.46 -46.23 84.01 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 124.412 1.07 . . . . 1.0 110.073 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.519 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 39.2 mmtm -62.94 -46.61 86.95 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.662 0.744 . . . . 1.0 109.051 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.607 ' SD ' HG21 ' A' ' 107' ' ' VAL . 7.2 mtp -65.3 -40.34 93.7 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.742 -1.117 . . . . 1.0 112.444 -176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.0 pp -73.55 -33.18 64.58 Favored 'General case' 0 C--O 1.22 -0.455 0 C-N-CA 120.514 -0.474 . . . . 1.0 111.123 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -62.1 -33.95 75.41 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.77 -0.65 . . . . 1.0 111.606 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 43' ' ' LYS . 19.0 mm-40 -67.08 -30.88 71.04 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.52 -0.764 . . . . 1.0 111.584 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.41 HD22 HE22 ' A' ' 25' ' ' GLN . 0.7 OUTLIER -108.62 -28.04 9.51 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 120.766 -0.373 . . . . 1.0 111.501 -173.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.77 13.68 21.64 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.181 0.515 . . . . 1.0 110.307 179.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -61.89 126.02 25.87 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 115.689 -0.687 . . . . 1.0 109.301 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 109.53 -20.02 28.08 Favored Glycine 0 N--CA 1.439 -1.113 0 N-CA-C 109.562 -1.415 . . . . 1.0 109.562 -176.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.75 131.85 23.0 Favored Pre-proline 0 C--N 1.307 -1.269 0 N-CA-C 108.422 -0.955 . . . . 1.0 108.422 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.493 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 51.2 Cg_endo -65.12 154.39 73.7 Favored 'Trans proline' 0 C--O 1.245 0.843 0 C-N-CA 122.481 2.12 . . . . 1.0 111.591 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.7 tp -59.21 -39.51 82.89 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.763 0.425 . . . . 1.0 111.769 -176.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.1 t -63.42 -23.95 67.62 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.569 -0.287 . . . . 1.0 111.587 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -94.16 -24.47 17.52 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 120.344 -0.542 . . . . 1.0 110.35 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.493 ' HG3' ' O ' ' A' ' 53' ' ' PRO . 89.4 mtt180 -65.77 145.68 99.02 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.226 -0.657 . . . . 1.0 109.226 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.61 142.88 96.02 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 121.919 1.746 . . . . 1.0 110.423 175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.437 ' OD2' ' HB2' ' A' ' 61' ' ' ARG . 19.8 t70 -77.35 117.28 64.33 Favored Pre-proline 0 C--N 1.312 -1.05 0 CA-C-N 116.599 -0.273 . . . . 1.0 110.666 -177.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . 40.4 Cg_endo -68.16 -13.62 38.47 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.183 2.589 . . . . 1.0 113.15 -175.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.437 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 98.4 mtt180 -93.73 -10.93 32.66 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.287 -176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.8 -21.15 11.33 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.037 0.446 . . . . 1.0 111.498 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 4.2 pp -88.54 162.93 16.13 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 116.374 -0.376 . . . . 1.0 111.437 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.458 ' HB2' ' CG2' ' A' ' 110' ' ' VAL . 4.9 m-20 -107.81 150.64 26.76 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.544 -1.28 . . . . 1.0 107.544 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.53 128.89 75.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 C-N-CA 120.108 -0.637 . . . . 1.0 109.5 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HG2' ' CD1' ' A' ' 76' ' ' ILE . 33.7 mt-10 -90.93 112.97 25.06 Favored 'General case' 0 CA--C 1.462 -2.407 0 N-CA-C 106.119 -1.808 . . . . 1.0 106.119 174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.613 ' CE2' HG11 ' A' ' 101' ' ' VAL . 3.5 t-105 -91.34 119.16 31.13 Favored 'General case' 1 N--CA 1.37 -4.448 0 N-CA-C 107.843 -1.169 . . . . 1.0 107.843 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -108.98 89.48 3.01 Favored 'General case' 0 N--CA 1.394 -3.225 0 N-CA-C 106.738 -1.579 . . . . 1.0 106.738 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 78.2 p -83.95 -12.49 55.28 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 113.797 -1.547 . . . . 1.0 110.906 -175.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 77.4 -60.97 3.58 Favored Glycine 0 C--N 1.302 -1.325 0 CA-C-N 114.834 -1.075 . . . . 1.0 111.695 -177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 C-N-CA 123.279 0.631 . . . . 1.0 112.049 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.12 -6.52 31.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.58 0.705 . . . . 1.0 109.751 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.35 -153.72 26.68 Favored Glycine 0 N--CA 1.414 -2.831 0 CA-C-N 115.06 -0.973 . . . . 1.0 111.24 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.568 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 0.5 OUTLIER -101.01 117.0 34.17 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.489 0.662 . . . . 1.0 111.678 -179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.92 146.75 45.5 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.772 -1.103 . . . . 1.0 108.069 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 66' ' ' GLU . 22.0 mm -89.76 102.85 13.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 108.668 -0.864 . . . . 1.0 108.668 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.8 159.47 15.79 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.669 -177.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.525 ' O ' ' HB2' ' A' ' 94' ' ' ASN . 3.3 t -167.95 165.74 13.59 Favored 'General case' 0 CA--C 1.469 -2.141 0 N-CA-C 105.789 -1.93 . . . . 1.0 105.789 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' HD22 ' A' ' 93' ' ' LEU . 11.3 p-10 -63.0 -39.54 95.06 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.559 -0.904 . . . . 1.0 108.559 176.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' CD ' ' HE ' ' A' ' 91' ' ' ARG . 3.0 tm-20 -163.47 95.2 0.82 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.253 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -150.56 -98.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.729 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.7 p -96.46 -44.94 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 114.034 1.124 . . . . 1.0 114.034 -175.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 p -84.44 7.95 18.01 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 122.046 0.927 . . . . 1.0 112.084 -175.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 80' ' ' GLU . 49.5 m -74.45 15.8 0.32 Allowed 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.718 -1.128 . . . . 1.0 113.189 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' OE1' ' HD3' ' A' ' 92' ' ' ARG . 60.4 mt-10 56.15 23.35 6.88 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 122.647 1.213 . . . . 1.0 111.438 -178.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.6 p -71.0 70.96 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 CA-C-N 113.426 -1.715 . . . . 1.0 112.0 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -99.15 -11.29 21.51 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 114.154 -1.384 . . . . 1.0 108.799 174.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 175.52 -114.74 0.51 Allowed Glycine 0 N--CA 1.411 -3.024 0 N-CA-C 108.262 -1.935 . . . . 1.0 108.262 177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.46 -2.65 58.35 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.471 0.653 . . . . 1.0 111.876 179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -80.44 12.43 3.02 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 121.889 0.852 . . . . 1.0 110.657 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HE ' ' CD ' ' A' ' 80' ' ' GLU . 75.4 ttt180 -65.34 116.42 6.65 Favored 'General case' 0 C--N 1.289 -2.036 0 CA-C-N 114.117 -1.402 . . . . 1.0 109.202 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.459 ' HD3' ' OE1' ' A' ' 85' ' ' GLU . 83.9 mtp180 -131.61 157.73 42.91 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.343 0.592 . . . . 1.0 112.402 -173.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.478 HD11 ' CG2' ' A' ' 36' ' ' THR . 3.3 tm? -72.51 144.73 47.9 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 125.201 1.4 . . . . 1.0 108.296 175.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' SER . 52.0 m-80 -101.97 137.9 39.64 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 119.533 -0.867 . . . . 1.0 112.03 -179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.415 ' OG1' ' HG2' ' A' ' 97' ' ' GLN . 0.8 OUTLIER -126.77 175.3 8.11 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 106.579 -1.637 . . . . 1.0 106.579 174.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.543 HD13 HG22 ' A' ' 101' ' ' VAL . 2.3 pp -72.42 -28.02 62.7 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.104 -1.438 . . . . 1.0 108.334 174.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.549 ' HA ' ' HD2' ' A' ' 100' ' ' LYS . 4.4 pt20 -66.86 -24.31 66.12 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.535 -0.757 . . . . 1.0 112.513 175.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -57.61 -40.95 80.27 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 120.756 -0.378 . . . . 1.0 110.217 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -107.62 8.92 29.38 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 113.011 0.745 . . . . 1.0 113.011 173.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.549 ' HD2' ' HA ' ' A' ' 97' ' ' GLN . 31.2 mmmt 38.02 65.13 0.61 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.207 1.403 . . . . 1.0 112.745 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.613 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -67.71 149.69 98.16 Favored Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 115.058 -0.973 . . . . 1.0 112.003 -178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.58 155.5 40.31 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.422 2.081 . . . . 1.0 111.228 175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 9' ' ' LEU . 8.3 p-10 -66.05 127.62 32.85 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 109.257 -0.646 . . . . 1.0 109.257 177.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 94.82 20.72 27.9 Favored Glycine 0 N--CA 1.433 -1.53 0 C-N-CA 120.087 -1.054 . . . . 1.0 110.934 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.405 ' HB3' ' CD1' ' A' ' 11' ' ' LEU . . . -71.65 163.95 26.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 1.0 110.129 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.6 m -112.01 131.15 55.58 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.854 -0.529 . . . . 1.0 111.452 -174.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.607 HG21 ' SD ' ' A' ' 44' ' ' MET . 17.3 m -117.07 138.76 46.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 109.39 -0.596 . . . . 1.0 109.39 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -129.0 137.83 51.58 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.542 -0.54 . . . . 1.0 109.542 177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.572 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 4.2 pp -109.85 143.83 39.19 Favored 'General case' 0 C--N 1.279 -2.496 0 C-N-CA 120.566 -0.454 . . . . 1.0 110.891 -175.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 35.0 m -131.8 125.54 20.4 Favored Pre-proline 0 N--CA 1.426 -1.666 0 N-CA-C 109.171 -0.677 . . . . 1.0 109.171 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.427 ' CD ' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -70.49 80.7 1.07 Allowed 'Trans proline' 0 C--O 1.239 0.527 0 C-N-CA 122.458 2.105 . . . . 1.0 112.067 -178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 46.3 t 63.25 83.04 0.17 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 114.877 -1.056 . . . . 1.0 110.597 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.505 ' O ' HG22 ' A' ' 114' ' ' THR . 2.7 mm? 62.75 14.3 7.17 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 125.144 1.378 . . . . 1.0 110.723 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER 67.76 14.49 9.48 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 125.077 1.351 . . . . 1.0 110.88 -179.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HE2' ' HA ' ' A' ' 115' ' ' LYS . 11.4 mmpt? -82.85 99.54 9.79 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 114.596 -1.184 . . . . 1.0 110.649 -175.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -84.07 96.45 8.9 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.234 -1.395 . . . . 1.0 107.234 174.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.9 m -134.1 172.16 16.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 114.661 -1.154 . . . . 1.0 108.868 -174.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 8.1 mp -78.97 74.21 5.49 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.825 -0.805 . . . . 1.0 108.825 177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -83.07 -51.17 7.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.306 0.574 . . . . 1.0 109.967 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.1 97.22 10.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.756 -0.657 . . . . 1.0 109.243 177.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -159.29 159.03 33.54 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 106.307 -1.738 . . . . 1.0 106.307 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? . . . . . 0 C--N 1.273 -2.755 0 CA-C-O 118.383 -0.817 . . . . 1.0 109.846 177.558 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 64.7 mttp . . . . . 0 CA--C 1.509 -0.604 0 N-CA-C 108.328 -0.99 . . . . 1.0 108.328 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.7 mtpp 56.02 37.21 28.6 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-O 121.863 0.84 . . . . 1.0 110.69 -176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -81.89 -6.21 58.91 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 122.428 1.109 . . . . 1.0 109.587 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.1 m -135.13 153.47 34.25 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.29 0 CA-C-N 113.469 -1.696 . . . . 1.0 106.585 176.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -114.23 105.07 12.74 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-O 122.075 0.941 . . . . 1.0 111.99 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.5 m-85 -123.17 -178.5 3.99 Favored 'General case' 0 N--CA 1.399 -2.989 0 N-CA-C 105.427 -2.064 . . . . 1.0 105.427 175.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 38.0 mmt180 -109.12 111.03 60.54 Favored Pre-proline 0 C--N 1.283 -2.308 0 C-N-CA 117.625 -1.63 . . . . 1.0 113.196 -170.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 21.8 Cg_exo -63.39 112.6 1.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.16 1.907 . . . . 1.0 108.44 171.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.4 tp -113.06 160.94 17.64 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.994 -172.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -98.9 125.99 44.46 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 108.091 -1.077 . . . . 1.0 108.091 177.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.592 HD12 ' SD ' ' A' ' 44' ' ' MET . 1.3 tm? -127.32 141.1 51.79 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 108.591 -0.892 . . . . 1.0 108.591 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.26 111.38 23.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 121.884 -0.51 . . . . 1.0 110.319 -177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.68 106.37 5.4 Favored 'General case' 0 C--O 1.248 1.013 0 CA-C-N 115.407 -0.815 . . . . 1.0 111.132 -176.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.52 HD21 ' HA2' ' A' ' 22' ' ' GLY . 29.2 tp -143.24 144.44 32.15 Favored 'General case' 0 N--CA 1.414 -2.226 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.563 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.594 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.9 pt? -121.02 144.29 48.61 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 116.091 -0.504 . . . . 1.0 109.851 -177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -114.25 34.54 4.63 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.447 0.642 . . . . 1.0 109.531 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.499 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 38.4 t -65.14 -45.44 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.379 0 C-N-CA 123.839 0.856 . . . . 1.0 112.924 -175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.38 -80.9 0.1 OUTLIER Glycine 0 C--N 1.313 -0.713 0 C-N-CA 119.026 -1.559 . . . . 1.0 113.902 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -58.98 -32.46 97.56 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.957 2.438 . . . . 1.0 112.429 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.45 41.36 1.61 Allowed Glycine 0 N--CA 1.419 -2.468 0 N-CA-C 110.22 -1.152 . . . . 1.0 110.22 178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -66.07 76.53 0.09 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.306 0.854 . . . . 1.0 113.306 -177.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.52 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 98.46 3.08 57.57 Favored Glycine 0 CA--C 1.489 -1.544 0 N-CA-C 110.157 -1.177 . . . . 1.0 110.157 175.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -130.58 24.51 5.09 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.593 -0.804 . . . . 1.0 110.143 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.07 -77.24 0.48 Allowed 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 113.805 1.039 . . . . 1.0 113.805 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' HB2' HG23 ' A' ' 27' ' ' VAL . 8.0 pt20 -125.89 -65.48 0.99 Allowed 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.229 -0.896 . . . . 1.0 111.919 -169.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.436 ' H ' ' HG3' ' A' ' 25' ' ' GLN . . . 63.83 64.71 3.48 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 111.235 -0.746 . . . . 1.0 111.235 -176.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.525 HG23 ' HB2' ' A' ' 25' ' ' GLN . 43.2 t -108.3 129.9 23.46 Favored Pre-proline 0 C--N 1.313 -0.997 0 N-CA-C 110.24 -0.282 . . . . 1.0 110.24 -174.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.49 108.25 2.18 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.126 1.884 . . . . 1.0 111.309 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 44' ' ' MET . 59.6 t -117.71 138.72 47.46 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 N-CA-C 108.13 -1.063 . . . . 1.0 108.13 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -84.16 155.94 22.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.885 0.698 . . . . 1.0 112.885 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.566 HG22 ' H ' ' A' ' 32' ' ' LEU . 14.2 p -151.3 -178.67 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.415 -1.266 . . . . 1.0 108.192 -176.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.566 ' H ' HG22 ' A' ' 31' ' ' VAL . 12.8 tp -119.1 155.39 31.62 Favored 'General case' 0 CA--C 1.484 -1.577 0 N-CA-C 107.739 -1.208 . . . . 1.0 107.739 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.429 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 30.5 t70 -64.0 -30.6 71.66 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.354 0.597 . . . . 1.0 109.649 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.401 ' HA ' ' NE2' ' A' ' 97' ' ' GLN . 2.7 t -104.81 33.48 3.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.401 -1.272 . . . . 1.0 110.352 -175.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.597 ' O ' HG22 ' A' ' 95' ' ' THR . 14.6 p-10 -70.22 -163.31 0.06 Allowed 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.475 -0.784 . . . . 1.0 109.636 172.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 25.4 p -140.51 161.91 36.59 Favored 'General case' 0 C--N 1.277 -2.56 0 N-CA-C 103.668 -2.716 . . . . 1.0 103.668 167.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.659 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 43.8 mm -57.78 -47.74 85.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 120.371 -0.531 . . . . 1.0 111.741 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.584 ' HB2' ' NH1' ' A' ' 61' ' ' ARG . 21.6 t -65.81 -43.87 87.35 Favored 'General case' 0 C--N 1.313 -1.014 0 O-C-N 123.677 0.611 . . . . 1.0 109.902 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -63.17 -40.44 97.53 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.28 0.562 . . . . 1.0 111.356 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' A' ' 44' ' ' MET . . . -63.92 -40.76 97.22 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 115.691 -0.686 . . . . 1.0 110.524 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -62.08 -33.17 73.91 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 123.674 0.609 . . . . 1.0 110.633 -178.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -64.36 -46.21 84.41 Favored 'General case' 0 C--O 1.223 -0.309 0 O-C-N 123.589 0.556 . . . . 1.0 110.526 -177.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -66.39 -37.68 85.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.193 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.746 ' HA ' HG11 ' A' ' 29' ' ' VAL . 3.8 mtp -62.61 -43.96 97.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.307 0.575 . . . . 1.0 110.633 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.407 ' HB2' ' HB2' ' A' ' 49' ' ' TYR . 4.6 pp -75.9 -25.66 56.26 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 116.126 -0.488 . . . . 1.0 112.25 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.47 -29.02 68.79 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.493 0.663 . . . . 1.0 110.991 -179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' HG3' HG13 ' A' ' 29' ' ' VAL . 11.0 mm-40 -83.87 -32.68 25.08 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.973 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.0 mt -115.64 -52.9 2.62 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 121.607 0.718 . . . . 1.0 112.572 -167.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 45' ' ' LEU . 95.1 m-85 -86.86 -1.31 57.7 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.039 -0.982 . . . . 1.0 110.957 -173.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 50' ' ' LYS . 3.7 tmmm? -78.2 123.32 26.77 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 105.608 -1.997 . . . . 1.0 105.608 170.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.61 -2.94 57.46 Favored Glycine 0 C--N 1.292 -1.893 0 C-N-CA 119.943 -1.122 . . . . 1.0 110.318 -175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.559 HG22 ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -98.25 155.08 37.32 Favored Pre-proline 0 C--N 1.32 -0.695 0 N-CA-C 106.28 -1.748 . . . . 1.0 106.28 176.274 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.559 ' HD2' HG22 ' A' ' 52' ' ' VAL . 19.7 Cg_endo -60.32 149.71 84.34 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 121.959 1.773 . . . . 1.0 111.553 178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 98.9 mt -60.47 -38.67 85.0 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.395 0.678 . . . . 1.0 111.187 -174.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.8 t -65.52 -24.5 67.14 Favored 'General case' 0 CA--C 1.558 1.287 0 CA-C-N 116.102 -0.499 . . . . 1.0 111.672 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.441 ' CG ' ' HG2' ' A' ' 53' ' ' PRO . 14.9 mm100 -87.9 -12.43 44.74 Favored 'General case' 0 CA--C 1.513 -0.445 0 O-C-N 122.226 -0.297 . . . . 1.0 111.581 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 78.6 mtt180 -79.86 117.66 68.48 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.21 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 20.6 Cg_exo -66.41 145.0 75.89 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.667 2.245 . . . . 1.0 112.22 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.497 ' O ' ' HG ' ' A' ' 63' ' ' LEU . 13.3 t70 -96.65 114.79 65.1 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.524 -0.547 . . . . 1.0 109.524 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.06 -13.42 33.89 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 122.755 2.303 . . . . 1.0 114.444 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' NH1' ' HB2' ' A' ' 38' ' ' SER . 16.8 mmm180 -73.33 -36.54 66.22 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.312 -0.555 . . . . 1.0 110.896 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 t -96.31 -24.18 16.3 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.791 -0.641 . . . . 1.0 112.333 -174.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.705 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 3.6 pp -96.38 162.51 13.46 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 113.57 0.952 . . . . 1.0 113.57 -174.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 115' ' ' LYS . 9.9 p-10 -114.71 153.2 30.7 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.468 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 109' ' ' LEU . 11.4 p -120.73 126.94 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.186 179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.75 112.55 24.52 Favored 'General case' 0 N--CA 1.411 -2.397 0 N-CA-C 106.96 -1.496 . . . . 1.0 106.96 174.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.548 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.3 t-105 -91.51 122.65 34.28 Favored 'General case' 0 N--CA 1.383 -3.801 0 CA-C-N 113.836 -1.529 . . . . 1.0 108.951 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.516 HH22 HD23 ' A' ' 14' ' ' LEU . 67.5 mtm180 -110.3 90.13 3.23 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-O 123.025 1.393 . . . . 1.0 107.314 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 77.6 p -79.72 -17.68 53.0 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 113.061 -1.881 . . . . 1.0 110.553 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.7 -56.95 4.52 Favored Glycine 0 C--N 1.298 -1.565 0 CA-C-N 115.1 -0.955 . . . . 1.0 111.676 -177.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 33.6 m -64.83 -43.01 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.505 0.557 . . . . 1.0 112.505 179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.54 -10.33 21.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.332 0.587 . . . . 1.0 109.541 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.11 -149.96 19.48 Favored Glycine 0 N--CA 1.418 -2.565 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.656 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.446 ' HA ' ' O ' ' A' ' 67' ' ' TRP . 7.2 p80 -105.56 114.0 27.91 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 121.314 0.578 . . . . 1.0 110.853 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -124.95 146.74 49.22 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.341 -0.845 . . . . 1.0 109.324 -176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.404 HG21 ' HA ' ' A' ' 115' ' ' LYS . 29.5 mm -85.97 115.58 27.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 176.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.532 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.9 mp -105.87 143.26 34.25 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-O 121.903 0.859 . . . . 1.0 111.768 -178.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 81' ' ' ASP . 9.6 m -158.3 146.03 18.26 Favored 'General case' 0 C--N 1.278 -2.519 0 N-CA-C 104.238 -2.505 . . . . 1.0 104.238 178.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.423 ' HA ' ' H ' ' A' ' 94' ' ' ASN . 5.2 p-10 -72.82 -36.2 67.47 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.043 -1.063 . . . . 1.0 111.004 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -109.46 91.9 3.83 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.228 176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 78' ' ' SER . 5.1 t70 -164.14 -69.38 0.04 OUTLIER 'General case' 0 CA--C 1.486 -1.496 0 CA-C-O 121.865 0.841 . . . . 1.0 111.973 175.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.556 HG12 HD21 ' A' ' 94' ' ' ASN . 5.0 p -93.18 -2.75 10.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 114.421 -1.263 . . . . 1.0 112.142 -172.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.511 HG22 ' ND2' ' A' ' 94' ' ' ASN . 14.7 t -143.72 25.74 1.62 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 122.067 0.937 . . . . 1.0 109.466 176.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -98.45 17.14 19.65 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.395 -0.82 . . . . 1.0 111.348 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.49 ' HB3' HE21 ' A' ' 87' ' ' GLN . 5.5 mp0 -63.2 112.21 2.57 Favored 'General case' 0 CA--C 1.509 -0.622 0 CA-C-O 121.54 0.686 . . . . 1.0 110.55 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 m -90.48 74.43 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 CA-C-O 122.305 1.05 . . . . 1.0 111.991 -175.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.49 HE21 ' HB3' ' A' ' 85' ' ' GLU . 8.7 pt20 -124.51 -8.88 7.43 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 114.386 -1.279 . . . . 1.0 110.239 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.67 -103.53 0.24 Allowed Glycine 0 N--CA 1.407 -3.299 0 C-N-CA 120.455 -0.879 . . . . 1.0 111.427 -179.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 36.5 mt -89.35 -5.58 57.38 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.351 0.596 . . . . 1.0 110.939 -174.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -85.79 -3.95 59.04 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.022 -0.99 . . . . 1.0 110.555 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -80.4 95.47 6.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.413 -1.699 . . . . 1.0 106.413 173.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -143.14 170.17 16.23 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.638 -0.71 . . . . 1.0 110.153 -170.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 76.4 mt -110.25 155.93 21.37 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.743 -0.836 . . . . 1.0 108.743 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.556 HD21 HG12 ' A' ' 82' ' ' VAL . 55.7 m-80 -94.24 135.96 35.05 Favored 'General case' 0 CA--C 1.493 -1.245 0 C-N-CA 119.228 -0.989 . . . . 1.0 110.723 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.4 p -109.46 172.75 6.67 Favored 'General case' 0 N--CA 1.419 -2.009 0 C-N-CA 125.115 1.366 . . . . 1.0 108.237 178.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.435 HD13 HG22 ' A' ' 101' ' ' VAL . 3.0 pp -72.15 -29.05 63.66 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 118.839 -1.145 . . . . 1.0 108.015 171.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.571 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.62 -25.05 67.79 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.327 -0.851 . . . . 1.0 112.029 177.948 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -59.55 -41.61 90.5 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -102.08 -3.44 27.57 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.578 176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 68.1 mmtt 46.26 68.52 0.59 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.223 1.009 . . . . 1.0 112.827 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.548 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.5 m -78.3 148.9 75.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 CA-C-N 115.178 -0.919 . . . . 1.0 111.462 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.66 160.58 34.57 Favored 'Trans proline' 0 C--O 1.246 0.885 0 C-N-CA 123.071 2.514 . . . . 1.0 111.898 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.19 117.93 9.19 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 109.172 -0.677 . . . . 1.0 109.172 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 104.01 22.17 9.01 Favored Glycine 0 C--N 1.288 -2.135 0 C-N-CA 120.314 -0.946 . . . . 1.0 111.437 -177.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.09 156.8 38.06 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 45.0 m -120.52 130.35 54.21 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.182 0.515 . . . . 1.0 110.687 -174.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.503 ' CG1' HD11 ' A' ' 11' ' ' LEU . 33.8 m -113.74 165.83 8.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 C-N-CA 119.692 -0.803 . . . . 1.0 111.077 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 16' ' ' ALA . . . -148.3 120.81 8.51 Favored 'General case' 0 N--CA 1.418 -2.036 0 CA-C-N 115.311 -0.859 . . . . 1.0 108.961 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.594 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 0.8 OUTLIER -106.17 137.7 43.64 Favored 'General case' 0 C--N 1.26 -3.299 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.072 -176.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.705 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 29.3 m -126.91 149.77 69.9 Favored Pre-proline 0 C--N 1.303 -1.44 0 CA-C-N 115.866 -0.606 . . . . 1.0 109.43 -175.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 73.5 Cg_endo -77.19 63.66 7.76 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 122.858 2.372 . . . . 1.0 113.32 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 42.1 t 64.28 70.65 0.49 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-O 122.075 0.941 . . . . 1.0 108.928 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.81 -50.74 2.95 Favored 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.152 -0.931 . . . . 1.0 110.198 -177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 4.6 t -139.68 50.81 1.75 Allowed 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 110.032 -0.358 . . . . 1.0 110.032 -175.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 64' ' ' ASP . 63.3 pttt -65.99 69.14 0.05 Allowed 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 115.174 1.546 . . . . 1.0 115.174 -175.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 63.18 7.16 2.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.48 1.912 . . . . 1.0 113.984 174.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.4 159.8 28.37 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.359 0 CA-C-N 114.834 -1.076 . . . . 1.0 109.145 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 118' ' ' LEU . 0.3 OUTLIER -108.93 109.18 20.19 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 108.493 -0.929 . . . . 1.0 108.493 174.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -98.48 120.97 39.82 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -89.85 140.94 29.11 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.226 -177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -96.61 95.15 7.76 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.17 -0.678 . . . . 1.0 109.17 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 . . . . . 0 C--N 1.3 -1.551 0 N-CA-C 108.486 -0.931 . . . . 1.0 108.486 -179.046 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.219 -0.517 0 N-CA-C 107.986 -1.116 . . . . 1.0 107.986 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm -90.12 84.42 6.12 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 174.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -88.1 8.13 28.24 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.896 0.855 . . . . 1.0 110.859 178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 49.0 t 73.73 -42.79 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.244 0.771 0 C-N-CA 126.054 1.742 . . . . 1.0 114.445 170.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.32 78.42 9.63 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.663 1.22 . . . . 1.0 112.619 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.559 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 38.5 m-85 -131.48 -177.01 4.22 Favored 'General case' 0 N--CA 1.405 -2.715 0 N-CA-C 104.544 -2.391 . . . . 1.0 104.544 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -99.78 108.77 53.02 Favored Pre-proline 0 C--N 1.283 -2.304 0 C-N-CA 119.746 -0.782 . . . . 1.0 111.93 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 31.6 Cg_exo -60.66 133.5 48.76 Favored 'Trans proline' 0 C--O 1.245 0.84 0 C-N-CA 122.691 2.261 . . . . 1.0 110.893 176.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.407 HD22 HD13 ' A' ' 96' ' ' LEU . 4.9 tp -126.95 156.27 41.79 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.604 -176.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.1 m -99.91 127.28 46.11 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.488 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.508 HD23 HG22 ' A' ' 31' ' ' VAL . 2.3 mm? -126.56 146.88 49.97 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 123.061 0.545 . . . . 1.0 110.697 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.44 HD22 HG23 ' A' ' 106' ' ' THR . 11.8 t30 -96.2 117.1 30.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 116.179 -0.464 . . . . 1.0 109.927 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.47 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -80.67 113.19 18.69 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 109.085 -0.709 . . . . 1.0 109.085 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 108' ' ' ALA . 27.2 tp -142.67 155.39 44.91 Favored 'General case' 0 N--CA 1.415 -2.202 0 N-CA-C 108.443 -0.947 . . . . 1.0 108.443 -177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.632 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -123.59 140.95 52.48 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 120.424 -0.511 . . . . 1.0 110.078 178.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 21' ' ' ALA . . . -119.29 36.19 4.56 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.239 0.542 . . . . 1.0 110.444 -177.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 111' ' ' PRO . 76.4 t -66.08 -46.44 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.832 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.028 -178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.87 -80.56 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 118.761 -1.685 . . . . 1.0 114.553 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -59.42 -31.29 94.56 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.097 2.531 . . . . 1.0 112.781 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.89 38.37 2.19 Favored Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.149 -1.18 . . . . 1.0 110.149 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HA ' ' HA ' ' A' ' 16' ' ' ALA . . . -65.23 80.3 0.05 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.682 0.753 . . . . 1.0 112.808 -176.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.57 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 95.14 -1.74 65.18 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.61 -1.396 . . . . 1.0 109.61 178.026 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -113.93 20.6 15.62 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-N 113.472 -1.364 . . . . 1.0 110.177 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -85.24 -82.14 0.18 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.368 -177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -146.79 -56.13 0.26 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.42 0.526 . . . . 1.0 112.42 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.65 91.81 1.11 Allowed Glycine 0 N--CA 1.433 -1.557 0 C-N-CA 119.728 -1.225 . . . . 1.0 110.49 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.29 126.1 30.41 Favored Pre-proline 0 C--N 1.309 -1.173 0 N-CA-C 109.927 -0.397 . . . . 1.0 109.927 -176.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -74.8 104.53 1.91 Allowed 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 121.719 1.613 . . . . 1.0 111.057 177.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.491 HG13 HE21 ' A' ' 47' ' ' GLN . 22.0 t -110.71 155.78 11.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.076 -1.083 . . . . 1.0 108.076 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -121.64 148.52 44.45 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.436 -0.906 . . . . 1.0 112.76 -176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.508 HG22 HD23 ' A' ' 11' ' ' LEU . 7.6 m -147.91 -174.29 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 C-N-CA 125.071 1.349 . . . . 1.0 108.312 -177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.2 mt -107.2 158.63 16.95 Favored 'General case' 0 CA--C 1.482 -1.637 0 CA-C-O 120.544 0.211 . . . . 1.0 110.662 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -62.75 -32.07 73.14 Favored 'General case' 0 C--O 1.26 1.629 0 O-C-N 124.224 0.953 . . . . 1.0 109.344 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 12.2 t -108.97 37.39 2.57 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 113.856 -1.52 . . . . 1.0 109.791 -176.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 95' ' ' THR . 11.1 p-10 -68.53 -166.94 0.08 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.02 -0.991 . . . . 1.0 110.267 173.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 35.6 p -139.95 146.18 38.85 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 104.707 -2.331 . . . . 1.0 104.707 171.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.591 HG21 ' HA ' ' A' ' 78' ' ' SER . 26.5 mm -57.17 -29.37 31.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 118.482 0.583 . . . . 1.0 110.863 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.4 m -60.99 -50.18 74.44 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -73.41 -40.36 64.34 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.828 -0.624 . . . . 1.0 112.34 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.706 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.95 -39.28 90.3 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.469 178.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.606 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 1.1 ttmp? -57.48 -41.85 81.48 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.594 -1.262 . . . . 1.0 107.594 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -67.28 -51.84 47.97 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-N 114.707 -1.133 . . . . 1.0 112.267 -178.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HD3' HG12 ' A' ' 31' ' ' VAL . 53.3 mtpt -63.9 -40.58 96.83 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.631 0.604 . . . . 1.0 112.631 -176.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 87.4 mmm -62.6 -45.96 90.48 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 123.337 0.398 . . . . 1.0 110.998 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 41' ' ' LYS . 3.9 pp -77.23 -28.5 53.72 Favored 'General case' 0 C--O 1.214 -0.815 0 N-CA-C 112.766 0.654 . . . . 1.0 112.766 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -57.51 -29.08 64.02 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.459 1.104 . . . . 1.0 112.775 -173.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.491 HE21 HG13 ' A' ' 29' ' ' VAL . 15.1 mm-40 -64.88 -37.27 87.06 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.581 0.705 . . . . 1.0 110.207 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -95.74 -41.48 8.85 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.98 0.895 . . . . 1.0 109.828 -177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.402 ' CD1' ' HB2' ' A' ' 45' ' ' LEU . 79.8 m-85 -91.81 25.45 2.75 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.341 -1.299 . . . . 1.0 111.429 -175.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -61.99 125.14 22.82 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 174.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.63 -4.78 53.99 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 -178.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 79.0 t -95.28 124.5 53.43 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 109.581 -0.526 . . . . 1.0 109.581 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -66.37 162.05 38.07 Favored 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 123.438 2.759 . . . . 1.0 112.613 -179.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.0 mt -62.4 -39.62 93.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.63 -0.714 . . . . 1.0 111.769 -175.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 t -64.73 -30.79 71.81 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.195 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -85.49 -26.67 26.14 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 120.497 -0.481 . . . . 1.0 110.379 -177.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.405 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 48.5 mtt180 -65.09 126.79 91.98 Favored Pre-proline 0 C--O 1.245 0.839 0 N-CA-C 108.64 -0.874 . . . . 1.0 108.64 173.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 57' ' ' ARG . 31.2 Cg_exo -58.82 134.2 58.83 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.846 1.697 . . . . 1.0 112.059 -179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.468 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 13.4 t70 -91.19 153.61 44.67 Favored Pre-proline 0 C--N 1.297 -1.701 0 CA-C-N 114.637 -1.165 . . . . 1.0 109.262 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 63' ' ' LEU . 18.7 Cg_endo -58.06 -17.14 30.06 Favored 'Trans proline' 0 C--N 1.358 1.065 0 C-N-CA 122.873 2.382 . . . . 1.0 113.286 177.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -70.94 -20.14 62.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 120.14 -0.624 . . . . 1.0 110.926 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.8 t -116.4 -15.93 10.89 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 120.483 -0.487 . . . . 1.0 111.562 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.621 ' HA ' ' H ' ' A' ' 112' ' ' CYS . 0.2 OUTLIER -138.29 162.0 35.47 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 113.359 0.874 . . . . 1.0 113.359 175.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 112' ' ' CYS . 9.5 m-20 -129.15 165.22 21.72 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 107.309 -1.367 . . . . 1.0 107.309 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.1 128.92 73.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.616 -0.833 . . . . 1.0 109.859 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 65.8 mt-10 -90.23 112.66 24.27 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 106.206 -1.776 . . . . 1.0 106.206 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.602 ' HZ2' HG11 ' A' ' 101' ' ' VAL . 3.4 t-105 -95.08 122.1 37.4 Favored 'General case' 1 N--CA 1.372 -4.325 0 C-N-CA 119.395 -0.922 . . . . 1.0 109.01 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -108.16 89.28 2.95 Favored 'General case' 0 N--CA 1.4 -2.949 0 N-CA-C 105.873 -1.899 . . . . 1.0 105.873 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.7 t -83.24 -17.7 41.75 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 113.511 -1.677 . . . . 1.0 109.261 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.13 -58.56 3.17 Favored Glycine 0 C--O 1.218 -0.865 0 CA-C-N 115.141 -0.936 . . . . 1.0 112.728 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -64.65 -37.16 79.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 122.737 0.415 . . . . 1.0 111.328 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.01 -5.23 30.8 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.777 0.798 . . . . 1.0 109.351 176.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 93.12 -140.31 15.01 Favored Glycine 0 N--CA 1.419 -2.438 0 CA-C-N 114.832 -1.077 . . . . 1.0 110.642 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -117.57 120.55 38.4 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.034 0.445 . . . . 1.0 109.915 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -125.56 146.48 49.66 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 109.053 -0.721 . . . . 1.0 109.053 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -85.01 116.43 28.5 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.767 -1.197 . . . . 1.0 107.767 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.432 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.6 mp -108.48 155.86 20.13 Favored 'General case' 0 CA--C 1.487 -1.443 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.421 -177.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.591 ' HA ' HG21 ' A' ' 37' ' ' ILE . 7.5 t -171.58 172.5 5.0 Favored 'General case' 0 N--CA 1.407 -2.6 0 CA-C-N 115.004 -0.998 . . . . 1.0 108.485 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -81.5 -2.48 49.92 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.859 -1.064 . . . . 1.0 109.438 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -165.08 84.62 0.39 Allowed 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 105.937 -1.875 . . . . 1.0 105.937 168.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.406 ' HB2' ' H ' ' A' ' 82' ' ' VAL . 4.6 p30 -95.2 -168.1 1.74 Allowed 'General case' 0 CA--C 1.477 -1.831 0 CA-C-O 122.896 1.331 . . . . 1.0 112.63 -173.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.406 ' H ' ' HB2' ' A' ' 81' ' ' ASP . 12.3 p -62.58 -28.96 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.382 -3.872 0 CA-C-N 111.798 -2.455 . . . . 1.0 113.042 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.9 t -113.3 1.02 15.01 Favored 'General case' 0 N--CA 1.436 -1.144 0 C-N-CA 119.385 -0.926 . . . . 1.0 111.479 -177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.3 p -89.69 70.69 7.79 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.587 -1.264 . . . . 1.0 107.587 173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 90' ' ' PHE . 43.0 mt-10 -71.1 122.51 20.24 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.248 -1.342 . . . . 1.0 111.404 -174.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.8 t -80.24 83.05 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 122.352 1.072 . . . . 1.0 110.033 -177.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.401 HE21 ' HB3' ' A' ' 87' ' ' GLN . 1.8 pt20 -135.07 -28.7 1.16 Allowed 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.183 -1.372 . . . . 1.0 109.739 178.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 156.32 137.66 2.38 Favored Glycine 0 N--CA 1.413 -2.843 0 N-CA-C 109.079 -1.608 . . . . 1.0 109.079 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.8 mt 73.38 -15.05 0.57 Allowed 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.393 1.077 . . . . 1.0 113.079 175.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 54.2 m-85 -97.56 -3.73 39.13 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 112.336 0.495 . . . . 1.0 112.336 -175.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 10.0 ptp180 -75.33 92.35 2.78 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.437 -0.949 . . . . 1.0 108.437 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -145.87 156.98 43.91 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.274 -1.01 . . . . 1.0 108.274 -177.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.38 122.01 38.81 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.182 -2.155 . . . . 1.0 105.182 170.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -74.56 142.39 44.71 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 112.512 0.56 . . . . 1.0 112.512 -173.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 35' ' ' ASP . 1.5 p -105.06 169.41 8.45 Favored 'General case' 0 N--CA 1.414 -2.249 0 C-N-CA 124.913 1.285 . . . . 1.0 108.709 177.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 9' ' ' LEU . 4.1 pp -70.32 -32.73 70.6 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.419 -0.956 . . . . 1.0 108.419 172.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.423 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -62.13 -29.79 70.58 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.526 -0.761 . . . . 1.0 112.429 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -65.23 -35.21 80.34 Favored 'General case' 0 C--O 1.221 -0.427 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -98.06 8.66 44.43 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.89 -0.595 . . . . 1.0 112.189 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 52.99 54.63 10.14 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.314 1.045 . . . . 1.0 111.334 176.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.602 HG11 ' HZ2' ' A' ' 67' ' ' TRP . 40.8 t -74.86 124.37 89.53 Favored Pre-proline 0 C--N 1.288 -2.071 0 CA-C-N 114.811 -1.086 . . . . 1.0 112.779 -177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.0 159.1 27.23 Favored 'Trans proline' 0 C--O 1.25 1.112 0 C-N-CA 123.525 2.816 . . . . 1.0 112.191 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -67.39 117.99 10.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.071 -0.513 . . . . 1.0 109.87 178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.88 18.3 14.3 Favored Glycine 0 N--CA 1.432 -1.592 0 C-N-CA 120.291 -0.957 . . . . 1.0 111.389 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.01 27.28 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.027 0.441 . . . . 1.0 110.554 178.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.44 HG23 HD22 ' A' ' 12' ' ' ASN . 30.9 m -115.8 132.06 56.75 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 122.066 -0.397 . . . . 1.0 111.076 -173.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 m -114.03 138.68 43.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.758 -0.831 . . . . 1.0 108.758 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' LEU . . . -127.98 135.26 49.68 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.42 0.628 . . . . 1.0 110.773 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.632 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 94.6 mt -95.43 129.26 42.65 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 19.0 m -132.84 142.38 44.52 Favored Pre-proline 0 C--N 1.31 -1.15 0 O-C-N 123.172 0.295 . . . . 1.0 110.284 -176.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.425 ' HD3' HG22 ' A' ' 17' ' ' VAL . 56.8 Cg_endo -72.37 79.6 1.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 122.14 1.893 . . . . 1.0 110.664 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.621 ' H ' ' HA ' ' A' ' 63' ' ' LEU . 3.1 t 53.55 82.02 0.09 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.931 1.692 . . . . 1.0 111.411 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' O ' HG22 ' A' ' 114' ' ' THR . 2.7 mm? 69.22 -1.06 2.27 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 125.155 1.382 . . . . 1.0 110.274 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 113' ' ' LEU . 0.5 OUTLIER 70.0 12.33 7.8 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 125.371 1.469 . . . . 1.0 109.879 -176.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -140.25 96.71 3.09 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 105.083 -2.191 . . . . 1.0 105.083 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 112' ' ' CYS . 29.5 p-80 -136.48 163.2 31.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 114.187 1.18 . . . . 1.0 114.187 -170.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 t -127.42 174.01 11.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 N-CA-C 105.581 -2.007 . . . . 1.0 105.581 177.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.6 mp -90.4 82.26 5.93 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.332 -1.358 . . . . 1.0 107.332 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -105.22 141.95 35.84 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.367 -0.833 . . . . 1.0 112.646 -171.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -156.58 163.08 39.78 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 106.312 -1.736 . . . . 1.0 106.312 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -135.57 92.82 2.88 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.189 -0.604 . . . . 1.0 111.044 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? . . . . . 0 N--CA 1.421 -1.885 0 N-CA-C 109.105 -0.702 . . . . 1.0 109.105 174.259 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.7 pttp . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 112.251 0.463 . . . . 1.0 112.251 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -109.6 40.99 1.76 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 106.715 -1.587 . . . . 1.0 106.715 172.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -93.07 10.94 29.38 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-N 114.667 -1.151 . . . . 1.0 111.265 -173.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.9 t -85.61 104.96 13.91 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 106.56 -1.645 . . . . 1.0 106.56 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 0.2 OUTLIER -82.64 60.29 5.16 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.152 0.977 . . . . 1.0 113.092 -172.236 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.483 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 26.8 m-85 -129.98 162.46 28.61 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 105.025 -2.213 . . . . 1.0 105.025 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.519 ' H ' ' HB3' ' A' ' 33' ' ' ASP . 20.1 mmt180 -104.01 108.17 59.17 Favored Pre-proline 0 C--N 1.277 -2.572 0 C-N-CA 119.384 -0.926 . . . . 1.0 111.841 -173.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 37.0 Cg_exo -59.43 131.45 40.73 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 122.255 1.97 . . . . 1.0 110.763 175.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.8 tp -136.41 159.93 40.27 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.76 -0.654 . . . . 1.0 110.085 -175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.1 m -95.22 131.26 41.46 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.007 -1.109 . . . . 1.0 108.007 177.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.41 HD23 ' SD ' ' A' ' 44' ' ' MET . 27.1 tp -127.66 142.09 51.43 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.694 -0.854 . . . . 1.0 108.694 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -99.88 113.35 25.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.784 -0.572 . . . . 1.0 110.604 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 44' ' ' MET . . . -77.51 112.69 14.55 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.626 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.517 HD21 ' HA2' ' A' ' 22' ' ' GLY . 31.3 tp -142.01 152.67 43.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.684 ' HA ' ' H ' ' A' ' 109' ' ' LEU . 1.4 pt? -124.02 140.2 53.21 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.881 -0.512 . . . . 1.0 110.897 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -119.42 41.74 3.03 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.622 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.88 -45.2 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.977 0 CA-C-N 116.546 -0.297 . . . . 1.0 110.546 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 163.32 -75.29 0.18 Allowed Glycine 0 C--O 1.22 -0.729 0 C-N-CA 119.777 -1.202 . . . . 1.0 113.764 178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.51 -27.38 76.76 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.53 2.82 . . . . 1.0 113.307 -175.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -128.69 34.41 2.88 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.68 76.3 1.11 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.065 0.765 . . . . 1.0 113.065 -174.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' HA2' HD21 ' A' ' 14' ' ' LEU . . . 114.19 -10.81 22.35 Favored Glycine 0 CA--C 1.475 -2.458 0 N-CA-C 110.752 -0.939 . . . . 1.0 110.752 173.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -109.88 8.66 24.46 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 114.948 -0.626 . . . . 1.0 111.613 -178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.87 -86.54 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.817 -0.629 . . . . 1.0 112.321 -175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -132.38 -61.69 0.86 Allowed 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 112.846 0.684 . . . . 1.0 112.846 -175.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 72.23 71.31 1.08 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 119.854 -1.165 . . . . 1.0 110.535 -176.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.7 t -101.34 125.33 38.11 Favored Pre-proline 0 C--N 1.306 -1.323 0 O-C-N 122.898 -0.177 . . . . 1.0 110.818 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.46 101.79 1.54 Allowed 'Trans proline' 0 N--CA 1.447 -1.238 0 C-N-CA 122.021 1.814 . . . . 1.0 111.757 177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.524 ' HB ' ' CE ' ' A' ' 44' ' ' MET . 45.7 t -104.99 155.42 6.26 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.465 -1.309 . . . . 1.0 107.465 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -102.31 150.04 23.73 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 118.813 -1.155 . . . . 1.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' H ' ' A' ' 32' ' ' LEU . 4.4 p -148.26 -178.44 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 115.05 -0.977 . . . . 1.0 108.709 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.449 ' H ' HG22 ' A' ' 31' ' ' VAL . 14.4 mt -110.92 162.29 14.98 Favored 'General case' 0 C--O 1.179 -2.617 0 CA-C-N 118.39 0.541 . . . . 1.0 110.852 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.519 ' HB3' ' H ' ' A' ' 7' ' ' ARG . 18.0 t70 -65.11 -31.3 72.44 Favored 'General case' 0 C--O 1.249 1.035 0 CA-C-O 121.407 0.623 . . . . 1.0 110.88 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 0.7 OUTLIER -102.85 28.6 6.03 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.147 -0.933 . . . . 1.0 110.334 -177.379 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.66 ' O ' ' HA ' ' A' ' 95' ' ' THR . 17.1 p-10 -67.75 135.54 52.85 Favored 'General case' 0 N--CA 1.414 -2.257 0 N-CA-C 108.427 -0.953 . . . . 1.0 108.427 175.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.2 p -91.08 157.05 17.46 Favored 'General case' 0 C--N 1.254 -3.573 0 N-CA-C 106.419 -1.697 . . . . 1.0 106.419 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 79' ' ' ASP . 45.0 mm -55.86 -40.42 61.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 120.889 0.376 . . . . 1.0 110.446 -178.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.5 p -62.8 -43.96 97.43 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.933 -0.576 . . . . 1.0 111.294 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -73.15 -37.69 66.51 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.835 0.35 . . . . 1.0 111.677 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.702 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -65.68 -38.39 89.13 Favored 'General case' 0 CA--C 1.493 -1.237 0 N-CA-C 109.883 -0.414 . . . . 1.0 109.883 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.37 -41.49 72.64 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.893 -0.781 . . . . 1.0 108.893 177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -68.32 -47.75 66.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.261 -0.882 . . . . 1.0 110.846 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -63.83 -44.6 92.73 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.994 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.702 ' HG2' ' O ' ' A' ' 40' ' ' ALA . 84.0 mmm -64.99 -42.76 94.23 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 123.567 0.542 . . . . 1.0 110.621 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 pp -74.24 -29.33 61.64 Favored 'General case' 0 C--O 1.204 -1.299 0 CA-C-N 116.385 -0.37 . . . . 1.0 111.818 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.08 -30.89 62.66 Favored 'General case' 0 C--O 1.209 -1.07 0 C-N-CA 124.228 1.011 . . . . 1.0 112.539 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.47 HE21 HG13 ' A' ' 29' ' ' VAL . 14.3 mm-40 -70.38 -37.13 74.47 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.162 0.506 . . . . 1.0 111.283 -178.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -94.32 -42.03 9.13 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-O 122.124 0.964 . . . . 1.0 109.654 -176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -97.25 33.47 1.96 Allowed 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 114.041 -1.436 . . . . 1.0 109.515 -177.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -55.61 115.88 2.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.104 177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.16 -2.73 37.79 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.745 -0.74 . . . . 1.0 112.929 179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.4 t -80.86 126.43 77.71 Favored Pre-proline 0 C--N 1.314 -0.948 0 N-CA-C 109.32 -0.622 . . . . 1.0 109.32 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HG2' ' HB2' ' A' ' 56' ' ' GLN . 31.4 Cg_endo -63.75 159.71 40.2 Favored 'Trans proline' 0 C--O 1.241 0.671 0 C-N-CA 122.643 2.228 . . . . 1.0 111.683 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.73 -42.17 96.78 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.306 0.643 . . . . 1.0 111.956 -171.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.3 t -74.2 -15.43 61.01 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 112.327 0.491 . . . . 1.0 112.327 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 10.1 tt0 -91.35 -9.86 43.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.412 0.625 . . . . 1.0 110.41 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -84.04 119.34 73.24 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.771 -0.649 . . . . 1.0 110.078 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.98 141.35 83.68 Favored 'Trans proline' 0 C--O 1.252 1.203 0 C-N-CA 122.365 2.043 . . . . 1.0 111.092 177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.43 ' HB3' ' HG2' ' A' ' 61' ' ' ARG . 29.1 m-20 -93.02 159.77 34.98 Favored Pre-proline 0 C--N 1.311 -1.096 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.343 -175.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -76.92 15.15 1.17 Allowed 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 122.565 2.177 . . . . 1.0 111.455 174.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.43 ' HG2' ' HB3' ' A' ' 59' ' ' ASP . 10.9 mmm180 -84.17 -40.35 18.27 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.382 -0.97 . . . . 1.0 108.382 176.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.535 ' O ' ' HB2' ' A' ' 112' ' ' CYS . 68.8 p -94.51 -8.97 36.81 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 114.702 -1.135 . . . . 1.0 111.167 -172.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 110' ' ' VAL . 2.3 pp -143.77 161.72 37.87 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 114.662 -1.154 . . . . 1.0 109.908 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.532 ' OD1' ' HB2' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -115.02 157.7 23.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 109.114 -0.699 . . . . 1.0 109.114 -177.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.09 121.87 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 108.489 -0.93 . . . . 1.0 108.489 174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -91.55 112.72 24.75 Favored 'General case' 0 N--CA 1.41 -2.459 0 N-CA-C 105.792 -1.929 . . . . 1.0 105.792 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.606 ' CE2' HG11 ' A' ' 101' ' ' VAL . 2.8 t-105 -86.49 128.72 34.99 Favored 'General case' 0 N--CA 1.388 -3.572 0 CA-C-N 115.672 -0.695 . . . . 1.0 109.906 -177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.98 89.84 3.18 Favored 'General case' 0 N--CA 1.413 -2.297 0 N-CA-C 108.623 -0.881 . . . . 1.0 108.623 -178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 72.4 m -90.1 -17.07 28.36 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.428 -0.909 . . . . 1.0 109.409 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.25 -46.88 3.48 Favored Glycine 0 C--N 1.309 -0.969 0 CA-C-N 114.998 -1.001 . . . . 1.0 112.306 178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -61.35 -27.06 41.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.146 0.578 . . . . 1.0 111.439 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.496 ' HB3' ' CE1' ' A' ' 99' ' ' TYR . . . -124.08 4.37 8.61 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.584 0.707 . . . . 1.0 109.775 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.13 -130.43 10.23 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.882 -1.054 . . . . 1.0 113.55 177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -118.34 123.97 46.63 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 125.144 1.377 . . . . 1.0 108.665 -179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -132.05 148.43 52.5 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 12.5 mm -94.55 116.11 35.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 C-N-CA 120.282 -0.567 . . . . 1.0 109.616 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.488 HD22 ' CE3' ' A' ' 67' ' ' TRP . 10.1 mp -111.03 158.02 19.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.614 -0.721 . . . . 1.0 111.061 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 m -158.0 159.7 36.69 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.851 -1.907 . . . . 1.0 105.851 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.531 ' O ' ' HA ' ' A' ' 93' ' ' LEU . 17.7 p-10 -66.71 -53.74 30.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.237 -0.585 . . . . 1.0 110.384 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -131.01 107.08 8.83 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.596 -0.891 . . . . 1.0 108.596 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.48 ' HB3' ' H ' ' A' ' 82' ' ' VAL . 11.5 t70 -169.49 -84.9 0.01 OUTLIER 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 121.721 0.772 . . . . 1.0 111.121 178.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.48 ' H ' ' HB3' ' A' ' 81' ' ' ASP . 2.5 p -74.96 -13.07 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.645 0 CA-C-N 113.889 -1.505 . . . . 1.0 112.956 -170.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.1 t -120.87 -1.95 9.85 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 119.554 -0.858 . . . . 1.0 110.744 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.476 ' HA ' ' HB2' ' A' ' 92' ' ' ARG . 19.0 p -100.6 96.69 7.53 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-O 121.42 0.629 . . . . 1.0 112.333 -171.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -121.23 128.88 52.85 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 108.162 -1.051 . . . . 1.0 108.162 172.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . 20.3 m -85.52 90.14 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.523 0 CA-C-O 123.462 1.601 . . . . 1.0 109.608 -176.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -118.24 12.98 13.63 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 112.724 -2.035 . . . . 1.0 111.506 -172.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.39 -43.16 1.51 Allowed Glycine 0 CA--C 1.47 -2.722 0 N-CA-C 108.924 -1.67 . . . . 1.0 108.924 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.2 mt -65.72 -34.39 78.09 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.467 -1.309 . . . . 1.0 107.467 172.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.675 ' HA ' ' HA ' ' A' ' 86' ' ' VAL 0.343 55.4 p90 60.71 -59.53 0.08 Allowed 'General case' 0 CA--C 1.479 -1.778 0 C-N-CA 129.426 3.09 . . . . 1.0 115.222 177.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -95.22 125.92 40.18 Favored 'General case' 1 C--N 1.24 -4.162 0 CA-C-N 115.442 -0.799 . . . . 1.0 110.101 -174.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 84' ' ' SER . 74.6 mmt-85 -147.82 103.06 3.47 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.273 0.559 . . . . 1.0 110.642 177.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 79' ' ' ASP . 89.0 mt -102.83 142.59 33.7 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.902 -1.147 . . . . 1.0 107.902 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -73.6 143.21 46.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.239 -0.585 . . . . 1.0 110.646 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 1.0 OUTLIER -120.58 165.96 14.3 Favored 'General case' 0 N--CA 1.416 -2.166 0 C-N-CA 124.641 1.176 . . . . 1.0 108.799 179.132 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.457 HD13 HG22 ' A' ' 101' ' ' VAL . 2.6 pp -65.39 -28.53 69.33 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.268 -0.973 . . . . 1.0 109.476 173.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.507 ' HG2' ' OG1' ' A' ' 95' ' ' THR . 0.1 OUTLIER -64.41 -25.93 68.23 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.249 -0.432 . . . . 1.0 111.483 177.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -64.72 -39.4 93.58 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.992 -0.744 . . . . 1.0 108.992 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.496 ' CE1' ' HB3' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -88.5 -19.22 26.72 Favored 'General case' 0 CA--C 1.568 1.644 0 CA-C-N 115.506 -0.77 . . . . 1.0 109.79 176.273 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 100' ' ' LYS . 9.3 mmmm 53.03 60.83 3.51 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.77 0.828 . . . . 1.0 110.957 -171.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 67' ' ' TRP . 1.3 m -76.62 150.46 82.0 Favored Pre-proline 0 C--N 1.312 -1.055 0 N-CA-C 113.185 0.809 . . . . 1.0 113.185 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -78.31 162.12 28.41 Favored 'Trans proline' 0 C--O 1.248 0.997 0 C-N-CA 123.501 2.801 . . . . 1.0 111.307 174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -66.19 130.97 45.06 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.611 0.719 . . . . 1.0 109.748 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.42 17.74 44.75 Favored Glycine 0 C--N 1.284 -2.313 0 CA-C-N 114.979 -1.01 . . . . 1.0 111.58 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.64 151.89 36.79 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 109.996 -0.372 . . . . 1.0 109.996 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 43.7 m -108.0 127.65 53.96 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-O 121.213 0.53 . . . . 1.0 110.995 -174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.402 HG13 HD11 ' A' ' 11' ' ' LEU . 31.5 m -109.74 141.36 25.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 N-CA-C 109.04 -0.726 . . . . 1.0 109.04 176.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.79 52.66 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.703 0.763 . . . . 1.0 110.596 177.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.684 ' H ' ' HA ' ' A' ' 15' ' ' LEU . 9.3 tt -95.18 122.91 38.35 Favored 'General case' 0 C--N 1.265 -3.108 0 CA-C-N 114.875 -1.057 . . . . 1.0 109.319 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.522 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 13.7 m -128.05 145.39 55.17 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.583 -0.525 . . . . 1.0 109.583 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.15 55.95 5.24 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.875 2.384 . . . . 1.0 113.511 -175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 62' ' ' THR . 0.1 OUTLIER 58.96 82.54 0.14 Allowed 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 124.586 1.154 . . . . 1.0 111.233 -179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.5 mt -122.39 -42.29 2.36 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.806 -1.088 . . . . 1.0 111.584 -176.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 8.8 t -127.87 24.55 6.05 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 114.356 1.243 . . . . 1.0 114.356 -170.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 34.0 ttpt -69.92 130.42 42.18 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.046 -0.662 . . . . 1.0 111.228 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -54.85 145.45 19.82 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 125.588 1.555 . . . . 1.0 111.413 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.6 160.87 31.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.67 -0.863 . . . . 1.0 108.67 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 90.3 mt -105.4 109.17 21.05 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.178 0.513 . . . . 1.0 110.831 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -144.04 -27.46 0.52 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.554 -0.748 . . . . 1.0 110.945 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -143.45 86.57 1.9 Allowed 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.39 0.614 . . . . 1.0 110.385 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -124.78 129.39 50.36 Favored 'General case' 0 N--CA 1.419 -1.981 0 N-CA-C 107.543 -1.281 . . . . 1.0 107.543 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 . . . . . 0 C--N 1.28 -2.438 0 N-CA-C 108.334 -0.987 . . . . 1.0 108.334 176.027 . . . . . . . . 0 0 . 1 stop_ save_